Alkaptonuria	fumarylacetoacetate-hydrolase	True Negative	1.807	10518553	<strong class="title">Manning K, Al-Dhalimy M, Finegold M, Grompe M: In vivo suppressor <span class="tagged-filter" title="Association Word">mutations</span> correct a murine model of <span class="tagged-disease" title="UMLS Concept ID: C0268490">hereditary tyrosinemia type I.</span> Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11928-33.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0268490">Hereditary tyrosinemia type I</span> and <span class="tagged-query" title="Query">alkaptonuria</span> are <span class="tagged-disease" title="UMLS Concept ID: C0751438">disorders of</span> <span class="tagged-metabolite" title="HMDB: HMDB00158"><span class="tagged-gene" title="SwissProt ID: P16930; Entrez Gene ID: 2184; HGNC ID: 3579; HPRD ID: 02040; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00158">tyrosine</a></span> catabolism <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">deficiency</span> of <a href="http://beta.uniprot.org/uniprot/P16930">fumarylacetoacetate hydrolase</a></span> <span class="tagged-gene" title="SwissProt ID: O15360; Entrez Gene ID: 2175; HGNC ID: 3582; HPRD ID: 06186; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15360">(FAH)</a></span> and <span class="tagged-gene" title="SwissProt ID: Q8WW71; Entrez Gene ID: 3081; HGNC ID: 4892; HPRD ID: 06315; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WW71">homogentisic acid dioxygenase</a></span> <span class="tagged-gene" title="SwissProt ID: Q8WW71; Entrez Gene ID: 3081; HGNC ID: 4892; HPRD ID: 06315; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WW71">(HGD),</a></span> respectively. <span class="tagged-disease" title="UMLS Concept ID: C0268483">Tyrosinemia</span> is a severe childhood disease that affects the liver and kidneys, but <span class="tagged-query" title="Query">alkaptonuria</span> is a more benign adult disorder in comparison. Because <span class="tagged-gene" title="SwissProt ID: Q8WW71; Entrez Gene ID: 3081; HGNC ID: 4892; HPRD ID: 06315; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WW71">HGD</a></span> is upstream of <span class="tagged-gene" title="SwissProt ID: O15360; Entrez Gene ID: 2175; HGNC ID: 3582; HPRD ID: 06186; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15360">FAH</a></span> in the <span class="tagged-metabolite" title="HMDB: HMDB00158"><span class="tagged-gene" title="SwissProt ID: Q8WW71; Entrez Gene ID: 3081; HGNC ID: 4892; HPRD ID: 06315; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00158">tyrosine</a></span> pathway, mice doubly mutant in both enzymes were found to be protected from the liver and renal damage of <span class="tagged-disease" title="UMLS Concept ID: C0268483">tyrosinemia</span> as hypothesized. Mice mutant at the tyrosinemic <span class="tagged-filter" title="Association Word">locus</span> but heterozygous for <span class="tagged-query" title="Query">alkaptonuria</span> spontaneously developed clonal nodules of functionally normal hepatocytes that were able to rescue the livers of some mice with this genotype. This phenotypic rescue was a result of an inactivating <span class="tagged-filter" title="Association Word">mutation</span> of the wild-type <a href="http://beta.uniprot.org/uniprot/Q8WW71">homogentisic acid dioxygenase</a></span> <span class="tagged-filter" title="Association Word">gene,</span> thus presenting an example of an in vivo suppressor <span class="tagged-filter" title="Association Word">mutation</span> in a mammalian model.
Alkaptonuria	4-hydroxyphenylpyruvate-dioxygenase	True Negative	1.807	15931605	<strong class="title">Suwannarat P, O'Brien K, Perry MB, Sebring N, Bernardini I, Kaiser-Kupfer MI, Rubin BI, Tsilou E, Gerber LH, Gahl WA: Use of <span class="tagged-drug" title="DrugBank: APRD01141"><span class="tagged-gene" title="SwissProt ID: Q8WW71; Entrez Gene ID: 3081; HGNC ID: 4892; HPRD ID: 06315; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">nitisinone</a></span> in patients with <span class="tagged-query" title="Query">alkaptonuria.</span> Metabolism. 2005 Jun;54(6):719-28.</strong> <span class="tagged-query" title="Query">Alkaptonuria,</span> a rare <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> disorder <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <a href="http://beta.uniprot.org/uniprot/Q8WW71">HGD</a></span> <span class="tagged-filter" title="Association Word">gene</span> and <span class="tagged-query" title="Query">deficiency of homogentisate 1,2 dioxygenase,</span> is characterized by <span class="tagged-disease" title="UMLS Concept ID: C0028817">ochronosis,</span> <span class="tagged-disease" title="UMLS Concept ID: C1559996">arthritis,</span> and daily excretion of gram quantities of <span class="tagged-metabolite" title="HMDB: HMDB00130"><span class="tagged-gene" title="SwissProt ID: P32754; Entrez Gene ID: 3242; HGNC ID: 5147; HPRD ID: 02041; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00130">homogentisic acid</a></span> (HGA). <span class="tagged-drug" title="DrugBank: APRD01141"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">Nitisinone,</a></span> an inhibitor of the <span class="tagged-filter" title="Association Word">enzyme</span> <a href="http://beta.uniprot.org/uniprot/P32754">4-hydroxyphenylpyruvate dioxygenase,</a></span> can drastically reduce urinary excretion of HGA in individuals with <span class="tagged-query" title="Query">alkaptonuria.</span> We investigated the safety and the HGA-depleting efficacy of <span class="tagged-drug" title="DrugBank: APRD01141"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">nitisinone</a></span> in an open-label, single-center study of 9 <span class="tagged-query" title="Query">alkaptonuria</span> patients (5 women, 4 men; 35-69 years of age) over the course of 3 to 4 months. Each patient received <span class="tagged-drug" title="DrugBank: APRD01141"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">nitisinone</a></span> in incremental doses, 0.35 mg bid followed by 1.05 mg bid, and remained on this dosage and a regular diet for 3 months. <span class="tagged-drug" title="DrugBank: APRD01141"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">Nitisinone</a></span> reduced urinary HGA levels from an average of 4.0 +/- 1.8 (SD) g/day to 0.2 +/- 0.2 g/day ( P < .001). The average plasma <span class="tagged-metabolite" title="HMDB: HMDB00158"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00158">tyrosine</a></span> concentration, initially 68 +/- 18 mmicro mol/L, rose to 760 +/- 181 micro mol/L ( P < .001). During the final week of the study, 5 patients adhered to a <span class="tagged-filter" title="Association Word">protein</span>-restricted diet (40 g/day), and their mean plasma <span class="tagged-metabolite" title="HMDB: HMDB00158"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00158">tyrosine</a></span> level fell from 755 +/- 167 to 603 +/- 114 mu mol/L. Six of the 7 patients who received <span class="tagged-drug" title="DrugBank: APRD01141"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">nitisinone</a></span> for more than 1 week reported decreased pain in their affected joints. Weekly ophthalmologic examinations showed no signs of corneal toxicity. Adverse events included the passing of <span class="tagged-disease" title="UMLS Concept ID: C0022650">kidney stones,</span> the recognition of symptoms <span class="tagged-filter" title="Association Word">related</span> to <span class="tagged-disease" title="UMLS Concept ID: C0003507">aortic stenosis,</span> and elevation of liver transaminase levels. We conclude that low-dose <span class="tagged-drug" title="DrugBank: APRD01141"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">nitisinone</a></span> effectively reduced urinary HGA levels in patients with <span class="tagged-query" title="Query">alkaptonuria.</span> Future long-term clinical trials are planned to determine the benefits of <span class="tagged-drug" title="DrugBank: APRD01141"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01141">nitisinone</a></span> in preventing joint deterioration and providing pain relief, and its long-term side effects.
Alkaptonuria	HLA-complex	True Negative	1.807	300896	<strong class="title">Gaucher A, Netter P, Fuare G, Raffoux C, Chanson B, Baumgartner J, Psurel J, Streiff F: <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">[HLA</a></span>-<span class="tagged-gene" title="SwissProt ID: Q8TCY5; Entrez Gene ID: 56246; HGNC ID: 1304; HPRD ID: 10758; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8TCY5">B27</a></span> <span class="tagged-filter" title="Association Word">antigen</span> and <span class="tagged-query" title="Query">alkaptonuria]</span> . Rev Rhum Mal Osteoartic. 1977 Apr;44(4):273-7.</strong> Study of urinary <span class="tagged-metabolite" title="HMDB: HMDB00130"><span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00130">homogentisic acid</a></span> and a determinantion of group <a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> were carried out for 36 members of a family spread over three generations with three cases of ochronotic <span class="tagged-disease" title="UMLS Concept ID: C0035435">rheumatism</span> in the second generation. <span class="tagged-query" title="Query">Alkaptonuria</span> was discovered in seven other subjects, six of them members of the third generation: urinary elimination was poor, less than 0.60 g/24 hours. There is a certain degree of consanguinity in the family studied here and these findings do not therefore rule out a <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-filter" title="Association Word">autosomal</span> transmission of the <span class="tagged-query" title="Query">alkaptonuria.</span> They do however <span class="tagged-filter" title="Association Word">lead</span> to the consideration that <span class="tagged-query" title="Query">alkaptonuria</span> may sometimes be found in heterozygotic subjects. A genetic relationship between <span class="tagged-gene" title="Protein Family or Complex">HLA complex</span> and <span class="tagged-query" title="Query">alkaptonuria</span> can only be claimed with difficulty from this familial study, but the high frequency of B 27 <span class="tagged-filter" title="Association Word">antigen</span> (29 out of 36 members carring it) leaves room for the hypothesis that the B 27 <span class="tagged-filter" title="Association Word">gene,</span> or more precisely a <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">associated</span> with the B 27 <span class="tagged-filter" title="Association Word">gene,</span> plays a part in the development of ochronotic <span class="tagged-disease" title="UMLS Concept ID: C0035435">rheumatism.</span>
Alkaptonuria	collagen	True Negative	1.807	3180550	<strong class="title">Forslind K, Wollheim FA, Akesson B, Rydholm U: <span class="tagged-query" title="Query">Alkaptonuria</span> and <span class="tagged-disease" title="UMLS Concept ID: C0028817">ochronosis</span> in three siblings. Clin Exp Rheumatol. 1988 Jul-Sep;6(3):289-92.</strong> <span class="tagged-metabolite" title="HMDB: HMDB00044"><span class="tagged-gene" title="SwissProt ID: Q5TAT6; Entrez Gene ID: 1305; HGNC ID: 2190; HPRD ID: 00383; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00044">Ascorbic acid</a></span> treatment monitored by urinary HGA excretion. Patients with <span class="tagged-query" title="Query">alkaptonuria</span> lack <span class="tagged-metabolite" title="HMDB: HMDB00130"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00130">homogentisate</a></span> 1,2-dioxygenase <span class="tagged-filter" title="Association Word">leading</span> to retention of homogentistic acid (HGA) in body fluids and eventually to tissue deposition of oxidation products, giving rise to the clinical picture of <span class="tagged-disease" title="UMLS Concept ID: C0028817">ochronosis.</span> <span class="tagged-metabolite" title="HMDB: HMDB00044"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00044">Ascorbic acid</a></span> is a known inhibitor of the <span class="tagged-filter" title="Association Word">enzyme</span> which catalyses the oxidation of <span class="tagged-metabolite" title="HMDB: HMDB00130"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00130">homogentisic acid</a></span> (HGA) to the polymer with affinity for <a href="http://beta.uniprot.org/uniprot/Q5TAT6">collagen</a></span> and was used in the treatment of three siblings with <span class="tagged-query" title="Query">alkaptonuria.</span> <span class="tagged-metabolite" title="HMDB: HMDB00044"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00044">Ascorbic acid</a></span> 500 mg bid was administered for 12 months. Two of the siblings tolerated the treatment, and in one the symptoms improved, whereas in the other they worsened. Plasma and urinary levels of HGA were monitored with a new HPLC method. <span class="tagged-metabolite" title="HMDB: HMDB00044"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00044">Ascorbic acid</a></span> is not effective in the treatment of symptomatic <span class="tagged-disease" title="UMLS Concept ID: C0028817">ochronosis.</span>
Cylindromatosis	APOA4	True Negative	1.025	16969477	<strong class="title">Kim M, Lee S, Yang SK, Song K, Lee I: Differential <span class="tagged-filter" title="Association Word">expression</span> in histologically normal crypts of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> suggests primary crypt disorder. Oncol Rep. 2006 Oct;16(4):663-70.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0009324">Ulcerative colitis</span> is characterized by crypt infiltration particularly of neutrophils. However, it is not known whether it reflects a primary crypt disorder or a secondary inflammatory response. In this study, we analyzed the <span class="tagged-filter" title="Association Word">expression</span> profiles of histologically normal crypts microdissected from formalin-fixed biopsies of early stage <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span> Total RNAs were extracted, amplified, and applied to Affymetrix GeneChip (R) X3P Array. For the control, similar crypts from nonspecific <span class="tagged-disease" title="UMLS Concept ID: C0156147">colitis</span> biopsies were applied. A total of 353 (4.3%) and 111 (1.4%) <span class="tagged-filter" title="Association Word">genes</span> were > 3 times up-, and down-regulated in <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span> Up-regulated <span class="tagged-filter" title="Association Word">genes</span> included <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">FCGBP</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">(Fc fragment of IgG binding protein),</a></span> <span class="tagged-gene" title="SwissProt ID: P62937; Entrez Gene ID: 5478; HGNC ID: 9253; HPRD ID: 00457; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62937">cyclophilin A,</a></span> <span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> (C-X-C motif) ligand 3, and <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">associated</span> with lipid metabolism. Down-regulated <span class="tagged-filter" title="Association Word">genes</span> included <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">APOA4</a></span> <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">(apolipoprotein A-IV),</a></span> <span class="tagged-query" title="Query">cylindromatosis,</span> <span class="tagged-gene" title="SwissProt ID: Q9HD36; Entrez Gene ID: 10017; HGNC ID: 993; HPRD ID: 06071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HD36">BCL2-like 10,</a></span> <span class="tagged-gene" title="SwissProt ID: P56748; Entrez Gene ID: 9073; HGNC ID: 2050; HPRD ID: 10835; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56748">claudin 8,</a></span> and numerous transcriptional regulators. <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">FCGBP</a></span> and <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">APOA4</a></span> have been implicated in <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> previously. Our data show differential <span class="tagged-filter" title="Association Word">expression</span> in the crypt epithelia of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> before active inflammation is initiated, suggesting primary crypt abnormalities that might be implicated in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span>
Cylindromatosis	IkappaB-kinase	True Negative	1.025	16301742	<strong class="title">Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM: <span class="tagged-disease" title="UMLS Concept ID: C0043407">Yersinia</span> virulence factor YopJ acts as a deubiquitinase to inhibit <span class="tagged-gene" title="SwissProt ID: P19838; Entrez Gene ID: 4790; HGNC ID: 7794; HPRD ID: 01238; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19838">NF-kappa B</a></span> activation. J Exp Med. 2005 Nov 21;202(10):1327-32.</strong> The bacterial pathogens of the genus <span class="tagged-disease" title="UMLS Concept ID: C0043407">Yersinia,</span> the causative agents of <span class="tagged-disease" title="UMLS Concept ID: C0032064">plague,</span> <span class="tagged-disease" title="UMLS Concept ID: C0809955">septicemia,</span> and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor kappaB (NF-kappaB) and <span class="tagged-gene" title="Protein Family or Complex">mitogen-activated protein kinase</span> pathways, which might be important for evasion of the host immune response and aid in establishing a <span class="tagged-disease" title="UMLS Concept ID: C0243026">systemic infection.</span> Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> moieties from critical <span class="tagged-filter" title="Association Word">proteins,</span> such as <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha.</a></span> In contrast to the <span class="tagged-query" title="Query">cylindromatosis</span> tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> which attenuates NF-kappaB signaling by selectively removing K63-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin</a></span> chains that activate <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase,</a></span> YopJ also cleaves K48-<span class="tagged-filter" title="Association Word">linked</span> chains and thereby inhibits proteasomal degradation of <span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha.</a></span> YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular <span class="tagged-filter" title="Association Word">proteins</span> and cleaved both K48- and K63-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin.</a></span> Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> of purified YopJ.
Cylindromatosis	IkappaB-kinase	True Negative	1.025	15226292	<strong class="title">Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD: NF-kappaB is essential for induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem. 2004 Aug 27;279(35):36171-4. Epub 2004 Jun 28.</strong> The transcription factor NF-kappaB regulates <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inflammatory and immune responses, <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis,</span> and apoptosis. In contrast to the pleiotropic stimuli that <span class="tagged-filter" title="Association Word">lead</span> to its positive <span class="tagged-filter" title="Association Word">regulation,</span> the known signaling mechanisms that underlie the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB are very few. Recent studies have identified the tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> loss of which <span class="tagged-filter" title="Association Word">causes</span> a benign human syndrome called <span class="tagged-query" title="Query">cylindromatosis,</span> as a key negative regulator for NF-kappaB signaling by deubiquitinating <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)</a></span> receptor-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF) 2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO</a></span> (NF-kappaB essential modulator, also known as <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> gamma). However, how <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is regulated remains unknown. The present study revealed a novel autoregulatory feedback pathway through which activation of NF-kappaB by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and bacterium nontypeable Haemophilus influenzae (NTHi) induces <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> that in turn <span class="tagged-filter" title="Association Word">leads</span> to the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB signaling. In addition, <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> appear to be differentially <span class="tagged-filter" title="Association Word">involved</span> in NF-kappaB-dependent induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and NTHi. These findings provide novel insights into the autoregulation of NF-kappaB activation.
Cylindromatosis	IkappaB-kinase	True Negative	1.025	12917691	<strong class="title">Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G: The tumour suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003 Aug 14;424(6950):801-5.</strong> NF-kappaB transcription factors have key <span class="tagged-filter" title="Association Word">roles</span> in inflammation, immune response, oncogenesis and protection against apoptosis. In most cells, these factors are kept inactive in the cytoplasm through <span class="tagged-filter" title="Association Word">association</span> with IkappaB inhibitors. After stimulation by various reagents, IkappaB is phosphorylated by the <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> <span class="tagged-gene" title="Protein Family or Complex">(IKK) complex</span> and degraded by the <span class="tagged-gene" title="Protein Family or Complex">proteasome,</span> allowing NF-kappaB to translocate to the nucleus and activate its target <span class="tagged-filter" title="Association Word">genes.</span> Here we report that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> a tumour suppressor that is <span class="tagged-filter" title="Association Word">mutated</span> in familial <span class="tagged-query" title="Query">cylindromatosis,</span> interacts with <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO,</a></span> the regulatory subunit of <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK.</a></span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> also interacts directly with <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour-necrosis</span> factor receptor (TNFR)-<span class="tagged-filter" title="Association Word">associated</span> factor 2 <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF2),</a></span> an adaptor molecule <span class="tagged-filter" title="Association Word">involved</span> in signalling by members of the family of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span>/<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">nerve growth factor</a></span> receptors. <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> has deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> that is directed towards non-K48-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin</a></span> chains, and negatively modulates TRAF-mediated activation of <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK,</a></span> strengthening the notion that ubiquitination is <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK</a></span> activation by TRAFs and suggesting that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> functions in this process. Truncations of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> found in <span class="tagged-query" title="Query">cylindromatosis</span> result in reduced enzymatic <span class="tagged-filter" title="Association Word">activity,</span> indicating a link between impaired deubiquitination of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> substrates and human pathophysiology.
Cylindromatosis	IkappaBalpha	True Negative	1.025	16301742	<strong class="title">Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM: <span class="tagged-disease" title="UMLS Concept ID: C0043407">Yersinia</span> virulence factor YopJ acts as a deubiquitinase to inhibit <span class="tagged-gene" title="SwissProt ID: P19838; Entrez Gene ID: 4790; HGNC ID: 7794; HPRD ID: 01238; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19838">NF-kappa B</a></span> activation. J Exp Med. 2005 Nov 21;202(10):1327-32.</strong> The bacterial pathogens of the genus <span class="tagged-disease" title="UMLS Concept ID: C0043407">Yersinia,</span> the causative agents of <span class="tagged-disease" title="UMLS Concept ID: C0032064">plague,</span> <span class="tagged-disease" title="UMLS Concept ID: C0809955">septicemia,</span> and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor kappaB (NF-kappaB) and <span class="tagged-gene" title="Protein Family or Complex">mitogen-activated protein kinase</span> pathways, which might be important for evasion of the host immune response and aid in establishing a <span class="tagged-disease" title="UMLS Concept ID: C0243026">systemic infection.</span> Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> moieties from critical <span class="tagged-filter" title="Association Word">proteins,</span> such as <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha.</a></span> In contrast to the <span class="tagged-query" title="Query">cylindromatosis</span> tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> which attenuates NF-kappaB signaling by selectively removing K63-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin</a></span> chains that activate <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase,</a></span> YopJ also cleaves K48-<span class="tagged-filter" title="Association Word">linked</span> chains and thereby inhibits proteasomal degradation of <span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha.</a></span> YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular <span class="tagged-filter" title="Association Word">proteins</span> and cleaved both K48- and K63-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin.</a></span> Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> of purified YopJ.
Cylindromatosis	BCL2-like-10	True Negative	1.025	16969477	<strong class="title">Kim M, Lee S, Yang SK, Song K, Lee I: Differential <span class="tagged-filter" title="Association Word">expression</span> in histologically normal crypts of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> suggests primary crypt disorder. Oncol Rep. 2006 Oct;16(4):663-70.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0009324">Ulcerative colitis</span> is characterized by crypt infiltration particularly of neutrophils. However, it is not known whether it reflects a primary crypt disorder or a secondary inflammatory response. In this study, we analyzed the <span class="tagged-filter" title="Association Word">expression</span> profiles of histologically normal crypts microdissected from formalin-fixed biopsies of early stage <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span> Total RNAs were extracted, amplified, and applied to Affymetrix GeneChip (R) X3P Array. For the control, similar crypts from nonspecific <span class="tagged-disease" title="UMLS Concept ID: C0156147">colitis</span> biopsies were applied. A total of 353 (4.3%) and 111 (1.4%) <span class="tagged-filter" title="Association Word">genes</span> were > 3 times up-, and down-regulated in <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span> Up-regulated <span class="tagged-filter" title="Association Word">genes</span> included <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">FCGBP</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">(Fc fragment of IgG binding protein),</a></span> <span class="tagged-gene" title="SwissProt ID: P62937; Entrez Gene ID: 5478; HGNC ID: 9253; HPRD ID: 00457; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62937">cyclophilin A,</a></span> <span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> (C-X-C motif) ligand 3, and <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">associated</span> with lipid metabolism. Down-regulated <span class="tagged-filter" title="Association Word">genes</span> included <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">APOA4</a></span> <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">(apolipoprotein A-IV),</a></span> <span class="tagged-query" title="Query">cylindromatosis,</span> <span class="tagged-gene" title="SwissProt ID: Q9HD36; Entrez Gene ID: 10017; HGNC ID: 993; HPRD ID: 06071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HD36">BCL2-like 10,</a></span> <span class="tagged-gene" title="SwissProt ID: P56748; Entrez Gene ID: 9073; HGNC ID: 2050; HPRD ID: 10835; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56748">claudin 8,</a></span> and numerous transcriptional regulators. <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">FCGBP</a></span> and <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">APOA4</a></span> have been implicated in <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> previously. Our data show differential <span class="tagged-filter" title="Association Word">expression</span> in the crypt epithelia of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> before active inflammation is initiated, suggesting primary crypt abnormalities that might be implicated in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span>
Cylindromatosis	toll-like-receptor-2	True Negative	1.025	16230348	<strong class="title">Yoshida H, Jono H, Kai H, Li JD: The tumor suppressor <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD)</a></span> acts as a negative regulator for <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">toll-like receptor 2</a></span> signaling via negative cross-talk with <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> AND <span class="tagged-gene" title="SwissProt ID: Q6Q0C0; Entrez Gene ID: 84231; HGNC ID: 20456; HPRD ID: 06977; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6Q0C0">TRAF7.</a></span> J Biol Chem. 2005 Dec 9;280(49):41111-21. Epub 2005 Oct 17.</strong> <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">Toll-like receptor 2</a></span> <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">(TLR2)</a></span> plays an important <span class="tagged-filter" title="Association Word">role</span> in host defense against bacterial pathogens. Activation of <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> signaling not only induces the activation of innate immunity and instructs the development of the acquired immunity but also <span class="tagged-filter" title="Association Word">leads</span> to the detrimental inflammatory responses in inflammatory and infectious diseases. To avoid detrimental inflammatory responses, <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> signaling must be tightly regulated. In contrast to the relative known positive regulation of <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> signaling, its negative <span class="tagged-filter" title="Association Word">regulation,</span> however, is largely unknown. In addition the distal signaling components that link <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> to its downstream signaling pathways have yet to be further defined. In the present study we have provided direct evidence for the negative <span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> signaling by the tumor suppressor <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD).</a></span> We showed that activation of <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> signaling by <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> ligands including peptidoglycan <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">(PGN),</a></span> MALP-2, and Pam3CSK4 induces activation of IKKs-<span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha</a></span> and <span class="tagged-gene" title="SwissProt ID: P46734; Entrez Gene ID: 5606; HGNC ID: 6843; HPRD ID: 03816; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P46734">MKK3</a></span>/6-<span class="tagged-gene" title="SwissProt ID: Q13155; Entrez Gene ID: 7965; HPRD ID: 02915; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13155">p38</a></span> pathways not only by <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> but also by <span class="tagged-gene" title="SwissProt ID: Q6Q0C0; Entrez Gene ID: 84231; HGNC ID: 20456; HPRD ID: 06977; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6Q0C0">TRAF7,</a></span> a recently identified TRAF family member. The activation of both pathways <span class="tagged-filter" title="Association Word">leads</span> to the transcription of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha,</a></span> IL-1beta, and <span class="tagged-gene" title="SwissProt ID: P10145; Entrez Gene ID: 3576; HGNC ID: 6025; HPRD ID: 00909; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10145">IL-8</a></span> as well as <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD.</a></span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> in turn <span class="tagged-filter" title="Association Word">leads</span> to the inhibition of <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> and <span class="tagged-gene" title="SwissProt ID: Q6Q0C0; Entrez Gene ID: 84231; HGNC ID: 20456; HPRD ID: 06977; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6Q0C0">TRAF7</a></span> likely via a deubiquitination-dependent mechanism. The present studies thus unveil a novel autoregulatory feedback mechanism that negatively controls <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span>-IKKs-<span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha</a></span>/<span class="tagged-gene" title="SwissProt ID: P46734; Entrez Gene ID: 5606; HGNC ID: 6843; HPRD ID: 03816; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P46734">MKK3</a></span>/6-<span class="tagged-gene" title="SwissProt ID: Q13155; Entrez Gene ID: 7965; HPRD ID: 02915; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13155">p38</a></span>-NF-kappaB-dependent induction of immune and inflammatory responses via negatively cross-talking with both <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> and <span class="tagged-gene" title="SwissProt ID: Q6Q0C0; Entrez Gene ID: 84231; HGNC ID: 20456; HPRD ID: 06977; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6Q0C0">TRAF7.</a></span> These findings provide novel insights into autoregulation and negative <span class="tagged-filter" title="Association Word">regulation</span> of TLR signaling.
Cylindromatosis	CYLD	True Positive	40.834	17495026	<strong class="title">Stegmeier F, Sowa ME, Nalepa G, Gygi SP, Harper JW, Elledge SJ: The tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> regulates entry into mitosis. Proc Natl Acad Sci U S A. 2007 May 22;104(21):8869-74. Epub 2007 May 10.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD)</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-disease" title="UMLS Concept ID: C0086692">benign tumors</span> of skin appendages, referred to as <span class="tagged-disease" title="UMLS Concept ID: C0010606">cylindromas.</span> The <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-filter" title="Association Word">gene</span> encodes a deubiquitinating <span class="tagged-filter" title="Association Word">enzyme</span> that removes <span class="tagged-metabolite" title="HMDB: HMDB00182"><span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00182">Lys</a></span>-63-<span class="tagged-filter" title="Association Word">linked</span> <a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> chains from I kappa B kinase signaling components and thereby inhibits NF-kappaB pathway activation. The dysregulation of NF-kappaB <span class="tagged-filter" title="Association Word">activity</span> has been proposed to promote cell transformation in part by increasing apoptosis resistance, but it is not clear whether this is CYLD's only or predominant tumor-suppressing function. Here, we show that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is also required for timely entry into mitosis. Consistent with a cell-cycle regulatory function, <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> localizes to microtubules in interphase and the midbody during telophase, and its <span class="tagged-filter" title="Association Word">protein</span> levels decrease as cells exit from mitosis. We identified the <span class="tagged-filter" title="Association Word">protein</span> kinase <span class="tagged-gene" title="SwissProt ID: P53350; Entrez Gene ID: 5347; HGNC ID: 9077; HPRD ID: 03652; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53350">Plk1</a></span> as a potential target of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> in the <span class="tagged-filter" title="Association Word">regulation</span> of mitotic entry, based on their physical interaction and similar loss-of-function and overexpression phenotypes. Our findings raise the possibility that, as with other <span class="tagged-filter" title="Association Word">genes</span> regulating <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis,</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> has not only tumor-suppressing (apoptosis <span class="tagged-filter" title="Association Word">regulation)</span> but also tumor-promoting activities (enhancer of mitotic entry). We propose that this additional function of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> could provide an explanation for the benign nature of most <span class="tagged-disease" title="UMLS Concept ID: C1305968">cylindroma</span> lesions.
Cylindromatosis	CYLD	True Positive	40.834	16922728	<strong class="title">Young AL, Kellermayer R, Szigeti R, Teszas A, Azmi S, Celebi JT: <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-filter" title="Association Word">mutations</span> underlie Brooke-Spiegler, familial <span class="tagged-query" title="Query">cylindromatosis,</span> and multiple familial <span class="tagged-disease" title="UMLS Concept ID: C0334261">trichoepithelioma</span> syndromes. Clin Genet. 2006 Sep;70(3):246-9.</strong> Brooke-Spiegler syndrome <span class="tagged-gene" title="SwissProt ID: P07359; Entrez Gene ID: 2811; HGNC ID: 4439; HPRD ID: 01976; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07359">(BSS),</a></span> familial <span class="tagged-query" title="Query">cylindromatosis</span> (FC), and multiple familial <span class="tagged-disease" title="UMLS Concept ID: C0334261">trichoepithelioma</span> <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">(MFT),</a></span> originally described as distinct inherited disorders, are characterized by a variety of skin appendage neoplasms. <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-filter" title="Association Word">gene</span> are found in individuals with these syndromes. We describe a single family with affected members exhibiting either the FC or the <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> phenotypes <span class="tagged-filter" title="Association Word">associated</span> with a <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-filter" title="Association Word">gene.</span> These findings support the notion that <span class="tagged-gene" title="SwissProt ID: P07359; Entrez Gene ID: 2811; HGNC ID: 4439; HPRD ID: 01976; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07359">BSS,</a></span> FC, and <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> represent phenotypic variation of a single defect. Of interest, one of the affected individuals described in this report exhibits a severe phenotype illustrating the morbidity of the disorder.
Cylindromatosis	CYLD	True Positive	40.834	16135788	<strong class="title">Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S: The <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1</a></span>- and <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM</a></span>-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> induces apoptosis by stimulating <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-query" title="Query">cylindromatosis</span> tumor suppressor <span class="tagged-filter" title="Association Word">gene.</span> Mol Cell Biol. 2005 Sep;25(18):7953-65.</strong> <span class="tagged-filter" title="Association Word">Mutation</span> of <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1,</a></span> <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM,</a></span> and their <span class="tagged-filter" title="Association Word">associated</span> factors, <span class="tagged-gene" title="SwissProt ID: Q12824; Entrez Gene ID: 6598; HGNC ID: 11103; HPRD ID: 03364; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12824">INI1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> in primary human tumors has suggested that inactivation of human <span class="tagged-gene" title="Protein Family or Complex">SWI/SNF</span> (hSWI/SNF) complexes may be <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-disease" title="UMLS Concept ID: C0007621">neoplastic transformation.</span> BT549 is an invasive human <span class="tagged-disease" title="UMLS Concept ID: C0678222">breast carcinoma</span> cell line that lacks <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> a key hSWI/SNF subunit that mediates interaction with transcriptional activators and corepressors. In this study we investigated the role of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in suppressing <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis</span> by establishing BT549 stable cell lines that expresses full-length <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> <span class="tagged-filter" title="Association Word">protein.</span> BT549 clones expressing <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> demonstrated marked phenotypic changes, slow growth kinetics, and restoration of contact inhibition. <span class="tagged-filter" title="Association Word">Altered</span> growth was found to be due in part to cell cycle arrest and induction of apoptosis. Furthermore, microarray analysis revealed that <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span>-mediated cell death was <span class="tagged-filter" title="Association Word">associated</span> with up-<span class="tagged-filter" title="Association Word">regulation</span> of proapoptotic <span class="tagged-filter" title="Association Word">genes</span> including the tumor suppressor familial <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD),</a></span> which was found to be a direct target of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> as determined by chromatin immunoprecipitation analysis. Increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> in BT549 cells induced apoptosis, while its suppression by small interfering RNA inhibited cell death in <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> expressing BT549 cells. These findings demonstrate the importance of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in cell growth <span class="tagged-filter" title="Association Word">regulation</span> and provide a novel link between hSWI/SNF chromatin remodelers and apoptosis.
Cylindromatosis	CYLD	True Positive	40.834	15854031	<strong class="title">Bowen S, Gill M, Lee DA, Fisher G, Geronemus RG, Vazquez ME, Celebi JT: <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-filter" title="Association Word">gene</span> in Brooke-Spiegler syndrome, familial <span class="tagged-query" title="Query">cylindromatosis,</span> and multiple familial <span class="tagged-disease" title="UMLS Concept ID: C0334261">trichoepithelioma:</span> lack of genotype-phenotype correlation. J Invest Dermatol. 2005 May;124(5):919-20.</strong> Brooke-Spiegler syndrome <span class="tagged-gene" title="SwissProt ID: P07359; Entrez Gene ID: 2811; HGNC ID: 4439; HPRD ID: 01976; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07359">(BSS),</a></span> familial <span class="tagged-query" title="Query">cylindromatosis</span> (FC), and multiple familial <span class="tagged-disease" title="UMLS Concept ID: C0334261">trichoepithelioma</span> <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">(MFT),</a></span> originally described as distinct entities, share overlapping clinical findings. Patients with <span class="tagged-gene" title="SwissProt ID: P07359; Entrez Gene ID: 2811; HGNC ID: 4439; HPRD ID: 01976; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07359">BSS</a></span> are predisposed to multiple skin appendage tumors such as <span class="tagged-disease" title="UMLS Concept ID: C1305968">cylindroma,</span> <span class="tagged-disease" title="UMLS Concept ID: C0334261">trichoepithelioma,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0334347">spiradenoma.</span> FC, however, is characterized by <span class="tagged-disease" title="UMLS Concept ID: C0010606">cylindromas</span> and <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> by trichoepitheliomas as the only tumor type. These disorders have recently been <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-filter" title="Association Word">gene.</span> In this report, we describe three families with <span class="tagged-gene" title="SwissProt ID: P07359; Entrez Gene ID: 2811; HGNC ID: 4439; HPRD ID: 01976; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07359">BSS,</a></span> one with FC, and two with <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> phenotypes <span class="tagged-filter" title="Association Word">associated</span> with novel and recurrent <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD.</a></span> We provide evidence that these disorders represent phenotypic variation of a single entity and lack genotype-phenotype correlation.
Cylindromatosis	CYLD	True Positive	40.834	15541090	<strong class="title">Oiso N, Mizuno N, Fukai K, Nakagawa K, Ishii M: Mild phenotype of familial <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-filter" title="Association Word">associated</span> with an R758X <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutation</span> in the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> tumour suppressor <span class="tagged-filter" title="Association Word">gene.</span> Br J Dermatol. 2004 Nov;151(5):1084-6.</strong> Familial <span class="tagged-query" title="Query">cylindromatosis</span> is a rare dominantly <span class="tagged-disease" title="UMLS Concept ID: C0019247">inherited disease</span> characterized by the development of multiple benign tumours of the skin appendages, including <span class="tagged-disease" title="UMLS Concept ID: C0010606">cylindromas,</span> trichoepitheliomas and spiradenomas. The <span class="tagged-filter" title="Association Word">gene</span> responsible was positionally cloned recently, and was designated <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD.</a></span> We describe a family with <span class="tagged-query" title="Query">cylindromatosis,</span> in which affected individuals have an inherited R758X <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutation</span> of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD.</a></span> Affected members of this family manifest a relatively mild tumour phenotype; the largest tumour was only 30 mm in diameter. Thus far, there is no evident genotype-phenotype relationship in <span class="tagged-query" title="Query">cylindromatosis,</span> although the number of families reported with both phenotypic and genotypic data remains small.
Cylindromatosis	CYLD	True Positive	40.834	15086550	<strong class="title">Zhang XJ, Liang YH, He PP, Yang S, Wang HY, Chen JJ, Yuan WT, Xu SJ, Cui Y, Huang W: Identification of the <span class="tagged-query" title="Query">cylindromatosis</span> tumor-suppressor <span class="tagged-filter" title="Association Word">gene</span> responsible for multiple familial <span class="tagged-disease" title="UMLS Concept ID: C0334261">trichoepithelioma.</span> J Invest Dermatol. 2004 Mar;122(3):658-64.</strong> Multiple familial <span class="tagged-disease" title="UMLS Concept ID: C0334261">trichoepithelioma</span> <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">(MFT)</a></span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-disease" title="UMLS Concept ID: C0037274">skin disease</span> characterized by the presence of many small <span class="tagged-disease" title="UMLS Concept ID: C0086692">benign tumors</span> with pilar differentiation predominantly on the face. The first <span class="tagged-filter" title="Association Word">locus</span> has been previously mapped to chromosome 9p21, but no <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> has been identified to date. To identify the disease <span class="tagged-filter" title="Association Word">gene</span> in a large Chinese family, we initially performed <span class="tagged-filter" title="Association Word">linkage</span> analysis with microsatellite <span class="tagged-filter" title="Association Word">markers</span> from 9p21, but failed to confirm the <span class="tagged-filter" title="Association Word">linkage</span> to this region. Previous publications showed <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> and familial <span class="tagged-query" title="Query">cylindromatosis</span> (FC) can occur within one family and in a single person. Therefore, we speculated that the <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLDI</a></span> <span class="tagged-filter" title="Association Word">gene)</span> responsible for FC may be <span class="tagged-filter" title="Association Word">related</span> to the pathogenesis of <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT.</a></span> In view of that, we genotyped all available individuals using 11 microsatellite <span class="tagged-filter" title="Association Word">markers</span> spanning the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLDI</a></span> <span class="tagged-filter" title="Association Word">gene</span> region at 16q12-q13. We identified the <span class="tagged-filter" title="Association Word">linkage</span> of <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> to this region. <span class="tagged-filter" title="Association Word">Mutation</span> analysis in the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLDI</a></span> <span class="tagged-filter" title="Association Word">gene</span> detected a <span class="tagged-disease" title="UMLS Concept ID: C0079380">frameshift mutation,</span> designated as c.2355-2358delCAGA. The study firstly identified the <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-filter" title="Association Word">gene</span> responsible for <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT</a></span> and showed that different <span class="tagged-filter" title="Association Word">mutations</span> of the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLDI</a></span> <span class="tagged-filter" title="Association Word">gene</span> can give rise to distinct clinical and histological <span class="tagged-filter" title="Association Word">expression</span> such as FC and <span class="tagged-gene" title="Entrez Gene ID: 8010; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8010">MFT.</a></span>
Cylindromatosis	CYLD	True Positive	40.834	14585643	<strong class="title">Wall NR, Shi Y: Small RNA: can RNA interference be exploited for therapy? . Lancet. 2003 Oct 25;362(9393):1401-3.</strong> CONTEXT: RNA interference (RNAi) is the sequence-specific <span class="tagged-filter" title="Association Word">gene</span>-silencing induced by double-stranded RNA (dsRNA), and gives information about <span class="tagged-filter" title="Association Word">gene</span> function quickly, easily, and inexpensively. The use of RNAi for genetic-based therapies is widely studied, especially in <span class="tagged-disease" title="UMLS Concept ID: C0042769">viral infections,</span> cancers, and inherited <span class="tagged-disease" title="UMLS Concept ID: C0019247">genetic disorders.</span> RNAi has been used to make tissue-specific knockdown mice for studying <span class="tagged-filter" title="Association Word">gene</span> function in a whole animal. Combined with genomics data, RNAi-directed <span class="tagged-filter" title="Association Word">gene</span>-silencing could allow functional determination of any <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">expressed</span> in a cell or pathway. The term RNAi came from the discovery that the injection of dsRNAs into Caenorhabditis elegans interferes with the <span class="tagged-filter" title="Association Word">expression</span> of specific <span class="tagged-filter" title="Association Word">genes</span> containing a complementary region to the delivered dsRNA. Although stalled for a time by the non-<span class="tagged-filter" title="Association Word">gene</span>-specific <span class="tagged-gene" title="Protein Family or Complex">interferon</span> response elicited by dsRNA molecules longer than about 30 nucleotides in mammalian cells, Tom Tuschl's group found that transfection of synthetic 21-nucleotide small-interfering RNA (siRNA) duplexes were highly selective and sequence-specific inhibitors of endogenous <span class="tagged-filter" title="Association Word">genes.</span> STARTING POINT: siRNA <span class="tagged-filter" title="Association Word">expression</span> has been studied with siRNA from plasmid and viral vectors that efficiently deliver siRNAs into both dividing and non-dividing cells, stem cells, zygotes, and their differentiated progeny. A collection of RNA interference vectors that suppress 50 human de-ubiquitinating enzymes allowed Thijn Brummelkamp and colleagues to study this <span class="tagged-filter" title="Association Word">gene</span> family and to identify de-ubiquitinating enzymes in cancer-relevant pathways (Nature 2003; 424: 797-801). These researchers found that the familial <span class="tagged-query" title="Query">cylindromatosis</span> tumour suppressor <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD),</a></span> previously of unknown function, could enhance the activation of the transcription factor NF-kappaB, <span class="tagged-filter" title="Association Word">leading</span> to increased resistance to apoptosis. They have now started to investigate the use of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> inhibitors in clinical trials. WHERE NEXT: The ability to efficiently and stably <span class="tagged-filter" title="Association Word">produce</span> and deliver sufficient amounts of siRNA to the proper target tissues require refinement before this new technology can be tried clinically. Initial in-vivo studies reported effective transgene suppression in adult mice by chemically synthesised siRNAs. More recently many researchers have used plasmid and viral vectors for transcription of short-hairpin RNAs, both in vitro and in vivo. With these <span class="tagged-filter" title="Association Word">expression</span> systems, gene expression was more stably inhibited than with the transient knockdown recorded with chemically synthesised siRNA. Human trials exploiting these latest findings are likely to soon follow.
Cylindromatosis	CYLD	True Positive	40.834	12917691	<strong class="title">Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G: The tumour suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003 Aug 14;424(6950):801-5.</strong> NF-kappaB transcription factors have key <span class="tagged-filter" title="Association Word">roles</span> in inflammation, immune response, oncogenesis and protection against apoptosis. In most cells, these factors are kept inactive in the cytoplasm through <span class="tagged-filter" title="Association Word">association</span> with IkappaB inhibitors. After stimulation by various reagents, IkappaB is phosphorylated by the <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> <span class="tagged-gene" title="Protein Family or Complex">(IKK) complex</span> and degraded by the <span class="tagged-gene" title="Protein Family or Complex">proteasome,</span> allowing NF-kappaB to translocate to the nucleus and activate its target <span class="tagged-filter" title="Association Word">genes.</span> Here we report that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> a tumour suppressor that is <span class="tagged-filter" title="Association Word">mutated</span> in familial <span class="tagged-query" title="Query">cylindromatosis,</span> interacts with <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO,</a></span> the regulatory subunit of <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK.</a></span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> also interacts directly with <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour-necrosis</span> factor receptor (TNFR)-<span class="tagged-filter" title="Association Word">associated</span> factor 2 <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF2),</a></span> an adaptor molecule <span class="tagged-filter" title="Association Word">involved</span> in signalling by members of the family of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span>/<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">nerve growth factor</a></span> receptors. <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> has deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> that is directed towards non-K48-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin</a></span> chains, and negatively modulates TRAF-mediated activation of <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK,</a></span> strengthening the notion that ubiquitination is <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK</a></span> activation by TRAFs and suggesting that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> functions in this process. Truncations of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> found in <span class="tagged-query" title="Query">cylindromatosis</span> result in reduced enzymatic <span class="tagged-filter" title="Association Word">activity,</span> indicating a link between impaired deubiquitination of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> substrates and human pathophysiology.
Cylindromatosis	CYLD	True Positive	40.834	12917690	<strong class="title">Brummelkamp TR, Nijman SM, Dirac AM, Bernards R: Loss of the <span class="tagged-query" title="Query">cylindromatosis</span> tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003 Aug 14;424(6950):797-801.</strong> <span class="tagged-filter" title="Association Word">Protein</span> modification by the conjugation of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> moieties--ubiquitination--plays a major part in many biological processes, including cell cycle and apoptosis. The enzymes that mediate <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-conjugation have been well-studied, but much less is known about the <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-specific proteases that mediate de-ubiquitination of cellular substrates. To study this <span class="tagged-filter" title="Association Word">gene</span> family, we designed a collection of RNA interference vectors to suppress 50 human de-ubiquitinating enzymes, and used these vectors to identify de-ubiquitinating enzymes in cancer-relevant pathways. We report here that inhibition of one of these enzymes, the familial <span class="tagged-query" title="Query">cylindromatosis</span> tumour suppressor <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD),</a></span> having no known function, enhances activation of the transcription factor NF-kappaB. We show that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> binds to the <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO</a></span> (also known as <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">IKKgamma)</a></span> component of the <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> <span class="tagged-gene" title="Protein Family or Complex">(IKK) complex,</span> and appears to regulate its <span class="tagged-filter" title="Association Word">activity</span> through de-ubiquitination of <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2,</a></span> as <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2</a></span> ubiquitination can be modulated by <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD.</a></span> Inhibition of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> increases resistance to apoptosis, suggesting a mechanism through which loss of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> contributes to oncogenesis. We show that this effect can be relieved by <span class="tagged-metabolite" title="HMDB: HMDB01879"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01879">aspirin</a></span> derivatives that inhibit NF-kappaB <span class="tagged-filter" title="Association Word">activity,</span> which suggests a therapeutic intervention strategy to restore growth control in patients suffering from familial <span class="tagged-query" title="Query">cylindromatosis.</span>
Cylindromatosis	CYLD	True Positive	40.834	12917689	<strong class="title">Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G: <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is a deubiquitinating <span class="tagged-filter" title="Association Word">enzyme</span> that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003 Aug 14;424(6950):793-6.</strong> Familial <span class="tagged-query" title="Query">cylindromatosis</span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> predisposition to tumours of skin appendages called <span class="tagged-disease" title="UMLS Concept ID: C0010606">cylindromas.</span> Familial <span class="tagged-query" title="Query">cylindromatosis</span> is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in a <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-filter" title="Association Word">protein</span> of previously unknown function. Here we show that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is a deubiquitinating <span class="tagged-filter" title="Association Word">enzyme</span> that negatively regulates activation of the transcription factor NF-kappaB by specific <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour-necrosis</span> factor receptors (TNFRs). Loss of the deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> correlates with <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis.</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> inhibits activation of NF-kappaB by the TNFR family members <span class="tagged-gene" title="SwissProt ID: P25942; Entrez Gene ID: 958; HGNC ID: 11919; HPRD ID: 00178; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25942">CD40,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9HAV5; Entrez Gene ID: 60401; HGNC ID: 17756; HPRD ID: 02230; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAV5">XEDAR</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9UNE0; Entrez Gene ID: 10913; HGNC ID: 2895; HPRD ID: 04974; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UNE0">EDAR</a></span> in a manner that depends on the deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD.</a></span> Downregulation of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> by RNA-mediated interference augments both basal and <span class="tagged-gene" title="SwissProt ID: P25942; Entrez Gene ID: 958; HGNC ID: 11919; HPRD ID: 00178; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25942">CD40</a></span>-mediated activation of NF-kappaB. The inhibition of NF-kappaB activation by <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is mediated, at least in part, by the deubiquitination and inactivation of TNFR-<span class="tagged-filter" title="Association Word">associated</span> factor 2 <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF2)</a></span> and, to a lesser extent, <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6.</a></span> These results indicate that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is a negative regulator of the <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span>-mediated activation of NF-kappaB that is required for appropriate cellular homeostasis of skin appendages.
Cylindromatosis	BRG1	True Negative	1.025	16135788	<strong class="title">Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S: The <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1</a></span>- and <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM</a></span>-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> induces apoptosis by stimulating <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-query" title="Query">cylindromatosis</span> tumor suppressor <span class="tagged-filter" title="Association Word">gene.</span> Mol Cell Biol. 2005 Sep;25(18):7953-65.</strong> <span class="tagged-filter" title="Association Word">Mutation</span> of <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1,</a></span> <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM,</a></span> and their <span class="tagged-filter" title="Association Word">associated</span> factors, <span class="tagged-gene" title="SwissProt ID: Q12824; Entrez Gene ID: 6598; HGNC ID: 11103; HPRD ID: 03364; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12824">INI1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> in primary human tumors has suggested that inactivation of human <span class="tagged-gene" title="Protein Family or Complex">SWI/SNF</span> (hSWI/SNF) complexes may be <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-disease" title="UMLS Concept ID: C0007621">neoplastic transformation.</span> BT549 is an invasive human <span class="tagged-disease" title="UMLS Concept ID: C0678222">breast carcinoma</span> cell line that lacks <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> a key hSWI/SNF subunit that mediates interaction with transcriptional activators and corepressors. In this study we investigated the role of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in suppressing <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis</span> by establishing BT549 stable cell lines that expresses full-length <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> <span class="tagged-filter" title="Association Word">protein.</span> BT549 clones expressing <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> demonstrated marked phenotypic changes, slow growth kinetics, and restoration of contact inhibition. <span class="tagged-filter" title="Association Word">Altered</span> growth was found to be due in part to cell cycle arrest and induction of apoptosis. Furthermore, microarray analysis revealed that <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span>-mediated cell death was <span class="tagged-filter" title="Association Word">associated</span> with up-<span class="tagged-filter" title="Association Word">regulation</span> of proapoptotic <span class="tagged-filter" title="Association Word">genes</span> including the tumor suppressor familial <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD),</a></span> which was found to be a direct target of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> as determined by chromatin immunoprecipitation analysis. Increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> in BT549 cells induced apoptosis, while its suppression by small interfering RNA inhibited cell death in <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> expressing BT549 cells. These findings demonstrate the importance of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in cell growth <span class="tagged-filter" title="Association Word">regulation</span> and provide a novel link between hSWI/SNF chromatin remodelers and apoptosis.
Cylindromatosis	integrin	True Negative	1.025	12714041	<strong class="title">Aumailley M, El Khal A, Knoss N, Tunggal L: <span class="tagged-gene" title="Protein Family or Complex">Laminin</span> 5 processing and its integration into the <span class="tagged-drug" title="DrugBank: APRD00264"><span class="tagged-gene" title="SwissProt ID: Q9UKX5; Entrez Gene ID: 22801; HGNC ID: 6136; HPRD ID: 05310; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00264">ECM.</a></span> . Matrix Biol. 2003 Mar;22(1):49-54.</strong> <span class="tagged-gene" title="Protein Family or Complex">Laminins</span> are a family of multi-functional basement membrane <span class="tagged-filter" title="Association Word">proteins.</span> Their C-terminal domain binds to cell surface receptors and is thereby responsible for cell anchorage and the initiation of specific outside-in and inside-out signals. With their N-terminal parts, <span class="tagged-gene" title="Protein Family or Complex">laminins</span> interact with <span class="tagged-filter" title="Association Word">proteins</span> of the extracellular matrix scaffold to secure the basement membrane to the underlying mesenchymal tissue. <span class="tagged-gene" title="Protein Family or Complex">Laminins</span> 5A (alpha3Abeta3gamma2), 5B (alpha3Bbeta3gamma2) and 6 (alpha3Abeta1gamma1) are isoforms specific of the basement membrane underneath the epidermis and they undergo a sequential series of extracellular proteolytic changes, which might successively turn on and off one or several of their biological and mechanical functions. Under physiological conditions, such as in adult human skin, epithelial <span class="tagged-gene" title="Protein Family or Complex">laminins</span> have lost part of the C- and N-terminal domains of the alpha3 and gamma2 chains, respectively. In contrast, in <span class="tagged-query" title="Query">cylindromatosis,</span> a rare <span class="tagged-disease" title="UMLS Concept ID: C0019247">inherited disease</span> characterised by major ultrastructural alterations of the basement membrane and <span class="tagged-filter" title="Association Word">altered</span> <span class="tagged-filter" title="Association Word">expression</span>/distribution of <a href="http://beta.uniprot.org/uniprot/Q9UKX5">integrin</a></span> receptors, <span class="tagged-gene" title="Protein Family or Complex">laminin</span> processing has not been completed. Together, these results suggest that <span class="tagged-gene" title="Protein Family or Complex">laminin</span> processing may regulate signalling pathways and the architecture of the basement membrane by restricting the repertoire of interactions with cell surface receptors and extracellular matrix components.
Cylindromatosis	ubiquitin	True Positive	3.500	16301742	<strong class="title">Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM: <span class="tagged-disease" title="UMLS Concept ID: C0043407">Yersinia</span> virulence factor YopJ acts as a deubiquitinase to inhibit <span class="tagged-gene" title="SwissProt ID: P19838; Entrez Gene ID: 4790; HGNC ID: 7794; HPRD ID: 01238; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19838">NF-kappa B</a></span> activation. J Exp Med. 2005 Nov 21;202(10):1327-32.</strong> The bacterial pathogens of the genus <span class="tagged-disease" title="UMLS Concept ID: C0043407">Yersinia,</span> the causative agents of <span class="tagged-disease" title="UMLS Concept ID: C0032064">plague,</span> <span class="tagged-disease" title="UMLS Concept ID: C0809955">septicemia,</span> and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor kappaB (NF-kappaB) and <span class="tagged-gene" title="Protein Family or Complex">mitogen-activated protein kinase</span> pathways, which might be important for evasion of the host immune response and aid in establishing a <span class="tagged-disease" title="UMLS Concept ID: C0243026">systemic infection.</span> Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> moieties from critical <span class="tagged-filter" title="Association Word">proteins,</span> such as <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha.</a></span> In contrast to the <span class="tagged-query" title="Query">cylindromatosis</span> tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> which attenuates NF-kappaB signaling by selectively removing K63-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin</a></span> chains that activate <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase,</a></span> YopJ also cleaves K48-<span class="tagged-filter" title="Association Word">linked</span> chains and thereby inhibits proteasomal degradation of <span class="tagged-gene" title="SwissProt ID: P25963; Entrez Gene ID: 4792; HGNC ID: 7797; HPRD ID: 01235; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25963">IkappaBalpha.</a></span> YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular <span class="tagged-filter" title="Association Word">proteins</span> and cleaved both K48- and K63-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin.</a></span> Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> of purified YopJ.
Cylindromatosis	CDH11	True Negative	1.025	16107186	<strong class="title">Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, Hahn A, Lu T, Gurbuz Y, Nikolaus S, Albrecht M, Hampe J, Lucius R, Kloppel G, Eickhoff H, Lehrach H, Lengauer T, Schreiber S: Dissection of the <span class="tagged-disease" title="UMLS Concept ID: C1522181">inflammatory bowel disease</span> transcriptome using genome-wide cDNA microarrays. PLoS Med. 2005 Aug;2(8):e199. Epub 2005 Aug 23.</strong> BACKGROUND: The differential pathophysiologic mechanisms that trigger and maintain the two forms of <span class="tagged-disease" title="UMLS Concept ID: C1522181">inflammatory bowel disease</span> <span class="tagged-disease" title="UMLS Concept ID: C0021390">(IBD),</span> <span class="tagged-disease" title="UMLS Concept ID: C0010346">Crohn disease</span> (CD), and <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> (UC) are only partially understood. cDNA microarrays can be used to decipher <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">regulation</span> events at a genome-wide level and to identify novel unknown <span class="tagged-filter" title="Association Word">genes</span> that might be <span class="tagged-filter" title="Association Word">involved</span> in perpetuating <span class="tagged-disease" title="UMLS Concept ID: C1290884">inflammatory disease</span> progression. METHODS AND FINDINGS: High-density cDNA microarrays representing 33,792 UniGene clusters were prepared. Biopsies were taken from the sigmoid colon of normal controls (n = 11), CD patients (n = 10) and UC patients (n = 10). 33P-radiolabeled cDNA from purified poly (A)+ RNA extracted from biopsies (unpooled) was hybridized to the arrays. We identified 500 and 272 transcripts differentially regulated in CD and UC, respectively. Interesting hits were independently verified by real-time PCR in a second sample of 100 individuals, and immunohistochemistry was used for exemplary localization. The main findings point to novel molecules important in abnormal immune <span class="tagged-filter" title="Association Word">regulation</span> and the highly disturbed cell biology of colonic epithelial cells in <span class="tagged-disease" title="UMLS Concept ID: C0021390">IBD</span> pathogenesis, e.g., <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> <span class="tagged-query" title="Query">(cylindromatosis,</span> <span class="tagged-disease" title="UMLS Concept ID: C1305968">turban tumor</span> syndrome) and <span class="tagged-gene" title="SwissProt ID: P55287; Entrez Gene ID: 1009; HGNC ID: 1750; HPRD ID: 08960; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55287">CDH11</a></span> <span class="tagged-gene" title="SwissProt ID: P55287; Entrez Gene ID: 1009; HGNC ID: 1750; HPRD ID: 08960; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55287">(cadherin 11,</a></span> type 2). By the nature of the array setup, many of the <span class="tagged-filter" title="Association Word">genes</span> identified were to our knowledge previously uncharacterized, and prediction of the putative function of a subsection of these <span class="tagged-filter" title="Association Word">genes</span> indicate that some could be <span class="tagged-filter" title="Association Word">involved</span> in early events in disease pathophysiology. CONCLUSION: A comprehensive set of candidate <span class="tagged-filter" title="Association Word">genes</span> not previously <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0021390">IBD</span> was revealed, which underlines the polygenic and complex nature of the disease. It points out substantial differences in pathophysiology between CD and UC. The multiple unknown <span class="tagged-filter" title="Association Word">genes</span> identified may stimulate new research in the fields of barrier mechanisms and cell signalling in the context of <span class="tagged-disease" title="UMLS Concept ID: C0021390">IBD,</span> and ultimately new therapeutic approaches.
Cylindromatosis	Laminin	True Negative	1.025	12714041	<strong class="title">Aumailley M, El Khal A, Knoss N, Tunggal L: <span class="tagged-gene" title="Protein Family or Complex">Laminin</span> 5 processing and its integration into the <span class="tagged-drug" title="DrugBank: APRD00264"><span class="tagged-gene" title="SwissProt ID: Q9UKX5; Entrez Gene ID: 22801; HGNC ID: 6136; HPRD ID: 05310; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00264">ECM.</a></span> . Matrix Biol. 2003 Mar;22(1):49-54.</strong> <span class="tagged-gene" title="Protein Family or Complex">Laminins</span> are a family of multi-functional basement membrane <span class="tagged-filter" title="Association Word">proteins.</span> Their C-terminal domain binds to cell surface receptors and is thereby responsible for cell anchorage and the initiation of specific outside-in and inside-out signals. With their N-terminal parts, <span class="tagged-gene" title="Protein Family or Complex">laminins</span> interact with <span class="tagged-filter" title="Association Word">proteins</span> of the extracellular matrix scaffold to secure the basement membrane to the underlying mesenchymal tissue. <span class="tagged-gene" title="Protein Family or Complex">Laminins</span> 5A (alpha3Abeta3gamma2), 5B (alpha3Bbeta3gamma2) and 6 (alpha3Abeta1gamma1) are isoforms specific of the basement membrane underneath the epidermis and they undergo a sequential series of extracellular proteolytic changes, which might successively turn on and off one or several of their biological and mechanical functions. Under physiological conditions, such as in adult human skin, epithelial <span class="tagged-gene" title="Protein Family or Complex">laminins</span> have lost part of the C- and N-terminal domains of the alpha3 and gamma2 chains, respectively. In contrast, in <span class="tagged-query" title="Query">cylindromatosis,</span> a rare <span class="tagged-disease" title="UMLS Concept ID: C0019247">inherited disease</span> characterised by major ultrastructural alterations of the basement membrane and <span class="tagged-filter" title="Association Word">altered</span> <span class="tagged-filter" title="Association Word">expression</span>/distribution of <a href="http://beta.uniprot.org/uniprot/Q9UKX5">integrin</a></span> receptors, <span class="tagged-gene" title="Protein Family or Complex">laminin</span> processing has not been completed. Together, these results suggest that <span class="tagged-gene" title="Protein Family or Complex">laminin</span> processing may regulate signalling pathways and the architecture of the basement membrane by restricting the repertoire of interactions with cell surface receptors and extracellular matrix components.
Cylindromatosis	NEMO	True Negative	1.025	15226292	<strong class="title">Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD: NF-kappaB is essential for induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem. 2004 Aug 27;279(35):36171-4. Epub 2004 Jun 28.</strong> The transcription factor NF-kappaB regulates <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inflammatory and immune responses, <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis,</span> and apoptosis. In contrast to the pleiotropic stimuli that <span class="tagged-filter" title="Association Word">lead</span> to its positive <span class="tagged-filter" title="Association Word">regulation,</span> the known signaling mechanisms that underlie the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB are very few. Recent studies have identified the tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> loss of which <span class="tagged-filter" title="Association Word">causes</span> a benign human syndrome called <span class="tagged-query" title="Query">cylindromatosis,</span> as a key negative regulator for NF-kappaB signaling by deubiquitinating <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)</a></span> receptor-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF) 2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO</a></span> (NF-kappaB essential modulator, also known as <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> gamma). However, how <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is regulated remains unknown. The present study revealed a novel autoregulatory feedback pathway through which activation of NF-kappaB by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and bacterium nontypeable Haemophilus influenzae (NTHi) induces <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> that in turn <span class="tagged-filter" title="Association Word">leads</span> to the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB signaling. In addition, <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> appear to be differentially <span class="tagged-filter" title="Association Word">involved</span> in NF-kappaB-dependent induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and NTHi. These findings provide novel insights into the autoregulation of NF-kappaB activation.
Cylindromatosis	NEMO	True Negative	1.025	12917691	<strong class="title">Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G: The tumour suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003 Aug 14;424(6950):801-5.</strong> NF-kappaB transcription factors have key <span class="tagged-filter" title="Association Word">roles</span> in inflammation, immune response, oncogenesis and protection against apoptosis. In most cells, these factors are kept inactive in the cytoplasm through <span class="tagged-filter" title="Association Word">association</span> with IkappaB inhibitors. After stimulation by various reagents, IkappaB is phosphorylated by the <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> <span class="tagged-gene" title="Protein Family or Complex">(IKK) complex</span> and degraded by the <span class="tagged-gene" title="Protein Family or Complex">proteasome,</span> allowing NF-kappaB to translocate to the nucleus and activate its target <span class="tagged-filter" title="Association Word">genes.</span> Here we report that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> a tumour suppressor that is <span class="tagged-filter" title="Association Word">mutated</span> in familial <span class="tagged-query" title="Query">cylindromatosis,</span> interacts with <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO,</a></span> the regulatory subunit of <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK.</a></span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> also interacts directly with <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour-necrosis</span> factor receptor (TNFR)-<span class="tagged-filter" title="Association Word">associated</span> factor 2 <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF2),</a></span> an adaptor molecule <span class="tagged-filter" title="Association Word">involved</span> in signalling by members of the family of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span>/<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">nerve growth factor</a></span> receptors. <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> has deubiquitinating <span class="tagged-filter" title="Association Word">activity</span> that is directed towards non-K48-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">polyubiquitin</a></span> chains, and negatively modulates TRAF-mediated activation of <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK,</a></span> strengthening the notion that ubiquitination is <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IKK</a></span> activation by TRAFs and suggesting that <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> functions in this process. Truncations of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> found in <span class="tagged-query" title="Query">cylindromatosis</span> result in reduced enzymatic <span class="tagged-filter" title="Association Word">activity,</span> indicating a link between impaired deubiquitination of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> substrates and human pathophysiology.
Cylindromatosis	TRAF2	True Positive	1.025	15226292	<strong class="title">Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD: NF-kappaB is essential for induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem. 2004 Aug 27;279(35):36171-4. Epub 2004 Jun 28.</strong> The transcription factor NF-kappaB regulates <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inflammatory and immune responses, <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis,</span> and apoptosis. In contrast to the pleiotropic stimuli that <span class="tagged-filter" title="Association Word">lead</span> to its positive <span class="tagged-filter" title="Association Word">regulation,</span> the known signaling mechanisms that underlie the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB are very few. Recent studies have identified the tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> loss of which <span class="tagged-filter" title="Association Word">causes</span> a benign human syndrome called <span class="tagged-query" title="Query">cylindromatosis,</span> as a key negative regulator for NF-kappaB signaling by deubiquitinating <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)</a></span> receptor-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF) 2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO</a></span> (NF-kappaB essential modulator, also known as <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> gamma). However, how <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is regulated remains unknown. The present study revealed a novel autoregulatory feedback pathway through which activation of NF-kappaB by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and bacterium nontypeable Haemophilus influenzae (NTHi) induces <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> that in turn <span class="tagged-filter" title="Association Word">leads</span> to the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB signaling. In addition, <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> appear to be differentially <span class="tagged-filter" title="Association Word">involved</span> in NF-kappaB-dependent induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and NTHi. These findings provide novel insights into the autoregulation of NF-kappaB activation.
Cylindromatosis	activating-transcription-factor-3	True Negative	1.025	17043644	<strong class="title">Zhong S, Fields CR, Su N, Pan YX, Robertson KD: Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of <span class="tagged-disease" title="UMLS Concept ID: C1510714">aberrant DNA methylation</span> and histone deacetylation in <span class="tagged-disease" title="UMLS Concept ID: C0242379">lung cancer.</span> Oncogene. 2007 Apr 19;26(18):2621-34. Epub 2006 Oct 9.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0242379">Lung cancer</span> is the <span class="tagged-filter" title="Association Word">leading</span> <span class="tagged-filter" title="Association Word">cause</span> of cancer-<span class="tagged-filter" title="Association Word">related</span> deaths in the United States due, in large part, to the lack of early detection methods. <span class="tagged-disease" title="UMLS Concept ID: C0242379">Lung cancer</span> arises from a complex series of genetic and epigenetic changes <span class="tagged-filter" title="Association Word">leading</span> to uncontrolled cell growth and metastasis. Unlike genetic changes, epigenetic changes, such as DNA methylation and histone acetylation, are reversible with currently available pharmaceuticals and are early events in lung <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis</span> detectable by non-invasive methods. In order to better understand how epigenetic changes contribute to <span class="tagged-disease" title="UMLS Concept ID: C0242379">lung cancer,</span> and to identify new disease <span class="tagged-filter" title="Association Word">biomarkers,</span> we combined pharmacologic inhibition of DNA methylation and histone deacetylation in <span class="tagged-disease" title="UMLS Concept ID: C0007131">non-small cell lung cancer</span> <span class="tagged-disease" title="UMLS Concept ID: C0007131">(NSCLC)</span> cell lines, with genome-wide <span class="tagged-filter" title="Association Word">expression</span> profiling. Of the more than 200 <span class="tagged-filter" title="Association Word">genes</span> upregulated by these treatments, three of these, <span class="tagged-gene" title="SwissProt ID: Q16517; Entrez Gene ID: 4826; HGNC ID: 7860; HPRD ID: 04377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16517">neuronatin,</a></span> <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">metallothionein 3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q15828; Entrez Gene ID: 1474; HGNC ID: 2478; HPRD ID: 03535; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15828">cystatin E/M,</a></span> were frequently hypermethylated and transcriptionally downregulated in <span class="tagged-disease" title="UMLS Concept ID: C0007131">NSCLC</span> cell lines and tumors. Interestingly, four other <span class="tagged-filter" title="Association Word">genes,</span> <span class="tagged-query" title="Query">cylindromatosis,</span> <span class="tagged-gene" title="SwissProt ID: P21926; Entrez Gene ID: 928; HGNC ID: 1709; HPRD ID: 00880; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21926">CD9,</a></span> <span class="tagged-gene" title="SwissProt ID: P18847; Entrez Gene ID: 467; HGNC ID: 785; HPRD ID: 04395; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P18847">activating transcription factor 3</a></span> and <span class="tagged-gene" title="SwissProt ID: P30559; Entrez Gene ID: 5021; HGNC ID: 8529; HPRD ID: 01328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30559">oxytocin receptor,</a></span> were dominantly regulated by histone deacetylation and were also frequently downregulated in lung tumors. The majority of these <span class="tagged-filter" title="Association Word">genes</span> also suppressed <span class="tagged-disease" title="UMLS Concept ID: C0007131">NSCLC</span> growth in culture when ectopically <span class="tagged-filter" title="Association Word">expressed.</span> This study therefore reveals new putative <span class="tagged-disease" title="UMLS Concept ID: C0007131">NSCLC</span> growth regulatory <span class="tagged-filter" title="Association Word">genes</span> and epigenetic disease <span class="tagged-filter" title="Association Word">biomarkers</span> that may enhance early detection strategies and serve as therapeutic targets.
Cylindromatosis	TNF-alpha	True Negative	1.025	15226292	<strong class="title">Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD: NF-kappaB is essential for induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem. 2004 Aug 27;279(35):36171-4. Epub 2004 Jun 28.</strong> The transcription factor NF-kappaB regulates <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inflammatory and immune responses, <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis,</span> and apoptosis. In contrast to the pleiotropic stimuli that <span class="tagged-filter" title="Association Word">lead</span> to its positive <span class="tagged-filter" title="Association Word">regulation,</span> the known signaling mechanisms that underlie the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB are very few. Recent studies have identified the tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> loss of which <span class="tagged-filter" title="Association Word">causes</span> a benign human syndrome called <span class="tagged-query" title="Query">cylindromatosis,</span> as a key negative regulator for NF-kappaB signaling by deubiquitinating <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)</a></span> receptor-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF) 2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO</a></span> (NF-kappaB essential modulator, also known as <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> gamma). However, how <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is regulated remains unknown. The present study revealed a novel autoregulatory feedback pathway through which activation of NF-kappaB by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and bacterium nontypeable Haemophilus influenzae (NTHi) induces <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> that in turn <span class="tagged-filter" title="Association Word">leads</span> to the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB signaling. In addition, <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> appear to be differentially <span class="tagged-filter" title="Association Word">involved</span> in NF-kappaB-dependent induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and NTHi. These findings provide novel insights into the autoregulation of NF-kappaB activation.
Cylindromatosis	oxytocin-receptor	True Negative	1.025	17043644	<strong class="title">Zhong S, Fields CR, Su N, Pan YX, Robertson KD: Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of <span class="tagged-disease" title="UMLS Concept ID: C1510714">aberrant DNA methylation</span> and histone deacetylation in <span class="tagged-disease" title="UMLS Concept ID: C0242379">lung cancer.</span> Oncogene. 2007 Apr 19;26(18):2621-34. Epub 2006 Oct 9.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0242379">Lung cancer</span> is the <span class="tagged-filter" title="Association Word">leading</span> <span class="tagged-filter" title="Association Word">cause</span> of cancer-<span class="tagged-filter" title="Association Word">related</span> deaths in the United States due, in large part, to the lack of early detection methods. <span class="tagged-disease" title="UMLS Concept ID: C0242379">Lung cancer</span> arises from a complex series of genetic and epigenetic changes <span class="tagged-filter" title="Association Word">leading</span> to uncontrolled cell growth and metastasis. Unlike genetic changes, epigenetic changes, such as DNA methylation and histone acetylation, are reversible with currently available pharmaceuticals and are early events in lung <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis</span> detectable by non-invasive methods. In order to better understand how epigenetic changes contribute to <span class="tagged-disease" title="UMLS Concept ID: C0242379">lung cancer,</span> and to identify new disease <span class="tagged-filter" title="Association Word">biomarkers,</span> we combined pharmacologic inhibition of DNA methylation and histone deacetylation in <span class="tagged-disease" title="UMLS Concept ID: C0007131">non-small cell lung cancer</span> <span class="tagged-disease" title="UMLS Concept ID: C0007131">(NSCLC)</span> cell lines, with genome-wide <span class="tagged-filter" title="Association Word">expression</span> profiling. Of the more than 200 <span class="tagged-filter" title="Association Word">genes</span> upregulated by these treatments, three of these, <span class="tagged-gene" title="SwissProt ID: Q16517; Entrez Gene ID: 4826; HGNC ID: 7860; HPRD ID: 04377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16517">neuronatin,</a></span> <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">metallothionein 3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q15828; Entrez Gene ID: 1474; HGNC ID: 2478; HPRD ID: 03535; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15828">cystatin E/M,</a></span> were frequently hypermethylated and transcriptionally downregulated in <span class="tagged-disease" title="UMLS Concept ID: C0007131">NSCLC</span> cell lines and tumors. Interestingly, four other <span class="tagged-filter" title="Association Word">genes,</span> <span class="tagged-query" title="Query">cylindromatosis,</span> <span class="tagged-gene" title="SwissProt ID: P21926; Entrez Gene ID: 928; HGNC ID: 1709; HPRD ID: 00880; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21926">CD9,</a></span> <span class="tagged-gene" title="SwissProt ID: P18847; Entrez Gene ID: 467; HGNC ID: 785; HPRD ID: 04395; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P18847">activating transcription factor 3</a></span> and <span class="tagged-gene" title="SwissProt ID: P30559; Entrez Gene ID: 5021; HGNC ID: 8529; HPRD ID: 01328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30559">oxytocin receptor,</a></span> were dominantly regulated by histone deacetylation and were also frequently downregulated in lung tumors. The majority of these <span class="tagged-filter" title="Association Word">genes</span> also suppressed <span class="tagged-disease" title="UMLS Concept ID: C0007131">NSCLC</span> growth in culture when ectopically <span class="tagged-filter" title="Association Word">expressed.</span> This study therefore reveals new putative <span class="tagged-disease" title="UMLS Concept ID: C0007131">NSCLC</span> growth regulatory <span class="tagged-filter" title="Association Word">genes</span> and epigenetic disease <span class="tagged-filter" title="Association Word">biomarkers</span> that may enhance early detection strategies and serve as therapeutic targets.
Cylindromatosis	hBRM	True Negative	1.025	16135788	<strong class="title">Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S: The <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1</a></span>- and <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM</a></span>-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> induces apoptosis by stimulating <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-query" title="Query">cylindromatosis</span> tumor suppressor <span class="tagged-filter" title="Association Word">gene.</span> Mol Cell Biol. 2005 Sep;25(18):7953-65.</strong> <span class="tagged-filter" title="Association Word">Mutation</span> of <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1,</a></span> <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM,</a></span> and their <span class="tagged-filter" title="Association Word">associated</span> factors, <span class="tagged-gene" title="SwissProt ID: Q12824; Entrez Gene ID: 6598; HGNC ID: 11103; HPRD ID: 03364; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12824">INI1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> in primary human tumors has suggested that inactivation of human <span class="tagged-gene" title="Protein Family or Complex">SWI/SNF</span> (hSWI/SNF) complexes may be <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-disease" title="UMLS Concept ID: C0007621">neoplastic transformation.</span> BT549 is an invasive human <span class="tagged-disease" title="UMLS Concept ID: C0678222">breast carcinoma</span> cell line that lacks <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> a key hSWI/SNF subunit that mediates interaction with transcriptional activators and corepressors. In this study we investigated the role of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in suppressing <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis</span> by establishing BT549 stable cell lines that expresses full-length <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> <span class="tagged-filter" title="Association Word">protein.</span> BT549 clones expressing <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> demonstrated marked phenotypic changes, slow growth kinetics, and restoration of contact inhibition. <span class="tagged-filter" title="Association Word">Altered</span> growth was found to be due in part to cell cycle arrest and induction of apoptosis. Furthermore, microarray analysis revealed that <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span>-mediated cell death was <span class="tagged-filter" title="Association Word">associated</span> with up-<span class="tagged-filter" title="Association Word">regulation</span> of proapoptotic <span class="tagged-filter" title="Association Word">genes</span> including the tumor suppressor familial <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD),</a></span> which was found to be a direct target of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> as determined by chromatin immunoprecipitation analysis. Increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> in BT549 cells induced apoptosis, while its suppression by small interfering RNA inhibited cell death in <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> expressing BT549 cells. These findings demonstrate the importance of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in cell growth <span class="tagged-filter" title="Association Word">regulation</span> and provide a novel link between hSWI/SNF chromatin remodelers and apoptosis.
Cylindromatosis	BAF57	True Negative	1.025	16135788	<strong class="title">Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S: The <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1</a></span>- and <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM</a></span>-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> induces apoptosis by stimulating <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-query" title="Query">cylindromatosis</span> tumor suppressor <span class="tagged-filter" title="Association Word">gene.</span> Mol Cell Biol. 2005 Sep;25(18):7953-65.</strong> <span class="tagged-filter" title="Association Word">Mutation</span> of <span class="tagged-gene" title="SwissProt ID: O95052; Entrez Gene ID: 6597; HGNC ID: 11100; HPRD ID: 04459; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95052">BRG1,</a></span> <span class="tagged-gene" title="SwissProt ID: P51531; Entrez Gene ID: 6595; HGNC ID: 11098; HPRD ID: 02483; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51531">hBRM,</a></span> and their <span class="tagged-filter" title="Association Word">associated</span> factors, <span class="tagged-gene" title="SwissProt ID: Q12824; Entrez Gene ID: 6598; HGNC ID: 11103; HPRD ID: 03364; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12824">INI1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> in primary human tumors has suggested that inactivation of human <span class="tagged-gene" title="Protein Family or Complex">SWI/SNF</span> (hSWI/SNF) complexes may be <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-disease" title="UMLS Concept ID: C0007621">neoplastic transformation.</span> BT549 is an invasive human <span class="tagged-disease" title="UMLS Concept ID: C0678222">breast carcinoma</span> cell line that lacks <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57,</a></span> a key hSWI/SNF subunit that mediates interaction with transcriptional activators and corepressors. In this study we investigated the role of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in suppressing <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis</span> by establishing BT549 stable cell lines that expresses full-length <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> <span class="tagged-filter" title="Association Word">protein.</span> BT549 clones expressing <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> demonstrated marked phenotypic changes, slow growth kinetics, and restoration of contact inhibition. <span class="tagged-filter" title="Association Word">Altered</span> growth was found to be due in part to cell cycle arrest and induction of apoptosis. Furthermore, microarray analysis revealed that <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span>-mediated cell death was <span class="tagged-filter" title="Association Word">associated</span> with up-<span class="tagged-filter" title="Association Word">regulation</span> of proapoptotic <span class="tagged-filter" title="Association Word">genes</span> including the tumor suppressor familial <span class="tagged-query" title="Query">cylindromatosis</span> <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">(CYLD),</a></span> which was found to be a direct target of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> as determined by chromatin immunoprecipitation analysis. Increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> in BT549 cells induced apoptosis, while its suppression by small interfering RNA inhibited cell death in <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> expressing BT549 cells. These findings demonstrate the importance of <span class="tagged-gene" title="SwissProt ID: Q969G3; Entrez Gene ID: 6605; HGNC ID: 11109; HPRD ID: 04382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q969G3">BAF57</a></span> in cell growth <span class="tagged-filter" title="Association Word">regulation</span> and provide a novel link between hSWI/SNF chromatin remodelers and apoptosis.
Cylindromatosis	TRAF6	False Positive	1.151	15226292	<strong class="title">Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD: NF-kappaB is essential for induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem. 2004 Aug 27;279(35):36171-4. Epub 2004 Jun 28.</strong> The transcription factor NF-kappaB regulates <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inflammatory and immune responses, <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis,</span> and apoptosis. In contrast to the pleiotropic stimuli that <span class="tagged-filter" title="Association Word">lead</span> to its positive <span class="tagged-filter" title="Association Word">regulation,</span> the known signaling mechanisms that underlie the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB are very few. Recent studies have identified the tumor suppressor <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD,</a></span> loss of which <span class="tagged-filter" title="Association Word">causes</span> a benign human syndrome called <span class="tagged-query" title="Query">cylindromatosis,</span> as a key negative regulator for NF-kappaB signaling by deubiquitinating <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)</a></span> receptor-<span class="tagged-filter" title="Association Word">associated</span> factor <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">(TRAF) 2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y6K9; Entrez Gene ID: 8517; HGNC ID: 5961; HPRD ID: 02217; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6K9">NEMO</a></span> (NF-kappaB essential modulator, also known as <span class="tagged-gene" title="SwissProt ID: O15111; Entrez Gene ID: 1147; HGNC ID: 1974; HPRD ID: 02811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15111">IkappaB kinase</a></span> gamma). However, how <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> is regulated remains unknown. The present study revealed a novel autoregulatory feedback pathway through which activation of NF-kappaB by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and bacterium nontypeable Haemophilus influenzae (NTHi) induces <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> that in turn <span class="tagged-filter" title="Association Word">leads</span> to the negative <span class="tagged-filter" title="Association Word">regulation</span> of NF-kappaB signaling. In addition, <span class="tagged-gene" title="SwissProt ID: Q12933; Entrez Gene ID: 7186; HGNC ID: 12032; HPRD ID: 03538; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12933">TRAF2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4K3; Entrez Gene ID: 7189; HGNC ID: 12036; HPRD ID: 03833; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4K3">TRAF6</a></span> appear to be differentially <span class="tagged-filter" title="Association Word">involved</span> in NF-kappaB-dependent induction of <span class="tagged-gene" title="SwissProt ID: Q9NQC7; Entrez Gene ID: 1540; HGNC ID: 2584; HPRD ID: 05427; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9NQC7">CYLD</a></span> by <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> and NTHi. These findings provide novel insights into the autoregulation of NF-kappaB activation.
Cylindromatosis	claudin-8	True Negative	1.025	16969477	<strong class="title">Kim M, Lee S, Yang SK, Song K, Lee I: Differential <span class="tagged-filter" title="Association Word">expression</span> in histologically normal crypts of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> suggests primary crypt disorder. Oncol Rep. 2006 Oct;16(4):663-70.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0009324">Ulcerative colitis</span> is characterized by crypt infiltration particularly of neutrophils. However, it is not known whether it reflects a primary crypt disorder or a secondary inflammatory response. In this study, we analyzed the <span class="tagged-filter" title="Association Word">expression</span> profiles of histologically normal crypts microdissected from formalin-fixed biopsies of early stage <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span> Total RNAs were extracted, amplified, and applied to Affymetrix GeneChip (R) X3P Array. For the control, similar crypts from nonspecific <span class="tagged-disease" title="UMLS Concept ID: C0156147">colitis</span> biopsies were applied. A total of 353 (4.3%) and 111 (1.4%) <span class="tagged-filter" title="Association Word">genes</span> were > 3 times up-, and down-regulated in <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span> Up-regulated <span class="tagged-filter" title="Association Word">genes</span> included <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">FCGBP</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">(Fc fragment of IgG binding protein),</a></span> <span class="tagged-gene" title="SwissProt ID: P62937; Entrez Gene ID: 5478; HGNC ID: 9253; HPRD ID: 00457; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62937">cyclophilin A,</a></span> <span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> (C-X-C motif) ligand 3, and <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">associated</span> with lipid metabolism. Down-regulated <span class="tagged-filter" title="Association Word">genes</span> included <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">APOA4</a></span> <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">(apolipoprotein A-IV),</a></span> <span class="tagged-query" title="Query">cylindromatosis,</span> <span class="tagged-gene" title="SwissProt ID: Q9HD36; Entrez Gene ID: 10017; HGNC ID: 993; HPRD ID: 06071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HD36">BCL2-like 10,</a></span> <span class="tagged-gene" title="SwissProt ID: P56748; Entrez Gene ID: 9073; HGNC ID: 2050; HPRD ID: 10835; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56748">claudin 8,</a></span> and numerous transcriptional regulators. <span class="tagged-gene" title="SwissProt ID: Q9Y6R7; Entrez Gene ID: 8857; HGNC ID: 13572; HPRD ID: 10956; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6R7">FCGBP</a></span> and <span class="tagged-gene" title="SwissProt ID: P06727; Entrez Gene ID: 337; HGNC ID: 602; HPRD ID: 00130; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06727">APOA4</a></span> have been implicated in <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> previously. Our data show differential <span class="tagged-filter" title="Association Word">expression</span> in the crypt epithelia of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis</span> before active inflammation is initiated, suggesting primary crypt abnormalities that might be implicated in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0009324">ulcerative colitis.</span>
Gilbert_syndrome	N-acetyltransferase	True Negative	1.226	16402080	<strong class="title">Hermann R, Borlak J, Munzel U, Niebch G, Fuhr U, Maus J, Erb K: The role of <span class="tagged-query" title="Query">Gilbert's syndrome</span> and frequent <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> slow acetylation <span class="tagged-filter" title="Association Word">polymorphisms</span> in the pharmacokinetics of retigabine. Pharmacogenomics J. 2006 May-Jun;6(3):211-9.</strong> Retigabine (RGB) is an investigational antiepileptic drug, which undergoes extensive <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1,</a></span> 1A9 and 1A4-mediated N-glucuronidation and N-acetylation. The mono-acetylated metabolite of RGB has some pharmacological <span class="tagged-filter" title="Association Word">activity</span> and is denoted AWD21-360. We investigated whether the pharmacokinetics (PK) of RGB and AWD21-360 are <span class="tagged-filter" title="Association Word">altered</span> in subjects with <span class="tagged-query" title="Query">Gilbert's syndrome</span> (GS) and/or with frequent <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">(NAT2)</a></span> slow acetylator (SA) <span class="tagged-filter" title="Association Word">polymorphisms.</span> Based on consistent genotyping and phenotyping screening results, 37 Caucasian subjects (21-46 years; 31 men, six women) were assigned to one of the following groups: (1) <span class="tagged-filter" title="Association Word">absence</span> of GS (non-GS)/rapid acetylator (RA) (N=11); (2) GS/RA (N=8); (3) non-GS/SA (N=11); (4) GS/SA (N=7). Subjects received single and multiple (b.i.d.) 200-mg oral RGB doses over 5 days. Blood samples were collected up to 60 h after dosing for plasma PK of RGB and AWD21-360. Group comparisons were performed by ANOVA. Single-dose PK of RGB and AWD21-360 and multiple-dose PK of RGB did not differ significantly between groups. After multiple dose treatment, RA subjects showed a significantly higher total exposure to AWD21-360 of about 32% (95% CI 101.9-172.5) relative to SA subjects (P=0.0362). The <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> metabolic capacity (i.e. presence or <span class="tagged-filter" title="Association Word">absence</span> of GS), however, did not significantly affect the overall exposure to AWD21-360. The results indicate that the PK of RGB is unaltered in individuals with GS, in subjects with <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> SA status, and in carriers of both variants, whereas the total exposure to AWD21-360 is significantly <span class="tagged-filter" title="Association Word">related</span> to the RA or SA status of subjects. Results further suggest that metabolic switching to the mono-acetylated metabolite AWD21-360 may partially compensate for the impaired glucuronidation capacity in GS subjects. RGB treatment showed no significant differences in tolerability and safety between groups.
Gilbert_syndrome	paraoxonase	True Negative	1.226	8361990	<strong class="title">Daly AK, Cholerton S, Gregory W, Idle JR: Metabolic <span class="tagged-filter" title="Association Word">polymorphisms.</span> Pharmacol Ther. 1993 Feb-Mar;57(2-3):129-60.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> have been detected in a variety of xenobiotic-metabolizing enzymes at both the phenotypic and genotypic level. In the case of four enzymes, the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> <span class="tagged-gene" title="SwissProt ID: P10635; Entrez Gene ID: 1565; HGNC ID: 2625; HPRD ID: 00487; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10635">CYP2D6,</a></span> <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> mu, <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> and serum <span class="tagged-gene" title="SwissProt ID: P06276; Entrez Gene ID: 590; HGNC ID: 983; HPRD ID: 01519; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06276">cholinesterase,</a></span> the majority of <span class="tagged-filter" title="Association Word">mutations</span> which give rise to a defective phenotype have now been identified. Another group of enzymes show definite <span class="tagged-filter" title="Association Word">polymorphism</span> at the phenotypic level but the exact genetic mechanisms responsible are not yet clear. These enzymes include the cytochromes P450 <span class="tagged-gene" title="SwissProt ID: P04798; Entrez Gene ID: 1543; HGNC ID: 2595; HPRD ID: 00148; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04798">CYP1A1,</a></span> <span class="tagged-gene" title="SwissProt ID: P05177; Entrez Gene ID: 1544; HGNC ID: 2596; HPRD ID: 00489; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05177">CYP1A2</a></span> and a <span class="tagged-gene" title="SwissProt ID: P33261; Entrez Gene ID: 1557; HGNC ID: 2621; HPRD ID: 00486; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P33261">CYP2C</a></span> form which metabolizes <span class="tagged-drug" title="DrugBank: APRD00512"><span class="tagged-gene" title="SwissProt ID: P27169; Entrez Gene ID: 5444; HGNC ID: 9204; HPRD ID: 01351; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00512">mephenytoin,</a></span> a <span class="tagged-drug" title="DrugBank: APRD00626"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00626">flavin</a></span>-<span class="tagged-filter" title="Association Word">linked</span> monooxygenase <span class="tagged-disease" title="UMLS Concept ID: C0342739">(fish-odour syndrome),</span> <a href="http://beta.uniprot.org/uniprot/P27169">paraoxonase,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-query" title="Query">(Gilbert's syndrome)</span> and <span class="tagged-gene" title="SwissProt ID: P51580; Entrez Gene ID: 7172; HGNC ID: 12014; HPRD ID: 01760; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51580">thiopurine S-methyltransferase.</a></span> In the case of a further group of enzymes, there is some evidence for <span class="tagged-filter" title="Association Word">polymorphism</span> at either the phenotypic or genotypic level but this has not been unambiguously demonstrated. Examples of this class include the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> enzymes <span class="tagged-gene" title="SwissProt ID: P11509; Entrez Gene ID: 1548; HGNC ID: 2610; HPRD ID: 00420; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11509">CYP2A6,</a></span> <span class="tagged-gene" title="SwissProt ID: P05181; Entrez Gene ID: 1571; HGNC ID: 2631; HPRD ID: 11813; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05181">CYP2E1,</a></span> <span class="tagged-gene" title="SwissProt ID: P11712; Entrez Gene ID: 1559; HGNC ID: 2623; HPRD ID: 03084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11712">CYP2C9</a></span> and <span class="tagged-gene" title="SwissProt ID: P05184; Entrez Gene ID: 1576; HGNC ID: 2637; HPRD ID: 00484; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05184">CYP3A4,</a></span> <span class="tagged-gene" title="SwissProt ID: P47989; Entrez Gene ID: 7498; HGNC ID: 12805; HPRD ID: 06363; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P47989">xanthine oxidase,</a></span> an S-oxidase which metabolizes <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P07099; Entrez Gene ID: 2052; HGNC ID: 3401; HPRD ID: 00581; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">carbocysteine,</a></span> <a href="http://beta.uniprot.org/uniprot/P07099">epoxide hydrolase,</a></span> two forms of sulphotransferase and several methyltransferases. The nature of all these <span class="tagged-filter" title="Association Word">polymorphisms</span> and possible <span class="tagged-filter" title="Association Word">polymorphisms</span> is discussed in detail, with particular reference to the effects of this variation on drug metabolism and susceptibility to chemically-induced diseases.
Gilbert_syndrome	alkaline-phosphatase	True Negative	1.226	2318988	<strong class="title">Lieverse AG, van Essen GG, Beukeveld GJ, Gazendam J, Dompeling EC, ten Kate LP, van Belle SA, Weits J: Familial increased serum <span class="tagged-gene" title="SwissProt ID: P09923; Entrez Gene ID: 248; HGNC ID: 437; HPRD ID: 01376; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09923">intestinal alkaline phosphatase:</a></span> a new variant <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> J Clin Pathol. 1990 Feb;43(2):125-8.</strong> Investigation of mild, inherited increased serum <span class="tagged-gene" title="SwissProt ID: P10696; Entrez Gene ID: 251; HGNC ID: 441; HPRD ID: 01380; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10696">alkaline phosphatase</a></span> <span class="tagged-filter" title="Association Word">activity</span> partially combined with <span class="tagged-query" title="Query">Gilbert's syndrome</span> in one family showed, apart from a normal liver fraction, an intestinal isoenzyme pattern and an extra band in the agar electrophoresis. Analysis by agarose electrophoresis before and after incubation of <span class="tagged-gene" title="SwissProt ID: Q99519; Entrez Gene ID: 4758; HGNC ID: 7758; HPRD ID: 09751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99519">neuraminidase</a></span> showed that the extra fraction was an intestinal variant isoenzyme. The precise genetic background of the two disorders in this family could not be determined from the available data. Abnormal activities of (regular) <span class="tagged-gene" title="SwissProt ID: P09923; Entrez Gene ID: 248; HGNC ID: 437; HPRD ID: 01376; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09923">intestinal alkaline phosphatase</a></span> isoenzyme <span class="tagged-filter" title="Association Word">caused</span> the increase in serum <span class="tagged-gene" title="SwissProt ID: P10696; Entrez Gene ID: 251; HGNC ID: 441; HPRD ID: 01380; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10696">alkaline phosphatase</a></span> in the <span class="tagged-filter" title="Association Word">absence</span> of disease.
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	17196409	<strong class="title">Ostanek B, Furlan D, Mavec T, Lukac-Bajalo J: <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> (TA) n promoter <span class="tagged-filter" title="Association Word">polymorphism</span>--a new case of a (TA) 8 allele in Caucasians. Blood Cells Mol Dis. 2007 Mar-Apr;38(2):78-82. Epub 2006 Dec 28.</strong> <span class="tagged-query" title="Query">Gilbert's syndrome</span> is a mild hereditary <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1).</a></span> The causative <span class="tagged-filter" title="Association Word">mutation</span> in Caucasians is almost exclusively a TA dinucleotide insertion in the TATA box of the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter. Affected individuals are homozygous for the variant promoter and have 7 instead of 6 TA repeats. The aim of the present study was to determine the genotypes of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> (TA) n promoter <span class="tagged-filter" title="Association Word">polymorphism</span> in the healthy Slovenian population and to investigate the <span class="tagged-filter" title="Association Word">association</span> of genotypes with serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels. 236 healthy subjects were genotyped by single-strand conformation <span class="tagged-filter" title="Association Word">polymorphism</span> analysis, which was validated by sequence analysis. The frequencies of genotypes were as follows: (TA)(6/6) (38.1%), (TA)(6/7) (47.9%), (TA)(7/7) (13.6%). There was a statistically significant <span class="tagged-filter" title="Association Word">association</span> of genotypes with serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels (p <0.001). Subjects with genotype (TA)(7/7) had the highest and subjects with genotype (TA)(6/6) the lowest total serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels. One individual in the group had the rare genotype (TA)(7/8) (0.4%). Analysis of his family showed the following genotypes: (TA)(6/8) in his father and sister and (TA)(7/8) in his two brothers. In conclusion, the frequency of <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> (TA) n promoter <span class="tagged-filter" title="Association Word">polymorphism</span> genotypes was determined for the first time in the Slovenian population and is similar to frequencies <span class="tagged-filter" title="Association Word">observed</span> in other Caucasian populations. The extremely rare (TA) 8 allele in Caucasians was found also in Slovenians.
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	17058217	<strong class="title">Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP: <span class="tagged-query" title="Query">Gilbert's disease</span> and <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">atazanavir:</a></span> from phenotype to <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> haplotype. Hepatology. 2006 Nov;44(5):1324-32.</strong> <span class="tagged-query" title="Query">Gilbert's disease</span> <span class="tagged-filter" title="Association Word">leads</span> to intermittent non-hemolytic <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> by a reduction of hepatic <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> glucuronidation <span class="tagged-filter" title="Association Word">associated</span> with the presence of the <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> 1A1*28 <span class="tagged-filter" title="Association Word">polymorphism.</span> It is considered benign because it does not result in <span class="tagged-disease" title="UMLS Concept ID: C0151763">hepatocellular damage.</span> However, pharmacogenetic analyses have <span class="tagged-filter" title="Association Word">linked</span> UGT1A1*28 to drug toxicity and cancer predisposition. The protease inhibitor <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">atazanavir</a></span> <span class="tagged-drug" title="DrugBank: APRD00804"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">(ATV)</a></span> is an inhibitor of hepatic <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">activity</span> <span class="tagged-filter" title="Association Word">leading</span> to <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> in individual patients. Whether this is <span class="tagged-filter" title="Association Word">linked</span> specifically to UGT1A1*28 or to more complex variants influencing glucuronidation is unclear. One hundred and six <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="SwissProt ID: P35503; Entrez Gene ID: 54659; HGNC ID: 12535; HPRD ID: 07566; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">ATV</a></span>-treated patients were characterized and genotyped for UGT1A1*28, the <a href="http://beta.uniprot.org/uniprot/P35503">UGT1A3</a></span> (-66C) and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> (-57G) promoter variants, and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> (129K/131K). <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="SwissProt ID: P35503; Entrez Gene ID: 54659; HGNC ID: 12535; HPRD ID: 07566; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">ATV</a></span> treatment increased median <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels from 10 to 41 micromol/L (P = .001) with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> exceeding 43 micromol/L in 37%. <span class="tagged-disease" title="UMLS Concept ID: C0020433">Hyperbilirubinemia</span> over 43 micromol/L was significantly <span class="tagged-filter" title="Association Word">associated</span> not only with UGT1A1*28 but also with <a href="http://beta.uniprot.org/uniprot/P35503">UGT1A3</a></span>-66C, <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span>-57G, and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> (129K/131K), although these variants do not naturally occur in <span class="tagged-filter" title="Association Word">linkage</span> dysequilibrium in blood donors. Homozygous combinations of UGT1A1*28 with the <span class="tagged-disease" title="UMLS Concept ID: C1518673">other variants</span> increased from 7.4% (normal <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> to 42 micromol/L) to 41% to 46.1% (43 to > 85 micromol/L), and 100% (> 85 micromol/L). All six patients with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> greater than 85 micromol/L were homozygous for all four variants identifying a haplotype inherited on a single allele. In conclusion, the genetic variant <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's disease</span> is identified as part of a haplotype of four <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> variants spanning three <span class="tagged-filter" title="Association Word">genes</span> at the <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">locus.</span> This haplotype predisposes to <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> in <span class="tagged-drug" title="DrugBank: APRD00804"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">ATV</a></span> treatment and may have an additional <span class="tagged-filter" title="Association Word">role</span> as a pharmacogenomic risk factor for drug therapy.
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	16610035	<strong class="title">Farheen S, Sengupta S, Santra A, Pal S, Dhali GK, Chakravorty M, Majumder PP, Chowdhury A: <span class="tagged-query" title="Query">Gilbert's syndrome:</span> High frequency of the (TA) 7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-filter" title="Association Word">gene.</span> World J Gastroenterol. 2006 Apr 14;12(14):2269-75.</strong> AIM: To identify the variants in <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> in <span class="tagged-query" title="Query">Gilbert's syndrome</span> (GS) and to estimate the <span class="tagged-filter" title="Association Word">association</span> between homozygosity for TA insertion and GS in India, as well as the frequency of TA insertion and its impact among normal controls in India. METHODS: Ninety-five GS cases and 95 normal controls were selected. Liver function and other tests were done. The promoter and all 5 exons of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> were resequenced. Functional assessment of a novel trinucleotide insertion was done by in silico analysis and by estimating <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter <span class="tagged-filter" title="Association Word">activity</span> carried out by luciferase reporter assay of appropriate constructs in Hep G2 cell line. RESULTS: Among the GS patients, 80% were homozygous for the TA insertion, which was several-fold higher than reports from other ethnic groups. The mean UCB level was <span class="tagged-filter" title="Association Word">elevated</span> among individuals with only one copy of this insertion, which was not significantly different from those with two copies. Many new DNA variants in <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> were discovered, including a trinucleotide (CAT) insertion in the promoter found in a subset (10%) of GS patients, but not among normal controls. In-silico analysis showed marked changes in the DNA-folding of the promoter and functional analysis showed a 20-fold reduction in transcription efficiency of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> resulting from this insertion, thereby significantly elevating the UCB level. CONCLUSION: The genetic epidemiology of GS is variable across ethnic groups and the epistatic interactions among <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter variants modulate <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> glucuronidation.
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	16244305	<strong class="title">Costa E, Vieira E, Dos Santos R: The <span class="tagged-filter" title="Association Word">polymorphism</span> c.-3279T> G in the <span class="tagged-drug" title="DrugBank: APRD00184"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00184">phenobarbital</a></span>-responsive enhancer module of the <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-filter" title="Association Word">gene</span> is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert syndrome.</span> Clin Chem. 2005 Nov;51(11):2204-6.</strong>
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	15378351	<strong class="title">Maruo Y, D'Addario C, Mori A, Iwai M, Takahashi H, Sato H, Takeuchi Y: Two <span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">polymorphic</span> <span class="tagged-filter" title="Association Word">mutations</span> (A (TA) 7TAA and T-3279G) of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> as the principal <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-query" title="Query">Gilbert syndrome.</span> Hum Genet. 2004 Nov;115(6):525-6. Epub 2004 Sep 17.</strong> <span class="tagged-query" title="Query">Gilbert syndrome</span> is a mild hereditary <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1).</a></span> The <span class="tagged-filter" title="Association Word">mutation,</span> A (TA) 7TAA, is thought to be the sole <span class="tagged-filter" title="Association Word">cause</span> of the syndrome in Caucasians, but an enhancer <span class="tagged-filter" title="Association Word">polymorphism</span> (T-3279G) that lowers transcriptional <span class="tagged-filter" title="Association Word">activity</span> has recently been reported. We have tested the <span class="tagged-filter" title="Association Word">linkage</span> of the two <span class="tagged-filter" title="Association Word">mutations</span> in 11 Caucasians and 12 Japanese patients who were homozygous for A (TA) 7TAA. All 23 patients were also homozygous for T-3279G, indicating that T-3279G and A (TA) 7TAA were <span class="tagged-filter" title="Association Word">linked.</span> The decrease in transcription <span class="tagged-filter" title="Association Word">caused</span> by both <span class="tagged-filter" title="Association Word">mutations</span> together may be essential to the syndrome.
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	14616765	<strong class="title">Maruo Y, Poon KK, Ito M, Iwai M, Takahashi H, Mori A, Sato H, Takeuchi Y: Co-occurrence of three different <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-filter" title="Association Word">gene</span> in a Chinese family with <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler-Najjar syndrome type I</span> and <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Clin Genet. 2003 Nov;64(5):420-3.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler-Najjar syndrome type I</span> is a severe form of hereditary <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> and is <span class="tagged-filter" title="Association Word">caused</span> by homozygous or compound heterozygous <span class="tagged-filter" title="Association Word">mutations</span> of the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1).</a></span> We analyzed the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-filter" title="Association Word">gene</span> in a female Chinese patient with <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler-Najjar syndrome type I.</span> Relatives of the patient were also analyzed. The patient was homozygous for a <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutation</span> of R341X. The patient's father, sister and brother, all <span class="tagged-filter" title="Association Word">diagnosed</span> with <span class="tagged-query" title="Query">Gilbert's syndrome,</span> were compound heterozygotes of R341X, P229Q, and an insertion <span class="tagged-filter" title="Association Word">mutation</span> of the TATA box [A (TA) 7TAA]. Heterozygotes of <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutations</span> (Q331X and C280X) in our previous study had either <span class="tagged-disease" title="UMLS Concept ID: C0268311">Crigler-Najjar syndrome type II</span> or <span class="tagged-query" title="Query">Gilbert's syndrome,</span> but heterozygotes of R341X (mother and grandmothers) were normal. An in vitro <span class="tagged-filter" title="Association Word">expression</span> study of homozygous and heterozygous models of R341X showed 0 and 58%, respectively, of normal <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity.</span> Therefore, the present results indicate that carriers of the <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutation</span> could be normal for plasma <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> concentration, <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0268311">Crigler-Najjar syndrome type II.</span> The results also suggest the importance of the accumulation of prevalent or <span class="tagged-filter" title="Association Word">polymorphic</span> <span class="tagged-filter" title="Association Word">mutation</span> in the etiology of <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0268311">Crigler-Najjar syndrome type II.</span>
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	12732365	<strong class="title">Kohle C, Mohrle B, Munzel PA, Schwab M, Wernet D, Badary OA, Bock KW: Frequent co-occurrence of the TATA box <span class="tagged-filter" title="Association Word">mutation</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome</span> (UGT1A1*28) with other <span class="tagged-filter" title="Association Word">polymorphisms</span> of the <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span>-1 <span class="tagged-filter" title="Association Word">locus</span> (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol. 2003 May 1;65(9):1521-7.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> of drug metabolizing enzymes are frequently <span class="tagged-filter" title="Association Word">associated</span> with diseases and side effects of drugs. Recently, a TATA box <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> (UGT1A1*28), a common genotype <span class="tagged-filter" title="Association Word">leading</span> to <span class="tagged-query" title="Query">Gilbert's syndrome,</span> and several missense <span class="tagged-filter" title="Association Word">mutations</span> of other <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT1)</a></span> family members have been described. Furthermore, co-occurrence of UGT1A1*28 and UGT1A6*2 has been <span class="tagged-filter" title="Association Word">observed.</span> In order to elucidate the basis for co-occurrence of <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1</a></span> <span class="tagged-filter" title="Association Word">mutations,</span> fluorescence resonance energy transfer techniques were developed for rapid determination of <span class="tagged-filter" title="Association Word">polymorphisms</span> of three <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> isoforms (UGT1A1*28, 1A6*2, and 1A7*2/*3). Hundred healthy Caucasians and 50 Egyptians were genotyped. All genotypes followed the Hardy-Weinberg equilibrium. Only three major haplotypes were found, including a haplotype consisting of allelic variants of all three isoforms (29% in Caucasians and 22% in Egyptians), all <span class="tagged-filter" title="Association Word">leading</span> to reduced <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">activity.</span> Frequent haplotypes containing several <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1</a></span> allelic variants should be taken into account in studies on the <span class="tagged-filter" title="Association Word">association</span> between diseases, abnormal drug reactions, and <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1</a></span> family <span class="tagged-filter" title="Association Word">polymorphisms.</span>
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	12499798	<strong class="title">Kim YH, Yeon JE, Jung GM, Kim HJ, Kim JS, Byun KS, Bak YT, Lee CH: [A study of <span class="tagged-filter" title="Association Word">polymorphism</span> in <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT</a></span>-1A1) promoter <span class="tagged-filter" title="Association Word">gene</span> in Korean patients with <span class="tagged-query" title="Query">Gilbert's syndrome].</span> Taehan Kan Hakhoe Chi. 2002 Jun;8(2):132-8.</strong> BACKGROUND/AIMS: Hepatic glucuronidating <span class="tagged-filter" title="Association Word">activity,</span> essential for efficient biliary excretion of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin,</a></span> is reduced to about 30 percent of normal in patients with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> have an additional TA insertion in the A (TA) TAA of <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT</a></span>-1A1) promoter <span class="tagged-filter" title="Association Word">gene.</span> This results in reduced frequency and accuracy of transcription initiation and <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity.</span> The frequency and location of the <span class="tagged-filter" title="Association Word">mutation</span> vary according to races. This study was done to determine the <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 promoter <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> in Korean cases of <span class="tagged-query" title="Query">Gilbert's syndrome.</span> METHODS: Promoter regions of the <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 in twelve patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> and twenty healthy subjects (controls) were sequenced. RESULTS: 1) Among twelve <span class="tagged-query" title="Query">Gilbert's syndrome</span> five patients were homozygous for A (TA) 6/6TAA, two were homozygous for A (TA) 7/7TAA, and the other five were heterozygous for A (TA) 6/7TAA. The prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> was 58.3 percent. 2) Among twenty healthy subjects seventeen were homozygous for A (TA) 6/6TAA, one was homozygous for A (TA) 7/7TAA, and two were heterozygous for A (TA) 6/7TAA. The prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> was 15 percent. 3) The prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-query" title="Query">Gilbert's syndrome</span> patients was significantly higher than in the controls (p=0.018). CONCLUSION: Although the prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> in Korean patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> is significantly higher than in the controls, the <span class="tagged-filter" title="Association Word">mutations</span> of the promoter region of <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 <span class="tagged-filter" title="Association Word">gene</span> appear not to be the main or sole <span class="tagged-filter" title="Association Word">cause</span> in <span class="tagged-query" title="Query">Gilbert's syndrome</span> in Korea since the prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> is not so high. Further studies to determine the relationship between other <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> and <span class="tagged-query" title="Query">Gilbert's syndrome</span> in Korea are needed.
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	12166768	<strong class="title">Chen YC, Chiou TJ, Yang MH, Yu IT: Two easy-to-perform diagnostic tests for <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Zhonghua Yi Xue Za Zhi. 2002 May;65(5):231-4.</strong> <span class="tagged-query" title="Query">Gilbert's syndrome</span> is a benign, often familial condition characterized by asymptomatic <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice.</span> A patient suffering from <span class="tagged-query" title="Query">Gilbert's syndrome</span> may have hepatic <span class="tagged-filter" title="Association Word">activity</span> of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span>-<a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> decreasing to levels around 30% of the normal. A clinical <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">Gilbert's syndrome</span> is usually followed in case of mild <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> with a high fraction of unconjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin,</a></span> normal values of liver enzymes, and no overt signs of hemolysis. This article reported a 17-year-old male with only partial indication of indirect <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia.</span> <span class="tagged-drug" title="DrugBank: APRD00207"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00207">Rifampicin</a></span> test and caloric restriction test were applied to assure the patient had <span class="tagged-query" title="Query">Gilbert's syndrome.</span> These two non-invasive diagnostic means, with the benefit of avoiding hazardous liver biopsy, are gaining popularity in our routine <span class="tagged-query" title="Query">Gilbert's syndrome</span> examination.
Gilbert_syndrome	UDP-glucuronosyltransferase	True Positive	7.560	12064902	<strong class="title">Beutler E, Gelbart T, Miller W: Severe <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice</span> in a patient with a previously undescribed <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">(G6PD)</a></span> <span class="tagged-filter" title="Association Word">mutation</span> and <span class="tagged-query" title="Query">Gilbert syndrome.</span> Blood Cells Mol Dis. 2002 Mar-Apr;28(2):104-7.</strong> A patient with chronic <span class="tagged-disease" title="UMLS Concept ID: C0002878">hemolytic anemia</span> and <span class="tagged-disease" title="UMLS Concept ID: C0017758">G6PD deficiency</span> was noted to be severely <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundiced</span> and to have a high serum <span class="tagged-gene" title="Protein Family or Complex">ferritin</span> level. Analysis of his DNA revealed only heterozygosity for the c.187 C--> G (H63D) <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: Q30201; Entrez Gene ID: 3077; HGNC ID: 4886; HPRD ID: 01993; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q30201">HFE,</a></span> but showed that he was homozygous for the <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP glucuronosyltransferase</a></span> promoter <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-query" title="Query">Gilbert's disease</span> and that he had a previously undescribed <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD,</a></span> c.832 T--> C (Ser278Pro). The new variant was named <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD</a></span> La Jolla.
Gilbert_syndrome	intestinal-alkaline-phosphatase	False Negative	1.226	2318988	<strong class="title">Lieverse AG, van Essen GG, Beukeveld GJ, Gazendam J, Dompeling EC, ten Kate LP, van Belle SA, Weits J: Familial increased serum <span class="tagged-gene" title="SwissProt ID: P09923; Entrez Gene ID: 248; HGNC ID: 437; HPRD ID: 01376; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09923">intestinal alkaline phosphatase:</a></span> a new variant <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> J Clin Pathol. 1990 Feb;43(2):125-8.</strong> Investigation of mild, inherited increased serum <span class="tagged-gene" title="SwissProt ID: P10696; Entrez Gene ID: 251; HGNC ID: 441; HPRD ID: 01380; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10696">alkaline phosphatase</a></span> <span class="tagged-filter" title="Association Word">activity</span> partially combined with <span class="tagged-query" title="Query">Gilbert's syndrome</span> in one family showed, apart from a normal liver fraction, an intestinal isoenzyme pattern and an extra band in the agar electrophoresis. Analysis by agarose electrophoresis before and after incubation of <span class="tagged-gene" title="SwissProt ID: Q99519; Entrez Gene ID: 4758; HGNC ID: 7758; HPRD ID: 09751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99519">neuraminidase</a></span> showed that the extra fraction was an intestinal variant isoenzyme. The precise genetic background of the two disorders in this family could not be determined from the available data. Abnormal activities of (regular) <span class="tagged-gene" title="SwissProt ID: P09923; Entrez Gene ID: 248; HGNC ID: 437; HPRD ID: 01376; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09923">intestinal alkaline phosphatase</a></span> isoenzyme <span class="tagged-filter" title="Association Word">caused</span> the increase in serum <span class="tagged-gene" title="SwissProt ID: P10696; Entrez Gene ID: 251; HGNC ID: 441; HPRD ID: 01380; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10696">alkaline phosphatase</a></span> in the <span class="tagged-filter" title="Association Word">absence</span> of disease.
Gilbert_syndrome	UDPGT	True Positive	18.445	16498946	<strong class="title">Mammaev SN: [Molecular <span class="tagged-filter" title="Association Word">diagnosis</span> of heritable unconjugated <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemias]</span> . Klin Lab Diagn. 2005 Dec;(12):8-13.</strong> There is considerable evidence suggesting that genetic damages to human <span class="tagged-metabolite" title="HMDB: HMDB00295"><span class="tagged-gene" title="SwissProt ID: Q9BY64; Entrez Gene ID: 54490; HGNC ID: 13479; HPRD ID: 05931; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span> glucuronyltransferase <a href="http://beta.uniprot.org/uniprot/Q9BY64">(UDPGT)</a></span> <span class="tagged-filter" title="Association Word">gene</span> located on clhromosome 2q37 are responsible for hereditary unconjugated <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemias</span> (HUHB). The <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler-Najjar syndrome</span> of types I and II is characterized by structural <span class="tagged-filter" title="Association Word">mutations</span> on one of 5 exons of HUHB <span class="tagged-filter" title="Association Word">gene,</span> resulting in the synthesis of defective catalytically inactive isoforms of the <span class="tagged-filter" title="Association Word">enzyme.</span> In <span class="tagged-query" title="Query">Gilbert's syndrome,</span> genetic alterations are located at the promoter of the <span class="tagged-filter" title="Association Word">gene</span> and accompanied by the nucleotide insert of <span class="tagged-metabolite" title="HMDB: HMDB00262"><span class="tagged-gene" title="SwissProt ID: Q9BY64; Entrez Gene ID: 54490; HGNC ID: 13479; HPRD ID: 05931; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00262">thymine</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00034"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00034">adenine</a></span> (TA). Promoter prolongation impairs the binding of IID transcription factor and <span class="tagged-filter" title="Association Word">leads</span> to the decreased <span class="tagged-filter" title="Association Word">production</span> of the <span class="tagged-filter" title="Association Word">enzyme</span> <a href="http://beta.uniprot.org/uniprot/Q9BY64">UDPGT</a></span> 1,1. Examination of the molecular epidemiology of <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations</span> of <span class="tagged-gene" title="SwissProt ID: Q9BY64; Entrez Gene ID: 54490; HGNC ID: 13479; HPRD ID: 05931; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9BY64">UDPGT</a></span> 1,1 that is typical of <span class="tagged-query" title="Query">Gilbert's syndrome</span> ascertained a great difference in the indices, from 2 to 16% in the Asian and European populations, respectively. In addition to polymerase chain reaction, high performance liquid chromatography may be used for the <span class="tagged-filter" title="Association Word">diagnosis</span> of genetic alterations in <span class="tagged-query" title="Query">Gilbert's syndrome.</span>
Gilbert_syndrome	UDPGT	True Positive	18.445	7252326	<strong class="title">Berk PD, Berman MD, Blitzer BL, Chretien P, Martin JF, Scharschmidt BF, Vierling JM, Wolkoff AW, Vergalla J, Waggoner JG: Effect of splenectomy of hepatic <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P16152; Entrez Gene ID: 873; HGNC ID: 1548; HPRD ID: 00267; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> clearance in patients with <span class="tagged-disease" title="UMLS Concept ID: C0037889">hereditary spherocytosis.</span> J Lab Clin Med. 1981 Jul;98(1):37-45.</strong> Implications for the <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">Gilbert's syndrome.</span> BRT and <a href="http://beta.uniprot.org/uniprot/P16152">CBR</a></span> were determined from studies of radiobilirubin kinetics in 14 patients undergoing splenectomy for <span class="tagged-disease" title="UMLS Concept ID: C0037889">hereditary spherocytosis.</span> Studies were conducted both before and after the operation in order to assess the effects of the postsplenectomy fall in BRT on <span class="tagged-gene" title="SwissProt ID: P16152; Entrez Gene ID: 873; HGNC ID: 1548; HPRD ID: 00267; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16152">CBR.</a></span> Splenectomy <span class="tagged-filter" title="Association Word">led</span> to a doubling of the RBC-t1/2 from 13.0 +/- 1.7 (S.E.) days to 26.1 +/- 1.5 and a fall in BRT from 15.9 +/- 4.4 mg/kg/day to 4.3 +/- 0.9. In seven patients (group A) initially normal values for <span class="tagged-gene" title="SwissProt ID: P16152; Entrez Gene ID: 873; HGNC ID: 1548; HPRD ID: 00267; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16152">CBR</a></span> were unaltered by surgery. In the remaining seven (group B), low preoperative values for <span class="tagged-gene" title="SwissProt ID: P16152; Entrez Gene ID: 873; HGNC ID: 1548; HPRD ID: 00267; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16152">CBR,</a></span> suggestive of <span class="tagged-query" title="Query">Gilbert's syndrome,</span> uniformly improved after splenectomy, becoming normal in five patients. Nevertheless, family studies and reduced values for <span class="tagged-gene" title="SwissProt ID: Q9BY64; Entrez Gene ID: 54490; HGNC ID: 13479; HPRD ID: 05931; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9BY64">UDPGT</a></span> <span class="tagged-filter" title="Association Word">activity</span> supported the initial impression of concomitant <span class="tagged-query" title="Query">Gilbert's syndrome</span> in group B. These studies suggest the existence of a latent state for <span class="tagged-query" title="Query">Gilbert's syndrome</span> that, in some patients, may be unmasked by a hemolytic stress. As such, they have important implications for both pedigree analysis and incidence studies of this condition.
Gilbert_syndrome	UDPGT	True Positive	18.445	383356	<strong class="title">Macklon AF, Savage RL, Rawlins MD: <span class="tagged-query" title="Query">Gilbert's syndrome</span> and drug metabolism. Clin Pharmacokinet. 1979 May-Jun;4(3):223-32.</strong> <span class="tagged-query" title="Query">Gilbert's syndrome</span> is an inherited disorder which is characterised by <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinaemia.</span> In patients with <span class="tagged-query" title="Query">Gilbert's syndrome,</span> both <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9BY64; Entrez Gene ID: 54490; HGNC ID: 13479; HPRD ID: 05931; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> clearance and in vitro hepatic microsomal <span class="tagged-metabolite" title="HMDB: HMDB00296"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00296">uridine</a></span> diphosphoglucuronyl transferase <a href="http://beta.uniprot.org/uniprot/Q9BY64">(UDPGT)</a></span> <span class="tagged-filter" title="Association Word">activity</span> are reduced. In addition, there is evidence suggesting impaired hepatic uptake of <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> in <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Glucuronidation of a number of substrates appears to be impaired in <span class="tagged-query" title="Query">Gilbert's syndrome,</span> but the significance of the reported changes in oxidation and acetylation are less clear.
Gilbert_syndrome	G6PD	True Negative	1.226	12064902	<strong class="title">Beutler E, Gelbart T, Miller W: Severe <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice</span> in a patient with a previously undescribed <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">(G6PD)</a></span> <span class="tagged-filter" title="Association Word">mutation</span> and <span class="tagged-query" title="Query">Gilbert syndrome.</span> Blood Cells Mol Dis. 2002 Mar-Apr;28(2):104-7.</strong> A patient with chronic <span class="tagged-disease" title="UMLS Concept ID: C0002878">hemolytic anemia</span> and <span class="tagged-disease" title="UMLS Concept ID: C0017758">G6PD deficiency</span> was noted to be severely <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundiced</span> and to have a high serum <span class="tagged-gene" title="Protein Family or Complex">ferritin</span> level. Analysis of his DNA revealed only heterozygosity for the c.187 C--> G (H63D) <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: Q30201; Entrez Gene ID: 3077; HGNC ID: 4886; HPRD ID: 01993; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q30201">HFE,</a></span> but showed that he was homozygous for the <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP glucuronosyltransferase</a></span> promoter <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-query" title="Query">Gilbert's disease</span> and that he had a previously undescribed <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD,</a></span> c.832 T--> C (Ser278Pro). The new variant was named <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD</a></span> La Jolla.
Gilbert_syndrome	G6PD	True Negative	1.226	10359058	<strong class="title">Iolascon A, Faienza MF, Giordani L, Perrotta S, Ruggiu G, Meloni GF, del Giudice EM: <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">Bilirubin</a></span> levels in the acute <span class="tagged-disease" title="UMLS Concept ID: C0302110">hemolytic crisis</span> of <span class="tagged-disease" title="UMLS Concept ID: C0017758">G6PD deficiency</span> are <span class="tagged-filter" title="Association Word">related</span> to <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Eur J Haematol. 1999 May;62(5):307-10.</strong> In this study we analyzed the effect of the (TA) 7 <span class="tagged-filter" title="Association Word">polymorphism</span> of the <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome</span> in <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> subjects during an acute <span class="tagged-disease" title="UMLS Concept ID: C0302110">hemolytic crisis</span> (fabic crisis). DNA from 44 subjects originating from the same geographic area in Sardinia was analyzed for the <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism.</span> The increase of unconjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> level during fabic crisis and its relationship with <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> <span class="tagged-filter" title="Association Word">polymorphism</span> was evaluated. The <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> (TA) 7 TATA box variant was found in 9/44 (21%) of the <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD</a></span> <span class="tagged-filter" title="Association Word">deficient</span> subjects examined. The median value for unit of increase of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> (mg/dl)/unit of decrease of <span class="tagged-gene" title="Protein Family or Complex">hemoglobin</span> (g/dl) was higher in variant homozygous than in heterozygous and normal subjects. These findings imply a contribution of the <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> <span class="tagged-filter" title="Association Word">polymorphism</span> <span class="tagged-filter" title="Association Word">associated</span> to <span class="tagged-query" title="Query">Gilbert's syndrome</span> to development of the <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> in <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD</a></span> <span class="tagged-filter" title="Association Word">deficient</span> subjects during acute <span class="tagged-disease" title="UMLS Concept ID: C0002878">hemolytic anemia.</span>
Gilbert_syndrome	CDA-II	True Negative	1.226	10753261	<strong class="title">Perrotta S, del Giudice EM, Carbone R, Servedio V, Schettini F Jr, Nobili B, Iolascon A: <span class="tagged-query" title="Query">Gilbert's syndrome</span> accounts for the phenotypic variability of <span class="tagged-disease" title="UMLS Concept ID: C1306589">congenital dyserythropoietic anemia type II</span> <span class="tagged-gene" title="Entrez Gene ID: 980; HGNC ID: 1714; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=980">(CDA-II).</a></span> J Pediatr. 2000 Apr;136(4):556-9.</strong> The molecular basis for the considerable variation of serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P32320; Entrez Gene ID: 978; HGNC ID: 1712; HPRD ID: 11744; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels and the incidence of <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002876">congenital dyserythropoietic anemia</span> <a href="http://beta.uniprot.org/uniprot/P32320">(CDA)</a></span> type II are unknown. We show that the combined effect of an increased <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 980; HGNC ID: 1714; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> load <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-disease" title="UMLS Concept ID: C0221143">dyserythropoiesis</span> in <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=980">CDA II</a></span> and decreased <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> conjugation <span class="tagged-filter" title="Association Word">caused</span> by reduced <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span> glucuronosyl transferase <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT1A)</a></span> would increase the risk of <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> (P <.005) and <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation (chi (2): P <. 001). The rate of <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation in patients with <span class="tagged-gene" title="Entrez Gene ID: 980; HGNC ID: 1714; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=980">CDA II</a></span> is 4. 75-fold the rate of patients without <span class="tagged-query" title="Query">Gilbert's syndrome,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> <span class="tagged-filter" title="Association Word">diagnosis</span> occurs at a younger age (P < 0.01). These findings should be considered during the follow-up of patients with <span class="tagged-gene" title="Entrez Gene ID: 980; HGNC ID: 1714; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=980">CDA II.</a></span>
Gilbert_syndrome	NF-1	False Negative	1.226	12828702	<strong class="title">Kocer U, Uysal A, Sungur N, Karaaslan O, Kankaya Y, Tiftikcioglu Y: Familial <span class="tagged-disease" title="UMLS Concept ID: C0027831">neurofibromatosis-1</span> and <span class="tagged-query" title="Query">Gilbert syndrome.</span> Dermatol Surg. 2003 Jul;29(7):759-65.</strong> BACKGROUND: <span class="tagged-disease" title="UMLS Concept ID: C0162678">Neurofibromatosis</span> (NF) is a <span class="tagged-disease" title="UMLS Concept ID: C0019247">genetic disorder</span> of the neural sheet, affecting almost all organ systems. METHOD: A family that consisted of the father and his three children, two males and one female, having <span class="tagged-gene" title="SwissProt ID: P21359; Entrez Gene ID: 4763; HGNC ID: 7765; HPRD ID: 01203; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21359">NF-1</a></span> is evaluated in detail for cosmetic purposes. The routine preoperative laboratory examinations, including complete blood counts, serum biochemistries, urinary analysis, extremity and chest roentgenograms, ultrasounds of the abdomen and the affected regions, and pelvic computed tomographies, revealed characteristics of <span class="tagged-gene" title="SwissProt ID: P21359; Entrez Gene ID: 4763; HGNC ID: 7765; HPRD ID: 01203; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21359">NF-1</a></span> and unexpected <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia.</span> The patients are evaluated further for the <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> by the fasting test. Variously localized <span class="tagged-disease" title="UMLS Concept ID: C0206728">plexiform neurofibromas</span> of the three children are totally excised. RESULTS: The father was affected as a result of a <span class="tagged-filter" title="Association Word">mutation,</span> and his three children had inherited the disease. The father, having subcutaneous <span class="tagged-disease" title="UMLS Concept ID: C0027830">neurofibromas,</span> differs from the children, as they have <span class="tagged-disease" title="UMLS Concept ID: C1275120">elephantiasis neurofibromatosa.</span> The children had various rare clinical presentations besides disfiguring deformities. Two male patients had retroperitoneal <span class="tagged-disease" title="UMLS Concept ID: C0027830">neurofibromas,</span> and one had splenomegaly and osseous changes. <span class="tagged-query" title="Query">Gilbert's disease</span> was <span class="tagged-filter" title="Association Word">diagnosed,</span> interestingly, and coincidentally in the three patients with <span class="tagged-disease" title="UMLS Concept ID: C0013882">elephantiasis</span> due to <span class="tagged-gene" title="SwissProt ID: P21359; Entrez Gene ID: 4763; HGNC ID: 7765; HPRD ID: 01203; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21359">NF-1.</a></span> DISCUSSION: An interesting <span class="tagged-filter" title="Association Word">diagnosis</span> of NF occurring coincidentally with <span class="tagged-query" title="Query">Gilbert's disease</span> in a family is reported. This clinical study is the first report of <span class="tagged-query" title="Query">Gilbert's disease</span> accompanying familial NF.
Gilbert_syndrome	beta-glucuronidase	True Negative	1.226	13696471	<strong class="title">CRISALLI M, BORRONE C: [Demonstration of an <span class="tagged-filter" title="Association Word">enzyme</span> defect <span class="tagged-gene" title="SwissProt ID: P08236; Entrez Gene ID: 2990; HGNC ID: 4696; HPRD ID: 02018; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08236">(beta-glucuronidase)</a></span> in a case of familial non-<span class="tagged-disease" title="UMLS Concept ID: C0242183">hemolytic jaundice</span> <span class="tagged-query" title="Query">(Gilbert's disease?).]</span> Minerva Pediatr. 1960 Aug 25;12:967-9.</strong>
Gilbert_syndrome	serum-albumin	True Negative	1.226	8251611	<strong class="title">Sugimoto M, Shimada N, Aikawa K, Sugiyama Y: Relationship between content of hepatic <span class="tagged-gene" title="Protein Family or Complex">glutathione S-transferases</span> and the kinetics of indocyanine green elimination in various <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases.</span> Biopharm Drug Dispos. 1993 Oct;14(7):567-78.</strong> The <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P48637; Entrez Gene ID: 2937; HGNC ID: 4624; HPRD ID: 03000; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> <a href="http://beta.uniprot.org/uniprot/P48637">(GSH) S</a></span>-transferases are believed to have dual functions as hepatic detoxifying enzymes and intrahepatic binding <span class="tagged-filter" title="Association Word">proteins.</span> Little is known about their alterations in human <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases.</span> Therefore, we have studied the relationship between the <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> and rose bengal (RB) binding in hepatic cytosol and plasma indocyanine green (ICG) kinetics in patients with various <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases.</span> The <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> was measured in samples of hepatic cytosol obtained from 52 patients. In addition, the content of cationic and neutral transferases was estimated in 17 biopsy samples by densitometry of Coomassie blue stained <span class="tagged-metabolite" title="HMDB: HMDB05004"><span class="tagged-gene" title="SwissProt ID: P06276; Entrez Gene ID: 590; HGNC ID: 983; HPRD ID: 01519; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB05004">sodium dodecyl sulphate</a></span> polyacrylamide gel electrophoretograms. RB binding studies also were performed on cytosol samples. ICG kinetic parameters were determined using the two-compartment open model in 17 patients who were given the dye (0.5 mg kg-1) intravenously. Correlations between the <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> and liver function tests, content of the <span class="tagged-filter" title="Association Word">enzyme,</span> RB binding and ICG kinetic parameters were evaluated. The following results were obtained. (1) The <span class="tagged-filter" title="Association Word">enzyme</span> activities were high in <span class="tagged-disease" title="UMLS Concept ID: C0023896">alcoholic liver disease,</span> fatty liver and <span class="tagged-query" title="Query">Gilbert's syndrome,</span> and low in <span class="tagged-disease" title="UMLS Concept ID: C1563323">cirrhosis.</span> (2) The <span class="tagged-filter" title="Association Word">enzyme</span> activities were positively correlated with serum <a href="http://beta.uniprot.org/uniprot/P06276">cholinesterase</a></span> <span class="tagged-filter" title="Association Word">activity,</span> <span class="tagged-gene" title="SwissProt ID: P02768; Entrez Gene ID: 213; HGNC ID: 399; HPRD ID: 00062; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02768">serum albumin</a></span> level and hepaplastin test, and negatively correlated with ICG retention rate at 15 min. (3) The <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity,</span> its content and RB binding affinity of the cytosol were positively correlated with each other. (4) The <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> was positively correlated with hepatic ICG distribution volume. These results are consistent with the <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-gene" title="SwissProt ID: P48637; Entrez Gene ID: 2937; HGNC ID: 4624; HPRD ID: 03000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P48637">GSH S</a></span>-transferases as ligandins in intracellular storage of dyes.
Gilbert_syndrome	cholinesterase	False Positive	1.374	8251611	<strong class="title">Sugimoto M, Shimada N, Aikawa K, Sugiyama Y: Relationship between content of hepatic <span class="tagged-gene" title="Protein Family or Complex">glutathione S-transferases</span> and the kinetics of indocyanine green elimination in various <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases.</span> Biopharm Drug Dispos. 1993 Oct;14(7):567-78.</strong> The <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P48637; Entrez Gene ID: 2937; HGNC ID: 4624; HPRD ID: 03000; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> <a href="http://beta.uniprot.org/uniprot/P48637">(GSH) S</a></span>-transferases are believed to have dual functions as hepatic detoxifying enzymes and intrahepatic binding <span class="tagged-filter" title="Association Word">proteins.</span> Little is known about their alterations in human <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases.</span> Therefore, we have studied the relationship between the <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> and rose bengal (RB) binding in hepatic cytosol and plasma indocyanine green (ICG) kinetics in patients with various <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases.</span> The <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> was measured in samples of hepatic cytosol obtained from 52 patients. In addition, the content of cationic and neutral transferases was estimated in 17 biopsy samples by densitometry of Coomassie blue stained <span class="tagged-metabolite" title="HMDB: HMDB05004"><span class="tagged-gene" title="SwissProt ID: P06276; Entrez Gene ID: 590; HGNC ID: 983; HPRD ID: 01519; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB05004">sodium dodecyl sulphate</a></span> polyacrylamide gel electrophoretograms. RB binding studies also were performed on cytosol samples. ICG kinetic parameters were determined using the two-compartment open model in 17 patients who were given the dye (0.5 mg kg-1) intravenously. Correlations between the <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> and liver function tests, content of the <span class="tagged-filter" title="Association Word">enzyme,</span> RB binding and ICG kinetic parameters were evaluated. The following results were obtained. (1) The <span class="tagged-filter" title="Association Word">enzyme</span> activities were high in <span class="tagged-disease" title="UMLS Concept ID: C0023896">alcoholic liver disease,</span> fatty liver and <span class="tagged-query" title="Query">Gilbert's syndrome,</span> and low in <span class="tagged-disease" title="UMLS Concept ID: C1563323">cirrhosis.</span> (2) The <span class="tagged-filter" title="Association Word">enzyme</span> activities were positively correlated with serum <a href="http://beta.uniprot.org/uniprot/P06276">cholinesterase</a></span> <span class="tagged-filter" title="Association Word">activity,</span> <span class="tagged-gene" title="SwissProt ID: P02768; Entrez Gene ID: 213; HGNC ID: 399; HPRD ID: 00062; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02768">serum albumin</a></span> level and hepaplastin test, and negatively correlated with ICG retention rate at 15 min. (3) The <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity,</span> its content and RB binding affinity of the cytosol were positively correlated with each other. (4) The <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> was positively correlated with hepatic ICG distribution volume. These results are consistent with the <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-gene" title="SwissProt ID: P48637; Entrez Gene ID: 2937; HGNC ID: 4624; HPRD ID: 03000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P48637">GSH S</a></span>-transferases as ligandins in intracellular storage of dyes.
Gilbert_syndrome	thiopurine-S-methyltransferase	True Negative	1.226	8361990	<strong class="title">Daly AK, Cholerton S, Gregory W, Idle JR: Metabolic <span class="tagged-filter" title="Association Word">polymorphisms.</span> Pharmacol Ther. 1993 Feb-Mar;57(2-3):129-60.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> have been detected in a variety of xenobiotic-metabolizing enzymes at both the phenotypic and genotypic level. In the case of four enzymes, the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> <span class="tagged-gene" title="SwissProt ID: P10635; Entrez Gene ID: 1565; HGNC ID: 2625; HPRD ID: 00487; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10635">CYP2D6,</a></span> <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> mu, <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> and serum <span class="tagged-gene" title="SwissProt ID: P06276; Entrez Gene ID: 590; HGNC ID: 983; HPRD ID: 01519; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06276">cholinesterase,</a></span> the majority of <span class="tagged-filter" title="Association Word">mutations</span> which give rise to a defective phenotype have now been identified. Another group of enzymes show definite <span class="tagged-filter" title="Association Word">polymorphism</span> at the phenotypic level but the exact genetic mechanisms responsible are not yet clear. These enzymes include the cytochromes P450 <span class="tagged-gene" title="SwissProt ID: P04798; Entrez Gene ID: 1543; HGNC ID: 2595; HPRD ID: 00148; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04798">CYP1A1,</a></span> <span class="tagged-gene" title="SwissProt ID: P05177; Entrez Gene ID: 1544; HGNC ID: 2596; HPRD ID: 00489; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05177">CYP1A2</a></span> and a <span class="tagged-gene" title="SwissProt ID: P33261; Entrez Gene ID: 1557; HGNC ID: 2621; HPRD ID: 00486; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P33261">CYP2C</a></span> form which metabolizes <span class="tagged-drug" title="DrugBank: APRD00512"><span class="tagged-gene" title="SwissProt ID: P27169; Entrez Gene ID: 5444; HGNC ID: 9204; HPRD ID: 01351; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00512">mephenytoin,</a></span> a <span class="tagged-drug" title="DrugBank: APRD00626"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00626">flavin</a></span>-<span class="tagged-filter" title="Association Word">linked</span> monooxygenase <span class="tagged-disease" title="UMLS Concept ID: C0342739">(fish-odour syndrome),</span> <a href="http://beta.uniprot.org/uniprot/P27169">paraoxonase,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-query" title="Query">(Gilbert's syndrome)</span> and <span class="tagged-gene" title="SwissProt ID: P51580; Entrez Gene ID: 7172; HGNC ID: 12014; HPRD ID: 01760; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51580">thiopurine S-methyltransferase.</a></span> In the case of a further group of enzymes, there is some evidence for <span class="tagged-filter" title="Association Word">polymorphism</span> at either the phenotypic or genotypic level but this has not been unambiguously demonstrated. Examples of this class include the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> enzymes <span class="tagged-gene" title="SwissProt ID: P11509; Entrez Gene ID: 1548; HGNC ID: 2610; HPRD ID: 00420; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11509">CYP2A6,</a></span> <span class="tagged-gene" title="SwissProt ID: P05181; Entrez Gene ID: 1571; HGNC ID: 2631; HPRD ID: 11813; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05181">CYP2E1,</a></span> <span class="tagged-gene" title="SwissProt ID: P11712; Entrez Gene ID: 1559; HGNC ID: 2623; HPRD ID: 03084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11712">CYP2C9</a></span> and <span class="tagged-gene" title="SwissProt ID: P05184; Entrez Gene ID: 1576; HGNC ID: 2637; HPRD ID: 00484; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05184">CYP3A4,</a></span> <span class="tagged-gene" title="SwissProt ID: P47989; Entrez Gene ID: 7498; HGNC ID: 12805; HPRD ID: 06363; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P47989">xanthine oxidase,</a></span> an S-oxidase which metabolizes <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P07099; Entrez Gene ID: 2052; HGNC ID: 3401; HPRD ID: 00581; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">carbocysteine,</a></span> <a href="http://beta.uniprot.org/uniprot/P07099">epoxide hydrolase,</a></span> two forms of sulphotransferase and several methyltransferases. The nature of all these <span class="tagged-filter" title="Association Word">polymorphisms</span> and possible <span class="tagged-filter" title="Association Word">polymorphisms</span> is discussed in detail, with particular reference to the effects of this variation on drug metabolism and susceptibility to chemically-induced diseases.
Gilbert_syndrome	pyruvate-dehydrogenase	True Negative	1.226	7768386	<strong class="title">Gordon SC, Quattrociocchi-Longe TM, Khan BA, Kodali VP, Chen J, Silverman AL, Kiechle FL: <span class="tagged-filter" title="Association Word">Antibodies</span> to <span class="tagged-gene" title="Protein Family or Complex">carbonic anhydrase</span> in patients with immune cholangiopathies. Gastroenterology. 1995 Jun;108(6):1802-9.</strong> BACKGROUND/AIMS: Bile duct epithelia contain an abundance of <span class="tagged-gene" title="Protein Family or Complex">carbonic anhydrase.</span> <span class="tagged-filter" title="Association Word">Antibodies</span> to this <span class="tagged-filter" title="Association Word">enzyme</span> have been described in <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune disorders.</span> Serum from patients with immune-mediated <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases</span> was studied to determine whether <span class="tagged-filter" title="Association Word">antibodies</span> to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> and/or <span class="tagged-gene" title="Protein Family or Complex">pyruvate dehydrogenase</span> could distinguish autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> as immunologically distinct from <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis.</span> METHODS: <span class="tagged-filter" title="Association Word">Antibody</span> assays to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> (Western blot) and <span class="tagged-gene" title="Protein Family or Complex">pyruvate dehydrogenase</span> (flow cytometry) were performed on the sera of patients with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> (6), <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis</span> (12), <span class="tagged-disease" title="UMLS Concept ID: C0566602">primary sclerosing cholangitis</span> (12), <span class="tagged-disease" title="UMLS Concept ID: C0241910">autoimmune hepatitis</span> (12), and control <span class="tagged-query" title="Query">(Gilbert syndrome;</span> 8). RESULTS: Reactivity to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> was detected in 5 of 6 patients with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis,</span> 1 of 12 patients with <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis,</span> 1 of 12 patients with <span class="tagged-disease" title="UMLS Concept ID: C0241910">autoimmune hepatitis,</span> and no other patients. Individuals with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> were more likely than the other patients to be reactive to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> (P < 0.001). Patients with <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis</span> were more reactive to <span class="tagged-gene" title="Protein Family or Complex">pyruvate dehydrogenase</span> compared with all other groups (P < 0.001). CONCLUSIONS: An <span class="tagged-filter" title="Association Word">antibody</span> to human <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> is frequently detected in the sera of patients with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> and is uncommon or not present in other cholangiopathies. These data provide evidence that autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis</span> represent distinct entities with unique patterns of immunoreactivity.
Gilbert_syndrome	CN-II	True Negative	1.226	9630669	<strong class="title">Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T: Contribution of two missense <span class="tagged-filter" title="Association Word">mutations</span> (G71R and Y486D) of the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q5NDL2; Entrez Gene ID: 285203; HGNC ID: 28526; HPRD ID: 12435; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">UDP</a></span> <a href="http://beta.uniprot.org/uniprot/Q5NDL2">glycosyltransferase</a></span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> to phenotypes of <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0268311">Crigler-Najjar syndrome type II.</span> Biochim Biophys Acta. 1998 Apr 28;1406(3):267-73.</strong> In our <span class="tagged-filter" title="Association Word">mutation</span> analyses of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q5NDL2; Entrez Gene ID: 285203; HGNC ID: 28526; HPRD ID: 12435; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">UDP</a></span> <a href="http://beta.uniprot.org/uniprot/Q5NDL2">glycosyltransferase</a></span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene,</span> we encountered six patients with <span class="tagged-disease" title="UMLS Concept ID: C0268311">Crigler-Najjar syndrome type II</span> who were double homozygotes for G71R and Y486D, a patient with <span class="tagged-query" title="Query">Gilbert's syndrome</span> who was a single homozygote for G71R and six patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> who were single heterozygote for G71R. To clarify the role of each <span class="tagged-filter" title="Association Word">mutation</span> in the occurrence of the two syndromes, we made four mutant <span class="tagged-filter" title="Association Word">expression</span> models. Relative <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">activity</span> of a single homozygous model of G71R was 32.2+/-1.6% of normal, that of a single homozygous model of Y486D was 7.6+/-0.5%, that of a double homozygous model of G71R and Y486D was 6.2+/-1.6% and that of a heterozygous model of G71R was 60.2+/-3.5%. The decreased activities of the single homozygous model of G71R and the double homozygous model were at an appropriate level to be <span class="tagged-filter" title="Association Word">diagnosed</span> as <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-gene" title="SwissProt ID: P49902; Entrez Gene ID: 22978; HGNC ID: 8022; HPRD ID: 02686; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P49902">CN-II,</a></span> respectively. The <span class="tagged-filter" title="Association Word">activity</span> of a single heterozygous model of G71R was somewhat high to develop to the phenotype of <span class="tagged-query" title="Query">Gilbert's syndrome,</span> suggesting the presence of additional factors for the etiology of <span class="tagged-query" title="Query">Gilbert's syndrome.</span>
Gilbert_syndrome	CYP2C	False Positive	4.353	8361990	<strong class="title">Daly AK, Cholerton S, Gregory W, Idle JR: Metabolic <span class="tagged-filter" title="Association Word">polymorphisms.</span> Pharmacol Ther. 1993 Feb-Mar;57(2-3):129-60.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> have been detected in a variety of xenobiotic-metabolizing enzymes at both the phenotypic and genotypic level. In the case of four enzymes, the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> <span class="tagged-gene" title="SwissProt ID: P10635; Entrez Gene ID: 1565; HGNC ID: 2625; HPRD ID: 00487; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10635">CYP2D6,</a></span> <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> mu, <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> and serum <span class="tagged-gene" title="SwissProt ID: P06276; Entrez Gene ID: 590; HGNC ID: 983; HPRD ID: 01519; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06276">cholinesterase,</a></span> the majority of <span class="tagged-filter" title="Association Word">mutations</span> which give rise to a defective phenotype have now been identified. Another group of enzymes show definite <span class="tagged-filter" title="Association Word">polymorphism</span> at the phenotypic level but the exact genetic mechanisms responsible are not yet clear. These enzymes include the cytochromes P450 <span class="tagged-gene" title="SwissProt ID: P04798; Entrez Gene ID: 1543; HGNC ID: 2595; HPRD ID: 00148; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04798">CYP1A1,</a></span> <span class="tagged-gene" title="SwissProt ID: P05177; Entrez Gene ID: 1544; HGNC ID: 2596; HPRD ID: 00489; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05177">CYP1A2</a></span> and a <span class="tagged-gene" title="SwissProt ID: P33261; Entrez Gene ID: 1557; HGNC ID: 2621; HPRD ID: 00486; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P33261">CYP2C</a></span> form which metabolizes <span class="tagged-drug" title="DrugBank: APRD00512"><span class="tagged-gene" title="SwissProt ID: P27169; Entrez Gene ID: 5444; HGNC ID: 9204; HPRD ID: 01351; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00512">mephenytoin,</a></span> a <span class="tagged-drug" title="DrugBank: APRD00626"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00626">flavin</a></span>-<span class="tagged-filter" title="Association Word">linked</span> monooxygenase <span class="tagged-disease" title="UMLS Concept ID: C0342739">(fish-odour syndrome),</span> <a href="http://beta.uniprot.org/uniprot/P27169">paraoxonase,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-query" title="Query">(Gilbert's syndrome)</span> and <span class="tagged-gene" title="SwissProt ID: P51580; Entrez Gene ID: 7172; HGNC ID: 12014; HPRD ID: 01760; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51580">thiopurine S-methyltransferase.</a></span> In the case of a further group of enzymes, there is some evidence for <span class="tagged-filter" title="Association Word">polymorphism</span> at either the phenotypic or genotypic level but this has not been unambiguously demonstrated. Examples of this class include the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> enzymes <span class="tagged-gene" title="SwissProt ID: P11509; Entrez Gene ID: 1548; HGNC ID: 2610; HPRD ID: 00420; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11509">CYP2A6,</a></span> <span class="tagged-gene" title="SwissProt ID: P05181; Entrez Gene ID: 1571; HGNC ID: 2631; HPRD ID: 11813; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05181">CYP2E1,</a></span> <span class="tagged-gene" title="SwissProt ID: P11712; Entrez Gene ID: 1559; HGNC ID: 2623; HPRD ID: 03084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11712">CYP2C9</a></span> and <span class="tagged-gene" title="SwissProt ID: P05184; Entrez Gene ID: 1576; HGNC ID: 2637; HPRD ID: 00484; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05184">CYP3A4,</a></span> <span class="tagged-gene" title="SwissProt ID: P47989; Entrez Gene ID: 7498; HGNC ID: 12805; HPRD ID: 06363; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P47989">xanthine oxidase,</a></span> an S-oxidase which metabolizes <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P07099; Entrez Gene ID: 2052; HGNC ID: 3401; HPRD ID: 00581; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">carbocysteine,</a></span> <a href="http://beta.uniprot.org/uniprot/P07099">epoxide hydrolase,</a></span> two forms of sulphotransferase and several methyltransferases. The nature of all these <span class="tagged-filter" title="Association Word">polymorphisms</span> and possible <span class="tagged-filter" title="Association Word">polymorphisms</span> is discussed in detail, with particular reference to the effects of this variation on drug metabolism and susceptibility to chemically-induced diseases.
Gilbert_syndrome	haptoglobin	True Negative	1.226	891855	<strong class="title">Platzer R, Bircher J: No <span class="tagged-filter" title="Association Word">association</span> between <span class="tagged-query" title="Query">Gilbert's syndrome,</span> the <span class="tagged-gene" title="SwissProt ID: O14759; Entrez Gene ID: 28; HGNC ID: 79; HPRD ID: 05821; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14759">ABO</a></span> blood groups and the <span class="tagged-gene" title="SwissProt ID: P00738; Entrez Gene ID: 3240; HGNC ID: 5141; HPRD ID: 00772; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00738">haptoglobin</a></span> phenotypes. Experientia. 1977 Sep 15;33(9):1142-3.</strong>
Gilbert_syndrome	CYP1A1	True Negative	1.226	8361990	<strong class="title">Daly AK, Cholerton S, Gregory W, Idle JR: Metabolic <span class="tagged-filter" title="Association Word">polymorphisms.</span> Pharmacol Ther. 1993 Feb-Mar;57(2-3):129-60.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> have been detected in a variety of xenobiotic-metabolizing enzymes at both the phenotypic and genotypic level. In the case of four enzymes, the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> <span class="tagged-gene" title="SwissProt ID: P10635; Entrez Gene ID: 1565; HGNC ID: 2625; HPRD ID: 00487; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10635">CYP2D6,</a></span> <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> mu, <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> and serum <span class="tagged-gene" title="SwissProt ID: P06276; Entrez Gene ID: 590; HGNC ID: 983; HPRD ID: 01519; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06276">cholinesterase,</a></span> the majority of <span class="tagged-filter" title="Association Word">mutations</span> which give rise to a defective phenotype have now been identified. Another group of enzymes show definite <span class="tagged-filter" title="Association Word">polymorphism</span> at the phenotypic level but the exact genetic mechanisms responsible are not yet clear. These enzymes include the cytochromes P450 <span class="tagged-gene" title="SwissProt ID: P04798; Entrez Gene ID: 1543; HGNC ID: 2595; HPRD ID: 00148; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04798">CYP1A1,</a></span> <span class="tagged-gene" title="SwissProt ID: P05177; Entrez Gene ID: 1544; HGNC ID: 2596; HPRD ID: 00489; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05177">CYP1A2</a></span> and a <span class="tagged-gene" title="SwissProt ID: P33261; Entrez Gene ID: 1557; HGNC ID: 2621; HPRD ID: 00486; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P33261">CYP2C</a></span> form which metabolizes <span class="tagged-drug" title="DrugBank: APRD00512"><span class="tagged-gene" title="SwissProt ID: P27169; Entrez Gene ID: 5444; HGNC ID: 9204; HPRD ID: 01351; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00512">mephenytoin,</a></span> a <span class="tagged-drug" title="DrugBank: APRD00626"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00626">flavin</a></span>-<span class="tagged-filter" title="Association Word">linked</span> monooxygenase <span class="tagged-disease" title="UMLS Concept ID: C0342739">(fish-odour syndrome),</span> <a href="http://beta.uniprot.org/uniprot/P27169">paraoxonase,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-query" title="Query">(Gilbert's syndrome)</span> and <span class="tagged-gene" title="SwissProt ID: P51580; Entrez Gene ID: 7172; HGNC ID: 12014; HPRD ID: 01760; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51580">thiopurine S-methyltransferase.</a></span> In the case of a further group of enzymes, there is some evidence for <span class="tagged-filter" title="Association Word">polymorphism</span> at either the phenotypic or genotypic level but this has not been unambiguously demonstrated. Examples of this class include the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> enzymes <span class="tagged-gene" title="SwissProt ID: P11509; Entrez Gene ID: 1548; HGNC ID: 2610; HPRD ID: 00420; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11509">CYP2A6,</a></span> <span class="tagged-gene" title="SwissProt ID: P05181; Entrez Gene ID: 1571; HGNC ID: 2631; HPRD ID: 11813; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05181">CYP2E1,</a></span> <span class="tagged-gene" title="SwissProt ID: P11712; Entrez Gene ID: 1559; HGNC ID: 2623; HPRD ID: 03084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11712">CYP2C9</a></span> and <span class="tagged-gene" title="SwissProt ID: P05184; Entrez Gene ID: 1576; HGNC ID: 2637; HPRD ID: 00484; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05184">CYP3A4,</a></span> <span class="tagged-gene" title="SwissProt ID: P47989; Entrez Gene ID: 7498; HGNC ID: 12805; HPRD ID: 06363; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P47989">xanthine oxidase,</a></span> an S-oxidase which metabolizes <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P07099; Entrez Gene ID: 2052; HGNC ID: 3401; HPRD ID: 00581; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">carbocysteine,</a></span> <a href="http://beta.uniprot.org/uniprot/P07099">epoxide hydrolase,</a></span> two forms of sulphotransferase and several methyltransferases. The nature of all these <span class="tagged-filter" title="Association Word">polymorphisms</span> and possible <span class="tagged-filter" title="Association Word">polymorphisms</span> is discussed in detail, with particular reference to the effects of this variation on drug metabolism and susceptibility to chemically-induced diseases.
Gilbert_syndrome	carbonic-anhydrase-II	True Negative	1.226	7768386	<strong class="title">Gordon SC, Quattrociocchi-Longe TM, Khan BA, Kodali VP, Chen J, Silverman AL, Kiechle FL: <span class="tagged-filter" title="Association Word">Antibodies</span> to <span class="tagged-gene" title="Protein Family or Complex">carbonic anhydrase</span> in patients with immune cholangiopathies. Gastroenterology. 1995 Jun;108(6):1802-9.</strong> BACKGROUND/AIMS: Bile duct epithelia contain an abundance of <span class="tagged-gene" title="Protein Family or Complex">carbonic anhydrase.</span> <span class="tagged-filter" title="Association Word">Antibodies</span> to this <span class="tagged-filter" title="Association Word">enzyme</span> have been described in <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune disorders.</span> Serum from patients with immune-mediated <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver diseases</span> was studied to determine whether <span class="tagged-filter" title="Association Word">antibodies</span> to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> and/or <span class="tagged-gene" title="Protein Family or Complex">pyruvate dehydrogenase</span> could distinguish autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> as immunologically distinct from <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis.</span> METHODS: <span class="tagged-filter" title="Association Word">Antibody</span> assays to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> (Western blot) and <span class="tagged-gene" title="Protein Family or Complex">pyruvate dehydrogenase</span> (flow cytometry) were performed on the sera of patients with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> (6), <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis</span> (12), <span class="tagged-disease" title="UMLS Concept ID: C0566602">primary sclerosing cholangitis</span> (12), <span class="tagged-disease" title="UMLS Concept ID: C0241910">autoimmune hepatitis</span> (12), and control <span class="tagged-query" title="Query">(Gilbert syndrome;</span> 8). RESULTS: Reactivity to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> was detected in 5 of 6 patients with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis,</span> 1 of 12 patients with <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis,</span> 1 of 12 patients with <span class="tagged-disease" title="UMLS Concept ID: C0241910">autoimmune hepatitis,</span> and no other patients. Individuals with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> were more likely than the other patients to be reactive to <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> (P < 0.001). Patients with <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis</span> were more reactive to <span class="tagged-gene" title="Protein Family or Complex">pyruvate dehydrogenase</span> compared with all other groups (P < 0.001). CONCLUSIONS: An <span class="tagged-filter" title="Association Word">antibody</span> to human <span class="tagged-gene" title="SwissProt ID: P00918; Entrez Gene ID: 760; HGNC ID: 1373; HPRD ID: 02023; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00918">carbonic anhydrase II</a></span> is frequently detected in the sera of patients with autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> and is uncommon or not present in other cholangiopathies. These data provide evidence that autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0008311">cholangitis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0008312">primary biliary cirrhosis</span> represent distinct entities with unique patterns of immunoreactivity.
Gilbert_syndrome	glucose-6-phosphate-dehydrogenase	True Negative	1.226	17426648	<strong class="title">Kaplan M, Renbaum P, Vreman HJ, Wong RJ, Levy-Lahad E, Hammerman C, Stevenson DK: (TA) n <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> 1A1 Promoter <span class="tagged-filter" title="Association Word">Polymorphism:</span> A Crucial Factor in the Pathophysiology of <span class="tagged-disease" title="UMLS Concept ID: C0022346">Jaundice</span> in G-6-PD <span class="tagged-filter" title="Association Word">Deficient</span> Neonates. Pediatr Res. 2007 Apr 5;.</strong> Increased heme catabolism has been reported in <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> (G-6-PD)-normal neonates who were also homozygous for (TA) 7/(TA) 7 (UGT1A1*28) <span class="tagged-metabolite" title="HMDB: HMDB00935"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00935">uridine diphosphoglucuronate</a></span>-glucuronosyltransferase 1A1 <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism</span> <span class="tagged-query" title="Query">(Gilbert syndrome).</span> As G-6-PD <span class="tagged-filter" title="Association Word">deficiency</span> is <span class="tagged-filter" title="Association Word">associated</span> with increased hemolysis, we hypothesized that in G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> neonates who also have the (TA) 7/(TA) 7 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter genotype, steady-state hemolysis would be even further increased. Male G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> neonates were sampled for plasma total <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9UKA9">(PTB),</a></span> blood carboxyhemoglobin corrected for inhaled <span class="tagged-metabolite" title="HMDB: HMDB01361"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01361">carbon monoxide</a></span> in ambient air (COHbc) (an index of heme catabolism), and <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> (TA) n promoter genotype determination and compared with previously published G-6-PD-normal neonates. Although COHbc values were higher in the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> than in the G-6-PD-normal cohorts (0.97 +/- 0.32% of total Hb (tHb) versus 0.76 +/- 0.19% of tHb, p < 0.001), <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB</a></span> values were similar (9.2 +/- 3.4 mg/dL versus 8.9 +/- 3.0 mg/dL, respectively, p = 0.3). Within the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> group, although COHbc values were alike between the three <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter genotypes, <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB</a></span> was higher in the (TA) 7/(TA) 7 homozygotes (11.1 +/- 4.0 mg/dL) compared with (TA) 6/(TA) 7 heterozygotes (9.1 +/- 3.2 mg/dL, p = 0.03) and wild-type (TA) 6/(TA) 6 homozygotes (8.8 +/- 3.4 mg/dL, p = 0.02). In the steady state, similar rates of hemolysis, but increased <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB</a></span> in the G-6-PD-<span class="tagged-filter" title="Association Word">deficient,</span> (TA) 7/(TA) 7 homozygotes, imply that (TA) 7/(TA) 7 homozygosity is central to increased <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB.</a></span>
Gilbert_syndrome	glucose-6-phosphate-dehydrogenase	True Negative	1.226	12064902	<strong class="title">Beutler E, Gelbart T, Miller W: Severe <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice</span> in a patient with a previously undescribed <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">(G6PD)</a></span> <span class="tagged-filter" title="Association Word">mutation</span> and <span class="tagged-query" title="Query">Gilbert syndrome.</span> Blood Cells Mol Dis. 2002 Mar-Apr;28(2):104-7.</strong> A patient with chronic <span class="tagged-disease" title="UMLS Concept ID: C0002878">hemolytic anemia</span> and <span class="tagged-disease" title="UMLS Concept ID: C0017758">G6PD deficiency</span> was noted to be severely <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundiced</span> and to have a high serum <span class="tagged-gene" title="Protein Family or Complex">ferritin</span> level. Analysis of his DNA revealed only heterozygosity for the c.187 C--> G (H63D) <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: Q30201; Entrez Gene ID: 3077; HGNC ID: 4886; HPRD ID: 01993; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q30201">HFE,</a></span> but showed that he was homozygous for the <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP glucuronosyltransferase</a></span> promoter <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-query" title="Query">Gilbert's disease</span> and that he had a previously undescribed <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD,</a></span> c.832 T--> C (Ser278Pro). The new variant was named <span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11413">G6PD</a></span> La Jolla.
Gilbert_syndrome	glucose-6-phosphate-dehydrogenase	True Negative	1.226	11787865	<strong class="title">Oner R, Acar C, Oner C, Yenicesu I, Gumruk F, Gurgey A, Altay C: Chronic <span class="tagged-disease" title="UMLS Concept ID: C0002878">hemolytic anemia</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose 6-phosphate dehydrogenase</a></span> (Guadalajara) 1 159 C --> T (387 <span class="tagged-metabolite" title="HMDB: HMDB00517"><span class="tagged-gene" title="SwissProt ID: P11413; Entrez Gene ID: 2539; HGNC ID: 4057; HPRD ID: 02377; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00517">Arg</a></span> --> Cys) <span class="tagged-filter" title="Association Word">deficiency</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert syndrome</span> in a Turkish patient. Pediatr Hematol Oncol. 2002 Jan-Feb;19(1):39-44.</strong> The case of an 8-year-old male child with severe <span class="tagged-disease" title="UMLS Concept ID: C0022610">kernicterus</span> sequelae is presented in this paper. The child's <span class="tagged-gene" title="Protein Family or Complex">hemoglobin</span> value varied between 6.0 and 10.8 g/dL and his reticulocyte count ranged between 3.4 and 46.0% during the steady-state condition and hyperhemolytic crisis, respectively. A chronic hemolytic type of red cell <span class="tagged-disease" title="UMLS Concept ID: C0017758">G6PD deficiency</span> was <span class="tagged-filter" title="Association Word">diagnosed.</span> DNA studies indicate that the <span class="tagged-filter" title="Association Word">mutation</span> was <a href="http://beta.uniprot.org/uniprot/P11413">G6PD</a></span> Guadalajara 1159 C --> T (387 <span class="tagged-metabolite" title="HMDB: HMDB00517"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00517">Arg</a></span> --> Cys) that is situated at the <span class="tagged-metabolite" title="HMDB: HMDB00217"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00217">NADP</a></span> binding site. Additionally, extra nucleotides of (TA) in the A (TA) n TAA motif of the promoter region of the <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span>-glucuronosyltransferase <span class="tagged-filter" title="Association Word">gene</span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT-1</a></span> A) were found to be homozygous in the patient. The coexistence of <span class="tagged-query" title="Query">Gilbert syndrome</span> with a chronic type of <span class="tagged-disease" title="UMLS Concept ID: C0017758">G6PD deficiency</span> was suggested as a <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-disease" title="UMLS Concept ID: C0857007">neonatal hyperbilirubinemia</span> <span class="tagged-filter" title="Association Word">leading</span> to <span class="tagged-disease" title="UMLS Concept ID: C0022610">kernicterus.</span>
Gilbert_syndrome	glucose-6-phosphate-dehydrogenase	True Negative	1.226	11568299	<strong class="title">Kaplan M, Hammerman C, Renbaum P, Levy-Lahad E, Vreman HJ, Stevenson DK: Differing pathogenesis of perinatal <span class="tagged-disease" title="UMLS Concept ID: C0020433">bilirubinemia</span> in <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> versus-normal neonates. Pediatr Res. 2001 Oct;50(4):532-7.</strong> The objective was to compare the contribution to perinatal <span class="tagged-disease" title="UMLS Concept ID: C0020433">bilirubinemia</span> of hemolysis and <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> <span class="tagged-filter" title="Association Word">gene</span> promoter <span class="tagged-filter" title="Association Word">polymorphism,</span> seen in <span class="tagged-query" title="Query">Gilbert's syndrome,</span> between <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> (G-6-PD)-<span class="tagged-filter" title="Association Word">deficient</span> and -normal neonates. Serum total <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> (STB) values from 52 G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> and 166 G-6-PD-normal term, male neonates, sampled within 3 h of delivery (first sample) and on d 3 (second sample), were analyzed in relation to blood carboxyhemoglobin corrected for inspired CO (COHbc), an accurate index of hemolysis, and <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter genotype. COHbc values (% total Hb) were greater in G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> neonates than controls: first sample 1.00 +/- 0.25% versus 0.84 +/- 0.24%, p < 0.0001; second sample 0.83 +/- 0.20% versus 0.76 +/- 0.19%, p = 0.002. First sample COHbc and STB values did not correlate in either the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> or control groups, whereas second sample COHbc values correlated significantly with corresponding STB values in the control population only (r = 0.28, p = 0.0007). At second sampling, there was a higher allele frequency of the variant <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter among those with STB values > or =75th percentile than those <75th among the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> neonates (0.60 versus 0.33, respectively, p = 0.025), but not controls (0.31 versus 0.40, respectively, p = 0.24). Among those infants with at least one variant <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter allele, STB values were higher in the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> neonates than controls at second sampling only (181 +/- 56 microM versus 149 +/- 46 microM, respectively, p = 0.03). Both within and between the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> and control groups, our data demonstrate changing and differing contributions of hemolysis and <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism</span> to <span class="tagged-disease" title="UMLS Concept ID: C0020433">bilirubinemia</span> during the first 3 d of life.
Gilbert_syndrome	glucose-6-phosphate-dehydrogenase	True Negative	1.226	11114816	<strong class="title">Kaplan M: <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice</span> in <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> <span class="tagged-filter" title="Association Word">deficient</span> neonates. Haematologica. 2000;85(E-letters):E01.</strong>
Gilbert_syndrome	glucose-6-phosphate-dehydrogenase	True Negative	1.226	10091404	<strong class="title">Iolascon A, Faienza MF, Perrotta S, Meloni GF, Ruggiu G, del Giudice EM: <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice</span> in <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> <span class="tagged-filter" title="Association Word">deficient</span> neonates. Haematologica. 1999 Feb;84(2):99-102.</strong> BACKGROUND AND OBJECTIVE: The pathogenesis of the <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> present in approximately 30% of neonates affected by <span class="tagged-disease" title="UMLS Concept ID: C0017758">glucose-6-phosphate dehydrogenase deficiency</span> is an unsolved problem. We evaluated the effect of <span class="tagged-query" title="Query">Gilbert's syndrome,</span> the most common defect of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> conjugation, on the <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> of these neonates. DESIGN AND METHODS: One hundred and two neonates affected by <span class="tagged-disease" title="UMLS Concept ID: C0017758">glucose-6-phosphate dehydrogenase deficiency</span> were enrolled in this study: 56 had <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> and 46 had normal <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels. The analysis of the A (TA) nTAA motif in the promoter region of the <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> <span class="tagged-filter" title="Association Word">gene</span> was performed by means of PCR, followed by separation on 6% denaturing polycrylamide gel. RESULTS: The frequency of the three different genotypes of the A (TA) nTAA motif was similar in the study and control groups. Our results demonstrated no difference in the percentage of homozygotes for the <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> (TA) 7 variant <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> INTERPRETATION AND CONCLUSIONS: These findings indicate that <span class="tagged-query" title="Query">Gilbert's syndrome</span> does not account for the <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> occurring in some neonates with <span class="tagged-disease" title="UMLS Concept ID: C0017758">glucose-6-phosphate dehydrogenase deficiency.</span> Furthermore our results suggest that hemolysis is not the major event in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> in these patients.
Gilbert_syndrome	UDP-glucuronosyl-transferase	True Positive	1.226	12895198	<strong class="title">Skarke C, Schmidt H, Geisslinger G, Darimont J, Lotsch J: Pharmacokinetics of <span class="tagged-drug" title="DrugBank: APRD00215"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span> are not <span class="tagged-filter" title="Association Word">altered</span> in subjects with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Br J Clin Pharmacol. 2003 Aug;56(2):228-31.</strong> AIMS: To verify that <span class="tagged-query" title="Query">Gilbert's syndrome,</span> which is <span class="tagged-filter" title="Association Word">caused</span> by decreased glucuronidation capacity of the <span class="tagged-gene" title="Protein Family or Complex">UDP-glucuronosyl transferase</span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> 1A1, does not account for impaired <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span> clearance. METHODS: Noncompartmental pharmacokinetic parameters for <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span> and its <span class="tagged-metabolite" title="HMDB: HMDB03141"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03141">glucuronide</a></span> metabolites were compared between five carriers of <span class="tagged-query" title="Query">Gilbert's syndrome</span> and six noncarriers after a 7.5 mg (19.8 micro mol) intravenous injection of <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span> sulphate pentahydrate. To estimate the amount of <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span>-6-<span class="tagged-metabolite" title="HMDB: HMDB03141"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03141">glucuronide</a></span> (M6G) formed from <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine,</a></span> 1 mg of deuterized M6G was injected intravenously at the same time. RESULTS: No differences were detected between carriers and noncarriers of <span class="tagged-query" title="Query">Gilbert's syndrome</span> in the clearance of <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span> (80.1 +/- 12 l h (-1) vs 87.9 +/- 22 l h (-1)) and in the percentage of <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span> that was metabolized to M6G (10.9 +/- 1.4 vs 13 +/- 2). The areas under the plasma concentration vs time curves of <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine,</a></span> M6G and <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine</a></span>-3-<span class="tagged-metabolite" title="HMDB: HMDB03141"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03141">glucuronide</a></span> also did not differ between carriers and noncarriers of <span class="tagged-query" title="Query">Gilbert's syndrome.</span> CONCLUSIONS: <span class="tagged-query" title="Query">Gilbert's syndrome</span> is not a factor to be considered when prescribing <span class="tagged-drug" title="DrugBank: APRD00215"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00215">morphine.</a></span>
Gilbert_syndrome	UDP-glucuronosyl-transferase	True Positive	1.226	10620585	<strong class="title">Pirulli D, Giordano M, Puzzer D, Crovella S, Rigato I, Tiribelli C, Momigliano-Richiardi P, Amoroso A: Rapid method for detection of extra (TA) in the promoter of the <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span>-<span class="tagged-gene" title="Protein Family or Complex">UDP-glucuronosyl transferase</span> 1 <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert syndrome.</span> Clin Chem. 2000 Jan;46(1):129-31.</strong>
Gilbert_syndrome	UDP-glucuronosyl-transferase	False Negative	1.226	10472535	<strong class="title">Kimura T, Akaba K, Ikegami T, Akiba K, Kanazawa C, Katsuura M, Shimizu Y, Imaizumi M, Lin C, Hayasaka K: Intermittent <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice</span> in patients with <span class="tagged-disease" title="UMLS Concept ID: C0085669">acute leukaemia:</span> a common <span class="tagged-filter" title="Association Word">mutation</span> of the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine-diphosphate</a></span> glucuronosyltransferase <span class="tagged-filter" title="Association Word">gene</span> among Asians. J Inherit Metab Dis. 1999 Aug;22(6):747-53.</strong> The Gly71Arg <span class="tagged-filter" title="Association Word">mutation</span> of the hepatic <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-gene" title="Protein Family or Complex">UDP glucuronosyl-transferase</span> (B-<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT)</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert syndrome</span> prevails among Japanese and its <span class="tagged-filter" title="Association Word">gene</span> frequency is 0.13. Among 20 patients with <span class="tagged-disease" title="UMLS Concept ID: C0085669">acute leukaemia,</span> 4 patients showed intermittent <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinaemia</span> during the course of combined chemotherapy. The Gly71Arg <span class="tagged-filter" title="Association Word">mutation</span> was detected in all 4 patients with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinaemia,</span> but was not found in 16 patients without <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinaemia.</span> Two of them were heterozygotes and one was a homozygote for the Gly71Arg <span class="tagged-filter" title="Association Word">mutation,</span> and the other was a compound heterozygote of the Gly71Arg <span class="tagged-filter" title="Association Word">mutation</span> and TA insertion <span class="tagged-filter" title="Association Word">mutation</span> in the TATA box of the B-<span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">gene.</span> In addition to the complications <span class="tagged-filter" title="Association Word">leading</span> to <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinaemia,</span> including liver damage due to drugs, <span class="tagged-disease" title="UMLS Concept ID: C0042769">viral infections</span> or tumour cell infiltrations and alloimmune haemolysis, carrier status for the Gly71Arg <span class="tagged-filter" title="Association Word">mutation</span> should be considered in a patient with <span class="tagged-disease" title="UMLS Concept ID: C1292766">leukaemia</span> showing intermittent <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinaemia</span> during the course of chemotherapy, especially among Japanese, Koreans and Chinese owing to its prevalence in those populations.
Gilbert_syndrome	UDP-glucuronosyl-transferase	True Positive	1.226	10412886	<strong class="title">Esteban A, Perez-Mateo M: Heterogeneity of <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">paracetamol</a></span> metabolism in <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):9-13.</strong> <span class="tagged-query" title="Query">Gilbert's syndrome</span> (GS) is an inherited <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-gene" title="Protein Family or Complex">UDP-glucuronosyl transferase</span> <span class="tagged-filter" title="Association Word">deficiency.</span> The object of this study was to investigate the possible effects of this disorder on the metabolism of a drug, such as <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">paracetamol,</a></span> which is basically eliminated by hepatic glucuronidation. We studied 32 healthy volunteers and 18 people with GS, all of whom were given 1.5 g of <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">paracetamol</a></span> orally. In the 24 h urine collected, we determined the elimination of free <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">paracetamol,</a></span> the conjugates <span class="tagged-metabolite" title="HMDB: HMDB03141"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03141">(glucuronide,</a></span> sulphate) and the oxidation products <span class="tagged-metabolite" title="HMDB: HMDB00574"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">(cysteine,</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01890"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01890">mercapturic acid)</a></span> by high pressure liquid chromatography (HPLC). The results are given as a percentage of the total quantity of <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">paracetamol</a></span> eliminated. The patients with GS were divided into 2 subgroups (GS-I and GS-II) according to whether glucuronidation was more or less than 50%. The overall results of the GS group showed no significant difference in the urinary elimination of metabolites as compared to the control group. However, in subgroup GS-I, a reduction in glucuronidation (P = 0.0012) and an increase in oxidation (P = 0.0051) was seen, as compared with the other 2 groups. There was inverse correlation between the <span class="tagged-metabolite" title="HMDB: HMDB03141"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03141">glucuronide</a></span> <span class="tagged-filter" title="Association Word">produced</span> by conjugation and the oxidation products (r = -0.8718; P <0.005). People with GS are a heterogeneous group with respect to the metabolism of <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">paracetamol.</a></span> In one subgroup this was normal. In the other subgroup there was a marked reduction in glucuronidation and an increase in oxidation. These changes could mean that people in this subgroup are more liable to liver damage after an overdose of <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">paracetamol.</a></span>
Gilbert_syndrome	CYP1A2	True Negative	1.226	8361990	<strong class="title">Daly AK, Cholerton S, Gregory W, Idle JR: Metabolic <span class="tagged-filter" title="Association Word">polymorphisms.</span> Pharmacol Ther. 1993 Feb-Mar;57(2-3):129-60.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> have been detected in a variety of xenobiotic-metabolizing enzymes at both the phenotypic and genotypic level. In the case of four enzymes, the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> <span class="tagged-gene" title="SwissProt ID: P10635; Entrez Gene ID: 1565; HGNC ID: 2625; HPRD ID: 00487; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10635">CYP2D6,</a></span> <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> mu, <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> and serum <span class="tagged-gene" title="SwissProt ID: P06276; Entrez Gene ID: 590; HGNC ID: 983; HPRD ID: 01519; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06276">cholinesterase,</a></span> the majority of <span class="tagged-filter" title="Association Word">mutations</span> which give rise to a defective phenotype have now been identified. Another group of enzymes show definite <span class="tagged-filter" title="Association Word">polymorphism</span> at the phenotypic level but the exact genetic mechanisms responsible are not yet clear. These enzymes include the cytochromes P450 <span class="tagged-gene" title="SwissProt ID: P04798; Entrez Gene ID: 1543; HGNC ID: 2595; HPRD ID: 00148; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04798">CYP1A1,</a></span> <span class="tagged-gene" title="SwissProt ID: P05177; Entrez Gene ID: 1544; HGNC ID: 2596; HPRD ID: 00489; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05177">CYP1A2</a></span> and a <span class="tagged-gene" title="SwissProt ID: P33261; Entrez Gene ID: 1557; HGNC ID: 2621; HPRD ID: 00486; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P33261">CYP2C</a></span> form which metabolizes <span class="tagged-drug" title="DrugBank: APRD00512"><span class="tagged-gene" title="SwissProt ID: P27169; Entrez Gene ID: 5444; HGNC ID: 9204; HPRD ID: 01351; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00512">mephenytoin,</a></span> a <span class="tagged-drug" title="DrugBank: APRD00626"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00626">flavin</a></span>-<span class="tagged-filter" title="Association Word">linked</span> monooxygenase <span class="tagged-disease" title="UMLS Concept ID: C0342739">(fish-odour syndrome),</span> <a href="http://beta.uniprot.org/uniprot/P27169">paraoxonase,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-query" title="Query">(Gilbert's syndrome)</span> and <span class="tagged-gene" title="SwissProt ID: P51580; Entrez Gene ID: 7172; HGNC ID: 12014; HPRD ID: 01760; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51580">thiopurine S-methyltransferase.</a></span> In the case of a further group of enzymes, there is some evidence for <span class="tagged-filter" title="Association Word">polymorphism</span> at either the phenotypic or genotypic level but this has not been unambiguously demonstrated. Examples of this class include the <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450</span> enzymes <span class="tagged-gene" title="SwissProt ID: P11509; Entrez Gene ID: 1548; HGNC ID: 2610; HPRD ID: 00420; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11509">CYP2A6,</a></span> <span class="tagged-gene" title="SwissProt ID: P05181; Entrez Gene ID: 1571; HGNC ID: 2631; HPRD ID: 11813; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05181">CYP2E1,</a></span> <span class="tagged-gene" title="SwissProt ID: P11712; Entrez Gene ID: 1559; HGNC ID: 2623; HPRD ID: 03084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11712">CYP2C9</a></span> and <span class="tagged-gene" title="SwissProt ID: P05184; Entrez Gene ID: 1576; HGNC ID: 2637; HPRD ID: 00484; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05184">CYP3A4,</a></span> <span class="tagged-gene" title="SwissProt ID: P47989; Entrez Gene ID: 7498; HGNC ID: 12805; HPRD ID: 06363; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P47989">xanthine oxidase,</a></span> an S-oxidase which metabolizes <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P07099; Entrez Gene ID: 2052; HGNC ID: 3401; HPRD ID: 00581; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">carbocysteine,</a></span> <a href="http://beta.uniprot.org/uniprot/P07099">epoxide hydrolase,</a></span> two forms of sulphotransferase and several methyltransferases. The nature of all these <span class="tagged-filter" title="Association Word">polymorphisms</span> and possible <span class="tagged-filter" title="Association Word">polymorphisms</span> is discussed in detail, with particular reference to the effects of this variation on drug metabolism and susceptibility to chemically-induced diseases.
Gilbert_syndrome	NAT2	True Negative	1.226	16402080	<strong class="title">Hermann R, Borlak J, Munzel U, Niebch G, Fuhr U, Maus J, Erb K: The role of <span class="tagged-query" title="Query">Gilbert's syndrome</span> and frequent <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> slow acetylation <span class="tagged-filter" title="Association Word">polymorphisms</span> in the pharmacokinetics of retigabine. Pharmacogenomics J. 2006 May-Jun;6(3):211-9.</strong> Retigabine (RGB) is an investigational antiepileptic drug, which undergoes extensive <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1,</a></span> 1A9 and 1A4-mediated N-glucuronidation and N-acetylation. The mono-acetylated metabolite of RGB has some pharmacological <span class="tagged-filter" title="Association Word">activity</span> and is denoted AWD21-360. We investigated whether the pharmacokinetics (PK) of RGB and AWD21-360 are <span class="tagged-filter" title="Association Word">altered</span> in subjects with <span class="tagged-query" title="Query">Gilbert's syndrome</span> (GS) and/or with frequent <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">(NAT2)</a></span> slow acetylator (SA) <span class="tagged-filter" title="Association Word">polymorphisms.</span> Based on consistent genotyping and phenotyping screening results, 37 Caucasian subjects (21-46 years; 31 men, six women) were assigned to one of the following groups: (1) <span class="tagged-filter" title="Association Word">absence</span> of GS (non-GS)/rapid acetylator (RA) (N=11); (2) GS/RA (N=8); (3) non-GS/SA (N=11); (4) GS/SA (N=7). Subjects received single and multiple (b.i.d.) 200-mg oral RGB doses over 5 days. Blood samples were collected up to 60 h after dosing for plasma PK of RGB and AWD21-360. Group comparisons were performed by ANOVA. Single-dose PK of RGB and AWD21-360 and multiple-dose PK of RGB did not differ significantly between groups. After multiple dose treatment, RA subjects showed a significantly higher total exposure to AWD21-360 of about 32% (95% CI 101.9-172.5) relative to SA subjects (P=0.0362). The <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> metabolic capacity (i.e. presence or <span class="tagged-filter" title="Association Word">absence</span> of GS), however, did not significantly affect the overall exposure to AWD21-360. The results indicate that the PK of RGB is unaltered in individuals with GS, in subjects with <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> SA status, and in carriers of both variants, whereas the total exposure to AWD21-360 is significantly <span class="tagged-filter" title="Association Word">related</span> to the RA or SA status of subjects. Results further suggest that metabolic switching to the mono-acetylated metabolite AWD21-360 may partially compensate for the impaired glucuronidation capacity in GS subjects. RGB treatment showed no significant differences in tolerability and safety between groups.
Gilbert_syndrome	UDP-glucuronosyltransferases	False Positive	7.560	17353700	<strong class="title">Lee P, Jones G, Seibel MJ: Dual <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-gene" title="Protein Family or Complex">UDP-glucuronosyltransferases</span> 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in <span class="tagged-query" title="Query">Gilbert's syndrome</span> mimicking <span class="tagged-disease" title="UMLS Concept ID: C0024586">carcinoid syndrome?.</span> Eur J Gastroenterol Hepatol. 2007 Apr;19(4):337-40.</strong> <span class="tagged-query" title="Query">Gilbert's syndrome</span> is a common inherited disorder, in which genetic defects in <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span>-glucuronosyltransferase 1A1 <span class="tagged-filter" title="Association Word">lead</span> to <span class="tagged-filter" title="Association Word">deficient</span> glucuronidation of <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> and hence <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinaemia.</span> Although usually considered asymptomatic, <span class="tagged-query" title="Query">Gilbert's syndrome</span> can be <span class="tagged-filter" title="Association Word">associated</span> with gastrointestinal and psychiatric symptoms unexplained by the metabolic defect. Genetic <span class="tagged-filter" title="Association Word">polymorphism</span> of a closely <span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">enzyme,</span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span>-glucuronosyltransferase 1A6, results in <span class="tagged-filter" title="Association Word">altered</span> metabolism and elimination of <span class="tagged-metabolite" title="HMDB: HMDB00259"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin.</a></span> On the basis of a case of hyperserotoninaemia in the <span class="tagged-filter" title="Association Word">absence</span> of a detectable <span class="tagged-disease" title="UMLS Concept ID: C0334299">carcinoid tumour</span> in a patient with <span class="tagged-query" title="Query">Gilbert's syndrome,</span> who presented with a history of night sweats, flushing, abdominal discomfort and intermittent <span class="tagged-disease" title="UMLS Concept ID: C0013369">diarrhoea,</span> we propose that in a subgroup of <span class="tagged-query" title="Query">Gilbert's syndrome</span> patients, homozygocity for dual <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span>-glucuronosyltransferase 1A1 and <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span>-glucuronosyltransferase 1A6 <span class="tagged-filter" title="Association Word">polymorphisms</span> may <span class="tagged-filter" title="Association Word">lead</span> to combined <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinaemia</span> and hyperserotoninaemia. The latter may account for symptoms experienced by patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> hitherto considered unrelated to, or unexplainable by, the known defect in <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> metabolism.
Gilbert_syndrome	UDP-glucuronosyltransferases	False Positive	7.560	12480553	<strong class="title">Peters WH, te Morsche RH, Roelofs HM: Combined <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-gene" title="Protein Family or Complex">UDP-glucuronosyltransferases</span> 1A1 and 1A6: implications for patients with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> J Hepatol. 2003 Jan;38(1):3-8.</strong> BACKGROUND/AIMS: <span class="tagged-gene" title="Protein Family or Complex">UDP-glucuronosyltransferases</span> (UGTs) are important enzymes <span class="tagged-filter" title="Association Word">involved</span> in glucuronidation of various exogenous and endogenous compounds. Studies were undertaken on the variability of three <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">enzyme</span> activities in human livers. <span class="tagged-filter" title="Association Word">Enzyme</span> activities were <span class="tagged-filter" title="Association Word">associated</span> with genetic <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> (UGT1A1*28) and <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> (UGT1A6*2). UGT1A1*28 is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome,</span> a <span class="tagged-filter" title="Association Word">deficiency</span> in glucuronidation of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-filter" title="Association Word">leading</span> to mild <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia,</span> whereas UGT1A6*2 may result in low glucuronidation rates of several drugs. METHODS: <span class="tagged-filter" title="Association Word">Enzyme</span> activities and genetic <span class="tagged-filter" title="Association Word">polymorphisms</span> were assessed in 39 human liver samples, and <span class="tagged-filter" title="Association Word">polymorphisms</span> were also assessed in blood of 253 healthy controls. RESULTS: Associations were found between <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">enzyme</span> activities of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: O95164; Entrez Gene ID: 5412; HGNC ID: 12504; HPRD ID: 05275; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> (B) and <span class="tagged-metabolite" title="HMDB: HMDB01232"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01232">4-nitrophenol</a></span> (NP; r=0.47, P=0.0024), B and 4-methylumbelliferone <a href="http://beta.uniprot.org/uniprot/O95164">(MUB;</a></span> r=0.54, P=0.0003), and NP and <span class="tagged-gene" title="SwissProt ID: O95164; Entrez Gene ID: 5412; HGNC ID: 12504; HPRD ID: 05275; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95164">MUB</a></span> (r=0.89, P <0.0001). In addition to the <span class="tagged-filter" title="Association Word">association</span> between B-<span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> and UGT1A1*28 (r=0.45, P=0.0034) as reported earlier, an <span class="tagged-filter" title="Association Word">association</span> between B-<span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> and UGT1A6*2 (r=0.43, P=0.007) was found. In 253 Dutch Caucasian controls, co-occurrence of UGT1A1*28 and UGT1A6*2 was found (r=0.9, P <0.0001). CONCLUSIONS: Most patients with <span class="tagged-query" title="Query">Gilbert's syndrome,</span> in addition to their reduced B-<span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity,</span> may have abnormalities in the glucuronidation of <span class="tagged-metabolite" title="HMDB: HMDB01879"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01879">aspirin</a></span> or <span class="tagged-metabolite" title="HMDB: HMDB01218"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01218">coumarin</a></span>- and <span class="tagged-metabolite" title="HMDB: HMDB00073"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00073">dopamine</a></span>-derivatives, due to this combination of UGT1A1*28 and UGT1A6*2 genotypes.
Gilbert_syndrome	UGT1A1	True Positive	18.445	17496722	<strong class="title">Hsieh TY, Shiu TY, Huang SM, Lin HH, Lee TC, Chen PJ, Chu HC, Chang WK, Jeng KS, Lai MM, Chao YC: Molecular pathogenesis of <span class="tagged-query" title="Query">Gilbert's syndrome:</span> decreased TATA-binding <span class="tagged-filter" title="Association Word">protein</span> binding affinity of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> promoter. Pharmacogenet Genomics. 2007 Apr;17(4):229-36.</strong> OBJECTIVES: <span class="tagged-query" title="Query">Gilbert's syndrome</span> is a congenital, nonhemolytic, <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia.</span> The most common genotype of <span class="tagged-query" title="Query">Gilbert's syndrome</span> is the homozygous <span class="tagged-filter" title="Association Word">polymorphism,</span> A (TA) 7TAA, in the promoter of the <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UDP-glucuronosyltransferase 1A1</a></span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1),</a></span> with a <span class="tagged-metabolite" title="HMDB: HMDB00262"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00262">thymine</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00034"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00034">adenine</a></span> insertion in the TATA-box-like sequence, which results in a decrease in <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">activity.</span> The mechanism responsible for this decrease in <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">activity,</span> however, has not been elucidated. To clarify the mechanism underlying this <span class="tagged-filter" title="Association Word">deficiency</span> in <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">activity</span> in patients with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> METHODS: The promoter <span class="tagged-filter" title="Association Word">activity</span> assay using the wild-type A (TA) 6TAA or the mutant A (TA) 7TAA promoter and a luciferase reporter was performed in two different <span class="tagged-disease" title="UMLS Concept ID: C0019204">hepatoma</span> cell lines. The binding affinity for a nuclear <span class="tagged-filter" title="Association Word">protein</span> complex or for TATA-binding <span class="tagged-filter" title="Association Word">protein</span> was evaluated by a competitive electophoretic mobility shift assay using wild-type or mutant TATA-box-like oligonucleotide probes and nuclear extract or TATA-binding <span class="tagged-filter" title="Association Word">protein.</span> The formation of complexes between TATA-binding <span class="tagged-filter" title="Association Word">protein</span> and wild-type or mutant oligonucleotide probes was also studied by a quantitive electophoretic mobility shift assay. RESULTS: A TA insertion in the TATA-box-like sequence of the promoter <span class="tagged-filter" title="Association Word">activity</span> of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene.</span> A competitive electrophoretic mobility shift assay showed a decrease in nuclear <span class="tagged-filter" title="Association Word">protein</span> complex binding affinity and TATA-binding <span class="tagged-filter" title="Association Word">protein</span> binding affinity of the mutant TATA-box-like sequence A (TA) 7TAA. When the mutants A (TA) 5TAA and A (TA) 8TAA were also compared, quantitative electrophoretic mobility shift assay demonstrated that the TATA-binding <span class="tagged-filter" title="Association Word">protein</span> binding affinity progressively decreased as the number of TA repeats in the TATA-box-like sequence increased. CONCLUSION: TA insertion in the TATA-box-like sequence of the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter affected its binding affinity for TATA-binding <span class="tagged-filter" title="Association Word">protein,</span> <span class="tagged-filter" title="Association Word">causing</span> a decrease in its <span class="tagged-filter" title="Association Word">activity.</span> This explains the pathogenesis of <span class="tagged-query" title="Query">Gilbert's syndrome.</span>
Gilbert_syndrome	UGT1A1	True Positive	18.445	17347060	<strong class="title">Clementi M, Di Gianantonio E, Fabris L, Forabosco P, Strazzabosco M, Tenconi R, Okolicsanyi L: Inheritance of <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia:</span> evidence for a major <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-filter" title="Association Word">gene.</span> Dig Liver Dis. 2007 Apr;39(4):351-5. Epub 2007 Mar 7.</strong> BACKGROUND AND AIM: To clarify the precise mode of inheritance of <span class="tagged-query" title="Query">Gilbert syndrome,</span> an unconjugated familial <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia,</span> where impaired <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> conjugation is <span class="tagged-filter" title="Association Word">caused</span> by reduced <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">activity</span> determined by a defective function of the A (TA) 6TAA promoter region of the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene.</span> SUBJECTS AND METHODS: Serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels were measured in a large, homogeneous resident population from North-Eastern Italy, consisting of 1.639 males (age 44.5+/-13.9, range 18-89 years), and 1.420 females (age 45.1+/-15.0, range 18-85). In 112 nuclear families from hyperbilirubinemic probands living in the same area a complex segregation analysis was then performed. In both samples we carefully excluded potentially confounding factors of <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels <span class="tagged-metabolite" title="HMDB: HMDB00108"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00108">(alcohol</a></span> abuse, excessive cigarette smoking, drug consumption, overt haemolysis and <span class="tagged-disease" title="UMLS Concept ID: C0023895">liver disease).</span> RESULTS: Mean serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> concentrations are higher in males than in females, showing fluctuations through the different age periods in males. Complex segregation results demonstrate that <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> exhibits a precise mode of inheritance in which a major <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-filter" title="Association Word">gene</span> with a frequency of 0.45 is responsible for higher serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> values. CONCLUSIONS: This major <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-filter" title="Association Word">gene</span> accounts only for a part of the serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> concentration, thus implying additional, environmental factors for the clinical appearance of GS.
Gilbert_syndrome	UGT1A1	True Positive	18.445	16969497	<strong class="title">Urawa N, Kobayashi Y, Araki J, Sugimoto R, Iwasa M, Kaito M, Adachi Y: <span class="tagged-filter" title="Association Word">Linkage</span> disequilibrium of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 and <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *28 in relation to <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> <span class="tagged-filter" title="Association Word">polymorphisms.</span> Oncol Rep. 2006 Oct;16(4):801-6.</strong> <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> enzymes are responsible for the glucuronidation and detoxification of many endogenous or exogenous xenobiotics. <span class="tagged-query" title="Query">Gilbert's syndrome</span> (GS) and <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler Najjar syndrome</span> type 2 (CNS-II) are characterized by <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> due to reduced enzymatic <span class="tagged-filter" title="Association Word">activity</span> of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1.</a></span> Recent studies have demonstrated the frequent co-existence of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *28 (-53 [TA] 6> 7) with other <span class="tagged-filter" title="Association Word">polymorphisms</span> of <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7.</a></span> This finding suggests the occurrence of <span class="tagged-filter" title="Association Word">linkage</span> disequilibrium (LD) among <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1,</a></span> <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> <span class="tagged-filter" title="Association Word">polymorphisms.</span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 (211G> A, G71R) and <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *28 are common in Asian populations. In the present study, we investigated the LD of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 and <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *28 in relation to <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> <span class="tagged-filter" title="Association Word">polymorphisms.</span> Exon 1 of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1,</a></span> <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> was sequenced using genomic DNA isolated from peripheral leukocytes of 390 Japanese subjects. LD and haplotypes were analyzed using SNPAlyze ver. 5.0 software. <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 had a strong LD in relation to <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> variants including 541A> G and 552A> C (D'=0.846-0.848, r (2)=0.413-0.438) and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> variants including 387T> G, 391C> A, 392G> A and 622T> C (D'=0.667-0.858, r (2)=0.207-0.413). <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *28 had a lower degree of LD than <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 in relation to these variants (D'=0.245-0.401, r (2)=0.025-0.063). All the haplotypes with G71R lacked -53 [TA] 6> 7. The present study showed for the first time that the LD of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 in relation to <span class="tagged-gene" title="SwissProt ID: P19224; Entrez Gene ID: 54578; HGNC ID: 12538; HPRD ID: 07071; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P19224">UGT1A6</a></span> and 1A7 <span class="tagged-filter" title="Association Word">polymorphisms</span> is far stronger than <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *28. The <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 allele appears to be independent of the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *28 allele. Although patients with GS and CNS-II are believed to have good prognosis, a subgroup of GS or CNS-II patients with the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> *6 <span class="tagged-filter" title="Association Word">polymorphism</span> might be at risk of abnormal drug metabolism and of developing <span class="tagged-disease" title="UMLS Concept ID: C0442867">malignant disease.</span>
Gilbert_syndrome	UGT1A1	True Positive	18.445	16792515	<strong class="title">Ferraris A, D'Amato G, Nobili V, Torres B, Marcellini M, Dallapiccola B: Combined test for <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> -3279T--> G and A (TA) nTAA <span class="tagged-filter" title="Association Word">polymorphisms</span> best predicts <span class="tagged-query" title="Query">Gilbert's syndrome</span> in Italian pediatric patients. Genet Test. 2006 Summer;10(2):121-5.</strong> <span class="tagged-query" title="Query">Gilbert's syndrome</span> is a common hereditary chronic or recurrent, mild <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia.</span> <span class="tagged-filter" title="Association Word">Polymorphisms</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span> glucuronosyl transferase <span class="tagged-filter" title="Association Word">gene</span> <a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">causing</span> a decreased <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> are <span class="tagged-filter" title="Association Word">associated</span> with susceptibility to the syndrome. Homozygosity for TA (7) allele of the A (TA)(n) TAA promoter <span class="tagged-filter" title="Association Word">polymorphism</span> is found in the majority of Caucasian patients. We sought to investigate the role of three <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">polymorphisms</span> (A [TA](n) TAA, -3279T--> G, and G71R) in the susceptibility to <span class="tagged-query" title="Query">Gilbert's syndrome</span> in 53 Italian pediatric subjects compared to 83 unaffected controls. Carriage of two TA (n) risk alleles (TA (7) and TA (8)) and -3279G homozygosity were similarly <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> (odds ratio [OR] = 11.59, 95% confidence interval [CI] = 4.80-27.98; p < 0.001, and OR = 11.51, 95% CI = 5.06-26.19; p < 0.001, respectively). Homozygosity for both TA7 and -3279G was <span class="tagged-filter" title="Association Word">associated</span> with the highest relative risk estimate (OR = 19.23, 95% CI = 7.34-50.4; p < 0.001), but a significant <span class="tagged-filter" title="Association Word">association</span> was found also for TA7 heterozygosity combined with -3279G/G genotype (OR = 7.98, 95% CI = 2.54-25.06; p < 0.001). The G71R variant was found only in two controls. Our results demonstrate that genotyping of both <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> A (TA)(n) TAA and -3279T--> G <span class="tagged-filter" title="Association Word">polymorphisms</span> best defines genetic susceptibility to <span class="tagged-query" title="Query">Gilbert's syndrome</span> in Caucasian pediatric patients, and the TA7 heterozygous genotype combined with homozygosity for the -3279G allele can also be <span class="tagged-filter" title="Association Word">associated</span> with pediatric mild <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia.</span>
Gilbert_syndrome	UGT1A1	True Positive	18.445	16610035	<strong class="title">Farheen S, Sengupta S, Santra A, Pal S, Dhali GK, Chakravorty M, Majumder PP, Chowdhury A: <span class="tagged-query" title="Query">Gilbert's syndrome:</span> High frequency of the (TA) 7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-filter" title="Association Word">gene.</span> World J Gastroenterol. 2006 Apr 14;12(14):2269-75.</strong> AIM: To identify the variants in <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> in <span class="tagged-query" title="Query">Gilbert's syndrome</span> (GS) and to estimate the <span class="tagged-filter" title="Association Word">association</span> between homozygosity for TA insertion and GS in India, as well as the frequency of TA insertion and its impact among normal controls in India. METHODS: Ninety-five GS cases and 95 normal controls were selected. Liver function and other tests were done. The promoter and all 5 exons of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> were resequenced. Functional assessment of a novel trinucleotide insertion was done by in silico analysis and by estimating <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter <span class="tagged-filter" title="Association Word">activity</span> carried out by luciferase reporter assay of appropriate constructs in Hep G2 cell line. RESULTS: Among the GS patients, 80% were homozygous for the TA insertion, which was several-fold higher than reports from other ethnic groups. The mean UCB level was <span class="tagged-filter" title="Association Word">elevated</span> among individuals with only one copy of this insertion, which was not significantly different from those with two copies. Many new DNA variants in <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> were discovered, including a trinucleotide (CAT) insertion in the promoter found in a subset (10%) of GS patients, but not among normal controls. In-silico analysis showed marked changes in the DNA-folding of the promoter and functional analysis showed a 20-fold reduction in transcription efficiency of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> resulting from this insertion, thereby significantly elevating the UCB level. CONCLUSION: The genetic epidemiology of GS is variable across ethnic groups and the epistatic interactions among <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter variants modulate <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> glucuronidation.
Gilbert_syndrome	UGT1A1	True Positive	18.445	16557566	<strong class="title">Wasmuth HE, Keppeler H, Herrmann U, Schirin-Sokhan R, Barker M, Lammert F: Coinheritance of <span class="tagged-query" title="Query">Gilbert syndrome</span>-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">mutation</span> increases <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> risk in <span class="tagged-disease" title="UMLS Concept ID: C0010674">cystic fibrosis.</span> Hepatology. 2006 Apr;43(4):738-41.</strong> The prevalence of "black" pigment <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstones</span> is increased in patients with <span class="tagged-disease" title="UMLS Concept ID: C0010674">cystic fibrosis</span> (CF). <span class="tagged-disease" title="UMLS Concept ID: Not Available">Bile acid malabsorption</span> with augmented <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> uptake from the intestine and the development of "hyperbilirubinbilia" have been proposed as key factors in <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation in CF patients. We have now tested the hypothesis that the coinheritance of the common <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter <span class="tagged-filter" title="Association Word">mutation</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert syndrome</span> is an additional lithogenic risk factor for <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation in CF. Our results show that patients with CF and <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstones</span> are significantly more likely to carry at least one Gilbert <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> allele compared with stone-free patients (OR 7.3; P = .042) and that these carriers display significantly higher serum levels of unconjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> (P = .002). In conclusion, the Gilbert <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> allele increases the risk of <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation in CF. This genetic <span class="tagged-filter" title="Association Word">association</span> supports the current concept for <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation in CF and suggests that genetic and exogenous sources contributing to hyperbilirubinbilia might be lithogenic in CF patients.
Gilbert_syndrome	UGT1A1	True Positive	18.445	16469709	<strong class="title">Yu LH, Gao J, Wang CL, Wang J, Gao Y, Yuan QL, Sun ZX, Wang HY, Zhang CG: [Genetic analysis of the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> sites in a Chinese family suffered from <span class="tagged-query" title="Query">Gilbert's syndrome].</span> Yi Chuan. 2006 Jan;28(1):11-6.</strong> To learn the variation in the <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">enzyme,</span> the genetic mechanism in a Chinese Han nationality family suffered from <span class="tagged-query" title="Query">Gilbert's syndrome</span> was studied. At first, genomic DNA from peripheral blood of the sufferer in this family was used for amplifying all of the five exons of the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> by PCR, and then direct sequencing of the PCR product was applied to analyze <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation.</span> The results showed that there existed a G--> A homozygous transition at nucleotide 211 <span class="tagged-filter" title="Association Word">leading</span> the substitution of <span class="tagged-metabolite" title="HMDB: HMDB00517"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00517">arginine</a></span> for <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span> at position 71 of corresponding <span class="tagged-filter" title="Association Word">protein</span> product (G71R) and a T--> G homozygous transition at nucleotide 1456 <span class="tagged-filter" title="Association Word">leading</span> the substitution of aspartic acid for <span class="tagged-metabolite" title="HMDB: HMDB00158"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00158">tyrosine</a></span> at position 486 of corresponding <span class="tagged-filter" title="Association Word">protein</span> product (Y486D). No <span class="tagged-filter" title="Association Word">mutation</span> was detected in promoter region and the splicing junction sites. The relevant <span class="tagged-filter" title="Association Word">mutation</span> sites of the other family members were sequenced and identified to be heterozygous in the two above-mentioned <span class="tagged-filter" title="Association Word">mutation</span> sites and in the TA repeat <span class="tagged-filter" title="Association Word">mutation</span> in the promoter region. Furthermore, fresh blood samples were collected from all of the members to detect the serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels to determine the sufferer. The result was consistent with the <span class="tagged-filter" title="Association Word">mutation</span> analysis. It could thus be inferred that this family was <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutation</span> in the open reading frame of the <span class="tagged-filter" title="Association Word">gene</span> <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1.</a></span>
Gilbert_syndrome	UGT1A1	True Positive	18.445	16210851	<strong class="title">Yusoff S, Van Rostenberghe H, Yusoff NM, Talib NA, Ramli N, Ismail NZ, Ismail WP, Matsuo M, Nishio H: Frequencies of A (TA) 7TAA, G71R, and G493R <span class="tagged-filter" title="Association Word">mutations</span> of the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> in the Malaysian population. Biol Neonate. 2006;89(3):171-6. Epub 2005 Oct 6.</strong> BACKGROUND: <span class="tagged-query" title="Query">Gilbert syndrome</span> is <span class="tagged-filter" title="Association Word">caused</span> by defects in the <span class="tagged-metabolite" title="HMDB: HMDB00295"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span> glucuronosyltransferase 1A1 <a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene.</span> These <span class="tagged-filter" title="Association Word">mutations</span> differ among different populations and many of them have been found to be genetic risk factors for the development of <span class="tagged-disease" title="UMLS Concept ID: C0022353">neonatal jaundice.</span> OBJECTIVES: The objective was to determine the frequencies of the following <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene:</span> A (TA) 7TAA (the most common <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-query" title="Query">Gilbert syndrome</span> in Caucasians), G71R (more common in the Japanese and Taiwanese population), and G493R (described in a homozygous Malay woman with <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler-Najjar syndrome</span> type 2) in a group of Malaysian babies with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> and a group of normal controls. METHODS: The GeneScan fragment analysis was used to detect the A (TA) 7TAA variant. <span class="tagged-filter" title="Association Word">Mutation</span> screening of both G71R and G493R was performed using denaturing high performance liquid chromatography. RESULTS: Fourteen out of fifty-five neonates with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> (25%) carried the A (TA) 7TAA <span class="tagged-filter" title="Association Word">mutation</span> (10 heterozygous, 4 homozygous). Seven out of fifty controls (14%) carried this <span class="tagged-filter" title="Association Word">mutation</span> (6 heterozygous, 1 homozygous). The allelic frequencies for <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> and control patients were 16 and 8%, respectively (p=0.20). Heterozygosity for the G71R <span class="tagged-filter" title="Association Word">mutation</span> was almost equal among both groups (5.5% for <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> patients and 6.0% for controls; p=0.61). One subject (1.8%) in the <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> group and none of the controls were heterozygous for the G493R <span class="tagged-filter" title="Association Word">mutation</span> (p=0.476). CONCLUSIONS: The A (TA) 7TAA seems more common than the G71R and G493R <span class="tagged-filter" title="Association Word">mutations</span> in the Malaysian population.
Gilbert_syndrome	UGT1A1	True Positive	18.445	16012956	<strong class="title">Cebecauerova D, Jirasek T, Budisova L, Mandys V, Volf V, Novotna Z, Subhanova I, Hrebicek M, Elleder M, Jirsa M: Dual hereditary <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice:</span> simultaneous occurrence of <span class="tagged-filter" title="Association Word">mutations</span> <span class="tagged-filter" title="Association Word">causing</span> Gilbert's and <span class="tagged-disease" title="UMLS Concept ID: C0022350">Dubin-Johnson syndrome.</span> Gastroenterology. 2005 Jul;129(1):315-20.</strong> BACKGROUND & AIMS: <span class="tagged-disease" title="UMLS Concept ID: C0022350">Dubin-Johnson syndrome</span> is recessively inherited, <span class="tagged-disease" title="UMLS Concept ID: C0268307">conjugated hyperbilirubinemia</span> induced by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">ABCC2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">MRP2</a></span> <span class="tagged-filter" title="Association Word">gene</span> encoding the canalicular transporter for conjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin.</a></span> <span class="tagged-query" title="Query">Gilbert's syndrome</span> is recessively inherited, <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> <span class="tagged-filter" title="Association Word">caused</span> by decreased conjugation rate of <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-filter" title="Association Word">associated</span> mostly with homozygous A (TA) 7 TAA variant of the TATAA-box in the <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> promoter. Our aim was to establish the molecular <span class="tagged-filter" title="Association Word">diagnosis</span> in a 3-year-old male with atypical, intermittent, predominantly <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated, hyperbilirubinemia.</span> METHODS: 99m Tc-HIDA cholescintigraphy was used for imaging the biliary tree. <span class="tagged-filter" title="Association Word">Expression</span> of <span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">ABCC2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">MRP2</a></span> <span class="tagged-filter" title="Association Word">protein</span> in hepatocytes was investigated immunohistochemically. <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">ABCC2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">MRP2</a></span> <span class="tagged-filter" title="Association Word">genes</span> were sequenced from genomic DNA, and the <span class="tagged-filter" title="Association Word">mutations</span> were verified by fragment analysis, sequencing the cloned exons, and restriction fragment length <span class="tagged-filter" title="Association Word">polymorphism.</span> RESULTS: Cholescintigraphy revealed delayed visualization of the gallbladder. A brown granular lipopigment differing from <span class="tagged-metabolite" title="HMDB: HMDB04068"><span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB04068">melanin</a></span>-like pigment reported in <span class="tagged-disease" title="UMLS Concept ID: C0022350">Dubin-Johnson syndrome</span> was present in hepatocytes, but, otherwise, liver histology was normal. <a href="http://beta.uniprot.org/uniprot/Q92887">ABCC2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">MRP2</a></span> <span class="tagged-filter" title="Association Word">protein</span> was not detected on the canalicular membrane of hepatocytes, and 2 novel <span class="tagged-filter" title="Association Word">mutations</span> were found in the <span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">ABCC2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">MRP2</a></span> <span class="tagged-filter" title="Association Word">gene:</span> a heterozygous in-frame insertion-deletion <span class="tagged-filter" title="Association Word">mutation</span> 1256insCT/delAAACAGTGAACCTGATG in exon 10 inherited from the father and a heterozygous deletion 4292delCA in exon 30 inherited from the mother. In addition, the patient was homozygous for -3279T> G and A (TA) 7 TAA <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">gene</span> promoter. CONCLUSIONS: Our patient represents a case of digenic mixed <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span>-a distinct type of constitutive <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice</span> resulting from coinherited defects in <span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">ABCC2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92887; Entrez Gene ID: 1244; HGNC ID: 53; HPRD ID: 03065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92887">MRP2</a></span> and <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">genes.</span>
Gilbert_syndrome	UGT1A1	True Positive	18.445	15985997	<strong class="title">Rossi F, Francese M, Iodice RM, Falcone E, Vetrella S, Punzo F, De Vita S, Perrotta S: [Inherited <span class="tagged-disease" title="UMLS Concept ID: C0751438">disorders of</span> <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> metabolism] . Minerva Pediatr. 2005 Apr;57(2):53-63.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0022346">Jaundice</span> in an infant or older child may reflect accumulation of either unconjugated or conjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> and could be <span class="tagged-filter" title="Association Word">related</span> to inherited <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> disorders. Three grades of inherited <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> are recognised in humans. This spectrum of disorders is distinguished primarily on the basis of the plasma <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> level, the response to <span class="tagged-drug" title="DrugBank: APRD00184"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00184">phenobarbital</a></span> administration, and the presence or <span class="tagged-filter" title="Association Word">absence</span> of <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> glucoronides in bile. The <span class="tagged-filter" title="Association Word">enzyme</span> responsible for the conjugation of <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> is the <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine-diphosphate</a></span>-glucuronosyltransferase <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT).</a></span> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> encoding <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span>-<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1),</a></span> <span class="tagged-filter" title="Association Word">lead</span> to complete or partial inactivation of the <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">causing</span> the rare <span class="tagged-filter" title="Association Word">autosomal</span> recessively inherited conditions, <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler-Najjar syndrome</span> type 1 (CN-1) and type 2 (CN-2). <span class="tagged-query" title="Query">Gilbert syndrome</span> (GS) is due to an insertional <span class="tagged-filter" title="Association Word">mutation</span> at homozygous state of the TATAA element (seven TA repeats) of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> producing a reduced level of <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-filter" title="Association Word">gene.</span> The <span class="tagged-filter" title="Association Word">association</span> of GS with haemolytic <span class="tagged-disease" title="UMLS Concept ID: C0002871">anemias,</span> e.g., <span class="tagged-disease" title="UMLS Concept ID: C0037889">Hereditary Spherocytosis</span> (HS) or <span class="tagged-disease" title="UMLS Concept ID: C0002876">Congenital Dyserythropoietic Anemia</span> type <span class="tagged-drug" title="DrugBank: APRD00260"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00260">2 (CDA</a></span> 2), increase the <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> level and the risk of <span class="tagged-disease" title="UMLS Concept ID: C1535187">cholelithiasis.</span> Forms of chronic <span class="tagged-disease" title="UMLS Concept ID: C0268307">conjugated hyperbilirubinemia</span> are <span class="tagged-disease" title="UMLS Concept ID: C0022350">Dubin-Johnson syndrome,</span> <span class="tagged-disease" title="UMLS Concept ID: C0220991">Rotor syndrome,</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Alagille syndrome</span> or <span class="tagged-disease" title="UMLS Concept ID: Not Available">arteriohepatic dysplasia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0019202">Wilson disease</span> or <span class="tagged-disease" title="UMLS Concept ID: C0019202">hepatolenticular degeneration.</span> Liver or liver cell transplantation is the therapy in some cases.
Gilbert_syndrome	glycosyltransferase	True Positive	3.682	9630669	<strong class="title">Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T: Contribution of two missense <span class="tagged-filter" title="Association Word">mutations</span> (G71R and Y486D) of the <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q5NDL2; Entrez Gene ID: 285203; HGNC ID: 28526; HPRD ID: 12435; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">UDP</a></span> <a href="http://beta.uniprot.org/uniprot/Q5NDL2">glycosyltransferase</a></span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> to phenotypes of <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0268311">Crigler-Najjar syndrome type II.</span> Biochim Biophys Acta. 1998 Apr 28;1406(3):267-73.</strong> In our <span class="tagged-filter" title="Association Word">mutation</span> analyses of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q5NDL2; Entrez Gene ID: 285203; HGNC ID: 28526; HPRD ID: 12435; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">UDP</a></span> <a href="http://beta.uniprot.org/uniprot/Q5NDL2">glycosyltransferase</a></span> <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene,</span> we encountered six patients with <span class="tagged-disease" title="UMLS Concept ID: C0268311">Crigler-Najjar syndrome type II</span> who were double homozygotes for G71R and Y486D, a patient with <span class="tagged-query" title="Query">Gilbert's syndrome</span> who was a single homozygote for G71R and six patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> who were single heterozygote for G71R. To clarify the role of each <span class="tagged-filter" title="Association Word">mutation</span> in the occurrence of the two syndromes, we made four mutant <span class="tagged-filter" title="Association Word">expression</span> models. Relative <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">activity</span> of a single homozygous model of G71R was 32.2+/-1.6% of normal, that of a single homozygous model of Y486D was 7.6+/-0.5%, that of a double homozygous model of G71R and Y486D was 6.2+/-1.6% and that of a heterozygous model of G71R was 60.2+/-3.5%. The decreased activities of the single homozygous model of G71R and the double homozygous model were at an appropriate level to be <span class="tagged-filter" title="Association Word">diagnosed</span> as <span class="tagged-query" title="Query">Gilbert's syndrome</span> and <span class="tagged-gene" title="SwissProt ID: P49902; Entrez Gene ID: 22978; HGNC ID: 8022; HPRD ID: 02686; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P49902">CN-II,</a></span> respectively. The <span class="tagged-filter" title="Association Word">activity</span> of a single heterozygous model of G71R was somewhat high to develop to the phenotype of <span class="tagged-query" title="Query">Gilbert's syndrome,</span> suggesting the presence of additional factors for the etiology of <span class="tagged-query" title="Query">Gilbert's syndrome.</span>
Gilbert_syndrome	UGT1A	True Positive	18.445	17426648	<strong class="title">Kaplan M, Renbaum P, Vreman HJ, Wong RJ, Levy-Lahad E, Hammerman C, Stevenson DK: (TA) n <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> 1A1 Promoter <span class="tagged-filter" title="Association Word">Polymorphism:</span> A Crucial Factor in the Pathophysiology of <span class="tagged-disease" title="UMLS Concept ID: C0022346">Jaundice</span> in G-6-PD <span class="tagged-filter" title="Association Word">Deficient</span> Neonates. Pediatr Res. 2007 Apr 5;.</strong> Increased heme catabolism has been reported in <span class="tagged-gene" title="SwissProt ID: O95479; Entrez Gene ID: 9563; HGNC ID: 4795; HPRD ID: 00681; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95479">glucose-6-phosphate dehydrogenase</a></span> (G-6-PD)-normal neonates who were also homozygous for (TA) 7/(TA) 7 (UGT1A1*28) <span class="tagged-metabolite" title="HMDB: HMDB00935"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00935">uridine diphosphoglucuronate</a></span>-glucuronosyltransferase 1A1 <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism</span> <span class="tagged-query" title="Query">(Gilbert syndrome).</span> As G-6-PD <span class="tagged-filter" title="Association Word">deficiency</span> is <span class="tagged-filter" title="Association Word">associated</span> with increased hemolysis, we hypothesized that in G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> neonates who also have the (TA) 7/(TA) 7 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter genotype, steady-state hemolysis would be even further increased. Male G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> neonates were sampled for plasma total <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/Q9UKA9">(PTB),</a></span> blood carboxyhemoglobin corrected for inhaled <span class="tagged-metabolite" title="HMDB: HMDB01361"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01361">carbon monoxide</a></span> in ambient air (COHbc) (an index of heme catabolism), and <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> (TA) n promoter genotype determination and compared with previously published G-6-PD-normal neonates. Although COHbc values were higher in the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> than in the G-6-PD-normal cohorts (0.97 +/- 0.32% of total Hb (tHb) versus 0.76 +/- 0.19% of tHb, p < 0.001), <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB</a></span> values were similar (9.2 +/- 3.4 mg/dL versus 8.9 +/- 3.0 mg/dL, respectively, p = 0.3). Within the G-6-PD-<span class="tagged-filter" title="Association Word">deficient</span> group, although COHbc values were alike between the three <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter genotypes, <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB</a></span> was higher in the (TA) 7/(TA) 7 homozygotes (11.1 +/- 4.0 mg/dL) compared with (TA) 6/(TA) 7 heterozygotes (9.1 +/- 3.2 mg/dL, p = 0.03) and wild-type (TA) 6/(TA) 6 homozygotes (8.8 +/- 3.4 mg/dL, p = 0.02). In the steady state, similar rates of hemolysis, but increased <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB</a></span> in the G-6-PD-<span class="tagged-filter" title="Association Word">deficient,</span> (TA) 7/(TA) 7 homozygotes, imply that (TA) 7/(TA) 7 homozygosity is central to increased <span class="tagged-gene" title="SwissProt ID: Q9UKA9; Entrez Gene ID: 58155; HGNC ID: 17662; HPRD ID: 12233; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKA9">PTB.</a></span>
Gilbert_syndrome	UGT1A	True Positive	18.445	17058217	<strong class="title">Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP: <span class="tagged-query" title="Query">Gilbert's disease</span> and <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">atazanavir:</a></span> from phenotype to <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> haplotype. Hepatology. 2006 Nov;44(5):1324-32.</strong> <span class="tagged-query" title="Query">Gilbert's disease</span> <span class="tagged-filter" title="Association Word">leads</span> to intermittent non-hemolytic <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> by a reduction of hepatic <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> glucuronidation <span class="tagged-filter" title="Association Word">associated</span> with the presence of the <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> 1A1*28 <span class="tagged-filter" title="Association Word">polymorphism.</span> It is considered benign because it does not result in <span class="tagged-disease" title="UMLS Concept ID: C0151763">hepatocellular damage.</span> However, pharmacogenetic analyses have <span class="tagged-filter" title="Association Word">linked</span> UGT1A1*28 to drug toxicity and cancer predisposition. The protease inhibitor <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">atazanavir</a></span> <span class="tagged-drug" title="DrugBank: APRD00804"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">(ATV)</a></span> is an inhibitor of hepatic <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">activity</span> <span class="tagged-filter" title="Association Word">leading</span> to <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> in individual patients. Whether this is <span class="tagged-filter" title="Association Word">linked</span> specifically to UGT1A1*28 or to more complex variants influencing glucuronidation is unclear. One hundred and six <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="SwissProt ID: P35503; Entrez Gene ID: 54659; HGNC ID: 12535; HPRD ID: 07566; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">ATV</a></span>-treated patients were characterized and genotyped for UGT1A1*28, the <a href="http://beta.uniprot.org/uniprot/P35503">UGT1A3</a></span> (-66C) and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> (-57G) promoter variants, and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> (129K/131K). <span class="tagged-drug" title="DrugBank: APRD00804"><span class="tagged-gene" title="SwissProt ID: P35503; Entrez Gene ID: 54659; HGNC ID: 12535; HPRD ID: 07566; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">ATV</a></span> treatment increased median <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels from 10 to 41 micromol/L (P = .001) with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> exceeding 43 micromol/L in 37%. <span class="tagged-disease" title="UMLS Concept ID: C0020433">Hyperbilirubinemia</span> over 43 micromol/L was significantly <span class="tagged-filter" title="Association Word">associated</span> not only with UGT1A1*28 but also with <a href="http://beta.uniprot.org/uniprot/P35503">UGT1A3</a></span>-66C, <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span>-57G, and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> (129K/131K), although these variants do not naturally occur in <span class="tagged-filter" title="Association Word">linkage</span> dysequilibrium in blood donors. Homozygous combinations of UGT1A1*28 with the <span class="tagged-disease" title="UMLS Concept ID: C1518673">other variants</span> increased from 7.4% (normal <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> to 42 micromol/L) to 41% to 46.1% (43 to > 85 micromol/L), and 100% (> 85 micromol/L). All six patients with <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> greater than 85 micromol/L were homozygous for all four variants identifying a haplotype inherited on a single allele. In conclusion, the genetic variant <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's disease</span> is identified as part of a haplotype of four <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> variants spanning three <span class="tagged-filter" title="Association Word">genes</span> at the <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">locus.</span> This haplotype predisposes to <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> in <span class="tagged-drug" title="DrugBank: APRD00804"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00804">ATV</a></span> treatment and may have an additional <span class="tagged-filter" title="Association Word">role</span> as a pharmacogenomic risk factor for drug therapy.
Gilbert_syndrome	UGT1A	True Positive	18.445	15716465	<strong class="title">Lankisch TO, Vogel A, Eilermann S, Fiebeler A, Krone B, Barut A, Manns MP, Strassburg CP: Identification and characterization of a functional TATA box <span class="tagged-filter" title="Association Word">polymorphism</span> of the <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UDP glucuronosyltransferase 1A7</a></span> <span class="tagged-filter" title="Association Word">gene.</span> Mol Pharmacol. 2005 May;67(5):1732-9. Epub 2005 Feb 16.</strong> <span class="tagged-gene" title="Protein Family or Complex">UDP glucuronosyltransferases</span> <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> detoxify <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> and therapeutic drugs, a process influenced by single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> <span class="tagged-filter" title="Association Word">(SNPs)</span> in their structural <span class="tagged-filter" title="Association Word">genes</span> and promoter elements. UGT1A1*28 is a functional <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's disease</span> and severe <span class="tagged-drug" title="DrugBank: APRD00579"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span> toxicity, which also occurs in the <span class="tagged-filter" title="Association Word">absence</span> of UGT1A1*28. The aim of this study was to identify and characterize <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter variants relevant for <span class="tagged-drug" title="DrugBank: APRD00579"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span> detoxification. Recombinant <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> <span class="tagged-filter" title="Association Word">proteins</span> were analyzed for <span class="tagged-drug" title="DrugBank: APRD00579"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span> metabolite glucuronidation by <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">activity</span> assays. In 427 healthy blood donors and 71 homozygous UGT1A1*28 carriers, the 5'-untranslated region of the <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">locus</span> was studied. An <span class="tagged-filter" title="Association Word">SNP</span> was detected by allelic discrimination and characterized by reporter <span class="tagged-filter" title="Association Word">gene</span> experiments. A novel -57 T--> G <span class="tagged-filter" title="Association Word">SNP</span> with a <span class="tagged-filter" title="Association Word">gene</span> frequency of 0.39 in healthy blood donors was identified in the putative TATA box of the <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> <span class="tagged-filter" title="Association Word">gene,</span> reducing promoter <span class="tagged-filter" title="Association Word">activity</span> to 30%. It is in <span class="tagged-filter" title="Association Word">linkage</span> dysequilibrium with a variant of the <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> first exon that is present in the reduced-<span class="tagged-filter" title="Association Word">activity</span> UGT1A7*3 and UGT1A7*4 alleles. Homozygous UGT1A1*28 carriers simultaneously carried this variant in 97%. We identified a novel reduced-function TATA box <span class="tagged-filter" title="Association Word">SNP</span> of the <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> <span class="tagged-filter" title="Association Word">gene</span> that catalyzes <span class="tagged-drug" title="DrugBank: APRD00579"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span> metabolite detoxification. Its <span class="tagged-filter" title="Association Word">association</span> with variants of the <a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> promoter and <span class="tagged-gene" title="SwissProt ID: Q9HAW7; Entrez Gene ID: 54577; HGNC ID: 12539; HPRD ID: 09397; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW7">UGT1A7</a></span> <span class="tagged-filter" title="Association Word">gene</span> may influence <span class="tagged-drug" title="DrugBank: APRD00579"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span> metabolism. Our finding emphasizes the importance of combinations of structural and regulatory <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">polymorphisms</span> that may be useful as <span class="tagged-filter" title="Association Word">markers</span> of drug toxicity.
Gilbert_syndrome	UGT1A	True Positive	18.445	15297419	<strong class="title">Rouits E, Boisdron-Celle M, Dumont A, Guerin O, Morel A, Gamelin E: Relevance of different <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-drug" title="DrugBank: APRD00579"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span>-induced toxicity: a molecular and clinical study of 75 patients. Clin Cancer Res. 2004 Aug 1;10(15):5151-9.</strong> PURPOSE: We wanted to assess <span class="tagged-filter" title="Association Word">polymorphisms</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00296"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00296">uridine</a></span> diphosphoglucuronosyl transferase 1A1 <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT</a></span> 1A1) <span class="tagged-filter" title="Association Word">gene:</span> the TATA box <span class="tagged-filter" title="Association Word">polymorphism</span> and <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> 1A1 G71R and Y486D <span class="tagged-filter" title="Association Word">mutations</span> in the coding sequence, the main <span class="tagged-filter" title="Association Word">mutations</span> characterizing <span class="tagged-query" title="Query">Gilbert's syndrome,</span> as predictors of severe toxic event occurrence after <span class="tagged-drug" title="DrugBank: APRD00579"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span> <span class="tagged-drug" title="DrugBank: APRD00718"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00718">(CPT</a></span>-11) administration. Therefore, we set up a rapid, sensitive, and reliable technique in routine practice to detect before <span class="tagged-drug" title="DrugBank: APRD00718"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00718">CPT</a></span>-11 treatment, the at-risk patients. EXPERIMENTAL DESIGN: Seventy-five patients with advanced <span class="tagged-disease" title="UMLS Concept ID: C1527249">colorectal cancer</span> and treated with <span class="tagged-drug" title="DrugBank: APRD00718"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00718">CPT</a></span>-11 and <span class="tagged-drug" title="DrugBank: APRD00516"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00516">5-fluorouracil,</a></span> entered the study. We used the Pyrosequencing technology a real-time sequencing method, to detect the <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> 1A1 TATA box <span class="tagged-filter" title="Association Word">polymorphisms</span> and <span class="tagged-filter" title="Association Word">mutations</span> in the coding regions. Patients were also assessed for both biochemical and clinical evaluation and tolerance to treatment. RESULTS: No G71R and Y486D <span class="tagged-filter" title="Association Word">mutations</span> were found in our population. Frequencies for <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> 1A1 TATA box <span class="tagged-filter" title="Association Word">polymorphisms</span> were 41, 47, and 9% for wild-type 6/6, heterozygous 6/7, and <span class="tagged-query" title="Query">Gilbert's syndrome</span> 7/7, respectively. Tolerance to treatment decreased with increased number of TA repeat with 71% of the patients in 7/7 group who experienced grade 3/4 toxicity. CONCLUSIONS: The method we set up is suitable for the detection of <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> 1A1 <span class="tagged-filter" title="Association Word">polymorphism</span> in routine practice before <span class="tagged-drug" title="DrugBank: APRD00579"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00579">irinotecan</a></span> treatment. It could help to detect the patients homozygous or heterozygous for <span class="tagged-query" title="Query">Gilbert's syndrome,</span> at-risk of <span class="tagged-drug" title="DrugBank: APRD00718"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00718">CPT</a></span> 11-induced toxicity, and thus could help to individualize the dose to optimize efficacy and limit toxicity.
Gilbert_syndrome	UGT1A	True Positive	18.445	12732365	<strong class="title">Kohle C, Mohrle B, Munzel PA, Schwab M, Wernet D, Badary OA, Bock KW: Frequent co-occurrence of the TATA box <span class="tagged-filter" title="Association Word">mutation</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome</span> (UGT1A1*28) with other <span class="tagged-filter" title="Association Word">polymorphisms</span> of the <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span>-1 <span class="tagged-filter" title="Association Word">locus</span> (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol. 2003 May 1;65(9):1521-7.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> of drug metabolizing enzymes are frequently <span class="tagged-filter" title="Association Word">associated</span> with diseases and side effects of drugs. Recently, a TATA box <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">UGT1A1</a></span> (UGT1A1*28), a common genotype <span class="tagged-filter" title="Association Word">leading</span> to <span class="tagged-query" title="Query">Gilbert's syndrome,</span> and several missense <span class="tagged-filter" title="Association Word">mutations</span> of other <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT1)</a></span> family members have been described. Furthermore, co-occurrence of UGT1A1*28 and UGT1A6*2 has been <span class="tagged-filter" title="Association Word">observed.</span> In order to elucidate the basis for co-occurrence of <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1</a></span> <span class="tagged-filter" title="Association Word">mutations,</span> fluorescence resonance energy transfer techniques were developed for rapid determination of <span class="tagged-filter" title="Association Word">polymorphisms</span> of three <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> isoforms (UGT1A1*28, 1A6*2, and 1A7*2/*3). Hundred healthy Caucasians and 50 Egyptians were genotyped. All genotypes followed the Hardy-Weinberg equilibrium. Only three major haplotypes were found, including a haplotype consisting of allelic variants of all three isoforms (29% in Caucasians and 22% in Egyptians), all <span class="tagged-filter" title="Association Word">leading</span> to reduced <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">activity.</span> Frequent haplotypes containing several <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1</a></span> allelic variants should be taken into account in studies on the <span class="tagged-filter" title="Association Word">association</span> between diseases, abnormal drug reactions, and <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1</a></span> family <span class="tagged-filter" title="Association Word">polymorphisms.</span>
Gilbert_syndrome	UGT1A	True Positive	18.445	12685510	<strong class="title">Kanou M, Saeki K, Kato TA, Takahashi K, Mizutani T: Study of in vitro glucuronidation of hydroxyquinolines with bovine liver microsomes. Fundam Clin Pharmacol. 2002 Dec;16(6):513-7.</strong> Glucuronidation of drugs by <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> is a major phase II conjugation reaction. Defects in <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> are <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0010324">Crigler-Najjar syndrome</span> and <span class="tagged-query" title="Query">Gilbert's syndrome</span> with severe hyperbilirubinaemias and <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice.</span> We analysed the reactivities of some hydroxyquinoline derivatives, which are naturally <span class="tagged-filter" title="Association Word">produced</span> from quinoline by <span class="tagged-gene" title="Protein Family or Complex">cytochrome P450.</span> The analyses were carried out using a microassay system for <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> <span class="tagged-filter" title="Association Word">activity</span> in bovine liver microsomes in the range 0.5-100 pmol/assay with the highly sensitive radio-image analyser Fuji BAS2500 (Fujifilm, Tokyo, Japan). 3-Hydroxylquinoline is a good substrate for glucuronidation, and the relative Kcat values were 3.1-fold higher than the values for <span class="tagged-metabolite" title="HMDB: HMDB01232"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01232">p-nitrophenol.</a></span> 5,6-Dihydroquinoline-5,6-trans-diol gave a similar Km value to that of 3-hydroxyquinoline, but the Vmax value was approximately 1/15 of that of <span class="tagged-metabolite" title="HMDB: HMDB01232"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01232">p-nitrophenol</a></span> and showed weak reactivity. Quinoline N-oxide gave a low Vmax value and showed marginal <span class="tagged-filter" title="Association Word">activity.</span> The Kcat values of 6-hydroxyquinoline and 5-hydroxyquinoline were 2.1- and 1.2-fold higher than that of <span class="tagged-metabolite" title="HMDB: HMDB01232"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01232">p-nitrophenol,</a></span> respectively. Fluoroquinoline (FQ) derivatives, such as 3FQ, 7.8diFQ and 6,7,8triFQ, did not show any substrate activities. These results suggest that there are therapeutic problems in administration of some quinoline drugs to patients with <span class="tagged-disease" title="UMLS Concept ID: C0022346">jaundice.</span>
Gilbert_syndrome	UGT1A	True Positive	18.445	12499798	<strong class="title">Kim YH, Yeon JE, Jung GM, Kim HJ, Kim JS, Byun KS, Bak YT, Lee CH: [A study of <span class="tagged-filter" title="Association Word">polymorphism</span> in <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT</a></span>-1A1) promoter <span class="tagged-filter" title="Association Word">gene</span> in Korean patients with <span class="tagged-query" title="Query">Gilbert's syndrome].</span> Taehan Kan Hakhoe Chi. 2002 Jun;8(2):132-8.</strong> BACKGROUND/AIMS: Hepatic glucuronidating <span class="tagged-filter" title="Association Word">activity,</span> essential for efficient biliary excretion of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin,</a></span> is reduced to about 30 percent of normal in patients with <span class="tagged-query" title="Query">Gilbert's syndrome.</span> Patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> have an additional TA insertion in the A (TA) TAA of <a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT</a></span>-1A1) promoter <span class="tagged-filter" title="Association Word">gene.</span> This results in reduced frequency and accuracy of transcription initiation and <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity.</span> The frequency and location of the <span class="tagged-filter" title="Association Word">mutation</span> vary according to races. This study was done to determine the <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 promoter <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> in Korean cases of <span class="tagged-query" title="Query">Gilbert's syndrome.</span> METHODS: Promoter regions of the <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 in twelve patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> and twenty healthy subjects (controls) were sequenced. RESULTS: 1) Among twelve <span class="tagged-query" title="Query">Gilbert's syndrome</span> five patients were homozygous for A (TA) 6/6TAA, two were homozygous for A (TA) 7/7TAA, and the other five were heterozygous for A (TA) 6/7TAA. The prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> was 58.3 percent. 2) Among twenty healthy subjects seventeen were homozygous for A (TA) 6/6TAA, one was homozygous for A (TA) 7/7TAA, and two were heterozygous for A (TA) 6/7TAA. The prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> was 15 percent. 3) The prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-query" title="Query">Gilbert's syndrome</span> patients was significantly higher than in the controls (p=0.018). CONCLUSION: Although the prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> in Korean patients with <span class="tagged-query" title="Query">Gilbert's syndrome</span> is significantly higher than in the controls, the <span class="tagged-filter" title="Association Word">mutations</span> of the promoter region of <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 <span class="tagged-filter" title="Association Word">gene</span> appear not to be the main or sole <span class="tagged-filter" title="Association Word">cause</span> in <span class="tagged-query" title="Query">Gilbert's syndrome</span> in Korea since the prevalence of A (TA) TAA <span class="tagged-filter" title="Association Word">mutation</span> is not so high. Further studies to determine the relationship between other <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span>-1A1 <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> and <span class="tagged-query" title="Query">Gilbert's syndrome</span> in Korea are needed.
Gilbert_syndrome	UGT1A	True Positive	18.445	11915038	<strong class="title">Kaplan M, Hammerman C, Rubaltelli FF, Vilei MT, Levy-Lahad E, Renbaum P, Vreman HJ, Stevenson DK, Muraca M: Hemolysis and <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> conjugation in <span class="tagged-filter" title="Association Word">association</span> with <a href="http://beta.uniprot.org/uniprot/P22309">UDP-glucuronosyltransferase 1A1</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism.</span> Hepatology. 2002 Apr;35(4):905-11.</strong> Hemolysis may contribute to <span class="tagged-disease" title="UMLS Concept ID: C0020433">hyperbilirubinemia</span> in <span class="tagged-query" title="Query">Gilbert's syndrome.</span> The authors examined blood carboxyhemoglobin corrected for inspired CO (COHbc) to index heme catabolism and serum conjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> fractions to reflect <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> conjugation. Both parameters were <span class="tagged-filter" title="Association Word">related</span> to <a href="http://beta.uniprot.org/uniprot/P22309">UDP-glucuronosyltransferase 1A1</a></span> <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT)</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism,</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert's syndrome,</span> in term male newborns. COHbc was <span class="tagged-filter" title="Association Word">expressed</span> as percentage of total <span class="tagged-gene" title="Protein Family or Complex">hemoglobin,</span> and total conjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P14618; Entrez Gene ID: 5315; HGNC ID: 9021; HPRD ID: 01529; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <a href="http://beta.uniprot.org/uniprot/P14618">(TCB)</a></span> value as a percentage of serum total <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: P14618; Entrez Gene ID: 5315; HGNC ID: 9021; HPRD ID: 01529; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> (STB), <a href="http://beta.uniprot.org/uniprot/P14618">(TCB</a></span>/STB [%]). A <span class="tagged-filter" title="Association Word">production</span>/conjugation index, COHbc/<span class="tagged-gene" title="SwissProt ID: P14618; Entrez Gene ID: 5315; HGNC ID: 9021; HPRD ID: 01529; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14618">(TCB</a></span>/STB [%]), represented <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-filter" title="Association Word">production</span> divided by conjugation. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter genotype was designated according to the number of promoter TA insertions in each allele: 6/6, homozygous normal; 6/7, heterozygous; 7/7, homozygous variant. STB and COHbc values were higher in the 7/7 subgroup than the other counterparts (P <.01). The COHbc/<span class="tagged-gene" title="SwissProt ID: P14618; Entrez Gene ID: 5315; HGNC ID: 9021; HPRD ID: 01529; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14618">(TCB</a></span>/STB [%]) was higher in the 7/7 than either the 6/6 or 6/7 subsets (1.93 [1.31-2.88] vs. 0.85 [0.51-1.72] and 0.84 [0.53-1.87], respectively; P <.01). In conclusion, 7/7 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphism</span> was <span class="tagged-filter" title="Association Word">associated</span> with increased blood COHbc values (unexpected finding) as well as diminished serum total conjugated <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> ratios (expected finding). The increased hemolysis may contribute to the pathogenesis of increased STB values seen in <span class="tagged-query" title="Query">Gilbert's syndrome,</span> and exacerbate <span class="tagged-disease" title="UMLS Concept ID: C0857007">neonatal hyperbilirubinemia</span> <span class="tagged-filter" title="Association Word">associated</span> with the promoter <span class="tagged-filter" title="Association Word">polymorphism.</span>
Gilbert_syndrome	UGT1A	True Positive	18.445	11878580	<strong class="title">Passon RG, Howard TA, Zimmerman SA, Schultz WH, Ware RE: Influence of <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span>-glucuronosyltransferase 1A promoter <span class="tagged-filter" title="Association Word">polymorphisms</span> on serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels and <span class="tagged-disease" title="UMLS Concept ID: C1535187">cholelithiasis</span> in children with <span class="tagged-disease" title="UMLS Concept ID: C0002895">sickle cell anemia.</span> J Pediatr Hematol Oncol. 2001 Oct;23(7):448-51.</strong> PURPOSE: Genetic <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00295"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00295">uridine diphosphate</a></span> <a href="http://beta.uniprot.org/uniprot/Q9HAW8">(UDP)-glucuronosyltransferase</a></span> 1A <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT1A)</a></span> <span class="tagged-filter" title="Association Word">enzyme</span> promoter have been <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia</span> and <span class="tagged-query" title="Query">Gilbert syndrome.</span> The effects of <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphisms</span> on serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels and symptomatic <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstone</span> formation were studied in a cohort of children with <span class="tagged-disease" title="UMLS Concept ID: C0002895">sickle cell anemia</span> (SCA). METHODS: The <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> promoter genotype was deterrmined for 115 consecutive children with SCA. Steady-state laboratory parameters and previous cholecystectomy for symptomatic <span class="tagged-disease" title="UMLS Concept ID: C0008350">gallstones</span> were recorded retrospectively, then analyzed according to <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> genotype. RESULTS: Children with SCA had a lower frequency of the normal (TA) 6 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> promoter allele (0.413) than the abnormal (TA) 7 allele (0.461). A previously described shorter (TA) 5 allele (frequency 0.074) and longer (TA) 8 allele (frequency 0.052) were also <span class="tagged-filter" title="Association Word">observed.</span> Children with the 7/7 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> genotype had a significantly higher mean <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> level (5.8 +/- 3.1 mg/dL) than those with the 6/6 (2.4 +/- 0.8 mg/dL) or 6/7 genotype (3.0 +/- 1.1 mg/dL; P < 0.001 by analysis of variance). Patients with the 7/7 genotype were more likely to have previous cholecystectomy (87.5%) than those with the 6/6 (35.7%) or the 6/7 genotype (36.1%; P = 0.002 by chi2). CONCLUSIONS: Genetic variation in the <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> promoter significantly influences serum <span class="tagged-metabolite" title="HMDB: HMDB00054"><span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00054">bilirubin</a></span> levels and the development of symptomatic <span class="tagged-disease" title="UMLS Concept ID: C1535187">cholelithiasis</span> in children with SCA. The <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">UGT1A</a></span> promoter <span class="tagged-filter" title="Association Word">polymorphisms</span> represent an important nonglobin genetic modifier of clinical disease <span class="tagged-filter" title="Association Word">expression</span> in SCA.
Gilbert_syndrome	UGT1A	True Positive	18.445	11857560	<strong class="title">Fertrin KY, Goncalves MS, Saad ST, Costa FF: Frequencies of <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="SwissProt ID: P22309; Entrez Gene ID: 54658; HGNC ID: 12530; HPRD ID: 08933; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22309">(UGT1A1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> promoter <span class="tagged-filter" title="Association Word">polymorphisms</span> among distinct ethnic groups from Brazil. Am J Med Genet. 2002 Mar 1;108(2):117-9.</strong> A <span class="tagged-filter" title="Association Word">polymorphism</span> in the promoter region of the <span class="tagged-gene" title="SwissProt ID: Q9HAW8; Entrez Gene ID: 54575; HGNC ID: 12531; HPRD ID: 07336; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HAW8">UDP-glucuronosyltransferase</a></span> 1 <span class="tagged-gene" title="Entrez Gene ID: 7361; HGNC ID: 12529; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7361">(UGT1A)</a></span> <span class="tagged-filter" title="Association Word">gene</span> is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Gilbert syndrome</span> (GS), a benign form of mild <span class="tagged-disease" title="UMLS Concept ID: C0268306">unconjugated hyperbilirubinemia.</span> We genotyped 157 individuals from Brazil, comprising 71 Caucasians, 54 African-derived subjects, and 32 Parakana Indians. Frequencies of the alelle (TA)(7) <span class="tagged-filter" title="Association Word">associated</span> with GS found in this study were 0.324, 0.407, and 0.328, respectively. The genotype frequencies differed significantly between Caucasians and African-derived individuals. The high frequencies of (TA)(7) <span class="tagged-filter" title="Association Word">polymorphism</span> among the three groups confirm previous data that this <span class="tagged-filter" title="Association Word">polymorphism</span> is very ancient and appears to be distributed throughout the world.
McLeod_syndrome	pantothenate-kinase	True Negative	4.061	17210889	<strong class="title">Walker RH, Jung HH, Dobson-Stone C, Rampoldi L, Sano A, Tison F, Danek A: Neurologic phenotypes <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis.</span> Neurology. 2007 Jan 9;68(2):92-8.</strong> The term <span class="tagged-disease" title="UMLS Concept ID: C0393576">"neuroacanthocytosis"</span> is normally used to refer to <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> chorea-<span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> and X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-query" title="Query">McLeod syndrome,</span> but there are other <span class="tagged-disease" title="UMLS Concept ID: C0026650">movement disorders</span> in which erythrocyte <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> may also be seen, such as <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington disease</span>-like 2 and <span class="tagged-gene" title="SwissProt ID: Q8TE04; Entrez Gene ID: 53354; HGNC ID: 8598; HPRD ID: 07549; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8TE04">pantothenate kinase</a></span>-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration.</span> <span class="tagged-disease" title="UMLS Concept ID: C0751438">Disorders of</span> serum lipoproteins such as <span class="tagged-disease" title="UMLS Concept ID: C0000744">Bassen-Kornzweig disease</span> form a distinct group of <span class="tagged-disease" title="UMLS Concept ID: C0393576">neuroacanthocytosis</span> syndromes in which <span class="tagged-disease" title="UMLS Concept ID: Not Available">ataxia</span> is <span class="tagged-filter" title="Association Word">observed,</span> but <span class="tagged-disease" title="UMLS Concept ID: C0026650">movement disorders</span> are not seen. Genetic testing has enabled us to distinguish between these disorders, even when there are considerable similarities between phenotypes. Improved detection is important for accurate genetic counseling, for monitoring for complications, and, it is hoped, for implementing causal treatments, once these become available. As in other neurodegenerative conditions, animal models are a promising strategy for the development of such therapies.
McLeod_syndrome	interferon-gamma	True Negative	4.061	8084323	<strong class="title">Kantar A, Oggiano N, Gabbianelli R, Fabrizzi G, Giorgi PL: Successful <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon gamma</a></span> therapy in a patient with X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: C0018203">chronic granulomatous disease,</span> <span class="tagged-query" title="Query">McLeod syndrome</span> and hyper-<span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE.</a></span> Minerva Pediatr. 1994 Apr;46(4):157-60.</strong> Case report. Recent studies have shown clinical benefit resulting from recombinant <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon gamma</a></span> (rIFN-gamma) therapy in patients affected by <span class="tagged-disease" title="UMLS Concept ID: C0018203">chronic granulomatous disease</span> <span class="tagged-gene" title="SwissProt ID: P04839; Entrez Gene ID: 1536; HGNC ID: 2578; HPRD ID: 02382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04839">(CGD),</a></span> which represents an important adjunct to conventional therapy. In order to evaluate the effect of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon gamma</a></span> therapy, we investigated clinical and haematological parameters in a child with X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P04839; Entrez Gene ID: 1536; HGNC ID: 2578; HPRD ID: 02382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04839">CGD,</a></span> McLeod phenotype (kell negative) and hyper-<span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE,</a></span> before and after 8 months of therapy. Our results show no significant effect of rIFN-gamma on the respiratory burst of peripheral polymorphonuclear leukocytes. This notwithstanding, we <span class="tagged-filter" title="Association Word">observed</span> improved clinical and haematological conditions. These results support the view that <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon gamma</a></span> may benefit these subjects by influencing <span class="tagged-metabolite" title="HMDB: HMDB01377"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01377">oxygen</a></span>-independent antimicrobial <span class="tagged-filter" title="Association Word">activity</span> or other immunological parameters.
McLeod_syndrome	Kell-blood-group	True Positive	16.432	11284140	<strong class="title">Stevenson VL, Hardie RJ: <span class="tagged-disease" title="UMLS Concept ID: C0687751">Acanthocytosis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0027765">neurological disorders.</span> J Neurol. 2001 Feb;248(2):87-94.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0687751">Acanthocytosis</span> occurs because of ultrastructural abnormalities of the erythrocyte membranous skeleton resulting in reduced membrane fluidity. At least three hereditary neurological conditions are <span class="tagged-filter" title="Association Word">associated</span> with it, although as yet the pathogenesis of the neurological features is unknown. In <span class="tagged-disease" title="UMLS Concept ID: C0000744">abetalipoproteinaemia,</span> an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> condition, <span class="tagged-disease" title="UMLS Concept ID: C0042875">vitamin E deficiency</span> results in a progressive spinocerebellar syndrome <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0031117">peripheral neuropathy</span> and <span class="tagged-disease" title="UMLS Concept ID: C0035334">retinitis pigmentosa.</span> <span class="tagged-disease" title="UMLS Concept ID: C0393576">Neuroacanthocytosis</span> is also probably an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> condition and is characterised by chorea, orofaciolingual <span class="tagged-disease" title="UMLS Concept ID: C1546349">dyskinesia,</span> dysarthria, areflexia, seizures and <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span> <span class="tagged-query" title="Query">McLeod syndrome</span> is an X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">recessive</span> disorder usually presenting in males as a benign <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> with areflexia, in <span class="tagged-filter" title="Association Word">association</span> with a particular abnormality of <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> <span class="tagged-filter" title="Association Word">antigens.</span> However, occasionally the neurological features are more severe and indistinguishable from those of <span class="tagged-disease" title="UMLS Concept ID: C0393576">neuroacanthocytosis.</span> Recent advances in molecular genetics may assist better understanding of the disease mechanisms and the search for more effective treatments.
McLeod_syndrome	Kell-blood-group	True Positive	16.432	11032622	<strong class="title">Barnett MH, Yang F, Iland H, Pollard JD: Unusual muscle pathology in <span class="tagged-query" title="Query">McLeod syndrome.</span> J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):655-7.</strong> Muscle pathology in <span class="tagged-query" title="Query">McLeod syndrome</span> is usually mild; patchy <span class="tagged-disease" title="UMLS Concept ID: C0027540">necrotic</span> or regenerating fibres, occasional internal nuclei, and the <span class="tagged-filter" title="Association Word">absence</span> of an inflammatory cell infiltrate are the usual findings. We report on a 29 year old man presenting with chronic fatiguability and excessive sweating in whom an open quadriceps muscle biopsy demonstrated grouped <span class="tagged-disease" title="UMLS Concept ID: C0027540">necrotic</span> fibres accompanied by striking patchy mononuclear cell infiltrates. The <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">McLeod syndrome</span> was made on the basis of red blood cell <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis,</span> raised serum <span class="tagged-metabolite" title="HMDB: HMDB00064"><span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> kinase, and weak <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> <span class="tagged-filter" title="Association Word">antigens.</span> The quadriceps muscle infiltrate consisted principally of histologically typical macrophages. These cells had prominent nucleoli, displayed numerous mitoses, and were strongly <span class="tagged-gene" title="SwissProt ID: P34810; Entrez Gene ID: 968; HGNC ID: 1693; HPRD ID: 01093; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34810">CD68+.</a></span> A small population of typical CD3+, <span class="tagged-gene" title="SwissProt ID: P16150; Entrez Gene ID: 6693; HGNC ID: 11249; HPRD ID: 06770; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16150">CD43+</a></span> lymphocytes was also present. In addition, a small population of large atypical CD3+ cells was noted. Immunoperoxidase stains for <span class="tagged-gene" title="SwissProt ID: P11836; Entrez Gene ID: 931; HGNC ID: 7315; HPRD ID: 00204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11836">CD20,</a></span> <span class="tagged-gene" title="SwissProt ID: P28908; Entrez Gene ID: 943; HGNC ID: 11923; HPRD ID: 01074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28908">CD30,</a></span> CD79a, and <span class="tagged-gene" title="SwissProt ID: P13591; Entrez Gene ID: 4684; HGNC ID: 7656; HPRD ID: 00301; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13591">CD56</a></span> were negative. Immunocytochemical studies for the common <span class="tagged-disease" title="UMLS Concept ID: C0026850">muscular dystrophies</span> were normal. The muscle biopsy findings highlight a potential for confusion of this condition with <span class="tagged-disease" title="UMLS Concept ID: C0554591">idiopathic polymyositis.</span> The expanding range of muscle pathology reported in <span class="tagged-query" title="Query">McLeod syndrome,</span> to which this case adds, may reflect variable involvement of the XK <span class="tagged-filter" title="Association Word">gene</span> on chromosome Xp21, or of the adjacent loci of <span class="tagged-disease" title="UMLS Concept ID: C0013264">Duchenne muscular dystrophy</span> and <span class="tagged-disease" title="UMLS Concept ID: C0018203">chronic granulomatous disease.</span>
McLeod_syndrome	Kell-blood-group	True Positive	16.432	10465497	<strong class="title">Kawakami T, Takiyama Y, Sakoe K, Ogawa T, Yoshioka T, Nishizawa M, Reid ME, Kobayashi O, Nonaka I, Nakano I: A case of <span class="tagged-query" title="Query">McLeod syndrome</span> with unusually severe <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy.</span> J Neurol Sci. 1999 Jun 15;166(1):36-9.</strong> A 51-year-old man developed weakness and <span class="tagged-disease" title="UMLS Concept ID: C0026846">muscle atrophy</span> in the legs at the age of 41, later followed by choreiform involuntary movements. Neurological and laboratory examinations revealed severe muscle weakness and atrophy, and areflexia in all the extremities, <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> and an <span class="tagged-filter" title="Association Word">elevated</span> serum <span class="tagged-metabolite" title="HMDB: HMDB00064"><span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> kinase level. Together with these findings, the weak <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> <span class="tagged-filter" title="Association Word">antigens</span> and the <span class="tagged-filter" title="Association Word">absence</span> of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen</a></span> <span class="tagged-filter" title="Association Word">led</span> to a definite <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">McLeod syndrome</span> for his condition. Brain magnetic resonance imaging revealed marked atrophy of the head of the caudate nuclei. Although immunocytochemical analysis of <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">dystrophin</a></span> in muscle specimens from our patient revealed normal staining, we found prominent fiber size variability, central nuclei, and connective tissue proliferation as well as <span class="tagged-disease" title="UMLS Concept ID: C0027540">necrotic</span> and regenerating fibers, which are as a whole compatible with the myopathology of <span class="tagged-disease" title="UMLS Concept ID: C0026850">muscular dystrophy.</span> Moreover, muscle computerized tomography of the lower extremities revealed the 'selectivity pattern' characteristically reported in <span class="tagged-disease" title="UMLS Concept ID: C0026850">muscular dystrophies</span> including Duchenne type <span class="tagged-disease" title="UMLS Concept ID: C0026850">muscular dystrophy.</span> The muscular symptoms and pathology in <span class="tagged-query" title="Query">McLeod syndrome</span> have been reported to be mild, but the present case clearly shows that the muscular features in this condition may be much more severe than previously thought.
McLeod_syndrome	Kell-blood-group	True Positive	16.432	10343080	<strong class="title">Jeren-Strujic B, Jeren T, Thaller N, Zivkovic Z, Raos V: A case of <span class="tagged-query" title="Query">McLeod syndrome</span> with <span class="tagged-disease" title="UMLS Concept ID: C0022661">chronic renal failure.</span> Blood Purif. 1998;16(6):336-40.</strong> A 50-year-old man with the rare <span class="tagged-query" title="Query">McLeod syndrome,</span> <span class="tagged-filter" title="Association Word">associated</span> with glomerular lesion to the end stage of <span class="tagged-disease" title="UMLS Concept ID: C0022661">chronic renal failure</span> and death, is reported. <span class="tagged-query" title="Query">McLeod syndrome</span> is an X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">recessive</span> disorder on the basis of abnormal <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> <span class="tagged-filter" title="Association Word">antigens</span> and <span class="tagged-filter" title="Association Word">absence</span> of erythrocyte surface <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen.</a></span> Most often the clinical and pathological findings are <span class="tagged-disease" title="UMLS Concept ID: C0035334">retinitis pigmentosa</span> to blindness, progressive chronic neuropathy, cortical atrophy, <span class="tagged-disease" title="UMLS Concept ID: C0007193">dilated cardiomyopathy,</span> and glomerular lesion with <span class="tagged-disease" title="UMLS Concept ID: C0022661">chronic renal failure.</span> Among the laboratory parameters the most important are very low level of <span class="tagged-metabolite" title="HMDB: HMDB00067"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00067">cholesterol</a></span> and triglycerides, then various numbers of acanthocytes in peripheral blood smears and sometimes in urine (as in our case).
McLeod_syndrome	Kell-blood-group	True Positive	16.432	9371984	<strong class="title">Tanner MJ: Advances in the molecular biology of erythrocyte <span class="tagged-filter" title="Association Word">antigens.</span> Curr Opin Hematol. 1995 Mar;2(2):139-45.</strong> The past year has seen further advances in our understanding of the molecular biology of the most abundant erythrocyte <span class="tagged-filter" title="Association Word">proteins</span> <span class="tagged-filter" title="Association Word">associated</span> with blood group <span class="tagged-filter" title="Association Word">antigens</span> (band 3, the glycophorins, and the Rh <span class="tagged-filter" title="Association Word">antigen</span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins).</span> There have also been several important developments in the structural and functional identification of some of the less abundant <span class="tagged-filter" title="Association Word">antigens.</span> These developments include the <span class="tagged-filter" title="Association Word">association</span> of the Colton <span class="tagged-filter" title="Association Word">antigens</span> with the erythrocyte water channel, <span class="tagged-gene" title="Protein Family or Complex">aquaporin;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: Q16570; Entrez Gene ID: 2532; HGNC ID: 4035; HPRD ID: 00192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16570">Duffy antigen</a></span> and its identification as a <span class="tagged-gene" title="Protein Family or Complex">chemokine receptor;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen,</a></span> which is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">McLeod syndrome;</span> and the cloning of the LW, <span class="tagged-gene" title="SwissProt ID: Q08722; Entrez Gene ID: 961; HGNC ID: 1682; HPRD ID: 03017; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q08722">CD47,</a></span> and Xga <span class="tagged-filter" title="Association Word">antigens.</span>
McLeod_syndrome	Kell-blood-group	True Positive	16.432	8290045	<strong class="title">Danek A, Uttner I, Vogl T, Tatsch K, Witt TN: Cerebral involvement in <span class="tagged-query" title="Query">McLeod syndrome.</span> Neurology. 1994 Jan;44(1):117-20.</strong> <span class="tagged-query" title="Query">McLeod syndrome</span> is an Xp21-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> variant due to lack of erythrocyte <span class="tagged-filter" title="Association Word">protein</span> Kx with <span class="tagged-filter" title="Association Word">associated</span> RBC membrane dysfunction such as <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis.</span> A man with this syndrome developed chorea and slight neuropsychological impairment. He had caudate atrophy on cerebral imaging and reduced striatal <span class="tagged-gene" title="SwissProt ID: P14416; Entrez Gene ID: 1813; HGNC ID: 3023; HPRD ID: 00539; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14416">dopamine D2-receptor</a></span> binding on single-photon emission computed tomography. Since Xp21 was partly <span class="tagged-filter" title="Association Word">deleted</span> in the patient, the missing <span class="tagged-filter" title="Association Word">gene</span> product (possibly Kx) may be essential for the integrity of the striatum.
McLeod_syndrome	Kell-blood-group	True Positive	16.432	7737196	<strong class="title">Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O: Purification and partial characterization of the erythrocyte Kx <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-filter" title="Association Word">deficient</span> in McLeod patients. Eur J Biochem. 1995 Mar 15;228(3):931-4.</strong> A 37-kDa <span class="tagged-filter" title="Association Word">protein</span> was immunopurified from human erythrocytes as a complex with a monoclonal <span class="tagged-filter" title="Association Word">antibody</span> directed against the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group protein</a></span> of 93 kDa. A rabbit <span class="tagged-filter" title="Association Word">antibody</span> raised against the purified complex reacted on a Western blot with the 93-kDa and 37-kDa <span class="tagged-filter" title="Association Word">proteins</span> and was able to immunoprecipitate the 37-kDa component from K0 erythrocytes which express large amount of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen,</a></span> but not from erythrocytes of patients suffering from <span class="tagged-query" title="Query">McLeod syndrome,</span> a X-<span class="tagged-filter" title="Association Word">linked</span> disorder in which the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen</a></span> is <span class="tagged-filter" title="Association Word">lacking.</span> Additional studies have shown that the 37-kDa <span class="tagged-filter" title="Association Word">protein</span> is not glycosylated, and permitted the sequence of the 22 first N-terminal amino acids to be established. This sequence was identical to the predicted <span class="tagged-filter" title="Association Word">protein</span> product of the XK <span class="tagged-filter" title="Association Word">gene</span> cloned recently, which is <span class="tagged-filter" title="Association Word">deleted</span> or <span class="tagged-filter" title="Association Word">mutated</span> in McLeod patients [Ho, M., Chelly, J., Carter, N., Danek, A., Crocker, P. & Monaco, A. P. (1994) Cell 77, 869-880]. Our findings provide strong evidence that the 37-kDa red cell membrane <span class="tagged-filter" title="Association Word">protein</span> is identical to the Kx <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-filter" title="Association Word">produced</span> by the XK structural <span class="tagged-filter" title="Association Word">gene</span> and demonstrate that Kx and Kell <span class="tagged-filter" title="Association Word">proteins</span> are two subunits <span class="tagged-filter" title="Association Word">expressed</span> as a complex hold by disulfide bond (s) at the red cell surface.
McLeod_syndrome	Kell-blood-group	True Positive	16.432	6685553	<strong class="title">Swash M, Schwartz MS, Carter ND, Heath R, Leak M, Rogers KL: Benign X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> with acanthocytes <span class="tagged-query" title="Query">(McLeod syndrome).</span> Brain. 1983 Sep;106 (Pt 3):717-33.</strong> Its relationship to X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: C0026850">muscular dystrophy.</span> Two healthy men with <span class="tagged-query" title="Query">McLeod syndrome,</span> a rare X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">recessive</span> phenotype characterized by <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> and weakened red blood cell antigenicity in the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> system, have been investigated. Both men showed raised blood <span class="tagged-metabolite" title="HMDB: HMDB00064"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> kinase levels, with myopathic EMG abnormalities. Biopsies of the quadriceps muscle showed the features of an active <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> although there was no clinical evidence of muscular abnormality. The combination of the <span class="tagged-filter" title="Association Word">association</span> of membrane abnormalities in red blood cells and a <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> in both McLeod phenotype and <span class="tagged-disease" title="UMLS Concept ID: C0013264">Duchenne muscular dystrophy</span> suggests that these syndromes may be due to <span class="tagged-filter" title="Association Word">related</span> genetic abnormalities. The genetic <span class="tagged-filter" title="Association Word">locus</span> for McLeod phenotype is situated near the end of the short arm of the X chromosome. The <span class="tagged-filter" title="Association Word">locus</span> for <span class="tagged-disease" title="UMLS Concept ID: C0013264">Duchenne muscular dystrophy</span> is unknown but it has been postulated that it is also situated on the short arm of the X chromosome at Xp 21. The occurrence of a subclinical X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> with <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> (McLeod phenotype) thus raises the possibility of a new approach to genetic investigations in <span class="tagged-disease" title="UMLS Concept ID: C0013264">Duchenne muscular dystrophy,</span> and in the <span class="tagged-filter" title="Association Word">related</span> milder forms of this disease.
McLeod_syndrome	Kell-blood-group	True Positive	16.432	2687930	<strong class="title">Hardie RJ: <span class="tagged-disease" title="UMLS Concept ID: C0687751">Acanthocytosis</span> and neurological impairment--a review. Q J Med. 1989 Apr;71(264):291-306.</strong> Acanthocytes have a distinct morphology and are not normally found in peripheral blood. They occur in <span class="tagged-filter" title="Association Word">association</span> with at least three neurological syndromes. In <span class="tagged-disease" title="UMLS Concept ID: C0000744">abetalipoproteinaemia,</span> a progressive <span class="tagged-disease" title="UMLS Concept ID: C0087012">spinocerebellar ataxia</span> and retinopathy occurs secondary to malabsorption of <span class="tagged-metabolite" title="HMDB: HMDB01893"><span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01893">vitamin E.</a></span> Cases with chorea are often familial, with <span class="tagged-disease" title="UMLS Concept ID: C0152115">orofacial dyskinesia</span> and an <span class="tagged-disease" title="UMLS Concept ID: C0270921">axonal neuropathy</span> <span class="tagged-filter" title="Association Word">causing</span> areflexia and <span class="tagged-disease" title="UMLS Concept ID: C0026846">muscle wasting.</span> Areflexia and a subclinical <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> also occur in the <span class="tagged-query" title="Query">McLeod syndrome,</span> in which there is abnormal <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> <span class="tagged-filter" title="Association Word">antigens.</span> The exact mechanism of <span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> in each disorder remains uncertain: passive changes in membrane lipids, surface receptor/ligand interactions, and a primary membrane defect are among the possibilities.
McLeod_syndrome	aquaporin	True Negative	4.061	9371984	<strong class="title">Tanner MJ: Advances in the molecular biology of erythrocyte <span class="tagged-filter" title="Association Word">antigens.</span> Curr Opin Hematol. 1995 Mar;2(2):139-45.</strong> The past year has seen further advances in our understanding of the molecular biology of the most abundant erythrocyte <span class="tagged-filter" title="Association Word">proteins</span> <span class="tagged-filter" title="Association Word">associated</span> with blood group <span class="tagged-filter" title="Association Word">antigens</span> (band 3, the glycophorins, and the Rh <span class="tagged-filter" title="Association Word">antigen</span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins).</span> There have also been several important developments in the structural and functional identification of some of the less abundant <span class="tagged-filter" title="Association Word">antigens.</span> These developments include the <span class="tagged-filter" title="Association Word">association</span> of the Colton <span class="tagged-filter" title="Association Word">antigens</span> with the erythrocyte water channel, <span class="tagged-gene" title="Protein Family or Complex">aquaporin;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: Q16570; Entrez Gene ID: 2532; HGNC ID: 4035; HPRD ID: 00192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16570">Duffy antigen</a></span> and its identification as a <span class="tagged-gene" title="Protein Family or Complex">chemokine receptor;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen,</a></span> which is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">McLeod syndrome;</span> and the cloning of the LW, <span class="tagged-gene" title="SwissProt ID: Q08722; Entrez Gene ID: 961; HGNC ID: 1682; HPRD ID: 03017; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q08722">CD47,</a></span> and Xga <span class="tagged-filter" title="Association Word">antigens.</span>
McLeod_syndrome	chemokine-receptor	True Negative	4.061	9371984	<strong class="title">Tanner MJ: Advances in the molecular biology of erythrocyte <span class="tagged-filter" title="Association Word">antigens.</span> Curr Opin Hematol. 1995 Mar;2(2):139-45.</strong> The past year has seen further advances in our understanding of the molecular biology of the most abundant erythrocyte <span class="tagged-filter" title="Association Word">proteins</span> <span class="tagged-filter" title="Association Word">associated</span> with blood group <span class="tagged-filter" title="Association Word">antigens</span> (band 3, the glycophorins, and the Rh <span class="tagged-filter" title="Association Word">antigen</span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins).</span> There have also been several important developments in the structural and functional identification of some of the less abundant <span class="tagged-filter" title="Association Word">antigens.</span> These developments include the <span class="tagged-filter" title="Association Word">association</span> of the Colton <span class="tagged-filter" title="Association Word">antigens</span> with the erythrocyte water channel, <span class="tagged-gene" title="Protein Family or Complex">aquaporin;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: Q16570; Entrez Gene ID: 2532; HGNC ID: 4035; HPRD ID: 00192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16570">Duffy antigen</a></span> and its identification as a <span class="tagged-gene" title="Protein Family or Complex">chemokine receptor;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen,</a></span> which is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">McLeod syndrome;</span> and the cloning of the LW, <span class="tagged-gene" title="SwissProt ID: Q08722; Entrez Gene ID: 961; HGNC ID: 1682; HPRD ID: 03017; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q08722">CD47,</a></span> and Xga <span class="tagged-filter" title="Association Word">antigens.</span>
McLeod_syndrome	ChAc-1	True Negative	4.061	17345646	<strong class="title">Saiki S, Sakai K, Murata KY, Saiki M, Nakanishi M, Kitagawa Y, Kaito M, Gondo Y, Kumamoto T, Matsui M, Hattori N, Hirose G: Primary skeletal muscle involvement in chorea-<span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis.</span> Mov Disord. 2007 Apr 30;22(6):848-52.</strong> Chorea-acanthocytosis (ChAc) is a <span class="tagged-disease" title="UMLS Concept ID: C0019247">hereditary disease</span> characterized by involuntary movements and <span class="tagged-disease" title="UMLS Concept ID: C0026846">amyotrophy</span> with elevation of serum <span class="tagged-metabolite" title="HMDB: HMDB00064"><span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> kinase. Although skeletal muscle involvement in ChAc has been suggested, the mechanism remains unclear. To investigate <a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> abnormalities of the skeletal muscles of ChAc patients with an apparently heterozygous <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">VPS13A</a></span> <span class="tagged-filter" title="Association Word">mutation</span> compared with those of other hereditary choreic diseases, we performed histological and immunohistochemical studies of the skeletal muscles from 3 <span class="tagged-gene" title="SwissProt ID: Q9BUX1; Entrez Gene ID: 79094; HGNC ID: 28680; HPRD ID: 14634; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9BUX1">ChAc, 1</a></span> <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease</span> (HD), 1 <span class="tagged-query" title="Query">McLeod syndrome</span> <span class="tagged-gene" title="Entrez Gene ID: 4307; HGNC ID: 7145; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4307">(MLS),</a></span> and 1 normal control (NC) with 2 originally generated anti-<span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> <span class="tagged-filter" title="Association Word">antibodies.</span> <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">Chorein</a></span> immunoreactivities in HD, <span class="tagged-gene" title="Entrez Gene ID: 4307; HGNC ID: 7145; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4307">MLS,</a></span> and NC were found linearly along the sarcolemma and appeared as speckles in the sarcoplasma, but those in ChAc were uneven and discontinuous along the sarcolemmas and increased in the sarcoplasma especially in type I fibers. This histological observation suggests <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> abnormalities of skeletal muscles might be <span class="tagged-filter" title="Association Word">associated</span> with primary involvement of skeletal muscles in this disorder.
McLeod_syndrome	CD47	True Negative	4.061	9371984	<strong class="title">Tanner MJ: Advances in the molecular biology of erythrocyte <span class="tagged-filter" title="Association Word">antigens.</span> Curr Opin Hematol. 1995 Mar;2(2):139-45.</strong> The past year has seen further advances in our understanding of the molecular biology of the most abundant erythrocyte <span class="tagged-filter" title="Association Word">proteins</span> <span class="tagged-filter" title="Association Word">associated</span> with blood group <span class="tagged-filter" title="Association Word">antigens</span> (band 3, the glycophorins, and the Rh <span class="tagged-filter" title="Association Word">antigen</span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins).</span> There have also been several important developments in the structural and functional identification of some of the less abundant <span class="tagged-filter" title="Association Word">antigens.</span> These developments include the <span class="tagged-filter" title="Association Word">association</span> of the Colton <span class="tagged-filter" title="Association Word">antigens</span> with the erythrocyte water channel, <span class="tagged-gene" title="Protein Family or Complex">aquaporin;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: Q16570; Entrez Gene ID: 2532; HGNC ID: 4035; HPRD ID: 00192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16570">Duffy antigen</a></span> and its identification as a <span class="tagged-gene" title="Protein Family or Complex">chemokine receptor;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen,</a></span> which is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">McLeod syndrome;</span> and the cloning of the LW, <span class="tagged-gene" title="SwissProt ID: Q08722; Entrez Gene ID: 961; HGNC ID: 1682; HPRD ID: 03017; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q08722">CD47,</a></span> and Xga <span class="tagged-filter" title="Association Word">antigens.</span>
McLeod_syndrome	Chorein	False Positive	7.703	17345646	<strong class="title">Saiki S, Sakai K, Murata KY, Saiki M, Nakanishi M, Kitagawa Y, Kaito M, Gondo Y, Kumamoto T, Matsui M, Hattori N, Hirose G: Primary skeletal muscle involvement in chorea-<span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis.</span> Mov Disord. 2007 Apr 30;22(6):848-52.</strong> Chorea-acanthocytosis (ChAc) is a <span class="tagged-disease" title="UMLS Concept ID: C0019247">hereditary disease</span> characterized by involuntary movements and <span class="tagged-disease" title="UMLS Concept ID: C0026846">amyotrophy</span> with elevation of serum <span class="tagged-metabolite" title="HMDB: HMDB00064"><span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> kinase. Although skeletal muscle involvement in ChAc has been suggested, the mechanism remains unclear. To investigate <a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> abnormalities of the skeletal muscles of ChAc patients with an apparently heterozygous <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">VPS13A</a></span> <span class="tagged-filter" title="Association Word">mutation</span> compared with those of other hereditary choreic diseases, we performed histological and immunohistochemical studies of the skeletal muscles from 3 <span class="tagged-gene" title="SwissProt ID: Q9BUX1; Entrez Gene ID: 79094; HGNC ID: 28680; HPRD ID: 14634; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9BUX1">ChAc, 1</a></span> <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease</span> (HD), 1 <span class="tagged-query" title="Query">McLeod syndrome</span> <span class="tagged-gene" title="Entrez Gene ID: 4307; HGNC ID: 7145; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4307">(MLS),</a></span> and 1 normal control (NC) with 2 originally generated anti-<span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> <span class="tagged-filter" title="Association Word">antibodies.</span> <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">Chorein</a></span> immunoreactivities in HD, <span class="tagged-gene" title="Entrez Gene ID: 4307; HGNC ID: 7145; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4307">MLS,</a></span> and NC were found linearly along the sarcolemma and appeared as speckles in the sarcoplasma, but those in ChAc were uneven and discontinuous along the sarcolemmas and increased in the sarcoplasma especially in type I fibers. This histological observation suggests <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> abnormalities of skeletal muscles might be <span class="tagged-filter" title="Association Word">associated</span> with primary involvement of skeletal muscles in this disorder.
McLeod_syndrome	Chorein	False Positive	7.703	15293285	<strong class="title">Dobson-Stone C, Velayos-Baeza A, Filippone LA, Westbury S, Storch A, Erdmann T, Wroe SJ, Leenders KL, Lang AE, Dotti MT, Federico A, Mohiddin SA, Fananapazir L, Daniels G, Danek A, Monaco AP: <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">Chorein</a></span> detection for the <span class="tagged-filter" title="Association Word">diagnosis</span> of chorea-<span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis.</span> Ann Neurol. 2004 Aug;56(2):299-302.</strong> Chorea-acanthocytosis (ChAc) is a severe, <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorder</span> that shares clinical features with <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease</span> and <span class="tagged-query" title="Query">McLeod syndrome.</span> It is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">VPS13A,</a></span> which encodes a large <span class="tagged-filter" title="Association Word">protein</span> called <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein.</a></span> Using antichorein antisera, we found <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> in all human cells analyzed. However, <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> <span class="tagged-filter" title="Association Word">expression</span> was absent or noticeably reduced in ChAc patient cells, but not <span class="tagged-query" title="Query">McLeod syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease</span> cells. This suggests that loss of <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span> <span class="tagged-filter" title="Association Word">expression</span> is a diagnostic feature of ChAc.
McLeod_syndrome	Chorein	False Positive	7.703	11761473	<strong class="title">Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HH, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP: McLeod <span class="tagged-disease" title="UMLS Concept ID: C0393576">neuroacanthocytosis:</span> genotype and phenotype. Ann Neurol. 2001 Dec;50(6):755-64.</strong> <span class="tagged-query" title="Query">McLeod syndrome</span> is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> of XK, an X-chromosomal <span class="tagged-filter" title="Association Word">gene</span> of unknown function. Originally defined as a peculiar <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> variant, the disease affects multiple organs, including the nervous system, but is certainly underdiagnosed. We analyzed the <span class="tagged-filter" title="Association Word">mutations</span> and clinical findings of 22 affected men, aged 27 to 72 years. Fifteen different XK <span class="tagged-filter" title="Association Word">mutations</span> were found, nine of which were novel, including the one of the eponymous case McLeod. Their common result is predicted <span class="tagged-filter" title="Association Word">absence</span> or truncation of the XK <span class="tagged-filter" title="Association Word">protein.</span> All patients showed <span class="tagged-filter" title="Association Word">elevated</span> levels of muscle <span class="tagged-metabolite" title="HMDB: HMDB00064"><span class="tagged-gene" title="SwissProt ID: P42858; Entrez Gene ID: 3064; HGNC ID: 4851; HPRD ID: 00883; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> phosphokinase, but clinical <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> was less common. A <span class="tagged-disease" title="UMLS Concept ID: C0031117">peripheral neuropathy</span> with areflexia was found in all but 2 patients. The central nervous system was affected in 15 patients, as obvious from the occurrence of seizures, cognitive impairment, psychopathology, and choreatic movements. Neuroimaging emphasized the particular involvement of the basal ganglia, which was also detected in 1 asymptomatic young patient. Most features develop with age, mainly after the fourth decade. The resemblance of <span class="tagged-query" title="Query">McLeod syndrome</span> with <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease</span> and with <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> chorea-<span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> suggests that the corresponding <span class="tagged-filter" title="Association Word">proteins</span>--XK, <a href="http://beta.uniprot.org/uniprot/P42858">huntingtin,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span>--might belong to a common pathway, the dysfunction of which <span class="tagged-filter" title="Association Word">causes</span> degeneration of the basal ganglia.
McLeod_syndrome	SRPX	False Positive	2.200	8634708	<strong class="title">Meindl A, Carvalho MR, Herrmann K, Lorenz B, Achatz H, Lorenz B, Apfelstedt-Sylla E, Wittwer B, Ross M, Meitinger T: A <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: O60687; Entrez Gene ID: 27286; HGNC ID: 30668; HPRD ID: 06726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60687">(SRPX)</a></span> encoding a <span class="tagged-gene" title="SwissProt ID: O60687; Entrez Gene ID: 27286; HGNC ID: 30668; HPRD ID: 06726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60687">sushi-repeat-containing protein</a></span> is <span class="tagged-filter" title="Association Word">deleted</span> in patients with X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: C0035334">retinitis pigmentosa.</span> Hum Mol Genet. 1995 Dec;4(12):2339-46.</strong> X-linked <span class="tagged-disease" title="UMLS Concept ID: C0035334">retinitis pigmentosa</span> (XLRP) is characterized by <span class="tagged-disease" title="UMLS Concept ID: C1537080">retinal degeneration</span> with <span class="tagged-disease" title="UMLS Concept ID: C1557326">night blindness</span> and progressive reduction of the visual fields. By <span class="tagged-filter" title="Association Word">linkage</span> and deletion analysis a <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">locus</span> <span class="tagged-gene" title="SwissProt ID: P51808; Entrez Gene ID: 6990; HGNC ID: 11694; HPRD ID: 02249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51808">(RP3)</a></span> has been mapped to the short arm of the X chromosome between the <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P04839; Entrez Gene ID: 1536; HGNC ID: 2578; HPRD ID: 02382; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04839">CYBB</a></span> and <span class="tagged-gene" title="SwissProt ID: P00480; Entrez Gene ID: 5009; HGNC ID: 8512; HPRD ID: 08947; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00480">OTC.</a></span> Analysis of transcript in this region has revealed a <span class="tagged-filter" title="Association Word">gene</span> which is abundantly <span class="tagged-filter" title="Association Word">expressed</span> in human retina and encodes a <span class="tagged-gene" title="SwissProt ID: Q9UM00; Entrez Gene ID: 54499; HGNC ID: 18188; HPRD ID: 14243; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UM00">putative membrane protein</a></span> with significant homologies to short consensus repeat (SCR/sushi) domains known from selections and complement <span class="tagged-filter" title="Association Word">proteins.</span> The <span class="tagged-filter" title="Association Word">gene</span> termed <span class="tagged-gene" title="SwissProt ID: O60687; Entrez Gene ID: 27286; HGNC ID: 30668; HPRD ID: 06726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60687">SRPX</a></span> <span class="tagged-gene" title="SwissProt ID: O60687; Entrez Gene ID: 27286; HGNC ID: 30668; HPRD ID: 06726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60687">(sushi-repeat-containing protein,</a></span> x chromosome) is <span class="tagged-filter" title="Association Word">deleted</span> in an RP patient who also suffers from <span class="tagged-disease" title="UMLS Concept ID: C0018203">chronic granulomatous disease</span> and <span class="tagged-query" title="Query">McLeod syndrome.</span> A 75 kb deletion removing exon 1 of the <span class="tagged-filter" title="Association Word">gene</span> was also found in two brothers of a second XLRP family. However, no further functionally significant <span class="tagged-filter" title="Association Word">mutations</span> were detected by SSCP screening of all 10 exons in 34 unrelated XLRP patients nor by full length RT-PCR sequencing in two <span class="tagged-gene" title="SwissProt ID: P51808; Entrez Gene ID: 6990; HGNC ID: 11694; HPRD ID: 02249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51808">RP3</a></span> families. The role of this highly conserved retinal <span class="tagged-filter" title="Association Word">gene</span> in the pathogenesis of RP therefore remains to be determined.
McLeod_syndrome	Huntingtin	False Positive	1.821	11761473	<strong class="title">Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HH, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP: McLeod <span class="tagged-disease" title="UMLS Concept ID: C0393576">neuroacanthocytosis:</span> genotype and phenotype. Ann Neurol. 2001 Dec;50(6):755-64.</strong> <span class="tagged-query" title="Query">McLeod syndrome</span> is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> of XK, an X-chromosomal <span class="tagged-filter" title="Association Word">gene</span> of unknown function. Originally defined as a peculiar <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kell blood group</a></span> variant, the disease affects multiple organs, including the nervous system, but is certainly underdiagnosed. We analyzed the <span class="tagged-filter" title="Association Word">mutations</span> and clinical findings of 22 affected men, aged 27 to 72 years. Fifteen different XK <span class="tagged-filter" title="Association Word">mutations</span> were found, nine of which were novel, including the one of the eponymous case McLeod. Their common result is predicted <span class="tagged-filter" title="Association Word">absence</span> or truncation of the XK <span class="tagged-filter" title="Association Word">protein.</span> All patients showed <span class="tagged-filter" title="Association Word">elevated</span> levels of muscle <span class="tagged-metabolite" title="HMDB: HMDB00064"><span class="tagged-gene" title="SwissProt ID: P42858; Entrez Gene ID: 3064; HGNC ID: 4851; HPRD ID: 00883; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> phosphokinase, but clinical <span class="tagged-disease" title="UMLS Concept ID: C0026848">myopathy</span> was less common. A <span class="tagged-disease" title="UMLS Concept ID: C0031117">peripheral neuropathy</span> with areflexia was found in all but 2 patients. The central nervous system was affected in 15 patients, as obvious from the occurrence of seizures, cognitive impairment, psychopathology, and choreatic movements. Neuroimaging emphasized the particular involvement of the basal ganglia, which was also detected in 1 asymptomatic young patient. Most features develop with age, mainly after the fourth decade. The resemblance of <span class="tagged-query" title="Query">McLeod syndrome</span> with <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease</span> and with <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> chorea-<span class="tagged-disease" title="UMLS Concept ID: C0687751">acanthocytosis</span> suggests that the corresponding <span class="tagged-filter" title="Association Word">proteins</span>--XK, <a href="http://beta.uniprot.org/uniprot/P42858">huntingtin,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q96RL7; Entrez Gene ID: 23230; HGNC ID: 1908; HPRD ID: 05814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96RL7">chorein</a></span>--might belong to a common pathway, the dysfunction of which <span class="tagged-filter" title="Association Word">causes</span> degeneration of the basal ganglia.
McLeod_syndrome	Duffy-antigen	True Negative	4.061	9371984	<strong class="title">Tanner MJ: Advances in the molecular biology of erythrocyte <span class="tagged-filter" title="Association Word">antigens.</span> Curr Opin Hematol. 1995 Mar;2(2):139-45.</strong> The past year has seen further advances in our understanding of the molecular biology of the most abundant erythrocyte <span class="tagged-filter" title="Association Word">proteins</span> <span class="tagged-filter" title="Association Word">associated</span> with blood group <span class="tagged-filter" title="Association Word">antigens</span> (band 3, the glycophorins, and the Rh <span class="tagged-filter" title="Association Word">antigen</span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins).</span> There have also been several important developments in the structural and functional identification of some of the less abundant <span class="tagged-filter" title="Association Word">antigens.</span> These developments include the <span class="tagged-filter" title="Association Word">association</span> of the Colton <span class="tagged-filter" title="Association Word">antigens</span> with the erythrocyte water channel, <span class="tagged-gene" title="Protein Family or Complex">aquaporin;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: Q16570; Entrez Gene ID: 2532; HGNC ID: 4035; HPRD ID: 00192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16570">Duffy antigen</a></span> and its identification as a <span class="tagged-gene" title="Protein Family or Complex">chemokine receptor;</span> the cloning of the <span class="tagged-gene" title="SwissProt ID: P51811; Entrez Gene ID: 7504; HGNC ID: 12811; HPRD ID: 02444; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51811">Kx antigen,</a></span> which is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">McLeod syndrome;</span> and the cloning of the LW, <span class="tagged-gene" title="SwissProt ID: Q08722; Entrez Gene ID: 961; HGNC ID: 1682; HPRD ID: 03017; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q08722">CD47,</a></span> and Xga <span class="tagged-filter" title="Association Word">antigens.</span>
Orofacial_cleft	EDN1	True Positive	1.011	11415518	<strong class="title">Pezzetti F, Scapoli L, Martinelli M, Carinci F, Brunelli G, Carls FP, Palomba F, Gombos F, Carinci P, Tognon M: <span class="tagged-filter" title="Association Word">Linkage</span> analysis of candidate endothelin pathway <span class="tagged-filter" title="Association Word">genes</span> in nonsyndromic familial <span class="tagged-query" title="Query">orofacial cleft.</span> Ann Hum Genet. 2000 Jul;64(Pt 4):341-7.</strong> There is good evidence from <span class="tagged-filter" title="Association Word">linkage</span> analysis and mouse model knockouts that the <span class="tagged-gene" title="SwissProt ID: P05305; Entrez Gene ID: 1906; HGNC ID: 3176; HPRD ID: 07030; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05305">endothelin-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P05305; Entrez Gene ID: 1906; HGNC ID: 3176; HPRD ID: 07030; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05305">(EDN1)</a></span> is a good candidate for non-syndromic <span class="tagged-query" title="Query">orofacial cleft</span> <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">(OFC)</a></span> disease. <span class="tagged-gene" title="SwissProt ID: P05305; Entrez Gene ID: 1906; HGNC ID: 3176; HPRD ID: 07030; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05305">EDN1</a></span> maps to the chromosomal region of the <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC1</a></span> <span class="tagged-filter" title="Association Word">locus</span> in 6p23. Therefore we have examined three other candidate <span class="tagged-filter" title="Association Word">genes</span> in the endothelin pathway <span class="tagged-gene" title="SwissProt ID: P42892; Entrez Gene ID: 1889; HGNC ID: 3146; HPRD ID: 02690; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42892">(ECE1,</a></span> <span class="tagged-gene" title="SwissProt ID: P25101; Entrez Gene ID: 1909; HGNC ID: 3179; HPRD ID: 00571; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25101">EDNRA</a></span> and <span class="tagged-gene" title="SwissProt ID: P24530; Entrez Gene ID: 1910; HGNC ID: 3180; HPRD ID: 08834; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24530">EDNRB,</a></span> which map to chromosomes 1, 4 and 13 respectively) in a <span class="tagged-filter" title="Association Word">linkage</span> study of 9 families with <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC,</a></span> where the disorder is not <span class="tagged-filter" title="Association Word">linked</span> to chromosome 6p23. The total lod score for these 9 multiplex families never exceeded -2.00 and thus our data suggest that <span class="tagged-gene" title="SwissProt ID: P05305; Entrez Gene ID: 1906; HGNC ID: 3176; HPRD ID: 07030; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05305">EDN1</a></span> and <span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes</span> are not <span class="tagged-filter" title="Association Word">involved</span> in non-syndromic familial <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC.</a></span>
Orofacial_cleft	NSCL	True Positive	1.011	17564975	<strong class="title">Beiraghi S, Nath SK, Gaines M, Mandhyan DD, Hutchings D, Ratnamala U, McElreavey K, Bartoloni L, Antonarakis GS, Antonarakis SE, Radhakrishna U: <span class="tagged-filter" title="Association Word">Autosomal</span> dominant nonsyndromic <span class="tagged-disease" title="UMLS Concept ID: C0158646">cleft lip and palate:</span> significant evidence of <span class="tagged-filter" title="Association Word">linkage</span> at 18q21.1. Am J Hum Genet. 2007 Jul;81(1):180-8. Epub 2007 May 18.</strong> Nonsyndromic <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with or without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> <span class="tagged-gene" title="SwissProt ID: Q02575; Entrez Gene ID: 4807; HGNC ID: 7817; HPRD ID: 01212; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02575">(NSCL</a></span>/P) is one of the most common congenital facial defects, with an incidence of 1 in 700-1,000 live births among individuals of European descent. Several <span class="tagged-filter" title="Association Word">linkage</span> and <span class="tagged-filter" title="Association Word">association</span> studies of <span class="tagged-gene" title="SwissProt ID: Q02575; Entrez Gene ID: 4807; HGNC ID: 7817; HPRD ID: 01212; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02575">NSCL</a></span>/P have suggested numerous candidate <span class="tagged-filter" title="Association Word">genes</span> and genomic regions. A genomewide <span class="tagged-filter" title="Association Word">linkage</span> analysis of a large multigenerational family (UR410) with <span class="tagged-gene" title="SwissProt ID: Q02575; Entrez Gene ID: 4807; HGNC ID: 7817; HPRD ID: 01212; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02575">NSCL</a></span>/P was performed using a single-nucleotide-<span class="tagged-filter" title="Association Word">polymorphism</span> array. Nonparametric <span class="tagged-filter" title="Association Word">linkage</span> <span class="tagged-gene" title="SwissProt ID: Q64L88; Entrez Gene ID: 80896; HGNC ID: 16781; HPRD ID: 14836; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q64L88">(NPL)</a></span> analysis provided significant evidence of <span class="tagged-filter" title="Association Word">linkage</span> for <span class="tagged-filter" title="Association Word">marker</span> rs728683 on chromosome 18q21.1 (NPL=43.33 and P=.000061; nonparametric LOD=3.97 and P=.00001). Parametric <span class="tagged-filter" title="Association Word">linkage</span> analysis with a <span class="tagged-filter" title="Association Word">dominant</span> mode of inheritance and reduced penetrance resulted in a maximum LOD score of 3.61 at position 47.4 Mb on chromosome 18q21.1. Haplotype analysis with informative crossovers defined a 5.7-Mb genomic region spanned by proximal <span class="tagged-filter" title="Association Word">marker</span> rs1824683 (42,403,918 bp) and distal <span class="tagged-filter" title="Association Word">marker</span> rs768206 (48,132,862 bp). Thus, a novel genomic region on 18q21.1 was identified that most likely harbors a high-risk variant for <span class="tagged-gene" title="SwissProt ID: Q02575; Entrez Gene ID: 4807; HGNC ID: 7817; HPRD ID: 01212; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02575">NSCL</a></span>/P in this family; we propose to name this <span class="tagged-filter" title="Association Word">locus</span> "OFC11" <span class="tagged-query" title="Query">(orofacial cleft</span> 11).
Orofacial_cleft	transforming-growth-factor-alpha	True Positive	9.197	9684776	<strong class="title">Shaw GM, Wasserman CR, Murray JC, Lammer EJ: Infant <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">TGF-alpha</a></span> genotype, orofacial clefts, and maternal periconceptional multivitamin use. Cleft Palate Craniofac J. 1998 Jul;35(4):366-70.</strong> OBJECTIVE: We previously demonstrated a strong <span class="tagged-filter" title="Association Word">association</span> between periconceptional maternal cigarette smoking, infant <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">transforming growth factor-alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">(TGFa)</a></span> genotype, and risk of orofacial clefts. Because serum <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span> may be decreased by cigarette smoking and because maternal periconceptional use of multivitamins containing <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> has been <span class="tagged-filter" title="Association Word">associated</span> with a reduced risk of clefting, we explored whether a potential relation existed between infant <a href="http://beta.uniprot.org/uniprot/P01135">TGFa</a></span> genotype, maternal multivitamin use, and risk of <span class="tagged-query" title="Query">orofacial cleft</span> phenotypes. DESIGN: Data were derived from a population-based case-control study of fetuses and live-born infants among a cohort of 1987 to 1989 California births (n = 548,844). Information concerning periconceptional multivitamin use was obtained via telephone interviews with mothers of 731 (84.7% of eligible) <span class="tagged-query" title="Query">orofacial cleft</span> case infants, and of 734 (78.2%) nonmalformed control infants. DNA was obtained from newborn screening bloodspots and genotyped for the Taql <span class="tagged-filter" title="Association Word">polymorphism</span> of <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">TGFa.</a></span> Among infants of interviewed mothers, genotypes were available for 571 (78.1%) case infants and 640 (87.2%) control infants. SETTING: The study encompassed all hospitals in selected California counties. MAIN OUTCOME MEASURE: The main outcome measures were the risks of specific cleft phenotypes among infants with uncommon <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">TGFa</a></span> genotypes and whose mothers did not use multivitamins periconceptionally. RESULTS: Compared with infants homozygous for the common <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">TGFa</a></span> genotype and whose mothers used multivitamins, increased clefting risks were <span class="tagged-filter" title="Association Word">observed</span> for infants with the A2 genotype (homozygous or heterozygous) and whose mothers did not use multivitamins. Risk estimates were 3.0 (1.4-6.6 [95% confidence interval]) for isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with or without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> <span class="tagged-gene" title="SwissProt ID: P50461; Entrez Gene ID: 8048; HGNC ID: 2472; HPRD ID: 07525; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P50461">(CLP),</a></span> 2.4 (0.69-11.6) for multiple <span class="tagged-gene" title="SwissProt ID: P50461; Entrez Gene ID: 8048; HGNC ID: 2472; HPRD ID: 07525; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P50461">CLP,</a></span> 2.6 (0.97-7.7) for isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> (CP), 4.2 (1.3-16.2) for multiple CP, and 8.1 (2.6-27.7) for "known-syndrome" clefts. Clefting risks for infants with the A2 genotype and whose mothers used multivitamins were substantially smaller, as were the risks for infants with the A1 genotype whose mothers did not use multivitamins. CONCLUSION: These data provide preliminary evidence for a <span class="tagged-filter" title="Association Word">gene</span>-nutrient interaction in risk of clefting.
Orofacial_cleft	transforming-growth-factor-alpha	True Positive	9.197	9676424	<strong class="title">Pezzetti F, Scapoli L, Martinelli M, Carinci F, Bodo M, Carinci P, Tognon M: A <span class="tagged-filter" title="Association Word">locus</span> in 2p13-<span class="tagged-gene" title="SwissProt ID: Q9Y2Q5; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y2Q5">p14</a></span> <span class="tagged-gene" title="Entrez Gene ID: 4964; HGNC ID: 8121; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4964">(OFC2),</a></span> in addition to that mapped in 6p23, is <span class="tagged-filter" title="Association Word">involved</span> in nonsyndromic familial <span class="tagged-query" title="Query">orofacial cleft</span> malformation. Genomics. 1998 Jun 15;50(3):299-305.</strong> An allelic <span class="tagged-filter" title="Association Word">association</span> between the <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">transforming growth factor alpha</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">(TGFA)</a></span> situated in the chromosome 2p13 region and nonsyndromic <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with or without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate,</span> also named <span class="tagged-query" title="Query">orofacial cleft</span> <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">(OFC),</a></span> was found in several population studies. However, no <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-filter" title="Association Word">gene</span> and malformation has shown up until now, probably due to the presence of genetic heterogeneity and the small sample size analyzed. Previously, we employed a collection of 38 <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC</a></span> families to demonstrate <span class="tagged-filter" title="Association Word">linkage</span> to the 6p23 chromosome region with the presence of genetic heterogeneity. In the present study we tested whether, in the same sample, <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC</a></span> and <span class="tagged-filter" title="Association Word">markers</span> on 2p13 could be determined. Evidence for genetic heterogeneity in our family set was apparent, by both pairwise and multipoint <span class="tagged-filter" title="Association Word">linkage</span> analyses. Moreover, lod scores > 3 were found for <span class="tagged-filter" title="Association Word">marker</span> D2S378 when families <span class="tagged-filter" title="Association Word">linked</span> to the 6p23 <span class="tagged-filter" title="Association Word">markers</span> were analyzed. Taken together these results indicate a <span class="tagged-filter" title="Association Word">role</span> for the <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">TGFA,</a></span> or for another <span class="tagged-filter" title="Association Word">gene</span> physically close to it, and suggest an interaction between two different <span class="tagged-filter" title="Association Word">genes,</span> <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC1</a></span> and <span class="tagged-gene" title="Entrez Gene ID: 4964; HGNC ID: 8121; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4964">OFC2,</a></span> mapped in 6p23 and 2p13, respectively, in the development of the cleft.
Orofacial_cleft	IRF6	False Positive	25.343	17564963	<strong class="title">Shi M, Umbach DM, Weinberg CR: Identification of Risk-<span class="tagged-filter" title="Association Word">Related</span> Haplotypes with the Use of Multiple <span class="tagged-filter" title="Association Word">SNPs</span> from Nuclear Families. Am J Hum Genet. 2007 Jul;81(1):53-66. Epub 2007 May 15.</strong> Family-based <span class="tagged-filter" title="Association Word">association</span> studies offer robustness to population stratification and can provide insight into maternally mediated and parent-of-origin effects. Usually, such studies investigate multiple <span class="tagged-filter" title="Association Word">markers</span> covering a <span class="tagged-filter" title="Association Word">gene</span> or chromosomal region of interest. We propose a simple and general method to test the <span class="tagged-filter" title="Association Word">association</span> of a disease trait with multiple, possibly <span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">SNP</span> <span class="tagged-filter" title="Association Word">markers</span> and, subsequently, to nominate a set of "risk-haplotype-tagging alleles." Our test, the max_Z (2) test, uses only the genotypes of affected individuals and their parents without requiring the user to either know or assign haplotypes and their phases. It also accommodates sporadically missing <span class="tagged-filter" title="Association Word">SNP</span> data. In the <span class="tagged-metabolite" title="HMDB: HMDB00108"><span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00108">spirit</a></span> of the pedigree disequilibrium test, our procedure requires only a vector of differences with expected value 0 under the null hypothesis. To enhance power against a range of alternatives when genotype data are complete, we also consider a method for combining multiple tests; here, we combine max_Z (2) and Hotelling's T (2). To facilitate discovery of risk-<span class="tagged-filter" title="Association Word">related</span> haplotypes, we develop a simple procedure for nominating risk-haplotype-tagging alleles. Our procedures can also be used to study maternally mediated genetic effects and to explore imprinting. We compare the statistical power of several competing testing procedures through simulation studies of case-parents triads, whose diplotypes are simulated on the basis of draws from the HapMap-based known haplotypes of four <span class="tagged-filter" title="Association Word">genes.</span> In our simulations, the max_Z (2) test and the max_TDT (transmission/disequilibrium test) proposed by McIntyre et al. perform almost identically, but max_Z (2), unlike max_TDT, extends directly to the investigation of maternal effects. As an illustration, we reanalyze data from a previously reported <span class="tagged-query" title="Query">orofacial cleft</span> study, to now investigate both fetal and maternal effects of the <a href="http://beta.uniprot.org/uniprot/O14896">IRF6</a></span> <span class="tagged-filter" title="Association Word">gene.</span>
Orofacial_cleft	IRF6	False Positive	25.343	15013698	<strong class="title">Gatta V, Scarciolla O, Cupaioli M, Palka C, Chiesa PL, Stuppia L: A novel <span class="tagged-filter" title="Association Word">mutation</span> of the <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">IRF6</a></span> <span class="tagged-filter" title="Association Word">gene</span> in an Italian family with <span class="tagged-disease" title="UMLS Concept ID: C0175697">Van der Woude syndrome.</span> Mutat Res. 2004 Mar 22;547(1-2):49-53.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0175697">Van der Woude syndrome</span> <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">(VWS)</a></span> is the most common type of syndromic <span class="tagged-query" title="Query">orofacial cleft,</span> being characterised by variable <span class="tagged-filter" title="Association Word">association</span> of lower lip pits, <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> and <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate.</span> <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">VWS</a></span> is transmitted in an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> manner, with high penetrance and variable expressivity, and a <span class="tagged-filter" title="Association Word">gene</span> for this disease has been mapped in 1q32-q41. Very recently, <span class="tagged-filter" title="Association Word">mutations</span> of the <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">interferon regulatory factor 6</a></span> <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">(IRF6)</a></span> <span class="tagged-filter" title="Association Word">gene</span> have been found in <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">VWS</a></span> patients, suggesting that this <span class="tagged-filter" title="Association Word">gene</span> plays an important <span class="tagged-filter" title="Association Word">role</span> in the orofacial development. We report a novel <span class="tagged-filter" title="Association Word">mutation</span> of the <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">IRF6</a></span> in an Italian family with six members affected by <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">VWS</a></span> with different <span class="tagged-filter" title="Association Word">expression.</span> This <span class="tagged-filter" title="Association Word">mutation,</span> the W217X, <span class="tagged-filter" title="Association Word">produces</span> a stop codon within exon 6 of the <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">IRF6</a></span> <span class="tagged-filter" title="Association Word">gene,</span> with loss of the SMIR domain of the <span class="tagged-gene" title="SwissProt ID: O14896; Entrez Gene ID: 3664; HGNC ID: 6121; HPRD ID: 06227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14896">IRF6</a></span> <span class="tagged-filter" title="Association Word">protein.</span>
Orofacial_cleft	RFC1	False Positive	1.920	15880745	<strong class="title">Vieira AR, Murray JC, Trembath D, Orioli IM, Castilla EE, Cooper ME, Marazita ML, Lennon-Graham F, Speer M: Studies of reduced <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span> carrier 1 <a href="http://beta.uniprot.org/uniprot/P41440">(RFC1)</a></span> A80G and <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">5,10-methylenetetrahydrofolate reductase</a></span> <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">(MTHFR)</a></span> C677T <span class="tagged-filter" title="Association Word">polymorphisms</span> with neural tube and <span class="tagged-query" title="Query">orofacial cleft</span> defects. Am J Med Genet A. 2005 Jun 1;135(2):220-3.</strong>
Orofacial_cleft	F13A	True Positive	1.693	2888553	<strong class="title">Eiberg H, Bixler D, Nielsen LS, Conneally PM, Mohr J: Suggestion of <span class="tagged-filter" title="Association Word">linkage</span> of a major <span class="tagged-filter" title="Association Word">locus</span> for nonsyndromic <span class="tagged-query" title="Query">orofacial cleft</span> with <span class="tagged-gene" title="SwissProt ID: P00488; Entrez Gene ID: 2162; HGNC ID: 3531; HPRD ID: 00604; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00488">F13A</a></span> and tentative assignment to chromosome 6. Clin Genet. 1987 Aug;32(2):129-32.</strong> A Danish material of 58 pedigrees with nonsyndromic <span class="tagged-query" title="Query">orofacial cleft,</span> selected out of a comprehensive Danish material for suggestiveness of <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> inheritance, was studied for <span class="tagged-filter" title="Association Word">linkage</span> with 42 non-DNA <span class="tagged-filter" title="Association Word">polymorphic</span> <span class="tagged-filter" title="Association Word">marker</span> systems. Both <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with or without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> (CL (P)) and <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> alone (CP) were, for the purpose of <span class="tagged-filter" title="Association Word">linkage</span> analysis, scored as if they were due to an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-filter" title="Association Word">gene</span> with complete penetrance. The highest lod score was with the blood clotting factor XIIIA <span class="tagged-gene" title="SwissProt ID: P00488; Entrez Gene ID: 2162; HGNC ID: 3531; HPRD ID: 00604; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00488">(F13A):</a></span> for males alone z = 3.40 at theta = 0.00, for females alone z = 0.30 at theta = 0.21, and for these together z = 3.66 at at theta = 0.00 for males and 0.26 for females. Since <span class="tagged-gene" title="SwissProt ID: P00488; Entrez Gene ID: 2162; HGNC ID: 3531; HPRD ID: 00604; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00488">F13A</a></span> is known to be located distally on chromosome 6, we tentatively assign a major <span class="tagged-filter" title="Association Word">locus</span> for <span class="tagged-query" title="Query">orofacial cleft</span> to this region. Since both CL (P) and CP pedigrees contribute to the positive score, the question arises whether this <span class="tagged-filter" title="Association Word">locus</span> carries two cleft alleles.
Orofacial_cleft	5,10-methylenetetrahydrofolate-reductase	False Positive	3.512	15880745	<strong class="title">Vieira AR, Murray JC, Trembath D, Orioli IM, Castilla EE, Cooper ME, Marazita ML, Lennon-Graham F, Speer M: Studies of reduced <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span> carrier 1 <a href="http://beta.uniprot.org/uniprot/P41440">(RFC1)</a></span> A80G and <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">5,10-methylenetetrahydrofolate reductase</a></span> <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">(MTHFR)</a></span> C677T <span class="tagged-filter" title="Association Word">polymorphisms</span> with neural tube and <span class="tagged-query" title="Query">orofacial cleft</span> defects. Am J Med Genet A. 2005 Jun 1;135(2):220-3.</strong>
Orofacial_cleft	NAT1	False Negative	1.011	15523664	<strong class="title">Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH: Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">(NAT1),</a></span> and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2004 Nov;70(11):846-52.</strong> BACKGROUND: Periconceptional supplementation of multivitamins that include <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> have been shown to prevent several birth defects, including neural tube defects and orofacial clefts. We investigated whether <span class="tagged-filter" title="Association Word">polymorphic</span> variants of fetal acetyl-N-transferase 1 <a href="http://beta.uniprot.org/uniprot/P78344">(NAT1),</a></span> an <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">involved</span> in the catabolism of folates, differentially interacted with maternal multivitamin use during early pregnancy to <span class="tagged-filter" title="Association Word">alter</span> the risk of delivering an infant with an <span class="tagged-query" title="Query">orofacial cleft</span> malformation. METHODS: Using a large population-based case-control study, we genotyped 421 California infants born with an isolated cleft and 299 controls for two <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> <span class="tagged-filter" title="Association Word">polymorphisms.</span> RESULTS: Compared to the homozygous wild-type genotypes, odds ratios for isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with/without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> were slightly increased among infants who were homozygous for the variant alleles of <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 and 1095. For isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate,</span> no similar associations with these two <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> variants were <span class="tagged-filter" title="Association Word">observed.</span> For <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 genotypes, we did not <span class="tagged-filter" title="Association Word">observe</span> any differential risks for clefts <span class="tagged-filter" title="Association Word">related</span> to maternal multivitamin intake. For <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1095 genotypes, however, we found a two-fold higher risk for isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with/without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> among infants who were homozygous for the variant allele and whose mothers did not take multivitamins during early pregnancy. CONCLUSIONS: We found evidence suggestive of an interaction between the <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1095 <span class="tagged-filter" title="Association Word">polymorphism</span> and lack of maternal multivitamin use that increased risks of isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with/without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate.</span>
Orofacial_cleft	NAT1	True Positive	1.011	15127906	<strong class="title">Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J, Finnell RH: Maternal smoking and the risk of orofacial clefts: Susceptibility with <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> <span class="tagged-filter" title="Association Word">polymorphisms.</span> Epidemiology. 2004 Mar;15(2):150-6.</strong> BACKGROUND: Orofacial clefts are etiologically heterogeneous malformations. One probable <span class="tagged-filter" title="Association Word">cause</span> is maternal smoking during pregnancy. The effect of maternal smoking may be modified by <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in biotransformation of toxic compounds derived from tobacco. We investigated whether <span class="tagged-filter" title="Association Word">polymorphic</span> variants of fetal acetyl-N-transferases 1 <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">(NAT1)</a></span> and 2 <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">(NAT2)</a></span> interact with maternal cigarette smoking during early pregnancy to increase the risk of delivering an infant with an <span class="tagged-query" title="Query">orofacial cleft.</span> METHODS: In a California population-based case-control study, we genotyped 421 infants born with an isolated cleft and 299 nonmal-formed controls for 2 <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> and 3 <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> RESULTS: Although smoking was independently <span class="tagged-filter" title="Association Word">associated</span> with increased risks for both isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> +/- <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> and isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate,</span> no independent associations were found for <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 or 1095 genotypes or for <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylator status. However, the infant <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 and 1095 <span class="tagged-filter" title="Association Word">polymorphisms</span> were strongly <span class="tagged-filter" title="Association Word">associated</span> with the risk of clefts among smoking mothers; infants with <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 genotype AA versus TT (odds ratio [OR] = 3.9; 95% confidence interval = 1.1-17.2) and with <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1095 genotype AA versus CC (OR = 4.2; 1.2-18.0). Infant <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylator status did not appreciably affect susceptibility of the fetus to the teratogenic effects of maternal smoking. CONCLUSIONS: Our results suggest that maternal smoking during pregnancy may increase risk for orofacial clefts particularly among smokers whose fetuses have <span class="tagged-filter" title="Association Word">polymorphic</span> variants of <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1,</a></span> an <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">involved</span> in phase II detoxification of tobacco smoke constituents.
Orofacial_cleft	NAT2	False Positive	1.920	15127906	<strong class="title">Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J, Finnell RH: Maternal smoking and the risk of orofacial clefts: Susceptibility with <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> <span class="tagged-filter" title="Association Word">polymorphisms.</span> Epidemiology. 2004 Mar;15(2):150-6.</strong> BACKGROUND: Orofacial clefts are etiologically heterogeneous malformations. One probable <span class="tagged-filter" title="Association Word">cause</span> is maternal smoking during pregnancy. The effect of maternal smoking may be modified by <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in biotransformation of toxic compounds derived from tobacco. We investigated whether <span class="tagged-filter" title="Association Word">polymorphic</span> variants of fetal acetyl-N-transferases 1 <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">(NAT1)</a></span> and 2 <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">(NAT2)</a></span> interact with maternal cigarette smoking during early pregnancy to increase the risk of delivering an infant with an <span class="tagged-query" title="Query">orofacial cleft.</span> METHODS: In a California population-based case-control study, we genotyped 421 infants born with an isolated cleft and 299 nonmal-formed controls for 2 <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> and 3 <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> RESULTS: Although smoking was independently <span class="tagged-filter" title="Association Word">associated</span> with increased risks for both isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> +/- <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate</span> and isolated <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate,</span> no independent associations were found for <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 or 1095 genotypes or for <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylator status. However, the infant <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 and 1095 <span class="tagged-filter" title="Association Word">polymorphisms</span> were strongly <span class="tagged-filter" title="Association Word">associated</span> with the risk of clefts among smoking mothers; infants with <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1088 genotype AA versus TT (odds ratio [OR] = 3.9; 95% confidence interval = 1.1-17.2) and with <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1</a></span> 1095 genotype AA versus CC (OR = 4.2; 1.2-18.0). Infant <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylator status did not appreciably affect susceptibility of the fetus to the teratogenic effects of maternal smoking. CONCLUSIONS: Our results suggest that maternal smoking during pregnancy may increase risk for orofacial clefts particularly among smokers whose fetuses have <span class="tagged-filter" title="Association Word">polymorphic</span> variants of <span class="tagged-gene" title="SwissProt ID: P78344; Entrez Gene ID: 1982; HGNC ID: 3297; HPRD ID: 09084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78344">NAT1,</a></span> an <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">involved</span> in phase II detoxification of tobacco smoke constituents.
Orofacial_cleft	NAT2	False Positive	1.920	12397635	<strong class="title">van Rooij IA, Groenen PM, van Drongelen M, Te Morsche RH, Peters WH, Steegers-Theunissen RP: Orofacial clefts and <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida:</span> <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase</a></span> phenotype, maternal smoking, and medication use. Teratology. 2002 Nov;66(5):260-6.</strong> BACKGROUND: Orofacial clefts and <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida</span> are midline defects with a multifactorial etiology. Maternal smoking and medication use periconceptionally have been studied as risk factors for these malformations. The biotransformation <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-gene" title="SwissProt ID: P11245; Entrez Gene ID: 10; HGNC ID: 7646; HPRD ID: 02000; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11245">N-acetyltransferase 2</a></span> <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">(NAT2),</a></span> plays a part in the inactivation of toxic compounds in cigarette smoke and medication. We investigated maternal <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> phenotype and the interaction with smoking and medication use periconceptionally on <span class="tagged-query" title="Query">orofacial cleft</span> and <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida</span> risk in offspring. METHODS: In this case-control study of 45 mothers of <span class="tagged-query" title="Query">orofacial cleft</span> children, 39 mothers of <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida</span> children and 73 control mothers, <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylator status was determined by measuring urinary <span class="tagged-metabolite" title="HMDB: HMDB01847"><span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01847">caffeine</a></span> metabolites. RESULTS: Slow <a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylators showed no increased risk for <span class="tagged-query" title="Query">orofacial cleft</span> (OR = 1.0, 95% CI: 0.4-2.3) or <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida</span> offspring (OR = 0.7, 95% CI: 0.3-1.7) compared to fast <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylators. More mothers with <span class="tagged-query" title="Query">orofacial cleft</span> and <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida</span> offspring smoked cigarettes (36% and 23% respectively) and used medication periconceptionally (38% and 44% respectively) compared to control mothers (smoking:18%, medication use:19%). No interaction between maternal <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylator status and smoking or medication use was <span class="tagged-filter" title="Association Word">observed</span> for <span class="tagged-query" title="Query">orofacial cleft</span> and <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida</span> risk. CONCLUSIONS: Maternal smoking and medication use is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">orofacial cleft</span> risk as well as medication use is with <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida.</span> The maternal <span class="tagged-gene" title="SwissProt ID: Q8NC61; Entrez Gene ID: 81539; HGNC ID: 13447; HPRD ID: 12245; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NC61">NAT2</a></span> acetylator status, however, was not <span class="tagged-filter" title="Association Word">associated</span> with an increased risk for <span class="tagged-query" title="Query">orofacial cleft</span> or <span class="tagged-disease" title="UMLS Concept ID: Not Available">spina bifida</span> offspring, nor in combination with periconceptional smoking or medication use.
Orofacial_cleft	OFC2	True Positive	3.512	9676424	<strong class="title">Pezzetti F, Scapoli L, Martinelli M, Carinci F, Bodo M, Carinci P, Tognon M: A <span class="tagged-filter" title="Association Word">locus</span> in 2p13-<span class="tagged-gene" title="SwissProt ID: Q9Y2Q5; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y2Q5">p14</a></span> <span class="tagged-gene" title="Entrez Gene ID: 4964; HGNC ID: 8121; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4964">(OFC2),</a></span> in addition to that mapped in 6p23, is <span class="tagged-filter" title="Association Word">involved</span> in nonsyndromic familial <span class="tagged-query" title="Query">orofacial cleft</span> malformation. Genomics. 1998 Jun 15;50(3):299-305.</strong> An allelic <span class="tagged-filter" title="Association Word">association</span> between the <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">transforming growth factor alpha</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">(TGFA)</a></span> situated in the chromosome 2p13 region and nonsyndromic <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft lip</span> with or without <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate,</span> also named <span class="tagged-query" title="Query">orofacial cleft</span> <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">(OFC),</a></span> was found in several population studies. However, no <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-filter" title="Association Word">gene</span> and malformation has shown up until now, probably due to the presence of genetic heterogeneity and the small sample size analyzed. Previously, we employed a collection of 38 <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC</a></span> families to demonstrate <span class="tagged-filter" title="Association Word">linkage</span> to the 6p23 chromosome region with the presence of genetic heterogeneity. In the present study we tested whether, in the same sample, <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC</a></span> and <span class="tagged-filter" title="Association Word">markers</span> on 2p13 could be determined. Evidence for genetic heterogeneity in our family set was apparent, by both pairwise and multipoint <span class="tagged-filter" title="Association Word">linkage</span> analyses. Moreover, lod scores > 3 were found for <span class="tagged-filter" title="Association Word">marker</span> D2S378 when families <span class="tagged-filter" title="Association Word">linked</span> to the 6p23 <span class="tagged-filter" title="Association Word">markers</span> were analyzed. Taken together these results indicate a <span class="tagged-filter" title="Association Word">role</span> for the <span class="tagged-gene" title="SwissProt ID: P01135; Entrez Gene ID: 7039; HGNC ID: 11765; HPRD ID: 07522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01135">TGFA,</a></span> or for another <span class="tagged-filter" title="Association Word">gene</span> physically close to it, and suggest an interaction between two different <span class="tagged-filter" title="Association Word">genes,</span> <span class="tagged-gene" title="Entrez Gene ID: 4963; HGNC ID: 8120; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4963">OFC1</a></span> and <span class="tagged-gene" title="Entrez Gene ID: 4964; HGNC ID: 8121; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4964">OFC2,</a></span> mapped in 6p23 and 2p13, respectively, in the development of the cleft.
Synpolydactyly	HOXD8	True Positive	1.136	7581388	<strong class="title">Sarfarazi M, Akarsu AN, Sayli BS: Localization of the <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> type II <span class="tagged-query" title="Query">(synpolydactyly)</span> <span class="tagged-filter" title="Association Word">locus</span> to 2q31 region and identification of tight <span class="tagged-filter" title="Association Word">linkage</span> to <span class="tagged-gene" title="SwissProt ID: P13378; Entrez Gene ID: 3234; HGNC ID: 5139; HPRD ID: 00868; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13378">HOXD8</a></span> intragenic <span class="tagged-filter" title="Association Word">marker.</span> Hum Mol Genet. 1995 Aug;4(8):1453-8.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Syndactyly</span> type II <span class="tagged-query" title="Query">(SynPolyDactyly;</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P13378; Entrez Gene ID: 3234; HGNC ID: 5139; HPRD ID: 00868; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD)</a></span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> condition with incomplete penetrance and variable expressivity. Sixty-two meioses from a kindred with 425 individuals were used to map the <span class="tagged-metabolite" title="HMDB: HMDB01257"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> <span class="tagged-filter" title="Association Word">locus</span> to 2q31 region, approximately 1.7 cM (Lod score = 12.96) centromeric to <a href="http://beta.uniprot.org/uniprot/P13378">HOXD8</a></span> intragenic <span class="tagged-filter" title="Association Word">marker.</span> Other <span class="tagged-gene" title="SwissProt ID: P52954; Entrez Gene ID: 10660; HGNC ID: 16960; HPRD ID: 09178; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52954">homeobox</a></span>-containing <span class="tagged-filter" title="Association Word">genes</span> in this region have previously been ordered as cen-<span class="tagged-gene" title="SwissProt ID: P56177; Entrez Gene ID: 1745; HGNC ID: 2914; HPRD ID: 08961; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56177">DLX1</a></span>/<span class="tagged-gene" title="SwissProt ID: Q07687; Entrez Gene ID: 1746; HGNC ID: 2915; HPRD ID: 00527; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07687">DLX2</a></span>-<span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03828">EVX2</a></span>-(5' --> HOXD13..HOXD8.HOXD1 --> 3')-tel')-tel. A single recombinant with <span class="tagged-gene" title="SwissProt ID: P13378; Entrez Gene ID: 3234; HGNC ID: 5139; HPRD ID: 00868; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13378">HOXD8</a></span> excluded the most 3' end of HOXD cluster as a candidate site for <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD,</a></span> but a <span class="tagged-filter" title="Association Word">mutation</span> in the 5' end of HOXD cluster, especially in <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> <span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03828">EVX2</a></span> or <span class="tagged-gene" title="SwissProt ID: Q07687; Entrez Gene ID: 1746; HGNC ID: 2915; HPRD ID: 00527; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07687">DLX2</a></span>/<span class="tagged-gene" title="SwissProt ID: P56177; Entrez Gene ID: 1745; HGNC ID: 2914; HPRD ID: 08961; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56177">DLX1,</a></span> may still be responsible for this phenotype. An updated order of D2S142-D2S111-(D2S335/D2S333)-D2S326-D2 S1238-<span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P13378; Entrez Gene ID: 3234; HGNC ID: 5139; HPRD ID: 00868; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span>- <a href="http://beta.uniprot.org/uniprot/P13378">(HOXD8</a></span>/D2S1244)-(D2S300/D2S138)-D2S148- D2S324- D2S1384-D2S434 [sequence:see text] was deduced from meiotic recombination events.
Synpolydactyly	HOXD13	True Positive	25.188	17236141	<strong class="title">Zhao X, Sun M, Zhao J, Leyva JA, Zhu H, Yang W, Zeng X, Ao Y, Liu Q, Liu G, Lo WH, Jabs EW, Amzel LM, Shan X, Zhang X: <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> underlie <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> type V and a novel <span class="tagged-disease" title="UMLS Concept ID: C0221357">brachydactyly</span>-<span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> syndrome. Am J Hum Genet. 2007 Feb;80(2):361-71. Epub 2007 Jan 3.</strong> <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> the <span class="tagged-gene" title="SwissProt ID: P52954; Entrez Gene ID: 10660; HGNC ID: 16960; HPRD ID: 09178; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52954">homeobox</a></span>-containing <span class="tagged-filter" title="Association Word">gene</span> located at the most 5' end of the HOXD cluster, plays a critical <span class="tagged-filter" title="Association Word">role</span> in limb development. It has been shown that <span class="tagged-filter" title="Association Word">mutations</span> in human <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> can give rise to limb malformations, with variable expressivity and a wide spectrum of clinical manifestations. Polyalanine expansions in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">synpolydactyly,</span> whereas amino acid substitutions in the homeodomain are <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0221357">brachydactyly</span> types D and E. We describe two large Han Chinese families with different limb malformations, one with <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> type V and the other with limb features overlapping <span class="tagged-disease" title="UMLS Concept ID: C0221357">brachydactyly</span> types A4, D, and E and mild <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> of toes 2 and 3. Two-point <span class="tagged-filter" title="Association Word">linkage</span> analysis showed LOD scores > 3 (theta =0) for <span class="tagged-filter" title="Association Word">markers</span> within and/or flanking the <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">locus</span> in both families. In the family with <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> type V, we identified a missense <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> homeodomain, c.950A--> G (p.Q317R), which <span class="tagged-filter" title="Association Word">leads</span> to substitution of the highly conserved <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">glutamine</a></span> that is important for DNA-binding specificity and affinity. In the family with complex <span class="tagged-disease" title="UMLS Concept ID: C0221357">brachydactyly</span> and <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly,</span> we detected a deletion of 21 bp in the imperfect GCN (where N denotes A, C, G, or T) triplet-containing exon 1 of <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> which results in a polyalanine contraction of seven residues. Moreover, we found that the mutant <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> with the p.Q317R substitution was unable to transactivate the human <span class="tagged-gene" title="SwissProt ID: Q15375; Entrez Gene ID: 2045; HGNC ID: 3390; HPRD ID: 03721; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15375">EPHA7</a></span> promoter. Molecular modeling data supported these experimental results. The calculated interactions energies were in agreement with the measured changes of the <span class="tagged-filter" title="Association Word">activity.</span> Our data established the link between <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and two additional limb phenotypes--<span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> type V and <span class="tagged-disease" title="UMLS Concept ID: C0221357">brachydactyly</span> type A4--and demonstrated that a polyalanine contraction in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> most likely, <span class="tagged-filter" title="Association Word">led</span> to other digital anomalies but not to <span class="tagged-query" title="Query">synpolydactyly.</span> We suggest the term <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">"HOXD13</a></span> limb morphopathies" for the spectrum of limb disorders <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">mutations.</span>
Synpolydactyly	HOXD13	True Positive	25.188	16712704	<strong class="title">Malik S, Abbasi AA, Ansar M, Ahmad W, Koch MC, Grzeschik KH: Genetic heterogeneity of <span class="tagged-query" title="Query">synpolydactyly:</span> a novel <span class="tagged-filter" title="Association Word">locus</span> SPD3 maps to chromosome 14q11.2-q12. Clin Genet. 2006 Jun;69(6):518-24.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Syndactyly</span> type II or <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD)</a></span> is the second most frequent <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> type and is inherited in an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> fashion. The cardinal features of this malformation are the cutaneous or bony fusion of third and fourth fingers, and fourth and fifth toes <span class="tagged-filter" title="Association Word">associated</span> with additional digital elements within the web. It shows incomplete penetrance and high inter- and intrafamilial phenotypic variability. Two loci are known for <span class="tagged-metabolite" title="HMDB: HMDB01257"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> (MIM 186000, MIM 608180) <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">mutations</span> in <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1,</a></span> respectively. Here, we report further genetic heterogeneity for SDP. Employing a whole genomic screen, we demonstrate, in a large Pakistani kindred, that the classical phenotype of <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> maps on a new <span class="tagged-filter" title="Association Word">locus</span> at chromosome 14q11.2-q12. The highest LOD score (Z (max) = 4.06) was obtained with microsatellite <span class="tagged-filter" title="Association Word">marker</span> D14S264, and the multipoint LOD score reached a maximum of 5.01. Haplotype analysis revealed that the disease interval is flanked by microsatellite <span class="tagged-filter" title="Association Word">markers</span> D14S283 and D14S1060, encompassing a physical distance of 10.72 Mb. We propose to allocate to this <span class="tagged-filter" title="Association Word">locus</span> the symbol SPD3 <span class="tagged-query" title="Query">(synpolydactyly</span> 3), and to name the loci <span class="tagged-filter" title="Association Word">associated</span> with <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> or <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span> <span class="tagged-filter" title="Association Word">mutations</span> SPD1 and SPD2, respectively.
Synpolydactyly	HOXD13	True Positive	25.188	15952114	<strong class="title">Dai L, Heng ZC, Zhu J, Cai R, Mao M, Wang H, Lin MJ: <span class="tagged-filter" title="Association Word">Mutation</span> analysis of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">gene</span> in a Chinese pedigree with <span class="tagged-query" title="Query">synpolydactyly.</span> Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Jun;22(3):277-80.</strong> OBJECTIVE: To study the clinical features and to identify <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">homeobox D13</a></span> <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">(HOXD13)</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> of the affected individuals in a Chinese <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD)</a></span> kindred. METHODS: Clinical data and peripheral blood samples of <span class="tagged-metabolite" title="HMDB: HMDB01257"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> family members were obtained through field investigation. For every member of this pedigreeithe fragment containing mutational hot spots of <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> was amplified by PCR for <span class="tagged-filter" title="Association Word">mutation</span> screening. To examine whether there is any other <span class="tagged-filter" title="Association Word">mutation</span> within coding sequence of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> exon 1 and exon 2 of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> were also amplified by PCR. All the amplified fragments were electrophoresed on 2% agarose gels and then the mutant fragments were electrophoresed on 5% polyacrylamide gels to be separated. Purified PCR products of normal and selected mutant alleles were directly sequenced. RESULTS: Comparing the <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> coding sequence of the affected individuals with <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> sequence in the GenBank and with that of the unaffected, an inserted segment coding 8 <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> residues within <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> was found segregating with the disorder. This <span class="tagged-filter" title="Association Word">mutation</span> is also termed polyalanine expansion. The 8-<span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> expansion can be interpreted as a reduplication of normal alanines 5-12. CONCLUSION: The results suggest that <span class="tagged-query" title="Query">synpolydactyly</span> in this kindred may be <span class="tagged-filter" title="Association Word">caused</span> by polyalanine expansion in <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13.</a></span>
Synpolydactyly	HOXD13	True Positive	25.188	15333588	<strong class="title">Albrecht AN, Kornak U, Boddrich A, Suring K, Robinson PN, Stiege AC, Lurz R, Stricker S, Wanker EE, Mundlos S: A molecular pathogenesis for transcription factor <span class="tagged-filter" title="Association Word">associated</span> poly-<span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> tract expansions. Hum Mol Genet. 2004 Oct 15;13(20):2351-9. Epub 2004 Aug 27.</strong> Poly-<span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">(Ala)</a></span> tract expansions in transcription factors have been shown to be <span class="tagged-filter" title="Association Word">associated</span> with human birth defects such as malformations of the brain, the digits, and other structures. Expansions of a poly-<span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">Ala</a></span> tract from 15 to 22 (+7)-29 (+14) <span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">Ala</a></span> in <a href="http://beta.uniprot.org/uniprot/P35453">Hoxd13,</a></span> for example, result in the limb malformation <span class="tagged-query" title="Query">synpolydactyly</span> in humans and in mice <span class="tagged-query" title="Query">[synpolydactyly</span> homolog (spdh)]. Here, we show that an increase of the <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">Ala</a></span> repeat above a certain length (22 <span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">Ala)</a></span> is <span class="tagged-filter" title="Association Word">associated</span> with a shift in the localization of <a href="http://beta.uniprot.org/uniprot/P35453">Hoxd13</a></span> from nuclear to cytoplasmic, where it forms large amorphous aggregates. We <span class="tagged-filter" title="Association Word">observed</span> similar aggregates for expansion <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P41225; Entrez Gene ID: 6658; HGNC ID: 11199; HPRD ID: 02432; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41225">SOX3,</a></span> <span class="tagged-gene" title="SwissProt ID: Q13950; Entrez Gene ID: 860; HGNC ID: 10472; HPRD ID: 02566; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13950">RUNX2</a></span> and <span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31271">HOXA13,</a></span> pointing to a common mechanism. Cytoplasmic aggregation of mutant <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">Hoxd13</a></span> <span class="tagged-filter" title="Association Word">protein</span> is influenced by the length of the repeat, the level of <span class="tagged-filter" title="Association Word">expression</span> and the efficacy of degradation by the <span class="tagged-gene" title="Protein Family or Complex">proteasome.</span> Heat shock <span class="tagged-filter" title="Association Word">proteins</span> <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> and <span class="tagged-gene" title="Entrez Gene ID: 171221; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=171221">Hsp40</a></span> co-localize with the aggregates and activation of the chaperone system by geldanamycin <span class="tagged-filter" title="Association Word">leads</span> to a reduction of aggregate formation. Furthermore, recombinant mutant <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">Hoxd13</a></span> <span class="tagged-filter" title="Association Word">protein</span> forms aggregates in vitro demonstrating spontaneous misfolding of the <span class="tagged-filter" title="Association Word">protein.</span> We analyzed the mouse mutant spdh, which harbors a +7 <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">Ala</a></span> expansion in <a href="http://beta.uniprot.org/uniprot/P35453">Hoxd13</a></span> similar to the human <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-filter" title="Association Word">mutations,</span> as an in vivo model and were able to show a reduction of mutant <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">Hoxd13</a></span> and, in contrast to wt <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">Hoxd13,</a></span> a primarily cytoplasmic localization of the <span class="tagged-filter" title="Association Word">protein.</span> Our results provide evidence that poly-<span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">Ala</a></span> repeat expansions in transcription factors result in misfolding, degradation and cytoplasmic aggregation of the mutant <span class="tagged-filter" title="Association Word">proteins.</span>
Synpolydactyly	HOXD13	True Positive	25.188	14669516	<strong class="title">Qin W, Shu AL, Xing QH, Yang MS, Feng GY, He L: [Genetic analysis of a Chinese pedigree with congenital <span class="tagged-query" title="Query">synpolydactyly]</span> . Yi Chuan Xue Bao. 2003 Oct;30(10):973-7.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Syndactyly</span> is a limb malformation that shows a characteristic manifestation in both hands and feet. This condition is inherited as an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> trait with reduced penetrance. Clinical presentation, in general, is complete or partial webbing between 3rd and 4th fingers. <span class="tagged-disease" title="UMLS Concept ID: Not Available">Syndactyly</span> type I, II and III were mapped to 2q34-36, 2q31-q32 and 6q21-23.2 respectively. <span class="tagged-disease" title="UMLS Concept ID: Not Available">Syndactyly</span> type II is named as <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD).</a></span> Expansion of a polyalanine tract in the <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">gene</span> is known to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">synpolydactyly.</span> <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">gene</span> locates in the HoxD complex. Nine homologous <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: Q9GZZ0; Entrez Gene ID: 3231; HGNC ID: 5132; HPRD ID: 00870; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9GZZ0">(HOXD1,</a></span> -D3, -D4, -D8, -D9, -D10, -D11, -D12, -D13) of HoxD complex locate on chromosome 2 in the order of <span class="tagged-gene" title="SwissProt ID: Q9GZZ0; Entrez Gene ID: 3231; HGNC ID: 5132; HPRD ID: 00870; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9GZZ0">HOXD1</a></span> to <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> among which <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> is closest to the centromere. Deletions and duplications in HoxD complex or its upstream regulator factors have been identified to <span class="tagged-filter" title="Association Word">cause</span> hand heteroplasia and consequently <span class="tagged-filter" title="Association Word">lead</span> to abnormity of finger number or abnormity of configuration. We performed <span class="tagged-filter" title="Association Word">linkage</span> analysis in a kindred with <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> hereditary <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly.</span> Tight <span class="tagged-filter" title="Association Word">linkage</span> to <span class="tagged-filter" title="Association Word">markers</span> on chromosome 2q31-q32 (maximum two-point lod score: 6.78 at recombination fraction theta = 0.00) was <span class="tagged-filter" title="Association Word">observed.</span> Multipoint <span class="tagged-filter" title="Association Word">linkage</span> analysis <span class="tagged-filter" title="Association Word">produced</span> a maximum LOD score of 7.02. Haplotype construction and analysis of recombination events narrowed this <span class="tagged-filter" title="Association Word">locus</span> to a 20.61 cM region between <span class="tagged-filter" title="Association Word">markers</span> D2S2302 and D2S315. No <span class="tagged-filter" title="Association Word">mutation</span> was found in the coding region, the intro-exon boundaries, or part of the promoter region of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13.</a></span> Our result demonstrates that <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-filter" title="Association Word">locus</span> in the Chinese Han Population is in the region of chromosome 2q31-q32 but a different causal <span class="tagged-filter" title="Association Word">gene</span> can be <span class="tagged-filter" title="Association Word">involved.</span>
Synpolydactyly	HOXD13	True Positive	25.188	12900906	<strong class="title">Kan SH, Johnson D, Giele H, Wilkie AO: An acceptor splice site <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> results in variable hand, but consistent foot malformations. Am J Med Genet A. 2003 Aug 15;121(1):69-74.</strong> <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> is the most 5' of the HOXD cluster of <span class="tagged-gene" title="SwissProt ID: P52954; Entrez Gene ID: 10660; HGNC ID: 16960; HPRD ID: 09178; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52954">homeobox</a></span> <span class="tagged-filter" title="Association Word">genes</span> in chromosome band 2q31.1. Heterozygous expansions of a polyalanine tract in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> are typically <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">synpolydactyly</span> characterized by insertional digit duplication <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly.</span> We screened for <span class="tagged-filter" title="Association Word">mutations</span> of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> in patients with a variety of limb malformations and identified a novel heterozygous <span class="tagged-filter" title="Association Word">mutation</span> (758-2delA) in a three-generation family without the typical <span class="tagged-query" title="Query">synpolydactyly</span> phenotype in the hands, but with bilateral partial duplication of the 2nd metatarsals within the first web space of the feet. This <span class="tagged-filter" title="Association Word">mutation</span> locates in the acceptor splice site of exon 2 and is predicted to <span class="tagged-filter" title="Association Word">cause</span> failure of normal splicing of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13.</a></span> The foot abnormality in this family is similar to that described in two families by Goodman et al. [1998: Am. J. Hum. Genet. 63: 992-1000] in which different deletions of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> were reported. These findings together lend support to a distinct phenotype resulting from haploinsufficiency of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13.</a></span>
Synpolydactyly	HOXD13	True Positive	25.188	12620993	<strong class="title">Caronia G, Goodman FR, McKeown CM, Scambler PJ, Zappavigna V: An I47L substitution in the <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> homeodomain <span class="tagged-filter" title="Association Word">causes</span> a novel human limb malformation by producing a selective loss of function. Development. 2003 Apr;130(8):1701-12.</strong> The 5' members of the Hoxa and Hoxd <span class="tagged-filter" title="Association Word">gene</span> clusters play major <span class="tagged-filter" title="Association Word">roles</span> in vertebrate limb development. One such <span class="tagged-filter" title="Association Word">gene,</span> <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> is <span class="tagged-filter" title="Association Word">mutated</span> in the human limb malformation syndrome <span class="tagged-query" title="Query">synpolydactyly.</span> Both polyalanine tract expansions and frameshifting deletions in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">cause</span> similar forms of this condition, but it remains unclear whether other kinds of <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">mutations</span> could <span class="tagged-filter" title="Association Word">produce</span> different phenotypes. We describe a six-generation family in which a novel combination of <span class="tagged-disease" title="UMLS Concept ID: C0221357">brachydactyly</span> and central <span class="tagged-disease" title="UMLS Concept ID: Not Available">polydactyly</span> co-segregates with a missense <span class="tagged-filter" title="Association Word">mutation</span> that substitutes <span class="tagged-metabolite" title="HMDB: HMDB00687"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00687">leucine</a></span> for <span class="tagged-metabolite" title="HMDB: HMDB00172"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00172">isoleucine</a></span> at position 47 of the <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> homeodomain. We compared the <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> (I47L) mutant <span class="tagged-filter" title="Association Word">protein</span> both in vitro and in vivo to the wild-type <span class="tagged-filter" title="Association Word">protein</span> and to an artificial <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> mutant, <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> (IQN), which is completely unable to bind DNA. We found that the <span class="tagged-filter" title="Association Word">mutation</span> <span class="tagged-filter" title="Association Word">causes</span> neither a <span class="tagged-filter" title="Association Word">dominant</span>-negative effect nor a gain of function, but instead impairs DNA binding at some sites bound by wild-type <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13.</a></span> Using retrovirus-mediated misexpression in developing chick limbs, we showed that wild-type <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> could upregulate chick <span class="tagged-gene" title="SwissProt ID: Q15375; Entrez Gene ID: 2045; HGNC ID: 3390; HPRD ID: 03721; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15375">EphA7</a></span> in the autopod, but that <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> (I47L) could not. In the zeugopod, however, <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> (I47L) <span class="tagged-filter" title="Association Word">produced</span> striking changes in tibial morphology and ectopic cartilages, which were never <span class="tagged-filter" title="Association Word">produced</span> by <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> (IQN), consistent with a selective rather than generalised loss of function. Thus, a mutant HOX <span class="tagged-filter" title="Association Word">protein</span> that recognises only a subset of sites recognised by the wild-type <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-filter" title="Association Word">causes</span> a novel human malformation, pointing to a hitherto undescribed mechanism by which missense <span class="tagged-filter" title="Association Word">mutations</span> in transcription factors can generate unexpected phenotypes. Intriguingly, both <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> (I47L) and <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> (IQN) <span class="tagged-filter" title="Association Word">produced</span> more severe shortening in proximal limb regions than did wild-type <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> suggesting that functional suppression of anterior Hox <span class="tagged-filter" title="Association Word">genes</span> by more posterior ones does not require DNA binding and is mediated by protein:protein interactions.
Synpolydactyly	HOXD13	True Positive	25.188	12357469	<strong class="title">Goodman FR: Limb malformations and the human HOX <span class="tagged-filter" title="Association Word">genes.</span> Am J Med Genet. 2002 Oct 15;112(3):256-65.</strong> HOX <span class="tagged-filter" title="Association Word">genes</span> encode a family of transcription factors of fundamental importance for body patterning during embryonic development. Humans, like most vertebrates, have 39 HOX <span class="tagged-filter" title="Association Word">genes</span> organized into four clusters, with major <span class="tagged-filter" title="Association Word">roles</span> in the development of the central nervous system, axial skeleton, gastrointestinal and urogenital tracts, <span class="tagged-disease" title="UMLS Concept ID: C0700039">external genitalia,</span> and limbs. The first two limb malformations shown to be <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the human HOX <span class="tagged-filter" title="Association Word">genes</span> were <span class="tagged-query" title="Query">synpolydactyly</span> and hand-foot-genital syndrome, which result from <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31271">HOXA13,</a></span> respectively. This review describes a variety of limb malformations now known to be <span class="tagged-filter" title="Association Word">caused</span> by specific different <span class="tagged-filter" title="Association Word">mutations</span> in these two <span class="tagged-filter" title="Association Word">genes,</span> including polyalanine tract expansions, <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutations,</span> and missense <span class="tagged-filter" title="Association Word">mutations,</span> many with phenotypic consequences that could not have been predicted from previous knowledge of mouse models or HOX <span class="tagged-filter" title="Association Word">protein</span> function. Limb malformations may also result from chromosomal deletions <span class="tagged-filter" title="Association Word">involving</span> the HOXD and HOXA clusters, and from regulatory <span class="tagged-filter" title="Association Word">mutations</span> affecting single or multiple HOX <span class="tagged-filter" title="Association Word">genes.</span>
Synpolydactyly	HOXD13	True Positive	25.188	12116248	<strong class="title">Kjaer KW, Hedeboe J, Bugge M, Hansen C, Friis-Henriksen K, Vestergaard MB, Tommerup N, Opitz JM: <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> polyalanine tract expansion in classical <span class="tagged-query" title="Query">synpolydactyly</span> type Vordingborg. Am J Med Genet. 2002 Jun 15;110(2):116-21.</strong> In 1927, Oluf Thomsen, in a classic paper, described a seven-generation family with <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> axial <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD)</a></span>--the Vordingborgtyp of axis duplication and <span class="tagged-disease" title="UMLS Concept ID: C0013393">dysostosis.</span> Expansion of a polyalanine tract in the <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">gene</span> is known to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">synpolydactyly.</span> We have rediscovered part of the family described by Thomsen, and detected a 9 triplet polyalanine expansion within HOXD13segregating with the disorder. The phenotypic spectrum in <span class="tagged-filter" title="Association Word">mutation</span> carriers ranged from severe to inapparent bone malformations. In the latter case, only dermatoglyphics revealed the genetic status.
Synpolydactyly	HOXD13	True Positive	25.188	12073020	<strong class="title">Utsch B, Becker K, Brock D, Lentze MJ, Bidlingmaier F, Ludwig M: A novel stable polyalanine [poly (A)] expansion in the <span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31271">HOXA13</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">associated</span> with hand-foot-genital syndrome: proper function of poly (A)-harbouring transcription factors depends on a critical repeat length?. Hum Genet. 2002 May;110(5):488-94. Epub 2002 Apr 4.</strong> Hand-foot-genital syndrome (HFGS) is a dominantly inherited congenital malformation affecting the distal limbs and genitourinary tract. Here, we describe the phenotype and its molecular basis in a family that presented with HFGS. Genetic analysis revealed that the condition is <span class="tagged-filter" title="Association Word">caused</span> by an 18-bp in-frame duplication within a cryptic trinucleotide repeat sequence encoding an 18-residue polyalanine tract in the homeoboxgene ( HOX) <span class="tagged-gene" title="Entrez Gene ID: 28888; HGNC ID: 5794; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=28888">A13.</a></span> This <span class="tagged-filter" title="Association Word">mutation</span> expands the stretch with six extra <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> residues. Similar types of <span class="tagged-filter" title="Association Word">mutation</span> (plus eight alanines) have recently been found in another HFGS family and also in the human <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">gene</span> (plus seven up to plus 14 residues) where it <span class="tagged-filter" title="Association Word">leads</span> to <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD),</a></span> a further congenital limb malformation rarely <span class="tagged-filter" title="Association Word">associated</span> with genital abnormalities. As <span class="tagged-filter" title="Association Word">observed</span> in our family, all the expanded tracts encoding polyalanine, either reported for <a href="http://beta.uniprot.org/uniprot/P31271">HOXA13</a></span> or <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> are quite stable when transmitted within affected families. Unlike disorders with unstable expansions of perfect trinucleotide repeats the molecular mechanism underlying these polyalanine expansions should be unequal crossing-over rather than replication slippage. The <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> tract elongation may prevent <span class="tagged-filter" title="Association Word">protein</span>-<span class="tagged-filter" title="Association Word">protein</span> interactions of the mutant <a href="http://beta.uniprot.org/uniprot/P31271">HOXA13,</a></span> thereby inducing a localized heterochrony in the sequence of distal limb and genitourinary development.
Synpolydactyly	fibulin-1	True Positive	6.683	16712704	<strong class="title">Malik S, Abbasi AA, Ansar M, Ahmad W, Koch MC, Grzeschik KH: Genetic heterogeneity of <span class="tagged-query" title="Query">synpolydactyly:</span> a novel <span class="tagged-filter" title="Association Word">locus</span> SPD3 maps to chromosome 14q11.2-q12. Clin Genet. 2006 Jun;69(6):518-24.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Syndactyly</span> type II or <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD)</a></span> is the second most frequent <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> type and is inherited in an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> fashion. The cardinal features of this malformation are the cutaneous or bony fusion of third and fourth fingers, and fourth and fifth toes <span class="tagged-filter" title="Association Word">associated</span> with additional digital elements within the web. It shows incomplete penetrance and high inter- and intrafamilial phenotypic variability. Two loci are known for <span class="tagged-metabolite" title="HMDB: HMDB01257"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> (MIM 186000, MIM 608180) <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">mutations</span> in <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1,</a></span> respectively. Here, we report further genetic heterogeneity for SDP. Employing a whole genomic screen, we demonstrate, in a large Pakistani kindred, that the classical phenotype of <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> maps on a new <span class="tagged-filter" title="Association Word">locus</span> at chromosome 14q11.2-q12. The highest LOD score (Z (max) = 4.06) was obtained with microsatellite <span class="tagged-filter" title="Association Word">marker</span> D14S264, and the multipoint LOD score reached a maximum of 5.01. Haplotype analysis revealed that the disease interval is flanked by microsatellite <span class="tagged-filter" title="Association Word">markers</span> D14S283 and D14S1060, encompassing a physical distance of 10.72 Mb. We propose to allocate to this <span class="tagged-filter" title="Association Word">locus</span> the symbol SPD3 <span class="tagged-query" title="Query">(synpolydactyly</span> 3), and to name the loci <span class="tagged-filter" title="Association Word">associated</span> with <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> or <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span> <span class="tagged-filter" title="Association Word">mutations</span> SPD1 and SPD2, respectively.
Synpolydactyly	fibulin-1	True Positive	6.683	11836357	<strong class="title">Debeer P, Schoenmakers EF, Twal WO, Argraves WS, De Smet L, Fryns JP, Van De Ven WJ: The <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">fibulin-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">(FBLN1)</a></span> is disrupted in a t (12;22) <span class="tagged-filter" title="Association Word">associated</span> with a complex type of <span class="tagged-query" title="Query">synpolydactyly.</span> J Med Genet. 2002 Feb;39(2):98-104.</strong> Molecular analysis of the reciprocal <span class="tagged-disease" title="UMLS Concept ID: C0040715">chromosomal translocation</span> t (12;22)(p11.2;q13.3) cosegregating with a complex type of <span class="tagged-query" title="Query">synpolydactyly</span> showed involvement of an alternatively spliced exon of the <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">fibulin-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">(FBLN1</a></span> located in 22q13.3) and the C12orf2 <span class="tagged-gene" title="SwissProt ID: Q8NHQ8; Entrez Gene ID: 11228; HGNC ID: 13232; HPRD ID: 07084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NHQ8">(HoJ-1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> on the short arm of chromosome 12. Investigation of the possible functional involvement of the <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">fibulin-1</a></span> <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">(FBLN1)</a></span> in the <span class="tagged-filter" title="Association Word">observed</span> phenotype showed that <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span> is <span class="tagged-filter" title="Association Word">expressed</span> in the extracellular matrix <span class="tagged-drug" title="DrugBank: APRD00264"><span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00264">(ECM)</a></span> in <span class="tagged-filter" title="Association Word">association</span> with the digits in the developing limb. Furthermore, fibroblasts derived from patients with the complex type of <span class="tagged-query" title="Query">synpolydactyly</span> displayed alterations in the level of <a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span>-D splice variant incorporated into the <span class="tagged-drug" title="DrugBank: APRD00264"><span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00264">ECM</a></span> and secreted into the conditioned culture medium. By contrast, the <span class="tagged-filter" title="Association Word">expression</span> of the <a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span>-C splice variant was not perturbed in the patient fibroblasts. Based on these findings, we propose that the t (12;22) results in haploinsufficiency of the <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span>-D variant, which could <span class="tagged-filter" title="Association Word">lead</span> to the <span class="tagged-filter" title="Association Word">observed</span> limb malformations.
Synpolydactyly	HOXD9	True Positive	1.136	11778160	<strong class="title">Goodman FR, Majewski F, Collins AL, Scambler PJ: A 117-kb microdeletion removing <span class="tagged-gene" title="SwissProt ID: P28356; Entrez Gene ID: 3235; HGNC ID: 5140; HPRD ID: 00865; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28356">HOXD9</a></span>-<span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03828">EVX2</a></span> <span class="tagged-filter" title="Association Word">causes</span> <span class="tagged-query" title="Query">synpolydactyly.</span> Am J Hum Genet. 2002 Feb;70(2):547-55. Epub 2002 Jan 3.</strong> Studies in mouse and chick have shown that the 5' HoxD <span class="tagged-filter" title="Association Word">genes</span> play major <span class="tagged-filter" title="Association Word">roles</span> in the development of the limbs and genitalia. In humans, <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">cause</span> the dominantly inherited limb malformation <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P28356; Entrez Gene ID: 3235; HGNC ID: 5140; HPRD ID: 00865; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD).</a></span> Haploinsufficiency for the 5' HOXD <span class="tagged-filter" title="Association Word">genes</span> has recently been proposed to underlie the monodactyly and penoscrotal <span class="tagged-disease" title="UMLS Concept ID: C0243069">hypoplasia</span> in two children with chromosomal deletions encompassing the entire HOXD cluster. Similar deletions, however, have previously been <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: Not Available">split-hand/foot malformation</span> (SHFM), including monodactyly. Here we report a father and daughter with <span class="tagged-metabolite" title="HMDB: HMDB01257"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> who carry a 117-kb microdeletion at the 5' end of the HOXD cluster. By sequencing directly across the deletion breakpoint, we show that this microdeletion removes only <a href="http://beta.uniprot.org/uniprot/P28356">HOXD9</a></span>-<span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03828">EVX2.</a></span> We also report a girl with bilateral split foot and a <span class="tagged-disease" title="UMLS Concept ID: C0008628">chromosomal deletion</span> that includes the entire HOXD cluster and extends approximately 5 Mb centromeric to it. Our findings indicate that haploinsufficiency for the 5' HOXD <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">causes</span> not SHFM but <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> and point to the presence of a novel <span class="tagged-filter" title="Association Word">locus</span> for SHFM in the interval between <a href="http://beta.uniprot.org/uniprot/Q03828">EVX2</a></span> and D2S294. They also suggest that there is a regulatory region, upstream of the HOXD cluster, that is responsible for activating the cluster as a whole.
Synpolydactyly	HoJ-1	True Negative	1.136	11836357	<strong class="title">Debeer P, Schoenmakers EF, Twal WO, Argraves WS, De Smet L, Fryns JP, Van De Ven WJ: The <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">fibulin-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">(FBLN1)</a></span> is disrupted in a t (12;22) <span class="tagged-filter" title="Association Word">associated</span> with a complex type of <span class="tagged-query" title="Query">synpolydactyly.</span> J Med Genet. 2002 Feb;39(2):98-104.</strong> Molecular analysis of the reciprocal <span class="tagged-disease" title="UMLS Concept ID: C0040715">chromosomal translocation</span> t (12;22)(p11.2;q13.3) cosegregating with a complex type of <span class="tagged-query" title="Query">synpolydactyly</span> showed involvement of an alternatively spliced exon of the <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">fibulin-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">(FBLN1</a></span> located in 22q13.3) and the C12orf2 <span class="tagged-gene" title="SwissProt ID: Q8NHQ8; Entrez Gene ID: 11228; HGNC ID: 13232; HPRD ID: 07084; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NHQ8">(HoJ-1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> on the short arm of chromosome 12. Investigation of the possible functional involvement of the <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">fibulin-1</a></span> <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">(FBLN1)</a></span> in the <span class="tagged-filter" title="Association Word">observed</span> phenotype showed that <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span> is <span class="tagged-filter" title="Association Word">expressed</span> in the extracellular matrix <span class="tagged-drug" title="DrugBank: APRD00264"><span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00264">(ECM)</a></span> in <span class="tagged-filter" title="Association Word">association</span> with the digits in the developing limb. Furthermore, fibroblasts derived from patients with the complex type of <span class="tagged-query" title="Query">synpolydactyly</span> displayed alterations in the level of <a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span>-D splice variant incorporated into the <span class="tagged-drug" title="DrugBank: APRD00264"><span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00264">ECM</a></span> and secreted into the conditioned culture medium. By contrast, the <span class="tagged-filter" title="Association Word">expression</span> of the <a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span>-C splice variant was not perturbed in the patient fibroblasts. Based on these findings, we propose that the t (12;22) results in haploinsufficiency of the <span class="tagged-gene" title="SwissProt ID: P23142; Entrez Gene ID: 2192; HGNC ID: 3600; HPRD ID: 00629; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23142">FBLN1</a></span>-D variant, which could <span class="tagged-filter" title="Association Word">lead</span> to the <span class="tagged-filter" title="Association Word">observed</span> limb malformations.
Synpolydactyly	HOXA13	False Positive	2.069	15643670	<strong class="title">Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR: The pathophysiology of HOX <span class="tagged-filter" title="Association Word">genes</span> and their <span class="tagged-filter" title="Association Word">role</span> in cancer. J Pathol. 2005 Jan;205(2):154-71.</strong> The HOM-C clustered prototype <span class="tagged-gene" title="SwissProt ID: P52954; Entrez Gene ID: 10660; HGNC ID: 16960; HPRD ID: 09178; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52954">homeobox</a></span> <span class="tagged-filter" title="Association Word">genes</span> of Drosophila, and their counterparts, the HOX <span class="tagged-filter" title="Association Word">genes</span> in humans, are highly conserved at the genomic level. These master regulators of development continue to be <span class="tagged-filter" title="Association Word">expressed</span> throughout adulthood in various tissues and organs. The physiological and patho-physiological functions of this network of <span class="tagged-filter" title="Association Word">genes</span> are being avidly pursued within the scientific community, but defined <span class="tagged-filter" title="Association Word">roles</span> for them remain elusive. The order of <span class="tagged-filter" title="Association Word">expression</span> of HOX <span class="tagged-filter" title="Association Word">genes</span> within a cluster is co-ordinated during development, so that the 3' <span class="tagged-filter" title="Association Word">genes</span> are <span class="tagged-filter" title="Association Word">expressed</span> more anteriorly and earlier than the 5' <span class="tagged-filter" title="Association Word">genes.</span> <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31271">HOXA13</a></span> and <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> are <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0751438">disorders of</span> limb formation such as hand-foot-genital syndrome (HFGS), <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: Q03164; Entrez Gene ID: 4297; HGNC ID: 7132; HPRD ID: 01162; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD),</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0221357">brachydactyly.</span> Haematopoietic progenitors express HOX <span class="tagged-filter" title="Association Word">genes</span> in a pattern characteristic of the lineage and stage of differentiation of the cells. In <span class="tagged-disease" title="UMLS Concept ID: C1292766">leukaemia,</span> dysregulated HOX gene expression can occur due to <span class="tagged-disease" title="UMLS Concept ID: C0040715">chromosomal translocations</span> <span class="tagged-filter" title="Association Word">involving</span> upstream regulators such as the <a href="http://beta.uniprot.org/uniprot/Q03164">MLL</a></span> <span class="tagged-filter" title="Association Word">gene,</span> or the fusion of a HOX <span class="tagged-filter" title="Association Word">gene</span> to another <span class="tagged-filter" title="Association Word">gene</span> such as the nucleoporin, <span class="tagged-gene" title="SwissProt ID: P52948; Entrez Gene ID: 4928; HGNC ID: 8068; HPRD ID: 03012; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52948">NUP98.</a></span> Recent investigations of HOX gene expression in <span class="tagged-disease" title="UMLS Concept ID: C1292766">leukaemia</span> are providing important insights into disease classification and prediction of clinical outcome. Whereas the oncogenic potential of certain HOX <span class="tagged-filter" title="Association Word">genes</span> in <span class="tagged-disease" title="UMLS Concept ID: C1292766">leukaemia</span> has already been defined, their <span class="tagged-filter" title="Association Word">role</span> in other neoplasms is currently being studied. Progress has been hampered by the experimental approach used in many studies in which the <span class="tagged-filter" title="Association Word">expression</span> of small subsets of HOX <span class="tagged-filter" title="Association Word">genes</span> was analysed, and complicated by the functional redundancy implicit in the HOX <span class="tagged-filter" title="Association Word">gene</span> system. Attempts to elucidate the function of HOX <span class="tagged-filter" title="Association Word">genes</span> in malignant transformation will be enhanced by a better understanding of their upstream regulators and downstream target <span class="tagged-filter" title="Association Word">genes.</span>
Synpolydactyly	HOXA13	False Positive	2.069	12357469	<strong class="title">Goodman FR: Limb malformations and the human HOX <span class="tagged-filter" title="Association Word">genes.</span> Am J Med Genet. 2002 Oct 15;112(3):256-65.</strong> HOX <span class="tagged-filter" title="Association Word">genes</span> encode a family of transcription factors of fundamental importance for body patterning during embryonic development. Humans, like most vertebrates, have 39 HOX <span class="tagged-filter" title="Association Word">genes</span> organized into four clusters, with major <span class="tagged-filter" title="Association Word">roles</span> in the development of the central nervous system, axial skeleton, gastrointestinal and urogenital tracts, <span class="tagged-disease" title="UMLS Concept ID: C0700039">external genitalia,</span> and limbs. The first two limb malformations shown to be <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the human HOX <span class="tagged-filter" title="Association Word">genes</span> were <span class="tagged-query" title="Query">synpolydactyly</span> and hand-foot-genital syndrome, which result from <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31271">HOXA13,</a></span> respectively. This review describes a variety of limb malformations now known to be <span class="tagged-filter" title="Association Word">caused</span> by specific different <span class="tagged-filter" title="Association Word">mutations</span> in these two <span class="tagged-filter" title="Association Word">genes,</span> including polyalanine tract expansions, <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutations,</span> and missense <span class="tagged-filter" title="Association Word">mutations,</span> many with phenotypic consequences that could not have been predicted from previous knowledge of mouse models or HOX <span class="tagged-filter" title="Association Word">protein</span> function. Limb malformations may also result from chromosomal deletions <span class="tagged-filter" title="Association Word">involving</span> the HOXD and HOXA clusters, and from regulatory <span class="tagged-filter" title="Association Word">mutations</span> affecting single or multiple HOX <span class="tagged-filter" title="Association Word">genes.</span>
Synpolydactyly	HOXA13	False Positive	2.069	11206481	<strong class="title">Goodman FR, Scambler PJ: Human HOX <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations.</span> Clin Genet. 2001 Jan;59(1):1-11.</strong> HOX <span class="tagged-filter" title="Association Word">genes</span> play a fundamental <span class="tagged-filter" title="Association Word">role</span> in the development of the vertebrate central nervous system, axial skeleton, limbs, gut, urogenital tract and <span class="tagged-disease" title="UMLS Concept ID: C0700039">external genitalia,</span> but it is only in the last 4 years that <span class="tagged-filter" title="Association Word">mutations</span> in two of the 39 human HOX <span class="tagged-filter" title="Association Word">genes</span> have been shown to <span class="tagged-filter" title="Association Word">cause</span> congenital malformations; <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13,</a></span> which is <span class="tagged-filter" title="Association Word">mutated</span> in <span class="tagged-query" title="Query">synpolydactyly,</span> and <span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31271">HOXA13,</a></span> which is <span class="tagged-filter" title="Association Word">mutated</span> in Hand-Foot-Genital syndrome. Here we review the <span class="tagged-filter" title="Association Word">mutations</span> already identified in these two <span class="tagged-filter" title="Association Word">genes,</span> consider how these <span class="tagged-filter" title="Association Word">mutations</span> may act, and discuss the possibility that further <span class="tagged-filter" title="Association Word">mutations</span> remain to be discovered both in developmental disorders and in cancer.
Synpolydactyly	HOXA13	False Positive	2.069	10364522	<strong class="title">Del Campo M, Jones MC, Veraksa AN, Curry CJ, Jones KL, Mascarello JT, Ali-Kahn-Catts Z, Drumheller T, McGinnis W: Monodactylous limbs and abnormal genitalia are <span class="tagged-filter" title="Association Word">associated</span> with hemizygosity for the human 2q31 region that includes the HOXD cluster. Am J Hum Genet. 1999 Jul;65(1):104-10.</strong> Vertebrates have four clusters of Hox <span class="tagged-filter" title="Association Word">genes</span> (HoxA, HoxB, HoxC, and HoxD). A variety of <span class="tagged-filter" title="Association Word">expression</span> and <span class="tagged-filter" title="Association Word">mutation</span> studies indicate that posterior members of the HoxA and HoxD clusters play an important <span class="tagged-filter" title="Association Word">role</span> in vertebrate limb development. In humans, <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> have been <span class="tagged-filter" title="Association Word">associated</span> with type II <span class="tagged-disease" title="UMLS Concept ID: Not Available">syndactyly</span> or <span class="tagged-query" title="Query">synpolydactyly,</span> and, in <span class="tagged-gene" title="SwissProt ID: P31271; Entrez Gene ID: 3209; HGNC ID: 5102; HPRD ID: 00847; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31271">HOXA13,</a></span> with hand-foot-genital syndrome. We have investigated two unrelated children with a previously unreported pattern of severe developmental defects on the anterior-posterior (a-p) limb axis and in the genitalia, consisting of a single bone in the zeugopod, either monodactyly or oligodactyly in the autopod of all four limbs, and penoscrotal <span class="tagged-disease" title="UMLS Concept ID: C0243069">hypoplasia.</span> Both children are heterozygous for a deletion that eliminates at least eight <span class="tagged-gene" title="SwissProt ID: P31249; Entrez Gene ID: 3232; HGNC ID: 5137; HPRD ID: 00863; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31249">(HOXD3</a></span>-<span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13)</a></span> of the nine <span class="tagged-filter" title="Association Word">genes</span> in the HOXD cluster. We propose that the patients' phenotypes are due in part to haploinsufficiency for HOXD-cluster <span class="tagged-filter" title="Association Word">genes.</span> This hypothesis is supported by the <span class="tagged-filter" title="Association Word">expression</span> patterns of these <span class="tagged-filter" title="Association Word">genes</span> in early vertebrate embryos. However, the involvement of additional <span class="tagged-filter" title="Association Word">genes</span> in the region could explain the discordance, in severity, between these human phenotypes and the milder, non-polarized phenotypes present in mice hemizygous for HoxD cluster <span class="tagged-filter" title="Association Word">genes.</span> These cases represent the first reported examples of deficiencies for an entire Hox cluster in vertebrates and suggest that the diploid dose of human HOXD <span class="tagged-filter" title="Association Word">genes</span> is crucial for normal growth and patterning of the limbs along the anterior-posterior axis.
Synpolydactyly	DAD-R	True Positive	1.136	10812081	<strong class="title">Kuittinen T, Eggert A, Lindholm P, Horelli-Kuitunen N, Palotie A, Maris JM, Saarma M: A novel human processed <span class="tagged-filter" title="Association Word">gene,</span> <span class="tagged-gene" title="Entrez Gene ID: 56286; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=56286">DAD-R,</a></span> maps to 12p12 and is <span class="tagged-filter" title="Association Word">expressed</span> in several organs. FEBS Lett. 2000 May 12;473(2):233-6.</strong> A cDNA of a processed <span class="tagged-filter" title="Association Word">gene</span> of human <span class="tagged-gene" title="SwissProt ID: P61803; Entrez Gene ID: 1603; HGNC ID: 2664; HPRD ID: 02589; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61803">DAD-1</a></span> (defender against apoptotic cell death) was cloned from the human neuroblastoma cell line SH-SY5Y. The genomic sequence of this novel processed <span class="tagged-filter" title="Association Word">gene,</span> <span class="tagged-gene" title="Entrez Gene ID: 56286; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=56286">DAD-R,</a></span> lacked introns and was flanked by 8 bp terminal repeats. RT-PCR showed that the transcript is <span class="tagged-filter" title="Association Word">expressed</span> predominantly in testis, ovaries, pancreas, lung and skeletal muscle. <span class="tagged-gene" title="Entrez Gene ID: 56286; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=56286">DAD-R</a></span> has several possible initiation codons, one of them producing an open reading frame comprising 75% of the <span class="tagged-gene" title="SwissProt ID: P61803; Entrez Gene ID: 1603; HGNC ID: 2664; HPRD ID: 02589; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61803">DAD-1</a></span> <span class="tagged-filter" title="Association Word">gene.</span> We determined the chromosomal localization of <span class="tagged-gene" title="Entrez Gene ID: 56286; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=56286">DAD-R</a></span> as 12p11.2-12p12.1, an area <span class="tagged-filter" title="Association Word">linked</span> to familial <span class="tagged-query" title="Query">synpolydactyly</span> and frequently amplified in a variety of cancers, including those of testis, ovaries, pancreas and lungs.
Synpolydactyly	homeobox	True Positive	1.136	16497573	<strong class="title">Horsnell K, Ali M, Malik S, Wilson L, Hall C, Debeer P, Crow Y: Clinical phenotype <span class="tagged-filter" title="Association Word">associated</span> with homozygosity for a <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> 7-residue polyalanine tract expansion. Eur J Med Genet. 2006 Sep-Oct;49(5):396-401. Epub 2006 Feb 9.</strong> <span class="tagged-query" title="Query">Synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P52954; Entrez Gene ID: 10660; HGNC ID: 16960; HPRD ID: 09178; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD)</a></span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> malformation of the distal limbs <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <a href="http://beta.uniprot.org/uniprot/P52954">homeobox</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> located on chromosome 2q31. We detail the clinical findings in a consanguineous Pakistani family segregating a <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> 7-residue polyalanine tract expansion. Three members of this pedigree were heterozygotes with features typical of <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD.</a></span> Two further members demonstrate a more severe phenotype consistent with homozygosity for the familial <span class="tagged-filter" title="Association Word">mutation.</span> We also report a child from a consanguineous Somali family homozygous for the same molecular lesion. Characteristic changes include a complex central <span class="tagged-disease" title="UMLS Concept ID: Not Available">polydactyly</span> in the hands, abnormal modelling of the metacarpals and metatarsals, an increased number of carpal bones with abnormal shapes, <span class="tagged-disease" title="UMLS Concept ID: C0243069">hypoplasia</span> or <span class="tagged-filter" title="Association Word">absence</span> of the fifth digital rays in the feet, <span class="tagged-disease" title="UMLS Concept ID: C0243069">hypoplasia</span> of the middle phalanges and abnormally long proximal phalanges in hands and feet. These cases illustrate the distinct phenotype <span class="tagged-filter" title="Association Word">associated</span> with homozygosity for a <a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">mutation</span> and also highlight the importance of considering homozygosity for a <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-filter" title="Association Word">mutation</span> in consanguineous pedigrees.
Synpolydactyly	EVX2	True Positive	1.136	11778160	<strong class="title">Goodman FR, Majewski F, Collins AL, Scambler PJ: A 117-kb microdeletion removing <span class="tagged-gene" title="SwissProt ID: P28356; Entrez Gene ID: 3235; HGNC ID: 5140; HPRD ID: 00865; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28356">HOXD9</a></span>-<span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03828">EVX2</a></span> <span class="tagged-filter" title="Association Word">causes</span> <span class="tagged-query" title="Query">synpolydactyly.</span> Am J Hum Genet. 2002 Feb;70(2):547-55. Epub 2002 Jan 3.</strong> Studies in mouse and chick have shown that the 5' HoxD <span class="tagged-filter" title="Association Word">genes</span> play major <span class="tagged-filter" title="Association Word">roles</span> in the development of the limbs and genitalia. In humans, <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> <span class="tagged-filter" title="Association Word">cause</span> the dominantly inherited limb malformation <span class="tagged-query" title="Query">synpolydactyly</span> <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: P28356; Entrez Gene ID: 3235; HGNC ID: 5140; HPRD ID: 00865; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">(SPD).</a></span> Haploinsufficiency for the 5' HOXD <span class="tagged-filter" title="Association Word">genes</span> has recently been proposed to underlie the monodactyly and penoscrotal <span class="tagged-disease" title="UMLS Concept ID: C0243069">hypoplasia</span> in two children with chromosomal deletions encompassing the entire HOXD cluster. Similar deletions, however, have previously been <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: Not Available">split-hand/foot malformation</span> (SHFM), including monodactyly. Here we report a father and daughter with <span class="tagged-metabolite" title="HMDB: HMDB01257"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> who carry a 117-kb microdeletion at the 5' end of the HOXD cluster. By sequencing directly across the deletion breakpoint, we show that this microdeletion removes only <a href="http://beta.uniprot.org/uniprot/P28356">HOXD9</a></span>-<span class="tagged-gene" title="SwissProt ID: P35453; Entrez Gene ID: 3239; HGNC ID: 5136; HPRD ID: 00872; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35453">HOXD13</a></span> and <span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03828">EVX2.</a></span> We also report a girl with bilateral split foot and a <span class="tagged-disease" title="UMLS Concept ID: C0008628">chromosomal deletion</span> that includes the entire HOXD cluster and extends approximately 5 Mb centromeric to it. Our findings indicate that haploinsufficiency for the 5' HOXD <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">causes</span> not SHFM but <span class="tagged-metabolite" title="HMDB: HMDB01257"><span class="tagged-gene" title="SwissProt ID: Q03828; Entrez Gene ID: 2129; HGNC ID: 3507; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01257">SPD</a></span> and point to the presence of a novel <span class="tagged-filter" title="Association Word">locus</span> for SHFM in the interval between <a href="http://beta.uniprot.org/uniprot/Q03828">EVX2</a></span> and D2S294. They also suggest that there is a regulatory region, upstream of the HOXD cluster, that is responsible for activating the cluster as a whole.
Vitelliform_macular_dystrophy	PYGM	True Negative	1.243	8064817	<strong class="title">Weber BH, Walker D, Muller B: Molecular evidence for non-penetrance in <span class="tagged-query" title="Query">Best's disease.</span> J Med Genet. 1994 May;31(5):388-92.</strong> The present study provides evidence for a possible case of non-penetrance in <span class="tagged-query" title="Query">Best's disease.</span> We have analysed the at risk members of a three generation family with an established history of <span class="tagged-query" title="Query">Best's disease</span> by ophthalmoscopic examination, electrophysiological tests, and genetic analysis. The clinical examination identified 10 affected and five unaffected persons in this family. Genetic <span class="tagged-filter" title="Association Word">linkage</span> analysis strongly supports <span class="tagged-filter" title="Association Word">linkage</span> of the disease <span class="tagged-filter" title="Association Word">locus</span> to DNA microsatellite <span class="tagged-filter" title="Association Word">markers</span> from proximal 11q. The genotyping data were used to construct the familial haplotype <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">Best's disease.</span> One person was identified who has inherited the <span class="tagged-query" title="Query">Best's disease</span> haplotype from his affected mother. Fundus examination and electrophysiological tests have repeatedly been performed in this patient but failed to show any signs of the disease. Based on these findings we have jointly estimated the most likely order of the <span class="tagged-query" title="Query">Best's disease</span> <span class="tagged-filter" title="Association Word">locus</span> relative to the closet flanking <span class="tagged-filter" title="Association Word">markers</span> at various penetrance values. A maximum likelihood estimate for the heterozygote penetrance was reached for the <span class="tagged-filter" title="Association Word">locus</span> order D11S903-<span class="tagged-query" title="Query">Best's disease</span>-<span class="tagged-gene" title="SwissProt ID: P11217; Entrez Gene ID: 5837; HGNC ID: 9726; HPRD ID: 01986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11217">PYGM</a></span> at a penetrance value of 0.96.
Vitelliform_macular_dystrophy	PYGM	True Negative	1.243	8020974	<strong class="title">Weber BH, Walker D, Muller B, Mar L: Best's <span class="tagged-query" title="Query">vitelliform dystrophy</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(VMD2)</a></span> maps between D11S903 and <span class="tagged-gene" title="SwissProt ID: P11217; Entrez Gene ID: 5837; HGNC ID: 9726; HPRD ID: 01986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11217">PYGM:</a></span> no evidence for <span class="tagged-filter" title="Association Word">locus</span> heterogeneity. Genomics. 1994 Mar 15;20(2):267-74.</strong> <span class="tagged-query" title="Query">Vitelliform macular dystrophy,</span> also known as <span class="tagged-query" title="Query">Best's disease</span> (BD), is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> disorder typically characterized by an accumulation of yellowish material in the macular area. The disease is slowly progressive and eventually results in atrophy of the retinal pigment epithelium and photoreceptor cells, thus severely impairing central vision. The biochemical defect underlying this condition is unknown. More recently, the BD <span class="tagged-filter" title="Association Word">locus</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(VMD2)</a></span> was mapped to chromosome 11 by genetic <span class="tagged-filter" title="Association Word">linkage</span> to microsatellite <span class="tagged-filter" title="Association Word">markers</span> at D11S871 and <span class="tagged-gene" title="SwissProt ID: P11487; Entrez Gene ID: 2248; HGNC ID: 3681; HPRD ID: 01289; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11487">INT2.</a></span> In the present study, we report a detailed genetic analysis in three multigeneration <span class="tagged-query" title="Query">Best's disease</span> families using eight microsatellite <span class="tagged-filter" title="Association Word">markers</span> spanning approximately 26 cM around the putative BD <span class="tagged-filter" title="Association Word">locus.</span> We demonstrate <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-query" title="Query">Best's disease</span> and the <span class="tagged-filter" title="Association Word">markers</span> used. Furthermore, haplotype analysis in our unrelated <span class="tagged-query" title="Query">Best's disease</span> families identified three distinct haplotypes <span class="tagged-filter" title="Association Word">associated</span> with the disease, strongly suggesting independent origins of the BD <span class="tagged-filter" title="Association Word">mutation.</span> Finally, we characterized two recombinant BD chromosomes that significantly refine the location of the disease <span class="tagged-filter" title="Association Word">gene</span> to a 3.7-cM interval between <span class="tagged-filter" title="Association Word">markers</span> at D11S903 and <span class="tagged-gene" title="SwissProt ID: P11217; Entrez Gene ID: 5837; HGNC ID: 9726; HPRD ID: 01986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11217">PYGM.</a></span> PCR-hybrid mapping sublocalized this interval to the pericentromeric region of chromosome 11.
Vitelliform_macular_dystrophy	flap-endonuclease-1	True Negative	1.243	10769175	<strong class="title">Leonard AE, Kelder B, Bobik EG, Chuang LT, Parker-Barnes JM, Thurmond JM, Kroeger PE, Kopchick JJ, Huang YS, Mukerji P: cDNA cloning and characterization of human Delta5-desaturase <span class="tagged-filter" title="Association Word">involved</span> in the biosynthesis of <span class="tagged-metabolite" title="HMDB: HMDB01043"><span class="tagged-gene" title="SwissProt ID: P49888; Entrez Gene ID: 6783; HGNC ID: 11377; HPRD ID: 08966; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01043">arachidonic acid.</a></span> Biochem J. 2000 May 1;347 Pt 3:719-24.</strong> Two human <span class="tagged-filter" title="Association Word">expressed</span> sequence tag <a href="http://beta.uniprot.org/uniprot/P49888">(EST)</a></span> cDNA sequences with identity with Delta (5)- and Delta (6)-desaturases from a filamentous fungus, Mortierella alpina, were identified from the LifeSeq (R) database of Incyte Pharmaceuticals, Inc. (Palo Alto, CA, U.S.A.). An oligonucleotide complementary to the 3' <span class="tagged-gene" title="SwissProt ID: P49888; Entrez Gene ID: 6783; HGNC ID: 11377; HPRD ID: 08966; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P49888">EST</a></span> cDNA sequences was used to screen human liver cDNA using rapid amplification of cDNA ends (RACE)-PCR. The amplified DNA fragment had 98% identity with a putative open reading frame <span class="tagged-disease" title="UMLS Concept ID: C0013570">(ORF)</span> predicted from a human genomic sequence, and encoded 444 amino acids. <span class="tagged-filter" title="Association Word">Expression</span> of this <span class="tagged-disease" title="UMLS Concept ID: C0013570">ORF</span> in mouse fibroblast cells demonstrated that the encoded <span class="tagged-filter" title="Association Word">protein</span> was a <span class="tagged-gene" title="SwissProt ID: O60427; Entrez Gene ID: 3992; HGNC ID: 3574; HPRD ID: 06935; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60427">Delta (5)-desaturase,</a></span> as determined by the conversion of <span class="tagged-metabolite" title="HMDB: HMDB02925"><span class="tagged-gene" title="SwissProt ID: O60427; Entrez Gene ID: 3992; HGNC ID: 3574; HPRD ID: 06935; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02925">dihomo-gamma-linolenic acid</a></span> (C (20:3,n-6)) into <span class="tagged-metabolite" title="HMDB: HMDB01043"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01043">arachidonic acid</a></span> (C (20:4,n-6)). The human <a href="http://beta.uniprot.org/uniprot/O60427">Delta (5)-desaturase</a></span> contained a predicted N-terminal <span class="tagged-gene" title="SwissProt ID: P00167; Entrez Gene ID: 1528; HGNC ID: 2570; HPRD ID: 08941; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00167">cytochrome b (5)</a></span>-like domain, as well as three <span class="tagged-metabolite" title="HMDB: HMDB00177"><span class="tagged-gene" title="SwissProt ID: P39748; Entrez Gene ID: 2237; HGNC ID: 3650; HPRD ID: 02670; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00177">histidine</a></span>-rich domains. A tissue <span class="tagged-filter" title="Association Word">expression</span> profile revealed that this <span class="tagged-filter" title="Association Word">gene</span> is highly <span class="tagged-filter" title="Association Word">expressed</span> in fetal liver, fetal brain, adult brain and adrenal gland. A search of the existing databases <span class="tagged-filter" title="Association Word">led</span> to localization of this <span class="tagged-disease" title="UMLS Concept ID: C0013570">ORF</span> within a 14 kb interval flanked by the <a href="http://beta.uniprot.org/uniprot/P39748">flap endonuclease-1</a></span> <span class="tagged-gene" title="SwissProt ID: P39748; Entrez Gene ID: 2237; HGNC ID: 3650; HPRD ID: 02670; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39748">(FEN1)</a></span> and <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-query" title="Query">(Best's disease;</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2)</a></span> loci of chromosome 11q12.
Vitelliform_macular_dystrophy	ABC1	True Negative	1.243	17491602	<strong class="title">Patel N, Adewoyin T, Chong NV: <span class="tagged-disease" title="UMLS Concept ID: C0242383">Age-related macular degeneration:</span> a perspective on genetic studies. Eye. 2007 May 11;.</strong> AimAge-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration</span> <span class="tagged-gene" title="SwissProt ID: P08603; Entrez Gene ID: 3075; HGNC ID: 4883; HPRD ID: 00601; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD)</a></span> is a common <span class="tagged-disease" title="UMLS Concept ID: C0730362">macular disease</span> in the developed world and recent studies have shown that specific <span class="tagged-filter" title="Association Word">genes</span> may be <span class="tagged-filter" title="Association Word">associated</span> with it and may contribute to a higher risk of developing AMD.ObjectiveOur objective was to review systematically recent publications <span class="tagged-filter" title="Association Word">related</span> to the genetics of <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> and provide relevant information that would help both scientists and clinicians in advising patients.MethodA systematic search was performed on PubMed, Medline, and National Library of <span class="tagged-drug" title="DrugBank: APRD00485"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00485">Medicine</a></span> as well as ARVO abstracts using key words relevant to the genetic associations of AMD.ResultsThe most important genetic associations in <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> <span class="tagged-filter" title="Association Word">involved</span> the <a href="http://beta.uniprot.org/uniprot/P08603">complement factor H</a></span> <span class="tagged-gene" title="SwissProt ID: P08603; Entrez Gene ID: 3075; HGNC ID: 4883; HPRD ID: 00601; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08603">(CFH)</a></span> <span class="tagged-filter" title="Association Word">gene,</span> which showed that possession of the variant Y402H <span class="tagged-filter" title="Association Word">polymorphism</span> significantly increases the risk for <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P00751; Entrez Gene ID: 629; HGNC ID: 1037; HPRD ID: 00718; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> Protective <span class="tagged-filter" title="Association Word">genes</span> have also been identified such as those on either factor B (BFor <a href="http://beta.uniprot.org/uniprot/P00751">complement factor B</a></span> <span class="tagged-gene" title="SwissProt ID: P00751; Entrez Gene ID: 629; HGNC ID: 1037; HPRD ID: 00718; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00751">(CFB))</a></span> or <span class="tagged-gene" title="SwissProt ID: P06681; Entrez Gene ID: 717; HGNC ID: 1248; HPRD ID: 08939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06681">complement component 2</a></span> (C2) <span class="tagged-filter" title="Association Word">genes.</span> The <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inherited macular dystrophies such as <span class="tagged-metabolite" title="HMDB: HMDB00538"><span class="tagged-gene" title="SwissProt ID: Q6AI08; Entrez Gene ID: 63897; HPRD ID: 12399; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00538">ATP</a></span>-binding cassette, subfamily A <a href="http://beta.uniprot.org/uniprot/Q6AI08">(ABC1),</a></span> member 4 <span class="tagged-gene" title="SwissProt ID: P78363; Entrez Gene ID: 24; HGNC ID: 34; HPRD ID: 03408; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78363">(ABCA4),</a></span> <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(VMD2),</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of matrix metalloproteinase-3</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">(TIMP3),</a></span> and EFEMP1have yielded some important information but further confirmatory work has yet to establish a clear <span class="tagged-filter" title="Association Word">association</span> with AMD.ConclusionPatients with <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> possess specific genetic variants of the CFHgene, which put them at a higher risk of developing the disease. Other unaffected individuals may possess certain protective genetic variants, which could prevent them from developing <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> Further research will no doubt shed light on other such mechanisms and these will be useful in identifying possible direct targets for drugs or indirectly through modulation of the <span class="tagged-filter" title="Association Word">genes</span> responsible for disease presentation.Eye advance online publication, 11 May 2007; doi:10.1038/sj.eye.6702844.
Vitelliform_macular_dystrophy	DCMD	True Negative	1.243	8905850	<strong class="title">Pinckers A, Cuypers MH, Aandekerk AL: The EOG in <span class="tagged-query" title="Query">Best's disease</span> and <span class="tagged-filter" title="Association Word">dominant</span> cystoid <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 1541; HGNC ID: 2587; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=1541">(DCMD).</a></span> . Ophthalmic Genet. 1996 Sep;17(3):103-8.</strong> The electro-oculogram (EOG) was studied in 156 normal patients, 103 patients with <span class="tagged-query" title="Query">Best's disease,</span> and 52 patients with <span class="tagged-filter" title="Association Word">dominant</span> cystoid <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 1541; HGNC ID: 2587; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=1541">(DCMD).</a></span> Statistical analysis was performed by comparing the distribution of Lp/Dt ratios of the groups. Strength of <span class="tagged-filter" title="Association Word">association</span> between Lp/Dt ratio and age was studied with correlation and regression analysis. In normal patients and in those with <span class="tagged-query" title="Query">Best's disease,</span> there was no significant correlation between age and Lp/Dt ratio. Obviously, the <span class="tagged-filter" title="Association Word">gene</span> defect in <span class="tagged-query" title="Query">Best's disease</span> <span class="tagged-filter" title="Association Word">causes</span> an <span class="tagged-filter" title="Association Word">altered</span> light-sensitive slow oscillation that remains stable throughout life. In <span class="tagged-gene" title="Entrez Gene ID: 1541; HGNC ID: 2587; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=1541">DCMD</a></span> patients, there was a significant negative correlation between age and Lp/Dt ratio for the total sample and for the female subgroup. Likely, the <span class="tagged-filter" title="Association Word">gene</span> defect in <span class="tagged-gene" title="Entrez Gene ID: 1541; HGNC ID: 2587; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=1541">DCMD</a></span> interferes with capillary permeability, that becomes susceptible to changes of the female hormones.
Vitelliform_macular_dystrophy	DDB1	True Negative	1.243	9781049	<strong class="title">Stohr H, Marquardt A, Rivera A, Kellner U, Weber BH: Refined mapping of the <span class="tagged-filter" title="Association Word">gene</span> encoding the p127 kDa UV-damaged DNA-binding <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: Q16531; Entrez Gene ID: 1642; HGNC ID: 2717; HPRD ID: 10952; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16531">(DDB1)</a></span> within 11q12-q13.1 and its exclusion in Best's <span class="tagged-query" title="Query">vitelliform macular dystrophy.</span> Eur J Hum Genet. 1998 Jul-Aug;6(4):400-5.</strong> Best's <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-query" title="Query">(Best's disease)</span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> disorder of unknown <span class="tagged-filter" title="Association Word">causes</span> and is typically characterised by an accumulation of lipofuscin-like material in the subretinal space of the macula. The disease <span class="tagged-filter" title="Association Word">gene</span> has been localised to chromosome 11q12-13.1 within a 1.4 Mbp interval flanked by <span class="tagged-filter" title="Association Word">markers</span> at D11S1765 and <span class="tagged-gene" title="SwissProt ID: P11684; Entrez Gene ID: 7356; HGNC ID: 12523; HPRD ID: 01884; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11684">uteroglobin</a></span> <span class="tagged-gene" title="SwissProt ID: P11684; Entrez Gene ID: 7356; HGNC ID: 12523; HPRD ID: 01884; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11684">(UGB).</a></span> Here we report the refined mapping of the <span class="tagged-filter" title="Association Word">gene</span> encoding the p127 kDa subunit <span class="tagged-gene" title="SwissProt ID: Q16531; Entrez Gene ID: 1642; HGNC ID: 2717; HPRD ID: 10952; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16531">(DDB1)</a></span> of a UV damage-specific DNA binding <span class="tagged-filter" title="Association Word">protein</span> within the D11S1765-<span class="tagged-gene" title="SwissProt ID: P11684; Entrez Gene ID: 7356; HGNC ID: 12523; HPRD ID: 01884; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11684">UGB</a></span> region. Northern blot analysis demonstrates an abundant <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-gene" title="SwissProt ID: Q16531; Entrez Gene ID: 1642; HGNC ID: 2717; HPRD ID: 10952; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16531">DDB1</a></span> transcript in the retina suggesting a functional <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: Q16531; Entrez Gene ID: 1642; HGNC ID: 2717; HPRD ID: 10952; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16531">DDB1</a></span> in this tissue. These considerations together with the chromosomal localisation have <span class="tagged-filter" title="Association Word">led</span> us to evaluate the possible involvement of <span class="tagged-gene" title="SwissProt ID: Q16531; Entrez Gene ID: 1642; HGNC ID: 2717; HPRD ID: 10952; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16531">DDB1</a></span> in the pathogenesis of <span class="tagged-query" title="Query">Best's disease.</span>
Vitelliform_macular_dystrophy	CACD	True Negative	1.243	9152224	<strong class="title">Felbor U, Doepner D, Schneider U, Zrenner E, Weber BH: Evaluation of the <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of metalloproteinases-3</a></span> in various maculopathies. Invest Ophthalmol Vis Sci. 1997 May;38(6):1054-9.</strong> PURPOSE: <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of metalloproteinases-3</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">(TIMP3)</a></span> have been shown previously to <span class="tagged-filter" title="Association Word">cause</span> Sorsby's fundus dystrophy, an <span class="tagged-filter" title="Association Word">autosomal</span>-<span class="tagged-filter" title="Association Word">dominant</span> disorder characterized by extracellular matrix irregularities in Bruch's membrane. To assess the involvement of <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> in a variety of other macular dystrophies, the authors have screened this <span class="tagged-filter" title="Association Word">gene</span> for disease-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD),</a></span> adult <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <a href="http://beta.uniprot.org/uniprot/P23942">(AVMD),</a></span> <span class="tagged-disease" title="UMLS Concept ID: C1536451">central areolar choroidal dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">(CACD),</a></span> syndrome-<span class="tagged-filter" title="Association Word">associated</span> macular dystrophies, <span class="tagged-disease" title="UMLS Concept ID: C0730290">cone-rod dystrophy,</span> and a group with unspecified <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration.</span> METHODS: Single-stranded conformational analysis of the entire coding region was performed using the polymerase chain reaction and oligonucleotide primers flanking the five exons of the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">gene</span> as well as the putative promotor region and a highly conserved fragment of the 3'-untranslated region. The authors analyzed a total of 217 patients, including 143 patients with <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> 28 patients with <a href="http://beta.uniprot.org/uniprot/P23942">AVMD,</a></span> 21 patients with <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">CACD,</a></span> and 25 patients with other forms of <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy.</span> RESULTS: In the 217 patients analyzed, the authors have identified one sequence alteration (a G-to-C base change) in the 5'-untranslated region in a patient with <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> However, the functional consequences of this <span class="tagged-filter" title="Association Word">mutation</span> are not clear. No other disease-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> were found. The authors have characterized a frequent intragenic <span class="tagged-filter" title="Association Word">polymorphism</span> in exon 3 of the <a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">gene</span> (heterozygosity = 0.57) that will be useful for genetic <span class="tagged-filter" title="Association Word">linkage</span> or allele sharing analyses or both. CONCLUSIONS: The authors' results suggest that <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> is not a major factor in the <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> <a href="http://beta.uniprot.org/uniprot/P23942">AVMD,</a></span> and <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">CACD.</a></span> Thus far, Sorsby's fundus dystrophy appears to be the only phenotype known to be <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3.</a></span>
Vitelliform_macular_dystrophy	glutamate-pyruvate-transaminase	True Positive	1.243	9119391	<strong class="title">Sohocki MM, Sullivan LS, Harrison WR, Sodergren EJ, Elder FF, Weinstock G, Tanase S, Daiger SP: Human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">glutamate pyruvate transaminase</a></span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">(GPT):</a></span> localization to 8q24.3, cDNA and genomic sequences, and <span class="tagged-filter" title="Association Word">polymorphic</span> sites. Genomics. 1997 Mar 1;40(2):247-52.</strong> Two frequent <span class="tagged-filter" title="Association Word">protein</span> variants of <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00243"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00243">pyruvate</a></span> transminase <a href="http://beta.uniprot.org/uniprot/P24298">(GPT)</a></span> (E.C.2.6.1.2) have been used as genetic <span class="tagged-filter" title="Association Word">markers</span> in humans for more than two decades, although chromosomal mapping of the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">locus</span> in the 1980s <span class="tagged-filter" title="Association Word">produced</span> conflicting results. To resolve this conflict and develop useful DNA <span class="tagged-filter" title="Association Word">markers</span> for this <span class="tagged-filter" title="Association Word">gene,</span> we isolated and characterized cDNA and genomic clones of <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT.</a></span> We have definitively mapped human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> to the terminus of 8q using several methods. First, two cosmids shown to contain the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> sequence were derived from a chromosome 8-specific library. Second, by fluorescence in situ hybridization, we mapped the cosmid containing the human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> to chromosome band 8q24.3. Third, we mapped the rat gpt cDNA to the syntenic region of rat chromosome 7. Finally, PCR primers specific to human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> amplify sequences contained within a "half-YAC" from the long arm of chromosome 8, that is, a YAC containing the 8q telomere. The human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> genomic sequence spans 2,7 kb and consists of 11 exons, ranging in size from 79 to 243 bp. The exonic sequence encodes a <span class="tagged-filter" title="Association Word">protein</span> of 495 amino acids that is nearly identical to the previously reported <span class="tagged-filter" title="Association Word">protein</span> sequence of human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT-1.</a></span> The two <span class="tagged-filter" title="Association Word">polymorphic</span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> isozymes are the results of a nucleotide substitution in codon 14, coding for a <span class="tagged-metabolite" title="HMDB: HMDB00177"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00177">histidine</a></span> in <a href="http://beta.uniprot.org/uniprot/P24298">GPT-1</a></span> and an <span class="tagged-metabolite" title="HMDB: HMDB00168"><span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00168">asparagine</a></span> in <a href="http://beta.uniprot.org/uniprot/Q8N9E2">GPT-2,</a></span> which <span class="tagged-filter" title="Association Word">causes</span> a gain or loss of an NlaIII restriction site. In addition, a cosmid containing the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> sequence also contains a previously unmapped, <span class="tagged-filter" title="Association Word">polymorphic</span> microsatellite sequence, D8S421. The cloned <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> and <span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">polymorphisms</span> will be useful for <span class="tagged-filter" title="Association Word">linkage</span> and physical mapping of disease loci that map to the terminus of 8q, including atypical <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD1)</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0079298">epidermolysis bullosa simplex,</span> type Ogna <span class="tagged-gene" title="SwissProt ID: Q15149; Entrez Gene ID: 5339; HGNC ID: 9069; HPRD ID: 03180; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15149">(EBS1).</a></span> In addition, this will be a useful system for characterizing the telomeric region of 8q. Finally, determination of the molecular basis of the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> isozyme variants will permit PCR-based detection of this world-wide <span class="tagged-filter" title="Association Word">polymorphism.</span>
Vitelliform_macular_dystrophy	glutamate-pyruvate-transaminase	True Positive	1.243	6823974	<strong class="title">Ferrell RE, Hittner HM, Antoszyk JH: <span class="tagged-filter" title="Association Word">Linkage</span> of atypical <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD-1)</a></span> to the soluble <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">glutamate pyruvate transaminase</a></span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">(GPT1)</a></span> <span class="tagged-filter" title="Association Word">locus.</span> Am J Hum Genet. 1983 Jan;35(1):78-84.</strong> One hundred twenty-eight blood samples were drawn from members of a single family with atypical <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD-1)</a></span> characterized by variable expressivity in affected members of at least 5 generations. Because of the late onset of detectable retinal lesions in most family members, phenotype data from only 93 individuals who were at least 14 years of age were analyzed for <span class="tagged-filter" title="Association Word">linkage.</span> Phenotype data from the remaining 35 members of the family who were under age 14 were excluded from the analysis. Maximum-likelihood analysis for <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">VMD-1</a></span> and 13 biochemical and serological <span class="tagged-filter" title="Association Word">markers</span> in the family demonstrated <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">VMD-1</a></span> and the soluble <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">glutamate pyruvate transaminase</a></span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">(GPT1)</a></span> <span class="tagged-filter" title="Association Word">locus,</span> which has been tentatively assigned to the short arm of chromosome 16. A maximum lod score of Z = 4.34 (odds favoring <span class="tagged-filter" title="Association Word">linkage</span> of approximately 22,000 to 1) was obtained at a recombination fraction of theta = .05.
Vitelliform_macular_dystrophy	glutamate-pyruvate-transaminase	False Negative	1.243	3165727	<strong class="title">Yoder FE, Cross HE, Chase GA, Fine SL, Freidhoff L, Machan CH, Bias WB: <span class="tagged-filter" title="Association Word">Linkage</span> studies of Best's <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy.</span> Clin Genet. 1988 Jul;34(1):26-30.</strong> Genetic <span class="tagged-filter" title="Association Word">linkage</span> studies are presented for nine kindreds with Best's <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> (BVMD). This condition is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> with reduced penetrance and highly variable expressivity. Asymptomatic carriers were identified with electro-oculography, fundus photographs and <span class="tagged-drug" title="DrugBank: APRD00979"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00979">fluorescein</a></span> angiography. Blood and saliva specimens were obtained from informative family members and genotyped for 26 <span class="tagged-filter" title="Association Word">polymorphic</span> genetic traits. No firm evidence was found for <span class="tagged-filter" title="Association Word">linkage</span> between BVMD and 18 informative <span class="tagged-filter" title="Association Word">markers;</span> the highest positive lod score was z = 0.57 for <a href="http://beta.uniprot.org/uniprot/P24298">GPT1</a></span> at a recombination fraction of theta = 0.30. An atypical form of <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD-1)</a></span> is <span class="tagged-filter" title="Association Word">linked</span> to <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT1</a></span> (theta less than 0.05) and is provisionally assigned to chromosome 16pter-<span class="tagged-gene" title="SwissProt ID: P21128; Entrez Gene ID: 8909; HPRD ID: 12110; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21128">p11.</a></span> Our data are not sufficient to rule out loose <span class="tagged-filter" title="Association Word">linkage</span> for <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT1</a></span> and BVMD. Thus we were not able to determine whether BVMD and <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">VMD-1</a></span> are allelic <span class="tagged-filter" title="Association Word">mutations</span> or separate <span class="tagged-disease" title="UMLS Concept ID: C0019247">genetic disorders.</span> Additional <span class="tagged-filter" title="Association Word">linkage</span> and <span class="tagged-filter" title="Association Word">gene</span> mapping studies of these loci and BVMD (as well as other atypical forms of <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy)</span> would be useful to further delineate these disorders.
Vitelliform_macular_dystrophy	VMD-1	False Negative	1.243	9119391	<strong class="title">Sohocki MM, Sullivan LS, Harrison WR, Sodergren EJ, Elder FF, Weinstock G, Tanase S, Daiger SP: Human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">glutamate pyruvate transaminase</a></span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">(GPT):</a></span> localization to 8q24.3, cDNA and genomic sequences, and <span class="tagged-filter" title="Association Word">polymorphic</span> sites. Genomics. 1997 Mar 1;40(2):247-52.</strong> Two frequent <span class="tagged-filter" title="Association Word">protein</span> variants of <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00243"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00243">pyruvate</a></span> transminase <a href="http://beta.uniprot.org/uniprot/P24298">(GPT)</a></span> (E.C.2.6.1.2) have been used as genetic <span class="tagged-filter" title="Association Word">markers</span> in humans for more than two decades, although chromosomal mapping of the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">locus</span> in the 1980s <span class="tagged-filter" title="Association Word">produced</span> conflicting results. To resolve this conflict and develop useful DNA <span class="tagged-filter" title="Association Word">markers</span> for this <span class="tagged-filter" title="Association Word">gene,</span> we isolated and characterized cDNA and genomic clones of <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT.</a></span> We have definitively mapped human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> to the terminus of 8q using several methods. First, two cosmids shown to contain the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> sequence were derived from a chromosome 8-specific library. Second, by fluorescence in situ hybridization, we mapped the cosmid containing the human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> to chromosome band 8q24.3. Third, we mapped the rat gpt cDNA to the syntenic region of rat chromosome 7. Finally, PCR primers specific to human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> amplify sequences contained within a "half-YAC" from the long arm of chromosome 8, that is, a YAC containing the 8q telomere. The human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> genomic sequence spans 2,7 kb and consists of 11 exons, ranging in size from 79 to 243 bp. The exonic sequence encodes a <span class="tagged-filter" title="Association Word">protein</span> of 495 amino acids that is nearly identical to the previously reported <span class="tagged-filter" title="Association Word">protein</span> sequence of human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT-1.</a></span> The two <span class="tagged-filter" title="Association Word">polymorphic</span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> isozymes are the results of a nucleotide substitution in codon 14, coding for a <span class="tagged-metabolite" title="HMDB: HMDB00177"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00177">histidine</a></span> in <a href="http://beta.uniprot.org/uniprot/P24298">GPT-1</a></span> and an <span class="tagged-metabolite" title="HMDB: HMDB00168"><span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00168">asparagine</a></span> in <a href="http://beta.uniprot.org/uniprot/Q8N9E2">GPT-2,</a></span> which <span class="tagged-filter" title="Association Word">causes</span> a gain or loss of an NlaIII restriction site. In addition, a cosmid containing the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> sequence also contains a previously unmapped, <span class="tagged-filter" title="Association Word">polymorphic</span> microsatellite sequence, D8S421. The cloned <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> and <span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">polymorphisms</span> will be useful for <span class="tagged-filter" title="Association Word">linkage</span> and physical mapping of disease loci that map to the terminus of 8q, including atypical <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD1)</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0079298">epidermolysis bullosa simplex,</span> type Ogna <span class="tagged-gene" title="SwissProt ID: Q15149; Entrez Gene ID: 5339; HGNC ID: 9069; HPRD ID: 03180; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15149">(EBS1).</a></span> In addition, this will be a useful system for characterizing the telomeric region of 8q. Finally, determination of the molecular basis of the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> isozyme variants will permit PCR-based detection of this world-wide <span class="tagged-filter" title="Association Word">polymorphism.</span>
Vitelliform_macular_dystrophy	VMD-1	True Positive	1.243	6823974	<strong class="title">Ferrell RE, Hittner HM, Antoszyk JH: <span class="tagged-filter" title="Association Word">Linkage</span> of atypical <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD-1)</a></span> to the soluble <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">glutamate pyruvate transaminase</a></span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">(GPT1)</a></span> <span class="tagged-filter" title="Association Word">locus.</span> Am J Hum Genet. 1983 Jan;35(1):78-84.</strong> One hundred twenty-eight blood samples were drawn from members of a single family with atypical <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD-1)</a></span> characterized by variable expressivity in affected members of at least 5 generations. Because of the late onset of detectable retinal lesions in most family members, phenotype data from only 93 individuals who were at least 14 years of age were analyzed for <span class="tagged-filter" title="Association Word">linkage.</span> Phenotype data from the remaining 35 members of the family who were under age 14 were excluded from the analysis. Maximum-likelihood analysis for <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">VMD-1</a></span> and 13 biochemical and serological <span class="tagged-filter" title="Association Word">markers</span> in the family demonstrated <span class="tagged-filter" title="Association Word">linkage</span> between <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">VMD-1</a></span> and the soluble <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">glutamate pyruvate transaminase</a></span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">(GPT1)</a></span> <span class="tagged-filter" title="Association Word">locus,</span> which has been tentatively assigned to the short arm of chromosome 16. A maximum lod score of Z = 4.34 (odds favoring <span class="tagged-filter" title="Association Word">linkage</span> of approximately 22,000 to 1) was obtained at a recombination fraction of theta = .05.
Vitelliform_macular_dystrophy	VMD-1	True Positive	1.243	3165727	<strong class="title">Yoder FE, Cross HE, Chase GA, Fine SL, Freidhoff L, Machan CH, Bias WB: <span class="tagged-filter" title="Association Word">Linkage</span> studies of Best's <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy.</span> Clin Genet. 1988 Jul;34(1):26-30.</strong> Genetic <span class="tagged-filter" title="Association Word">linkage</span> studies are presented for nine kindreds with Best's <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> (BVMD). This condition is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> with reduced penetrance and highly variable expressivity. Asymptomatic carriers were identified with electro-oculography, fundus photographs and <span class="tagged-drug" title="DrugBank: APRD00979"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00979">fluorescein</a></span> angiography. Blood and saliva specimens were obtained from informative family members and genotyped for 26 <span class="tagged-filter" title="Association Word">polymorphic</span> genetic traits. No firm evidence was found for <span class="tagged-filter" title="Association Word">linkage</span> between BVMD and 18 informative <span class="tagged-filter" title="Association Word">markers;</span> the highest positive lod score was z = 0.57 for <a href="http://beta.uniprot.org/uniprot/P24298">GPT1</a></span> at a recombination fraction of theta = 0.30. An atypical form of <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD-1)</a></span> is <span class="tagged-filter" title="Association Word">linked</span> to <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT1</a></span> (theta less than 0.05) and is provisionally assigned to chromosome 16pter-<span class="tagged-gene" title="SwissProt ID: P21128; Entrez Gene ID: 8909; HPRD ID: 12110; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21128">p11.</a></span> Our data are not sufficient to rule out loose <span class="tagged-filter" title="Association Word">linkage</span> for <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT1</a></span> and BVMD. Thus we were not able to determine whether BVMD and <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">VMD-1</a></span> are allelic <span class="tagged-filter" title="Association Word">mutations</span> or separate <span class="tagged-disease" title="UMLS Concept ID: C0019247">genetic disorders.</span> Additional <span class="tagged-filter" title="Association Word">linkage</span> and <span class="tagged-filter" title="Association Word">gene</span> mapping studies of these loci and BVMD (as well as other atypical forms of <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy)</span> would be useful to further delineate these disorders.
Vitelliform_macular_dystrophy	tissue-inhibitor-of-matrix-metalloproteinase-3	True Negative	1.243	17491602	<strong class="title">Patel N, Adewoyin T, Chong NV: <span class="tagged-disease" title="UMLS Concept ID: C0242383">Age-related macular degeneration:</span> a perspective on genetic studies. Eye. 2007 May 11;.</strong> AimAge-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P08603; Entrez Gene ID: 3075; HGNC ID: 4883; HPRD ID: 00601; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD)</a></span> is a common <span class="tagged-disease" title="UMLS Concept ID: C0730362">macular disease</span> in the developed world and recent studies have shown that specific <span class="tagged-filter" title="Association Word">genes</span> may be <span class="tagged-filter" title="Association Word">associated</span> with it and may contribute to a higher risk of developing AMD.ObjectiveOur objective was to review systematically recent publications <span class="tagged-filter" title="Association Word">related</span> to the genetics of <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> and provide relevant information that would help both scientists and clinicians in advising patients.MethodA systematic search was performed on PubMed, Medline, and National Library of <span class="tagged-drug" title="DrugBank: APRD00485"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00485">Medicine</a></span> as well as ARVO abstracts using key words relevant to the genetic associations of AMD.ResultsThe most important genetic associations in <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> <span class="tagged-filter" title="Association Word">involved</span> the <a href="http://beta.uniprot.org/uniprot/P08603">complement factor H</a></span> <span class="tagged-gene" title="SwissProt ID: P08603; Entrez Gene ID: 3075; HGNC ID: 4883; HPRD ID: 00601; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08603">(CFH)</a></span> <span class="tagged-filter" title="Association Word">gene,</span> which showed that possession of the variant Y402H <span class="tagged-filter" title="Association Word">polymorphism</span> significantly increases the risk for <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P00751; Entrez Gene ID: 629; HGNC ID: 1037; HPRD ID: 00718; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> Protective <span class="tagged-filter" title="Association Word">genes</span> have also been identified such as those on either factor B (BFor <a href="http://beta.uniprot.org/uniprot/P00751">complement factor B</a></span> <span class="tagged-gene" title="SwissProt ID: P00751; Entrez Gene ID: 629; HGNC ID: 1037; HPRD ID: 00718; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00751">(CFB))</a></span> or <span class="tagged-gene" title="SwissProt ID: P06681; Entrez Gene ID: 717; HGNC ID: 1248; HPRD ID: 08939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06681">complement component 2</a></span> (C2) <span class="tagged-filter" title="Association Word">genes.</span> The <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inherited macular dystrophies such as <span class="tagged-metabolite" title="HMDB: HMDB00538"><span class="tagged-gene" title="SwissProt ID: Q6AI08; Entrez Gene ID: 63897; HPRD ID: 12399; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00538">ATP</a></span>-binding cassette, subfamily A <a href="http://beta.uniprot.org/uniprot/Q6AI08">(ABC1),</a></span> member 4 <span class="tagged-gene" title="SwissProt ID: P78363; Entrez Gene ID: 24; HGNC ID: 34; HPRD ID: 03408; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78363">(ABCA4),</a></span> <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(VMD2),</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of matrix metalloproteinase-3</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">(TIMP3),</a></span> and EFEMP1have yielded some important information but further confirmatory work has yet to establish a clear <span class="tagged-filter" title="Association Word">association</span> with AMD.ConclusionPatients with <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> possess specific genetic variants of the CFHgene, which put them at a higher risk of developing the disease. Other unaffected individuals may possess certain protective genetic variants, which could prevent them from developing <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> Further research will no doubt shed light on other such mechanisms and these will be useful in identifying possible direct targets for drugs or indirectly through modulation of the <span class="tagged-filter" title="Association Word">genes</span> responsible for disease presentation.Eye advance online publication, 11 May 2007; doi:10.1038/sj.eye.6702844.
Vitelliform_macular_dystrophy	tissue-inhibitor-of-matrix-metalloproteinase-3	True Negative	1.243	11556487	<strong class="title">Scullica L, Falsini B: <span class="tagged-filter" title="Association Word">Diagnosis</span> and classification of <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degenerations:</span> an approach based on retinal function testing. Doc Ophthalmol. 2001 May;102(3):237-50.</strong> The results from literature concerning some aspects of retinal function in <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degenerations</span> (MDs) were reviewed in order to evaluate whether (a) specific patterns of retinal dysfunction may be <span class="tagged-filter" title="Association Word">linked</span> to different clinical phenotypes, and (b) distinct functional profiles may help in orienting molecular <span class="tagged-filter" title="Association Word">diagnosis</span> of diseases. Examined clinical phenotypes included: <span class="tagged-disease" title="UMLS Concept ID: C0271093">Stargardt disease</span>/<span class="tagged-disease" title="UMLS Concept ID: C0271093">fundus flavimaculatus</span> (St/FF), <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related maculopathy</span> (ARM) and <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD),</a></span> pattern dystrophies (PD), Best <span class="tagged-query" title="Query">vitelliform dystrophy</span> (BVD), Sorsby's fundus dystrophy <a href="http://beta.uniprot.org/uniprot/P35625">(SFD),</a></span> <span class="tagged-filter" title="Association Word">autosomal</span> cone-rod dystrophies <span class="tagged-gene" title="SwissProt ID: O43186; Entrez Gene ID: 1406; HGNC ID: 2383; HPRD ID: 03748; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43186">(CRD).</a></span> The following functional tests were evaluated: (1) electroretinogram <span class="tagged-gene" title="SwissProt ID: P11308; Entrez Gene ID: 2078; HGNC ID: 3446; HPRD ID: 01298; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11308">(ERG)</a></span> (scotopic and photopic according to ISCEV standards, rod and cone photoresponses, rod and cone b-wave intensity-response function, focal ERGs); (2) dark adaptometry (pre-bleach sensitivity and post-bleach recovery kinetics); (3) fundus reflectometry (pigment density and regeneration kinetics). Specific patterns of retinal dysfunction were identified for St/FF, ARM/<span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> <a href="http://beta.uniprot.org/uniprot/P35625">SFD</a></span> and BVD, whereas partially overlapping profiles were found for PD and <span class="tagged-gene" title="SwissProt ID: O43186; Entrez Gene ID: 1406; HGNC ID: 2383; HPRD ID: 03748; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43186">CRD.</a></span> Specific functional patterns were <span class="tagged-filter" title="Association Word">associated</span> with different <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q16762; Entrez Gene ID: 7263; HGNC ID: 12388; HPRD ID: 01583; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16762">RDS</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations,</span> as well as with <span class="tagged-gene" title="SwissProt ID: O43186; Entrez Gene ID: 1406; HGNC ID: 2383; HPRD ID: 03748; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43186">CRX</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Combined analysis of different retinal function tests may help to identify different phenotypes of MD, and to orient molecular <span class="tagged-filter" title="Association Word">diagnosis</span> for selected genotypes.
Vitelliform_macular_dystrophy	tissue-inhibitor-of-matrix-metalloproteinase-3	True Negative	1.243	9643018	<strong class="title">Felbor U, Weber BH: [Sorsby's fundus dystrophy. Ophthalmologe. 1998 May;95(5):287-90.</strong> A genetically homogeneous disease] . BACKGROUND: The recent identification of the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of metalloproteinases-3</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">(TIMP3)</a></span> as the <span class="tagged-filter" title="Association Word">gene</span> underlying <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">SFD</a></span> pathology has made it possible to address the question of genetic heterogeneity in this disorder. In addition, it now has become feasible to clarify whether <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">SFD</a></span> is directly <span class="tagged-filter" title="Association Word">involved</span> in other maculopathies and, in particular, may represent a genetic model for <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration.</span> PATIENTS: Genetic analysis were performed in five unrelated and 18 <span class="tagged-filter" title="Association Word">related</span> British <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">SFD</a></span> pedigrees as well as in 143 patients affected with <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration,</span> 28 patients with adult <span class="tagged-query" title="Query">vitelliform macular dystrophy,</span> 21 patients with <span class="tagged-disease" title="UMLS Concept ID: C1536451">central areolar choroidal dystrophy</span> and 25 individuals with other forms of macular dystrophies. RESULTS: Molecular genetic analyses confirmed the <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> mode of inheritance in <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">SFD.</a></span> In all five unrelated <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">SFD</a></span> pedigrees individual <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">mutations</span> were identified introducing an additional <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">cysteine</a></span> residue into the C-terminal region of the mature <span class="tagged-filter" title="Association Word">protein.</span> Affected individuals from 18 <a href="http://beta.uniprot.org/uniprot/P35625">SFD</a></span> families residing in Great Britain, Canada, Oregon and South Africa were found to carry a common ancestral Ser181Cys <span class="tagged-filter" title="Association Word">mutation.</span> The clinical variability of this Ser181Cys <span class="tagged-filter" title="Association Word">mutation</span> was reevaluated. A mutational screen in 217 patients with various maculopathies revealed no disease-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">gene.</span> CONCLUSION: So far, <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">mutations</span> have exclusively been <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">SFD.</a></span> Therefore, this disorder appears to be genetically homogeneous with complete penetrance but variable expressivity.
Vitelliform_macular_dystrophy	tissue-inhibitor-of-matrix-metalloproteinase-3	True Negative	1.243	9152224	<strong class="title">Felbor U, Doepner D, Schneider U, Zrenner E, Weber BH: Evaluation of the <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of metalloproteinases-3</a></span> in various maculopathies. Invest Ophthalmol Vis Sci. 1997 May;38(6):1054-9.</strong> PURPOSE: <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of metalloproteinases-3</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">(TIMP3)</a></span> have been shown previously to <span class="tagged-filter" title="Association Word">cause</span> Sorsby's fundus dystrophy, an <span class="tagged-filter" title="Association Word">autosomal</span>-<span class="tagged-filter" title="Association Word">dominant</span> disorder characterized by extracellular matrix irregularities in Bruch's membrane. To assess the involvement of <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> in a variety of other macular dystrophies, the authors have screened this <span class="tagged-filter" title="Association Word">gene</span> for disease-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD),</a></span> adult <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <a href="http://beta.uniprot.org/uniprot/P23942">(AVMD),</a></span> <span class="tagged-disease" title="UMLS Concept ID: C1536451">central areolar choroidal dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">(CACD),</a></span> syndrome-<span class="tagged-filter" title="Association Word">associated</span> macular dystrophies, <span class="tagged-disease" title="UMLS Concept ID: C0730290">cone-rod dystrophy,</span> and a group with unspecified <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration.</span> METHODS: Single-stranded conformational analysis of the entire coding region was performed using the polymerase chain reaction and oligonucleotide primers flanking the five exons of the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">gene</span> as well as the putative promotor region and a highly conserved fragment of the 3'-untranslated region. The authors analyzed a total of 217 patients, including 143 patients with <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> 28 patients with <a href="http://beta.uniprot.org/uniprot/P23942">AVMD,</a></span> 21 patients with <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">CACD,</a></span> and 25 patients with other forms of <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy.</span> RESULTS: In the 217 patients analyzed, the authors have identified one sequence alteration (a G-to-C base change) in the 5'-untranslated region in a patient with <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> However, the functional consequences of this <span class="tagged-filter" title="Association Word">mutation</span> are not clear. No other disease-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> were found. The authors have characterized a frequent intragenic <span class="tagged-filter" title="Association Word">polymorphism</span> in exon 3 of the <a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">gene</span> (heterozygosity = 0.57) that will be useful for genetic <span class="tagged-filter" title="Association Word">linkage</span> or allele sharing analyses or both. CONCLUSIONS: The authors' results suggest that <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> is not a major factor in the <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> <a href="http://beta.uniprot.org/uniprot/P23942">AVMD,</a></span> and <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">CACD.</a></span> Thus far, Sorsby's fundus dystrophy appears to be the only phenotype known to be <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3.</a></span>
Vitelliform_macular_dystrophy	EBS1	True Negative	1.243	9119391	<strong class="title">Sohocki MM, Sullivan LS, Harrison WR, Sodergren EJ, Elder FF, Weinstock G, Tanase S, Daiger SP: Human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">glutamate pyruvate transaminase</a></span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">(GPT):</a></span> localization to 8q24.3, cDNA and genomic sequences, and <span class="tagged-filter" title="Association Word">polymorphic</span> sites. Genomics. 1997 Mar 1;40(2):247-52.</strong> Two frequent <span class="tagged-filter" title="Association Word">protein</span> variants of <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00243"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00243">pyruvate</a></span> transminase <a href="http://beta.uniprot.org/uniprot/P24298">(GPT)</a></span> (E.C.2.6.1.2) have been used as genetic <span class="tagged-filter" title="Association Word">markers</span> in humans for more than two decades, although chromosomal mapping of the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">locus</span> in the 1980s <span class="tagged-filter" title="Association Word">produced</span> conflicting results. To resolve this conflict and develop useful DNA <span class="tagged-filter" title="Association Word">markers</span> for this <span class="tagged-filter" title="Association Word">gene,</span> we isolated and characterized cDNA and genomic clones of <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT.</a></span> We have definitively mapped human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> to the terminus of 8q using several methods. First, two cosmids shown to contain the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> sequence were derived from a chromosome 8-specific library. Second, by fluorescence in situ hybridization, we mapped the cosmid containing the human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> to chromosome band 8q24.3. Third, we mapped the rat gpt cDNA to the syntenic region of rat chromosome 7. Finally, PCR primers specific to human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> amplify sequences contained within a "half-YAC" from the long arm of chromosome 8, that is, a YAC containing the 8q telomere. The human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> genomic sequence spans 2,7 kb and consists of 11 exons, ranging in size from 79 to 243 bp. The exonic sequence encodes a <span class="tagged-filter" title="Association Word">protein</span> of 495 amino acids that is nearly identical to the previously reported <span class="tagged-filter" title="Association Word">protein</span> sequence of human <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT-1.</a></span> The two <span class="tagged-filter" title="Association Word">polymorphic</span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> isozymes are the results of a nucleotide substitution in codon 14, coding for a <span class="tagged-metabolite" title="HMDB: HMDB00177"><span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00177">histidine</a></span> in <a href="http://beta.uniprot.org/uniprot/P24298">GPT-1</a></span> and an <span class="tagged-metabolite" title="HMDB: HMDB00168"><span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00168">asparagine</a></span> in <a href="http://beta.uniprot.org/uniprot/Q8N9E2">GPT-2,</a></span> which <span class="tagged-filter" title="Association Word">causes</span> a gain or loss of an NlaIII restriction site. In addition, a cosmid containing the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> sequence also contains a previously unmapped, <span class="tagged-filter" title="Association Word">polymorphic</span> microsatellite sequence, D8S421. The cloned <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> and <span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">polymorphisms</span> will be useful for <span class="tagged-filter" title="Association Word">linkage</span> and physical mapping of disease loci that map to the terminus of 8q, including atypical <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 7438; HGNC ID: 12702; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7438">(VMD1)</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0079298">epidermolysis bullosa simplex,</span> type Ogna <span class="tagged-gene" title="SwissProt ID: Q15149; Entrez Gene ID: 5339; HGNC ID: 9069; HPRD ID: 03180; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15149">(EBS1).</a></span> In addition, this will be a useful system for characterizing the telomeric region of 8q. Finally, determination of the molecular basis of the <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">GPT</a></span> isozyme variants will permit PCR-based detection of this world-wide <span class="tagged-filter" title="Association Word">polymorphism.</span>
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	17477921	<strong class="title">Bakall B, Radu RA, Stanton JB, Burke JM, McKay BS, Wadelius C, Mullins RF, Stone EM, Travis GH, Marmorstein AD: Enhanced accumulation of A2E in individuals homozygous or heterozygous for <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">BEST1</a></span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(VMD2).</a></span> Exp Eye Res. 2007 Jul;85(1):34-43. Epub 2007 Mar 19.</strong> Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">(BMD)</a></span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> inherited macular <span class="tagged-disease" title="UMLS Concept ID: C1285162">degenerative disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">BEST1</a></span> (formerly <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2).</a></span> Prior reports indicate that <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> is characterized histopathologically by accumulation of lipofuscin in the retinal pigment epithelium <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">(RPE).</a></span> However, this accumulation has not been quantified and the chemical composition of lipofuscin in <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> has not been examined. In this study we characterize the histopathology of a donor eye from a rare individual homozygous for a <span class="tagged-filter" title="Association Word">mutation</span> (W93C) in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">BEST1.</a></span> We find that this individual's disease was not any more severe than has been described for heterozygotes. We then used this tissue to quantify <span class="tagged-disease" title="UMLS Concept ID: C0333638">lipofuscin accumulation</span> by enriching intracellular granules from <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">RPE</a></span> cells on <span class="tagged-metabolite" title="HMDB: HMDB00258"><span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00258">sucrose</a></span> gradients and counting the granules in each density fraction. Granules from the homozygous donor eye as well as a donor eye from an individual heterozygous for the <span class="tagged-filter" title="Association Word">mutation</span> T6R were compared with age-matched control eyes. Interestingly, the least dense fraction, representing classical lipofuscin granules was either not present or significantly diminished in the <a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> donor eyes and the autoflourescence <span class="tagged-filter" title="Association Word">associated</span> with lipofuscin had shifted to denser fractions. However, a substantial enrichment for granules in fractions of higher density was also noted in the <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> samples. Inspection of granules from the homozygous donor eye by electron microscopy revealed a complex abnormal multilobular structure. Analysis of granules by HPLC indicated a approximately 1.6- and approximately fourfold overall increase in A2E in the <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> eyes versus age-matched control eyes, with a shift of A2E to more dense granules in the <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> donor eyes. Despite the increase in A2E and total intracellular granules, the <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">RPE</a></span> in the homozygous donor eyes was relatively well preserved. Based on these data we conclude that the clinical and histopathologic consequences to the homozygous donor were not any more severe than has been reported previously for individuals who are established or presumptive heterozygotes. We find that A2E is a component of the lipofuscin accumulated in <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> and that it is more abundant than in control eyes suggesting that the etiology of <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> is similar to <span class="tagged-disease" title="UMLS Concept ID: C0271093">Stargardt's disease</span> and Stargardt-like <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy.</span> Finally, the changes we <span class="tagged-filter" title="Association Word">observe</span> in the granules suggest that the histopathology and eventual <span class="tagged-disease" title="UMLS Concept ID: C0456909">vision loss</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> may be due to defects in the ability of the <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">RPE</a></span> to fully degrade phagocytosed photoreceptor outer segments.
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	17287362	<strong class="title">Marchant D, Yu K, Bigot K, Roche O, Germain A, Bonneau D, Drouin-Garraud V, Schorderet DF, Munier F, Schmidt D, Le Neindre P, Marsac C, Menasche M, Dufier JL, Fischmeister R, Hartzell C, Abitbol M: New <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations</span> identified in patients affected by Best <span class="tagged-query" title="Query">vitelliform macular dystrophy.</span> J Med Genet. 2007 Mar;44(3):e70. Epub 2007 Feb 7.</strong> PURPOSE: The <span class="tagged-filter" title="Association Word">mutations</span> responsible for Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> (BVMD) are found in a <span class="tagged-filter" title="Association Word">gene</span> called <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2.</a></span> The <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">gene</span> encodes a transmembrane <span class="tagged-filter" title="Association Word">protein</span> named <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> (hBest1) which is a Ca (2+)-sensitive <span class="tagged-gene" title="Protein Family or Complex">chloride channel.</span> This study was performed to identify disease-specific <span class="tagged-filter" title="Association Word">mutations</span> in 27 patients with BVMD. Because this disease is characterised by an alteration in Cl (-) channel function, patch clamp analysis was used to test the hypothesis that one of the <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">mutated</span> variants <span class="tagged-filter" title="Association Word">causes</span> the disease. METHODS: Direct sequencing analysis of the 11 <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> exons was performed to detect new abnormal sequences. The mutant of hBest1 was <span class="tagged-filter" title="Association Word">expressed</span> in <span class="tagged-gene" title="SwissProt ID: P29320; Entrez Gene ID: 2042; HGNC ID: 3387; HPRD ID: 01555; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29320">HEK</a></span>-293 cells and the <span class="tagged-filter" title="Association Word">associated</span> Cl (-) current was examined using whole-cell patch clamp analysis. RESULTS: Six new <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> were identified, located exclusively in exons four, six and eight. One of these <span class="tagged-filter" title="Association Word">mutations</span> (Q293H) was particularly severe. Patch clamp analysis of human embryonic kidney cells expressing the Q293H mutant showed that this mutant channel is non-functional. Furthermore, the Q293H mutant inhibited the function of wild-type <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> channels in a <span class="tagged-filter" title="Association Word">dominant</span> negative manner. CONCLUSIONS: This study provides further support for the idea that <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> are a necessary factor for <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease.</span> However, because variable expressivity of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> was <span class="tagged-filter" title="Association Word">observed</span> in a family with the Q293H <span class="tagged-filter" title="Association Word">mutation,</span> it is also clear that a disease-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> is not sufficient to <span class="tagged-filter" title="Association Word">produce</span> BVMD. The finding that the Q293H mutant does not form functional channels in the membrane could be explained either by disruption of channel conductance or gating mechanisms or by improper trafficking of the <span class="tagged-filter" title="Association Word">protein</span> to the plasma membrane.
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	17110374	<strong class="title">Milenkovic VM, Rivera A, Horling F, Weber BH: Insertion and topology of normal and mutant <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> in the endoplasmic reticulum membrane. J Biol Chem. 2007 Jan 12;282(2):1313-21. Epub 2006 Nov 15.</strong> The <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> type 2 <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(VMD2)</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutated</span> in Best <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> encodes a 585-amino acid putative transmembrane <span class="tagged-filter" title="Association Word">protein</span> termed <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1.</a></span> The vast majority of known disease-<span class="tagged-filter" title="Association Word">associated</span> alterations are of the missense type, which cluster near predicted transmembrane domains (TMDs). To investigate <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> membrane topology and to assess consequences of point <span class="tagged-filter" title="Association Word">mutations</span> on membrane integration, we have analyzed the insertion of putative TMDs into the endoplasmic reticulum (ER) membrane. Out of six potential TMDs, our data suggest a topological model of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> with four transmembrane-spanning segments and one large cytoplasmatic loop between putative TMD2 and TMD5. Consequently, a relatively hydrophobic segment containing putative TMD3 (aa 130-149) and TMD4 (aa 179-201) is located within the cytoplasm. Furthermore, we show that three out of 18 disease-<span class="tagged-filter" title="Association Word">associated</span> alterations investigated (I73N, Y85H, F281del) reveal measurable effects on membrane insertion suggesting that defective membrane integration of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> may represent a potential disease mechanism for a small subset of Best <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">mutations.</span>
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	17065513	<strong class="title">Yu K, Cui Y, Hartzell HC: The <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> <span class="tagged-filter" title="Association Word">mutation</span> A243V, <span class="tagged-filter" title="Association Word">linked</span> to adult-onset <span class="tagged-query" title="Query">vitelliform macular dystrophy,</span> impairs its <span class="tagged-gene" title="Protein Family or Complex">chloride channel</span> function. Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4956-61.</strong> PURPOSE: It has been proposed that Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> (BVMD) is <span class="tagged-filter" title="Association Word">caused</span> by dysfunction in the Cl (-) channel function of human <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> (hBest1), but some patients with BVMD who have the hBest1 A243V <span class="tagged-filter" title="Association Word">mutation</span> have normal electro-oculograms, suggesting that this <span class="tagged-filter" title="Association Word">mutation</span> may not affect Cl (-) channel function. The purpose of this study was to determine whether the A243V <span class="tagged-filter" title="Association Word">mutation</span> affects the Cl (-) channel function of hBest1. METHODS: Wild-type <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P29320; Entrez Gene ID: 2042; HGNC ID: 3387; HPRD ID: 01555; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> at position 243 was changed to <span class="tagged-metabolite" title="HMDB: HMDB00883"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00883">valine</a></span> by PCR-based mutagenesis. Wild-type (WT) and A243V hBest1 were transfected into <a href="http://beta.uniprot.org/uniprot/P29320">HEK</a></span>-293 cells, and Cl (-) currents were measured with the whole-cell patch-clamp technique. The trafficking of <span class="tagged-filter" title="Association Word">proteins</span> to the plasma membrane was tested by cell-surface biotinylation. RESULTS: WT hBest1 induced Ca (2+)-activated Cl (-) currents in <span class="tagged-gene" title="SwissProt ID: P29320; Entrez Gene ID: 2042; HGNC ID: 3387; HPRD ID: 01555; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29320">HEK</a></span> cells that were > 1 nA in amplitude. The currents <span class="tagged-filter" title="Association Word">produced</span> by the A243V mutant, however, were only approximately 10% as large as WT. This was not due to the inability of the A243V mutant to reach the plasma membrane, as shown by cell-surface biotinylation. The A243V <span class="tagged-filter" title="Association Word">mutation</span> changed channel anion selectivity. The WT current exhibited a relative permeability P (X)/P (Cl) order of <span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > or = I (-) > or = NO (3)(-) > Br (-) > Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-) and a relative conductance G (X)/G (Cl) order of NO (3)(-) > <a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > I (-) > or = Br (-) > or = Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-). However, the A243V current exhibited different sequences: P (X)/P (Cl) was <a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > NO (3)(-) > I (-) > Br (-) > Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-) and G (X)/G (Cl) was <a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > NO (3)(-) > or = I (-) > or = Br (-) > Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-). Unlike several other hBest1 <span class="tagged-filter" title="Association Word">mutations</span> that have <span class="tagged-filter" title="Association Word">dominant</span>-negative effects on wild-type channels, the A243V-<span class="tagged-filter" title="Association Word">mutation</span> did not influence the wild-type current when A243V and WT hBest1 were transfected together. CONCLUSIONS: The disease-<span class="tagged-filter" title="Association Word">causing</span> A243V <span class="tagged-filter" title="Association Word">mutation</span> is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">altered</span> hBest1 Cl (-) channel <span class="tagged-filter" title="Association Word">activity.</span> The <span class="tagged-filter" title="Association Word">absence</span> of a <span class="tagged-filter" title="Association Word">dominant</span> negative effect of A243V is consistent with the more mild symptoms <span class="tagged-filter" title="Association Word">associated</span> with this <span class="tagged-filter" title="Association Word">mutation.</span> These results are interpreted in terms of the hypotheses that bestrophins are Cl (-) channels and regulators of Ca signaling.
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	16865191	<strong class="title">Li Y, Wang G, Dong B, Sun X, Turner MJ, Kamaya S, Zhang K: A novel <span class="tagged-filter" title="Association Word">mutation</span> of the <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">gene</span> in a Chinese family with best <span class="tagged-query" title="Query">vitelliform macular dystrophy.</span> Ann Acad Med Singapore. 2006 Jun;35(6):408-10.</strong> INTRODUCTION: In this paper, we report a novel <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> in a Chinese family with Best <span class="tagged-query" title="Query">vitelliform macular dystrophy.</span> MATERIALS AND METHODS: Ophthalmologic examination and optical coherence tomography <span class="tagged-gene" title="SwissProt ID: O75051; Entrez Gene ID: 5362; HGNC ID: 9100; HPRD ID: 03033; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O75051">(OCT)</a></span> were performed in 2 members of this family. Mutational screening was performed by single-strand conformation <span class="tagged-filter" title="Association Word">polymorphism</span> (SSCP) and direct sequencing of PCR-amplified DNA fragments, corresponding to the 11 exons of the <span class="tagged-filter" title="Association Word">gene.</span> RESULTS: Sequence analysis identified a previously unreported C to G change, predicting a <span class="tagged-metabolite" title="HMDB: HMDB00159"><span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00159">Phe</a></span>-113-<span class="tagged-metabolite" title="HMDB: HMDB00687"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00687">Leu</a></span> substitution. Both the proband and his sister harboured this novel <span class="tagged-filter" title="Association Word">mutation.</span> Each had bilateral vitelliform lesions. CONCLUSIONS: A novel <span class="tagged-filter" title="Association Word">mutation</span> in the <a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">gene</span> (C427G) was found in Chinese patients with Best <span class="tagged-query" title="Query">vitelliform macular dystrophy.</span>
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	16754206	<strong class="title">Schatz P, Klar J, Andreasson S, Ponjavic V, Dahl N: Variant phenotype of Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-filter" title="Association Word">associated</span> with compound heterozygous <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2.</a></span> Ophthalmic Genet. 2006 Jun;27(2):51-6.</strong> PURPOSE: To characterize the phenotype of members of a Swedish family with Best <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> and two distinct <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2.</a></span> METHODS: Venous blood samples were obtained from six family members and screened for <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2.</a></span> Six individuals were examined clinically, four of whom were further investigated with full-field electroretinography <span class="tagged-gene" title="SwissProt ID: P11308; Entrez Gene ID: 2078; HGNC ID: 3446; HPRD ID: 01298; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11308">(ERG),</a></span> electro-oculography (EOG), multifocal electroretinography (mfERG), and optical coherence tomography <span class="tagged-gene" title="SwissProt ID: O75051; Entrez Gene ID: 5362; HGNC ID: 9100; HPRD ID: 03033; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O75051">(OCT).</a></span> RESULTS: The <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> resulting in Arg141His and Tyr29stop were identified in family members. Two individuals harbored both <span class="tagged-filter" title="Association Word">mutations,</span> one <span class="tagged-filter" title="Association Word">mutation</span> in each <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> allele. These two family members had an abnormal EOG and their full-field <span class="tagged-gene" title="SwissProt ID: P11308; Entrez Gene ID: 2078; HGNC ID: 3446; HPRD ID: 01298; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11308">ERG</a></span> demonstrated widespread degeneration with a prolonged implicit time in the cone 30-Hz flicker <span class="tagged-gene" title="SwissProt ID: P11308; Entrez Gene ID: 2078; HGNC ID: 3446; HPRD ID: 01298; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11308">ERG.</a></span> MfERG verified reduction of the central retinal function and <span class="tagged-gene" title="SwissProt ID: O75051; Entrez Gene ID: 5362; HGNC ID: 9100; HPRD ID: 03033; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O75051">OCT</a></span> demonstrated intraretinal fluid, swelling, and thickening of the outer retina-<span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">RPE</a></span>-choroid complex (ORCC). CONCLUSION: A previously undescribed severe form of Best <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> is <span class="tagged-filter" title="Association Word">associated</span> with compound heterozygous <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2.</a></span>
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	16678528	<strong class="title">Maruko I, Iida T, Spaide RF, Kishi S: Indocyanine green angiography abnormality of the periphery in <span class="tagged-query" title="Query">vitelliform macular dystrophy.</span> Am J Ophthalmol. 2006 May;141(5):976-8.</strong> PURPOSE: To report the peripheral abnormalities seen only with indocyanine green angiography in patients with <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">(Best disease,</span> <span class="tagged-filter" title="Association Word">caused</span> by a <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> <span class="tagged-filter" title="Association Word">gene).</span> DESIGN: Observational case report series. METHODS: Eight eyes of four patients, two with only a central macular lesion and two with multifocal lesions, were studied. Results of indocyanine green angiography were compared with findings from ophthalmoscopy and <span class="tagged-drug" title="DrugBank: APRD00979"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00979">fluorescein</a></span> angiography. RESULTS: Throughout the fundus periphery, indocyanine green angiography demonstrated a number of hyperfluorescent spots in all eight eyes. The spots were <span class="tagged-filter" title="Association Word">observed</span> in the midperiphery and the periphery in areas with no abnormality visible by ophthalmoscopy or <span class="tagged-drug" title="DrugBank: APRD00979"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00979">fluorescein</a></span> angiography. CONCLUSIONS: Although <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease</span> generally <span class="tagged-filter" title="Association Word">causes</span> lesions visible in the posterior pole, the extensive distribution of the hyperfluorescent spots is consistent with the wide-ranging abnormalities of the retinal pigment epithelium, Bruch membrane, and the choroid as seen histopathologically.
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	16636205	<strong class="title">Marmorstein LY, Wu J, McLaughlin P, Yocom J, Karl MO, Neussert R, Wimmers S, Stanton JB, Gregg RG, Strauss O, Peachey NS, Marmorstein AD: The light peak of the electroretinogram is dependent on voltage-gated <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> channels and antagonized by <a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(best-1).</a></span> J Gen Physiol. 2006 May;127(5):577-89.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2,</a></span> encoding <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(best-1),</a></span> <span class="tagged-filter" title="Association Word">cause</span> Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">(BMD),</a></span> adult-onset <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">(AVMD),</a></span> and <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> vitreoretinochoroidopathy (ADVIRC). <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> is distinguished from <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">AVMD</a></span> by a diminished electrooculogram light peak (LP) in the <span class="tagged-filter" title="Association Word">absence</span> of changes in the flash electroretinogram. Although the LP is thought to be generated by <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1,</a></span> we find enhanced LP luminance responsiveness with normal amplitude in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Vmd2</a></span>-/- mice and no differences in cellular Cl- currents in comparison to <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Vmd2+</a></span>/+ littermates. The putative Ca2+ sensitivity of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1,</a></span> and our recent observation that <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> <span class="tagged-filter" title="Association Word">alters</span> the kinetics of voltage-dependent Ca2+ channels (VDCC), <span class="tagged-filter" title="Association Word">led</span> us to examine the role of VDCCs in the LP. <span class="tagged-drug" title="DrugBank: APRD00612"><span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00612">Nimodipine</a></span> diminished the LP, <span class="tagged-filter" title="Association Word">leading</span> us to survey VDCC beta-subunit mutant mice. Lethargic mice, which harbor a loss of function <span class="tagged-filter" title="Association Word">mutation</span> in the beta4 subunit of VDCCs, exhibited a significant shift in LP luminance response, establishing a <span class="tagged-filter" title="Association Word">role</span> for Ca2+ in LP generation. When stimulated with <span class="tagged-metabolite" title="HMDB: HMDB00538"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00538">ATP,</a></span> which increases [Ca++] I, retinal pigment epithelial cells derived from <a href="http://beta.uniprot.org/uniprot/O76090">Vmd2</a></span>-/- mice exhibited a fivefold greater response than <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Vmd2+</a></span>/+ littermates, indicating that <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> can suppress the rise in [Ca2+] I <span class="tagged-filter" title="Association Word">associated</span> with the LP. We conclude that VDCCs regulated by a beta4 subunit are required to generate the LP and that <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> antagonizes the LP luminance response potentially via its ability to modulate VDCC function. Furthermore, we suggest that the <span class="tagged-disease" title="UMLS Concept ID: C0456909">loss of vision</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> is not <span class="tagged-filter" title="Association Word">caused</span> by the same <span class="tagged-disease" title="UMLS Concept ID: C0030660">pathologic process</span> as the diminished LP, but rather is <span class="tagged-filter" title="Association Word">caused</span> by as yet unidentified effects of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> on other cellular processes.
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	16282372	<strong class="title">Rosenthal R, Bakall B, Kinnick T, Peachey N, Wimmers S, Wadelius C, Marmorstein A, Strauss O: <span class="tagged-filter" title="Association Word">Expression</span> of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1,</a></span> the product of the <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">gene,</span> modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells. FASEB J. 2006 Jan;20(1):178-80. Epub 2005 Nov 10.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">Best's disease,</span> an inherited form of <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration.</span> The reduction in the light-peak amplitude in the patient's electro-oculogram suggests that <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> influences the membrane conductance of the retinal pigment epithelium <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">(RPE).</a></span> Systemic application of the L-type Ca2+ channel blocker <span class="tagged-drug" title="DrugBank: APRD00612"><span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00612">nimodipine</a></span> reduced the light-peak amplitude in the rat electroretinogram but not a- and b-waves. <span class="tagged-filter" title="Association Word">Expression</span> of <a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> in a <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">RPE</a></span> cell line <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">(RPE</a></span>-J) <span class="tagged-filter" title="Association Word">led</span> to changes in L-type channel properties. Wild-type <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> induced an acceleration of activation kinetics of Ba2+ currents through L-type Ca2+ channels and a shift of the voltage-dependent activation to more negative values, closer to the resting potential of <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">RPE</a></span> cells. <span class="tagged-filter" title="Association Word">Expression</span> of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> with <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease</span>-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> <span class="tagged-filter" title="Association Word">led</span> to comparable shifts in voltage-dependent activation but different effects on activation and inactivation kinetics. <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Bestrophin</a></span> W93C exhibited slowed activation and inactivation, and <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> R218C accelerated the activation and inactivation. Thus, transfection of <span class="tagged-gene" title="SwissProt ID: Q53TV9; Entrez Gene ID: 6120; HGNC ID: 10293; HPRD ID: 01608; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q53TV9">RPE</a></span> cells with <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> distinctively changed L-type Ca2+ channel kinetics and voltage-dependence. On the basis of these data, we propose that presence of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> influences kinetics and voltage-dependence of voltage-dependent Ca2+ channels and that these effects might open new ways to understand the mechanisms <span class="tagged-filter" title="Association Word">leading</span> to <span class="tagged-disease" title="UMLS Concept ID: C1537080">retinal degeneration</span> in <span class="tagged-query" title="Query">Best's disease.</span>
Vitelliform_macular_dystrophy	VMD2	True Positive	11.322	16154901	<strong class="title">Hagen AR, Barabote RD, Saier MH: The <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> family of anion channels: identification of prokaryotic homologues. Mol Membr Biol. 2005 Jul-Aug;22(4):291-302.</strong> The human disease <span class="tagged-filter" title="Association Word">protein,</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Bestrophin-1,</a></span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">vitelliform macular dystrophy,</span> has recently been shown to be an integral membrane anion channel-forming <span class="tagged-filter" title="Association Word">protein.</span> In this study we have recovered all <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> homologues from the NCBI database and analyzed their sequences using bioinformatic approaches. Eukaryotic homologues were found in animals and fungi but not in plants or protozoans, and prokaryotic homologues distantly <span class="tagged-filter" title="Association Word">related</span> to the eukaryotic <span class="tagged-filter" title="Association Word">proteins,</span> were identified in certain Gram-negative bacterial kingdoms but not in Gram-positive bacteria or archaea. Our analyses suggest a uniform 4 <span class="tagged-gene" title="SwissProt ID: P04818; Entrez Gene ID: 7298; HGNC ID: 12441; HPRD ID: 01774; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04818">TMS</a></span> topology for most of these homologues with regions of conservation overlapping and preceding the odd numbered TMSs and overlapping and following the even numbered TMSs. Well-conserved motifs were identified in both the eukaryotic and the prokaryotic homologues, and these proved to overlap, suggesting common structural and functional properties. Phylogenetic analyses revealed that the eukaryotic <span class="tagged-filter" title="Association Word">proteins</span> cluster according to organismal type, and that the prokaryotic <span class="tagged-filter" title="Association Word">proteins</span> sometimes (but not always) do so. This suggests that eukaryotic paralogues arose exclusively by recent <span class="tagged-filter" title="Association Word">gene</span> duplication events although both early and late <span class="tagged-filter" title="Association Word">gene</span> duplication events occurred in prokaryotes.
Vitelliform_macular_dystrophy	peripherin	True Positive	2.114	16636205	<strong class="title">Marmorstein LY, Wu J, McLaughlin P, Yocom J, Karl MO, Neussert R, Wimmers S, Stanton JB, Gregg RG, Strauss O, Peachey NS, Marmorstein AD: The light peak of the electroretinogram is dependent on voltage-gated <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> channels and antagonized by <a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(best-1).</a></span> J Gen Physiol. 2006 May;127(5):577-89.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2,</a></span> encoding <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(best-1),</a></span> <span class="tagged-filter" title="Association Word">cause</span> Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">(BMD),</a></span> adult-onset <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">(AVMD),</a></span> and <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> vitreoretinochoroidopathy (ADVIRC). <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> is distinguished from <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">AVMD</a></span> by a diminished electrooculogram light peak (LP) in the <span class="tagged-filter" title="Association Word">absence</span> of changes in the flash electroretinogram. Although the LP is thought to be generated by <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1,</a></span> we find enhanced LP luminance responsiveness with normal amplitude in <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Vmd2</a></span>-/- mice and no differences in cellular Cl- currents in comparison to <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Vmd2+</a></span>/+ littermates. The putative Ca2+ sensitivity of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1,</a></span> and our recent observation that <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> <span class="tagged-filter" title="Association Word">alters</span> the kinetics of voltage-dependent Ca2+ channels (VDCC), <span class="tagged-filter" title="Association Word">led</span> us to examine the role of VDCCs in the LP. <span class="tagged-drug" title="DrugBank: APRD00612"><span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00612">Nimodipine</a></span> diminished the LP, <span class="tagged-filter" title="Association Word">leading</span> us to survey VDCC beta-subunit mutant mice. Lethargic mice, which harbor a loss of function <span class="tagged-filter" title="Association Word">mutation</span> in the beta4 subunit of VDCCs, exhibited a significant shift in LP luminance response, establishing a <span class="tagged-filter" title="Association Word">role</span> for Ca2+ in LP generation. When stimulated with <span class="tagged-metabolite" title="HMDB: HMDB00538"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00538">ATP,</a></span> which increases [Ca++] I, retinal pigment epithelial cells derived from <a href="http://beta.uniprot.org/uniprot/O76090">Vmd2</a></span>-/- mice exhibited a fivefold greater response than <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">Vmd2+</a></span>/+ littermates, indicating that <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> can suppress the rise in [Ca2+] I <span class="tagged-filter" title="Association Word">associated</span> with the LP. We conclude that VDCCs regulated by a beta4 subunit are required to generate the LP and that <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> antagonizes the LP luminance response potentially via its ability to modulate VDCC function. Furthermore, we suggest that the <span class="tagged-disease" title="UMLS Concept ID: C0456909">loss of vision</span> <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: P11532; Entrez Gene ID: 1756; HGNC ID: 2928; HPRD ID: 02303; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11532">BMD</a></span> is not <span class="tagged-filter" title="Association Word">caused</span> by the same <span class="tagged-disease" title="UMLS Concept ID: C0030660">pathologic process</span> as the diminished LP, but rather is <span class="tagged-filter" title="Association Word">caused</span> by as yet unidentified effects of <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">best-1</a></span> on other cellular processes.
Vitelliform_macular_dystrophy	peripherin	True Positive	2.114	10737974	<strong class="title">White K, Marquardt A, Weber BH: <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">(Best disease)</span> and other maculopathies. Hum Mutat. 2000;15(4):301-8.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> are <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">(Best disease).</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> is <span class="tagged-filter" title="Association Word">expressed</span> in the retinal pigment epithelium and codes for a 585 amino acid putative transmembrane <span class="tagged-filter" title="Association Word">protein</span> with undetermined functional properties. To date, 48 different <span class="tagged-filter" title="Association Word">mutations,</span> predominantly missense, have been described in <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease</span> families. These <span class="tagged-filter" title="Association Word">mutations</span> generally affect amino acids in the first 50% of the <span class="tagged-filter" title="Association Word">protein,</span> and occur in four distinct clusters possibly representing regions of functional importance. <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> has also been investigated in other macular diseases. <span class="tagged-filter" title="Association Word">Mutations</span> have been documented in a significant percentage of patients with adult <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">(AVMD)</a></span> and in a single case of "bull's-eye" <span class="tagged-disease" title="UMLS Concept ID: C0730362">maculopathy.</span> Results of analysis in two large series of individuals with <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD)</a></span> suggest that <a href="http://beta.uniprot.org/uniprot/O76090">VMD2</a></span> does not play a major <span class="tagged-filter" title="Association Word">role</span> in this prevalent disorder.
Vitelliform_macular_dystrophy	peripherin	True Positive	2.114	10562654	<strong class="title">Zack DJ, Dean M, Molday RS, Nathans J, Redmond TM, Stone EM, Swaroop A, Valle D, Weber BH: What can we learn about <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration</span> from other <span class="tagged-disease" title="UMLS Concept ID: C0035309">retinal diseases?.</span> Mol Vis. 1999 Nov 3;5:30.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0242383">Age-related macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD)</a></span> is increasingly recognized as a complex <span class="tagged-disease" title="UMLS Concept ID: C0019247">genetic disorder</span> in which one or more <span class="tagged-filter" title="Association Word">genes</span> contribute to an individual's susceptibility for developing the condition. Twin and family studies as well as population-based genetic epidemiologic methods have convincingly demonstrated the importance of genetics in <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> though the extent of heritability, the number of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved,</span> and the phenotypic and genetic heterogeneity of the condition remain unresolved. The extent to which other hereditary macular dystrophies such as <span class="tagged-disease" title="UMLS Concept ID: C0271093">Stargardts disease,</span> familial radial drusen (malattia leventinese), <span class="tagged-query" title="Query">Best's disease,</span> and <a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q16762; Entrez Gene ID: 7263; HGNC ID: 12388; HPRD ID: 01583; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16762">RDS</a></span>-<span class="tagged-filter" title="Association Word">related</span> dystrophy are <span class="tagged-filter" title="Association Word">related</span> to <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> remains unclear. <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease,</span> another late onset, heterogeneous <span class="tagged-disease" title="UMLS Concept ID: C1285162">degenerative disorder</span> of the central nervous system, offers a valuable model for identifying the issues that confront <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> genetics.
Vitelliform_macular_dystrophy	peripherin	True Positive	2.114	10562653	<strong class="title">Gorin MB, Breitner JC, De Jong PT, Hageman GS, Klaver CC, Kuehn MH, Seddon JM: The genetics of <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration.</span> Mol Vis. 1999 Nov 3;5:29.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0242383">Age-related macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD)</a></span> is increasingly recognized as a complex <span class="tagged-disease" title="UMLS Concept ID: C0019247">genetic disorder</span> in which one or more <span class="tagged-filter" title="Association Word">genes</span> contribute to an individual's susceptibility for developing the condition. Twin and family studies as well as population-based genetic epidemiologic methods have convincingly demonstrated the importance of genetics in <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> though the extent of heritability, the number of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved,</span> and the phenotypic and genetic heterogeneity of the condition remain unresolved. The extent to which other hereditary macular dystrophies such as <span class="tagged-disease" title="UMLS Concept ID: C0271093">Stargardts disease,</span> familial radial drusen (malattia leventinese), <span class="tagged-query" title="Query">Best's disease,</span> and <a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q16762; Entrez Gene ID: 7263; HGNC ID: 12388; HPRD ID: 01583; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16762">RDS</a></span>-<span class="tagged-filter" title="Association Word">related</span> dystrophy are <span class="tagged-filter" title="Association Word">related</span> to <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> remains unclear. <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease,</span> another late onset, heterogeneous <span class="tagged-disease" title="UMLS Concept ID: C1285162">degenerative disorder</span> of the central nervous system, offers a valuable model for identifying the issues that confront <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> genetics.
Vitelliform_macular_dystrophy	peripherin	True Positive	2.114	9338584	<strong class="title">Felbor U, Schilling H, Weber BH: Adult <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> is frequently <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q16762; Entrez Gene ID: 7263; HGNC ID: 12388; HPRD ID: 01583; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16762">RDS</a></span> <span class="tagged-filter" title="Association Word">gene.</span> Hum Mutat. 1997;10(4):301-9.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q16762; Entrez Gene ID: 7263; HGNC ID: 12388; HPRD ID: 01583; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16762">RDS</a></span> <span class="tagged-filter" title="Association Word">gene,</span> which encodes a photoreceptor-specific membrane glycoprotein, have been identified in a variety of retinal phenotypes. However, the mechanisms by which specific <span class="tagged-filter" title="Association Word">mutations</span> in this <span class="tagged-filter" title="Association Word">gene</span> can <span class="tagged-filter" title="Association Word">cause</span> typical features of retinal dystrophies clinically as distinct as <span class="tagged-disease" title="UMLS Concept ID: C0035334">retinitis pigmentosa</span> or <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration</span> are still unknown. Recently, a single case of adult <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">(AVMD)</a></span> has been <span class="tagged-filter" title="Association Word">associated</span> with a Y258Stop <span class="tagged-filter" title="Association Word">mutation.</span> To assess the frequency of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q16762; Entrez Gene ID: 7263; HGNC ID: 12388; HPRD ID: 01583; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16762">RDS</a></span> <span class="tagged-filter" title="Association Word">mutations</span> in the clinically heterogeneous group of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">AVMD,</a></span> we analyzed the entire coding region of the <span class="tagged-filter" title="Association Word">gene</span> in 28 unrelated patients. We identified five novel <span class="tagged-filter" title="Association Word">mutations</span> including two presumed null allele <span class="tagged-filter" title="Association Word">mutations.</span> Thus, our results demonstrate that a significant portion of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">AVMD</a></span> patients (18%) carry point <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q16762; Entrez Gene ID: 7263; HGNC ID: 12388; HPRD ID: 01583; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16762">RDS,</a></span> suggesting that this <span class="tagged-filter" title="Association Word">gene</span> is frequently <span class="tagged-filter" title="Association Word">involved</span> in the pathogenesis of this <span class="tagged-disease" title="UMLS Concept ID: C0730362">macular disorder.</span> In addition, this study shows that the variable phenotypes in <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">AVMD</a></span> are due, at least in part, to genetic heterogeneity and are likely to be <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in disease <span class="tagged-filter" title="Association Word">genes</span> thus far unknown.
Vitelliform_macular_dystrophy	peripherin	True Positive	2.114	9152224	<strong class="title">Felbor U, Doepner D, Schneider U, Zrenner E, Weber BH: Evaluation of the <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of metalloproteinases-3</a></span> in various maculopathies. Invest Ophthalmol Vis Sci. 1997 May;38(6):1054-9.</strong> PURPOSE: <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of metalloproteinases-3</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">(TIMP3)</a></span> have been shown previously to <span class="tagged-filter" title="Association Word">cause</span> Sorsby's fundus dystrophy, an <span class="tagged-filter" title="Association Word">autosomal</span>-<span class="tagged-filter" title="Association Word">dominant</span> disorder characterized by extracellular matrix irregularities in Bruch's membrane. To assess the involvement of <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> in a variety of other macular dystrophies, the authors have screened this <span class="tagged-filter" title="Association Word">gene</span> for disease-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD),</a></span> adult <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <a href="http://beta.uniprot.org/uniprot/P23942">(AVMD),</a></span> <span class="tagged-disease" title="UMLS Concept ID: C1536451">central areolar choroidal dystrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">(CACD),</a></span> syndrome-<span class="tagged-filter" title="Association Word">associated</span> macular dystrophies, <span class="tagged-disease" title="UMLS Concept ID: C0730290">cone-rod dystrophy,</span> and a group with unspecified <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration.</span> METHODS: Single-stranded conformational analysis of the entire coding region was performed using the polymerase chain reaction and oligonucleotide primers flanking the five exons of the <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">gene</span> as well as the putative promotor region and a highly conserved fragment of the 3'-untranslated region. The authors analyzed a total of 217 patients, including 143 patients with <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> 28 patients with <a href="http://beta.uniprot.org/uniprot/P23942">AVMD,</a></span> 21 patients with <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">CACD,</a></span> and 25 patients with other forms of <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy.</span> RESULTS: In the 217 patients analyzed, the authors have identified one sequence alteration (a G-to-C base change) in the 5'-untranslated region in a patient with <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> However, the functional consequences of this <span class="tagged-filter" title="Association Word">mutation</span> are not clear. No other disease-<span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-filter" title="Association Word">mutations</span> were found. The authors have characterized a frequent intragenic <span class="tagged-filter" title="Association Word">polymorphism</span> in exon 3 of the <a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> <span class="tagged-filter" title="Association Word">gene</span> (heterozygosity = 0.57) that will be useful for genetic <span class="tagged-filter" title="Association Word">linkage</span> or allele sharing analyses or both. CONCLUSIONS: The authors' results suggest that <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3</a></span> is not a major factor in the <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD,</a></span> <a href="http://beta.uniprot.org/uniprot/P23942">AVMD,</a></span> and <span class="tagged-gene" title="Entrez Gene ID: 772; HGNC ID: 1387; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=772">CACD.</a></span> Thus far, Sorsby's fundus dystrophy appears to be the only phenotype known to be <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">TIMP3.</a></span>
Vitelliform_macular_dystrophy	chloride-channel	True Negative	1.243	17065513	<strong class="title">Yu K, Cui Y, Hartzell HC: The <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin</a></span> <span class="tagged-filter" title="Association Word">mutation</span> A243V, <span class="tagged-filter" title="Association Word">linked</span> to adult-onset <span class="tagged-query" title="Query">vitelliform macular dystrophy,</span> impairs its <span class="tagged-gene" title="Protein Family or Complex">chloride channel</span> function. Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4956-61.</strong> PURPOSE: It has been proposed that Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> (BVMD) is <span class="tagged-filter" title="Association Word">caused</span> by dysfunction in the Cl (-) channel function of human <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">bestrophin-1</a></span> (hBest1), but some patients with BVMD who have the hBest1 A243V <span class="tagged-filter" title="Association Word">mutation</span> have normal electro-oculograms, suggesting that this <span class="tagged-filter" title="Association Word">mutation</span> may not affect Cl (-) channel function. The purpose of this study was to determine whether the A243V <span class="tagged-filter" title="Association Word">mutation</span> affects the Cl (-) channel function of hBest1. METHODS: Wild-type <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P29320; Entrez Gene ID: 2042; HGNC ID: 3387; HPRD ID: 01555; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> at position 243 was changed to <span class="tagged-metabolite" title="HMDB: HMDB00883"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00883">valine</a></span> by PCR-based mutagenesis. Wild-type (WT) and A243V hBest1 were transfected into <a href="http://beta.uniprot.org/uniprot/P29320">HEK</a></span>-293 cells, and Cl (-) currents were measured with the whole-cell patch-clamp technique. The trafficking of <span class="tagged-filter" title="Association Word">proteins</span> to the plasma membrane was tested by cell-surface biotinylation. RESULTS: WT hBest1 induced Ca (2+)-activated Cl (-) currents in <span class="tagged-gene" title="SwissProt ID: P29320; Entrez Gene ID: 2042; HGNC ID: 3387; HPRD ID: 01555; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29320">HEK</a></span> cells that were > 1 nA in amplitude. The currents <span class="tagged-filter" title="Association Word">produced</span> by the A243V mutant, however, were only approximately 10% as large as WT. This was not due to the inability of the A243V mutant to reach the plasma membrane, as shown by cell-surface biotinylation. The A243V <span class="tagged-filter" title="Association Word">mutation</span> changed channel anion selectivity. The WT current exhibited a relative permeability P (X)/P (Cl) order of <span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > or = I (-) > or = NO (3)(-) > Br (-) > Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-) and a relative conductance G (X)/G (Cl) order of NO (3)(-) > <a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > I (-) > or = Br (-) > or = Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-). However, the A243V current exhibited different sequences: P (X)/P (Cl) was <a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > NO (3)(-) > I (-) > Br (-) > Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><span class="tagged-gene" title="SwissProt ID: P30626; Entrez Gene ID: 6717; HGNC ID: 11292; HPRD ID: 01680; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-) and G (X)/G (Cl) was <a href="http://beta.uniprot.org/uniprot/P30626">SCN</a></span> (-) > NO (3)(-) > or = I (-) > or = Br (-) > Cl (-) > <span class="tagged-metabolite" title="HMDB: HMDB01993"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01993">HCO</a></span> (3)(-). Unlike several other hBest1 <span class="tagged-filter" title="Association Word">mutations</span> that have <span class="tagged-filter" title="Association Word">dominant</span>-negative effects on wild-type channels, the A243V-<span class="tagged-filter" title="Association Word">mutation</span> did not influence the wild-type current when A243V and WT hBest1 were transfected together. CONCLUSIONS: The disease-<span class="tagged-filter" title="Association Word">causing</span> A243V <span class="tagged-filter" title="Association Word">mutation</span> is <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">altered</span> hBest1 Cl (-) channel <span class="tagged-filter" title="Association Word">activity.</span> The <span class="tagged-filter" title="Association Word">absence</span> of a <span class="tagged-filter" title="Association Word">dominant</span> negative effect of A243V is consistent with the more mild symptoms <span class="tagged-filter" title="Association Word">associated</span> with this <span class="tagged-filter" title="Association Word">mutation.</span> These results are interpreted in terms of the hypotheses that bestrophins are Cl (-) channels and regulators of Ca signaling.
Vitelliform_macular_dystrophy	ABCA4	True Negative	1.243	17491602	<strong class="title">Patel N, Adewoyin T, Chong NV: <span class="tagged-disease" title="UMLS Concept ID: C0242383">Age-related macular degeneration:</span> a perspective on genetic studies. Eye. 2007 May 11;.</strong> AimAge-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration</span> <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P08603; Entrez Gene ID: 3075; HGNC ID: 4883; HPRD ID: 00601; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">(AMD)</a></span> is a common <span class="tagged-disease" title="UMLS Concept ID: C0730362">macular disease</span> in the developed world and recent studies have shown that specific <span class="tagged-filter" title="Association Word">genes</span> may be <span class="tagged-filter" title="Association Word">associated</span> with it and may contribute to a higher risk of developing AMD.ObjectiveOur objective was to review systematically recent publications <span class="tagged-filter" title="Association Word">related</span> to the genetics of <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> and provide relevant information that would help both scientists and clinicians in advising patients.MethodA systematic search was performed on PubMed, Medline, and National Library of <span class="tagged-drug" title="DrugBank: APRD00485"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00485">Medicine</a></span> as well as ARVO abstracts using key words relevant to the genetic associations of AMD.ResultsThe most important genetic associations in <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> <span class="tagged-filter" title="Association Word">involved</span> the <a href="http://beta.uniprot.org/uniprot/P08603">complement factor H</a></span> <span class="tagged-gene" title="SwissProt ID: P08603; Entrez Gene ID: 3075; HGNC ID: 4883; HPRD ID: 00601; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08603">(CFH)</a></span> <span class="tagged-filter" title="Association Word">gene,</span> which showed that possession of the variant Y402H <span class="tagged-filter" title="Association Word">polymorphism</span> significantly increases the risk for <span class="tagged-drug" title="DrugBank: APRD01106"><span class="tagged-gene" title="SwissProt ID: P00751; Entrez Gene ID: 629; HGNC ID: 1037; HPRD ID: 00718; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> Protective <span class="tagged-filter" title="Association Word">genes</span> have also been identified such as those on either factor B (BFor <a href="http://beta.uniprot.org/uniprot/P00751">complement factor B</a></span> <span class="tagged-gene" title="SwissProt ID: P00751; Entrez Gene ID: 629; HGNC ID: 1037; HPRD ID: 00718; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00751">(CFB))</a></span> or <span class="tagged-gene" title="SwissProt ID: P06681; Entrez Gene ID: 717; HGNC ID: 1248; HPRD ID: 08939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06681">complement component 2</a></span> (C2) <span class="tagged-filter" title="Association Word">genes.</span> The <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in inherited macular dystrophies such as <span class="tagged-metabolite" title="HMDB: HMDB00538"><span class="tagged-gene" title="SwissProt ID: Q6AI08; Entrez Gene ID: 63897; HPRD ID: 12399; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00538">ATP</a></span>-binding cassette, subfamily A <a href="http://beta.uniprot.org/uniprot/Q6AI08">(ABC1),</a></span> member 4 <span class="tagged-gene" title="SwissProt ID: P78363; Entrez Gene ID: 24; HGNC ID: 34; HPRD ID: 03408; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P78363">(ABCA4),</a></span> <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> <span class="tagged-gene" title="SwissProt ID: O76090; Entrez Gene ID: 7439; HGNC ID: 12703; HPRD ID: 01094; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O76090">(VMD2),</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">tissue inhibitor of matrix metalloproteinase-3</a></span> <span class="tagged-gene" title="SwissProt ID: P35625; Entrez Gene ID: 7078; HGNC ID: 11822; HPRD ID: 01785; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35625">(TIMP3),</a></span> and EFEMP1have yielded some important information but further confirmatory work has yet to establish a clear <span class="tagged-filter" title="Association Word">association</span> with AMD.ConclusionPatients with <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD</a></span> possess specific genetic variants of the CFHgene, which put them at a higher risk of developing the disease. Other unaffected individuals may possess certain protective genetic variants, which could prevent them from developing <span class="tagged-drug" title="DrugBank: APRD01106"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01106">AMD.</a></span> Further research will no doubt shed light on other such mechanisms and these will be useful in identifying possible direct targets for drugs or indirectly through modulation of the <span class="tagged-filter" title="Association Word">genes</span> responsible for disease presentation.Eye advance online publication, 11 May 2007; doi:10.1038/sj.eye.6702844.
Vitelliform_macular_dystrophy	ROM1	True Negative	1.243	8279475	<strong class="title">Nichols BE, Bascom R, Litt M, McInnes R, Sheffield VC, Stone EM: Refining the <span class="tagged-filter" title="Association Word">locus</span> for Best <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> and <span class="tagged-filter" title="Association Word">mutation</span> analysis of the candidate <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1.</a></span> Am J Hum Genet. 1994 Jan;54(1):95-103.</strong> <span class="tagged-query" title="Query">Vitelliform macular dystrophy</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">(Best disease)</span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-disease" title="UMLS Concept ID: C0730292">macular dystrophy</span> which shares important clinical features with <span class="tagged-disease" title="UMLS Concept ID: C0242383">age-related macular degeneration,</span> the most common <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-disease" title="UMLS Concept ID: C0271215">legal blindness</span> in the elderly. Unfortunately, our understanding and treatment for this common age-<span class="tagged-filter" title="Association Word">related</span> disorder is limited. Discovery of the <span class="tagged-filter" title="Association Word">gene</span> which <span class="tagged-filter" title="Association Word">causes</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease</span> has the potential to increase our understanding of the pathogenesis of all types of <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration,</span> including the common age-<span class="tagged-filter" title="Association Word">related</span> form. <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease</span> has recently been mapped to chromosome 11q13. The photoreceptor-specific <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> has also been recently mapped to this location, and the <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> <span class="tagged-filter" title="Association Word">gene</span> is a candidate <span class="tagged-filter" title="Association Word">gene</span> for <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease.</span> Using highly <span class="tagged-filter" title="Association Word">polymorphic</span> <span class="tagged-filter" title="Association Word">markers,</span> we have narrowed the genetic region which contains the <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease</span> <span class="tagged-filter" title="Association Word">gene</span> to the 10-cM region between <span class="tagged-filter" title="Association Word">markers</span> D11S871 and <span class="tagged-gene" title="SwissProt ID: P11217; Entrez Gene ID: 5837; HGNC ID: 9726; HPRD ID: 01986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11217">PYGM.</a></span> <span class="tagged-filter" title="Association Word">Marker</span> D11S956 demonstrated no recombinants with <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease</span> in three large families and resulted in a lod score of 18.2. In addition, a <span class="tagged-filter" title="Association Word">polymorphism</span> within the <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> <span class="tagged-filter" title="Association Word">gene</span> also demonstrated no recombinants and resulted in a lod score of 10.0 in these same three families. We used a combination of SSCP analysis, denaturing gradient gel electrophoresis, and DNA sequencing to screen the entire coding region of the <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> <span class="tagged-filter" title="Association Word">gene</span> in 11 different unrelated patients affected with <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease.</span> No nucleotide changes were found in the coding sequence of any affected patient, indicating that <span class="tagged-filter" title="Association Word">mutations</span> within the coding sequence are unlikely to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Best disease.</span>
Vitelliform_macular_dystrophy	ROM1	True Negative	1.243	7860071	<strong class="title">Stohr H, Weber BH: A recombination event excludes the <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> <span class="tagged-filter" title="Association Word">locus</span> from the Best's <span class="tagged-query" title="Query">vitelliform macular dystrophy</span> region. Hum Genet. 1995 Feb;95(2):219-22.</strong> Best's vitelliform <span class="tagged-disease" title="UMLS Concept ID: C0024437">macular degeneration</span> has been genetically <span class="tagged-filter" title="Association Word">linked</span> to chromosome 11. Subsequently, the disease <span class="tagged-filter" title="Association Word">locus</span> has been refined to an interval between D11S903 and <span class="tagged-gene" title="SwissProt ID: P11217; Entrez Gene ID: 5837; HGNC ID: 9726; HPRD ID: 01986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11217">PYGM</a></span> and, more recently, between D11S986 and D11S480. The <span class="tagged-filter" title="Association Word">gene</span> encoding <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1,</a></span> a photoreceptor-specific membrane <span class="tagged-filter" title="Association Word">protein,</span> has been independently mapped within the <span class="tagged-query" title="Query">Best's disease</span> region and has thus become a strong candidate for the <span class="tagged-query" title="Query">Best's disease</span> <span class="tagged-filter" title="Association Word">gene.</span> In this study, we have mapped <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> relative to <span class="tagged-query" title="Query">Best's disease</span> and the loci D11S986, <span class="tagged-gene" title="SwissProt ID: P11684; Entrez Gene ID: 7356; HGNC ID: 12523; HPRD ID: 01884; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11684">UGB</a></span> <span class="tagged-gene" title="SwissProt ID: P11684; Entrez Gene ID: 7356; HGNC ID: 12523; HPRD ID: 01884; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11684">(uteroglobin),</a></span> and <span class="tagged-gene" title="SwissProt ID: P11217; Entrez Gene ID: 5837; HGNC ID: 9726; HPRD ID: 01986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11217">PYGM</a></span> (human <span class="tagged-gene" title="SwissProt ID: P11217; Entrez Gene ID: 5837; HGNC ID: 9726; HPRD ID: 01986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11217">muscle glycogen phosphorylase)</a></span> in recombinant <span class="tagged-query" title="Query">Best's disease</span> chromosomes. We demonstrate that <span class="tagged-gene" title="SwissProt ID: P11684; Entrez Gene ID: 7356; HGNC ID: 12523; HPRD ID: 01884; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11684">UGB</a></span> is localized proximal to <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> and that both <span class="tagged-gene" title="SwissProt ID: P11684; Entrez Gene ID: 7356; HGNC ID: 12523; HPRD ID: 01884; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11684">UGB</a></span> and <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> recombine with the disease phenotype. Thus, this analysis excluded <span class="tagged-gene" title="SwissProt ID: Q03395; Entrez Gene ID: 6094; HGNC ID: 10254; HPRD ID: 01616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q03395">ROM1</a></span> as the <span class="tagged-query" title="Query">Best's disease</span> <span class="tagged-filter" title="Association Word">gene.</span>
motor_neuron_disease	Apolipoprotein-E	True Positive	3.767	10833320	<strong class="title">Pickering-Brown SM, Owen F, Isaacs A, Snowden J, Varma A, Neary D, Furlong R, Daniel SE, Cairns NJ, Mann DM: <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">Apolipoprotein E</a></span> epsilon4 allele has no effect on age at onset or duration of disease in cases of <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> with pick- or microvacuolar-type histology. Exp Neurol. 2000 Jun;163(2):452-6.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0338451">Frontotemporal dementia</span> (FTD) is the second most common <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-disease" title="UMLS Concept ID: C0011265">presenile dementia.</span> Here we have investigated the frequency of the epsilon4 allele of the <span class="tagged-gene" title="SwissProt ID: Q16609; Entrez Gene ID: 80350; HGNC ID: 21210; HPRD ID: 17441; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16609">Apolipoprotein</a></span> <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">(APOE)</a></span> <span class="tagged-filter" title="Association Word">gene</span> in FTD and in other non-Alzheimer forms of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">related</span> to FTD such as <span class="tagged-query" title="Query">Motor Neurone disease</span> <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0338462">semantic dementia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0338457">progressive aphasia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration.</span> In none of these diagnostic groups did we find a significant increase in the <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">APOE</a></span> epsilon4 allelic frequency, compared to population values. Neither did we <span class="tagged-filter" title="Association Word">observe</span> any affects of the epsilon4 allele upon age at onset or duration of disease. We conclude therefore that <span class="tagged-filter" title="Association Word">polymorphic</span> variations in the <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">APOE</a></span> <span class="tagged-filter" title="Association Word">gene</span> do not modulate either the occurrence or progression of these non-Alzheimer forms of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span>
motor_neuron_disease	ciliary-neurotrophic-factor	True Positive	6.933	12645079	<strong class="title">Sakamoto T, Kawazoe Y, Shen JS, Takeda Y, Arakawa Y, Ogawa J, Oyanagi K, Ohashi T, Watanabe K, Inoue K, Eto Y, Watabe K: Adenoviral <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">TGF beta 2,</a></span> but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res. 2003 Apr 1;72(1):54-64.</strong> We examined neuroprotective effects of recombinant adenoviral vectors encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">ciliary neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">(CNTF),</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">(CT1),</a></span> <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor-1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1),</a></span> and transforming growth factor-beta2 (TGFbeta2) on lesioned adult rat facial motoneurons. The right facial nerves of adult Fischer 344 male rats were avulsed and removed from the stylomastoid foramen, and adenoviral vectors were injected into the facial canal. Animals avulsed and treated with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1,</a></span> <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> and TGFbeta2 showed intense immunolabeling for these factors in lesioned facial motoneurons, respectively, indicating adenoviral induction of the neurotrophic factors in these neurons. The treatment with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> or TGFbeta2 after avulsion significantly prevented the loss of lesioned facial motoneurons, improved <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity and prevented the induction of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <span class="tagged-filter" title="Association Word">activity</span> in these neurons. The treatment with adenovirus encoding <a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> however, failed to protect these neurons after avulsion. These results indicate that the <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and TGFbeta2 but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	ciliary-neurotrophic-factor	True Positive	6.933	11951178	<strong class="title">Giess R, Holtmann B, Braga M, Grimm T, Muller-Myhsok B, Toyka KV, Sendtner M: Early onset of severe familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> with a <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD-1</a></span> <span class="tagged-filter" title="Association Word">mutation:</span> potential impact of <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> as a candidate modifier <span class="tagged-filter" title="Association Word">gene.</span> Am J Hum Genet. 2002 May;70(5):1277-86. Epub 2002 Apr 9.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00657"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00657">copper</a></span>/zinc <a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD-1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> are found in approximately 20% of patients with familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS), or <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> 1. Here we describe a 25-year-old male patient who died from FALS after a rapid disease course of 11 mo. Sequencing of the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> revealed a heterozygous T--> G exchange at position 1513 within exon 5, coding for a V--> G substitution at position 148 of the mature <span class="tagged-filter" title="Association Word">protein.</span> Genetic analysis of this family revealed the same <span class="tagged-filter" title="Association Word">mutation</span> in both his healthy 35-year-old sister and his mother, who did not develop the disease before age 54 years. Screening for candidate modifier <span class="tagged-filter" title="Association Word">genes</span> that might be responsible for the early onset and severe course of the disease in the 25-year-old patient revealed an additional homozygous <span class="tagged-filter" title="Association Word">mutation</span> of the <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> <span class="tagged-filter" title="Association Word">gene</span> not found in his yet unaffected sister. hSOD-1G93A mice were crossbred with <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> (-/-) mice and were investigated with respect to disease onset and duration, to test the hypothesis that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> acts as a candidate modifier <span class="tagged-filter" title="Association Word">gene</span> in FALS with <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD-1</a></span> <span class="tagged-filter" title="Association Word">gene.</span> Such hSOD-1G93A/<span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice develop <span class="tagged-query" title="Query">motoneuron disease</span> at a significantly earlier stage than hSOD-1G93A/<span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span>-wild-type mice. <span class="tagged-filter" title="Association Word">Linkage</span> analysis revealed that the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> was solely responsible for the disease. However, disease onset as a quantitative trait was regulated by the allelic constitution at the <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> <span class="tagged-filter" title="Association Word">locus.</span> In addition, patients with sporadic <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> who had a homozygous <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> <span class="tagged-filter" title="Association Word">gene</span> defect showed significantly earlier disease onset but did not show a significant difference in disease duration. Thus, we conclude that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> acts as a modifier <span class="tagged-filter" title="Association Word">gene</span> that <span class="tagged-filter" title="Association Word">leads</span> to early onset of disease in patients with FALS who have <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD-1</a></span> <span class="tagged-filter" title="Association Word">mutations,</span> in patients with sporadic <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> and in the hSOD-1G93A mouse model.
motor_neuron_disease	ciliary-neurotrophic-factor	True Positive	6.933	11259650	<strong class="title">Lambert PD, Anderson KD, Sleeman MW, Wong V, Tan J, Hijarunguru A, Corcoran TL, Murray JD, Thabet KE, Yancopoulos GD, Wiegand SJ: <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">Ciliary neurotrophic factor</a></span> activates <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin</a></span>-like pathways and reduces body fat, without cachexia or rebound weight gain, even in <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin</a></span>-resistant obesity. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4652-7. Epub 2001 Mar 20.</strong> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">Ciliary Neurotrophic Factor</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">(CNTF)</a></span> was first characterized as a trophic factor for motor neurons in the ciliary ganglion and spinal cord, <span class="tagged-filter" title="Association Word">leading</span> to its evaluation in humans suffering from <span class="tagged-query" title="Query">motor neuron disease.</span> In these trials, <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> <span class="tagged-filter" title="Association Word">caused</span> unexpected and substantial weight loss, raising concerns that it might <span class="tagged-filter" title="Association Word">produce</span> cachectic-like effects. Countering this possibility was the suggestion that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> was working via a <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin</a></span>-like mechanism to <span class="tagged-filter" title="Association Word">cause</span> weight loss, based on the findings that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> acts via receptors that are not only <span class="tagged-filter" title="Association Word">related</span> to <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin</a></span> receptors, but also similarly distributed within hypothalamic nuclei <span class="tagged-filter" title="Association Word">involved</span> in feeding. However, although <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> mimics the ability of <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin</a></span> to <span class="tagged-filter" title="Association Word">cause</span> fat loss in mice that are obese because of genetic <span class="tagged-filter" title="Association Word">deficiency</span> of <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin</a></span> (ob/ob mice), <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> is also effective in diet-induced obesity models that are more representative of human obesity, and which are resistant to <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin.</a></span> This discordance again raised the possibility that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> might be acting via nonleptin pathways, perhaps more analogous to those activated by cachectic cytokines. Arguing strongly against this possibility, we now show that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> can activate hypothalamic <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin</a></span>-like pathways in diet-induced obesity models unresponsive to <span class="tagged-gene" title="SwissProt ID: P41159; Entrez Gene ID: 3952; HGNC ID: 6553; HPRD ID: 01249; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41159">leptin,</a></span> that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> improves prediabetic parameters in these models, and that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> acts very differently than the prototypical cachectic <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine,</a></span> <span class="tagged-gene" title="SwissProt ID: P01584; Entrez Gene ID: 3553; HGNC ID: 5992; HPRD ID: 00985; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01584">IL-1.</a></span> Further analyses of hypothalamic signaling reveals that <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> can suppress food intake without triggering hunger signals or <span class="tagged-filter" title="Association Word">associated</span> stress responses that are otherwise <span class="tagged-filter" title="Association Word">associated</span> with food deprivation; thus, unlike forced dieting, cessation of <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF</a></span> treatment does not result in <span class="tagged-disease" title="UMLS Concept ID: C0424419">binge overeating</span> and immediate rebound weight gain.
motor_neuron_disease	SCA3	True Negative	1.441	15122458	<strong class="title">Teive HA, Arruda WO: [The Drew family of Walworth: one century from the first evaluation until the final <span class="tagged-filter" title="Association Word">diagnosis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0024408">Machado-Joseph disease].</span> Arq Neuropsiquiatr. 2004 Mar;62(1):177-80. Epub 2004 Apr 28.</strong> <span class="tagged-filter" title="Association Word">Autosomal</span> dominant <span class="tagged-disease" title="UMLS Concept ID: C0087012">spinocerebellar ataxia</span> (SCA) is an heterogeneous group of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> <span class="tagged-filter" title="Association Word">involving</span> cerebellum and its connections. Several forms have already been described, and it seems the most common form of SCA <span class="tagged-filter" title="Association Word">observed</span> among the many series of families described worldwide is <span class="tagged-gene" title="SwissProt ID: P54252; Entrez Gene ID: 4287; HGNC ID: 7106; HPRD ID: 06131; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54252">SCA3</a></span> <span class="tagged-disease" title="UMLS Concept ID: C0024408">(Machado-Joseph disease).</span> <span class="tagged-gene" title="SwissProt ID: P54252; Entrez Gene ID: 4287; HGNC ID: 7106; HPRD ID: 06131; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54252">SCA3</a></span> is characterized by a marked phenotypic <span class="tagged-filter" title="Association Word">expression</span> with a wide spectrum of clinical findings including <span class="tagged-disease" title="UMLS Concept ID: Not Available">cerebellar ataxia,</span> pyramidal and extrapyramidal (e.g. <span class="tagged-disease" title="UMLS Concept ID: C0393593">dystonia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0242422">parkinsonism),</span> lower <span class="tagged-query" title="Query">motor neuron syndrome</span> and <span class="tagged-disease" title="UMLS Concept ID: C0031117">peripheral neuropathy.</span> The Drew family of Walworth, England, has several affected members seen and described by famous neurologists including Gowers, Stewart, Collier, Kinnier-Wilson, Turner, Worster-Drought, Ferguson, Critchley, and Anita Harding from 1895 to our days. In fact, the final genetic <span class="tagged-filter" title="Association Word">diagnosis</span> of this family, 100 years after its initial description, turned out to be <span class="tagged-gene" title="SwissProt ID: P54252; Entrez Gene ID: 4287; HGNC ID: 7106; HPRD ID: 06131; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54252">SCA3.</a></span> In this paper, we describe the full of twists and turns historical trajectory from the initial clinical description to the final genetic <span class="tagged-filter" title="Association Word">diagnosis.</span>
motor_neuron_disease	PGRN	True Positive	1.441	17436289	<strong class="title">Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, Laquerriere A, De Pooter T, Camuzat A, Van den Broeck M, Dubois B, Sellal F, Lacomblez L, Vercelletto M, Thomas-Anterion C, Michel BF, Golfier V, Didic M, Salachas F, Duyckaerts C, Cruts M, Verpillat P, Van Broeckhoven C, Brice A: <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">Progranulin</a></span> null <span class="tagged-filter" title="Association Word">mutations</span> in both sporadic and familial <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia.</span> Hum Mutat. 2007 Apr 13;.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0338451">Frontotemporal dementia</span> (FTD) is the second most frequent type of neurodegenerative <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias.</span> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">(GRN,</a></span> <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN)</a></span> were recently identified in FTDU-17, an FTD subtype characterized by <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-immunoreactive inclusions and <span class="tagged-filter" title="Association Word">linkage</span> to chromosome 17q21. We looked for <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">mutations</span> in a large series of 210 FTD patients (52 familial, 158 sporadic) to accurately evaluate the frequency of <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">mutations</span> in both sporadic and familial FTD, and FTD with <span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-query" title="Query">motoneuron disease</span> (FTD-MND), as well as to study the clinical phenotype of patients with a <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">mutation.</span> We identified nine novel <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> null <span class="tagged-filter" title="Association Word">mutations</span> in 10 index patients. The relative frequency of <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> null <span class="tagged-filter" title="Association Word">mutations</span> in FTD was 4.8% (10/210) and 12.8% (5/39) in pure familial forms. Interestingly, 5/158 (3.2%) apparently sporadic FTD patients carried a <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">mutation,</span> suggesting the possibility of de novo <span class="tagged-filter" title="Association Word">mutations</span> or incomplete penetrance. In contrast, none of the 43 patients with FTD-MND had <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">mutations,</span> supporting that FTDU-17 and FTD-MND are genetically distinct. The clinical phenotype of <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">mutation</span> carriers was particular because of the wide range in onset age and the frequent occurrence of early <span class="tagged-disease" title="UMLS Concept ID: C0003635">apraxia</span> (50%), visual <span class="tagged-disease" title="UMLS Concept ID: C0018524">hallucinations</span> (30%), and <span class="tagged-disease" title="UMLS Concept ID: C0242422">parkinsonism</span> (30%) during the course of the disease. This study supports that <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> null <span class="tagged-filter" title="Association Word">mutations</span> represent a more frequent <span class="tagged-filter" title="Association Word">cause</span> of FTD than <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> <span class="tagged-filter" title="Association Word">mutations</span> (4.8% vs. 2.9%) but are not responsible for FTD-MND. It also demonstrates that half of the patients with a <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">mutation</span> in our series had no apparent family history of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span> Taking this into account, genetic testing should be now considered more systematically, even in patients without obvious familial history of FTD. Hum Mutat 0, 1-10, 2007. (c) 2007 Wiley-Liss, Inc.
motor_neuron_disease	PGRN	False Negative	1.441	17360763	<strong class="title">Seelaar H, Schelhaas HJ, Azmani A, Kusters B, Rosso S, Majoor-Krakauer D, de Rijik MC, Rizzu P, ten Brummelhuis M, van Doorn PA, Kamphorst W, Willemsen R, van Swieten JC: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> pathology in familial <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> and <span class="tagged-query" title="Query">motor neuron disease</span> without <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">Progranulin</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Brain. 2007 May;130(Pt 5):1375-85. Epub 2007 Mar 14.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0338451">Frontotemporal dementia</span> is accompanied by <span class="tagged-query" title="Query">motor neuron disease</span> (FTD + MND) in approximately 10% of cases. There is accumulating evidence for a clinicopathological overlap between FTD and MND based on observations of familial aggregation and neuropathological findings of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive neuronal cytoplasmatic inclusions (NCI) in lower motor neurons, hippocampus and neocortex in both conditions. Several familial forms exist with different genetic loci and defects. We investigated the familial aggregation and clinical presentation of FTD + MND cases in a large cohort of 368 FTD patients in The Netherlands. Immunohistochemistry of available brain tissue of deceased patients was investigated using a panel of <span class="tagged-filter" title="Association Word">antibodies</span> including <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y6M1; Entrez Gene ID: 10644; HGNC ID: 28867; HPRD ID: 10507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6M1">p62</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TAR DNA-binding protein</a></span> of 43 kDa <span class="tagged-filter" title="Association Word">antibodies.</span> A total of eight patients coming from six families had a family history positive for FTD + MND (mean age at onset 53.2 +/- 8.4 years). Five patients presented with behavioural changes and cognitive changes followed by <span class="tagged-query" title="Query">motor neuron disease,</span> whereas symptoms of <span class="tagged-query" title="Query">motor neuron disease</span> were the presenting features in the remaining three patients. Other affected relatives in these families showed <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span>/FTD, MND or FTD + MND reflecting the clinical interfamilial variation. No <span class="tagged-filter" title="Association Word">mutations</span> were identified in any of the candidate <span class="tagged-filter" title="Association Word">genes,</span> including <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">Superoxide Dismutase 1,</a></span> <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin,</a></span> <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">Microtubule-Associated Protein Tau,</a></span> <span class="tagged-gene" title="SwissProt ID: P55072; Entrez Gene ID: 7415; HGNC ID: 12666; HPRD ID: 03013; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55072">valosin-containing protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin.</a></span> Available brain tissue of five patients with familial FTD + MND showed NCI in hippocampus, neocortex and spinal cord in all, and neuronal intranuclear inclusions (NII) in two brains. <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> <span class="tagged-filter" title="Association Word">antibody</span> showed robust staining of neuronal inclusions similar in distribution and morphology to NCI and NII. Additionally, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> <span class="tagged-filter" title="Association Word">antibody</span> also stained <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-negative glial inclusions in the basal striatum of one case. In conclusion, there exists considerable clinical variation within families with FTD + MND, which may be determined by other genetic or environmental factors. NII are also found in some cases of familial FTD + MND without <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">Progranulin</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> The observation of glial <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> positive inclusions in one brain is very interesting, although their pathophysiological significance is yet unknown.
motor_neuron_disease	PGRN	True Positive	1.441	16862116	<strong class="title">Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M: <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin</a></span> <span class="tagged-filter" title="Association Word">cause</span> tau-negative <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> <span class="tagged-filter" title="Association Word">linked</span> to chromosome 17. Nature. 2006 Aug 24;442(7105):916-9. Epub 2006 Jul 16.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0338451">Frontotemporal dementia</span> (FTD) is the second most common <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia,</span> consistent with a strong genetic component to the disease. In 1998, <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> encoding the <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">microtubule-associated protein tau</a></span> <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">(MAPT)</a></span> were shown to <span class="tagged-filter" title="Association Word">cause</span> familial FTD with <span class="tagged-disease" title="UMLS Concept ID: C0242422">parkinsonism</span> <span class="tagged-filter" title="Association Word">linked</span> to chromosome 17q21 <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">(FTDP-17).</a></span> The neuropathology of patients with defined <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> <span class="tagged-filter" title="Association Word">mutations</span> is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for <span class="tagged-filter" title="Association Word">linkage</span> to the same region on chromosome 17q21 (D17S1787-D17S806), <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin</a></span> <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">(PGRN)</a></span> that are likely to create null alleles. <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> is located 1.7 Mb centromeric of <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor <span class="tagged-filter" title="Association Word">involved</span> in the <span class="tagged-filter" title="Association Word">regulation</span> of multiple processes including development, wound repair and inflammation. <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> has also been strongly <span class="tagged-filter" title="Association Word">linked</span> to <span class="tagged-disease" title="UMLS Concept ID: C1326912">tumorigenesis.</span> Moreover, <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> <span class="tagged-filter" title="Association Word">expression</span> is increased in activated microglia in many <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> including <span class="tagged-disease" title="UMLS Concept ID: C0022336">Creutzfeldt-Jakob disease,</span> <span class="tagged-query" title="Query">motor neuron disease</span> and <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease.</span> Our results identify <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> as a <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disease</span> and indicate the importance of <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">PGRN</a></span> function for neuronal survival.
motor_neuron_disease	envelope-protein	True Positive	3.489	17453631	<strong class="title">Oluwole SO, Yao Y, Conradi S, Kristensson K, Karlsson H: <span class="tagged-filter" title="Association Word">Elevated</span> levels of transcripts encoding a human retroviral <span class="tagged-gene" title="SwissProt ID: Q9UQF0; Entrez Gene ID: 30816; HGNC ID: 13525; HPRD ID: 05231; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQF0">envelope protein</a></span> <span class="tagged-gene" title="SwissProt ID: Q9UQF0; Entrez Gene ID: 30816; HGNC ID: 13525; HPRD ID: 05231; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQF0">(syncytin)</a></span> in muscles from patients with <span class="tagged-query" title="Query">motor neuron disease.</span> Amyotroph Lateral Scler. 2007 Apr;8(2):67-72.</strong> Retroviral components of both exogenous and endogenous origins have been <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0027765">nervous system diseases</span> in both animals and humans. In the present study, the levels of transcripts from elements in the human endogenous retrovirus <span class="tagged-gene" title="SwissProt ID: Q9UQF0; Entrez Gene ID: 30816; HGNC ID: 13525; HPRD ID: 05231; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQF0">(HERV) W</a></span> family were determined in muscle biopsies from patients with <span class="tagged-query" title="Query">motor neuron disease</span> (MND) and control subjects. Transcripts from the <span class="tagged-gene" title="SwissProt ID: Q9UQF0; Entrez Gene ID: 30816; HGNC ID: 13525; HPRD ID: 05231; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQF0">HERV-W</a></span> element on chromosome 7q21.2 encoding <span class="tagged-gene" title="SwissProt ID: Q9UQF0; Entrez Gene ID: 30816; HGNC ID: 13525; HPRD ID: 05231; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQF0">syncytin</a></span> and from the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">gene</span> were detected at <span class="tagged-filter" title="Association Word">elevated</span> levels in biopsies from the most affected muscles from MND patients compared to biopsies from control individuals. According to a recent study, <span class="tagged-gene" title="SwissProt ID: Q9UQF0; Entrez Gene ID: 30816; HGNC ID: 13525; HPRD ID: 05231; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQF0">syncytin</a></span> is <span class="tagged-filter" title="Association Word">expressed</span> in microglia in normal brain and can be up-regulated in macrophages/microglia during inflammation. Although <span class="tagged-gene" title="SwissProt ID: Q9UQF0; Entrez Gene ID: 30816; HGNC ID: 13525; HPRD ID: 05231; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQF0">syncytin</a></span> may have cytotoxic effects, it is therefore more likely that the present findings reflect a macrophage response in the muscles undergoing neurogenic atrophy than a primary pathogenetic event in MND.
motor_neuron_disease	immunoglobulins	True Positive	7.208	16339214	<strong class="title">Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R, Crimi M, Bordoni A, Fortunato F, Strazzer S, Menozzi G, Salani S, Bresolin N, Comi GP: Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, an animal model of <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> Hum Mol Genet. 2006 Jan 15;15(2):167-87. Epub 2005 Dec 8.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> with respiratory distress type 1 <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">(SMARD1)</a></span> is an infantile <span class="tagged-filter" title="Association Word">autosomal</span>-<span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> micro-binding <span class="tagged-filter" title="Association Word">protein</span> 2. We investigated the potential of a spinal cord neural stem cell population isolated on the basis of <span class="tagged-gene" title="Protein Family or Complex">aldehyde dehydrogenase</span> (ALDH) <span class="tagged-filter" title="Association Word">activity</span> to modify disease progression of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, an animal model of <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> ALDH (hi) SSC (lo) stem cells are self-renewing and multipotent and when intrathecally transplanted in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice generate motor neurons properly localized in the spinal cord ventral horns. Transplanted <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> animals presented delayed disease progression, sparing of motor neurons and ventral root axons and increased lifespan. To further investigate the molecular events responsible for these differences, microarray and real-time reverse transcription-polymerase chain reaction analyses of wild-type, <span class="tagged-filter" title="Association Word">mutated</span> and transplanted <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> spinal cord were undertaken. We demonstrated a down-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in excitatory amino acid toxicity and oxidative stress handling, as well as an up-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">related</span> to the chromatin organization in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> compared with wild-type mice, suggesting that they may play a <span class="tagged-filter" title="Association Word">role</span> in <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1</a></span> pathogenesis. Spinal cord of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span>-transplanted mice <span class="tagged-filter" title="Association Word">expressed</span> high transcript levels for <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">related</span> to neurogenesis such as <span class="tagged-gene" title="SwissProt ID: O43602; Entrez Gene ID: 1641; HGNC ID: 2714; HPRD ID: 02127; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43602">doublecortin</a></span> <span class="tagged-gene" title="SwissProt ID: O43602; Entrez Gene ID: 1641; HGNC ID: 2714; HPRD ID: 02127; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43602">(DCX),</a></span> <span class="tagged-gene" title="SwissProt ID: P43034; Entrez Gene ID: 5048; HGNC ID: 8574; HPRD ID: 03329; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43034">LIS1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q16643; Entrez Gene ID: 1627; HGNC ID: 2695; HPRD ID: 00545; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16643">drebrin.</a></span> The presence of <span class="tagged-gene" title="SwissProt ID: O43602; Entrez Gene ID: 1641; HGNC ID: 2714; HPRD ID: 02127; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43602">DCX</a></span>-expressing cells in adult <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> spinal cord suggests that both exogenous and endogenous neurogeneses may contribute to the <span class="tagged-filter" title="Association Word">observed</span> <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> phenotype amelioration.
motor_neuron_disease	immunoglobulins	True Positive	7.208	15104695	<strong class="title">Cai Z, Blumbergs PC, Koblar SA, Cash K, Manavis J, Ghabriel MN, Thompson PD: Peripheral nervous system and central nervous system pathology in rapidly progressive lower <span class="tagged-query" title="Query">motor neuron syndrome</span> with <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> M anti-<span class="tagged-metabolite" title="HMDB: HMDB00809"><span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00809">GM1 ganglioside</a></span> <span class="tagged-filter" title="Association Word">antibody.</span> J Peripher Nerv Syst. 2004 Jun;9(2):79-91.</strong> Pathological studies, including novel teased peripheral nerve fiber studies, were performed in a patient who presented with a rapidly progressive, lower <span class="tagged-query" title="Query">motor neuron syndrome</span> and high titer of <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> M anti-<span class="tagged-metabolite" title="HMDB: HMDB00809"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00809">GM1 ganglioside</a></span> <span class="tagged-filter" title="Association Word">antibody.</span> In the central nervous system, there was a severe loss of motor neurons and central <span class="tagged-disease" title="UMLS Concept ID: C0333712">chromatolysis</span> with <a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> immunopositive cytoplasmic inclusions in residual motor neurons. In the peripheral nervous system, axonal degeneration of myelinated fibers in the anterior nerve roots was evident. Pathologic evidence of sensory nerve involvement was also found despite the <span class="tagged-filter" title="Association Word">absence</span> of clinical or electrophysiological sensory abnormalities. Sectional studies of single myelinated nerve fibers from an antemortem sural nerve biopsy showed remyelination and globular paranodal swellings due to focal complex myelin folding and degeneration in 13% of fibers. Postmortem studies of the sural nerves 4 weeks later showed paranodal <span class="tagged-disease" title="UMLS Concept ID: C0011304">demyelination</span> (90% of fibers), but no paranodal swellings and similar findings were present in samples of the ulnar, radial, median, tibial, and common peroneal nerves. Paranodal abnormalities of enlargement of the adaxonal space, <span class="tagged-disease" title="UMLS Concept ID: C0333456">myelin degeneration,</span> and axonal compaction were found on cross-sectional studies of individual teased fibers, which on conventional light microscopic assessment appeared normal. These changes suggest a disturbance of paranodal axonal-myelin adhesion due to binding of the anti-<span class="tagged-metabolite" title="HMDB: HMDB00809"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00809">GM1 ganglioside</a></span> <span class="tagged-filter" title="Association Word">antibody</span> to the common epitope known to be present on the myelin sheath and nodal axolemma in the paranodal region of both motor and sensory nerves.
motor_neuron_disease	Pleiotrophin	False Negative	1.441	17360581	<strong class="title">Mi R, Chen W, Hoke A: <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">Pleiotrophin</a></span> is a <span class="tagged-gene" title="SwissProt ID: P20783; Entrez Gene ID: 4908; HGNC ID: 8023; HPRD ID: 01219; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20783">neurotrophic factor</a></span> for spinal motor neurons. Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4664-9. Epub 2007 Mar 5.</strong> Regeneration in the peripheral nervous system is poor after chronic denervation. Denervated Schwann cells act as a "transient target" by secreting growth factors to promote regeneration of axons but lose this ability with chronic denervation. We discovered that the <span class="tagged-filter" title="Association Word">mRNA</span> for <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">pleiotrophin</a></span> <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">(PTN)</a></span> was highly up-regulated in acutely denervated distal sciatic nerves, but high levels of <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">PTN</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> were not maintained in chronically denervated nerves. <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">PTN</a></span> protected spinal motor neurons against chronic excitotoxic injury and <span class="tagged-filter" title="Association Word">caused</span> increased outgrowth of motor axons out of the spinal cord explants and formation of "miniventral rootlets." In neonatal mice, <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">PTN</a></span> protected the facial motor neurons against cell death induced by deprivation from target-derived growth factors. Similarly, <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">PTN</a></span> significantly enhanced regeneration of myelinated axons across a graft in the transected sciatic nerve of adult rats. Our findings suggest a neurotrophic <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: P21246; Entrez Gene ID: 5764; HGNC ID: 9630; HPRD ID: 01199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21246">PTN</a></span> that may <span class="tagged-filter" title="Association Word">lead</span> to previously unrecognized treatment options for <span class="tagged-query" title="Query">motor neuron disease</span> and motor axonal regeneration.
motor_neuron_disease	HSP27	False Positive	1.036	16303141	<strong class="title">Chiba S, Yokota S, Yonekura K, Tanaka S, Furuyama H, Kubota H, Fujii N, Matsumoto H: Autoantibodies against HSP70 family <span class="tagged-filter" title="Association Word">proteins</span> were detected in the cerebrospinal fluid from patients with <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis.</span> J Neurol Sci. 2006 Feb 15;241(1-2):39-43. Epub 2005 Nov 21.</strong> We evaluated the specific IgG <span class="tagged-filter" title="Association Word">antibodies</span> against heat shock <span class="tagged-filter" title="Association Word">proteins</span> (HSPs) in cerebrospinal fluids (CSF) from patients with <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis</span> (MS). ELISA was employed to examine IgG <span class="tagged-filter" title="Association Word">antibodies</span> against ten HSPs <span class="tagged-gene" title="SwissProt ID: Q16082; Entrez Gene ID: 3316; HGNC ID: 5247; HPRD ID: 03712; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16082">(HSP27,</a></span> alphaA and alphaB crystallins, <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP60,</a></span> <span class="tagged-gene" title="Entrez Gene ID: 907; HGNC ID: 1614; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=907">CCT,</a></span> Mycobacterium bovis <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP65,</a></span> Escherichia coli GroEL, HSP70, <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70</a></span> and HSP90) in CSF from 30 patients with MS, and 25 patients with <span class="tagged-query" title="Query">motor neuron diseases</span> (MND). Significantly higher <span class="tagged-filter" title="Association Word">antibody</span> titers against HSP70 and <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70</a></span> <span class="tagged-filter" title="Association Word">proteins</span> were found in CSF obtained from patients with MS as compared with MND independent of CSF total <span class="tagged-filter" title="Association Word">protein,</span> IgG concentrations and IgG indices, respectively. The <span class="tagged-filter" title="Association Word">antibody</span> titers against HSP70 were indicated to be significantly higher in the progressive cases than in cases of remission. The results suggest that IgG <span class="tagged-filter" title="Association Word">antibodies</span> against specific types of HSPs especially HSP70 family <span class="tagged-filter" title="Association Word">proteins</span> (HSP70 and <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70)</a></span> in CSF may play an important <span class="tagged-filter" title="Association Word">role</span> in the pathophysiology of MS through the modification of immune response and cytoprotective functions of molecular chaperons.
motor_neuron_disease	HSP27	False Positive	1.036	15465612	<strong class="title">Yonekura K, Yokota S, Tanaka S, Kubota H, Fujii N, Matsumoto H, Chiba S: Prevalence of anti-heat shock <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-filter" title="Association Word">antibodies</span> in cerebrospinal fluids of patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">Guillain-Barre syndrome.</span> J Neuroimmunol. 2004 Nov;156(1-2):204-9.</strong> We examined <span class="tagged-filter" title="Association Word">antibodies</span> against 10 heat shock <span class="tagged-filter" title="Association Word">proteins</span> (HSPs) in cerebrospinal fluids (CSF) and sera from patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">Guillain-Barre syndrome</span> <span class="tagged-disease" title="UMLS Concept ID: C0018378">(GBS).</span> Significantly higher IgG <span class="tagged-filter" title="Association Word">antibody</span> titers against <span class="tagged-gene" title="SwissProt ID: Q16082; Entrez Gene ID: 3316; HGNC ID: 5247; HPRD ID: 03712; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16082">HSP27,</a></span> <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP60,</a></span> HSP70 and HSP90 family, including mycobacterial <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP65</a></span> and Escherichia coli GroEL, were found in CSF from <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> patients as compared with <span class="tagged-query" title="Query">motor neuron disease.</span> Serum IgG <span class="tagged-filter" title="Association Word">antibodies</span> against each <span class="tagged-gene" title="SwissProt ID: Q58FF3; Entrez Gene ID: 7190; HGNC ID: 12099; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q58FF3">HSP</a></span> showed no difference between <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> patients and normal controls. <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> seems to be induced by reactive <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune responses</span> frequently triggered by infections. The CSF <span class="tagged-filter" title="Association Word">antibodies</span> against HSPs may modify the immune responses and/or cell-protective functions of HSPs in the pathophysiology of <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS.</span>
motor_neuron_disease	angiogenin	True Positive	2.249	16843725	<strong class="title">Lambrechts D, Lafuste P, Carmeliet P, Conway EM: Another angiogenic <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">linked</span> to <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Trends Mol Med. 2006 Aug;12(8):345-7. Epub 2006 Jul 14.</strong> A new study by Greenway and colleagues links <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> <span class="tagged-filter" title="Association Word">gene</span> to patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS)--a progressive and fatal <span class="tagged-query" title="Query">motoneuron disease.</span> This is an unexpected finding because <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> was originally identified as a molecule <span class="tagged-filter" title="Association Word">involved</span> in the formation of blood vessels (angiogenesis). <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">Angiogenin</a></span> bears striking similarity to <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">(VEGF),</a></span> which is the prototypic angiogenic factor that has recently emerged as a molecule with important neuroprotective activities. Besides <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF,</a></span> <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> is the second so-called angiogenic factor implicated in ALS, raising the question of whether additional angiogenic factors might have a <span class="tagged-filter" title="Association Word">role</span> in ALS. Overall, these findings identify <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> as a novel candidate <span class="tagged-filter" title="Association Word">gene</span> in the pathogenesis of ALS--a discovery that ultimately might <span class="tagged-filter" title="Association Word">lead</span> to the development of new therapeutic strategies.
motor_neuron_disease	angiogenin	True Positive	2.249	16533145	<strong class="title">Bruijn LI, Cudkowicz M: Therapeutic targets for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis:</span> current treatments and prospects for more effective therapies. Expert Rev Neurother. 2006 Mar;6(3):417-28.</strong> Although <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) was described more than 130 years ago, the <span class="tagged-filter" title="Association Word">cause</span> (s) of most cases of this adult <span class="tagged-query" title="Query">motor neuron disease</span> remains a mystery. With the discovery of <span class="tagged-filter" title="Association Word">mutations</span> in one <span class="tagged-filter" title="Association Word">gene</span> (Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase)</a></span> as a primary <span class="tagged-filter" title="Association Word">cause</span> of some forms of ALS, model systems have been developed that have helped us begin to understand mechanisms <span class="tagged-filter" title="Association Word">involved</span> in motor neuron death and enabled testing of potential new therapies. Several other <span class="tagged-filter" title="Association Word">genes</span> have been implicated as risk factors in <span class="tagged-query" title="Query">motor neuron diseases,</span> including neurofilaments, cytoplasmic dynein and <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor,</a></span> and <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin.</a></span> With advances in the basic research of the disease, many hypotheses accounting for motor neuron death are being explored, including loss of trophic support, <span class="tagged-filter" title="Association Word">protein</span> mishandling, mitochondrial dysfunction, excitotoxicity, axonal abnormalities and inflammation. Many of these mechanisms are the focus of research in other <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders,</span> such as Parkinson's, Alzheimer's and <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease.</span>
motor_neuron_disease	NMDA-receptor	True Negative	1.441	17157201	<strong class="title">Sanelli T, Strong MJ: Loss of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P42574; Entrez Gene ID: 836; HGNC ID: 1504; HPRD ID: 02799; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span>-mediated down-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-gene" title="Protein Family or Complex">NMDA receptors</span> in neurofilament aggregate-bearing motor neurons in vitro: implications for <span class="tagged-query" title="Query">motor neuron disease.</span> Free Radic Biol Med. 2007 Jan 1;42(1):143-51. Epub 2006 Oct 20.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0002736">Amyotrophic lateral sclerosis</span> (ALS) is an adult-onset <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorder</span> in which excitotoxicity has been implicated as a <span class="tagged-filter" title="Association Word">cause</span> for cell death. To examine neurofilament (NF) aggregate-mediated sensitization of motor neurons to <span class="tagged-metabolite" title="HMDB: HMDB02393"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02393">NMDA</a></span> excitotoxicity, we examined <span class="tagged-gene" title="Protein Family or Complex">NMDA receptor</span> <span class="tagged-filter" title="Association Word">expression</span> and the impact of NO donors (NOC12 or NOC5) or <span class="tagged-metabolite" title="HMDB: HMDB00588"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB02084"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02084">cyanide</a></span> (NaCN) on <span class="tagged-metabolite" title="HMDB: HMDB00464"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> influx and viability in dissociated motor neurons derived from wt and hNFL+/+ (NF aggregate-forming) mice. Alterations in intracellular <span class="tagged-metabolite" title="HMDB: HMDB00464"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> were assayed using Oregon Green <span class="tagged-metabolite" title="HMDB: HMDB00464"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> dye and the extent of apoptosis using active <a href="http://beta.uniprot.org/uniprot/P42574">caspase-3</a></span> immunoreactivity. Although NF aggregate-bearing neurons demonstrated increased intracellular <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: P42574; Entrez Gene ID: 836; HGNC ID: 1504; HPRD ID: 02799; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> levels and enhanced cell death in response to <span class="tagged-gene" title="Protein Family or Complex">NMDA receptor</span> activation, this was not <span class="tagged-filter" title="Association Word">associated</span> with increased <span class="tagged-gene" title="Protein Family or Complex">NMDA receptor</span> <span class="tagged-filter" title="Association Word">expression.</span> The down-<span class="tagged-filter" title="Association Word">regulation</span> of the <span class="tagged-gene" title="Protein Family or Complex">NMDA receptor</span> using NO donors decreased <span class="tagged-metabolite" title="HMDB: HMDB00464"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> influx and <a href="http://beta.uniprot.org/uniprot/P42574">caspase-3</a></span> activation in aggregate-bearing neurons, but had no effect on wt cultures. The converse was <span class="tagged-filter" title="Association Word">observed</span> with NaCN in which intracellular <span class="tagged-metabolite" title="HMDB: HMDB00464"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span> levels increased significantly in wt cultures in <span class="tagged-filter" title="Association Word">association</span> with increased cell death. No effect was <span class="tagged-filter" title="Association Word">observed</span> in aggregate-bearing neurons. These findings suggest that the presence of NF aggregates renders motor neurons more susceptible to <span class="tagged-metabolite" title="HMDB: HMDB02393"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02393">NMDA</a></span>-mediated excitotoxicity, and that this can be reversed by NO.
motor_neuron_disease	BSCL2	True Positive	1.423	17387721	<strong class="title">Ito D, Suzuki N: Molecular pathogenesis of <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">BSCL2</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-query" title="Query">motor neuron diseases.</span> Ann Neurol. 2007 Mar;61(3):237-50.</strong> OBJECTIVE: Heterozygous <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">Seipin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">BSCL2</a></span> <span class="tagged-filter" title="Association Word">gene</span> have recently been identified in two <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-query" title="Query">motor neuron diseases,</span> distal hereditary <span class="tagged-disease" title="UMLS Concept ID: C0235025">motor neuropathy</span> type V and Silver's syndrome. <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">Seipin</a></span> <span class="tagged-filter" title="Association Word">protein</span> is reportedly a transmembrane <span class="tagged-filter" title="Association Word">protein</span> localized in the endoplasmic reticulum (ER). N88S and S90L <span class="tagged-filter" title="Association Word">mutations</span> of this <span class="tagged-filter" title="Association Word">protein</span> disrupt its glycosylation, resulting in its aggregation, but the mechanism of <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration</span> remains unclear. To clarify the molecular pathogenesis of <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-query" title="Query">motor neuron diseases,</span> we <span class="tagged-filter" title="Association Word">expressed</span> wild-type and mutant <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span> <span class="tagged-filter" title="Association Word">proteins</span> in neuronal and nonneuronal cells. METHODS AND RESULTS: Coexpression of human <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span> and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> showed that <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span> is polyubiquitinated and its ubiquitination is enhanced by <span class="tagged-filter" title="Association Word">mutation.</span> Treatment of cells with a <span class="tagged-gene" title="Protein Family or Complex">proteasome</span> inhibitor increased the amounts of mutant <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span> in the cells, suggesting that they are degraded through the ER-<span class="tagged-filter" title="Association Word">associated</span> degradation pathway. Immunoprecipitation studies showed that mutant <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span> stably binds to the ER chaperone <span class="tagged-gene" title="SwissProt ID: P27824; Entrez Gene ID: 821; HGNC ID: 1473; HPRD ID: 00252; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27824">calnexin,</a></span> indicating accumulation of unfolded mutant <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span> in the ER. Furthermore, <span class="tagged-filter" title="Association Word">expression</span> of mutant <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span> increased the level of ER stress-mediated molecules and induced apoptosis in cultured cells. INTERPRETATION: These findings demonstrate that <span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">seipin</a></span>/<span class="tagged-gene" title="SwissProt ID: Q96G97; Entrez Gene ID: 26580; HGNC ID: 15832; HPRD ID: 05858; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96G97">BSCL2</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-query" title="Query">motor neuron diseases</span> are novel conformational diseases, and we suspect that they are tightly <span class="tagged-filter" title="Association Word">associated</span> with ER stress-mediated cell death.
motor_neuron_disease	Ighmbp2	True Positive	2.800	16339214	<strong class="title">Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R, Crimi M, Bordoni A, Fortunato F, Strazzer S, Menozzi G, Salani S, Bresolin N, Comi GP: Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, an animal model of <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> Hum Mol Genet. 2006 Jan 15;15(2):167-87. Epub 2005 Dec 8.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> with respiratory distress type 1 <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">(SMARD1)</a></span> is an infantile <span class="tagged-filter" title="Association Word">autosomal</span>-<span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> micro-binding <span class="tagged-filter" title="Association Word">protein</span> 2. We investigated the potential of a spinal cord neural stem cell population isolated on the basis of <span class="tagged-gene" title="Protein Family or Complex">aldehyde dehydrogenase</span> (ALDH) <span class="tagged-filter" title="Association Word">activity</span> to modify disease progression of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, an animal model of <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> ALDH (hi) SSC (lo) stem cells are self-renewing and multipotent and when intrathecally transplanted in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice generate motor neurons properly localized in the spinal cord ventral horns. Transplanted <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> animals presented delayed disease progression, sparing of motor neurons and ventral root axons and increased lifespan. To further investigate the molecular events responsible for these differences, microarray and real-time reverse transcription-polymerase chain reaction analyses of wild-type, <span class="tagged-filter" title="Association Word">mutated</span> and transplanted <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> spinal cord were undertaken. We demonstrated a down-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in excitatory amino acid toxicity and oxidative stress handling, as well as an up-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">related</span> to the chromatin organization in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> compared with wild-type mice, suggesting that they may play a <span class="tagged-filter" title="Association Word">role</span> in <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1</a></span> pathogenesis. Spinal cord of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span>-transplanted mice <span class="tagged-filter" title="Association Word">expressed</span> high transcript levels for <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">related</span> to neurogenesis such as <span class="tagged-gene" title="SwissProt ID: O43602; Entrez Gene ID: 1641; HGNC ID: 2714; HPRD ID: 02127; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43602">doublecortin</a></span> <span class="tagged-gene" title="SwissProt ID: O43602; Entrez Gene ID: 1641; HGNC ID: 2714; HPRD ID: 02127; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43602">(DCX),</a></span> <span class="tagged-gene" title="SwissProt ID: P43034; Entrez Gene ID: 5048; HGNC ID: 8574; HPRD ID: 03329; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43034">LIS1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q16643; Entrez Gene ID: 1627; HGNC ID: 2695; HPRD ID: 00545; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16643">drebrin.</a></span> The presence of <span class="tagged-gene" title="SwissProt ID: O43602; Entrez Gene ID: 1641; HGNC ID: 2714; HPRD ID: 02127; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43602">DCX</a></span>-expressing cells in adult <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> spinal cord suggests that both exogenous and endogenous neurogeneses may contribute to the <span class="tagged-filter" title="Association Word">observed</span> <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> phenotype amelioration.
motor_neuron_disease	Ighmbp2	True Positive	2.800	16174646	<strong class="title">Maddatu TP, Garvey SM, Schroeder DG, Zhang W, Kim SY, Nicholson AI, Davis CJ, Cox GA: <span class="tagged-disease" title="UMLS Concept ID: C0007193">Dilated cardiomyopathy</span> in the <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mouse: transgenic rescue and QTLs that improve cardiac function and survival. Hum Mol Genet. 2005 Nov 1;14(21):3179-89. Epub 2005 Sep 20.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">immunoglobulin mu binding protein-2</a></span> <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">(Ighmbp2)</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">motor neuron disease</span> and <span class="tagged-disease" title="UMLS Concept ID: C0007193">dilated cardiomyopathy</span> <span class="tagged-disease" title="UMLS Concept ID: C0264793">(DCM)</span> in the neuromuscular degeneration <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">(nmd)</a></span> mouse and <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> with respiratory distress <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">(SMARD1)</a></span> in humans. To investigate the role of <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">IGHMBP2</a></span> in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0264793">DCM,</span> we generated transgenic mice expressing the full-length <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">Ighmbp2</a></span> cDNA specifically in myocytes under the control of the mouse <span class="tagged-gene" title="SwissProt ID: Q10465; Entrez Gene ID: 7273; HGNC ID: 12403; HPRD ID: 01787; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q10465">titin</a></span> promoter. This tissue-specific transgene increased the lifespan of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice up to 8-fold by preventing primary <span class="tagged-disease" title="UMLS Concept ID: C0264793">DCM</span> and showed complete functional correction as measured by ECG, echocardiography and plasma <span class="tagged-metabolite" title="HMDB: HMDB00064"><span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00064">creatine</a></span> kinase-MB. Double-transgenic <a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice expressing <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">Ighmbp2</a></span> both in myocytes and in neurons display correction of both <span class="tagged-disease" title="UMLS Concept ID: C0264793">DCM</span> and <span class="tagged-query" title="Query">motor neuron disease,</span> resulting in an essentially wild-type appearance. Additionally, quantitative trait <span class="tagged-filter" title="Association Word">locus</span> (QTL) analysis was undertaken to identify genetic modifier loci responsible for the preservation of cardiac function and a marked delay in the onset of cardiomyopathy in a CAST/EiJ backcross population. Three major CAST-derived cardiac modifiers of <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> were identified on chromosomes 9, 10 and 16, which account for over 26% of the genetic variance and that continue to suppress the exacerbation of cardiomyopathy, otherwise resulting in early death, as incipient B6.CAST congenics. Overall, our results verify the tissue-specific requirement for <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">IGHMBP2</a></span> in cardiomyocyte maintenance and survival and describe genetic modifiers that can <span class="tagged-filter" title="Association Word">alter</span> the course of <span class="tagged-disease" title="UMLS Concept ID: C0264793">DCM</span> through cardiac functional adaptation and physical remodeling in response to changes in load and respiratory demand.
motor_neuron_disease	Ighmbp2	True Positive	2.800	15888478	<strong class="title">Ruiz R, Lin J, Forgie A, Foletti D, Shelton D, Rosenthal A, Tabares L: Treatment with trkC agonist <span class="tagged-filter" title="Association Word">antibodies</span> delays disease progression in neuromuscular degeneration <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">(nmd)</a></span> mice. Hum Mol Genet. 2005 Jul 1;14(13):1825-37. Epub 2005 May 11.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> with respiratory distress type 1 <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">(SMARD1)</a></span> is a fatal <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> disorder seen in infants. It is characterized by lower motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration,</span> progressive muscle paralysis and <span class="tagged-disease" title="UMLS Concept ID: C1145670">respiratory failure,</span> for which no effective treatment exists. The phenotype of neuromuscular degeneration <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">(nmd)</a></span> mice closely resembles the human <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> The identification of the <span class="tagged-filter" title="Association Word">mutated</span> mouse <span class="tagged-filter" title="Association Word">gene</span> in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">Ighmbp2,</a></span> <span class="tagged-filter" title="Association Word">led</span> to the discovery of <span class="tagged-filter" title="Association Word">mutations</span> of the homologous <span class="tagged-filter" title="Association Word">gene</span> in humans with <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> We have studied the <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mouse model with in vivo electrophysiological techniques and evaluated the efficacy of Mab2256, a monoclonal <span class="tagged-filter" title="Association Word">antibody</span> with agonist effect on the <span class="tagged-gene" title="SwissProt ID: O75682; Entrez Gene ID: 4916; HGNC ID: 8033; HPRD ID: 01870; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O75682">tyrosine kinase receptor C,</a></span> trkC, on disease progression in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice. Treatment with Mab2256 resulted in a significant but transient improvement of muscle strength in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, as well as normalization of the neuromuscular depression during high-frequency nerve stimulation. These results suggest the potential of using monoclonal agonist <span class="tagged-filter" title="Association Word">antibodies</span> for <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">neurotrophin</a></span> receptors in lower <span class="tagged-query" title="Query">motor neuron diseases</span> such as <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span>
motor_neuron_disease	SIP1	True Positive	2.380	11943600	<strong class="title">Aerbajinai W, Ishihara T, Arahata K, Tsukahara T: Increased <span class="tagged-filter" title="Association Word">expression</span> level of the splicing variant of <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span> in <span class="tagged-query" title="Query">motor neuron diseases.</span> Int J Biochem Cell Biol. 2002 Jun;34(6):699-707.</strong> Survival motor neuron <span class="tagged-gene" title="SwissProt ID: O14893; Entrez Gene ID: 8487; HGNC ID: 10884; HPRD ID: 03999; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14893">(SMN) interacting protein 1</a></span> <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">(SIP1)</a></span> interacts with <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> and plays a crucial <span class="tagged-filter" title="Association Word">role</span> in the biogenesis of spliceosomes. We have identified three novel splicing variants of the <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span> <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">(SIP1</a></span>-beta, -gamma and -delta), in addition to the full-length <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span>-alpha. <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span>-alpha as found to be ubiquitously <span class="tagged-filter" title="Association Word">expressed</span> at high levels in the various normal tissues examined. In contrast, <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span>-beta and -gamma were <span class="tagged-filter" title="Association Word">expressed</span> at very low levels in these tissues. In muscle specimens from patients with <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS), the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span>-alpha was dramatically decreased compared to that <span class="tagged-filter" title="Association Word">observed</span> in the normal tissues. In addition, the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span>-beta was significantly increased in tissues derived from patients with either disease. These findings suggest that an aberrant alternative splicing event in <span class="tagged-gene" title="SwissProt ID: O60315; Entrez Gene ID: 9839; HGNC ID: 14881; HPRD ID: 05780; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60315">SIP1</a></span> occurs tissues derived from patients with the <span class="tagged-query" title="Query">motor neuron diseases,</span> and contributes to the <span class="tagged-disease" title="UMLS Concept ID: C0030660">pathological process</span> of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> and ALS.
motor_neuron_disease	neurotrophin	True Positive	10.239	16382788	<strong class="title">Watabe K, Hayashi Y, Kawazoe Y: Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration. Neuropathology. 2005 Dec;25(4):371-80.</strong> We have used adult rat peripheral nerve avulsion models to evaluate the effects of neuroprotective molecules on motoneuron degeneration. The right facial nerves of adult Fischer 344 male rats were avulsed and adenoviral vectors encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> transforming growth factor-beta2 (TGFbeta2), and <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">growth inhibitory factor</a></span> <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">(GIF)</a></span> were injected into the facial canal. The treatment with the vectors significantly prevented the loss of lesioned facial motoneurons, improved <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">(ChAT)</a></span> immunoreactivity and suppressed the induction of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <span class="tagged-filter" title="Association Word">activity</span> in these neurons. In separate experiments, animals were orally administered a solution of a neuroprotective compound T-588 after avulsion. Both free oral administration and oral tube administration of T-588 improved the survival of injured motoneurons and ameliorated their <a href="http://beta.uniprot.org/uniprot/P28329">ChAT</a></span> immunoreactivity. These results indicate that the <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> TGFbeta2, and <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">GIF</a></span> and oral administration of T-588 may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	neurotrophin	True Positive	10.239	15888478	<strong class="title">Ruiz R, Lin J, Forgie A, Foletti D, Shelton D, Rosenthal A, Tabares L: Treatment with trkC agonist <span class="tagged-filter" title="Association Word">antibodies</span> delays disease progression in neuromuscular degeneration <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">(nmd)</a></span> mice. Hum Mol Genet. 2005 Jul 1;14(13):1825-37. Epub 2005 May 11.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> with respiratory distress type 1 <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">(SMARD1)</a></span> is a fatal <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> disorder seen in infants. It is characterized by lower motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration,</span> progressive muscle paralysis and <span class="tagged-disease" title="UMLS Concept ID: C1145670">respiratory failure,</span> for which no effective treatment exists. The phenotype of neuromuscular degeneration <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">(nmd)</a></span> mice closely resembles the human <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> The identification of the <span class="tagged-filter" title="Association Word">mutated</span> mouse <span class="tagged-filter" title="Association Word">gene</span> in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">Ighmbp2,</a></span> <span class="tagged-filter" title="Association Word">led</span> to the discovery of <span class="tagged-filter" title="Association Word">mutations</span> of the homologous <span class="tagged-filter" title="Association Word">gene</span> in humans with <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span> We have studied the <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mouse model with in vivo electrophysiological techniques and evaluated the efficacy of Mab2256, a monoclonal <span class="tagged-filter" title="Association Word">antibody</span> with agonist effect on the <span class="tagged-gene" title="SwissProt ID: O75682; Entrez Gene ID: 4916; HGNC ID: 8033; HPRD ID: 01870; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O75682">tyrosine kinase receptor C,</a></span> trkC, on disease progression in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice. Treatment with Mab2256 resulted in a significant but transient improvement of muscle strength in <span class="tagged-gene" title="SwissProt ID: O95991; Entrez Gene ID: 51365; HGNC ID: 17661; HPRD ID: 07078; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95991">nmd</a></span> mice, as well as normalization of the neuromuscular depression during high-frequency nerve stimulation. These results suggest the potential of using monoclonal agonist <span class="tagged-filter" title="Association Word">antibodies</span> for <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">neurotrophin</a></span> receptors in lower <span class="tagged-query" title="Query">motor neuron diseases</span> such as <span class="tagged-gene" title="SwissProt ID: P38935; Entrez Gene ID: 3508; HGNC ID: 5542; HPRD ID: 02736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P38935">SMARD1.</a></span>
motor_neuron_disease	neurotrophin	True Positive	10.239	12645079	<strong class="title">Sakamoto T, Kawazoe Y, Shen JS, Takeda Y, Arakawa Y, Ogawa J, Oyanagi K, Ohashi T, Watanabe K, Inoue K, Eto Y, Watabe K: Adenoviral <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">TGF beta 2,</a></span> but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> protects injured adult motoneurons after facial nerve avulsion. Brain Res. 2002 Jul 19;944(1-2):195-9.</strong> We examined neuroprotective effects of recombinant adenoviral vectors encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">ciliary neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">(CNTF),</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">(CT1),</a></span> <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor-1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1),</a></span> and transforming growth factor-beta2 (TGFbeta2) on lesioned adult rat facial motoneurons. The right facial nerves of adult Fischer 344 male rats were avulsed and removed from the stylomastoid foramen, and adenoviral vectors were injected into the facial canal. Animals avulsed and treated with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1,</a></span> <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> and TGFbeta2 showed intense immunolabeling for these factors in lesioned facial motoneurons, respectively, indicating adenoviral induction of the neurotrophic factors in these neurons. The treatment with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> or TGFbeta2 after avulsion significantly prevented the loss of lesioned facial motoneurons, improved <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity and prevented the induction of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <span class="tagged-filter" title="Association Word">activity</span> in these neurons. The treatment with adenovirus encoding <a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> however, failed to protect these neurons after avulsion. These results indicate that the <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and TGFbeta2 but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	neurotrophin	True Positive	10.239	12106680	<strong class="title">Ishiyama T, Ogo H, Wong V, Klinkosz B, Noguchi H, Nakayama C, Mitsumoto H: <span class="tagged-metabolite" title="HMDB: HMDB00696"><span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00696">Methionine</a></span>-free <a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> in wobbler mouse <span class="tagged-query" title="Query">motor neuron disease:</span> dose-<span class="tagged-filter" title="Association Word">related</span> effects and comparison with the methionyl form.  viii.</strong> We compared the clinical and pharmacodynamic effects of N-terminal <span class="tagged-metabolite" title="HMDB: HMDB00696"><span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00696">methionine</a></span> <a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> (met-<span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF)</a></span> and endogenous met-free <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> in wobbler mouse <span class="tagged-query" title="Query">motor neuron disease</span> (MND). Met- or met-free <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> at 5 or 20 mg/kg was subcutaneously injected daily, six times/week for 4 weeks. At 20 mg/kg, grip strength (P <0.05, met-free <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF;</a></span> P <0.01, met-<span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF)</a></span> and running speed (P <0.01 for both groups) improved compared to vehicle. At 5 mg/kg, the beneficial effect was more modest. Plasma <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> levels after the final injection were dose-dependent and did not differ between <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> groups. Endogenous met-free <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> exerts effects similar to met-<span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> in wobbler MND.
motor_neuron_disease	neurotrophin	True Positive	10.239	11268018	<strong class="title">Tsuzaka K, Ishiyama T, Pioro EP, Mitsumoto H: <span class="tagged-filter" title="Association Word">Role</span> of <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> in wobbler mouse <span class="tagged-query" title="Query">motor neuron disease.</span> Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Mar;2(1):19-22.</strong> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">Brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF)</a></span> is neuroprotective for motoneurons undergoing degeneration, including those in natural <span class="tagged-query" title="Query">motor neuron disease</span> (MND) in wobbler mice. To assess the role of <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> in this model of MND, endogenous <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> immunoreactivity was analyzed by semiquantitative video-image analysis. Affected cervical spinal cord motoneurons had significantly greater <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> immunoreactivity compared to motoneurons of healthy littermates (P = 0.01) and affected lumbar spinal cord motoneurons (P = 0.008 at age 4 weeks; P = 0.005 at age 8 weeks). Neuronal nitric oxide synthase <span class="tagged-gene" title="SwissProt ID: P29475; Entrez Gene ID: 4842; HGNC ID: 7872; HPRD ID: 01226; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29475">(n-NOS)</a></span> immunocytochemistry revealed increased immunoreactivity in the affected cervical spinal cord motoneurons. Exogenous <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> treatment partially inhibited the increased <span class="tagged-gene" title="SwissProt ID: P35228; Entrez Gene ID: 4843; HGNC ID: 7873; HPRD ID: 01225; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35228">NOS</a></span> <span class="tagged-filter" title="Association Word">activity,</span> as quantitatively measured by <span class="tagged-metabolite" title="HMDB: HMDB00217"><span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00217">nicotinamide adenine dinucleotide phosphate</a></span> diaphorase <span class="tagged-metabolite" title="HMDB: HMDB00221"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00221">(NADPH</a></span>-d) histochemistry. The mean number of <span class="tagged-metabolite" title="HMDB: HMDB00221"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00221">NADPH</a></span>-d (+) motoneurons in the cervical anterior horn decreased from 3.5 +/- 1.2 to 1.5 +/- 1.2 (P = 0.002). The increase in endogenous <a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> immunoreactivity in the affected spinal cord may be compensatory in diseased motoneurons, yet it appears to still be inadequate because exogenous <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> treatment is required to suppress increased <span class="tagged-gene" title="SwissProt ID: P35228; Entrez Gene ID: 4843; HGNC ID: 7873; HPRD ID: 01225; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35228">NOS</a></span> <span class="tagged-filter" title="Association Word">activity</span> in degenerating motoneurons. Our study indicates that <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> is important in halting <span class="tagged-metabolite" title="HMDB: HMDB03378"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> (NO)-mediated motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration,</span> which has potential implications for the treatment of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders.</span>
motor_neuron_disease	Tumor-necrosis-factor	False Negative	1.441	17079668	<strong class="title">Gowing G, Dequen F, Soucy G, Julien JP: <span class="tagged-filter" title="Association Word">Absence</span> of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor-alpha</a></span> does not affect <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> J Neurosci. 2006 Nov 1;26(44):11397-402.</strong> An increase in the <span class="tagged-filter" title="Association Word">expression</span> of the proinflammatory <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF-alpha)</a></span> has been <span class="tagged-filter" title="Association Word">observed</span> in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and in the mice models of the disease. <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> is a potent activator of macrophages and microglia and, under certain conditions, can induce or exacerbate neuronal cell death. Here, we assessed the contribution of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> in <span class="tagged-query" title="Query">motor neuron disease</span> in mice overexpressing mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">linked</span> to familial ALS. This was accomplished by the generation of mice expressing <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G37R) or <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) mutants in the context of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> <span class="tagged-filter" title="Association Word">gene</span> knock out. Surprisingly, the <span class="tagged-filter" title="Association Word">absence</span> of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> did not affect the lifespan or the extent of motor <span class="tagged-disease" title="UMLS Concept ID: C0598940">neuron loss</span> in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mice. These results provide compelling evidence indicating that <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> does not directly contribute to motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mutations.</span>
motor_neuron_disease	Tumor-necrosis-factor	True Positive	1.441	11847479	<strong class="title">Ghezzi P, Mennini T: <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">Tumor necrosis factor</a></span> and motoneuronal degeneration: an open problem. Neuroimmunomodulation. 2001;9(4):178-82.</strong> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">Tumor necrosis factor</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)</a></span> has been implicated in the pathogenesis of various <span class="tagged-disease" title="UMLS Concept ID: C0007682">central nervous system diseases</span> with an inflammatory component. <span class="tagged-filter" title="Association Word">Elevated</span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> levels were <span class="tagged-filter" title="Association Word">observed</span> in animal models of <span class="tagged-query" title="Query">motor neuron disease</span> (MND), and activation of the <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> system has been reported in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). The easy availability of scientific reports to the layman through the web, often based only on the abstracts, has prompted many patients to ask whether anti-<span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> therapy might be beneficial in ALS. This review discusses the possible <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> in motoneuronal degeneration. Although <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> is mostly regarded as <span class="tagged-metabolite" title="HMDB: HMDB02227"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02227">neurotoxic</a></span> <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine,</a></span> there are reports of a neuroprotective and neurotrophic action. Studies with animal models of ALS are not sufficient to show whether <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> has a pathogenic or a protective <span class="tagged-filter" title="Association Word">role</span> in MND though anti-<span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> have shown protective effects in <span class="tagged-disease" title="UMLS Concept ID: C0014072">experimental allergic encephalomyelitis</span> <span class="tagged-disease" title="UMLS Concept ID: C0014072">(EAE),</span> an animal model of <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis</span> (MS). On the other hand, while <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice are protected from <span class="tagged-disease" title="UMLS Concept ID: C0014072">EAE,</span> anti-<span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> worsen the disease in MS patients, suggesting caution in extrapolating preliminary basic studies to the patient.
motor_neuron_disease	cystathionine-gamma-lyase	True Negative	1.441	17095121	<strong class="title">Diwakar L, Ravindranath V: Inhibition of <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine-gamma-lyase</a></span> <span class="tagged-filter" title="Association Word">leads</span> to loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int. 2007 Jan;50(2):418-26. Epub 2006 Nov 13.</strong> Oxidative stress has been implicated in the pathogenesis and progression of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders</span> and antioxidants potentially have a major <span class="tagged-filter" title="Association Word">role</span> in neuroprotection. Optimum levels of <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> (gamma-glutamylcysteinyl <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine),</a></span> an endogenous thiol antioxidant are required for the maintenance of the redox status of cells. <a href="http://beta.uniprot.org/uniprot/P32929">Cystathionine gamma-lyase</a></span> is the rate-limiting <span class="tagged-filter" title="Association Word">enzyme</span> for the synthesis of <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">cysteine</a></span> from <span class="tagged-metabolite" title="HMDB: HMDB00696"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00696">methionine</a></span> and availability of <span class="tagged-metabolite" title="HMDB: HMDB00574"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">cysteine</a></span> is a critical factor in <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> synthesis. In the present study, we have examined the role of <a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> in maintaining the redox homeostasis in brain, particularly with reference to mitochondrial function since the <span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> of the electron transport chain is sensitive to redox perturbation. Inhibition of <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> by l-propargylglycine <span class="tagged-filter" title="Association Word">caused</span> loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and decrease in <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> in the brain although the <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> in mouse brain was 1% of the corresponding hepatic <span class="tagged-filter" title="Association Word">activity.</span> We then examined the effect of this inhibition on the neurotoxicity mediated by the excitatory amino acid, l-beta-oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine,</a></span> which is the causative factor of a type of <span class="tagged-query" title="Query">motor neuron disease,</span> neurolathyrism. l-beta-Oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine</a></span> toxicity was exacerbated by l-propargylglycine measured as loss of <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> indicating the importance of <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> in maintaining <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> levels and in turn the mitochondrial function during excitotoxicity. Oxidative stress generated by l-beta-oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine</a></span> itself inhibited <a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase,</a></span> which could be prevented by prior treatment with thiol antioxidant. Thus, <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> itself is susceptible to inactivation by oxidative stress and this can potentially exacerbate oxidant-induced damage. <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">Cystathionine gamma-lyase</a></span> is present in neuronal cells in human brain and its <span class="tagged-filter" title="Association Word">activity</span> is several-fold higher compared to mouse brain. It could potentially play an important <span class="tagged-filter" title="Association Word">role</span> in maintaining <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and <span class="tagged-filter" title="Association Word">protein</span> thiol homeostasis in brain and hence afford neuroprotection.
motor_neuron_disease	Spastin	True Negative	1.441	15079007	<strong class="title">Molon A, Di Giovanni S, Chen YW, Clarkson PM, Angelini C, Pegoraro E, Hoffman EP: Large-scale disruption of microtubule pathways in morphologically normal human <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> muscle. Neurology. 2004 Apr 13;62(7):1097-104.</strong> OBJECTIVE: To investigate the molecular pathways disrupted by <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> <span class="tagged-filter" title="Association Word">mutations</span> in apparently unaffected skeletal muscle from patients with <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">(SPG4).</a></span> METHODS: The authors studied muscle of three individuals from two unrelated families affected by <span class="tagged-disease" title="UMLS Concept ID: C0037772">spastic paraplegia</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> The authors compared RNA <span class="tagged-filter" title="Association Word">expression</span> profiles to 7 normal and 13 pathologic muscle U95A profiles (Duchenne dystrophy, <span class="tagged-disease" title="UMLS Concept ID: C1135345">acute quadriplegic myopathy,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy).</span> Data were validated with U133A arrays with seven different control specimens. <span class="tagged-filter" title="Association Word">mRNA</span> and <span class="tagged-filter" title="Association Word">protein</span> confirmations were done for a subset of <span class="tagged-filter" title="Association Word">genes.</span> RESULTS: Both nonsense and missense <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> <span class="tagged-filter" title="Association Word">gene</span> disrupted microtubule pathways in nonpathologic tissue, including microtubule dynamics, stability, exocytosis, and endocytosis. CONCLUSIONS: Normal muscle can be used to uncover biochemical perturbation in <span class="tagged-query" title="Query">motor neuron disease.</span> <span class="tagged-filter" title="Association Word">Altered</span> microtubule metabolism in <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">SPG4</a></span>-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: C0037773">hereditary spastic paraplegia</span> patients <span class="tagged-filter" title="Association Word">leads</span> to pathology of the long descending tracks of motor neurons that likely have a stringent need for efficient microtubular transport. As many inherited neurologic conditions show a systemic biochemical defect with disease limited to neurons, our data have broader implications for biochemical pathway studies of many <span class="tagged-disease" title="UMLS Concept ID: C0027765">neurologic disorders.</span>
motor_neuron_disease	Spastin	True Negative	1.441	14506940	<strong class="title">McDermott CJ, Roberts D, Tomkins J, Bushby KM, Shaw PJ: <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">Spastin</a></span> and <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">gene</span> analysis in selected cases of <span class="tagged-query" title="Query">motor neurone disease</span> (MND). Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun;4(2):96-9.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in both the <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> and <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">genes</span> have been <span class="tagged-filter" title="Association Word">associated</span> with upper motor neurone degeneration in hereditary spastic paraparesis. The aim of this study was to investigate if <span class="tagged-filter" title="Association Word">mutation</span> in these <span class="tagged-filter" title="Association Word">genes</span> is <span class="tagged-filter" title="Association Word">associated</span> with upper motor neurone degeneration in <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis</span> <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">(PLS)</a></span> or selected <span class="tagged-query" title="Query">motor neurone disease</span> (MND) cases. DNA was extracted from whole blood and screened using single stranded conformation <span class="tagged-filter" title="Association Word">polymorphism</span> and heteroduplex analysis. No <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> or <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">genes</span> was identified in the <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">PLS</a></span> or MND cases. <span class="tagged-filter" title="Association Word">Polymorphism</span> was identified in the <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">gene</span> but no <span class="tagged-filter" title="Association Word">association</span> was shown with <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">PLS</a></span> or MND. We therefore conclude that <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> and <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">genes</span> does not appear to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">PLS</a></span> or MND.
motor_neuron_disease	Metallothionein	False Negative	1.441	17114818	<strong class="title">Ono S, Endo Y, Tokuda E, Ishige K, Tabata K, Asami S, Ito Y, Suzuki T: Upregulation of <span class="tagged-gene" title="Protein Family or Complex">metallothionein</span>-I <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> in a rodent model for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Biol Trace Elem Res. 2006 Oct;113(1):93-104.</strong> <span class="tagged-gene" title="Protein Family or Complex">Metallothionein</span> (MT) <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> was investigated in a rodent model (G93A <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mouse) for a lethal <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). In 8-wk-old mice that did not yet exhibit motor paralysis, MT-I <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> was already significantly upregulated in the region of the spinal cord responsible for motor paralysis. The <span class="tagged-filter" title="Association Word">expression</span> of another isoform, <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">MT-III,</a></span> was not changed. In the cerebellum, which is not responsible for motor paralysis in ALS, neither the <span class="tagged-filter" title="Association Word">expression</span> profiles of MT-I nor <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">MT-III</a></span> were <span class="tagged-filter" title="Association Word">altered.</span> In 16-wk-old mice exhibiting motor paralysis, the <span class="tagged-filter" title="Association Word">expression</span> of MT-I <span class="tagged-filter" title="Association Word">mRNA</span> remained upregulated and the <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">MT-III</a></span> level tended to be <span class="tagged-filter" title="Association Word">elevated.</span> Although no significant differences were found in the levels of both isoforms in the liver or kidney of 8-wk-old mice, the MT-I <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> level was significantly upregulated in the kidney and liver of 16-wk-old mice. These results indicated that the MT-I isoform, but not the <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">MT-III</a></span> isoform, is <span class="tagged-filter" title="Association Word">associated</span> with motor neuron death in ALS and suggested that the disease might be a systemic disorder to which the spinal cord is particularly susceptible.
motor_neuron_disease	GluR1	False Positive	1.314	16523673	<strong class="title">Zherebtsova AL, Shadrina MI, Semenova EV, Levitskii GN, Alekhin AV, Slominskii PA, Skvortsova VI, Limborskaia SA: [Analysis of the possible involvement of the <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> transporter <span class="tagged-filter" title="Association Word">gene</span> <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> and the <span class="tagged-gene" title="SwissProt ID: Q6EER8; Entrez Gene ID: 145781; HPRD ID: 08091; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6EER8">glutamate receptor</a></span> <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> in pathogenesis of <span class="tagged-query" title="Query">motor neuron disease</span> in the Russian population]. Genetika. 2006 Jan;42(1):104-9.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> of the <span class="tagged-filter" title="Association Word">genes</span> of the glutamatergic system <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> have been analyzed in patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> (MND) from Russia. The disease is not <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">polymorphic</span> alleles of the <span class="tagged-filter" title="Association Word">genes</span> studied, which indicates that <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> play an insignificant <span class="tagged-filter" title="Association Word">role</span> in the pathogenesis of sporadic MND.
motor_neuron_disease	Cop-1	True Negative	1.441	12668759	<strong class="title">Angelov DN, Waibel S, Guntinas-Lichius O, Lenzen M, Neiss WF, Tomov TL, Yoles E, Kipnis J, Schori H, Reuter A, Ludolph A, Schwartz M: Therapeutic vaccine for acute and chronic <span class="tagged-query" title="Query">motor neuron diseases:</span> implications for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4790-5. Epub 2003 Mar 31.</strong> Therapeutic vaccination with <span class="tagged-drug" title="DrugBank: APRD00999"><span class="tagged-gene" title="SwissProt ID: Q5EG05; Entrez Gene ID: 114769; HPRD ID: 16740; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00999">Copaxone</a></span> <span class="tagged-drug" title="DrugBank: APRD00999"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00999">(glatiramer acetate,</a></span> <a href="http://beta.uniprot.org/uniprot/Q5EG05">Cop-1)</a></span> protects motor neurons against acute and chronic degenerative conditions. In acute degeneration after facial nerve axotomy, the number of surviving motor neurons was almost two times higher in <span class="tagged-gene" title="SwissProt ID: Q5EG05; Entrez Gene ID: 114769; HPRD ID: 16740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5EG05">Cop-1</a></span>-vaccinated mice than in nonvaccinated mice, or in mice injected with <span class="tagged-gene" title="SwissProt ID: P30536; Entrez Gene ID: 706; HGNC ID: 1158; HPRD ID: 15913; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30536">PBS</a></span> emulsified in complete Freund's adjuvant (P < 0.05). In mice that express the mutant human <span class="tagged-filter" title="Association Word">gene</span> Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> G93A <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1),</a></span> and therefore simulate the chronic human <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> <span class="tagged-gene" title="SwissProt ID: Q5EG05; Entrez Gene ID: 114769; HPRD ID: 16740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5EG05">Cop-1</a></span> vaccination prolonged life span compared to untreated matched controls, from 211 +/- 7 days (n = 15) to 263 +/- 8 days (n = 14; P < 0.0001). Our studies show that vaccination significantly improved motor <span class="tagged-filter" title="Association Word">activity.</span> In line with the experimentally based concept of protective autoimmunity, these findings suggest that <span class="tagged-gene" title="SwissProt ID: Q5EG05; Entrez Gene ID: 114769; HPRD ID: 16740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5EG05">Cop-1</a></span> vaccination boosts the local immune response needed to combat destructive self-compounds <span class="tagged-filter" title="Association Word">associated</span> with motor neuron death. Its differential action in CNS <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune diseases</span> and <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders,</span> depending on the regimen used, allows its use as a therapy for either condition. Daily administration of <span class="tagged-gene" title="SwissProt ID: Q5EG05; Entrez Gene ID: 114769; HPRD ID: 16740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5EG05">Cop-1</a></span> is an approved treatment for <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis.</span> The protocol for non-autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> such as <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> remains to be established by future studies.
motor_neuron_disease	TDP-43	False Positive	5.831	17591968	<strong class="title">Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in Familial and Sporadic <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal Lobar Degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span> Inclusions. Am J Pathol. 2007 Jul;171(1):227-40.</strong> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TAR DNA-binding protein 43</a></span> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TDP-43)</a></span> is a major pathological <span class="tagged-filter" title="Association Word">protein</span> of sporadic and familial <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive, tau-negative inclusions (FTLD-U) with or without <span class="tagged-query" title="Query">motor neuron disease</span> (MND). Thus, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> defines a novel class of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> called <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies. We performed <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias</span> (FTDs) included four groups: 1) familial FTD with <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin</a></span> (n = 36), <span class="tagged-gene" title="SwissProt ID: P55072; Entrez Gene ID: 7415; HGNC ID: 12666; HPRD ID: 03013; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55072">valosin-containing protein</a></span> (n = 5), <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> (n = 4), and <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p (n = 7); 2) familial cases of FTD with unknown <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">association</span> (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p but not FTD with <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> is a common pathological substrate underlying a large subset of these disorders, thereby implicating <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in novel and unifying mechanisms of FTLD pathogenesis.
motor_neuron_disease	TDP-43	False Positive	5.831	17513340	<strong class="title">Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in Familial and Sporadic <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal Lobar Degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span> Inclusions. Am J Pathol. 2007 May 18;.</strong> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TAR DNA-binding protein 43</a></span> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TDP-43)</a></span> is a major pathological <span class="tagged-filter" title="Association Word">protein</span> of sporadic and familial <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive, tau-negative inclusions (FTLD-U) with or without <span class="tagged-query" title="Query">motor neuron disease</span> (MND). Thus, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> defines a novel class of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> called <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies. We performed <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias</span> (FTDs) included four groups: 1) familial FTD with <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin</a></span> (n = 36), <span class="tagged-gene" title="SwissProt ID: P55072; Entrez Gene ID: 7415; HGNC ID: 12666; HPRD ID: 03013; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55072">valosin-containing protein</a></span> (n = 5), <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> (n = 4), and <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p (n = 7); 2) familial cases of FTD with unknown <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">association</span> (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p but not FTD with <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> is a common pathological substrate underlying a large subset of these disorders, thereby implicating <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in novel and unifying mechanisms of FTLD pathogenesis.
motor_neuron_disease	TDP-43	False Positive	5.831	17492294	<strong class="title">Kwong LK, Neumann M, Sampathu DM, Lee VM, Trojanowski JQ: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathy: the neuropathology underlying major forms of sporadic and familial <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> and <span class="tagged-query" title="Query">motor neuron disease.</span> Acta Neuropathol. 2007 Jul;114(1):63-70. Epub 2007 May 10.</strong> The rapid confirmation of the initial report by Neumann et al. (Science 314:130-133, 2006) that transactive response <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TAR)-DNA-binding protein 43</a></span> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TDP-43)</a></span> is the major disease <span class="tagged-filter" title="Association Word">protein</span> linking <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive inclusions (FTLD-U) with and without <span class="tagged-query" title="Query">motor neuron disease</span> (MND) as well as <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) implies that <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathy underlies major forms of sporadic as well as familial FTLD and ALS. Not only was the identity of the ubiquitinated <span class="tagged-filter" title="Association Word">proteins</span> that accumulate in neurons and glia of these disorders finally resolved, but it also was shown that pathologic <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> was hyperphosphorylated, ubiquitinated and cleaved to generate C-terminal fragments in affected brain and spinal cord of FTLD-U and ALS. This review summarizes the growing evidence that <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathy is the common pathologic substrate linking FTLD and ALS, and it considers the implications of these findings for developing better strategies to diagnose and treat these <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders.</span>
motor_neuron_disease	TDP-43	False Positive	5.831	17360763	<strong class="title">Seelaar H, Schelhaas HJ, Azmani A, Kusters B, Rosso S, Majoor-Krakauer D, de Rijik MC, Rizzu P, ten Brummelhuis M, van Doorn PA, Kamphorst W, Willemsen R, van Swieten JC: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> pathology in familial <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> and <span class="tagged-query" title="Query">motor neuron disease</span> without <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">Progranulin</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Brain. 2007 May;130(Pt 5):1375-85. Epub 2007 Mar 14.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0338451">Frontotemporal dementia</span> is accompanied by <span class="tagged-query" title="Query">motor neuron disease</span> (FTD + MND) in approximately 10% of cases. There is accumulating evidence for a clinicopathological overlap between FTD and MND based on observations of familial aggregation and neuropathological findings of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive neuronal cytoplasmatic inclusions (NCI) in lower motor neurons, hippocampus and neocortex in both conditions. Several familial forms exist with different genetic loci and defects. We investigated the familial aggregation and clinical presentation of FTD + MND cases in a large cohort of 368 FTD patients in The Netherlands. Immunohistochemistry of available brain tissue of deceased patients was investigated using a panel of <span class="tagged-filter" title="Association Word">antibodies</span> including <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin,</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y6M1; Entrez Gene ID: 10644; HGNC ID: 28867; HPRD ID: 10507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6M1">p62</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TAR DNA-binding protein</a></span> of 43 kDa <span class="tagged-filter" title="Association Word">antibodies.</span> A total of eight patients coming from six families had a family history positive for FTD + MND (mean age at onset 53.2 +/- 8.4 years). Five patients presented with behavioural changes and cognitive changes followed by <span class="tagged-query" title="Query">motor neuron disease,</span> whereas symptoms of <span class="tagged-query" title="Query">motor neuron disease</span> were the presenting features in the remaining three patients. Other affected relatives in these families showed <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span>/FTD, MND or FTD + MND reflecting the clinical interfamilial variation. No <span class="tagged-filter" title="Association Word">mutations</span> were identified in any of the candidate <span class="tagged-filter" title="Association Word">genes,</span> including <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">Superoxide Dismutase 1,</a></span> <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin,</a></span> <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">Microtubule-Associated Protein Tau,</a></span> <span class="tagged-gene" title="SwissProt ID: P55072; Entrez Gene ID: 7415; HGNC ID: 12666; HPRD ID: 03013; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55072">valosin-containing protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin.</a></span> Available brain tissue of five patients with familial FTD + MND showed NCI in hippocampus, neocortex and spinal cord in all, and neuronal intranuclear inclusions (NII) in two brains. <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> <span class="tagged-filter" title="Association Word">antibody</span> showed robust staining of neuronal inclusions similar in distribution and morphology to NCI and NII. Additionally, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> <span class="tagged-filter" title="Association Word">antibody</span> also stained <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-negative glial inclusions in the basal striatum of one case. In conclusion, there exists considerable clinical variation within families with FTD + MND, which may be determined by other genetic or environmental factors. NII are also found in some cases of familial FTD + MND without <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">Progranulin</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> The observation of glial <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> positive inclusions in one brain is very interesting, although their pathophysiological significance is yet unknown.
motor_neuron_disease	Rac1	True Negative	1.441	16769894	<strong class="title">Devon RS, Orban PC, Gerrow K, Barbieri MA, Schwab C, Cao LP, Helm JR, Bissada N, Cruz-Aguado R, Davidson TL, Witmer J, Metzler M, Lam CK, Tetzlaff W, Simpson EM, McCaffery JM, El-Husseini AE, Leavitt BR, Hayden MR: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice exhibit disturbances in endosome trafficking <span class="tagged-filter" title="Association Word">associated</span> with motor behavioral abnormalities. Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9595-600. Epub 2006 Jun 12.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> form of spastic paraparesis <span class="tagged-query" title="Query">(motor neuron disease)</span> with juvenile onset and slow progression <span class="tagged-filter" title="Association Word">caused</span> by loss of function of alsin, an activator of <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span> and <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> small GTPases. To establish an animal model of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and derive insights into the pathogenesis of this illness, we have generated alsin-null mice. Cytosol from brains of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice shows marked diminution of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span>-dependent endosome fusion <span class="tagged-filter" title="Association Word">activity.</span> Furthermore, primary neurons from <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice show a disturbance in endosomal transport of <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor 1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1)</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> receptors, whereas neuronal viability and endocytosis of <span class="tagged-gene" title="SwissProt ID: P02787; Entrez Gene ID: 7018; HGNC ID: 11740; HPRD ID: 01811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02787">transferrin</a></span> and dextran seem unaltered. There is a significant decrease in the size of cortical motor neurons, and <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice are mildly hypoactive. <span class="tagged-filter" title="Association Word">Altered</span> trophic receptor trafficking in neurons of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice may underlie the histopathological and behavioral changes <span class="tagged-filter" title="Association Word">observed</span> and the pathogenesis of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span>
motor_neuron_disease	GSTT1	True Positive	6.039	12500684	<strong class="title">Shadrina MI, Kondrat'eva EA, Slominskii PA, Levitskaia NI, Levitskii GN, Skvortsova VA, Limborskaia SA: <span class="tagged-filter" title="Association Word">[Polymorphism</span> of <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> <span class="tagged-filter" title="Association Word">genes</span> M1 and T1 in patients with <span class="tagged-query" title="Query">motor neuron disease</span> from the city of Moscow]. Genetika. 2002 Nov;38(11):1566-8.</strong> Comparison of the frequency distributions of alleles, genotypes, and genotype combinations of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P09488; Entrez Gene ID: 2944; HGNC ID: 4632; HPRD ID: 00707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09488">GSTM1</a></span> and <span class="tagged-gene" title="SwissProt ID: P30711; Entrez Gene ID: 2952; HGNC ID: 4641; HPRD ID: 02700; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30711">GSTT1</a></span> did not show statistically significant differences between patients with <span class="tagged-query" title="Query">motor neuron disease</span> (MND) and a random sample from the Moscow population. Apparently, these <span class="tagged-filter" title="Association Word">genes</span> are not <span class="tagged-filter" title="Association Word">involved</span> in MND pathogenesis in these patients.
motor_neuron_disease	MNDA	True Negative	1.441	17241187	<strong class="title">Rio A, Cawadias E: Nutritional advice and treatment by dietitians to patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span>/<span class="tagged-query" title="Query">motor neurone disease:</span> a survey of current practice in England, Wales, Northern <span class="tagged-drug" title="DrugBank: APRD00396"><span class="tagged-gene" title="SwissProt ID: P41218; Entrez Gene ID: 4332; HGNC ID: 7183; HPRD ID: 15932; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00396">Ireland</a></span> and Canada. J Hum Nutr Diet. 2007 Feb;20(1):3-13.</strong> BACKGROUND: The management of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span>/<span class="tagged-query" title="Query">motor neurone disease</span> (ALS/MND) has shifted from an attitude of <span class="tagged-disease" title="UMLS Concept ID: C0233677">nihilism</span> to treatments that prolong survival and offer hope. Nutrition is an integral component of ALS/MND care requiring coordination among acute and community multi-disciplinary teams (MDT). Evidence-based nutrition guidelines exist for this patient group but their use among dietitians is unknown. The aim of this study was to survey the knowledge, practice and guideline use of dietitians working in ALS/MND centres/clinics across England, Wales, Northern <span class="tagged-drug" title="DrugBank: APRD00396"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00396">Ireland</a></span> (EWNI) and Canada. METHOD: Dietetic contact details were obtained from the <span class="tagged-query" title="Query">Motor Neurone Disease</span> <span class="tagged-filter" title="Association Word">Association</span> <a href="http://beta.uniprot.org/uniprot/P41218">(MNDA)</a></span> and the ALS Society of Canada (ALSSC) websites. Telephone interviews were conducted with 23 dietitians using a standardized questionnaire. RESULTS: Multi-disciplinary team membership was high (78%). Only 22% dietitians had > 4-years experience in ALS/MND care. Dietitians reported using body weight, percentage weight loss (PWL) and body mass index (BMI) to assess nutritional status. Equations used to estimate energy and <span class="tagged-filter" title="Association Word">protein</span> requirements differed. Most frequent dietary advice was high calorie, texture modification and prescription nutritional supplements. Artificial nutrition and hydration (ANH) was discussed when patients developed <span class="tagged-disease" title="UMLS Concept ID: C0011168">dysphagia,</span> energy intake was inadequate, weight loss of 10% or forced vital capacity (FVC) was reduced. A percutaneous endoscopic gastrostomy <span class="tagged-gene" title="SwissProt ID: P09466; Entrez Gene ID: 5047; HGNC ID: 8573; HPRD ID: 01411; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09466">(PEG)</a></span> service was available at all clinics/centres. CONCLUSION: Nutritional assessment techniques and dietary advice should be standardized. Dietetic collaboration at national and international level is recommended to reduce professional isolation. Training and support in ALS/MND nutrition should be made available as part of post-dietetic registration. Further dietetic research is required to stimulate nutritional care.
motor_neuron_disease	Thy1	True Negative	1.441	12077179	<strong class="title">Lino MM, Schneider C, Caroni P: Accumulation of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants in postnatal motoneurons does not <span class="tagged-filter" title="Association Word">cause</span> motoneuron pathology or <span class="tagged-query" title="Query">motoneuron disease.</span> J Neurosci. 2002 Jun 15;22(12):4825-32.</strong> Transgenic mice expressing high levels of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS)-<span class="tagged-filter" title="Association Word">associated</span> mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> under the control of a human <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> minigene (hMg) accumulate mutant <span class="tagged-filter" title="Association Word">protein</span> ubiquitously and develop <span class="tagged-query" title="Query">motoneuron disease.</span> However, restricted expression of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants in neurons apparently does not <span class="tagged-filter" title="Association Word">cause</span> motor impairments in mice. Here, we investigated the possible pathogenic <span class="tagged-filter" title="Association Word">roles</span> of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> accumulation in motoneurons. First, we used a <span class="tagged-gene" title="SwissProt ID: P04216; Entrez Gene ID: 7070; HGNC ID: 11801; HPRD ID: 01769; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04216">Thy1</a></span> <span class="tagged-filter" title="Association Word">expression</span> cassette to drive high constitutive <span class="tagged-filter" title="Association Word">expression</span> of transgene in postnatal mouse neurons, including upper and lower motoneurons. Second, we <span class="tagged-filter" title="Association Word">expressed</span> human (h) <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) and hSOD1 (G85R) as transgenes (i.e., two <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants with aggressive pathogenic properties in inducing FALS). Third, in addition to clinical signs of disease, we monitored early signs of disease onset and pathogenesis, including muscle innervation, astrogliosis in the spinal cord, and accumulation of ubiquitinated deposits in motoneurons and astrocytes. We report that high-level <span class="tagged-filter" title="Association Word">expression</span> and accumulation of the mutant <span class="tagged-filter" title="Association Word">proteins</span> in neurons failed to <span class="tagged-filter" title="Association Word">produce</span> any detectable sign of pathology or disease in these transgenic mice. Crossing hMg-<span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) mice (Gurney et al., 1994) with <span class="tagged-gene" title="SwissProt ID: P04216; Entrez Gene ID: 7070; HGNC ID: 11801; HPRD ID: 01769; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04216">Thy1</a></span>-<span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) mice <span class="tagged-filter" title="Association Word">produced</span> double-transgenic mice with spinal cord <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) levels that were approximately twofold higher than in the hMg-<span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) single transgenics but did not affect the onset or progression of pathology or <span class="tagged-query" title="Query">motoneuron disease.</span> The accumulation of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> in postnatal motoneurons is thus not sufficient and probably also not critical to induce or accelerate <span class="tagged-query" title="Query">motoneuron disease</span> in FALS mice. The pathogenic process in FALS may <span class="tagged-filter" title="Association Word">involve</span> non-neuronal cells, and selective vulnerability of motoneurons to this process may <span class="tagged-filter" title="Association Word">lead</span> to motoneuron pathology and disease.
motor_neuron_disease	HSP60	True Negative	1.441	16303141	<strong class="title">Chiba S, Yokota S, Yonekura K, Tanaka S, Furuyama H, Kubota H, Fujii N, Matsumoto H: Autoantibodies against HSP70 family <span class="tagged-filter" title="Association Word">proteins</span> were detected in the cerebrospinal fluid from patients with <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis.</span> J Neurol Sci. 2006 Feb 15;241(1-2):39-43. Epub 2005 Nov 21.</strong> We evaluated the specific IgG <span class="tagged-filter" title="Association Word">antibodies</span> against heat shock <span class="tagged-filter" title="Association Word">proteins</span> (HSPs) in cerebrospinal fluids (CSF) from patients with <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis</span> (MS). ELISA was employed to examine IgG <span class="tagged-filter" title="Association Word">antibodies</span> against ten HSPs <span class="tagged-gene" title="SwissProt ID: Q16082; Entrez Gene ID: 3316; HGNC ID: 5247; HPRD ID: 03712; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16082">(HSP27,</a></span> alphaA and alphaB crystallins, <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP60,</a></span> <span class="tagged-gene" title="Entrez Gene ID: 907; HGNC ID: 1614; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=907">CCT,</a></span> Mycobacterium bovis <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP65,</a></span> Escherichia coli GroEL, HSP70, <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70</a></span> and HSP90) in CSF from 30 patients with MS, and 25 patients with <span class="tagged-query" title="Query">motor neuron diseases</span> (MND). Significantly higher <span class="tagged-filter" title="Association Word">antibody</span> titers against HSP70 and <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70</a></span> <span class="tagged-filter" title="Association Word">proteins</span> were found in CSF obtained from patients with MS as compared with MND independent of CSF total <span class="tagged-filter" title="Association Word">protein,</span> IgG concentrations and IgG indices, respectively. The <span class="tagged-filter" title="Association Word">antibody</span> titers against HSP70 were indicated to be significantly higher in the progressive cases than in cases of remission. The results suggest that IgG <span class="tagged-filter" title="Association Word">antibodies</span> against specific types of HSPs especially HSP70 family <span class="tagged-filter" title="Association Word">proteins</span> (HSP70 and <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70)</a></span> in CSF may play an important <span class="tagged-filter" title="Association Word">role</span> in the pathophysiology of MS through the modification of immune response and cytoprotective functions of molecular chaperons.
motor_neuron_disease	HSP60	True Negative	1.441	15465612	<strong class="title">Yonekura K, Yokota S, Tanaka S, Kubota H, Fujii N, Matsumoto H, Chiba S: Prevalence of anti-heat shock <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-filter" title="Association Word">antibodies</span> in cerebrospinal fluids of patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">Guillain-Barre syndrome.</span> J Neuroimmunol. 2004 Nov;156(1-2):204-9.</strong> We examined <span class="tagged-filter" title="Association Word">antibodies</span> against 10 heat shock <span class="tagged-filter" title="Association Word">proteins</span> (HSPs) in cerebrospinal fluids (CSF) and sera from patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">Guillain-Barre syndrome</span> <span class="tagged-disease" title="UMLS Concept ID: C0018378">(GBS).</span> Significantly higher IgG <span class="tagged-filter" title="Association Word">antibody</span> titers against <span class="tagged-gene" title="SwissProt ID: Q16082; Entrez Gene ID: 3316; HGNC ID: 5247; HPRD ID: 03712; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16082">HSP27,</a></span> <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP60,</a></span> HSP70 and HSP90 family, including mycobacterial <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP65</a></span> and Escherichia coli GroEL, were found in CSF from <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> patients as compared with <span class="tagged-query" title="Query">motor neuron disease.</span> Serum IgG <span class="tagged-filter" title="Association Word">antibodies</span> against each <span class="tagged-gene" title="SwissProt ID: Q58FF3; Entrez Gene ID: 7190; HGNC ID: 12099; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q58FF3">HSP</a></span> showed no difference between <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> patients and normal controls. <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> seems to be induced by reactive <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune responses</span> frequently triggered by infections. The CSF <span class="tagged-filter" title="Association Word">antibodies</span> against HSPs may modify the immune responses and/or cell-protective functions of HSPs in the pathophysiology of <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS.</span>
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	16737688	<strong class="title">Leichsenring A, Linnartz B, Zhu XR, Lubbert H, Stichel CC: Ascending neuropathology in the CNS of a mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mouse model of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Neurobiol Dis. 2000 Dec;7(6 Pt B):623-43.</strong> Transgenic mice expressing a <span class="tagged-filter" title="Association Word">mutated</span> human Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> develop a <span class="tagged-query" title="Query">motor neuron disease</span> similar to familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS). While the histopathology and the inflammatory reactions in the spinal cord of these mice are well described, their spatiotemporal extension into brain areas and the relationship between degenerative and inflammatory events remain obscure. In the present study, we investigated the time course and extent of degenerative changes and inflammatory reactions in the CNS during progression of the disease in a transgenic FALS model, the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-G93A mouse with histological and immunohistochemical methods. Compared to non-transgenic littermates, the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-G93A transgenics developed widespread degeneration in both motor and extra-motor regions up to telencephalic regions, including the cerebral cortex but sparing distinct regions like the striatum and hippocampus. We provide evidence that these degenerative processes are accompanied by intense inflammatory reactions in the brain, which spatiotemporally correlate with degeneration and comprise besides strong astro- and microgliotic reactions also an influx of peripheral immune cells such as T-lymphocytes and dendritic cells. Both degeneration and inflammatory reactions spread caudocranially, starting at 2 months in the spinal cord and reaching the telencephalon at 5 months of age. Since the corticospinal tract lacked any signs of degeneration, we conclude that the upper and the lower motor neurons degenerate independently of each other.
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	16184763	<strong class="title">Batulan Z, Nalbantoglu J, Durham HD: Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells. Neuromuscul Disord. 2007 Jul 9;.</strong> Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to amplify the heat shock response in cell lines by increasing the binding of <span class="tagged-gene" title="SwissProt ID: Q00613; Entrez Gene ID: 3297; HGNC ID: 5224; HPRD ID: 00778; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q00613">heat shock transcription factor-1</a></span> to heat shock elements within heat shock <span class="tagged-filter" title="Association Word">gene</span> promoters. Because overexpression of the inducible heat shock <span class="tagged-filter" title="Association Word">protein</span> 70 <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">(Hsp70)</a></span> was neuroprotective in a culture model of <span class="tagged-query" title="Query">motor neuron disease,</span> this study investigated whether NSAIDs induce <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> and confer cytoprotection in motor neurons of dissociated spinal cord cultures exposed to various stresses. Two NSAIDs, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> and niflumic acid, lowered the temperature threshold for induction of <a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in glia but failed to do so in motor neurons. At concentrations that increased <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in heat shocked glial cells, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> failed to delay death of motor neurons exposed to <span class="tagged-disease" title="UMLS Concept ID: C0236832">hyperthermia,</span> paraquat-mediated oxidative stress, and <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> excitotoxicity. Neither <span class="tagged-metabolite" title="HMDB: HMDB00588"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> nor the <a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> inhibitor, niflumic acid, protected motor neurons from the toxicity of <span class="tagged-filter" title="Association Word">mutated</span> Cu/Zn-<span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD-1)</a></span> <span class="tagged-filter" title="Association Word">linked</span> to a familial form of the <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Thus, treatment with 2 types of NSAIDs failed to overcome the high threshold for the activation of heat shock response in motor neurons.
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	15773754	<strong class="title">Julien JP, Millecamps S, Kriz J: Cytoskeletal defects in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> <span class="tagged-query" title="Query">(motor neuron disease).</span> Novartis Found Symp. 2005;264:183-92; discussion 192-6</strong> There is growing evidence for the involvement of cytoskeletal defects in the pathogenesis of <span class="tagged-query" title="Query">motor neuron disease</span> and especially in components of the microtubule-based transport system. Here we will review our recent work aiming to elucidate the role of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and to address the mechanism of disease <span class="tagged-filter" title="Association Word">caused</span> by deletions in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> that <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-filter" title="Association Word">recessive</span> forms of juvenile ALS and <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis</span> <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">(PLS).</a></span> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin</a></span> is an intermediate filament <span class="tagged-filter" title="Association Word">protein</span> detected in spheroids, a hallmark of ALS, and increased levels of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> have been found in some ALS cases. Our transgenic mouse and cell culture studies support the view of a <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> involvement in ALS. However, a <span class="tagged-filter" title="Association Word">gene</span> knockout approach demonstrated that <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> is not a key contributor of <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by mutant <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-filter" title="Association Word">linked</span> to familial ALS. A recent breakthrough in the field of ALS came with the discovery of frameshift deletions in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> coding for <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin.</a></span> Our transfection experiments in cultured cells suggest that <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin</a></span> is a cytoskeletal <span class="tagged-filter" title="Association Word">protein</span> with dual endosomal and centrosomal localizations. We have generated a mouse knockout for <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin</a></span> that develops progressive motor dysfunction during ageing. Thus, it is anticipated that this mouse model will be useful to investigate the pathogenic pathways <span class="tagged-filter" title="Association Word">linked</span> to <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations.</span>
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	15738401	<strong class="title">Ray SS, Nowak RJ, Brown RH Jr, Lansbury PT Jr: Small-molecule-mediated stabilization of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span>-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> mutants against unfolding and aggregation. Ann N Y Acad Sci. 2003 Dec;1010:552-6.</strong> Familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS) is a fatal <span class="tagged-query" title="Query">motor neuron disease</span> that is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> encoding <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span>-type 1 <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1).</a></span> The affected regions of the FALS brain are characterized by aggregated <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1,</a></span> and the <span class="tagged-filter" title="Association Word">mutations</span> that destabilize <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> appear to promote its aggregation in vitro. Because dissociation of the native <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> dimer is required for its in vitro aggregation, we initiated an in silico screening program to find drug-like molecules that would stabilize the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> dimer. A potential binding site for such molecules at the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> dimer interface was identified, and its importance was validated by mutagenesis. About 1.5 million molecules from commercial databases were docked at the dimer interface. Of the 100 molecules with the highest predicted binding affinity, 15 significantly inhibited in vitro aggregation and denaturation of A4V, a FALS-<span class="tagged-filter" title="Association Word">linked</span> variant of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span> In the presence of several of these molecules, A4V and other FALS-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants such as G93A and G85R behaved similarly to wild-type <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1,</a></span> suggesting that these compounds could be <span class="tagged-filter" title="Association Word">leads</span> toward effective therapeutics against FALS.
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	15056757	<strong class="title">Hough MA, Grossmann JG, Antonyuk SV, Strange RW, Doucette PA, Rodriguez JA, Whitson LJ, Hart PJ, Hayward LJ, Valentine JS, Hasnain SS: Dimer destabilization in <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> may result in disease-<span class="tagged-filter" title="Association Word">causing</span> properties: structures of <span class="tagged-query" title="Query">motor neuron disease</span> mutants. Neurobiol Aging. 2006 Sep 11;.</strong> More than 90 point <span class="tagged-filter" title="Association Word">mutations</span> in human CuZn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-filter" title="Association Word">lead</span> to the development of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> known also as <span class="tagged-query" title="Query">motor neuron disease.</span> A growing body of evidence suggests that a subset of <span class="tagged-filter" title="Association Word">mutations</span> located close to the dimeric interface can <span class="tagged-filter" title="Association Word">lead</span> to a major destabilization of the mutant enzymes. We have determined the crystal structures of the Ala4Val (A4V) and Ile113Thr (I113T) mutants to 1.9 and 1.6 A, respectively. In the A4V structure, small changes at the dimer interface result in a substantial reorientation of the two monomers. This effect is also seen in the case of the I113T crystal structure, but to a smaller extent. X-ray solution scattering data show that in the solution state, both of the mutants undergo a more pronounced conformational change compared with wild-type <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD)</a></span> than that <span class="tagged-filter" title="Association Word">observed</span> in the A4V crystal structure. Shape reconstructions from the x-ray scattering data illustrate the nature of this destabilization. Comparison of these scattering data with those for bovine CuZn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD</a></span> measured at different temperatures shows that an analogous change in the scattering profile occurs for the bovine <span class="tagged-filter" title="Association Word">enzyme</span> in the temperature range of 70-80 degrees C. These results demonstrate that the A4V and I113T mutants are substantially destabilized in comparison with wild-type <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1,</a></span> and it is possible that the pathogenic properties of this subset of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> mutants are at least in part due to this destabilization.
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	14681966	<strong class="title">Skvortsova VI, Limborskaia SA, Slominskii PA, Levitskii GN, Levitskaia NI, Shadrina MI, Kondrat'eva EA, Brusov OS, Lysko AI, Karakhan VB, Alekhin AV, Serdiuk AV: [Peculiarities of sporadic <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">associated</span> with D90A and G12R <span class="tagged-filter" title="Association Word">mutations</span> in Russian population]. Brain. 2002 Apr;125(Pt 4):722-31.</strong> Fifty-one blood samples of Russian patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> were examined for <span class="tagged-filter" title="Association Word">mutations</span> in Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD-1)</a></span> <span class="tagged-filter" title="Association Word">gene.</span> One female patient with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) was heterozygous for G12R <span class="tagged-filter" title="Association Word">mutation.</span> This patient suffered from ALS with cervical cord onset, pyramidal variant and fast progression. <span class="tagged-filter" title="Association Word">Mutation</span> was also detected in her healthy son. Earlier, such <span class="tagged-filter" title="Association Word">mutation</span> was described in 5 Italian patients with slow progressive ALS. Also, D90A <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">associated</span> haplotypes of the female ALS patients previously examined by the authors have been analyzed. A homozygous female patient with ALS was characterized by typical lumbar onset and extremely slow progression, as well as a female patient with heterozygous <span class="tagged-filter" title="Association Word">mutation</span> and moderate progression carried so-called "Scandinavian" haplotype. To our knowledge, it is the first report on the finding of the haplotype considered as a "protective" one in the subjects heterozygous for D90A <span class="tagged-filter" title="Association Word">mutation</span> with clinical symptoms of ALS. Mechanisms of "protective" influence of this haplotype on ALS course are not yet elucidated. Our finding suggests that the presence of "Scandinavian" haplotype does not completely protect from the disease development in patients exposed to other more pathogenic causative factors. This assumption is in line with modern conceptions on <span class="tagged-query" title="Query">motor neuron disease</span> as a complicated multifactor disorder.
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	12828939	<strong class="title">Lariviere RC, Beaulieu JM, Nguyen MD, Julien JP: <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin</a></span> is not a contributing factor to <span class="tagged-query" title="Query">motor neuron disease</span> in a mouse model of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> <span class="tagged-filter" title="Association Word">caused</span> by mutant <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase.</a></span> Mol Med. 2000 May;6(5):410-29.</strong> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin</a></span> is a type III intermediate filament <span class="tagged-filter" title="Association Word">protein</span> detected in axonal spheroids <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). The overexpression of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> induces degeneration of spinal motor neurons during aging in transgenic mice and in cultured neuronal cells derived from <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> transgenic embryos. Here, we investigated whether <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> is a contributor of pathogenesis in mice overexpressing a mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1</a></span> (G37R)) <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">linked</span> to familial ALS. This was done by the generation and analysis of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G37R) mice that either overexpress a <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> transgene (G37R;TgPer mice) or lack the endogenous <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">gene</span> (G37R;Per-/- mice). Surprisingly, upregulation or suppression of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">expression</span> had no effects on disease onset, mortality, and loss of motor neurons in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G37R) mice. These results provide compelling evidence that <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> is not a key contributor of motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> <span class="tagged-filter" title="Association Word">associated</span> with toxicity of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span>
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	12165567	<strong class="title">Kirby J, Menzies FM, Cookson MR, Bushby K, Shaw PJ: Differential gene expression in a cell culture model of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-<span class="tagged-filter" title="Association Word">related</span> familial <span class="tagged-query" title="Query">motor neurone disease.</span> Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(11):46-52.</strong> <span class="tagged-query" title="Query">Motor neurone disease</span> is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> in 15-20% of familial cases, due to a toxic gain of function by the mutant <span class="tagged-filter" title="Association Word">enzyme.</span> However, the underlying mechanism of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-mediated <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration</span> remains uncertain. By investigating alterations in gene expression in the presence of mutant Cu/Zn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD,</a></span> we aimed to identify pathways that contribute to motor neurone injury and cell death. Using a cellular model of familial <span class="tagged-query" title="Query">motor neurone disease,</span> the motor neuronal cell line NSC34 was stably transfected with either normal or mutant (G37R, G93A, I113T) <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> cDNAs, and the effect of the presence of these <span class="tagged-filter" title="Association Word">proteins</span> on gene expression was analysed. This model allowed gene expression changes to be studied specifically in cells with a motor neurone phenotype, without interference from <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">expressed</span> by glia, astrocytes and other cell types located in the central nervous system. Using a commercially available cDNA membrane array, we investigated the <span class="tagged-filter" title="Association Word">expression</span> levels of 588 <span class="tagged-filter" title="Association Word">genes</span> from key biological pathways. Gene expression was studied in the cells under both basal culture conditions and following oxidative stress induced by serum withdrawal. Twenty-nine differentially <span class="tagged-filter" title="Association Word">expressed</span> <span class="tagged-filter" title="Association Word">genes</span> were identified, 7 of which were specifically downregulated in the presence of the mutant Cu/Zn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD</a></span> <span class="tagged-filter" title="Association Word">protein,</span> and whose <span class="tagged-filter" title="Association Word">expression</span> was further studied by real-time PCR. Presence of the mutant Cu/Zn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD</a></span> was confirmed to <span class="tagged-filter" title="Association Word">lead</span> to a decrease in <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: O15066; Entrez Gene ID: 9371; HGNC ID: 6320; HPRD ID: 04781; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O15066">KIF3B,</a></span> a kinesin-like <span class="tagged-filter" title="Association Word">protein,</span> which forms part of the <span class="tagged-gene" title="SwissProt ID: Q9Y496; Entrez Gene ID: 11127; HGNC ID: 6319; HPRD ID: 05250; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y496">KIF3</a></span> molecular motor. <span class="tagged-gene" title="SwissProt ID: P07332; Entrez Gene ID: 2242; HGNC ID: 3657; HPRD ID: 01814; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07332">c-Fes,</a></span> thought to be <span class="tagged-filter" title="Association Word">involved</span> in intracellular vesicle transport was also decreased, further implicating the involvement of vesicular trafficking as a mode of action for mutant Cu/Zn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD.</a></span> In addition, a decrease was confirmed in <span class="tagged-gene" title="SwissProt ID: P05362; Entrez Gene ID: 3383; HGNC ID: 5344; HPRD ID: 00996; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05362">ICAM1,</a></span> a response in part due to the increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1,</a></span> and decreased <span class="tagged-gene" title="SwissProt ID: Q99933; Entrez Gene ID: 573; HGNC ID: 937; HPRD ID: 03292; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99933">Bag1</a></span> <span class="tagged-filter" title="Association Word">expression</span> was confirmed in two of the three mutant cell lines, providing further support for the involvement of apoptosis in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-<span class="tagged-filter" title="Association Word">associated</span> motor neurone death.
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	11717358	<strong class="title">Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH Jr, Itoyama Y: Rats expressing human cytosolic <span class="tagged-metabolite" title="HMDB: HMDB00657"><span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00657">copper</a></span>-zinc <a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> transgenes with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis:</span> <span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">mutations</span> develop <span class="tagged-query" title="Query">motor neuron disease.</span> Am J Med Genet A. 2004 Sep 1;129(3):248-53.</strong> Some cases of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) are <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> encoding cytosolic, <span class="tagged-metabolite" title="HMDB: HMDB00657"><span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00657">copper</a></span>-zinc <a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1).</a></span> We report here that rats that express a human <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgene with two different ALS-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">mutations</span> (G93A and H46R) develop striking motor neuron degeneration and paralysis. As in the human disease and transgenic ALS mice, pathological analysis demonstrates selective loss of motor neurons in the spinal cords of these transgenic rats. In spinal cord tissues, this is accompanied by activation of apoptotic <span class="tagged-filter" title="Association Word">genes</span> known to be activated by mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">protein</span> in vitro and in vivo. These animals provide additional support for the proposition that motor neuron death in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-<span class="tagged-filter" title="Association Word">related</span> ALS reflects one or more acquired, <span class="tagged-metabolite" title="HMDB: HMDB02227"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02227">neurotoxic</a></span> properties of the mutant <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">protein.</span> The larger size of this rat model as compared with the ALS mice will facilitate studies <span class="tagged-filter" title="Association Word">involving</span> manipulations of spinal fluid (implantation of intrathecal catheters for chronic therapeutic studies; CSF sampling) and spinal cord (e.g., direct administration of viral- and cell-mediated therapies).
motor_neuron_disease	superoxide-dismutase	True Positive	5.831	11290408	<strong class="title">Williams RE, Cookson MR, Fray AE, Manning PM, Menzies FM, Figlewicz DA, Shaw PJ: Cultured glial cells are resistant to the effects of <span class="tagged-query" title="Query">motor neurone disease</span>-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Neurosci Lett. 2001 Apr 20;302(2-3):146-50.</strong> Free radical damage has been implicated in the pathophysiology of <span class="tagged-query" title="Query">motor neurone disease</span> (MND); <span class="tagged-filter" title="Association Word">mutations</span> have been identified in the <span class="tagged-filter" title="Association Word">gene</span> encoding Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1).</a></span> There is evidence that glial cell dysfunction may contribute to motor neurone injury, but the exact <span class="tagged-filter" title="Association Word">role</span> of glial cells in MND has yet to be established. The aim of this study was to determine whether <span class="tagged-filter" title="Association Word">expression</span> of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> affects the response of glia to oxidative stress. Stable C6 glioma cells expressing mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> and cortical astrocyte cultures from G93A-<span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mice were exposed to: <span class="tagged-metabolite" title="HMDB: HMDB00292"><span class="tagged-gene" title="SwissProt ID: P47989; Entrez Gene ID: 7498; HGNC ID: 12805; HPRD ID: 06363; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00292">xanthine</a></span>/<a href="http://beta.uniprot.org/uniprot/P47989">xanthine oxidase;</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01362"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01362">hydrogen</a></span> peroxide; A23187 and 3-morpholinosydonimine. Cell viability was measured using the 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium <span class="tagged-metabolite" title="HMDB: HMDB02500"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02500">bromide</a></span> assay. Neither C6 glioma cells nor cortical astrocytes expressing mutant <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> were more susceptible to any of the free radical generating systems compared to control cells. These results suggest that astrocytes are resistant to the toxic effects of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> widely reported for neuronal cells.
motor_neuron_disease	GLT-1	True Positive	1.858	16523673	<strong class="title">Zherebtsova AL, Shadrina MI, Semenova EV, Levitskii GN, Alekhin AV, Slominskii PA, Skvortsova VI, Limborskaia SA: [Analysis of the possible involvement of the <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> transporter <span class="tagged-filter" title="Association Word">gene</span> <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> and the <span class="tagged-gene" title="SwissProt ID: Q6EER8; Entrez Gene ID: 145781; HPRD ID: 08091; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6EER8">glutamate receptor</a></span> <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> in pathogenesis of <span class="tagged-query" title="Query">motor neuron disease</span> in the Russian population]. Genetika. 2006 Jan;42(1):104-9.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> of the <span class="tagged-filter" title="Association Word">genes</span> of the glutamatergic system <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> have been analyzed in patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> (MND) from Russia. The disease is not <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">polymorphic</span> alleles of the <span class="tagged-filter" title="Association Word">genes</span> studied, which indicates that <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> play an insignificant <span class="tagged-filter" title="Association Word">role</span> in the pathogenesis of sporadic MND.
motor_neuron_disease	GLT-1	True Positive	1.858	12752781	<strong class="title">Legay V, Deleage C, Beaulieux F, Giraudon P, Aymard M, Lina B: Impaired <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> uptake and <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> downregulation in an enterovirus chronically infected human glial cell line. Eur J Neurosci. 2003 May;17(9):1820-8.</strong> Rapid and efficient uptake of <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43005; Entrez Gene ID: 6505; HGNC ID: 10939; HPRD ID: 00597; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> via the <a href="http://beta.uniprot.org/uniprot/P43005">high-affinity glutamate transporter</a></span> <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> is important for limiting <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span>-mediated excitotoxicity <span class="tagged-filter" title="Association Word">involved</span> in neuronal death. Furthermore, there is evidence of <span class="tagged-filter" title="Association Word">altered</span> <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> uptake and catabolism in <span class="tagged-query" title="Query">motor neuron diseases.</span> Such a defect has been reported in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> the major <span class="tagged-query" title="Query">motor neuron disease,</span> and was <span class="tagged-filter" title="Association Word">associated</span> with impairment in <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> processing. We recently reported the presence of enterovirus genome specifically in the anterior horn of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> cases, suggesting the involvement of a chronic/persistent <span class="tagged-disease" title="UMLS Concept ID: C0014378">enterovirus infection</span> in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> To investigate a putative link between <span class="tagged-disease" title="UMLS Concept ID: C0014378">enterovirus infection</span> and the <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span>-mediated excitotoxicity <span class="tagged-filter" title="Association Word">observed</span> in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> we developed an in vitro model consisting of a human glial cell line infected with ECHOvirus 6, one of the enteroviruses with sequences closely <span class="tagged-filter" title="Association Word">related</span> to those detected in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> In these glial cells, an ECHOvirus 6 <span class="tagged-disease" title="UMLS Concept ID: C0151317">chronic infection</span> was established, resulting in <span class="tagged-filter" title="Association Word">altered</span> extracellular <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> uptake. This correlated with an aberrant splicing of the <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> pre-messenger ribonucleic acid and a significant loss of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-filter" title="Association Word">expression,</span> similar to that <span class="tagged-filter" title="Association Word">observed</span> in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> These results provide convincing evidence that an enterovirus chronic/<span class="tagged-disease" title="UMLS Concept ID: C1264606">persistent infection</span> may <span class="tagged-filter" title="Association Word">alter</span> glial <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> uptake and catabolism. As enteroviruses are extremely common human pathogens, they may act as a trigger in the development of certain <span class="tagged-query" title="Query">motor neuron diseases,</span> such as <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span>
motor_neuron_disease	GLT-1	True Positive	1.858	12153483	<strong class="title">Munch C, Ebstein M, Seefried U, Zhu B, Stamm S, Landwehrmeyer GB, Ludolph AC, Schwalenstocker B, Meyer T: Alternative splicing of the 5'-sequences of the mouse <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> transporter and <span class="tagged-filter" title="Association Word">expression</span> in a <span class="tagged-disease" title="UMLS Concept ID: C1519606">transgenic model</span> for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> J Neurochem. 2002 Aug;82(3):594-603.</strong> <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">Glutamate</a></span>-mediated neurotoxicity and a reduced <span class="tagged-filter" title="Association Word">expression</span> of the <a href="http://beta.uniprot.org/uniprot/P43004">excitatory amino acid transporter 2</a></span> <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">(EAAT2)</a></span> have been described in the pathogenesis of several acute and chronic neurological conditions. <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> is the major carrier of <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> in the mammalian brain. However, the principles of <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> <span class="tagged-filter" title="Association Word">expression</span> <span class="tagged-filter" title="Association Word">regulation</span> are not fully understood. For the human brain, extensive alternative splicing of the <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> RNA has been shown. To delineate the complex RNA <span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> we investigated whether the murine species is a suitable model for the study of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> splicing events. We identified five splice variants (mEAAT2/5UT1-5) encoding different 5'-untranslated sequences and two distinct N-termini of the putative <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> polypeptide. In the murine CNS we found a region-specific <span class="tagged-filter" title="Association Word">expression</span> pattern of the novel 5'-variants of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> as shown by in situ hybridization, dot blotting and competitive reverse transcription polymerase chain reaction. Furthermore, we performed an <span class="tagged-filter" title="Association Word">expression</span> analysis of the <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> splice variants in the spinal cord of a <span class="tagged-disease" title="UMLS Concept ID: C1519606">transgenic model</span> (SOD1G93A) of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> a <span class="tagged-query" title="Query">motor neurone disease</span> for which <span class="tagged-filter" title="Association Word">altered</span> splicing of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> has been discussed. We found an increased <span class="tagged-filter" title="Association Word">expression</span> of mEAAT2/5UT4 and a reduction of mEAAT2/5UT5 in the early course of the disease. We conclude that alternative splicing of 5'-sequences may contribute to the regional <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> RNA and was <span class="tagged-filter" title="Association Word">altered</span> in the pre-symptomatic stage of the SOD1G93A-mouse model for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span>
motor_neuron_disease	GLT-1	True Positive	1.858	11784698	<strong class="title">Banner SJ, Fray AE, Ince PG, Steward M, Cookson MR, Shaw PJ: The <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> re-uptake transporter <a href="http://beta.uniprot.org/uniprot/P43003">excitatory amino acid transporter 1</a></span> <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">(EAAT1)</a></span> in the normal human CNS and in <span class="tagged-query" title="Query">motor neurone disease:</span> an immunohistochemical study. Neuroscience. 2002;109(1):27-44.</strong> A monoclonal <span class="tagged-filter" title="Association Word">antibody</span> to <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">excitatory amino acid transporter 1</a></span> <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">(EAAT1)</a></span> has been generated which robustly stains paraffin-embedded, <span class="tagged-metabolite" title="HMDB: HMDB01426"><span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01426">formaldehyde</a></span>-fixed as well as snap-frozen human post-mortem brain tissue. We have used this <span class="tagged-filter" title="Association Word">antibody</span> to map the distribution of <a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> throughout normal human CNS tissue. In addition this <span class="tagged-filter" title="Association Word">antibody</span> has been used to perform a semi-quantitative immunohistochemical analysis of the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> in motor cortex and cervical cord tissue taken from <span class="tagged-query" title="Query">motor neurone disease</span> cases (n=17) and neurologically normal controls (n=12). By comparing the relative optical density measurements of identical regions of motor cortex and cervical spinal cord an increase in the <span class="tagged-filter" title="Association Word">expression</span> levels of <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> was <span class="tagged-filter" title="Association Word">observed</span> in <span class="tagged-query" title="Query">motor neurone disease</span> tissue compared to the control tissue and in both motor cortex and cervical spinal cord (9-17% and 13-33% increases respectively). <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> was <span class="tagged-filter" title="Association Word">observed</span> to be the most abundant transporter in more "caudal" brain regions such as the diencephalon and brainstem and its <span class="tagged-filter" title="Association Word">expression</span> in other regions was frequently more uniform than that of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2.</a></span> In the motor cortex, <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> immunoreactivity was present in all grey matter laminae, with some staining of individual astrocytes in the white matter. In spinal cord, <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> immunoreactivity was strongest in the substantia gelatinosa. In the ventral horn, motor neurones were surrounded with a dense rim of perisomatic <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> immunoreactivity, and the neuropil showed diffuse staining. Additional studies using double-labelling immunocytochemistry demonstrated that astrocytic co-localisation of <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> and <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> may occasionally be seen, but was not widespread in the human CNS and that in general astrocytes were positive for either <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> or EAAT2.These results demonstrate that the <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> has a widespread abundance throughout all regions of the human CNS examined and that there exist discrete populations of astrocytes that are positive solely for either <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2.</a></span> Furthermore, there is evidence to suggest that <span class="tagged-filter" title="Association Word">altered</span> <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> <span class="tagged-filter" title="Association Word">expression</span> in <span class="tagged-query" title="Query">motor neurone disease</span> follows a different pattern to the reported changes of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in this condition, indicating that the <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> transporters in the pathogenesis of <span class="tagged-query" title="Query">motor neurone disease</span> appears more complex than previously appreciated.
motor_neuron_disease	huntingtin	True Negative	1.441	12070670	<strong class="title">Adamec E, Mohan P, Vonsattel JP, Nixon RA: <span class="tagged-gene" title="Protein Family or Complex">Calpain</span> activation in <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases:</span> confocal immunofluorescence study with <span class="tagged-filter" title="Association Word">antibodies</span> specifically recognizing the active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2.</a></span> Acta Neuropathol. 2002 Jul;104(1):92-104. Epub 2002 Mar 23.</strong> The <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span>-activated protease <span class="tagged-gene" title="Protein Family or Complex">calpain</span> cleaves a variety of biologically important <span class="tagged-filter" title="Association Word">proteins</span> and serves, therefore, as a key regulator of many cellular functions. Activation of both main isoforms, <span class="tagged-gene" title="Protein Family or Complex">calpain</span> 1 and <a href="http://beta.uniprot.org/uniprot/P17655">calpain 2,</a></span> was demonstrated previously in <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease.</span> In this report, <span class="tagged-filter" title="Association Word">antibodies</span> specifically recognizing the active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> were used to investigate <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> activation in a broad range of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases,</span> utilizing multiple-label confocal immunofluorescence imaging. With rare exceptions, the active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> was found in colocalization with hyperphosphorylated tau protein. Aggregates of <span class="tagged-filter" title="Association Word">mutated</span> <span class="tagged-gene" title="SwissProt ID: P42858; Entrez Gene ID: 3064; HGNC ID: 4851; HPRD ID: 00883; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42858">huntingtin,</a></span> <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">alpha-synuclein,</a></span> or unidentified <span class="tagged-filter" title="Association Word">protein</span> in <span class="tagged-query" title="Query">motor neuron disease</span> type of <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> were always negative. These findings indicate that <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> activation is not a general response to <span class="tagged-filter" title="Association Word">protein</span> aggregation. In <span class="tagged-disease" title="UMLS Concept ID: C0949664">tauopathies,</span> more pathological inclusions were labeled for hyperphosphorylated tau than for activated <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2.</a></span> The extent of colocalization varied in both a disease-specific and cell-type specific manner. The active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> was detected in 50-75% of tau neurofibrillary pathology in <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease,</span> Alzheimer neurofibrillary changes and <span class="tagged-disease" title="UMLS Concept ID: C0013080">Down's syndrome,</span> as well as in the accompanying Alzheimer-type tau pathology in diffuse Lewy bodies disease, <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration.</span> For glial cells, only 10-25% of tuft-shaped astrocytes, glial plaques, or coiled bodies contained activated <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2.</a></span> The majority of Pick bodies were negative. The <span class="tagged-filter" title="Association Word">association</span> of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> activation with hyperphosphorylated tau might be the result of an attempt by the <span class="tagged-gene" title="Protein Family or Complex">calpain</span> proteolytic system to degrade the tau <span class="tagged-filter" title="Association Word">protein</span> aggregates. Alternatively, <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> could be directly <span class="tagged-filter" title="Association Word">involved</span> in tau hyperphosphorylation by modulating <span class="tagged-filter" title="Association Word">protein</span> kinase activities. Overall, these results provide evidence of the important <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-gene" title="Protein Family or Complex">calpain</span> proteolytic system in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> with tau neurofibrillary pathology.
motor_neuron_disease	Gemin2	True Positive	2.380	15843395	<strong class="title">Feng W, Gubitz AK, Wan L, Battle DJ, Dostie J, Golembe TJ, Dreyfuss G: Gemins modulate the <span class="tagged-filter" title="Association Word">expression</span> and <span class="tagged-filter" title="Association Word">activity</span> of the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex. Hum Mol Genet. 2005 Jun 15;14(12):1605-11. Epub 2005 Apr 20.</strong> Reduction in the <span class="tagged-filter" title="Association Word">expression</span> of the survival of motor neurons <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">(SMN)</a></span> <span class="tagged-filter" title="Association Word">protein</span> results in <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA),</a></span> a common motor neuron <span class="tagged-disease" title="UMLS Concept ID: C1285162">degenerative disease.</span> <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> is part of a large macromolecular complex (the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex) that includes at least six additional <span class="tagged-filter" title="Association Word">proteins</span> called Gemins <span class="tagged-gene" title="SwissProt ID: O14893; Entrez Gene ID: 8487; HGNC ID: 10884; HPRD ID: 03999; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14893">(Gemin2</a></span>-7). The <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex is <span class="tagged-filter" title="Association Word">expressed</span> in all cells and is present throughout the cytoplasm and in the nucleus where it is concentrated in Gems. The <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex plays an essential <span class="tagged-filter" title="Association Word">role</span> in the <span class="tagged-filter" title="Association Word">production</span> of spliceosomal small nuclear ribonucleoproteins (snRNPs) and likely other RNPs. To study the <span class="tagged-filter" title="Association Word">roles</span> of the individual <span class="tagged-filter" title="Association Word">proteins,</span> we systematically reduced the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> and each of the Gemins (2-6) by RNA interference. We show that the reduction of <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">leads</span> to a decrease in <span class="tagged-gene" title="SwissProt ID: Q9Y333; Entrez Gene ID: 57819; HGNC ID: 13940; HPRD ID: 06282; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y333">snRNP</a></span> assembly, the disappearance of Gems, and to a drastic reduction in the amounts of several Gemins. Moreover, reduction of <span class="tagged-gene" title="SwissProt ID: O14893; Entrez Gene ID: 8487; HGNC ID: 10884; HPRD ID: 03999; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14893">Gemin2</a></span> or <span class="tagged-gene" title="SwissProt ID: Q8WXD5; Entrez Gene ID: 79833; HGNC ID: 20044; HPRD ID: 06110; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WXD5">Gemin6</a></span> strongly decreases the <span class="tagged-filter" title="Association Word">activity</span> of the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex. These findings demonstrate that other components of the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex, in addition to <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN,</a></span> are critical for the <span class="tagged-filter" title="Association Word">activity</span> of the complex and suggest that <span class="tagged-gene" title="SwissProt ID: O14893; Entrez Gene ID: 8487; HGNC ID: 10884; HPRD ID: 03999; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14893">Gemin2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q8WXD5; Entrez Gene ID: 79833; HGNC ID: 20044; HPRD ID: 06110; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WXD5">Gemin6</a></span> are potentially important modifiers of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> as well as potential disease <span class="tagged-filter" title="Association Word">genes</span> for non-<span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	Tet1	True Negative	1.441	16023583	<strong class="title">Liu JK, Teng Q, Garrity-Moses M, Federici T, Tanase D, Imperiale MJ, Boulis NM: A novel peptide defined through phage display for therapeutic <span class="tagged-filter" title="Association Word">protein</span> and vector neuronal targeting. Neurobiol Dis. 2005 Aug;19(3):407-18.</strong> A novel peptide with the binding characteristics of <span class="tagged-disease" title="UMLS Concept ID: C0039614">tetanus</span> toxin was identified with phage display, for application in therapeutic <span class="tagged-filter" title="Association Word">protein</span> and vector motor and sensory neuron targeting. A 12mer phage library was biopanned on trisialoganglioside (G (T1b)) and eluted with the <span class="tagged-disease" title="UMLS Concept ID: C0039614">tetanus</span> toxin C fragment (rTTC). Phage ELISAs revealed increases in G (T1b) binding for the <span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q96JX5; Entrez Gene ID: 54790; HGNC ID: 25941; HPRD ID: 07876; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96JX5">Tet2</a></span> phage clones when compared to peptideless phage <span class="tagged-metabolite" title="HMDB: HMDB01491"><span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01491">(PLP).</a></span> rTTC displaced both <a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q96JX5; Entrez Gene ID: 54790; HGNC ID: 25941; HPRD ID: 07876; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96JX5">Tet2</a></span> phage clones from G (T1b), and both clones reduced rTTC-G (T1b) binding. Comparison of <span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1,</a></span> <span class="tagged-gene" title="SwissProt ID: Q96JX5; Entrez Gene ID: 54790; HGNC ID: 25941; HPRD ID: 07876; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96JX5">Tet2,</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01491"><span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01491">PLP,</a></span> and the random phage library binding to PC12 and HEK293 cells revealed enhanced cellular binding by <a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q96JX5; Entrez Gene ID: 54790; HGNC ID: 25941; HPRD ID: 07876; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96JX5">Tet2</a></span> phage. <span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1</a></span> phage binding was selective for neurons. Immunofluorescence also confirmed selective PC12 binding of <span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q96JX5; Entrez Gene ID: 54790; HGNC ID: 25941; HPRD ID: 07876; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96JX5">Tet2</a></span> phage. <span class="tagged-drug" title="DrugBank: APRD00979"><span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00979">Fluorescein</a></span>-conjugated synthetic <a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1,</a></span> but not <span class="tagged-gene" title="SwissProt ID: Q96JX5; Entrez Gene ID: 54790; HGNC ID: 25941; HPRD ID: 07876; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96JX5">Tet2,</a></span> peptide showed strong binding to cultured PC12, primary motor neurons, and dorsal root ganglion <span class="tagged-gene" title="SwissProt ID: Q9Y295; Entrez Gene ID: 4733; HGNC ID: 3029; HPRD ID: 16034; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y295">(DRG)</a></span> cells. Synthetic <span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1</a></span> bound <span class="tagged-gene" title="SwissProt ID: Q9Y295; Entrez Gene ID: 4733; HGNC ID: 3029; HPRD ID: 16034; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y295">DRG</a></span> and motor neurons but not muscle in tissue sections. The enhanced neuronal binding affinity and specificity of <span class="tagged-gene" title="SwissProt ID: Q8NFU7; Entrez Gene ID: 80312; HGNC ID: 29484; HPRD ID: 09694; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NFU7">Tet1,</a></span> a novel 12 amino acid peptide, suggests potential utility for targeting neurotherapeutic <span class="tagged-filter" title="Association Word">proteins</span> and viral vectors in the treatment of <span class="tagged-query" title="Query">motor neuron disease,</span> neuropathy, and pain.
motor_neuron_disease	NF-L	True Positive	1.441	16236762	<strong class="title">Lin H, Zhai J, Schlaepfer WW: <span class="tagged-gene" title="SwissProt ID: Q8NI52; Entrez Gene ID: 54502; HPRD ID: 13373; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NI52">RNA-binding protein</a></span> is <span class="tagged-filter" title="Association Word">involved</span> in aggregation of light <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">neurofilament protein</a></span> and is implicated in the pathogenesis of motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> Hum Mol Genet. 2005 Dec 1;14(23):3643-59. Epub 2005 Oct 19.</strong> Abnormal <span class="tagged-filter" title="Association Word">protein</span> aggregation is emerging as a common theme in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disease.</span> Our previous studies have shown that overexpression of untranslated light neurofilament <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">(NF-L)</a></span> RNA <span class="tagged-filter" title="Association Word">causes</span> motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in transgenic mice, <span class="tagged-filter" title="Association Word">leads</span> to accumulation of ubiquitinated aggregates in degenerating cultured motor neurons and triggers aggregation of <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">protein</span> and co-aggregation of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">protein</span> in neuronal cells. Here, we report that p190RhoGEF, an <span class="tagged-gene" title="SwissProt ID: Q8NI52; Entrez Gene ID: 54502; HPRD ID: 13373; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8NI52">RNA-binding protein</a></span> that binds to a destabilizing element in <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">mRNA,</span> is <span class="tagged-filter" title="Association Word">involved</span> in aggregation of <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">protein</span> and is implicated in the pathogenesis of motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> We show that p190RhoGEF co-aggregates with unassembled <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">protein</span> and that co-aggregation is <span class="tagged-filter" title="Association Word">associated</span> with down-<span class="tagged-filter" title="Association Word">regulation</span> of parent <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> in neuronal cells. Co-<span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P07197; Entrez Gene ID: 4741; HGNC ID: 7734; HPRD ID: 01205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07197">NF-M</a></span> increases NF assembly and reduces RNA-triggered aggregation as well as loss of solubility of <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">protein.</span> siRNA-induced down-<span class="tagged-filter" title="Association Word">regulation</span> of p190RhoGEF not only reduces aggregation and promotes assembly of <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> and <span class="tagged-gene" title="SwissProt ID: P07197; Entrez Gene ID: 4741; HGNC ID: 7734; HPRD ID: 01205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07197">NF-M,</a></span> but also <span class="tagged-filter" title="Association Word">causes</span> reversal of aggregation and recovery of NF assembly in transfected cells. Examination of transgenic models of <span class="tagged-query" title="Query">motor neuron disease</span> shows that prominent aggregates of p190RhoGEF and <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> and down-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">expression</span> occur in degenerating motor neurons of mice expressing untranslated <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> RNA or a G93A mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgene. Moreover, aggregates of p190RhoGEF and <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> appear as early pathological changes in presymptomatic G93A mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mice. Together, the findings indicate that p190RhoGEF is <span class="tagged-filter" title="Association Word">involved</span> in aggregation of <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> <span class="tagged-filter" title="Association Word">protein</span> and support a working hypothesis that aggregation of p190RhoGEF and <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> is an upstream event triggering neurotoxicity in <span class="tagged-query" title="Query">motor neuron disease.</span>
motor_neuron_disease	NF-L	True Positive	1.441	15742362	<strong class="title">Dubois M, Lalonde R, Julien JP, Strazielle C: Mice with the <span class="tagged-filter" title="Association Word">deleted</span> neurofilament of low-molecular-weight (Nefl) <span class="tagged-filter" title="Association Word">gene:</span> 1. J Neurosci Res. 2005 Jun 15;80(6):741-50.</strong> Effects on regional brain metabolism. Neuronal intermediate filaments consist of the <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NFL</a></span> subunit <span class="tagged-filter" title="Association Word">linked</span> with <span class="tagged-gene" title="SwissProt ID: P07197; Entrez Gene ID: 4741; HGNC ID: 7734; HPRD ID: 01205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07197">NFM</a></span> and <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">NFH,</a></span> and their alterations have been proposed as a pathogenesic <span class="tagged-filter" title="Association Word">cause</span> in <span class="tagged-query" title="Query">motor neuron diseases.</span> Depletion of the Nefl <span class="tagged-filter" title="Association Word">gene</span> in mice mimicks the reduced <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NFL</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> levels seen in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> and <span class="tagged-filter" title="Association Word">causes</span> perikaryal accumulation of neurofilament <span class="tagged-filter" title="Association Word">proteins</span> and axonal hypotrophy in motoneurons. <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NFL</a></span> -/- mice were evaluated for regional brain metabolism by means of quantitative histochemical estimation of cytochrome oxidase (COx) <span class="tagged-filter" title="Association Word">activity.</span> The <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NFL</a></span> null mice displayed enzymatic <span class="tagged-filter" title="Association Word">activity</span> alterations in numerous hindbrain regions, mainly the cerebellum, connected regions of the brainstem (red nucleus, vestibular nuclei, and reticular formation), and cranial nerve nuclei. All of the affected regions presented <span class="tagged-filter" title="Association Word">elevated</span> COx <span class="tagged-filter" title="Association Word">activity,</span> except for the Purkinje cells of the cerebellum and the magnocellular red nucleus, where enzymatic <span class="tagged-filter" title="Association Word">activity</span> was lower. <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NFL</a></span>-disrupted mice displayed functional alterations in brainstem sensorimotor regions affected in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span>
motor_neuron_disease	NF-L	False Negative	1.441	10515233	<strong class="title">Meier J, Couillard-Despres S, Jacomy H, Gravel C, Julien JP: Extra neurofilament <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> subunits rescue <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by overexpression of the human <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">NF-H</a></span> <span class="tagged-filter" title="Association Word">gene</span> in mice. J Neuropathol Exp Neurol. 1999 Oct;58(10):1099-110.</strong> Previous studies demonstrated that transgenic mice overexpressing human neurofilament heavy (hNF-<span class="tagged-gene" title="SwissProt ID: Q13203; Entrez Gene ID: 4608; HGNC ID: 7552; HPRD ID: 01186; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13203">H) protein</a></span> develop a progressive <span class="tagged-query" title="Query">motor neuron disease</span> characterized by the perikaryal accumulations of neurofilaments resembling those found in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). To further investigate this neurofilament-induced pathology, we generated transgenic mice expressing, solely or concomitantly, the hNF-H and the human neurofilament light (hNF-L) <span class="tagged-filter" title="Association Word">proteins.</span> We report here that the <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by excess hNF-H <span class="tagged-filter" title="Association Word">proteins</span> can be rescued by overexpression of hNF-L in a dosage-dependent fashion. In hNF-H transgenic mice, the additional hNF-L <span class="tagged-filter" title="Association Word">led</span> to reduction of perikaryal swellings, relief of axonal transport defect and restoration of axonal radial growth. A <span class="tagged-filter" title="Association Word">gene</span> delivery approach based on recombinant adenoviruses bearing the hNF-L <span class="tagged-filter" title="Association Word">gene</span> also demonstrated the possibility to reduce perikaryal swellings after their formation in adult mice. The finding that extra <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> can protect against <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">NF-H</a></span>-mediated pathogenesis is of potential importance for ALS, particularly for cases with <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">NF-H</a></span> abnormalities.
motor_neuron_disease	14-3-3	True Negative	1.441	17190946	<strong class="title">Bersano A, Fiorini M, Allaria S, Zanusso G, Fasoli E, Gelati M, Monaco H, Squintani G, Monaco S, Nobile-Orazio E: Detection of CSF <span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> <span class="tagged-filter" title="Association Word">protein</span> in <span class="tagged-disease" title="UMLS Concept ID: C0018378">Guillain-Barre syndrome.</span> Neurology. 2006 Dec 26;67(12):2211-6.</strong> OBJECTIVE: To search for biologic <span class="tagged-filter" title="Association Word">markers</span> in the <span class="tagged-disease" title="UMLS Concept ID: C0018378">Guillain-Barre syndrome</span> <span class="tagged-disease" title="UMLS Concept ID: C0018378">(GBS),</span> we studied CSF samples from patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> and neuropathy of various etiologies for the presence of <span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> <span class="tagged-filter" title="Association Word">protein.</span> METHODS: CSF samples from patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS,</span> chronic neuropathies, <span class="tagged-query" title="Query">motor neuron disease</span> (MND), definite sporadic <span class="tagged-disease" title="UMLS Concept ID: C0022336">Creutzfeldt-Jakob disease</span> (sCJD), and normal control subjects were analyzed by standard immunoblot assay, using a polyclonal anti-<span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> <span class="tagged-filter" title="Association Word">antibody.</span> CSF samples were also tested with <span class="tagged-filter" title="Association Word">antibodies</span> recognizing specific isoforms of <span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> <span class="tagged-filter" title="Association Word">proteins,</span> either after one-dimensional or two-dimensional electrophoretic separation. RESULTS: A positive <span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> assay was <span class="tagged-filter" title="Association Word">observed</span> in 29 of 38 patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> and in 4 patients with MND and other neuropathies, including 2 subjects with vasculitic neuropathy (VN). In <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS,</span> <span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> <span class="tagged-filter" title="Association Word">protein</span> was detected as early as 12 to 48 hours after disease onset and showed an isoform pattern different from that encountered in patients with noninflammatory neuropathies, VN, MND, and sCJD. Immunohistochemical studies performed in archival fatal <span class="tagged-disease" title="UMLS Concept ID: C0018378">GBS</span> cases disclosed marked <span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> <span class="tagged-filter" title="Association Word">expression</span> by mononuclear inflammatory infiltrates and Schwann cells. CONCLUSION: CSF <span class="tagged-gene" title="SwissProt ID: P27348; Entrez Gene ID: 10971; HGNC ID: 12854; HPRD ID: 00886; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27348">14-3-3</a></span> assay may represent a useful biologic <span class="tagged-filter" title="Association Word">marker</span> in patients with <span class="tagged-disease" title="UMLS Concept ID: C0018378">Guillain-Barre syndrome.</span>
motor_neuron_disease	Paraplegin	True Negative	1.441	14506940	<strong class="title">McDermott CJ, Roberts D, Tomkins J, Bushby KM, Shaw PJ: <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">Spastin</a></span> and <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">gene</span> analysis in selected cases of <span class="tagged-query" title="Query">motor neurone disease</span> (MND). Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun;4(2):96-9.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in both the <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> and <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">genes</span> have been <span class="tagged-filter" title="Association Word">associated</span> with upper motor neurone degeneration in hereditary spastic paraparesis. The aim of this study was to investigate if <span class="tagged-filter" title="Association Word">mutation</span> in these <span class="tagged-filter" title="Association Word">genes</span> is <span class="tagged-filter" title="Association Word">associated</span> with upper motor neurone degeneration in <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis</span> <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">(PLS)</a></span> or selected <span class="tagged-query" title="Query">motor neurone disease</span> (MND) cases. DNA was extracted from whole blood and screened using single stranded conformation <span class="tagged-filter" title="Association Word">polymorphism</span> and heteroduplex analysis. No <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> or <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">genes</span> was identified in the <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">PLS</a></span> or MND cases. <span class="tagged-filter" title="Association Word">Polymorphism</span> was identified in the <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">gene</span> but no <span class="tagged-filter" title="Association Word">association</span> was shown with <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">PLS</a></span> or MND. We therefore conclude that <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-gene" title="SwissProt ID: Q9UBP0; Entrez Gene ID: 6683; HGNC ID: 11233; HPRD ID: 05044; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UBP0">spastin</a></span> and <span class="tagged-gene" title="SwissProt ID: O43535; Entrez Gene ID: 6687; HGNC ID: 11237; HPRD ID: 04149; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43535">paraplegin</a></span> <span class="tagged-filter" title="Association Word">genes</span> does not appear to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">PLS</a></span> or MND.
motor_neuron_disease	androgen-receptor	True Positive	5.280	17494697	<strong class="title">Adachi H, Waza M, Tokui K, Katsuno M, Minamiyama M, Tanaka F, Doyu M, Sobue G: <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">CHIP</a></span> overexpression reduces mutant <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> <span class="tagged-filter" title="Association Word">protein</span> and ameliorates phenotypes of the <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy</span> transgenic mouse model. J Neurosci. 2007 May 9;27(19):5115-26.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an inherited <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by the expansion of a <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> tract within the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR). The pathologic features of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> are motor <span class="tagged-disease" title="UMLS Concept ID: C0598940">neuron loss</span> in the spinal cord and brainstem and diffuse nuclear accumulation and nuclear inclusions of the mutant AR in the residual motor neurons and certain visceral organs. Many components of the <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-<span class="tagged-gene" title="Protein Family or Complex">proteasome</span> and molecular chaperones are also sequestered in the inclusions, suggesting that they may be actively engaged in an attempt to degrade or refold the mutant AR. C terminus of Hsc70 (heat shock cognate <span class="tagged-filter" title="Association Word">protein</span> 70)-interacting <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">(CHIP),</a></span> a U-box type E3 <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> ligase, has been shown to interact with heat shock <span class="tagged-filter" title="Association Word">protein</span> 90 <span class="tagged-gene" title="SwissProt ID: P07900; Entrez Gene ID: 3320; HGNC ID: 5253; HPRD ID: 00777; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07900">(Hsp90)</a></span> or <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> and ubiquitylates unfolded <span class="tagged-filter" title="Association Word">proteins</span> trapped by molecular chaperones and degrades them. Here, we demonstrate that transient overexpression of <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">CHIP</a></span> in a neuronal cell model reduces the monomeric mutant AR more effectively than it does the wild type, suggesting that the mutant AR is more sensitive to <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">CHIP</a></span> than is the wild type. High <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">CHIP</a></span> in an <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> transgenic mouse model also ameliorated motor symptoms and inhibited neuronal nuclear accumulation of the mutant AR. When <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">CHIP</a></span> was overexpressed in transgenic <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> mice, mutant AR was also preferentially degraded over wild-type AR. These findings suggest that <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">CHIP</a></span> overexpression ameliorates <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> phenotypes in mice by reducing nuclear-localized mutant AR via enhanced mutant AR degradation. Thus, <span class="tagged-gene" title="SwissProt ID: Q9HBT1; Entrez Gene ID: 10273; HGNC ID: 11427; HPRD ID: 06232; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9HBT1">CHIP</a></span> overexpression would provide a potential therapeutic avenue for <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA.</a></span>
motor_neuron_disease	androgen-receptor	True Positive	5.280	16621916	<strong class="title">Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G: Natural history of <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA):</a></span> a study of 223 Japanese patients. Brain. 2006 Jun;129(Pt 6):1446-55. Epub 2006 Apr 18.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an adult-onset <span class="tagged-query" title="Query">motoneuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by a CAG-repeat expansion in the <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR) <span class="tagged-filter" title="Association Word">gene</span> and for which no curative therapy exists. However, since recent research may provide opportunities for medical treatment, information concerning the natural history of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> would be beneficial in planning future clinical trials. We investigated the natural course of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> as assessed by nine activities of daily living <span class="tagged-gene" title="SwissProt ID: Q16586; Entrez Gene ID: 6442; HGNC ID: 10805; HPRD ID: 02525; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16586">(ADL)</a></span> milestones in 223 Japanese <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> patients (mean age at data collection = 55.2 years; range = 30-87 years) followed from 1 to 20 years. All the patients were <span class="tagged-filter" title="Association Word">diagnosed</span> by genetic analysis. Hand tremor was an early event that was noticed at a median age of 33 years. Muscular weakness occurred predominantly in the lower limbs, and was noticed at a median age of 44 years, followed by the requirement of a handrail to ascend stairs at 49, dysarthria at 50, <span class="tagged-disease" title="UMLS Concept ID: C0011168">dysphagia</span> at 54, use of a cane at 59 and a wheelchair at 61 years. Twenty-one of the patients developed <span class="tagged-disease" title="UMLS Concept ID: C1535472">pneumonia</span> at a median age of 62 and 15 of them died at a median age of 65 years. The most common <span class="tagged-filter" title="Association Word">cause</span> of death in these cases was <span class="tagged-disease" title="UMLS Concept ID: C1535472">pneumonia</span> and <span class="tagged-disease" title="UMLS Concept ID: C1145670">respiratory failure.</span> The ages at onset of each <span class="tagged-gene" title="SwissProt ID: Q16586; Entrez Gene ID: 6442; HGNC ID: 10805; HPRD ID: 02525; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16586">ADL</a></span> milestone were strongly correlated with the length of CAG repeats in the AR <span class="tagged-filter" title="Association Word">gene.</span> However CAG-repeat length did not correlate with the time intervals between each <span class="tagged-gene" title="SwissProt ID: Q16586; Entrez Gene ID: 6442; HGNC ID: 10805; HPRD ID: 02525; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16586">ADL</a></span> milestone, suggesting that although the onset age of each <span class="tagged-gene" title="SwissProt ID: Q16586; Entrez Gene ID: 6442; HGNC ID: 10805; HPRD ID: 02525; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16586">ADL</a></span> milestone depends on the CAG-repeat length in the AR <span class="tagged-filter" title="Association Word">gene,</span> the rate of disease progression does not. The levels of serum <span class="tagged-metabolite" title="HMDB: HMDB00234"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00234">testosterone,</a></span> an important triggering factor for <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span>-mediated motoneuron degeneration, were maintained at relatively high levels even at advanced ages. These results provide beneficial information for future clinical therapeutic trials, although further detailed prospective studies are also needed.
motor_neuron_disease	androgen-receptor	True Positive	5.280	16260738	<strong class="title">Katsuno M, Sang C, Adachi H, Minamiyama M, Waza M, Tanaka F, Doyu M, Sobue G: Pharmacological induction of heat-shock <span class="tagged-filter" title="Association Word">proteins</span> alleviates <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span>-mediated <span class="tagged-query" title="Query">motor neuron disease.</span> Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16801-6. Epub 2005 Oct 31.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Spinal and bulbar muscular atrophy</span> <a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an adult-onset <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by the expansion of a trinucleotide CAG repeat encoding the <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> tract in the first exon of the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> <span class="tagged-filter" title="Association Word">gene</span> (AR). The pathogenic, <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: Q58FF3; Entrez Gene ID: 7190; HGNC ID: 12099; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span>-expanded AR <span class="tagged-filter" title="Association Word">protein</span> accumulates in the cell nucleus in a ligand-dependent manner and inhibits transcription by interfering with transcriptional factors and coactivators. Heat-shock <span class="tagged-filter" title="Association Word">proteins</span> (HSPs) are stress-induced chaperones that facilitate the refolding and, thus, the degradation of abnormal <span class="tagged-filter" title="Association Word">proteins.</span> Geranylgeranylacetone (GGA), a nontoxic antiulcer drug, has been shown to potently induce <a href="http://beta.uniprot.org/uniprot/Q58FF3">HSP</a></span> <span class="tagged-filter" title="Association Word">expression</span> in various tissues, including the central nervous system. In a cell model of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA,</a></span> GGA increased the levels of <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70,</a></span> <span class="tagged-gene" title="SwissProt ID: P07900; Entrez Gene ID: 3320; HGNC ID: 5253; HPRD ID: 00777; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07900">Hsp90,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92598; Entrez Gene ID: 10808; HGNC ID: 16969; HPRD ID: 09990; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92598">Hsp105</a></span> and inhibited cell death and the accumulation of pathogenic AR. Oral administration of GGA also up-regulated the <span class="tagged-filter" title="Association Word">expression</span> of HSPs in the central nervous system of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span>-transgenic mice and suppressed nuclear accumulation of the pathogenic AR <span class="tagged-filter" title="Association Word">protein,</span> resulting in amelioration of <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span>-dependent neuromuscular phenotypes. These observations suggest that, although a high dose appears to be needed for clinical effects, oral GGA administration is a safe and promising therapeutic candidate for <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span>-mediated <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases,</span> including <a href="http://beta.uniprot.org/uniprot/P10275">SBMA.</a></span>
motor_neuron_disease	androgen-receptor	True Positive	5.280	15876692	<strong class="title">Sulek A, Hoffman-Zacharska D, Krysa W, Szirkowiec W, Fidzianska E, Zaremba J: CAG repeat <span class="tagged-filter" title="Association Word">polymorphism</span> in the <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR) <span class="tagged-filter" title="Association Word">gene</span> of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> patients and a control group. J Appl Genet. 2005;46(2):237-9.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0752353">Spinobulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an X-<span class="tagged-filter" title="Association Word">linked</span> form of <span class="tagged-query" title="Query">motor neuron disease</span> characterized by <span class="tagged-disease" title="UMLS Concept ID: C1265895">progressive atrophy</span> of the muscles, <span class="tagged-disease" title="UMLS Concept ID: C0011168">dysphagia,</span> dysarthria and mild <span class="tagged-disease" title="UMLS Concept ID: Not Available">androgen insensitivity.</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> is <span class="tagged-filter" title="Association Word">caused</span> by CAG repeat expansion in the <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> <span class="tagged-filter" title="Association Word">gene.</span> CAG repeat <span class="tagged-filter" title="Association Word">polymorphism</span> was analysed in a Polish control group (n = 150) and patients suspected of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> (n = 60). Normal and abnormal ranges of CAG repeats were established in the control group and in 21 patients whose clinical <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> was molecularly confirmed. The ranges are similar to those reported for other populations.
motor_neuron_disease	androgen-receptor	True Positive	5.280	15659427	<strong class="title">Adachi H, Katsuno M, Minamiyama M, Waza M, Sang C, Nakagomi Y, Kobayashi Y, Tanaka F, Doyu M, Inukai A, Yoshida M, Hashizume Y, Sobue G: Widespread nuclear and <span class="tagged-disease" title="UMLS Concept ID: C0544951">cytoplasmic accumulation</span> of mutant <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> in <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> patients. Brain. 2005 Mar;128(Pt 3):659-70. Epub 2005 Jan 19.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an inherited adult onset <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by the expansion of a <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> (polyQ) tract within the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR), affecting only males. The characteristic pathological finding is nuclear inclusions (NIs) consisting of mutant AR with an expanded polyQ in residual motor neurons, and in certain visceral organs. We immunohistochemically examined 11 <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> patients at autopsy with 1C2, an <span class="tagged-filter" title="Association Word">antibody</span> that specifically recognizes expanded polyQ. Our study demonstrated that diffuse nuclear accumulation of mutant AR was far more frequent and extensive than NIs being distributed in a wide array of CNS nuclei, and in more visceral organs than thus far believed. Mutant AR accumulation was also present in the cytoplasm, particularly in the Golgi apparatus; nuclear or cytoplasmic predominance of accumulation was tissue specific. Furthermore, the extent of diffuse nuclear accumulation of mutant AR in motor and sensory neurons of the spinal cord was closely <span class="tagged-filter" title="Association Word">related</span> to CAG repeat length. Thus, diffuse nuclear accumulation of mutant AR apparently is a cardinal pathogenetic process underlying neurological manifestations, as in <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> transgenic mice, while <span class="tagged-disease" title="UMLS Concept ID: C0544951">cytoplasmic accumulation</span> may also contribute to <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> pathophysiology.
motor_neuron_disease	androgen-receptor	True Positive	5.280	15152038	<strong class="title">Chevalier-Larsen ES, O'Brien CJ, Wang H, Jenkins SC, Holder L, Lieberman AP, Merry DE: Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy.</span> J Neurosci. 2004 May 19;24(20):4778-86.</strong> Transgenic models of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disease</span> have proved uniquely powerful for delineating pathways of neuronal dysfunction and cell death. We have developed a <span class="tagged-disease" title="UMLS Concept ID: C1519606">transgenic model</span> of the <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> disease <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy</span> <a href="http://beta.uniprot.org/uniprot/P10275">(SBMA),</a></span> an adult-onset, slowly progressive <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> expansion in the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR). Mice bearing a human AR with 112 glutamines reproduce many aspects of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA,</a></span> including slowly progressive, gender-specific motor deficits, and neuronal intranuclear inclusions. Despite substantial motor deficits in male AR112Q mice, no motor <span class="tagged-disease" title="UMLS Concept ID: C0598940">neuron loss</span> was <span class="tagged-filter" title="Association Word">observed,</span> indicating that neuronal dysfunction, rather than neuronal death, is central to disease. Moreover, reduced levels of unphosphorylated neurofilament heavy chain <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">(NF-H)</a></span> were <span class="tagged-filter" title="Association Word">observed</span> in motor neurons, suggesting a <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">NF-H</a></span> in <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> neuronal dysfunction. The elimination of androgens by surgical castration of severely affected, aged 112Q male mice partially restored motor function as well as <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">NF-H</a></span> levels. These data suggest that hormone-based therapies designed to treat <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> patients, even with advanced disease, are likely to be effective.
motor_neuron_disease	androgen-receptor	True Positive	5.280	15102712	<strong class="title">Minamiyama M, Katsuno M, Adachi H, Waza M, Sang C, Kobayashi Y, Tanaka F, Doyu M, Inukai A, Sobue G: <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">Sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00039"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00039">butyrate</a></span> ameliorates phenotypic <span class="tagged-filter" title="Association Word">expression</span> in a transgenic mouse model of <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy.</span> Hum Mol Genet. 2004 Jun 1;13(11):1183-92. Epub 2004 Apr 21.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Spinal and bulbar muscular atrophy</span> <a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an inherited <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by the expansion of a <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> (polyQ) tract within the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor.</a></span> Unifying mechanisms have been implicated in the pathogenesis of polyQ-dependent <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> including <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA,</a></span> <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington disease</span> and <span class="tagged-disease" title="UMLS Concept ID: C0087012">spinocerebellar ataxias.</span> It has been suggested that mutant <span class="tagged-filter" title="Association Word">protein</span> containing polyQ inhibits <span class="tagged-gene" title="SwissProt ID: Q69YR9; Entrez Gene ID: 23522; HGNC ID: 17582; HPRD ID: 07065; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q69YR9">histone acetyltransferase</a></span> <span class="tagged-filter" title="Association Word">activity,</span> resulting in transcriptional dysfunction and subsequent neuronal dysfunction. <span class="tagged-gene" title="Protein Family or Complex">Histone deacetylase</span> <span class="tagged-gene" title="SwissProt ID: Q9UKV0; Entrez Gene ID: 9734; HGNC ID: 14065; HPRD ID: 05944; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKV0">(HDAC)</a></span> inhibitors alleviate neurological phenotypes in fly and mouse models of polyQ disease, although the therapeutic effect is limited by the toxicity of these compounds. We studied the therapeutic effects of <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: Q9UKV0; Entrez Gene ID: 9734; HGNC ID: 14065; HPRD ID: 05944; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00039"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00039">butyrate</a></span> (SB), an <a href="http://beta.uniprot.org/uniprot/Q9UKV0">HDAC</a></span> inhibitor, in a transgenic mouse model of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA.</a></span> Oral administration of SB ameliorated neurological phenotypes as well as increased acetylation of nuclear histone in neural tissues. These therapeutic effects, however, were seen only within a narrow range of SB dosage. Our results indicate that SB is a possible therapeutic agent for <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> and other polyQ diseases, although an appropriate dose should be determined for clinical application.
motor_neuron_disease	androgen-receptor	True Positive	5.280	12657679	<strong class="title">Adachi H, Katsuno M, Minamiyama M, Sang C, Pagoulatos G, Angelidis C, Kusakabe M, Yoshiki A, Kobayashi Y, Doyu M, Sobue G: Heat shock <span class="tagged-filter" title="Association Word">protein</span> 70 chaperone overexpression ameliorates phenotypes of the <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy</span> transgenic mouse model by reducing nuclear-localized mutant <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> <span class="tagged-filter" title="Association Word">protein.</span> J Neurosci. 2003 Mar 15;23(6):2203-11.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an inherited <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by the expansion of the <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> (polyQ) tract within the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR). The nuclear inclusions consisting of the mutant AR <span class="tagged-filter" title="Association Word">protein</span> are characteristic and combine with many components of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-<span class="tagged-gene" title="Protein Family or Complex">proteasome</span> and molecular chaperone pathways, raising the possibility that misfolding and <span class="tagged-filter" title="Association Word">altered</span> degradation of mutant AR may be <span class="tagged-filter" title="Association Word">involved</span> in the pathogenesis. We have reported that the overexpression of heat shock <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: Q58FF3; Entrez Gene ID: 7190; HGNC ID: 12099; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q58FF3">(HSP)</a></span> chaperones reduces mutant AR aggregation and cell death in a neuronal cell model (Kobayashi et al., 2000). To determine whether increasing the <span class="tagged-filter" title="Association Word">expression</span> level of chaperone improves the phenotype in a mouse model, we cross-bred <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> transgenic mice with mice overexpressing the inducible form of human HSP70. We demonstrated that high <span class="tagged-filter" title="Association Word">expression</span> of HSP70 markedly ameliorated the motor function of the <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> model mice. In double-transgenic mice, the nuclear-localized mutant AR <span class="tagged-filter" title="Association Word">protein,</span> particularly that of the large complex form, was significantly reduced. Monomeric mutant AR was also reduced in amount by HSP70 overexpression, suggesting the enhanced degradation of mutant AR. These findings suggest that HSP70 overexpression ameliorates <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> phenotypes in mice by reducing nuclear-localized mutant AR, probably <span class="tagged-filter" title="Association Word">caused</span> by enhanced mutant AR degradation. Our study may provide the basis for the development of an HSP70-<span class="tagged-filter" title="Association Word">related</span> therapy for <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> and other polyQ diseases.
motor_neuron_disease	androgen-receptor	True Positive	5.280	12189162	<strong class="title">McManamny P, Chy HS, Finkelstein DI, Craythorn RG, Crack PJ, Kola I, Cheema SS, Horne MK, Wreford NG, O'Bryan MK, De Kretser DM, Morrison JR: A mouse model of <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy.</span> Hum Mol Genet. 2002 Sep 1;11(18):2103-11.</strong> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an adult-onset <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-filter" title="Association Word">caused</span> by the expansion of a trinucleotide repeat <span class="tagged-gene" title="SwissProt ID: Q92752; Entrez Gene ID: 7143; HGNC ID: 11953; HPRD ID: 03589; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92752">(TNR)</a></span> in exon 1 of the <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR) <span class="tagged-filter" title="Association Word">gene.</span> This disorder is characterized by degeneration of motor and sensory neurons, proximal <span class="tagged-disease" title="UMLS Concept ID: C0026846">muscular atrophy,</span> and endocrine abnormalities, such as <span class="tagged-disease" title="UMLS Concept ID: C0018418">gynecomastia</span> and reduced fertility. We describe the development of a <span class="tagged-disease" title="UMLS Concept ID: C1519606">transgenic model</span> of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> expressing a full-length human AR (hAR) cDNA carrying 65 (AR (65)) or 120 CAG repeats (AR (120)), with widespread <span class="tagged-filter" title="Association Word">expression</span> driven by the cytomegalovirus promoter. Mice carrying the AR (120) transgene displayed behavioral and motor dysfunction, while mice carrying 65 CAG repeats showed a mild phenotype. Progressive muscle weakness and atrophy was <span class="tagged-filter" title="Association Word">observed</span> in AR (120) mice and was <span class="tagged-filter" title="Association Word">associated</span> with the loss of alpha-motor neurons in the spinal cord. There was no evidence of <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration</span> in other brain structures. Motor dysfunction was <span class="tagged-filter" title="Association Word">observed</span> in both male and female animals, showing that in <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> the <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> repeat expansion <span class="tagged-filter" title="Association Word">causes</span> a <span class="tagged-filter" title="Association Word">dominant</span> gain-of-function <span class="tagged-filter" title="Association Word">mutation</span> in the AR. The male mice displayed a progressive reduction in sperm <span class="tagged-filter" title="Association Word">production</span> consistent with testis defects reported in human patients. These mice represent the first model to reproduce the key features of <a href="http://beta.uniprot.org/uniprot/P10275">SBMA,</a></span> making them a useful resource for characterizing disease progression, and for testing therapeutic strategies for both <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	androgen-receptor	True Positive	5.280	11751688	<strong class="title">Welch WJ, Diamond MI: Glucocorticoid modulation of <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> nuclear aggregation and cellular toxicity is <span class="tagged-filter" title="Association Word">associated</span> with distinct forms of soluble expanded <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> <span class="tagged-filter" title="Association Word">protein.</span> Hum Mol Genet. 2001 Dec 15;10(26):3063-74.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0752353">Spinobulbar muscular atrophy</span> is a progressive <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by abnormal <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> tract expansion in the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR) <span class="tagged-filter" title="Association Word">gene,</span> and is part of a family of central nervous system (CNS) <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases,</span> including <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease</span> (HD). Each pathologic <span class="tagged-filter" title="Association Word">protein</span> is widely <span class="tagged-filter" title="Association Word">expressed,</span> but the <span class="tagged-filter" title="Association Word">cause</span> of neuronal degeneration within the CNS remains unknown. Many reports now link abnormal <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P04150; Entrez Gene ID: 2908; HGNC ID: 7978; HPRD ID: 00679; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> <span class="tagged-filter" title="Association Word">protein</span> aggregation to pathogenesis. A previous study reported that activation of the wild-type <a href="http://beta.uniprot.org/uniprot/P04150">glucocorticoid receptor</a></span> (wtGR) suppressed the aggregation of expanded <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P42858; Entrez Gene ID: 3064; HGNC ID: 4851; HPRD ID: 00883; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> <span class="tagged-filter" title="Association Word">proteins</span> derived from AR and <a href="http://beta.uniprot.org/uniprot/P42858">huntingtin,</a></span> whereas a mutant receptor containing an internal deletion, GRDelta108-317, increased <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> <span class="tagged-filter" title="Association Word">protein</span> aggregation, in this case primarily within the nucleus. In this study, we use these two forms of GR to study expanded <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> AR <span class="tagged-filter" title="Association Word">protein</span> in different cell contexts. Using cell biology and biochemical approaches, we find that wtGR promotes soluble forms of the <span class="tagged-filter" title="Association Word">protein</span> and prevents nuclear aggregation in NIH3T3 cells and cultured neurons. In contrast, GRDelta108-317 decreases <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> <span class="tagged-filter" title="Association Word">protein</span> solubility, and <span class="tagged-filter" title="Association Word">causes</span> formation of nuclear aggregates in non-neuronal cells. Nuclear aggregates recruit hsp72 more rapidly than cytoplasmic aggregates, and are <span class="tagged-filter" title="Association Word">associated</span> with decreased cell viability. Limited proteolysis and chemical cross-linking suggest unique soluble forms of the expanded AR <span class="tagged-filter" title="Association Word">protein</span> underlie these distinct biological activities. These observations provide an experimental framework to understand why expanded <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> <span class="tagged-filter" title="Association Word">proteins</span> may be toxic only to certain populations of cells, and suggest that unique <span class="tagged-filter" title="Association Word">protein</span> associations or conformations of expanded <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> <span class="tagged-filter" title="Association Word">proteins</span> may determine subsequent cellular effects such as nuclear localization and cellular toxicity.
motor_neuron_disease	complex-I	True Negative	1.441	17512091	<strong class="title">Diwakar L, Kenchappa RS, Annepu J, Ravindranath V: Downregulation of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> but not <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> loss <span class="tagged-filter" title="Association Word">leads</span> to mitochondrial dysfunction in female mice CNS: Implications in excitotoxicity. Neurochem Int. 2007 Jul;51(1):37-46. Epub 2007 Apr 5.</strong> Oxidative stress, excitotoxicity and mitochondrial dysfunction play synergistic <span class="tagged-filter" title="Association Word">roles</span> in <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration.</span> Maintenance of thiol homeostasis is important for normal mitochondrial function and dysregulation of <span class="tagged-filter" title="Association Word">protein</span> thiol homeostasis by oxidative stress <span class="tagged-filter" title="Association Word">leads</span> to mitochondrial dysfunction and <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration.</span> We examined the critical <span class="tagged-filter" title="Association Word">roles</span> played by the antioxidant, non-<span class="tagged-filter" title="Association Word">protein</span> thiol, <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and <span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">enzyme,</span> <a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in maintaining mitochondrial function during excitotoxicity <span class="tagged-filter" title="Association Word">caused</span> by beta-N-oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine</a></span> (l-BOAA), the causative factor of neurolathyrism, a <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">involving</span> the pyramidal system. l-BOAA <span class="tagged-filter" title="Association Word">causes</span> loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> and inhibition of mitochondrial <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C1535036">lumbosacral</span> cord of male mice through oxidation of thiol groups, while female mice are resistant. Reducing <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> levels in female mice CNS by pretreatment with diethyl <span class="tagged-metabolite" title="HMDB: HMDB00176"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00176">maleate</a></span> or l-propargyl <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span> did not result in inhibition of <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity,</span> unlike male mice. Further, treatment of female mice depleted of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> with l-BOAA did not induce inhibition of <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> indicating that <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> levels were not critical for maintaining <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> in female mice unlike their male counterpart. <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">Glutaredoxin,</a></span> a thiol disulfide <span class="tagged-gene" title="SwissProt ID: O14756; Entrez Gene ID: 8630; HGNC ID: 23316; HPRD ID: 09431; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14756">oxidoreductase</a></span> helps maintain redox status of <span class="tagged-filter" title="Association Word">proteins</span> and downregulation of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> results in loss of mitochondrial <span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity.</span> Female mice express higher levels of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in certain CNS regions and downregulation of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> using antisense oligonucleotides sensitizes them to l-BOAA toxicity seen as mitochondrial <span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> loss. Ovariectomy downregulates <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> and renders female mice vulnerable to l-BOAA toxicity as evidenced by activation of <span class="tagged-gene" title="SwissProt ID: P05412; Entrez Gene ID: 3725; HGNC ID: 6204; HPRD ID: 01302; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05412">AP1,</a></span> loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> and <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> indicating the important <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in neuroprotection. <span class="tagged-metabolite" title="HMDB: HMDB01926"><span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01926">Estrogen</a></span> protects against mitochondrial dysfunction <span class="tagged-filter" title="Association Word">caused</span> by excitotoxicity by maintaining cellular redox status through higher constitutive <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in the CNS. Therapeutic interventions designed to upregulate <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> may offer neuroprotection against excitotoxicity in motor neurons.
motor_neuron_disease	complex-I	True Negative	1.441	17095121	<strong class="title">Diwakar L, Ravindranath V: Inhibition of <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine-gamma-lyase</a></span> <span class="tagged-filter" title="Association Word">leads</span> to loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int. 2007 Jan;50(2):418-26. Epub 2006 Nov 13.</strong> Oxidative stress has been implicated in the pathogenesis and progression of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders</span> and antioxidants potentially have a major <span class="tagged-filter" title="Association Word">role</span> in neuroprotection. Optimum levels of <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> (gamma-glutamylcysteinyl <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine),</a></span> an endogenous thiol antioxidant are required for the maintenance of the redox status of cells. <a href="http://beta.uniprot.org/uniprot/P32929">Cystathionine gamma-lyase</a></span> is the rate-limiting <span class="tagged-filter" title="Association Word">enzyme</span> for the synthesis of <span class="tagged-metabolite" title="HMDB: HMDB00574"><span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">cysteine</a></span> from <span class="tagged-metabolite" title="HMDB: HMDB00696"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00696">methionine</a></span> and availability of <span class="tagged-metabolite" title="HMDB: HMDB00574"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00574">cysteine</a></span> is a critical factor in <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> synthesis. In the present study, we have examined the role of <a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> in maintaining the redox homeostasis in brain, particularly with reference to mitochondrial function since the <span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> of the electron transport chain is sensitive to redox perturbation. Inhibition of <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> by l-propargylglycine <span class="tagged-filter" title="Association Word">caused</span> loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and decrease in <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> in the brain although the <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity</span> in mouse brain was 1% of the corresponding hepatic <span class="tagged-filter" title="Association Word">activity.</span> We then examined the effect of this inhibition on the neurotoxicity mediated by the excitatory amino acid, l-beta-oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine,</a></span> which is the causative factor of a type of <span class="tagged-query" title="Query">motor neuron disease,</span> neurolathyrism. l-beta-Oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine</a></span> toxicity was exacerbated by l-propargylglycine measured as loss of <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> indicating the importance of <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> in maintaining <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> levels and in turn the mitochondrial function during excitotoxicity. Oxidative stress generated by l-beta-oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine</a></span> itself inhibited <a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase,</a></span> which could be prevented by prior treatment with thiol antioxidant. Thus, <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">cystathionine gamma-lyase</a></span> itself is susceptible to inactivation by oxidative stress and this can potentially exacerbate oxidant-induced damage. <span class="tagged-gene" title="SwissProt ID: P32929; Entrez Gene ID: 1491; HGNC ID: 2501; HPRD ID: 09633; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32929">Cystathionine gamma-lyase</a></span> is present in neuronal cells in human brain and its <span class="tagged-filter" title="Association Word">activity</span> is several-fold higher compared to mouse brain. It could potentially play an important <span class="tagged-filter" title="Association Word">role</span> in maintaining <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and <span class="tagged-filter" title="Association Word">protein</span> thiol homeostasis in brain and hence afford neuroprotection.
motor_neuron_disease	ALS2	True Positive	11.113	17566607	<strong class="title">Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE: Molecular and cellular function of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>/alsin: Implication of membrane dynamics in neuronal development and degeneration. Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9595-600. Epub 2006 Jun 12.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is a causative <span class="tagged-filter" title="Association Word">gene</span> for a juvenile <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> form of <span class="tagged-query" title="Query">motor neuron diseases</span> (MNDs), including <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> 2 <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">(ALS2),</a></span> juvenile <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis,</span> and infantile-onset ascending hereditary <span class="tagged-disease" title="UMLS Concept ID: C0085621">spastic paralysis.</span> These disorders are characterized by <span class="tagged-disease" title="UMLS Concept ID: C0333452">ascending degeneration</span> of the upper motor neurons with or without lower motor neuron involvement. Thus far, a total of 12 independent <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">mutations,</span> which include a small deletion, non-sense <span class="tagged-filter" title="Association Word">mutation,</span> or missense <span class="tagged-filter" title="Association Word">mutation</span> spreading widely across the entire coding sequence, are reported. They are predicted to result in either premature termination of translation or substitution of an evolutionarily conserved amino acid. Thus, a loss of functions in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-coded <span class="tagged-filter" title="Association Word">protein</span> accounts for motor dysfunction and/or degeneration in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">linked</span> MNDs. The <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> encodes a novel 184kDa <span class="tagged-filter" title="Association Word">protein</span> of 1657 amino acids, <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> or alsin, comprising three predicted <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">(GEF)</a></span> domains: the N-terminal <span class="tagged-gene" title="SwissProt ID: Q9P258; Entrez Gene ID: 55920; HGNC ID: 30297; HPRD ID: 18171; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9P258">RCC1-like</a></span> domain, the central Dbl homology and <span class="tagged-gene" title="SwissProt ID: P08567; Entrez Gene ID: 5341; HGNC ID: 9070; HPRD ID: 15935; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08567">pleckstrin</a></span> homology (DH/PH) domains, and the C-terminal vacuolar <span class="tagged-filter" title="Association Word">protein</span> sorting 9 <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">(VPS9) domain.</a></span> In addition, eight consecutive membrane occupation and recognition nexus (MORN) motifs are noted in the region between DH/PH and VPS9 domains. <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> activates <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> small GTPase and involves in endosome/membrane trafficking and fusions in the cells, and also promotes neurite outgrowth in neuronal cultures. Further, a neuroprotective <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> against cytotoxicity; i.e., the mutant Cu/Zn-<span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span>-mediated toxicity, oxidative stress, and excitotoxicity, has recently been implied. This review outlines current understandings of the molecular and cellular functions of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and its <span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins</span> on safeguarding the integrity of motor neurons, and sheds light on the molecular pathogenesis of MNDs as well as other conditions of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases.</span>
motor_neuron_disease	ALS2	True Positive	11.113	17409386	<strong class="title">Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE: The <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> activator <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>/alsin acts as a novel <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span> effector through <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span>-activated endocytosis. J Neurosci. 2005 Aug 17;25(33):7567-74.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">cause</span> a number of <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases,</span> indicating that the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">(ALS2</a></span>/alsin) is vital for motor neurons. <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> acts as a <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">(GEF)</a></span> for <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> (Rab5GEF) and is <span class="tagged-filter" title="Association Word">involved</span> in endosome dynamics. However, the spatiotemporal <span class="tagged-filter" title="Association Word">regulation</span> of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-mediated <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> activation is unclear. Here we identified an upstream activator for <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and showed a functional significance of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> activation in endosome dynamics. <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> preferentially interacts with activated <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1.</a></span> In the cells activated <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span> recruits cytoplasmic <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> to membrane ruffles and subsequently to nascent macropinosomes via <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span>-activated macropinocytosis. At later endocytic stages macropinosomal <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> augments fusion of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-localized macropinosomes with the <span class="tagged-gene" title="SwissProt ID: P02787; Entrez Gene ID: 7018; HGNC ID: 11740; HPRD ID: 01811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02787">transferrin</a></span>-positive endosomes, depending on the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">associated</span> Rab5GEF <span class="tagged-filter" title="Association Word">activity.</span> These results indicate that <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span> promotes the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> membranous localization, thereby rendering <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> active via <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span>-activated endocytosis. Thus, <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is a novel <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span> effector and is <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span>-activated macropinocytosis. All together, loss of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> may perturb macropinocytosis and/or the following membrane trafficking, which gives rise to neuronal dysfunction in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	ALS2	True Positive	11.113	17239822	<strong class="title">Suzuki-Utsunomiya K, Hadano S, Otomo A, Kunita R, Mizumura H, Osuga H, Ikeda JE: <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-interactor, modulates <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-mediated endosome dynamics. Biochem Biophys Res Commun. 2007 Mar 9;354(2):491-7. Epub 2007 Jan 11.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> the causative <span class="tagged-filter" title="Association Word">gene</span> product for a number of <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases,</span> is a <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine-nucleotide exchange factor</a></span> for <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5,</a></span> and acts as a modulator for endosome dynamics. Recently, we have identified a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> homolog, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> which is highly homologous to the C-terminal half of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> In this study, we investigate the molecular features of <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> and its functional relationship with <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> A majority of <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is present as a homo-dimeric form, which can interact with the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-oligomer, resulting in the formation of the large <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> heteromeric complex. In cultured cells, overexpressed <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is colocalized with <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> onto membranous compartments. Further, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> dominantly suppresses the endosome enlargement induced by a constitutively active form of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> and results in an extensive perinuclear tubulo-membranous phenotype, which are dependent upon the <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span>-<span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> interaction. Collectively, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-interacting <span class="tagged-filter" title="Association Word">protein</span> and is implicated in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-mediated endosome dynamics.
motor_neuron_disease	ALS2	True Positive	11.113	16973244	<strong class="title">Lin X, Shim H, Cai H: <span class="tagged-filter" title="Association Word">Deficiency</span> in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> does not affect the motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) transgenic mice. J Neurosci. 2006 Nov 8;26(45):11798-806.</strong> Dysfunction of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> has been <span class="tagged-filter" title="Association Word">linked</span> to one form of juvenile onset <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). Previous in vitro studies suggest that over-<span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> protects cells from mutant Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span>-induced cytotoxicity. To test whether <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> plays a protective <span class="tagged-filter" title="Association Word">role</span> against mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-mediated motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in vivo, we examined the progression of <span class="tagged-query" title="Query">motor neuron disease</span> in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) mice on an <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> null background. Our data suggest that <span class="tagged-filter" title="Association Word">deficiency</span> in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> does not affect the pathogenesis of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) mice.
motor_neuron_disease	ALS2	True Positive	11.113	16802286	<strong class="title">Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW: Progressive spinal axonal degeneration and slowness in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice. Neurobiol Aging. 2006 Sep 11;.</strong> OBJECTIVE: Homozygous <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> and the resulting loss of the <span class="tagged-metabolite" title="HMDB: HMDB00132"><span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00132">guanine</a></span> exchange factor <span class="tagged-filter" title="Association Word">activity</span> of the <a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> is causative for <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> early-onset <span class="tagged-query" title="Query">motor neuron disease</span> that is thought to predominantly affect upper motor neurons. The goal of this study was to elucidate how the motor system is affected by the deletion of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> METHODS: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice were generated by <span class="tagged-filter" title="Association Word">gene</span> targeting. Motor function and upper and lower motor neuron pathology were examined in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice and in mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> mice that develop ALS-like disease from <span class="tagged-filter" title="Association Word">expression</span> of an ALS-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span> RESULTS: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice demonstrated progressive axonal degeneration in the lateral spinal cord that is also prominent in mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice. Despite the vulnerability of these spinal axons, lower motor neurons in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice were preserved. Behavioral studies demonstrated slowed movement without muscle weakness in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> (-/-) mice, consistent with upper motor neuron defects that <span class="tagged-filter" title="Association Word">lead</span> to spasticity in humans. INTERPRETATION: The combined evidence from mice and humans shows that <span class="tagged-filter" title="Association Word">deficiency</span> in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">causes</span> an <span class="tagged-disease" title="UMLS Concept ID: C0521659">upper motor neuron disease</span> that in humans closely resembles a severe form of hereditary <span class="tagged-disease" title="UMLS Concept ID: C0085621">spastic paralysis,</span> and that is quite distinct from <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span>
motor_neuron_disease	ALS2	True Positive	11.113	16769894	<strong class="title">Devon RS, Orban PC, Gerrow K, Barbieri MA, Schwab C, Cao LP, Helm JR, Bissada N, Cruz-Aguado R, Davidson TL, Witmer J, Metzler M, Lam CK, Tetzlaff W, Simpson EM, McCaffery JM, El-Husseini AE, Leavitt BR, Hayden MR: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice exhibit disturbances in endosome trafficking <span class="tagged-filter" title="Association Word">associated</span> with motor behavioral abnormalities. Biochim Biophys Acta. 2005 Aug 15;1745(1):84-100. Epub 2005 Jan 19.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> form of spastic paraparesis <span class="tagged-query" title="Query">(motor neuron disease)</span> with juvenile onset and slow progression <span class="tagged-filter" title="Association Word">caused</span> by loss of function of alsin, an activator of <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span> and <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> small GTPases. To establish an animal model of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and derive insights into the pathogenesis of this illness, we have generated alsin-null mice. Cytosol from brains of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice shows marked diminution of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span>-dependent endosome fusion <span class="tagged-filter" title="Association Word">activity.</span> Furthermore, primary neurons from <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice show a disturbance in endosomal transport of <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor 1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1)</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> receptors, whereas neuronal viability and endocytosis of <span class="tagged-gene" title="SwissProt ID: P02787; Entrez Gene ID: 7018; HGNC ID: 11740; HPRD ID: 01811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02787">transferrin</a></span> and dextran seem unaltered. There is a significant decrease in the size of cortical motor neurons, and <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice are mildly hypoactive. <span class="tagged-filter" title="Association Word">Altered</span> trophic receptor trafficking in neurons of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice may underlie the histopathological and behavioral changes <span class="tagged-filter" title="Association Word">observed</span> and the pathogenesis of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span>
motor_neuron_disease	ALS2	True Positive	11.113	16473597	<strong class="title">Hadano S, Ikeda JE: Purification and functional analyses of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and its homologue.  227-30.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is a causative <span class="tagged-filter" title="Association Word">gene</span> product for a form of the familial <span class="tagged-query" title="Query">motor neuron diseases.</span> Computational genomic analysis identified <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> which is a <span class="tagged-gene" title="SwissProt ID: Q96GI7; Entrez Gene ID: 375061; HGNC ID: 25057; HPRD ID: 11845; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96GI7">novel protein</a></span> highly homologous to the C-terminal region of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> Both <span class="tagged-filter" title="Association Word">proteins</span> contain the <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain,</a></span> which is a hallmark for all known members of the <span class="tagged-metabolite" title="HMDB: HMDB00132"><span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00132">guanine</a></span> nucleotide exchange factors for <a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> (Rab5GEF), and are known to act as novel factors modulating the <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span>-mediated endosome dynamics in the cells. It has also been reported that oligomerization of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is one of the fundamental features of its biochemical and physiological function <span class="tagged-filter" title="Association Word">involving</span> endosome dynamics. This chapter describes methods, including purification of the recombinant <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> and Rab5GEF assay, which have been utilized to clarify the molecular function for <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL.</a></span>
motor_neuron_disease	ALS2	True Positive	11.113	16321985	<strong class="title">Hadano S, Benn SC, Kakuta S, Otomo A, Sudo K, Kunita R, Suzuki-Utsunomiya K, Mizumura H, Shefner JM, Cox GA, Iwakura Y, Brown RH Jr, Ikeda JE: Mice <span class="tagged-filter" title="Association Word">deficient</span> in the <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>/alsin exhibit age-dependent neurological deficits and <span class="tagged-filter" title="Association Word">altered</span> endosome trafficking. J Biol Chem. 2007 Jun 1;282(22):16599-611. Epub 2007 Apr 4.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>/alsin is a member of <span class="tagged-metabolite" title="HMDB: HMDB00132"><span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00132">guanine</a></span> nucleotide exchange factors for the small GTPase <a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> (Rab5GEFs), which act as modulators in endocytic pathway. Loss-of-function <span class="tagged-filter" title="Association Word">mutations</span> in human <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> account for a number of juvenile <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases</span> (MNDs). However, the normal physiological <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> in vivo and the molecular mechanisms underlying motor dysfunction are still unknown. To address these issues, we have generated mice homozygous for disruption of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> <span class="tagged-filter" title="Association Word">gene.</span> The <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span>-null mice <span class="tagged-filter" title="Association Word">observed</span> through 21 months of age demonstrated no obvious developmental, reproductive or motor abnormalities. However, immunohistochemical and electrophysiological analyses identified an age-dependent, slowly progressive loss of cerebellar Purkinje cells and disturbance of spinal motor neurons <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0751171">astrocytosis</span> and microglial cell activation, indicating a subclinical dysfunction of motor system in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span>-null mice. Further, quantitative <span class="tagged-gene" title="SwissProt ID: P01133; Entrez Gene ID: 1950; HGNC ID: 3229; HPRD ID: 00578; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01133">epidermal growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P01133; Entrez Gene ID: 1950; HGNC ID: 3229; HPRD ID: 00578; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01133">(EGF)</a></span>-uptake analysis identified significantly smaller-sized <span class="tagged-gene" title="SwissProt ID: P01133; Entrez Gene ID: 1950; HGNC ID: 3229; HPRD ID: 00578; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01133">EGF</a></span>-positive endosomes in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span>-null fibroblasts, suggesting an alteration of endosome/vesicle trafficking in the cells. Collectively, while loss of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> does not <span class="tagged-filter" title="Association Word">produce</span> a severe disease phenotype in mice, these <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span>-null animals should provide a useful model with which to understand the interplay between endosomal dynamics and the long-term viability of large neurons such as Purkinje cells and spinal motor neurons.
motor_neuron_disease	ALS2	True Positive	11.113	15651293	<strong class="title">Ikeda JE: <span class="tagged-filter" title="Association Word">[Recessive</span> <span class="tagged-query" title="Query">motor neuron diseases:</span> <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> and molecular pathogenesis for the upper motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration].</span> Ann Neurol. 2006 Jul;60(1):95-104.</strong> We have initially identified a <span class="tagged-filter" title="Association Word">mutation</span> in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> as a causative for a juvenile <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> form of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS), termed <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> (OMIM 205100). <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> also are causative for an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> juvenile <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis,</span> and infantile-ascending hereditary <span class="tagged-disease" title="UMLS Concept ID: C0085621">spastic paralysis.</span> To date, nine homozygous <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> mutaions from nine independent families have been identified. All of these <span class="tagged-filter" title="Association Word">mutations</span> result in predicted premature translation termination <span class="tagged-filter" title="Association Word">caused</span> by the <span class="tagged-filter" title="Association Word">recessive</span> frameshift or <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutation.</span> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is a 184-kD <span class="tagged-filter" title="Association Word">protein</span> comprising several putative <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">(GEF)</a></span> domains [RLD; <span class="tagged-gene" title="SwissProt ID: Q9P258; Entrez Gene ID: 55920; HGNC ID: 30297; HPRD ID: 18171; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9P258">RCC1 like</a></span> domain, DH. PH domain, VPS9; Vacuolar protein sorting 9 domain]. In vitro, <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> specifically binds to the small GTPase <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> and functions as a <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">GEF</a></span> for <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5.</a></span> Ectopic <span class="tagged-filter" title="Association Word">expression</span> of full-length <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> has further implied an <span class="tagged-filter" title="Association Word">association</span> with endosomal membranes mediated by the <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain,</a></span> consistent with <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> involvement in endosomal trafficking and fusion in conjunction with the activation of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5.</a></span> These results combined with our findings suggest that an obstruction of endosomal dynamics might underlie neuronal dysfunction and degeneration in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">PLSJ,</a></span> and <span class="tagged-gene" title="SwissProt ID: Q58FF3; Entrez Gene ID: 7190; HGNC ID: 12099; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q58FF3">HSP,</a></span> as well as in a number of <span class="tagged-disease" title="UMLS Concept ID: C0154683">other motor neuron diseases.</span>
motor_neuron_disease	ALS2	True Positive	11.113	14970233	<strong class="title">Kanekura K, Hashimoto Y, Niikura T, Aiso S, Matsuoka M, Nishimoto I: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin,</a></span> the product of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene,</span> suppresses <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutant neurotoxicity through RhoGEF domain by interacting with <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants. J Biol Chem. 2004 Apr 30;279(18):19247-56. Epub 2004 Feb 16.</strong> <span class="tagged-filter" title="Association Word">Mutation</span> of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> encoding alsin is <span class="tagged-filter" title="Association Word">linked</span> to the onset of <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases,</span> including juvenile-onset <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin</a></span> long form (LF) belongs to the family of the <span class="tagged-metabolite" title="HMDB: HMDB00132"><span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00132">guanine</a></span> nucleotide exchanging factor <a href="http://beta.uniprot.org/uniprot/Q92974">(GEF)</a></span> for small GTPases. <span class="tagged-filter" title="Association Word">Expression</span> of alsin LF, but not alsin short form, protected motor neuronal cells from toxicity induced by mutants of the Cu/Zn-<span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> <span class="tagged-filter" title="Association Word">gene,</span> which <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> ALS. In contrast, <span class="tagged-filter" title="Association Word">expression</span> of alsin did not suppress neurotoxicity by other neurodegenerative insults such as <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease</span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes.</span> Deletion analysis of alsin LF demonstrated that the RhoGEF domain is essential for alsin-mediated neuroprotection. Furthermore, we found that alsin LF bound to <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants, but not to wtSOD1, via the RhoGEF domain. Such functional and physical interaction between two ALS-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes</span> will become a promising clue to clarify the pathogenesis of ALS and <span class="tagged-disease" title="UMLS Concept ID: C0154683">other motor neuron diseases.</span>
motor_neuron_disease	Bcl-XL	False Negative	1.441	16116646	<strong class="title">Garrity-Moses ME, Teng Q, Liu J, Tanase D, Boulis NM: Neuroprotective adeno-<span class="tagged-filter" title="Association Word">associated</span> virus <span class="tagged-gene" title="SwissProt ID: Q07817; Entrez Gene ID: 598; HGNC ID: 992; HPRD ID: 02497; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07817">Bcl-xL</a></span> <span class="tagged-filter" title="Association Word">gene</span> transfer in models of <span class="tagged-query" title="Query">motor neuron disease.</span> Muscle Nerve. 2005 Dec;32(6):734-44.</strong> Recent work implicates excitotoxicity-induced apoptosis as the mechanism triggering motor neuron death in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). Our laboratory has previously utilized <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: Q07817; Entrez Gene ID: 598; HGNC ID: 992; HPRD ID: 02497; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> excitotoxicity in vitro to study this process. The present experiment tests whether overexpression of the <span class="tagged-filter" title="Association Word">gene</span> for <a href="http://beta.uniprot.org/uniprot/Q07817">Bcl-xL</a></span> can inhibit excitotoxicity in this model system. To track <span class="tagged-gene" title="SwissProt ID: Q07817; Entrez Gene ID: 598; HGNC ID: 992; HPRD ID: 02497; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07817">Bcl-xL</a></span> <span class="tagged-filter" title="Association Word">expression,</span> the <span class="tagged-filter" title="Association Word">gene</span> for green fluorescent <span class="tagged-filter" title="Association Word">protein</span> (GFP) was inserted in-frame, upstream of the <span class="tagged-gene" title="SwissProt ID: Q07817; Entrez Gene ID: 598; HGNC ID: 992; HPRD ID: 02497; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07817">Bcl-xL</a></span> <span class="tagged-filter" title="Association Word">gene.</span> The GFP-<span class="tagged-gene" title="SwissProt ID: Q07817; Entrez Gene ID: 598; HGNC ID: 992; HPRD ID: 02497; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07817">Bcl-xL</a></span> <span class="tagged-filter" title="Association Word">gene</span> was then cloned into an adeno-<span class="tagged-filter" title="Association Word">associated</span> viral (AAV2) vector. GFP <span class="tagged-filter" title="Association Word">expression</span> in both SH-SY5Y and embryonic day 15 (E15) motor neurons (MNs) peaked 48 hours after infection. <span class="tagged-gene" title="SwissProt ID: Q07817; Entrez Gene ID: 598; HGNC ID: 992; HPRD ID: 02497; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07817">Bcl-xL</a></span> <span class="tagged-filter" title="Association Word">expression</span> in SH-SY5Y cells significantly reduced terminal <span class="tagged-metabolite" title="HMDB: HMDB01191"><span class="tagged-gene" title="SwissProt ID: Q07817; Entrez Gene ID: 598; HGNC ID: 992; HPRD ID: 02497; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01191">deoxy-UTP</a></span> nick-end labeling (TUNEL)-positive cells and maintained cell density after <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> exposure. Similarly, <a href="http://beta.uniprot.org/uniprot/Q07817">Bcl-xL</a></span> <span class="tagged-filter" title="Association Word">expression</span> inhibited the development of TUNEL staining in E15 MNs and supported cell density after <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="Entrez Gene ID: 17; HGNC ID: 22; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> exposure. These findings suggest that <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=17">AAV</a></span>-mediated <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-filter" title="Association Word">genes</span> for antiapoptotic <span class="tagged-filter" title="Association Word">proteins</span> may provide a means for ALS <span class="tagged-filter" title="Association Word">gene</span> therapy.
motor_neuron_disease	PU.1	True Negative	1.441	17043238	<strong class="title">Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH: Wild-type microglia extend survival in <span class="tagged-gene" title="SwissProt ID: P17947; Entrez Gene ID: 6688; HGNC ID: 11241; HPRD ID: 01305; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17947">PU.1</a></span> knockout mice with familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16021-6. Epub 2006 Oct 16.</strong> The most common inherited form of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS), a <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disease</span> affecting adult motoneurons, is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-filter" title="Association Word">mutations</span> in the ubiquitously <span class="tagged-filter" title="Association Word">expressed</span> Cu (2+)/Zn (2+) <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1).</a></span> Recent studies suggest that glia may contribute to motoneuron injury in animal models of familial ALS. To determine whether the <span class="tagged-filter" title="Association Word">expression</span> of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (mSOD1 (G93A)) in CNS microglia contributes to motoneuron injury, <span class="tagged-gene" title="SwissProt ID: P17947; Entrez Gene ID: 6688; HGNC ID: 11241; HPRD ID: 01305; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17947">PU.1</a></span> (-/-) mice that are unable to develop myeloid and lymphoid cells received bone marrow transplants resulting in donor-derived microglia. Donor-derived microglia from mice overexpressing mSOD1 (G93A), an animal model of familial ALS, transplanted into <span class="tagged-gene" title="SwissProt ID: P17947; Entrez Gene ID: 6688; HGNC ID: 11241; HPRD ID: 01305; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17947">PU.1</a></span> (-/-) mice could not induce weakness, motoneuron injury, or an ALS-like disease. To determine whether <span class="tagged-filter" title="Association Word">expression</span> of mSOD1 (G93A) in motoneurons and astroglia, as well as microglia, was required to <span class="tagged-filter" title="Association Word">produce</span> <span class="tagged-query" title="Query">motoneuron disease,</span> <span class="tagged-gene" title="SwissProt ID: P17947; Entrez Gene ID: 6688; HGNC ID: 11241; HPRD ID: 01305; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17947">PU.1</a></span> (-/-) mice were bred with mSOD1 (G93A) mice. In mSOD1 (G93A)/<span class="tagged-gene" title="SwissProt ID: P17947; Entrez Gene ID: 6688; HGNC ID: 11241; HPRD ID: 01305; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17947">PU.1</a></span> (-/-) mice, wild-type donor-derived microglia slowed motoneuron loss and prolonged disease duration and survival when compared with mice receiving mSOD1 (G93A) expressing cells or mSOD1 (G93A) mice. In vitro studies confirmed that wild-type microglia were less <span class="tagged-metabolite" title="HMDB: HMDB02227"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02227">neurotoxic</a></span> than similarly cultured mSOD1 (G93A) microglia. Compared with wild-type microglia, mSOD1 (G93A) microglia <span class="tagged-filter" title="Association Word">produced</span> and released more <span class="tagged-metabolite" title="HMDB: HMDB02168"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02168">superoxide</a></span> and nitrite+nitrate, and induced more neuronal death. These data demonstrate that the <span class="tagged-filter" title="Association Word">expression</span> of mSOD1 (G93A) results in activated and <span class="tagged-metabolite" title="HMDB: HMDB02227"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02227">neurotoxic</a></span> microglia, and suggests that the lack of mSOD1 (G93A) <span class="tagged-filter" title="Association Word">expression</span> in microglia may contribute to motoneuron protection. This study confirms the importance of microglia as a double-edged sword, and focuses on the importance of targeting microglia to minimize cytotoxicity and maximize neuroprotection in <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases.</span>
motor_neuron_disease	insulin-like-growth-factor-I	False Negative	1.441	12645079	<strong class="title">Sakamoto T, Kawazoe Y, Shen JS, Takeda Y, Arakawa Y, Ogawa J, Oyanagi K, Ohashi T, Watanabe K, Inoue K, Eto Y, Watabe K: Adenoviral <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">TGF beta 2,</a></span> but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> protects injured adult motoneurons after facial nerve avulsion. Neurol Res. 2005 Oct;27(7):768-72.</strong> We examined neuroprotective effects of recombinant adenoviral vectors encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">ciliary neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">(CNTF),</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">(CT1),</a></span> <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor-1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1),</a></span> and transforming growth factor-beta2 (TGFbeta2) on lesioned adult rat facial motoneurons. The right facial nerves of adult Fischer 344 male rats were avulsed and removed from the stylomastoid foramen, and adenoviral vectors were injected into the facial canal. Animals avulsed and treated with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1,</a></span> <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> and TGFbeta2 showed intense immunolabeling for these factors in lesioned facial motoneurons, respectively, indicating adenoviral induction of the neurotrophic factors in these neurons. The treatment with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> or TGFbeta2 after avulsion significantly prevented the loss of lesioned facial motoneurons, improved <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity and prevented the induction of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <span class="tagged-filter" title="Association Word">activity</span> in these neurons. The treatment with adenovirus encoding <a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> however, failed to protect these neurons after avulsion. These results indicate that the <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and TGFbeta2 but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	insulin-like-growth-factor-I	True Positive	1.441	10817918	<strong class="title">Di Giulio AM, Germani E, Lesma E, Muller E, Gorio A: Glycosaminoglycans co-administration enhance <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">insulin-like growth factor-I</a></span> neuroprotective and neuroregenerative <span class="tagged-filter" title="Association Word">activity</span> in traumatic and genetic models of <span class="tagged-query" title="Query">motor neuron disease:</span> a review. Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):339-46.</strong> In this report it is shown how glycosaminoglycans and <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">insulin-like growth factor-I</a></span> (IGF-I) promote muscle reinnervation and prevent motor neuron death in experimental models of <span class="tagged-query" title="Query">motor neuron disease.</span> Such effect appears to be mediated by <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor-1. The glycosaminoglycan moiety of proteoglycans is a constituent of the basal lamina active on nerve regeneration by means of the interaction with <span class="tagged-gene" title="Protein Family or Complex">laminin</span> and with several growth factors. We have previously shown that supplementation by means of subcutaneous injections of glycosaminoglycans affects neuronal degeneration and regeneration. In this study we report that following neonatal lesion of the rat sciatic nerve, glycosaminoglycan treatment promoted extensor digitorum longus muscle reinnervation with consequent improvement of muscle morphology. In saline-treated rats, reinnervation was only partial and there was a marked <span class="tagged-disease" title="UMLS Concept ID: C0333751">muscle fibre atrophy,</span> whereas, glycosaminoglycan treatment of lesioned rats increased IGF-I <span class="tagged-filter" title="Association Word">mRNA</span> and <span class="tagged-filter" title="Association Word">protein</span> in the reinnervated muscle, and IGF-I and <span class="tagged-gene" title="SwissProt ID: P17936; Entrez Gene ID: 3486; HGNC ID: 5472; HPRD ID: 00899; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17936">insulin-like growth factor binding protein-3</a></span> plasma levels. Similarly, treatment of lesioned rats with IGF-I promoted muscle reinnervation, and prevented <span class="tagged-disease" title="UMLS Concept ID: C0333751">muscle fibre atrophy,</span> higher levels of IGF-I in the reinnervated muscle, of IGF-I, and <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor binding <span class="tagged-filter" title="Association Word">proteins</span> in plasma. In the wobbler mouse IGF-I and glycosaminoglycans alone promote only a partial motor neuron survival and the preservation of forelimb function decays after 3 weeks of treatment. However when glycosaminoglycans and <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor are administered together the <span class="tagged-query" title="Query">motor neuron disease</span> in the wobbler mouse is halted and there is no more loss of motor neurons.
motor_neuron_disease	VPS9-domain	True Positive	1.441	12837691	<strong class="title">Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, Showguchi-Miyata J, Yanagisawa Y, Kohiki E, Suga E, Yasuda M, Osuga H, Nishimoto T, Narumiya S, Ikeda JE: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> a novel <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> for the small GTPase <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5,</a></span> is implicated in endosomal dynamics. Hum Mol Genet. 2003 Jul 15;12(14):1671-87.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> account for a number of <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases</span> including forms of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0037773">hereditary spastic paraplegia.</span> Although computational predictions suggest that <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> encodes a <span class="tagged-filter" title="Association Word">protein</span> containing multiple <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">(GEF)</a></span> domains <span class="tagged-gene" title="SwissProt ID: Q9P258; Entrez Gene ID: 55920; HGNC ID: 30297; HPRD ID: 18171; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9P258">[RCC1-like</a></span> domain (RLD), the Dbl homology and <span class="tagged-gene" title="SwissProt ID: P08567; Entrez Gene ID: 5341; HGNC ID: 9070; HPRD ID: 15935; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08567">pleckstrin</a></span> homology (DH/PH), and the vacuolar <span class="tagged-filter" title="Association Word">protein</span> sorting 9 (VPS9)], the functions of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> have not been revealed as yet. Here we show that the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> specifically binds to small GTPase <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> and functions as a <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">GEF</a></span> for <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5.</a></span> Ectopically <span class="tagged-filter" title="Association Word">expressed</span> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> localizes with <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> and <span class="tagged-gene" title="SwissProt ID: Q15075; Entrez Gene ID: 8411; HGNC ID: 3185; HPRD ID: 05460; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15075">early endosome antigen-1</a></span> <span class="tagged-gene" title="SwissProt ID: Q15075; Entrez Gene ID: 8411; HGNC ID: 3185; HPRD ID: 05460; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15075">(EEA1)</a></span> onto early endosomal compartments and stimulates the enlargement of endosomes in cultured cortical neurons. The carboxy-terminus of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> carrying a <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain</a></span> mediates not only the activation of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> via a <span class="tagged-metabolite" title="HMDB: HMDB00132"><span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00132">guanine</a></span>-nucleotide exchanging reaction but also the endosomal localization of the <a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein,</span> while the amino-terminal half containing RLD acts suppressive in its membranous localization. Further, the DH/PH domain in the middle portion of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> enhances the <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain</a></span>-mediated endosome fusions. Taken together, the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> as a novel <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span>-<span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">GEF,</a></span> ALS2rab5GEF seems to be implicated in the endosomal dynamics in vivo. Notably, a feature common to eight reported <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> among <span class="tagged-query" title="Query">motor neuron diseases</span> is the loss of <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain,</a></span> resulting in the failure of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> activation. Thus, a perturbation of endosomal dynamics <span class="tagged-filter" title="Association Word">caused</span> by loss of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> rab5GEF <span class="tagged-filter" title="Association Word">activity</span> might underlie neuronal dysfunction and degeneration in a number of <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	alpha-synuclein	False Positive	1.049	16406315	<strong class="title">Sasaki S, Komori T, Iwata M: Neuronal inclusions in sporadic <span class="tagged-query" title="Query">motor neuron disease</span> are negative for <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">alpha-synuclein.</a></span> Neurosci Lett. 2006 Apr 10-17;397(1-2):15-9. Epub 2006 Jan 6.</strong> <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">Alpha-synuclein</a></span> has been implicated in <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> characterized by Lewy bodies. However, we have only scanty information on the immunoreactivity of <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">alpha-synuclein</a></span> in other inclusion bodies such as the Lewy body-like inclusions and the skein-like inclusions <span class="tagged-filter" title="Association Word">observed</span> in <span class="tagged-query" title="Query">motor neuron disease</span> (MND). In this report, we immunocytochemically investigated inclusion bodies <span class="tagged-filter" title="Association Word">observed</span> in the anterior horn neurons of the spinal cord in 29 patients with sporadic MND. Sixteen age-matched patients without any <span class="tagged-disease" title="UMLS Concept ID: C0027765">neurological disease</span> served as controls. In MND patients, we recognized Lewy body-like hyaline inclusions, skein-like inclusions, Bunina bodies, basophilic inclusions, and intracytoplasmic hyaline (colloid) inclusions, but none of them were immunostained for <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">alpha-synuclein.</a></span> Our findings in this study do not support the hypothesis that MND could be classified as one of the diseases grouped as alpha-synucleinopathies.
motor_neuron_disease	alpha-synuclein	False Positive	1.049	14991384	<strong class="title">Yokota O, Terada S, Ishizu H, Ishihara T, Nakashima H, Kugo A, Tsuchiya K, Ikeda K, Hayabara T, Saito Y, Murayama S, Ueda K, Checler F, Kuroda S: Increased <span class="tagged-filter" title="Association Word">expression</span> of neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> in the hippocampus in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> both with and without <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span> Acta Neuropathol. 2004 May;107(5):399-405. Epub 2004 Feb 25.</strong> The pathophysiological basis of cognitive dysfunction, including <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> (FTD), in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and ALS with <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (ALSD) remains unclear. On the other hand, increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">(COX-2)</a></span> in the spinal cord is thought to play a pivotal <span class="tagged-filter" title="Association Word">role</span> in motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in ALS. In this study, to assess the relationship between the neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in the cerebrum, the formation of tau- and <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">alpha-synuclein</a></span>-negative but <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive neuronal inclusions (UPIs), and <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> in <span class="tagged-query" title="Query">motor neuron disease</span> (MND), we examined neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> immunoreactivity in the frontal cortex and hippocampus of patients with non-demented ALS without UPIs ( n=11), ALSD with UPIs ( n=6), and normal controls ( n=24) using a quantitative immunohistochemical technique. Neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in all <span class="tagged-gene" title="SwissProt ID: P00915; Entrez Gene ID: 759; HGNC ID: 1368; HPRD ID: 00265; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00915">CA1</a></span>-4 in the hippocampus was significantly up-regulated in the ALSD group, and, to lesser degree but significantly, in the ALS group. Neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in the frontal cortex was also significantly up-regulated in the ALSD group but not in the ALS group. These findings suggest that (1) the frontal cortex and hippocampus of MND are <span class="tagged-filter" title="Association Word">involved</span> in the same pathogenic process <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> induction that has been <span class="tagged-filter" title="Association Word">observed</span> in spinal anterior horn cells, (2) <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> induction in the cerebrum is a pathogenic process that can occur even in the <span class="tagged-filter" title="Association Word">absence</span> of UPI formation in MND, and (3) <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in the cerebrum may be <span class="tagged-filter" title="Association Word">associated</span> with cognitive dysfunction in MND.
motor_neuron_disease	alpha-synuclein	False Positive	1.049	12070670	<strong class="title">Adamec E, Mohan P, Vonsattel JP, Nixon RA: <span class="tagged-gene" title="Protein Family or Complex">Calpain</span> activation in <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases:</span> confocal immunofluorescence study with <span class="tagged-filter" title="Association Word">antibodies</span> specifically recognizing the active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2.</a></span> Acta Neuropathol. 2002 Jul;104(1):92-104. Epub 2002 Mar 23.</strong> The <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span>-activated protease <span class="tagged-gene" title="Protein Family or Complex">calpain</span> cleaves a variety of biologically important <span class="tagged-filter" title="Association Word">proteins</span> and serves, therefore, as a key regulator of many cellular functions. Activation of both main isoforms, <span class="tagged-gene" title="Protein Family or Complex">calpain</span> 1 and <a href="http://beta.uniprot.org/uniprot/P17655">calpain 2,</a></span> was demonstrated previously in <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease.</span> In this report, <span class="tagged-filter" title="Association Word">antibodies</span> specifically recognizing the active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> were used to investigate <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> activation in a broad range of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases,</span> utilizing multiple-label confocal immunofluorescence imaging. With rare exceptions, the active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> was found in colocalization with hyperphosphorylated tau protein. Aggregates of <span class="tagged-filter" title="Association Word">mutated</span> <span class="tagged-gene" title="SwissProt ID: P42858; Entrez Gene ID: 3064; HGNC ID: 4851; HPRD ID: 00883; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42858">huntingtin,</a></span> <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">alpha-synuclein,</a></span> or unidentified <span class="tagged-filter" title="Association Word">protein</span> in <span class="tagged-query" title="Query">motor neuron disease</span> type of <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> were always negative. These findings indicate that <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> activation is not a general response to <span class="tagged-filter" title="Association Word">protein</span> aggregation. In <span class="tagged-disease" title="UMLS Concept ID: C0949664">tauopathies,</span> more pathological inclusions were labeled for hyperphosphorylated tau than for activated <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2.</a></span> The extent of colocalization varied in both a disease-specific and cell-type specific manner. The active form of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> was detected in 50-75% of tau neurofibrillary pathology in <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease,</span> Alzheimer neurofibrillary changes and <span class="tagged-disease" title="UMLS Concept ID: C0013080">Down's syndrome,</span> as well as in the accompanying Alzheimer-type tau pathology in diffuse Lewy bodies disease, <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration.</span> For glial cells, only 10-25% of tuft-shaped astrocytes, glial plaques, or coiled bodies contained activated <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2.</a></span> The majority of Pick bodies were negative. The <span class="tagged-filter" title="Association Word">association</span> of <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> activation with hyperphosphorylated tau might be the result of an attempt by the <span class="tagged-gene" title="Protein Family or Complex">calpain</span> proteolytic system to degrade the tau <span class="tagged-filter" title="Association Word">protein</span> aggregates. Alternatively, <span class="tagged-gene" title="SwissProt ID: P17655; Entrez Gene ID: 824; HGNC ID: 1479; HPRD ID: 00254; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P17655">calpain 2</a></span> could be directly <span class="tagged-filter" title="Association Word">involved</span> in tau hyperphosphorylation by modulating <span class="tagged-filter" title="Association Word">protein</span> kinase activities. Overall, these results provide evidence of the important <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-gene" title="Protein Family or Complex">calpain</span> proteolytic system in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> with tau neurofibrillary pathology.
motor_neuron_disease	GSTP1	True Positive	1.496	15341277	<strong class="title">Zherebtsova AL, Shadrina MI, Levitskii GN, Levintskaia NI, Alekhin AV, Slominskii PA, Skvortsova VI, Limborskaia SA: [Analysis of the <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> P1 <span class="tagged-filter" title="Association Word">gene</span> Ile105Val <span class="tagged-filter" title="Association Word">polymorphism</span> in the patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> from Russia]. Genetika. 2004 Jun;40(6):850-2.</strong> Ile105Val <span class="tagged-filter" title="Association Word">polymorphism</span> in exon 5 of <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> <span class="tagged-gene" title="SwissProt ID: P09211; Entrez Gene ID: 2950; HGNC ID: 4638; HPRD ID: 00614; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09211">(GSTP1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> was examined in a group of patients with <span class="tagged-query" title="Query">motor neuron disease</span> (MND) and control sample. No statistically significant differences in the allele and genotype frequency distributions between the samples examined were demonstrated. We conclude that Ile105Val <span class="tagged-filter" title="Association Word">polymorphism</span> is not <span class="tagged-filter" title="Association Word">associated</span> with the risk of the disease development in the patients from Russia with sporadic form of MND.
motor_neuron_disease	DLDH	True Negative	1.441	16317257	<strong class="title">Katsuse O, Dickson DW: <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span> immunohistochemistry of <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> differentiates cases with and without <span class="tagged-query" title="Query">motor neuron disease.</span> Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19 Suppl 1:S37-43.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal lobar degeneration</span> (FTLD) without tau pathology is clinically and pathologically heterogeneous. The present report describes the neuropathology of 52 brains with FTLD without tau pathology compared with 10 brains of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) without <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> using <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> immunohistochemistry. The 52 cases were classified into 47 cases of FTLD with <span class="tagged-query" title="Query">motor neuron disease</span> (MND)-type inclusions but without MND (FTLD-MNI), three cases of FTLD with MND (FTLD-MND), and two cases of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinctive histopathology <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">(DLDH)</a></span> based on the features of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-immunoreactive <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">(ubiquitin</a></span>-ir) structures in the caudate, frontotemporal cortices and dentate fascia, and presence or <span class="tagged-filter" title="Association Word">absence</span> of neuronal loss in lower motor neurons. Many <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir neuronal inclusions and neurites in the caudate nucleus, frontotemporal cortices, and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir crescent-or ring-shaped neuronal inclusions in the dentate fascia characterized FTLD-MNI. <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span>-ir neuronal intranuclear inclusions (NII) were <span class="tagged-filter" title="Association Word">observed</span> in 26 of 43 cases and <span class="tagged-filter" title="Association Word">associated</span> with many neurites in the caudate nucleus as well as a familial history in most cases. A subset of cases had Pick-body-like inclusions in the dentate fascia and caudate nucleus with paucity of neuritic pathology and no NII; another had crescent-shaped inclusions in the dentate fascia and neuritic pathology with NII in the caudate. FTLD with MND was characterized by a few or no <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir inclusions in the caudate nucleus and frontotemporal cortices and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir granular inclusions in the dentate fascia, as well as loss of lower motor neurons. These features were similar to ALS, but different from FTLD-MNI. The findings suggest that FTLD-MNI has a different pathogenesis from FTLD-MND and ALS.
motor_neuron_disease	DLDH	True Negative	1.441	16033782	<strong class="title">Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG: The evolution and pathology of <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia.</span> Brain. 2005 Sep;128(Pt 9):1996-2005. Epub 2005 Jul 20.</strong> This is a clinicopathologic study of a prospective, clinic-based cohort of patients with <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> (FTD)/Pick complex, who were followed to autopsy. A total of 60 patients with the clinical syndromes of the behavioural variant of FTD (FTD-bv) (n = 32), <span class="tagged-disease" title="UMLS Concept ID: C0282513">primary progressive aphasia</span> <span class="tagged-metabolite" title="HMDB: HMDB04110"><span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB04110">(PPA)</a></span> (n = 22), <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration</span> syndrome (CBDS) (n = 4) and <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy</span> <a href="http://beta.uniprot.org/uniprot/P52758">(PSP)</a></span> (n = 2) at onset, referred to a cognitive neurology clinic who had subsequent post-mortem examination were included. The most common histological variety was <span class="tagged-query" title="Query">motor neurone disease</span> type inclusion (MNDI) (n = 18), followed by <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration</span> <span class="tagged-gene" title="SwissProt ID: P04001; Entrez Gene ID: 2652; HGNC ID: 4206; HPRD ID: 02365; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04001">(CBD)</a></span> (n = 12), then <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick's disease</span> (n = 6), <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinctive histology <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">(DLDH)</a></span> (n = 6) and <span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52758">PSP</a></span> (n = 3). Others fulfilled the histological criteria for <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease</span> combined with glial pathology (n = 6), <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease</span> only (n = 4), Lewy body variant (n = 2), <span class="tagged-disease" title="UMLS Concept ID: C0162534">prion disease</span> (n = 1), <span class="tagged-disease" title="UMLS Concept ID: C0011269">vascular dementia</span> (n = 1) and undetermined (n = 1). The most common first syndrome among the MNDI and <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">DLDH</a></span> (tau negative) pathologies was FTD-bv, but subsequently <span class="tagged-disease" title="UMLS Concept ID: C0338457">progressive aphasia</span> (PA), occasionally CBDS and <span class="tagged-disease" title="UMLS Concept ID: C0338462">semantic dementia</span> also developed. Tau positive histologies of <span class="tagged-gene" title="SwissProt ID: P04001; Entrez Gene ID: 2652; HGNC ID: 4206; HPRD ID: 02365; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04001">CBD,</a></span> <span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52758">PSP</a></span> and Pick bodies were most frequently <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-metabolite" title="HMDB: HMDB04110"><span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB04110">PPA</a></span> onset or CBDS/<a href="http://beta.uniprot.org/uniprot/P52758">PSP,</a></span> but behavioural symptoms were also common. Age of onset was earlier in tau negative cases, but the duration of illness and gender distribution were about the same in all histological variants. Although the tau negative and positive histologies are predicted to some extent by the clinical onset, the extent of the overlap and the convergence of the syndromes in the course of the disease argue in favour of maintaining the clinical and pathological varieties under a single umbrella.
motor_neuron_disease	DLDH	True Negative	1.441	15892300	<strong class="title">Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VM, Forman M, Van Deerlin V, Ervin JF, Wang DS, Schmechel DE, Hulette CM: Neuropathologic, biochemical, and molecular characterization of the frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias.</span> J Neuropathol Exp Neurol. 2005 May;64(5):420-8.</strong> The frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias</span> (FTDs) are a heterogeneous group of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders</span> that are characterized clinically by <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia,</span> personality changes, <span class="tagged-disease" title="UMLS Concept ID: C0023015">language impairment,</span> and occasionally extrapyramidal <span class="tagged-disease" title="UMLS Concept ID: C0026650">movement disorders.</span> Historically, the <span class="tagged-filter" title="Association Word">diagnosis</span> and classification of FTDs has been fraught with difficulties, especially with regard to establishing a consensus on the neuropathologic <span class="tagged-filter" title="Association Word">diagnosis.</span> Recently, an international group of scientists participated in a consensus conference to develop such neuropathologic criteria. They recommended a diagnostic classification scheme that incorporated a biochemical analysis of the insoluble tau isoform composition, as well as <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> immunohistochemistry. The use and reliability of this classification system has yet to be examined. In this study, we evaluated 21 cases of FTD. Using traditional histochemical stains and tau <span class="tagged-filter" title="Association Word">protein</span> and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> immunohistochemistry, we separated each case into one of the following categories: classic <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick disease</span> (PiD; n = 7), <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration</span> <span class="tagged-gene" title="SwissProt ID: P04001; Entrez Gene ID: 2652; HGNC ID: 4206; HPRD ID: 02365; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04001">(CBD;</a></span> n = 5), <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinctive histopathologic features <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">(DLDH;</a></span> n = 4), <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy</span> <span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52758">(PSP;</a></span> n = 2), <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-query" title="Query">motor neuron disease</span> or <span class="tagged-query" title="Query">motor neuron disease</span>-type inclusions (FTLD-MND/MNI; n = 2), and neurofibrillary tangle <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (NFTD; n = 1). Additionally, we independently categorized each case by the insoluble tau isoform pattern, including 3R (n = 5), 4R (n = 7), 3R/4R (n = 3), and no insoluble tau (n = 6). As suggested by the proposed diagnostic scheme, we found that the insoluble tau isoform patterns correlated strongly with the independently derived histopathologic diagnoses (p < 0.001). The data show that cases containing predominantly 3R tau were classic PiD (100%). Cases with predominantly 4R tau were either <span class="tagged-gene" title="SwissProt ID: P04001; Entrez Gene ID: 2652; HGNC ID: 4206; HPRD ID: 02365; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04001">CBD</a></span> (71%) or <span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52758">PSP</a></span> (29%). Cases with both 3R and 4R tau were either a combination of PiD and <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer disease</span> (67%) or NFTD (33%). Finally, cases with no insoluble tau were either <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">DLDH</a></span> (67%) or FTLD-MND/MNI (33%). To further characterize these cases, we also performed quantitative Western blots for soluble tau, <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">APOE</a></span> genotyping, and, in selected cases, tau <span class="tagged-filter" title="Association Word">gene</span> sequencing. We show that soluble tau is reduced in <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">DLDH</a></span> and FTLD-MND/MNI and that APOE4 is overrepresented in PiD and <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">DLDH.</a></span> We also identified a new family with the R406W <span class="tagged-filter" title="Association Word">mutation</span> and pathology consistent with NFTD. This study validates the recently proposed diagnostic criteria and forms a framework for further refinement of this classification scheme.
motor_neuron_disease	acetylcholine-receptor	True Positive	1.441	12019486	<strong class="title">Salazar Cabrera C, de Saa Alvarez Md Mdel R, Aparicio Perez MS, Marcos Calle J, Garcia Garcia B: <span class="tagged-disease" title="UMLS Concept ID: C0026896">Myasthenia gravis:</span> the otolaryngologist's perspective. Am J Otolaryngol. 2002 May-Jun;23(3):169-72.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026896">Myasthenia gravis</span> is a <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by the presence of <span class="tagged-filter" title="Association Word">antibodies</span> against <span class="tagged-gene" title="Protein Family or Complex">acetylcholine receptors</span> that interfere with the proper function of the neuromuscular junction. Twenty percent of patients with <span class="tagged-disease" title="UMLS Concept ID: C0026896">myasthenia gravis</span> present some type of bulbar deficits such as rhinolalia, <span class="tagged-disease" title="UMLS Concept ID: C0011168">dysphagia</span> or <span class="tagged-disease" title="UMLS Concept ID: C1527344">dysphonia</span> as the first symptom of disease. We report 5 patients with deficits that illustrate different aspects of the disease. Our <span class="tagged-filter" title="Association Word">role</span> as otolaryngologists is to establish a <span class="tagged-filter" title="Association Word">diagnosis</span> or to provide a solution for the <span class="tagged-disease" title="UMLS Concept ID: C1145670">respiratory failure</span> <span class="tagged-filter" title="Association Word">caused</span> by chronic aspiration.
motor_neuron_disease	acetylcholine-receptor	False Negative	1.441	10799942	<strong class="title">Salazar C, De Saa MR, Aparicio M, Garcia B, Casado I: <span class="tagged-disease" title="UMLS Concept ID: C0026896">[Myasthenia gravis.</span> Acta Otorrinolaringol Esp. 2000 Jan-Feb;51(1):92-6.</strong> Otorhinolaryngological considerations] . <span class="tagged-disease" title="UMLS Concept ID: C0026896">Myasthenia gravis</span> is a <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by the presence of <span class="tagged-filter" title="Association Word">antibodies</span> against <span class="tagged-gene" title="Protein Family or Complex">acetylcholine receptors</span> that interfere with proper functioning of the neuromuscular junction. Twenty percent of patients show bulbar involvement as the first indication of disease, with symptoms such as rhinolalia, <span class="tagged-disease" title="UMLS Concept ID: C0011168">dysphagia</span> or phonasthenia. We report the cases of five patients for which our intervention was requested. We were <span class="tagged-filter" title="Association Word">involved</span> in capacities ranging from the interpretation of the first symptom of disease to assessment of surgical possibilities for the treatment of chronic aspiration and severe respiratory symptoms in patients with major <span class="tagged-disease" title="UMLS Concept ID: C0011168">dysphagia.</span> We review the scant bibliography published in the last five years.
motor_neuron_disease	GDNF	True Positive	5.831	16382788	<strong class="title">Watabe K, Hayashi Y, Kawazoe Y: Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration. Neuropathology. 2005 Dec;25(4):371-80.</strong> We have used adult rat peripheral nerve avulsion models to evaluate the effects of neuroprotective molecules on motoneuron degeneration. The right facial nerves of adult Fischer 344 male rats were avulsed and adenoviral vectors encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> transforming growth factor-beta2 (TGFbeta2), and <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">growth inhibitory factor</a></span> <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">(GIF)</a></span> were injected into the facial canal. The treatment with the vectors significantly prevented the loss of lesioned facial motoneurons, improved <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">(ChAT)</a></span> immunoreactivity and suppressed the induction of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <span class="tagged-filter" title="Association Word">activity</span> in these neurons. In separate experiments, animals were orally administered a solution of a neuroprotective compound T-588 after avulsion. Both free oral administration and oral tube administration of T-588 improved the survival of injured motoneurons and ameliorated their <a href="http://beta.uniprot.org/uniprot/P28329">ChAT</a></span> immunoreactivity. These results indicate that the <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> TGFbeta2, and <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">GIF</a></span> and oral administration of T-588 may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	GDNF	True Positive	5.831	12699624	<strong class="title">Ferri A, Sanes JR, Coleman MP, Cunningham JM, Kato AC: Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of <span class="tagged-query" title="Query">motoneuron disease.</span> Curr Biol. 2003 Apr 15;13(8):669-73.</strong> Apoptosis is a hallmark of motoneuron diseases such as <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> [1]. In a widely used mouse model of <span class="tagged-query" title="Query">motoneuron disease</span> (progressive <span class="tagged-disease" title="UMLS Concept ID: Not Available">motor neuronopathy</span> or pmn) [2-4], transgenic <span class="tagged-filter" title="Association Word">expression</span> of the anti-apoptotic <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">bcl-2</a></span> <span class="tagged-filter" title="Association Word">gene</span> [5] or treatment with <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell-derived neurotrophic factor</a></span> [6] prevents the apoptosis of the motoneuron soma; however, they were unable to affect the life span of the animals. The goal of the present work was to determine whether the pmn phenotype could be rescued by means of a <span class="tagged-filter" title="Association Word">gene</span> that inhibits axon degeneration. For this reason, the pmn mice were crossed with mice bearing the <span class="tagged-filter" title="Association Word">dominant</span> Wlds ("slow <span class="tagged-disease" title="UMLS Concept ID: C0043020">Wallerian degeneration")</span> <span class="tagged-filter" title="Association Word">mutation,</span> which slows axon degeneration and synapse loss [7-9]. We show here that the Wlds <span class="tagged-filter" title="Association Word">gene</span> product attenuates symptoms, extends life span, prevents axon degeneration, rescues motoneuron number and size, and delays retrograde transport deficits in pmn/pmn mice. These results suggest new pathogenic mechanisms and therapeutic avenues for motoneuron diseases.
motor_neuron_disease	GDNF	True Positive	5.831	12645079	<strong class="title">Sakamoto T, Kawazoe Y, Shen JS, Takeda Y, Arakawa Y, Ogawa J, Oyanagi K, Ohashi T, Watanabe K, Inoue K, Eto Y, Watabe K: Adenoviral <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">TGF beta 2,</a></span> but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res. 2003 Apr 1;72(1):54-64.</strong> We examined neuroprotective effects of recombinant adenoviral vectors encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">ciliary neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">(CNTF),</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">(CT1),</a></span> <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor-1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1),</a></span> and transforming growth factor-beta2 (TGFbeta2) on lesioned adult rat facial motoneurons. The right facial nerves of adult Fischer 344 male rats were avulsed and removed from the stylomastoid foramen, and adenoviral vectors were injected into the facial canal. Animals avulsed and treated with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1,</a></span> <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> and TGFbeta2 showed intense immunolabeling for these factors in lesioned facial motoneurons, respectively, indicating adenoviral induction of the neurotrophic factors in these neurons. The treatment with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> or TGFbeta2 after avulsion significantly prevented the loss of lesioned facial motoneurons, improved <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity and prevented the induction of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <span class="tagged-filter" title="Association Word">activity</span> in these neurons. The treatment with adenovirus encoding <a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> however, failed to protect these neurons after avulsion. These results indicate that the <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and TGFbeta2 but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	GDNF	True Positive	5.831	11436355	<strong class="title">Watabe K, Sakamoto T, Ohashi T, Kawazoe Y, Oyanagi K, Takeshima T, Inoue K, Eto Y, Kim SU: Adenoviral <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> to injured adult motoneurons. Hum Cell. 2001 Mar;14(1):7-15.</strong> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">Glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF)</a></span> strongly supports the survival of injured neonatal motoneurons, suggesting its potential uses in the treatment of motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span> We examined neuroprotective effects of an adenoviral vector encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> (AxCAhGDNF) on the survival of lesioned adult rat facial and spinal motoneurons. The facial nerve or the seventh cervical segment (C7) ventral and dorsal roots of 3 month-old Fischer 344 male rats were avulsed and removed from the stylomastoid or vertebral foramen, respectively, and AxCALacZ (adenovirus containing beta-galactosidase <span class="tagged-filter" title="Association Word">gene),</span> AxCAhGDNF, or <span class="tagged-gene" title="SwissProt ID: P30536; Entrez Gene ID: 706; HGNC ID: 1158; HPRD ID: 15913; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30536">PBS</a></span> was inoculated in the lesioned foramen. One week after the avulsion and treatment with AxCALacZ, the animal showed <span class="tagged-filter" title="Association Word">expression</span> of beta-galactosidase <span class="tagged-filter" title="Association Word">activity</span> in lesioned facial and spinal motoneurons. Animals avulsed and treated with AxCAhGDNF showed intense immunolabeling for <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> in lesioned facial and spinal motoneurons and <span class="tagged-filter" title="Association Word">expression</span> of virus-induced human <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> transcripts in the lesioned brain stem and spinal cord tissues. The treatment with AxCAhGDNF after avulsion significantly prevented the loss of lesioned facial and C7 spinal motoneurons, ameliorated <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity, and suppressed the <span class="tagged-filter" title="Association Word">activity</span> of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase in these neurons. These results indicate that the adenovirus-mediated <span class="tagged-filter" title="Association Word">gene</span> transfer of <a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	GDNF	True Positive	5.831	10884032	<strong class="title">Sakamoto T, Watabe K, Ohashi T, Kawazoe Y, Oyanagi K, Inoue K, Eto Y: Adenoviral vector-mediated <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">gene</span> transfer prevents death of adult facial motoneurons. Neuroreport. 2000 Jun 26;11(9):1857-60.</strong> We examined neuroprotective effects of an adenoviral vector encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> (AxCAhGDNF) on the lesioned adult rat facial motoneurons. After facial nerve avulsion, animals locally injected into the facial canal with AxCALacZ (adenovirus encoding beta-galactosidase <span class="tagged-filter" title="Association Word">gene)</span> or AxCAhGDNF showed <span class="tagged-filter" title="Association Word">expression</span> of beta-galactosidase <span class="tagged-filter" title="Association Word">activity</span> or intense immunolabeling for <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> in lesioned facial motoneurons, respectively. The treatment with AxCAhGDNF after avulsion significantly prevented the loss of lesioned facial motoneurons, ameliorated <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity, and suppressed the <span class="tagged-filter" title="Association Word">activity</span> of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase in these neurons. These results indicate that the adenovirus-mediated <span class="tagged-filter" title="Association Word">gene</span> transfer of <a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> may prevent the degeneration of motoneurons in adult humans with peripheral nerve injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	GDNF	True Positive	5.831	10797554	<strong class="title">Watabe K, Ohashi T, Sakamoto T, Kawazoe Y, Takeshima T, Oyanagi K, Inoue K, Eto Y, Kim SU: Rescue of lesioned adult rat spinal motoneurons by adenoviral <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor.</a></span> J Neurosci Res. 2000 May 15;60(4):511-9.</strong> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">Glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF)</a></span> has been shown to protect cranial and spinal motoneurons, that suggests potential uses of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> in the treatment of spinal cord injury and <span class="tagged-query" title="Query">motor neuron diseases.</span> We examined neuroprotective effect of human <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> encoded by an adenovirus vector (AxCAhGDNF) on the death of lesioned adult rat spinal motoneurons. The seventh cervical segment (C7) ventral and dorsal roots and dorsal root ganglia of adult Fisher 344 rats were avulsed, and AxCAhGDNF, AxCALacZ (adenovirus encoding beta-galactosidase <span class="tagged-filter" title="Association Word">gene)</span> or <span class="tagged-gene" title="SwissProt ID: P30536; Entrez Gene ID: 706; HGNC ID: 1158; HPRD ID: 15913; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30536">PBS</a></span> was inoculated in C7 vertebral foramen. One week after the avulsion and treatment with AxCALacZ, the animals showed <span class="tagged-filter" title="Association Word">expression</span> of beta-galactosidase <span class="tagged-filter" title="Association Word">activity</span> in lesioned spinal motoneurons. Animals avulsed and treated with AxCAhGDNF showed intense immunolabeling for <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> in lesioned spinal motoneurons and <span class="tagged-filter" title="Association Word">expression</span> of virus-induced human <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> transcripts in the lesioned spinal cord tissue. Nissl-stained cell counts revealed that the treatment with AxCAhGDNF significantly prevented the loss of lesioned ventral horn motoneurons 2 to 8 weeks after avulsion, as compared to AxCALacZ or <span class="tagged-gene" title="SwissProt ID: P30536; Entrez Gene ID: 706; HGNC ID: 1158; HPRD ID: 15913; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30536">PBS</a></span> treatment. Furthermore, the AxCAhGDNF treatment ameliorated <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity in the lesioned motoneurons after avulsion. These results indicate that the adenovirus-mediated <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> may prevent the degeneration of motoneurons in adult humans with spinal cord injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	GDNF	True Positive	5.831	10447463	<strong class="title">Yamamoto M, Mitsuma N, Inukai A, Ito Y, Li M, Mitsuma T, Sobue G: <span class="tagged-filter" title="Association Word">Expression</span> of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> <span class="tagged-filter" title="Association Word">mRNAs</span> in muscles of patients with <span class="tagged-query" title="Query">motor neuron diseases.</span> Neurochem Res. 1999 Jun;24(6):785-90.</strong> The <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> levels of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> and <span class="tagged-gene" title="SwissProt ID: O43519; Entrez Gene ID: 5979; HGNC ID: 9967; HPRD ID: 01266; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43519">RET</a></span> were examined in the muscles of amyotrophic lateral screlosis (ALS) and X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA).</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> levels were significantly <span class="tagged-filter" title="Association Word">elevated</span> to variable extent in the diseased muscles compared to control muscles, although they were not specific to the type of the diseases. The diseased muscles also have a different <span class="tagged-filter" title="Association Word">expression</span> pattern of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> isoforms from controls. <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression,</span> however, tended to reduce in advanced muscle pathology. On the other hand, <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> levels were not changed significantly on <span class="tagged-filter" title="Association Word">expression</span> levels in the diseased muscles. In situ hybridization study revealed that <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> <span class="tagged-filter" title="Association Word">mRNAs</span> were localized in subsarcolemmal space of muscle cells. <span class="tagged-gene" title="SwissProt ID: O43519; Entrez Gene ID: 5979; HGNC ID: 9967; HPRD ID: 01266; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43519">RET</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> was not detected in control nor diseased muscles. These results suggest that the <span class="tagged-filter" title="Association Word">elevated</span> muscle <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> acts as a trophic signal for motor neurons of <span class="tagged-query" title="Query">motor neuron diseases,</span> implying a possible therapeutic implication of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> to this type of diseases.
motor_neuron_disease	alpha-internexin	True Negative	1.441	15170578	<strong class="title">Cairns NJ, Uryu K, Bigio EH, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Arnold SE, Lee VM, Trojanowski JQ: <span class="tagged-gene" title="SwissProt ID: Q16352; Entrez Gene ID: 9118; HGNC ID: 6057; HPRD ID: 05628; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16352">alpha-Internexin</a></span> aggregates are abundant in neuronal intermediate filament <span class="tagged-disease" title="UMLS Concept ID: C0010823">inclusion disease</span> (NIFID) but rare in other <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases.</span> Acta Neuropathol. 2004 Sep;108(3):213-23. Epub 2004 May 28.</strong> Abnormal neuronal aggregates of <span class="tagged-gene" title="SwissProt ID: Q16352; Entrez Gene ID: 9118; HGNC ID: 6057; HPRD ID: 05628; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16352">alpha-internexin</a></span> and the three neurofilament (NF) subunits, <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L,</a></span> <span class="tagged-gene" title="SwissProt ID: P07197; Entrez Gene ID: 4741; HGNC ID: 7734; HPRD ID: 01205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07197">NF-M,</a></span> and <span class="tagged-gene" title="SwissProt ID: P12036; Entrez Gene ID: 4744; HGNC ID: 7737; HPRD ID: 01204; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12036">NF-H</a></span> have recently been identified as the pathological hallmarks of neuronal intermediate filament (IF) <span class="tagged-disease" title="UMLS Concept ID: C0010823">inclusion disease</span> (NIFID), a novel <span class="tagged-disease" title="UMLS Concept ID: C0027765">neurological disease</span> of early onset with a variable clinical phenotype including <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia,</span> pyramidal and extrapyramidal signs. <span class="tagged-gene" title="SwissProt ID: Q16352; Entrez Gene ID: 9118; HGNC ID: 6057; HPRD ID: 05628; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16352">alpha-Internexin,</a></span> a class IV IF <span class="tagged-gene" title="SwissProt ID: P07602; Entrez Gene ID: 5660; HGNC ID: 9498; HPRD ID: 01460; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07602">protein, a</a></span> major component of inclusions in NIFID, has not previously been identified as a component of the pathological <span class="tagged-filter" title="Association Word">protein</span> aggregates of any other <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disease.</span> Therefore, to determine the specificity of this <span class="tagged-filter" title="Association Word">protein,</span> <span class="tagged-gene" title="SwissProt ID: Q16352; Entrez Gene ID: 9118; HGNC ID: 6057; HPRD ID: 05628; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16352">alpha-internexin</a></span> immunohistochemistry was undertaken on cases of NIFID, non-tau frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias,</span> <span class="tagged-query" title="Query">motor neuron disease,</span> alpha-synucleinopathies, <span class="tagged-disease" title="UMLS Concept ID: C0949664">tauopathies,</span> and normal aged control brains. Our results indicate that class IV IF <span class="tagged-filter" title="Association Word">proteins</span> are present within the pleomorphic inclusions of all cases of NIFID. Small subsets of abnormal neuronal inclusions in <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease,</span> Lewy body diseases, and <span class="tagged-query" title="Query">motor neuron disease</span> also contain epitopes of <span class="tagged-gene" title="SwissProt ID: Q16352; Entrez Gene ID: 9118; HGNC ID: 6057; HPRD ID: 05628; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16352">alpha-internexin.</a></span> Thus, <span class="tagged-gene" title="SwissProt ID: Q16352; Entrez Gene ID: 9118; HGNC ID: 6057; HPRD ID: 05628; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16352">alpha-internexin</a></span> is a major component of the neuronal inclusions in NIFID and a relatively minor component of inclusions in other <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases.</span> The discovery of <span class="tagged-gene" title="SwissProt ID: Q16352; Entrez Gene ID: 9118; HGNC ID: 6057; HPRD ID: 05628; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16352">alpha-internexin</a></span> in neuronal cytoplasmic inclusions implicates novel mechanisms of pathogenesis in NIFID and other neurological diseases with pathological filamentous neuronal inclusions.
motor_neuron_disease	GluR-B	True Positive	1.441	16523673	<strong class="title">Zherebtsova AL, Shadrina MI, Semenova EV, Levitskii GN, Alekhin AV, Slominskii PA, Skvortsova VI, Limborskaia SA: [Analysis of the possible involvement of the <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> transporter <span class="tagged-filter" title="Association Word">gene</span> <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> and the <span class="tagged-gene" title="SwissProt ID: Q6EER8; Entrez Gene ID: 145781; HPRD ID: 08091; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6EER8">glutamate receptor</a></span> <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> in pathogenesis of <span class="tagged-query" title="Query">motor neuron disease</span> in the Russian population]. Genetika. 2006 Jan;42(1):104-9.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> of the <span class="tagged-filter" title="Association Word">genes</span> of the glutamatergic system <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> have been analyzed in patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> (MND) from Russia. The disease is not <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">polymorphic</span> alleles of the <span class="tagged-filter" title="Association Word">genes</span> studied, which indicates that <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> play an insignificant <span class="tagged-filter" title="Association Word">role</span> in the pathogenesis of sporadic MND.
motor_neuron_disease	GluR-B	True Positive	1.441	16179532	<strong class="title">Kuner R, Groom AJ, Muller G, Kornau HC, Stefovska V, Bresink I, Hartmann B, Tschauner K, Waibel S, Ludolph AC, Ikonomidou C, Seeburg PH, Turski L: Mechanisms of disease: <span class="tagged-query" title="Query">motoneuron disease</span> aggravated by transgenic <span class="tagged-filter" title="Association Word">expression</span> of a functionally modified AMPA receptor subunit. Ann N Y Acad Sci. 2005 Aug;1053:269-86.</strong> To reveal whether increased Ca2+ permeability of <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> AMPA channels triggered by the transgene for <a href="http://beta.uniprot.org/uniprot/P42262">GluR-B</a></span> (N) induces <span class="tagged-filter" title="Association Word">decline</span> in motor functions and <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration</span> in the spinal cord, we evaluated growth, motor coordination, and spinal reflexes in transgenic <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GluR-B</a></span> (N) and wild-type (wt) mice. To reveal whether the transgenic <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GluR-B</a></span> (N) <span class="tagged-filter" title="Association Word">expression</span> aggravates the course of <span class="tagged-query" title="Query">motoneuron disease</span> in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice, we mated heterozygous <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GluR-B</a></span> (N) and <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> [C57BL6Ico-TgN (hSOD1-G93A) 1Gur] mice to generate double-transgenic progeny. The phenotypic sequelae in mice carrying <span class="tagged-filter" title="Association Word">mutations</span> were evaluated by monitoring growth, motor coordination, and survival. Neuronal degeneration was assessed by morphological and stereological analysis of spinal cord and brain. We found that transgenic <span class="tagged-filter" title="Association Word">expression</span> in mice of <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GluR-B</a></span> (N)-containing <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> AMPA receptors with increased Ca2+ permeability <span class="tagged-filter" title="Association Word">leads</span> to a late-onset degeneration of neurons in the spinal cord and <span class="tagged-filter" title="Association Word">decline</span> of motor functions. Neuronal death progressed over the entire life span, but manifested clinically in late adulthood, resembling the course of a slow <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorder.</span> Additional transgenic <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-filter" title="Association Word">mutated</span> human <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> accelerated disease progression, aggravated severity of motor <span class="tagged-filter" title="Association Word">decline,</span> and decreased survival. These observations reveal that moderate, but persistently <span class="tagged-filter" title="Association Word">elevated</span> Ca2+ influx via <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> AMPA channels <span class="tagged-filter" title="Association Word">causes</span> degeneration of spinal motoneurons and motor <span class="tagged-filter" title="Association Word">decline</span> over the span of life. These features resemble the course of sporadic <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) in humans and suggest that modified function of <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> AMPA channels may be causally <span class="tagged-filter" title="Association Word">linked</span> to pathogenesis of ALS.
motor_neuron_disease	SOD1	True Positive	26.494	17079668	<strong class="title">Gowing G, Dequen F, Soucy G, Julien JP: <span class="tagged-filter" title="Association Word">Absence</span> of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor-alpha</a></span> does not affect <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> J Neurosci. 2006 Nov 1;26(44):11397-402.</strong> An increase in the <span class="tagged-filter" title="Association Word">expression</span> of the proinflammatory <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF-alpha)</a></span> has been <span class="tagged-filter" title="Association Word">observed</span> in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and in the mice models of the disease. <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> is a potent activator of macrophages and microglia and, under certain conditions, can induce or exacerbate neuronal cell death. Here, we assessed the contribution of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> in <span class="tagged-query" title="Query">motor neuron disease</span> in mice overexpressing mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">linked</span> to familial ALS. This was accomplished by the generation of mice expressing <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G37R) or <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) mutants in the context of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> <span class="tagged-filter" title="Association Word">gene</span> knock out. Surprisingly, the <span class="tagged-filter" title="Association Word">absence</span> of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> did not affect the lifespan or the extent of motor <span class="tagged-disease" title="UMLS Concept ID: C0598940">neuron loss</span> in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mice. These results provide compelling evidence indicating that <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha</a></span> does not directly contribute to motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mutations.</span>
motor_neuron_disease	SOD1	True Positive	26.494	16737688	<strong class="title">Leichsenring A, Linnartz B, Zhu XR, Lubbert H, Stichel CC: Ascending neuropathology in the CNS of a mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mouse model of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Brain Res. 2006 Jun 22;1096(1):180-95. Epub 2006 Jun 5.</strong> Transgenic mice expressing a <span class="tagged-filter" title="Association Word">mutated</span> human Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> develop a <span class="tagged-query" title="Query">motor neuron disease</span> similar to familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS). While the histopathology and the inflammatory reactions in the spinal cord of these mice are well described, their spatiotemporal extension into brain areas and the relationship between degenerative and inflammatory events remain obscure. In the present study, we investigated the time course and extent of degenerative changes and inflammatory reactions in the CNS during progression of the disease in a transgenic FALS model, the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-G93A mouse with histological and immunohistochemical methods. Compared to non-transgenic littermates, the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-G93A transgenics developed widespread degeneration in both motor and extra-motor regions up to telencephalic regions, including the cerebral cortex but sparing distinct regions like the striatum and hippocampus. We provide evidence that these degenerative processes are accompanied by intense inflammatory reactions in the brain, which spatiotemporally correlate with degeneration and comprise besides strong astro- and microgliotic reactions also an influx of peripheral immune cells such as T-lymphocytes and dendritic cells. Both degeneration and inflammatory reactions spread caudocranially, starting at 2 months in the spinal cord and reaching the telencephalon at 5 months of age. Since the corticospinal tract lacked any signs of degeneration, we conclude that the upper and the lower motor neurons degenerate independently of each other.
motor_neuron_disease	SOD1	True Positive	26.494	16675207	<strong class="title">Julien JP, Kriz J: Transgenic mouse models of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1013-24. Epub 2006 Apr 21.</strong> The discovery of missense <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> coding for the Cu/Zn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> in subsets of familial cases was rapidly followed by the generation of transgenic mice expressing various forms of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants. The mice overexpressing high levels of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mRNAs</span> do develop <span class="tagged-query" title="Query">motor neuron disease</span> but unraveling the mechanisms of pathogenesis has been very challenging. Studies with mouse lines suggest that the toxicity of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> is unrelated to <span class="tagged-metabolite" title="HMDB: HMDB00657"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00657">copper</a></span>-mediated catalysis but rather to propensity of a subfraction of mutant <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">proteins</span> to form misfolded <span class="tagged-filter" title="Association Word">protein</span> species and aggregates. However, the mechanism of toxicity of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mutants remains to be elucidated. Involvement of cytoskeletal components in ALS pathogenesis is supported by several mouse models of <span class="tagged-query" title="Query">motor neuron disease</span> with neurofilament abnormalities and with genetic defects in microtubule-based transport. Here, we describe how transgenic mouse models have been used for understanding pathogenic pathways of <span class="tagged-query" title="Query">motor neuron disease</span> and for pre-clinical drug testing.
motor_neuron_disease	SOD1	True Positive	26.494	16184763	<strong class="title">Batulan Z, Nalbantoglu J, Durham HD: Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells. Neuromuscul Disord. 2007 Jul 9;.</strong> Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to amplify the heat shock response in cell lines by increasing the binding of <span class="tagged-gene" title="SwissProt ID: Q00613; Entrez Gene ID: 3297; HGNC ID: 5224; HPRD ID: 00778; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q00613">heat shock transcription factor-1</a></span> to heat shock elements within heat shock <span class="tagged-filter" title="Association Word">gene</span> promoters. Because overexpression of the inducible heat shock <span class="tagged-filter" title="Association Word">protein</span> 70 <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">(Hsp70)</a></span> was neuroprotective in a culture model of <span class="tagged-query" title="Query">motor neuron disease,</span> this study investigated whether NSAIDs induce <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> and confer cytoprotection in motor neurons of dissociated spinal cord cultures exposed to various stresses. Two NSAIDs, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> and niflumic acid, lowered the temperature threshold for induction of <a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in glia but failed to do so in motor neurons. At concentrations that increased <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in heat shocked glial cells, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> failed to delay death of motor neurons exposed to <span class="tagged-disease" title="UMLS Concept ID: C0236832">hyperthermia,</span> paraquat-mediated oxidative stress, and <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> excitotoxicity. Neither <span class="tagged-metabolite" title="HMDB: HMDB00588"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> nor the <a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> inhibitor, niflumic acid, protected motor neurons from the toxicity of <span class="tagged-filter" title="Association Word">mutated</span> Cu/Zn-<span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD-1)</a></span> <span class="tagged-filter" title="Association Word">linked</span> to a familial form of the <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Thus, treatment with 2 types of NSAIDs failed to overcome the high threshold for the activation of heat shock response in motor neurons.
motor_neuron_disease	SOD1	True Positive	26.494	16054517	<strong class="title">Pamphlett R, Heath PR, Holden H, Ince PG, Shaw PJ: Detection of <span class="tagged-filter" title="Association Word">mutations</span> in whole genome-amplified DNA from laser-microdissected neurons. Neuron. 2004 Jul 8;43(1):5-17.</strong> <span class="tagged-drug" title="DrugBank: APRD01135"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01135">Laser</a></span> microdissection allows removal of individual cells for DNA extraction, but obtaining reliably amplified DNA from the small numbers of cells that survive <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> can be difficult. We therefore tested a recently-available technique to amplify genomic DNA to see if it could reliably detect a <span class="tagged-filter" title="Association Word">mutation</span> in nervous system cells. Fifty cortical motor neurons were removed by laser microdissection from cases of <span class="tagged-query" title="Query">motor neuron disease</span> both with and without known <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-filter" title="Association Word">gene</span> for <a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1).</a></span> DNA was extracted and amplified with a linear genomic amplification kit (GenomiPhitrade mark). The PCR product of exon 4 of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> from this DNA was then sequenced. The GenomiPhi kit amplified the extracted DNA approximately 70 times. When exon 4 of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> from this DNA was amplified by PCR the E100G <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mutation</span> could be identified on sequencing. No errors in replication were found. In conclusion, the GenomiPhi method of genomic DNA amplification appears to result in reliable replication of <span class="tagged-filter" title="Association Word">mutations</span> in neurons. This technique can be used to obtain increased amounts of genomic DNA to study <span class="tagged-filter" title="Association Word">mutations</span> within cells of the nervous system.
motor_neuron_disease	SOD1	True Positive	26.494	16046140	<strong class="title">Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR: Coincident thresholds of mutant <span class="tagged-filter" title="Association Word">protein</span> for paralytic disease and <span class="tagged-filter" title="Association Word">protein</span> aggregation <span class="tagged-filter" title="Association Word">caused</span> by restrictively <span class="tagged-filter" title="Association Word">expressed</span> <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> cDNA. Nihon Shinkei Seishin Yakurigaku Zasshi. 2001 Feb;21(1):21-25.</strong> Familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS) has been modeled in transgenic mice by introducing <span class="tagged-filter" title="Association Word">mutated</span> versions of human genomic DNA encompassing the entire <span class="tagged-filter" title="Association Word">gene</span> for Cu,Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1).</a></span> In this setting, the transgene is <span class="tagged-filter" title="Association Word">expressed</span> throughout the body and results in mice that faithfully recapitulate many pathological and behavioral aspects of FALS. By contrast, transgenic mice made by introducing recombinant vectors, encoding cDNA <span class="tagged-filter" title="Association Word">genes,</span> that target mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">expression</span> to motor neurons, only, or astrocytes, only, do not develop disease. Here, we report that mice transgenic for human <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> cDNA with the G37R <span class="tagged-filter" title="Association Word">mutation,</span> driven by the mouse prion promoter, develop <span class="tagged-query" title="Query">motor neuron disease.</span> In this model, <span class="tagged-filter" title="Association Word">expression</span> of the transgene is highest in CNS (both neurons and astrocytes) and muscle. The <span class="tagged-filter" title="Association Word">gene</span> was not <span class="tagged-filter" title="Association Word">expressed</span> in cells of the macrophage lineage. Although the highest expressing hemizygous transgenic mice fail to develop disease by 20 months of age, mice homozygous for the transgene show typical ALS-like phenotypes as early as 7 months of age. Spinal cords and brain stems from homozygous animals with <span class="tagged-query" title="Query">motor neuron disease</span> were found to contain aggregated species of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span> The establishment of this <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-G37R cDNA <span class="tagged-disease" title="UMLS Concept ID: C1519606">transgenic model</span> indicates that <span class="tagged-filter" title="Association Word">expression</span> of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">proteins</span> in the neuromuscular unit is sufficient to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">motor neuron disease.</span> The <span class="tagged-filter" title="Association Word">expression</span> levels required to induce disease coincide with the levels required to induce the formation of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> aggregates.
motor_neuron_disease	SOD1	True Positive	26.494	15872021	<strong class="title">Kirby J, Halligan E, Baptista MJ, Allen S, Heath PR, Holden H, Barber SC, Loynes CA, Wood-Allum CA, Lunec J, Shaw PJ: Mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">alters</span> the motor neuronal transcriptome: implications for familial ALS. Brain. 2005 Jul;128(Pt 7):1686-706. Epub 2005 May 4.</strong> Familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS) is <span class="tagged-filter" title="Association Word">caused,</span> in 20% of cases, by <span class="tagged-filter" title="Association Word">mutations</span> in the Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1).</a></span> Although motor neuron injury occurs through a toxic gain of function, the precise mechanism (s) remains unclear. Using an established NSC34 cellular model for <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-<span class="tagged-filter" title="Association Word">associated</span> FALS, we investigated the effects of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> specifically in cells modelling the vulnerable cell population, the motor neurons, without contamination from non-neuronal cells present in CNS. Using gene expression profiling, 268 transcripts were differentially expressed in the presence of mutant human G93A <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span> Of these, 197 were decreased, demonstrating that the presence of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">leads</span> to a marked degree of transcriptional repression. Amongst these were a group of antioxidant response element (ARE) <span class="tagged-filter" title="Association Word">genes</span> encoding phase II detoxifying enzymes and antioxidant response <span class="tagged-filter" title="Association Word">proteins</span> (so-called 'programmed cell life' <span class="tagged-filter" title="Association Word">genes),</span> the <span class="tagged-filter" title="Association Word">expression</span> of which is regulated by the transcription factor <span class="tagged-gene" title="SwissProt ID: Q06546; Entrez Gene ID: 2551; HGNC ID: 4071; HPRD ID: 11793; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06546">NRF2.</a></span> We provide evidence that dysregulation of <span class="tagged-gene" title="SwissProt ID: Q06546; Entrez Gene ID: 2551; HGNC ID: 4071; HPRD ID: 11793; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06546">Nrf2</a></span> and the ARE, coupled with reduced pentose phosphate pathway <span class="tagged-filter" title="Association Word">activity</span> and decreased generation of <span class="tagged-metabolite" title="HMDB: HMDB00221"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00221">NADPH,</a></span> represent significant and hitherto unrecognized components of the toxic gain of function of mutant <a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span> Other <span class="tagged-filter" title="Association Word">genes</span> of interest significantly <span class="tagged-filter" title="Association Word">altered</span> in the presence of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> include several previously implicated in <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration,</span> as well as <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-filter" title="Association Word">protein</span> degradation, the immune response, cell death/survival and the heat shock response. Preliminary studies on isolated motor neurons from <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span>-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-query" title="Query">motor neuron disease</span> cases suggest key <span class="tagged-filter" title="Association Word">genes</span> are also differently <span class="tagged-filter" title="Association Word">expressed</span> in the human disease.
motor_neuron_disease	SOD1	True Positive	26.494	15857664	<strong class="title">Watanabe Y, Yasui K, Nakano T, Doi K, Fukada Y, Kitayama M, Ishimoto M, Kurihara S, Kawashima M, Fukuda H, Adachi Y, Inoue T, Nakashima K: Mouse <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by truncated <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> with or without C-terminal modification. Neurobiol Dis. 2002 Jul;10(2):128-38.</strong> <span class="tagged-filter" title="Association Word">Mutation</span> of Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> contributes to a portion of the cases of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS). We previously reported on a FALS family whose members had a mutant form of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> characterized by a 2-base pair (bp) deletion at codon 126 of the <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">gene.</span> To investigate the cellular consequences of this <span class="tagged-filter" title="Association Word">mutation,</span> we <span class="tagged-filter" title="Association Word">produced</span> transgenic mice that <span class="tagged-filter" title="Association Word">expressed</span> normal and <span class="tagged-filter" title="Association Word">mutated</span> copies of human <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1:</a></span> wild-type <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (W), wild-type <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> with a FLAG epitope at C-terminal (WF), <span class="tagged-filter" title="Association Word">mutated</span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> with the 2-bp deletion (D), and <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> with the 2-bp deletion with FLAG (DF). The mice heterozygotic for the human <span class="tagged-filter" title="Association Word">mutated</span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (D and DF) showed distinct ALS-like motor symptoms, whereas the mice heterozygotic for the normal <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (W and WF) mice did not. Homozygotes of D and DF lines showed the ALS symptoms at an earlier age and died earlier than the heterozygotes. By Northern blot analysis, the <span class="tagged-filter" title="Association Word">mRNAs</span> for all human SOD1s were confirmed in these lines. All the human <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">proteins,</span> except the D mutant, were detectable by immunoblot. The D <span class="tagged-filter" title="Association Word">protein</span> was only confirmed when it was concentrated by immunoprecipitation. Neuropathologically, loss of spinal motor neurons and reactive <span class="tagged-disease" title="UMLS Concept ID: C0017639">gliosis</span> were common features in the symptomatic lines. The remaining motor neurons in these mice also exhibited eosinophilic inclusions. The biochemical and pathological characteristics of these mice are quite similar to those of human FALS patients with same <span class="tagged-filter" title="Association Word">mutation.</span> This intriguing model will provide an important source of information of the pathogenesis of FALS.
motor_neuron_disease	SOD1	True Positive	26.494	14681966	<strong class="title">Skvortsova VI, Limborskaia SA, Slominskii PA, Levitskii GN, Levitskaia NI, Shadrina MI, Kondrat'eva EA, Brusov OS, Lysko AI, Karakhan VB, Alekhin AV, Serdiuk AV: [Peculiarities of sporadic <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">associated</span> with D90A and G12R <span class="tagged-filter" title="Association Word">mutations</span> in Russian population]. Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(11):46-52.</strong> Fifty-one blood samples of Russian patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> were examined for <span class="tagged-filter" title="Association Word">mutations</span> in Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD-1)</a></span> <span class="tagged-filter" title="Association Word">gene.</span> One female patient with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) was heterozygous for G12R <span class="tagged-filter" title="Association Word">mutation.</span> This patient suffered from ALS with cervical cord onset, pyramidal variant and fast progression. <span class="tagged-filter" title="Association Word">Mutation</span> was also detected in her healthy son. Earlier, such <span class="tagged-filter" title="Association Word">mutation</span> was described in 5 Italian patients with slow progressive ALS. Also, D90A <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD-1</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">associated</span> haplotypes of the female ALS patients previously examined by the authors have been analyzed. A homozygous female patient with ALS was characterized by typical lumbar onset and extremely slow progression, as well as a female patient with heterozygous <span class="tagged-filter" title="Association Word">mutation</span> and moderate progression carried so-called "Scandinavian" haplotype. To our knowledge, it is the first report on the finding of the haplotype considered as a "protective" one in the subjects heterozygous for D90A <span class="tagged-filter" title="Association Word">mutation</span> with clinical symptoms of ALS. Mechanisms of "protective" influence of this haplotype on ALS course are not yet elucidated. Our finding suggests that the presence of "Scandinavian" haplotype does not completely protect from the disease development in patients exposed to other more pathogenic causative factors. This assumption is in line with modern conceptions on <span class="tagged-query" title="Query">motor neuron disease</span> as a complicated multifactor disorder.
motor_neuron_disease	SOD1	True Positive	26.494	14527871	<strong class="title">Turner BJ, Lopes EC, Cheema SS: The <span class="tagged-metabolite" title="HMDB: HMDB00259"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> precursor <span class="tagged-metabolite" title="HMDB: HMDB00472"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">5-hydroxytryptophan</a></span> delays <span class="tagged-disease" title="UMLS Concept ID: C0027868">neuromuscular disease</span> in murine familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Neurology. 1999 Oct 12;53(6):1239-46.</strong> INTRODUCTION: Reduction in the levels of whole-blood <span class="tagged-metabolite" title="HMDB: HMDB00259"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> is a common feature of <span class="tagged-disease" title="UMLS Concept ID: C0013080">Down syndrome</span> (DS) individuals and transgenic mice overexpressing wild-type <a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span> Administration of the metabolic precursor <span class="tagged-metabolite" title="HMDB: HMDB00472"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">5-hydroxytryptophan</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00472"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">(5-HTP)</a></span> <span class="tagged-filter" title="Association Word">leads</span> to reversal of both <span class="tagged-metabolite" title="HMDB: HMDB00259"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> deficits and hypotonia in humans. The effect of <span class="tagged-metabolite" title="HMDB: HMDB00472"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">5-HTP</a></span> treatment on the progression of <span class="tagged-query" title="Query">motor neuron disease</span> in mutant <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice was examined. METHODS: Pre-disease transgenic <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> G93A mice and wild-type littermates were systemically administered <span class="tagged-metabolite" title="HMDB: HMDB00472"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">5-HTP</a></span> thrice weekly (0, 5 or 50 mg/kg). Animal weights, locomotor function and survival were recorded weekly. Plasma <span class="tagged-metabolite" title="HMDB: HMDB00259"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> levels were measured post-mortem. RESULTS: Treatment with <span class="tagged-metabolite" title="HMDB: HMDB00472"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">5-HTP</a></span> significantly delayed hindlimb weakness and mortality in <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> G93A mice in a dose-dependent manner. Wild-type mice were not adversely affected by <span class="tagged-metabolite" title="HMDB: HMDB00472"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">5-HTP</a></span> administration. Baseline <span class="tagged-metabolite" title="HMDB: HMDB00259"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> levels did not differ between wild-type and ALS mice. Blood platelet <span class="tagged-metabolite" title="HMDB: HMDB00259"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> levels increased proportionally with dose. CONCLUSIONS: Increased blood <span class="tagged-metabolite" title="HMDB: HMDB00259"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> by administration of <span class="tagged-metabolite" title="HMDB: HMDB00472"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00472">5-HTP</a></span> in <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> G93A mice <span class="tagged-filter" title="Association Word">led</span> to improved locomotor function and survival. A <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-metabolite" title="HMDB: HMDB00259"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00259">serotonin</a></span> metabolism in mice with <span class="tagged-filter" title="Association Word">elevated</span> <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">expression</span> and <span class="tagged-query" title="Query">motor neuron disease</span> is suggested by these studies.
motor_neuron_disease	cardiotrophin-1	True Negative	1.441	12645079	<strong class="title">Sakamoto T, Kawazoe Y, Shen JS, Takeda Y, Arakawa Y, Ogawa J, Oyanagi K, Ohashi T, Watanabe K, Inoue K, Eto Y, Watabe K: Adenoviral <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">TGF beta 2,</a></span> but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res. 2003 Apr 1;72(1):54-64.</strong> We examined neuroprotective effects of recombinant adenoviral vectors encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell line-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">(GDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">ciliary neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">(CNTF),</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">cardiotrophin-1</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">(CT1),</a></span> <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor-1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1),</a></span> and transforming growth factor-beta2 (TGFbeta2) on lesioned adult rat facial motoneurons. The right facial nerves of adult Fischer 344 male rats were avulsed and removed from the stylomastoid foramen, and adenoviral vectors were injected into the facial canal. Animals avulsed and treated with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1,</a></span> <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> and TGFbeta2 showed intense immunolabeling for these factors in lesioned facial motoneurons, respectively, indicating adenoviral induction of the neurotrophic factors in these neurons. The treatment with adenovirus encoding <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> or TGFbeta2 after avulsion significantly prevented the loss of lesioned facial motoneurons, improved <span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> immunoreactivity and prevented the induction of <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <span class="tagged-filter" title="Association Word">activity</span> in these neurons. The treatment with adenovirus encoding <a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> however, failed to protect these neurons after avulsion. These results indicate that the <span class="tagged-filter" title="Association Word">gene</span> transfer of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> and TGFbeta2 but not <span class="tagged-gene" title="SwissProt ID: P26441; Entrez Gene ID: 1270; HGNC ID: 2169; HPRD ID: 00347; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P26441">CNTF,</a></span> <span class="tagged-gene" title="SwissProt ID: Q16619; Entrez Gene ID: 1489; HGNC ID: 2499; HPRD ID: 02699; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16619">CT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1</a></span> may prevent the degeneration of motoneurons in adult humans with motoneuron injury and <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	SMN1	True Positive	6.106	17318264	<strong class="title">Avila AM, Burnett BG, Taye AA, Gabanella F, Knight MA, Hartenstein P, Cizman Z, Di Prospero NA, Pellizzoni L, Fischbeck KH, Sumner CJ: Trichostatin A increases <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">expression</span> and survival in a mouse model of <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy.</span> J Clin Invest. 2007 Mar;117(3):659-71. Epub 2007 Feb 22.</strong> The inherited <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutation</span> of the telomeric survival motor neuron 1 <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> with retention of the centromeric <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene.</span> We sought to establish whether the potent and specific hydroxamic acid class of <span class="tagged-gene" title="Protein Family or Complex">histone deacetylase</span> <span class="tagged-gene" title="SwissProt ID: Q9UKV0; Entrez Gene ID: 9734; HGNC ID: 14065; HPRD ID: 05944; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKV0">(HDAC)</a></span> inhibitors activates <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> gene expression in vivo and modulates the <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> disease phenotype when delivered after disease onset. Single intraperitoneal doses of 10 mg/kg trichostatin A <span class="tagged-gene" title="SwissProt ID: P32119; Entrez Gene ID: 7001; HGNC ID: 9353; HPRD ID: 02763; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32119">(TSA)</a></span> in nontransgenic and <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> model mice resulted in increased levels of acetylated H3 and H4 histones and modest increases in <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> gene expression. Repeated daily doses of <span class="tagged-gene" title="SwissProt ID: P32119; Entrez Gene ID: 7001; HGNC ID: 9353; HPRD ID: 02763; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32119">TSA</a></span> <span class="tagged-filter" title="Association Word">caused</span> increases in both <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span>-derived transcript and <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> levels in neural tissues and muscle, which were <span class="tagged-filter" title="Association Word">associated</span> with an improvement in small nuclear ribonucleoprotein <span class="tagged-gene" title="SwissProt ID: Q9Y333; Entrez Gene ID: 57819; HGNC ID: 13940; HPRD ID: 06282; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y333">(snRNP)</a></span> assembly. When <span class="tagged-gene" title="SwissProt ID: P32119; Entrez Gene ID: 7001; HGNC ID: 9353; HPRD ID: 02763; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32119">TSA</a></span> was delivered daily beginning on P5, after the onset of weight loss and motor deficit, there was improved survival, attenuated weight loss, and enhanced motor behavior. Pathological analysis showed increased myofiber size and number and increased anterior horn cell size. These results indicate that the hydroxamic acid class of <span class="tagged-gene" title="SwissProt ID: Q9UKV0; Entrez Gene ID: 9734; HGNC ID: 14065; HPRD ID: 05944; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UKV0">HDAC</a></span> inhibitors activates <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> gene expression in vivo and has an ameliorating effect on the <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> disease phenotype when administered after disease onset.
motor_neuron_disease	SMN1	True Positive	6.106	16931506	<strong class="title">Corcia P, Camu W, Halimi JM, Vourc'h P, Antar C, Vedrine S, Giraudeau B, de Toffol B, Andres CR: <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> <span class="tagged-filter" title="Association Word">gene,</span> but not <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2,</a></span> is a risk factor for sporadic ALS. Neurology. 2006 Oct 10;67(7):1147-50. Epub 2006 Aug 23.</strong> BACKGROUND: <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> <span class="tagged-filter" title="Association Word">gene</span> deletions <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy,</span> and <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene</span> deletions have been <span class="tagged-filter" title="Association Word">associated</span> with sporadic lower <span class="tagged-query" title="Query">motor neuron diseases.</span> OBJECTIVES: To study the frequency of abnormal <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> <span class="tagged-filter" title="Association Word">gene</span> copy numbers and to determine whether <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene</span> modulates the risk of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) or the duration of evolution. METHOD: The authors studied <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">genes</span> in 600 patients with sporadic ALS and 621 controls using a quantitative PCR method. RESULTS: The authors found an <span class="tagged-filter" title="Association Word">association</span> of ALS with an abnormal copy number (one or three copies) of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> <span class="tagged-filter" title="Association Word">gene</span> (p < 0.0001) with an OR of 2.8 (1.8 to 4.4, 95% CI). There was no <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> copy numbers and no effect of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> copies on the duration of evolution in ALS independently of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> copy number. CONCLUSION: Abnormal <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> <span class="tagged-filter" title="Association Word">gene</span> copy numbers are a genetic risk factor in sporadic <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> There was no modulator effect of the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene.</span>
motor_neuron_disease	SMN1	True Positive	6.106	14595654	<strong class="title">Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD, Schussler K, Chen X, Jarecki J, Burghes AH, Taylor JP, Fischbeck KH: <span class="tagged-metabolite" title="HMDB: HMDB00901"><span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00901">Valproic acid</a></span> increases <a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> levels in <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> patient cells. Ann Neurol. 2003 Nov;54(5):647-54.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> is an inherited <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutation</span> of the telomeric copy of the survival motor neuron <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1).</a></span> Although a centromeric copy of the survival motor neuron <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN2)</a></span> is retained in all patients with <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA,</a></span> it differs from <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> at a critical nucleotide such that the majority of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> transcripts lack exon 7 and encode an unstable, truncated <span class="tagged-filter" title="Association Word">protein.</span> Here, we show that <span class="tagged-metabolite" title="HMDB: HMDB00901"><span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00901">valproic acid</a></span> increases levels of exon 7-containing <a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> transcript and <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> in type I <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> patient-derived fibroblast cell lines. <span class="tagged-metabolite" title="HMDB: HMDB00901"><span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00901">Valproic acid</a></span> may increase <a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> levels both by activating the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> promoter and by preventing exon 7 skipping in <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> transcripts. <span class="tagged-metabolite" title="HMDB: HMDB00901"><span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00901">Valproic acid</a></span> and <span class="tagged-filter" title="Association Word">related</span> compounds warrant further investigation as potential treatment for <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA.</a></span>
motor_neuron_disease	SMN1	True Positive	6.106	14506714	<strong class="title">Haddad H, Cifuentes-Diaz C, Miroglio A, Roblot N, Joshi V, Melki J: <span class="tagged-drug" title="DrugBank: APRD00145"><span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00145">Riluzole</a></span> attenuates <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> disease progression in a mouse model. Muscle Nerve. 2003 Oct;28(4):432-7.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> is a <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> of the survival motor neuron 1 <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1).</a></span> No curative treatment is available. Mutant mice carrying homozygous deletion of Smn exon 7 directed to neurons display a degenerative process of motor neurons similar to that found in human <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA.</a></span> To test whether <span class="tagged-drug" title="DrugBank: APRD00145"><span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00145">riluzole,</a></span> which exhibits neurotrophic properties, might have a protective <span class="tagged-filter" title="Association Word">role</span> in <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA,</a></span> mutant mice were treated with it after the onset of the degenerative process. <span class="tagged-drug" title="DrugBank: APRD00145"><span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00145">Riluzole</a></span> improved median survival and exerted a protective effect against aberrant cytoskeletal organization of motor synaptic terminals but not against loss of proximal axons. These results demonstrate that the disease course of <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> can be attenuated after the onset of neuromuscular defects and may warrant further investigation in a therapeutic trial in <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA.</a></span>
motor_neuron_disease	SMN1	True Positive	6.106	12165565	<strong class="title">Hofmann Y, Wirth B: <span class="tagged-gene" title="Entrez Gene ID: 3186; HGNC ID: 9911; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3186">hnRNP-G</a></span> promotes exon 7 inclusion of survival motor neuron <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">(SMN)</a></span> via direct interaction with <span class="tagged-gene" title="SwissProt ID: O43464; Entrez Gene ID: 27429; HGNC ID: 14348; HPRD ID: 05919; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43464">Htra2</a></span>-beta1. Hum Mol Genet. 2002 Aug 15;11(17):2037-49.</strong> Proximal <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> is a common <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by homozygous loss of the survival motor neuron <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1).</a></span> <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2,</a></span> a nearly identical copy of the <span class="tagged-filter" title="Association Word">gene</span> and present in all <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> patients, fails to provide protection from <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA,</a></span> due to the disruption of an exonic splicing enhancer (ESE) by a single translationally silent nucleotide exchange, which <span class="tagged-filter" title="Association Word">causes</span> alternative splicing of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> exon 7. Identification of splicing factors that stimulate exon 7 inclusion and thereby <span class="tagged-filter" title="Association Word">produce</span> sufficient amounts of full-length transcripts from the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene</span> is of great importance for therapy approaches. Here, by use of in vivo splicing assays, we identified the <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="Entrez Gene ID: 3186; HGNC ID: 9911; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3186">hnRNP-G</a></span> and its paralogue <span class="tagged-gene" title="SwissProt ID: Q13385; Entrez Gene ID: 731568; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13385">RBM</a></span> as two novel splicing factors that promote the inclusion of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> exon 7. Moreover, <span class="tagged-gene" title="Entrez Gene ID: 3186; HGNC ID: 9911; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3186">hnRNP-G</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13385; Entrez Gene ID: 731568; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13385">RBM</a></span> non-specifically bind RNA, but directly and specifically bind <span class="tagged-gene" title="SwissProt ID: O43464; Entrez Gene ID: 27429; HGNC ID: 14348; HPRD ID: 05919; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43464">Htra2</a></span>-beta1, an SR-like splicing factor which we have previously shown to stimulate inclusion of exon 7 through a direct interaction with the AG-rich ESE in <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> exon 7 pre-<span class="tagged-filter" title="Association Word">mRNA.</span> By using deletion mutants of <span class="tagged-gene" title="Entrez Gene ID: 3186; HGNC ID: 9911; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3186">hnRNP-G,</a></span> we show that the specific <span class="tagged-filter" title="Association Word">protein</span>-<span class="tagged-filter" title="Association Word">protein</span> interaction of <span class="tagged-gene" title="Entrez Gene ID: 3186; HGNC ID: 9911; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3186">hnRNP-G</a></span> with <span class="tagged-gene" title="SwissProt ID: O43464; Entrez Gene ID: 27429; HGNC ID: 14348; HPRD ID: 05919; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43464">Htra2</a></span>-beta1 mediates the inclusion of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> exon 7 rather than the non-specific interaction of <span class="tagged-gene" title="Entrez Gene ID: 3186; HGNC ID: 9911; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3186">hnRNP-G</a></span> with <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> pre-<span class="tagged-filter" title="Association Word">mRNA.</span> Additionally, we show for the first time that recombinant trans-acting splicing factors such as <span class="tagged-gene" title="Entrez Gene ID: 3186; HGNC ID: 9911; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3186">hnRNP-G</a></span> and <span class="tagged-gene" title="SwissProt ID: O43464; Entrez Gene ID: 27429; HGNC ID: 14348; HPRD ID: 05919; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43464">Htra2</a></span>-beta1 are also effective on endogenous <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> transcripts and increase the endogenous <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> level. Finally, we suggest a model of how the exon 7 mRNA processing is regulated by the splicing factors identified so far.
motor_neuron_disease	SMN1	True Positive	6.106	12126878	<strong class="title">Wehner KA, Ayala L, Kim Y, Young PJ, Hosler BA, Lorson CL, Baserga SJ, Francis JW: <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">Survival motor neuron protein</a></span> in the nucleolus of mammalian neurons. Brain Res. 2002 Aug 2;945(2):160-73.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> is an inherited <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in the survival motor neuron <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1).</a></span> While it has been shown that the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> is <span class="tagged-filter" title="Association Word">involved</span> in spliceosome biogenesis and pre-<span class="tagged-filter" title="Association Word">mRNA</span> splicing, there is increasing evidence indicating that <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> may also perform important functions in the nucleolus. We demonstrate here through the use of a previously characterized polyclonal anti-<span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">antibody,</span> abSMN, that the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> shows a striking colocalization with the <span class="tagged-gene" title="Protein Family or Complex">nucleolar protein,</span> <span class="tagged-gene" title="SwissProt ID: P22087; Entrez Gene ID: 2091; HGNC ID: 3599; HPRD ID: 00617; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22087">fibrillarin,</a></span> in both nucleoli and Cajal bodies/gems of primary neurons. Immunoblot analysis with antifibrillarin and two different anti-<span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> reveals that <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> and <span class="tagged-gene" title="SwissProt ID: P22087; Entrez Gene ID: 2091; HGNC ID: 3599; HPRD ID: 00617; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22087">fibrillarin</a></span> also cofractionate in the insoluble <span class="tagged-filter" title="Association Word">protein</span> fraction of cultured cell lysates. Immunoprecipitation experiments using whole cell extracts of HeLa cells and cultured neurons revealed that abSMN coprecipitated small amounts of the U3 small nucleolar RNA <span class="tagged-gene" title="Entrez Gene ID: 6079; HGNC ID: 10114; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6079">(snoRNA)</a></span> previously shown to be <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: P22087; Entrez Gene ID: 2091; HGNC ID: 3599; HPRD ID: 00617; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22087">fibrillarin</a></span> in vivo. These studies raise the possibility that <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> may serve a function in rRNA maturation/ribosome synthesis similar to its <span class="tagged-filter" title="Association Word">role</span> in spliceosome biogenesis.
motor_neuron_disease	SMN1	True Positive	6.106	11313744	<strong class="title">Sossi V, Giuli A, Vitali T, Tiziano F, Mirabella M, Antonelli A, Neri G, Brahe C: Premature termination <span class="tagged-filter" title="Association Word">mutations</span> in exon 3 of the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> <span class="tagged-filter" title="Association Word">gene</span> are <span class="tagged-filter" title="Association Word">associated</span> with exon skipping and a relatively mild <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> phenotype. Eur J Hum Genet. 2001 Feb;9(2):113-20.</strong> <span class="tagged-filter" title="Association Word">Autosomal</span> recessive <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> is a common <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">absence</span> or <span class="tagged-filter" title="Association Word">mutation</span> in the survival motor neuron <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1)</a></span> <span class="tagged-filter" title="Association Word">gene.</span> <span class="tagged-gene" title="SwissProt ID: Q6PJP8; Entrez Gene ID: 9937; HGNC ID: 17660; HPRD ID: 08519; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6PJP8">SNM1</a></span> and a nearly identical copy, <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2,</a></span> encode identical <span class="tagged-filter" title="Association Word">proteins,</span> but <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> only <span class="tagged-filter" title="Association Word">produces</span> a little full length <span class="tagged-filter" title="Association Word">protein</span> due to alternative splicing. The level of functional <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> and the number of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">genes</span> correlate with the clinical phenotype ranging from severe to very mild. Here, we report on premature termination <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> exon 3 (425del5 and W102X) which induce skipping of the <span class="tagged-filter" title="Association Word">mutated</span> exon. The novel <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutation</span> W102X was detected in two patients with a relatively mild phenotype who had only two copies of the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene,</span> a number that has previously been found <span class="tagged-filter" title="Association Word">associated</span> with the severe form of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA.</a></span> We show that the shortened transcripts are translated into predicted in frame <span class="tagged-filter" title="Association Word">protein</span> isoforms. Aminoglycoside treatment suppressed the <span class="tagged-disease" title="UMLS Concept ID: C0544885">nonsense mutation</span> in cultured cells and abolished exon skipping. Fibroblasts from both patients show a high number of nuclear structures containing <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> (gems). These findings suggest that the <span class="tagged-filter" title="Association Word">protein</span> isoform <span class="tagged-filter" title="Association Word">lacking</span> the exon 3 encoded region contributes to the formation of the nuclear <span class="tagged-filter" title="Association Word">protein</span> complex which may account for the milder clinical phenotype.
motor_neuron_disease	SMN1	True Positive	6.106	11274309	<strong class="title">Veldink JH, van den Berg LH, Cobben JM, Stulp RP, De Jong JM, Vogels OJ, Baas F, Wokke JH, Scheffer H: Homozygous deletion of the survival motor neuron 2 <span class="tagged-filter" title="Association Word">gene</span> is a prognostic factor in sporadic ALS. Neurology. 2001 Mar 27;56(6):749-52.</strong> BACKGROUND: <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> results from <span class="tagged-filter" title="Association Word">mutations</span> of the survival motor neuron <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">(SMN)</a></span> <span class="tagged-filter" title="Association Word">gene</span> on chromosome 5. The <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">gene</span> exists in two highly homologous copies, telomeric <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1)</a></span> and centromeric <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN2).</a></span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> but not <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2.</a></span> The clinical phenotype of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> appears to be <span class="tagged-filter" title="Association Word">related</span> to the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2.</a></span> Patients suffering from the milder forms of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> carry more copies of the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene</span> compared with patients with more severe <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA.</a></span> It is suggested that the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene</span> is translated into an at least partially functional <span class="tagged-filter" title="Association Word">protein</span> that protects against loss of motor neurons. OBJECTIVE: To investigate whether genetic mechanisms implicated in motor neuron death in <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> have a <span class="tagged-filter" title="Association Word">role</span> in ALS. METHODS: The presence of deletions of exons 7 and 8 of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> and <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> was determined in 110 patients with sporadic ALS and compared with 100 unaffected controls. RESULTS: The presence of a homozygous <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> deletion was overrepresented in patients with ALS compared with controls (16% versus 4%; OR, 4.4; 95% CI, 1.4 to 13.5). Patients with a homozygous <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> deletion had a shorter median time of survival (p < 0.009). Furthermore, multivariate regression analysis showed that the presence of an <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> deletion was independently <span class="tagged-filter" title="Association Word">associated</span> with survival time (p < 0.02). No homozygous deletions in <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> were found. Carrier status of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> appeared to be equally present in patients and controls (1 in 20). CONCLUSION: These results indicate that, similar to <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA,</a></span> the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene</span> can act as a prognostic factor and may therefore be a phenotypic modifier in sporadic ALS. Increasing the <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> <span class="tagged-filter" title="Association Word">gene</span> may provide a strategy for treatment of <span class="tagged-query" title="Query">motor neuron disease.</span>
motor_neuron_disease	SMN1	True Positive	6.106	10615130	<strong class="title">Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH, Li H: A mouse model for <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy.</span> Nat Genet. 2000 Jan;24(1):66-70.</strong> The survival motor neuron <span class="tagged-filter" title="Association Word">gene</span> is present in humans in a telomeric copy, <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1,</a></span> and several centromeric copies, <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2.</a></span> Homozygous <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> is <span class="tagged-filter" title="Association Word">associated</span> with proximal <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA),</a></span> a severe <span class="tagged-query" title="Query">motor neuron disease</span> characterized by early childhood onset of progressive muscle weakness. To understand the functional <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1</a></span> in <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA,</a></span> we <span class="tagged-filter" title="Association Word">produced</span> mouse lines <span class="tagged-filter" title="Association Word">deficient</span> for mouse Smn and transgenic mouse lines that <span class="tagged-filter" title="Association Word">expressed</span> human <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2.</a></span> Smn-/- mice died during the peri-implantation stage. In contrast, transgenic mice harbouring <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> in the Smn-/- background showed pathological changes in the spinal cord and skeletal muscles similar to those of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> patients. The severity of the pathological changes in these mice correlated with the amount of <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> that contained the region encoded by exon 7. Our results demonstrate that <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> can partially compensate for lack of <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN1.</a></span> The variable phenotypes of Smn-/-<span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">SMN2</a></span> mice reflect those seen in <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> patients, providing a mouse model for this disease.
motor_neuron_disease	tubulin-specific-chaperone-E	True Positive	1.441	12446740	<strong class="title">Bommel H, Xie G, Rossoll W, Wiese S, Jablonka S, Boehm T, Sendtner M: Missense <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: Q15813; Entrez Gene ID: 6905; HGNC ID: 11582; HPRD ID: 05381; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15813">tubulin-specific chaperone E</a></span> (Tbce) <span class="tagged-filter" title="Association Word">gene</span> in the mouse mutant progressive <span class="tagged-disease" title="UMLS Concept ID: Not Available">motor neuronopathy,</span> a model of human <span class="tagged-query" title="Query">motoneuron disease.</span> J Cell Biol. 2002 Nov 25;159(4):563-9.</strong> Progressive <span class="tagged-disease" title="UMLS Concept ID: Not Available">motor neuronopathy</span> (pmn) mutant mice have been widely used as a model for human <span class="tagged-query" title="Query">motoneuron disease.</span> Mice that are homozygous for the pmn <span class="tagged-filter" title="Association Word">gene</span> defect appear healthy at birth but develop progressive <span class="tagged-query" title="Query">motoneuron disease,</span> resulting in severe skeletal muscle weakness and <span class="tagged-disease" title="UMLS Concept ID: C1145670">respiratory failure</span> by postnatal week 3. The disease starts at the motor endplates, and then <span class="tagged-filter" title="Association Word">leads</span> to axonal loss and finally to apoptosis of the corresponding cell bodies. We localized the genetic defect in pmn mice to a missense <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: Q15813; Entrez Gene ID: 6905; HGNC ID: 11582; HPRD ID: 05381; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15813">tubulin-specific chaperone E</a></span> (Tbce) <span class="tagged-filter" title="Association Word">gene</span> on mouse chromosome 13. The human orthologue maps to chromosome 1q42.3. The Tbce <span class="tagged-filter" title="Association Word">gene</span> encodes a <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: Q15813; Entrez Gene ID: 6905; HGNC ID: 11582; HPRD ID: 05381; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15813">(cofactor E)</a></span> that is essential for the formation of primary <span class="tagged-gene" title="SwissProt ID: P68363; Entrez Gene ID: 10376; HPRD ID: 03960; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P68363">alpha-tubulin</a></span> and beta-tubulin heterodimeric complexes. Isolated motoneurons from pmn mutant mice exhibit shorter axons and <span class="tagged-disease" title="UMLS Concept ID: C0544925">axonal swelling</span> with irregularly structured beta-tubulin and tau immunoreactivity. Thus, the pmn <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> provides the first genetic evidence that alterations in tubulin assembly <span class="tagged-filter" title="Association Word">lead</span> to <span class="tagged-disease" title="UMLS Concept ID: C0035354">retrograde degeneration</span> of motor axons, ultimately resulting in motoneuron cell death.
motor_neuron_disease	nerve-growth-factor	True Positive	1.441	17188890	<strong class="title">Domeniconi M, Hempstead BL, Chao MV: Pro-<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">NGF</a></span> secreted by astrocytes promotes motor neuron cell death. J Neural Transm Suppl. 2000;(60):247-59.</strong> It is well established that motor neurons depend for their survival on many trophic factors. In this study, we show that the precursor form of <span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">NGF</a></span> (pro-<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">NGF)</a></span> can induce the death of motor neurons via engagement of the <span class="tagged-gene" title="SwissProt ID: P14317; Entrez Gene ID: 3059; HGNC ID: 4844; HPRD ID: 03199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14317">p75</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">neurotrophin</a></span> receptor. The pro-apoptotic <span class="tagged-filter" title="Association Word">activity</span> was dependent upon the presence of <span class="tagged-gene" title="SwissProt ID: Q99523; Entrez Gene ID: 6272; HGNC ID: 11186; HPRD ID: 03910; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99523">sortilin,</a></span> a <span class="tagged-gene" title="SwissProt ID: P14317; Entrez Gene ID: 3059; HGNC ID: 4844; HPRD ID: 03199; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14317">p75</a></span> co-receptor <span class="tagged-filter" title="Association Word">expressed</span> on motor neurons. One potential source of pro-<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">NGF</a></span> is reactive astrocytes, which up-regulate the levels of pro-<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">NGF</a></span> in response to <span class="tagged-metabolite" title="HMDB: HMDB02179"><span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02179">peroxynitrite,</a></span> an oxidant and producer of free radicals. Indeed, motor neuron viability was sensitive to conditioned media from cultured astrocytes treated with <span class="tagged-metabolite" title="HMDB: HMDB02179"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB02179">peroxynitrite</a></span> and this effect could be reversed using a specific <span class="tagged-filter" title="Association Word">antibody</span> against the pro-domain of pro-<a href="http://beta.uniprot.org/uniprot/P01138">NGF.</a></span> These results are consistent with a <span class="tagged-filter" title="Association Word">role</span> for activated astrocytes and pro-<span class="tagged-gene" title="SwissProt ID: P01138; Entrez Gene ID: 4803; HGNC ID: 7808; HPRD ID: 08874; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01138">NGF</a></span> in the induction of motor neuron death and suggest a possible therapeutic target for the treatment of <span class="tagged-query" title="Query">motor neuron disease.</span>
motor_neuron_disease	excitatory-amino-acid-transporter-1	True Positive	1.441	11784698	<strong class="title">Banner SJ, Fray AE, Ince PG, Steward M, Cookson MR, Shaw PJ: The <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> re-uptake transporter <a href="http://beta.uniprot.org/uniprot/P43003">excitatory amino acid transporter 1</a></span> <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">(EAAT1)</a></span> in the normal human CNS and in <span class="tagged-query" title="Query">motor neurone disease:</span> an immunohistochemical study. Neuroscience. 2002;109(1):27-44.</strong> A monoclonal <span class="tagged-filter" title="Association Word">antibody</span> to <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">excitatory amino acid transporter 1</a></span> <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">(EAAT1)</a></span> has been generated which robustly stains paraffin-embedded, <span class="tagged-metabolite" title="HMDB: HMDB01426"><span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01426">formaldehyde</a></span>-fixed as well as snap-frozen human post-mortem brain tissue. We have used this <span class="tagged-filter" title="Association Word">antibody</span> to map the distribution of <a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> throughout normal human CNS tissue. In addition this <span class="tagged-filter" title="Association Word">antibody</span> has been used to perform a semi-quantitative immunohistochemical analysis of the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> in motor cortex and cervical cord tissue taken from <span class="tagged-query" title="Query">motor neurone disease</span> cases (n=17) and neurologically normal controls (n=12). By comparing the relative optical density measurements of identical regions of motor cortex and cervical spinal cord an increase in the <span class="tagged-filter" title="Association Word">expression</span> levels of <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> was <span class="tagged-filter" title="Association Word">observed</span> in <span class="tagged-query" title="Query">motor neurone disease</span> tissue compared to the control tissue and in both motor cortex and cervical spinal cord (9-17% and 13-33% increases respectively). <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> was <span class="tagged-filter" title="Association Word">observed</span> to be the most abundant transporter in more "caudal" brain regions such as the diencephalon and brainstem and its <span class="tagged-filter" title="Association Word">expression</span> in other regions was frequently more uniform than that of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2.</a></span> In the motor cortex, <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> immunoreactivity was present in all grey matter laminae, with some staining of individual astrocytes in the white matter. In spinal cord, <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> immunoreactivity was strongest in the substantia gelatinosa. In the ventral horn, motor neurones were surrounded with a dense rim of perisomatic <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> immunoreactivity, and the neuropil showed diffuse staining. Additional studies using double-labelling immunocytochemistry demonstrated that astrocytic co-localisation of <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> and <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> may occasionally be seen, but was not widespread in the human CNS and that in general astrocytes were positive for either <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> or EAAT2.These results demonstrate that the <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> has a widespread abundance throughout all regions of the human CNS examined and that there exist discrete populations of astrocytes that are positive solely for either <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> or <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2.</a></span> Furthermore, there is evidence to suggest that <span class="tagged-filter" title="Association Word">altered</span> <span class="tagged-gene" title="SwissProt ID: P43003; Entrez Gene ID: 6507; HGNC ID: 10941; HPRD ID: 02523; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43003">EAAT1</a></span> <span class="tagged-filter" title="Association Word">expression</span> in <span class="tagged-query" title="Query">motor neurone disease</span> follows a different pattern to the reported changes of <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in this condition, indicating that the <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> transporters in the pathogenesis of <span class="tagged-query" title="Query">motor neurone disease</span> appears more complex than previously appreciated.
motor_neuron_disease	catalase	True Negative	1.441	10486188	<strong class="title">Reinholz MM, Merkle CM, Poduslo JF: Therapeutic benefits of <span class="tagged-metabolite" title="HMDB: HMDB01414"><span class="tagged-gene" title="SwissProt ID: P04040; Entrez Gene ID: 847; HGNC ID: 1516; HPRD ID: 00282; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01414">putrescine</a></span>-modified <a href="http://beta.uniprot.org/uniprot/P04040">catalase</a></span> in a transgenic mouse model of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Exp Neurol. 1999 Sep;159(1):204-16.</strong> <span class="tagged-filter" title="Association Word">Dominant</span> <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-metabolite" title="HMDB: HMDB00657"><span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00657">copper</a></span>/zinc <a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> have been <span class="tagged-filter" title="Association Word">observed</span> in 15-20% of familial <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (FALS) cases. The mechanism by which <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mutations</span> result in motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in FALS mice partly involves oxidative damage and an increased peroxidase <span class="tagged-filter" title="Association Word">activity</span> of the mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span> A new therapeutic approach designed to eliminate the substrate of this peroxidase <span class="tagged-filter" title="Association Word">activity</span> was examined in two lines of transgenic mice expressing the FALS-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-filter" title="Association Word">mutation</span> <span class="tagged-metabolite" title="HMDB: HMDB00123"><span class="tagged-gene" title="SwissProt ID: P04040; Entrez Gene ID: 847; HGNC ID: 1516; HPRD ID: 00282; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span> to <span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> (G93A). We investigated the ability of <span class="tagged-metabolite" title="HMDB: HMDB01414"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01414">putrescine</a></span>-modified <a href="http://beta.uniprot.org/uniprot/P04040">catalase</a></span> (PUT-CAT), an antioxidant <span class="tagged-filter" title="Association Word">enzyme</span> that removes <span class="tagged-metabolite" title="HMDB: HMDB01362"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01362">hydrogen</a></span> peroxide and has increased permeability at the blood-brain barrier, to modify the time course of the <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mutation</span>-induced <span class="tagged-query" title="Query">motor neuron disease</span> in these FALS mice. Continuous, subcutaneous administration of PUT-CAT significantly delayed the age at which onset of clinical disease occurred (indicated by loss of splay and/or tremors of hindlimbs) in a high-expressor line of FALS transgenic mice. Intraperitoneal injection of PUT-CAT given two times per week also significantly delayed the onset of clinical disease in a low-expressor line of FALS mice. PUT-CAT also significantly delayed the age at which clinical weakness developed (quantified by measuring the shortening of stride length) in both lines of FALS animals. No significant changes were <span class="tagged-filter" title="Association Word">observed</span> in the survival times of the high-expressor FALS mice in any of the treatment groups. However, a trend toward a prolongation of survival was <span class="tagged-filter" title="Association Word">observed</span> in the PUT-CAT-treated low-expressor FALS mice. These results support the <span class="tagged-filter" title="Association Word">role</span> of free radical-mediated damage in the <span class="tagged-drug" title="DrugBank: APRD00153"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00153">cascade</a></span> of events <span class="tagged-filter" title="Association Word">leading</span> to motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration</span> in FALS and indicate that PUT-CAT interacts with a critical step in this <span class="tagged-drug" title="DrugBank: APRD00153"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00153">cascade</a></span> to delay the onset of clinical disease as well as the development of clinical weakness in FALS transgenic mice.
motor_neuron_disease	HSC70	True Negative	1.441	16303141	<strong class="title">Chiba S, Yokota S, Yonekura K, Tanaka S, Furuyama H, Kubota H, Fujii N, Matsumoto H: Autoantibodies against HSP70 family <span class="tagged-filter" title="Association Word">proteins</span> were detected in the cerebrospinal fluid from patients with <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis.</span> J Neurol Sci. 2006 Feb 15;241(1-2):39-43. Epub 2005 Nov 21.</strong> We evaluated the specific IgG <span class="tagged-filter" title="Association Word">antibodies</span> against heat shock <span class="tagged-filter" title="Association Word">proteins</span> (HSPs) in cerebrospinal fluids (CSF) from patients with <span class="tagged-disease" title="UMLS Concept ID: C0026769">multiple sclerosis</span> (MS). ELISA was employed to examine IgG <span class="tagged-filter" title="Association Word">antibodies</span> against ten HSPs <span class="tagged-gene" title="SwissProt ID: Q16082; Entrez Gene ID: 3316; HGNC ID: 5247; HPRD ID: 03712; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16082">(HSP27,</a></span> alphaA and alphaB crystallins, <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP60,</a></span> <span class="tagged-gene" title="Entrez Gene ID: 907; HGNC ID: 1614; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=907">CCT,</a></span> Mycobacterium bovis <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">HSP65,</a></span> Escherichia coli GroEL, HSP70, <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70</a></span> and HSP90) in CSF from 30 patients with MS, and 25 patients with <span class="tagged-query" title="Query">motor neuron diseases</span> (MND). Significantly higher <span class="tagged-filter" title="Association Word">antibody</span> titers against HSP70 and <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70</a></span> <span class="tagged-filter" title="Association Word">proteins</span> were found in CSF obtained from patients with MS as compared with MND independent of CSF total <span class="tagged-filter" title="Association Word">protein,</span> IgG concentrations and IgG indices, respectively. The <span class="tagged-filter" title="Association Word">antibody</span> titers against HSP70 were indicated to be significantly higher in the progressive cases than in cases of remission. The results suggest that IgG <span class="tagged-filter" title="Association Word">antibodies</span> against specific types of HSPs especially HSP70 family <span class="tagged-filter" title="Association Word">proteins</span> (HSP70 and <span class="tagged-gene" title="SwissProt ID: P11142; Entrez Gene ID: 3312; HGNC ID: 5241; HPRD ID: 07205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11142">HSC70)</a></span> in CSF may play an important <span class="tagged-filter" title="Association Word">role</span> in the pathophysiology of MS through the modification of immune response and cytoprotective functions of molecular chaperons.
motor_neuron_disease	Dynein	True Positive	10.777	17265455	<strong class="title">El-Kadi AM, Soura V, Hafezparast M: Defective axonal transport in <span class="tagged-query" title="Query">motor neuron disease.</span> J Neurosci Res. 2007 Jan 30;.</strong> Several recent studies have highlighted the role of axonal transport in the pathogenesis of <span class="tagged-query" title="Query">motor neuron diseases.</span> <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-filter" title="Association Word">genes</span> that control microtubule <span class="tagged-filter" title="Association Word">regulation</span> and dynamics have been shown to <span class="tagged-filter" title="Association Word">cause</span> motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in mice and in a form of human <span class="tagged-query" title="Query">motor neuron disease.</span> In addition, <span class="tagged-filter" title="Association Word">mutations</span> in the molecular motors <span class="tagged-gene" title="Protein Family or Complex">dynein</span> and kinesins and several <span class="tagged-filter" title="Association Word">proteins</span> <span class="tagged-filter" title="Association Word">associated</span> with the membranes of intracellular vesicles that undergo transport <span class="tagged-filter" title="Association Word">cause</span> motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in humans and mice. Paradoxically, evidence from studies on the legs at odd angles (Loa) mouse and a transgenic mouse model for human <span class="tagged-query" title="Query">motor neuron disease</span> suggest that partial limitation of the function of <span class="tagged-gene" title="Protein Family or Complex">dynein</span> may in fact <span class="tagged-filter" title="Association Word">lead</span> to improved axonal transport in the transgenic mouse, <span class="tagged-filter" title="Association Word">leading</span> to delayed disease onset and increased life span. (c) 2007 Wiley-Liss, Inc.
motor_neuron_disease	Dynein	True Positive	10.777	16546759	<strong class="title">Shah PR, Ahmad-Annuar A, Ahmadi KR, Russ C, Sapp PC, Horvitz HR, Brown RH Jr, Goldstein DB, Fisher EM: No <span class="tagged-filter" title="Association Word">association</span> of <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> with sporadic ALS in a case-control study of a northern European derived population: a tagging <span class="tagged-filter" title="Association Word">SNP</span> approach. Amyotroph Lateral Scler. 2006 Mar;7(1):46-56.</strong> The cytoplasmic <span class="tagged-gene" title="Protein Family or Complex">dynein</span>-<span class="tagged-gene" title="Protein Family or Complex">dynactin</span> complex has been implicated in the aetiology of motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in both mouse models and human forms of <span class="tagged-query" title="Query">motor neuron disease.</span> We have previously shown that <span class="tagged-filter" title="Association Word">mutations</span> in the cytoplasmic <span class="tagged-gene" title="Protein Family or Complex">dynein</span> 1 heavy chain 1 <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(Dync1h1)</a></span> are causal in a mouse model of late-onset motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> but have found no <span class="tagged-filter" title="Association Word">association</span> of the homologous sites in human <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> with human <span class="tagged-query" title="Query">motor neuron disease.</span> Here we extend these analyses to investigate the <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> genomic <span class="tagged-filter" title="Association Word">locus</span> to determine if it is <span class="tagged-filter" title="Association Word">associated</span> with sporadic <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) in a northern European-derived population. Among the 16 single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> <span class="tagged-filter" title="Association Word">(SNPs)</span> we examined, just two <span class="tagged-filter" title="Association Word">SNPs</span> (rs2251644 and rs941793) were sufficient to tag the majority of haplotypic variation (r2 > or = 0.85) and these were tested in a case-control <span class="tagged-filter" title="Association Word">association</span> study with 266 North American sporadic ALS patients and 225 matched controls. We found no <span class="tagged-filter" title="Association Word">association</span> between genetic variation at <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> and sporadic ALS (rs2251644; p = 0.538, rs941793; p = 0.204, haplotype; p = 0.956). In addition we investigated patterns of diversity at <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> in Japanese and Cameroonian populations to establish the evolutionary history for this <span class="tagged-filter" title="Association Word">gene</span> and <span class="tagged-filter" title="Association Word">observed</span> reduced genetic diversity in the northern Europeans suggestive of selection at this <span class="tagged-filter" title="Association Word">locus.</span>
motor_neuron_disease	Dynein	True Positive	10.777	15980862	<strong class="title">Ravikumar B, Acevedo-Arozena A, Imarisio S, Berger Z, Vacher C, O'Kane CJ, Brown SD, Rubinsztein DC: <span class="tagged-gene" title="Protein Family or Complex">Dynein</span> <span class="tagged-filter" title="Association Word">mutations</span> impair autophagic clearance of aggregate-prone <span class="tagged-filter" title="Association Word">proteins.</span> Nat Genet. 2005 Jul;37(7):771-6. Epub 2005 Jun 26.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> that affect the <span class="tagged-gene" title="Protein Family or Complex">dynein</span> motor machinery are sufficient to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">motor neuron disease.</span> It is not known why there are aggregates or inclusions in affected tissues in mice with such <span class="tagged-filter" title="Association Word">mutations</span> and in most forms of human <span class="tagged-query" title="Query">motor neuron disease.</span> Here we identify a new mechanism of inclusion formation by showing that decreased <span class="tagged-gene" title="Protein Family or Complex">dynein</span> function impairs autophagic clearance of aggregate-prone <span class="tagged-filter" title="Association Word">proteins.</span> We show that <span class="tagged-filter" title="Association Word">mutations</span> of the <span class="tagged-gene" title="Protein Family or Complex">dynein</span> machinery enhanced the toxicity of the <span class="tagged-filter" title="Association Word">mutation</span> that <span class="tagged-filter" title="Association Word">causes</span> <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington disease</span> in fly and mouse models. Furthermore, loss of <span class="tagged-gene" title="Protein Family or Complex">dynein</span> function resulted in premature aggregate formation by mutant <span class="tagged-gene" title="SwissProt ID: P42858; Entrez Gene ID: 3064; HGNC ID: 4851; HPRD ID: 00883; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42858">huntingtin</a></span> and increased levels of the autophagosome <span class="tagged-filter" title="Association Word">marker</span> LC3-II in both cell culture and mouse models, compatible with impaired autophagosome-lysosome fusion.
motor_neuron_disease	Dynein	True Positive	10.777	13129801	<strong class="title">Ahmad-Annuar A, Shah P, Hafezparast M, Hummerich H, Witherden AS, Morrison KE, Shaw PJ, Kirby J, Warner TT, Crosby A, Proukakis C, Wilkinson P, Orrell RW, Bradley L, Martin JE, Fisher EM: No <span class="tagged-filter" title="Association Word">association</span> with common Caucasian genotypes in exons 8, 13 and 14 of the human <span class="tagged-gene" title="SwissProt ID: O00432; Entrez Gene ID: 79659; HGNC ID: 2962; HPRD ID: 10344; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00432">cytoplasmic dynein heavy chain</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(DNCHC1)</a></span> and familial motor neuron disorders. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):150-7.</strong> We have shown in a mouse model of <span class="tagged-query" title="Query">motor neuron disease,</span> the legs-at-odd-angles (Loa) mutant, and that <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: O00432; Entrez Gene ID: 79659; HGNC ID: 2962; HPRD ID: 10344; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00432">cytoplasmic dynein heavy chain</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(Dnchc1)</a></span> <span class="tagged-filter" title="Association Word">cause</span> motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> Mice exhibiting the Loa phenotype suffer progressive loss of locomotor function and homozygous animals have neuronal inclusion bodies that are positive for <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1,</a></span> <span class="tagged-gene" title="SwissProt ID: Q00535; Entrez Gene ID: 1020; HGNC ID: 1774; HPRD ID: 00449; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q00535">CDK5,</a></span> neurofilament and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> <span class="tagged-filter" title="Association Word">proteins.</span> As this phenotype models some aspects of human motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> disorders, we think there is a reasonable likelihood that <span class="tagged-gene" title="Protein Family or Complex">dynein</span> may be a causative <span class="tagged-filter" title="Association Word">gene</span> or susceptibility factor in human <span class="tagged-query" title="Query">motor neuron disease.</span> Therefore we have screened exons of this <span class="tagged-filter" title="Association Word">gene</span> in a set of human patients with familial forms of disparate motor neuron degeneration diseases, affecting both upper and lower motor neurons: <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS), <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA),</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0037773">hereditary spastic paraplegia.</span> As part of this study, we have determined that <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DNCHC1</a></span> is a large <span class="tagged-filter" title="Association Word">gene</span> of 78 exons spanning 86 kb genomic length. We have focused on the exons known to be <span class="tagged-filter" title="Association Word">mutated</span> in Loa, and in a very similar mouse <span class="tagged-filter" title="Association Word">mutation,</span> cramping 1 (Cra1); both <span class="tagged-filter" title="Association Word">mutations</span> result in loss of anterior horn cells. The exons studied are highly conserved in a wide range of eukaryotes. We screened our patient samples by sequencing and although we detect single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms,</span> our results show these occur at the same frequency in our patient group as in control samples of unaffected individuals. Therefore we do not find any <span class="tagged-filter" title="Association Word">association</span> between <span class="tagged-disease" title="UMLS Concept ID: C0270763">familial motor neuron disease</span> and the genotypes presented here in the exons screened.
motor_neuron_disease	ubiquitin	False Positive	3.388	17591968	<strong class="title">Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in Familial and Sporadic <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal Lobar Degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span> Inclusions. Brain. 2007 May;130(Pt 5):1375-85. Epub 2007 Mar 14.</strong> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TAR DNA-binding protein 43</a></span> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TDP-43)</a></span> is a major pathological <span class="tagged-filter" title="Association Word">protein</span> of sporadic and familial <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive, tau-negative inclusions (FTLD-U) with or without <span class="tagged-query" title="Query">motor neuron disease</span> (MND). Thus, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> defines a novel class of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> called <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies. We performed <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias</span> (FTDs) included four groups: 1) familial FTD with <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin</a></span> (n = 36), <span class="tagged-gene" title="SwissProt ID: P55072; Entrez Gene ID: 7415; HGNC ID: 12666; HPRD ID: 03013; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55072">valosin-containing protein</a></span> (n = 5), <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> (n = 4), and <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p (n = 7); 2) familial cases of FTD with unknown <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">association</span> (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p but not FTD with <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> is a common pathological substrate underlying a large subset of these disorders, thereby implicating <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in novel and unifying mechanisms of FTLD pathogenesis.
motor_neuron_disease	ubiquitin	False Positive	3.388	17513340	<strong class="title">Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in Familial and Sporadic <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal Lobar Degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span> Inclusions. Am J Pathol. 2007 May 18;.</strong> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TAR DNA-binding protein 43</a></span> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TDP-43)</a></span> is a major pathological <span class="tagged-filter" title="Association Word">protein</span> of sporadic and familial <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive, tau-negative inclusions (FTLD-U) with or without <span class="tagged-query" title="Query">motor neuron disease</span> (MND). Thus, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> defines a novel class of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases</span> called <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies. We performed <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias</span> (FTDs) included four groups: 1) familial FTD with <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P28799; Entrez Gene ID: 2896; HGNC ID: 4601; HPRD ID: 00733; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28799">progranulin</a></span> (n = 36), <span class="tagged-gene" title="SwissProt ID: P55072; Entrez Gene ID: 7415; HGNC ID: 12666; HPRD ID: 03013; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P55072">valosin-containing protein</a></span> (n = 5), <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> (n = 4), and <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p (n = 7); 2) familial cases of FTD with unknown <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">association</span> (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9p but not FTD with <span class="tagged-gene" title="SwissProt ID: Q9UQN3; Entrez Gene ID: 25978; HGNC ID: 24537; HPRD ID: 13174; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9UQN3">charged multivesicular body protein 2B</a></span> <span class="tagged-filter" title="Association Word">mutations.</span> Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> is a common pathological substrate underlying a large subset of these disorders, thereby implicating <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> in novel and unifying mechanisms of FTLD pathogenesis.
motor_neuron_disease	ubiquitin	False Positive	3.388	17492294	<strong class="title">Kwong LK, Neumann M, Sampathu DM, Lee VM, Trojanowski JQ: <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathy: the neuropathology underlying major forms of sporadic and familial <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> and <span class="tagged-query" title="Query">motor neuron disease.</span> Acta Neuropathol. 2007 Jul;114(1):63-70. Epub 2007 May 10.</strong> The rapid confirmation of the initial report by Neumann et al. (Science 314:130-133, 2006) that transactive response <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TAR)-DNA-binding protein 43</a></span> <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">(TDP-43)</a></span> is the major disease <span class="tagged-filter" title="Association Word">protein</span> linking <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive inclusions (FTLD-U) with and without <span class="tagged-query" title="Query">motor neuron disease</span> (MND) as well as <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) implies that <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathy underlies major forms of sporadic as well as familial FTLD and ALS. Not only was the identity of the ubiquitinated <span class="tagged-filter" title="Association Word">proteins</span> that accumulate in neurons and glia of these disorders finally resolved, but it also was shown that pathologic <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> was hyperphosphorylated, ubiquitinated and cleaved to generate C-terminal fragments in affected brain and spinal cord of FTLD-U and ALS. This review summarizes the growing evidence that <span class="tagged-gene" title="SwissProt ID: Q13148; Entrez Gene ID: 23435; HGNC ID: 11571; HPRD ID: 05466; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13148">TDP-43</a></span> proteinopathy is the common pathologic substrate linking FTLD and ALS, and it considers the implications of these findings for developing better strategies to diagnose and treat these <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders.</span>
motor_neuron_disease	ubiquitin	False Positive	3.388	17133330	<strong class="title">O'Neill S, Andreotti M, de Simone V: <span class="tagged-disease" title="UMLS Concept ID: C0338462">[Semantic dementia,</span> a many-worded disorder] . J Neurol Sci. 2004 Jan 15;217(1):47-54.</strong> INTRODUCTION: <span class="tagged-disease" title="UMLS Concept ID: C0338462">Semantic dementia</span> is a progressive, relatively selective disorder affecting the semantic system with involvement of the verbal and non-verbal functions. The clinical picture is well characterised despite the confusion that may be generated by the different ways of classifying it. AIM. To determine the clinical, neurolinguistic, imaging and pathological features of this progressive <span class="tagged-disease" title="UMLS Concept ID: C0023015">language disorder.</span> DEVELOPMENT: Evaluation of language reveals above all the existence of semantic paraphasias, disorders affecting the comprehension of isolated words and <span class="tagged-disease" title="UMLS Concept ID: C0454594">surface dyslexia.</span> Flow of speech, complex syntactic comprehension and grammar are preserved. Both episodic and autobiographic memory are close to normality. Both the clinical signs and symptoms and imaging studies agree on the fact that the most heavily affected area is the anteroinferomedial region of the temporal lobe on a bilateral scale but with predominance of the left-hand side. Pathologically, in most cases positive intraneuronal <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> inclusions are <span class="tagged-filter" title="Association Word">observed</span> like those described in <span class="tagged-query" title="Query">motor neuron diseases.</span> CONCLUSIONS: <span class="tagged-disease" title="UMLS Concept ID: C0338462">Semantic dementia</span> constitutes a <span class="tagged-filter" title="Association Word">diagnosis</span> challenge, mainly from the neuropsychological point of view. Further advances towards reaching a <span class="tagged-filter" title="Association Word">diagnosis</span> would allow us to determine which area is mainly affected and, in the future, to find an effective treatment for this progressive, <span class="tagged-disease" title="UMLS Concept ID: C1285162">degenerative disorder.</span>
motor_neuron_disease	ubiquitin	False Positive	3.388	16317257	<strong class="title">Katsuse O, Dickson DW: <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span> immunohistochemistry of <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> differentiates cases with and without <span class="tagged-query" title="Query">motor neuron disease.</span> Behav Brain Res. 2005 Jul 30;162(2):233-9.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal lobar degeneration</span> (FTLD) without tau pathology is clinically and pathologically heterogeneous. The present report describes the neuropathology of 52 brains with FTLD without tau pathology compared with 10 brains of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) without <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> using <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> immunohistochemistry. The 52 cases were classified into 47 cases of FTLD with <span class="tagged-query" title="Query">motor neuron disease</span> (MND)-type inclusions but without MND (FTLD-MNI), three cases of FTLD with MND (FTLD-MND), and two cases of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinctive histopathology <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">(DLDH)</a></span> based on the features of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-immunoreactive <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">(ubiquitin</a></span>-ir) structures in the caudate, frontotemporal cortices and dentate fascia, and presence or <span class="tagged-filter" title="Association Word">absence</span> of neuronal loss in lower motor neurons. Many <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir neuronal inclusions and neurites in the caudate nucleus, frontotemporal cortices, and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir crescent-or ring-shaped neuronal inclusions in the dentate fascia characterized FTLD-MNI. <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span>-ir neuronal intranuclear inclusions (NII) were <span class="tagged-filter" title="Association Word">observed</span> in 26 of 43 cases and <span class="tagged-filter" title="Association Word">associated</span> with many neurites in the caudate nucleus as well as a familial history in most cases. A subset of cases had Pick-body-like inclusions in the dentate fascia and caudate nucleus with paucity of neuritic pathology and no NII; another had crescent-shaped inclusions in the dentate fascia and neuritic pathology with NII in the caudate. FTLD with MND was characterized by a few or no <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir inclusions in the caudate nucleus and frontotemporal cortices and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-ir granular inclusions in the dentate fascia, as well as loss of lower motor neurons. These features were similar to ALS, but different from FTLD-MNI. The findings suggest that FTLD-MNI has a different pathogenesis from FTLD-MND and ALS.
motor_neuron_disease	ubiquitin	False Positive	3.388	15892300	<strong class="title">Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VM, Forman M, Van Deerlin V, Ervin JF, Wang DS, Schmechel DE, Hulette CM: Neuropathologic, biochemical, and molecular characterization of the frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias.</span> Neurology. 2000 Feb 22;54(4):818-27.</strong> The frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias</span> (FTDs) are a heterogeneous group of <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders</span> that are characterized clinically by <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia,</span> personality changes, <span class="tagged-disease" title="UMLS Concept ID: C0023015">language impairment,</span> and occasionally extrapyramidal <span class="tagged-disease" title="UMLS Concept ID: C0026650">movement disorders.</span> Historically, the <span class="tagged-filter" title="Association Word">diagnosis</span> and classification of FTDs has been fraught with difficulties, especially with regard to establishing a consensus on the neuropathologic <span class="tagged-filter" title="Association Word">diagnosis.</span> Recently, an international group of scientists participated in a consensus conference to develop such neuropathologic criteria. They recommended a diagnostic classification scheme that incorporated a biochemical analysis of the insoluble tau isoform composition, as well as <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> immunohistochemistry. The use and reliability of this classification system has yet to be examined. In this study, we evaluated 21 cases of FTD. Using traditional histochemical stains and tau <span class="tagged-filter" title="Association Word">protein</span> and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> immunohistochemistry, we separated each case into one of the following categories: classic <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick disease</span> (PiD; n = 7), <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration</span> <span class="tagged-gene" title="SwissProt ID: P04001; Entrez Gene ID: 2652; HGNC ID: 4206; HPRD ID: 02365; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04001">(CBD;</a></span> n = 5), <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinctive histopathologic features <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">(DLDH;</a></span> n = 4), <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy</span> <span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52758">(PSP;</a></span> n = 2), <span class="tagged-disease" title="UMLS Concept ID: C0751072">frontotemporal lobar degeneration</span> with <span class="tagged-query" title="Query">motor neuron disease</span> or <span class="tagged-query" title="Query">motor neuron disease</span>-type inclusions (FTLD-MND/MNI; n = 2), and neurofibrillary tangle <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (NFTD; n = 1). Additionally, we independently categorized each case by the insoluble tau isoform pattern, including 3R (n = 5), 4R (n = 7), 3R/4R (n = 3), and no insoluble tau (n = 6). As suggested by the proposed diagnostic scheme, we found that the insoluble tau isoform patterns correlated strongly with the independently derived histopathologic diagnoses (p < 0.001). The data show that cases containing predominantly 3R tau were classic PiD (100%). Cases with predominantly 4R tau were either <span class="tagged-gene" title="SwissProt ID: P04001; Entrez Gene ID: 2652; HGNC ID: 4206; HPRD ID: 02365; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04001">CBD</a></span> (71%) or <span class="tagged-gene" title="SwissProt ID: P52758; Entrez Gene ID: 10247; HGNC ID: 16897; HPRD ID: 03924; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P52758">PSP</a></span> (29%). Cases with both 3R and 4R tau were either a combination of PiD and <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer disease</span> (67%) or NFTD (33%). Finally, cases with no insoluble tau were either <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">DLDH</a></span> (67%) or FTLD-MND/MNI (33%). To further characterize these cases, we also performed quantitative Western blots for soluble tau, <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">APOE</a></span> genotyping, and, in selected cases, tau <span class="tagged-filter" title="Association Word">gene</span> sequencing. We show that soluble tau is reduced in <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">DLDH</a></span> and FTLD-MND/MNI and that APOE4 is overrepresented in PiD and <span class="tagged-gene" title="SwissProt ID: P09622; Entrez Gene ID: 1738; HGNC ID: 2898; HPRD ID: 02006; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09622">DLDH.</a></span> We also identified a new family with the R406W <span class="tagged-filter" title="Association Word">mutation</span> and pathology consistent with NFTD. This study validates the recently proposed diagnostic criteria and forms a framework for further refinement of this classification scheme.
motor_neuron_disease	ubiquitin	False Positive	3.388	15641590	<strong class="title">Furukawa Y, Iseki E, Hino H, Odawara T, Ikeda K, Tsuchiya K, Kosaka K: <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">Ubiquitin</a></span> and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins</span> in the brains of patients with atypical <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick's disease</span> without Pick bodies and <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> with <span class="tagged-query" title="Query">motor neuron disease.</span> Neuropathology. 2004 Dec;24(4):306-14.</strong> Nine cases of atypical <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick's disease</span> without Pick bodies (aPiD) and seven cases of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> with <span class="tagged-query" title="Query">motor neuron diseases</span> (D-MND) were compared using immunohistochemistry of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> (ub) and ub-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins.</span> All cases showed rostral-<span class="tagged-filter" title="Association Word">dominant</span> atrophy in the temporal and frontal lobes, although the degree of atrophy with neuronal loss was much more severe in the aPiD cases. In both aPiD and D-MND cases, ub-positive and tau-negative structures were found mainly in the hippocampal dentate gyrus and cerebral cortex. Granular cells of the dentate gyrus showed similar ub-positive intraneuronal inclusions in both cases. In the aPiD cases, most of the ub-positive cortical structures were ub-positive dendrites in layers II-IIIab and layers V-VI, although some neurons also showed diffuse ub-positive staining in the cytoplasm. In the D-MND cases, some neurons showed ub-positive inclusions in layers II-IIIab, and ub-positive dendrites were unremarkable. The number of ub-positive neurons and dendrites in relation to the degree of neuronal loss in the cerebral cortex were then evaluated. The number of ub-positive neurons in the regions showing very mild to mild neuronal loss was significantly greater in the D-MND cases than in the aPiD cases. However, in the aPiD cases, the number of ub-positive neurons was significantly greater in the regions showing moderate neuronal loss. When double-immunostained, almost all ub-positive structures were positive for ub-binding <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: Q9Y6M1; Entrez Gene ID: 10644; HGNC ID: 28867; HPRD ID: 10507; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y6M1">p62.</a></span> Some ub-positive or negative neurons in the cerebral cortex were immunostained with anti-ub ligase <span class="tagged-drug" title="DrugBank: APRD00729"><span class="tagged-gene" title="SwissProt ID: P09936; Entrez Gene ID: 7345; HGNC ID: 12513; HPRD ID: 01877; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00729">(Parkin)</a></span> and anti-ub C-terminal hydrolase <a href="http://beta.uniprot.org/uniprot/P09936">(UCH-L1)</a></span> <span class="tagged-filter" title="Association Word">antibodies.</span> Granular cells of the dentate gyrus were weakly positive for <span class="tagged-gene" title="SwissProt ID: P09936; Entrez Gene ID: 7345; HGNC ID: 12513; HPRD ID: 01877; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09936">UCH-L1.</a></span> There could be some differences in the mechanism by which neurons in the cerebral cortex accumulate ub between aPiD and D-MND.
motor_neuron_disease	ubiquitin	False Positive	3.388	15641588	<strong class="title">Yaguchi M, Fujita Y, Amari M, Takatama M, Al-Sarraj S, Leigh PN, Okamoto K: Morphological differences of intraneuronal <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive inclusions in the dentate gyrus and parahippocampal gyrus of <span class="tagged-query" title="Query">motor neuron disease</span> with <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span> Neuropathology. 2004 Dec;24(4):296-301.</strong> Semiquantitative morphological analysis of cerebral intraneuronal <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive tau-negative inclusions, a pathologic <span class="tagged-filter" title="Association Word">marker</span> for <span class="tagged-query" title="Query">motor neuron disease</span> with <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (MND-D), was performed in the dentate gyrus and parahippocampal gyrus of 20 clinicopathologically confirmed patients with MND-D. The forms of the inclusions were tentatively classified into three types: (i) C-type, consisting of relatively large and intensely stained crescent or circular structures; (ii) L-type, showing fine linear structures around the nuclei; and (iii) G-type, showing faintly stained granular structures. The frequencies of the C-type, L-type and G-type was 0.5-9.3%,0.2-6.5% and 0-6.6% of dentate granule cells, respectively. In contrast to the dentate gyrus, almost all inclusions showed either the C-type or L-type form in the parahippocampal gyrus. A positive correlation was noted only between incidences of C-type inclusion of the dentate gyrus and that of the parahippocampal gyrus (r = 0.69, P < 0.05). The morphological differences of the inclusions probably reflect different stages of their formation.
motor_neuron_disease	ubiquitin	False Positive	3.388	15139588	<strong class="title">Ikeda K, Tsuchiya K: <span class="tagged-query" title="Query">Motor neuron disease</span> group accompanied by inclusions of unidentified <span class="tagged-filter" title="Association Word">protein</span> signaled by <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin.</a></span> Neuropathology. 2004 Jun;24(2):117-24.</strong> Peculiar tau-negative, <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive inclusions appear in <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> with ALS (ALS-D), the majority of <span class="tagged-disease" title="UMLS Concept ID: C0333667">lobar atrophy</span> <span class="tagged-disease" title="UMLS Concept ID: C0236642">(Pick's disease)</span> without Pick body and a small portion of ALS. Another common neuropathological lesion in these diseases is the motor neuron involvement with the degenerative processes. The lower motor neuron is predominantly <span class="tagged-filter" title="Association Word">involved</span> in ALS and ALS-D the upper motor neuron is predominantly <span class="tagged-filter" title="Association Word">involved,</span> but in varying degrees in a considerable number of patients with <span class="tagged-disease" title="UMLS Concept ID: C0333667">lobar atrophy</span> that lack Pick bodies. There are, however, some points that have yet to be elucidated. The boundary between these diseases is not always clear and a significant number of cases are considered to be the transitional form. <span class="tagged-disease" title="UMLS Concept ID: C0333667">Lobar atrophy</span> without Pick body seems to be a heterogeneous disease group. The nature of <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> inclusions also needs to be clarified. Nevertheless, we postulate that these diseases are grouped with the concept of <span class="tagged-query" title="Query">motor neuron disease</span>-inclusion <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span>
motor_neuron_disease	HEXB	True Negative	1.441	11897243	<strong class="title">Yoshizawa T, Kohno Y, Nissato S, Shoji S: Compound heterozygosity with two novel <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P07686; Entrez Gene ID: 3074; HGNC ID: 4879; HPRD ID: 06043; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07686">HEXB</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">produces</span> <span class="tagged-disease" title="UMLS Concept ID: C0751489">adult Sandhoff disease</span> presenting as a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype. J Neurol Sci. 2002 Mar 30;195(2):129-38.</strong> Little information is available on molecular defects <span class="tagged-filter" title="Association Word">involved</span> in <span class="tagged-disease" title="UMLS Concept ID: C0751489">adult Sandhoff disease</span> presenting as <span class="tagged-query" title="Query">motor neuron disease</span> phenotype. We studied <span class="tagged-filter" title="Association Word">enzyme</span> activities of beta-<span class="tagged-gene" title="Protein Family or Complex">hexosaminidase</span> (Hex) and the <span class="tagged-gene" title="SwissProt ID: P07686; Entrez Gene ID: 3074; HGNC ID: 4879; HPRD ID: 06043; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07686">HEXB</a></span> <span class="tagged-filter" title="Association Word">gene</span> encoding the beta-subunit of Hex in a family of the Japanese case. <span class="tagged-filter" title="Association Word">Enzyme</span> assay with 4-methylumbelliferyl-2-acetamido-2-deoxy-beta-D-glucopyranoside revealed a reduction in Hex A and B <span class="tagged-filter" title="Association Word">activity</span> in proband's leukocytes. Although the <span class="tagged-filter" title="Association Word">activity</span> of both in the mother were intermediate between those of controls and the proband, only Hex B reduction determined with heat inactivation was found in the father. Analysis of <span class="tagged-gene" title="SwissProt ID: P07686; Entrez Gene ID: 3074; HGNC ID: 4879; HPRD ID: 06043; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07686">HEXB</a></span> <span class="tagged-filter" title="Association Word">gene</span> demonstrated two novel point <span class="tagged-filter" title="Association Word">mutations.</span> The first <span class="tagged-filter" title="Association Word">mutation,</span> IVS2-1G> A, was located at the 3'-splice acceptor site of intron 2 derived from the mother, <span class="tagged-filter" title="Association Word">causing</span> exon 3 skipping. The resultant <span class="tagged-filter" title="Association Word">mRNA</span> encoded a shorter beta-chain, which may not form an active <span class="tagged-filter" title="Association Word">enzyme.</span> The second <span class="tagged-filter" title="Association Word">mutation</span> was a G-to-A transition in exon 13 (c.1598G> A) derived from the father and resulted in <span class="tagged-metabolite" title="HMDB: HMDB00517"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00517">arginine</a></span>-to-<span class="tagged-metabolite" title="HMDB: HMDB00177"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00177">histidine</a></span> substitution at amino acid position 533 (R533H). <span class="tagged-filter" title="Association Word">Expression</span> of R533H <span class="tagged-filter" title="Association Word">mutation</span> in COS-1 cells demonstrated a lack of normal Hex <span class="tagged-filter" title="Association Word">activity,</span> indicating that this <span class="tagged-filter" title="Association Word">mutation</span> is pathological. Compound heterozygosity of these two <span class="tagged-filter" title="Association Word">mutations</span> may trigger the development of <span class="tagged-disease" title="UMLS Concept ID: C0751489">adult Sandhoff disease</span> with a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype.
motor_neuron_disease	choline-acetyltransferase	True Negative	1.441	15002737	<strong class="title">Iwasaki Y, Ichikawa Y, Igarashi O, Konno S, Aoyagi J, Ikeda K, Marabuchi S, Ono S, Iguchi H, Kawabe K, Fujioka T: T-588 protects motor neuron death following axotomy. Neurochem Res. 2004 Feb;29(2):403-6.</strong> R (-)-1-(benzo [b] thiophen-5-yl)-2-[2-(N,N-diethylamino) ethoxy] <span class="tagged-metabolite" title="HMDB: HMDB00108"><span class="tagged-gene" title="SwissProt ID: P28329; Entrez Gene ID: 1103; HGNC ID: 1912; HPRD ID: 07510; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00108">ethanol</a></span> hydrochloride) (T-588) enhances <span class="tagged-metabolite" title="HMDB: HMDB00895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00895">acetylcholine</a></span> release. This compound slows the motor deterioration of wobbler mouse <span class="tagged-query" title="Query">motor neuron disease</span> and enhances neurite outgrowth and <a href="http://beta.uniprot.org/uniprot/P28329">choline acetyltransferase</a></span> <span class="tagged-filter" title="Association Word">activity</span> in cultured rat spinal motor neurons. We examined the ability of T-588 on axotomized spinal motor neuron death in the rat spinal cord. After the postnatal unilateral section of sciatic nerve, there was approximately a 50% survival of motor neurons in the fourth lumbar segment. In comparison with vehicle, intraperitoneal injection of T-588 for 14 consecutive days rescued spinal motor neuron death. Our results showing in vivo neurotrophic <span class="tagged-filter" title="Association Word">activity</span> of T-588 for motor neurons support the applicability of T-588 for the treatment of <span class="tagged-query" title="Query">motor neuron diseases,</span> such as <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> and motor neuropathies.
motor_neuron_disease	MAPT	True Positive	1.441	15883319	<strong class="title">Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atares B, Puig B, Gomez-Esteban JC, Fernandez-Maiztegui C, Rouco I, Perez-Concha T, Fernandez M, Rodriguez O, Rodriguez-Martinez AB, de Pancorbo MM, Pastor P, Perez-Tur J: A novel <span class="tagged-filter" title="Association Word">mutation</span> (K317M) in the <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">causes</span> FTDP and <span class="tagged-query" title="Query">motor neuron disease.</span> Neurology. 2005 May 10;64(9):1578-85.</strong> BACKGROUND: <span class="tagged-disease" title="UMLS Concept ID: C0338451">Frontotemporal dementia</span> with <span class="tagged-disease" title="UMLS Concept ID: C0242422">parkinsonism</span> is often <span class="tagged-filter" title="Association Word">linked</span> to chromosome 17 and is <span class="tagged-filter" title="Association Word">related</span> to <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> <span class="tagged-filter" title="Association Word">gene.</span> In some families the genetic basis is still unknown. The authors report two pedigrees with <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">FTDP-17</a></span> harboring a novel <span class="tagged-filter" title="Association Word">mutation</span> (K317M) in exon 11 in the <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> <span class="tagged-filter" title="Association Word">gene.</span> METHODS: The authors identified two apparently unrelated pedigrees with an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> neurodegenerative condition. Thirteen patients were examined and eight autopsies were performed. RESULTS: Mean age at onset was 48 years. Mean disease duration was 6 years. Dysarthria often heralded the disease. All cases had <span class="tagged-disease" title="UMLS Concept ID: C0242422">parkinsonism</span> and pyramidalism and half of them had <span class="tagged-disease" title="UMLS Concept ID: C0026846">amyotrophy.</span> Behavioral or personality changes were not a prominent feature. Cognitive <span class="tagged-filter" title="Association Word">decline</span> appeared late in the evolution. Neuropathologically, a massive degeneration of the substantia nigra without Lewy bodies was a constant finding. A variable degree of frontotemporal atrophy was found. Corticospinal tract degeneration and anterior horn <span class="tagged-disease" title="UMLS Concept ID: C0598940">neuron loss</span> were present in six of seven autopsies in which the spinal cord was examined. An extensive deposition of abnormal tau <span class="tagged-filter" title="Association Word">protein</span> in a mixed pattern (neuronal, glial) was <span class="tagged-filter" title="Association Word">observed.</span> Pick's bodies were not seen. Biochemical analysis of tau revealed two bands of 64 and 68 kDa. CONCLUSION: Genetic analysis revealed the same novel <span class="tagged-filter" title="Association Word">mutation</span> (K317M) in exon 11 of the <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">MAPT</a></span> <span class="tagged-filter" title="Association Word">gene</span> in both pedigrees. A common haplotype between members of the two pedigrees suggests that they belong to the same family.
motor_neuron_disease	MAPT	True Positive	1.441	14503643	<strong class="title">Yancopoulou D, Crowther RA, Chakrabarti L, Gydesen S, Brown JM, Spillantini MG: Tau protein in <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> <span class="tagged-filter" title="Association Word">linked</span> to chromosome 3 (FTD-3). J Neuropathol Exp Neurol. 2003 Aug;62(8):878-82.</strong> Recent work on <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> (FTD) has revealed the existence of at least 3 genetically distinct groups of inherited FTD: <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">FTDP-17,</a></span> FTD and <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9, and FTD <span class="tagged-filter" title="Association Word">linked</span> to chromosome 3 (FTD-3). Tau, on chromosome 17, is the only <span class="tagged-filter" title="Association Word">gene</span> where <span class="tagged-filter" title="Association Word">mutations</span> have been identified and its involvement in FTD has been firmly established. The <span class="tagged-filter" title="Association Word">genes</span> on chromosome 9 and chromosome 3 <span class="tagged-filter" title="Association Word">associated</span> with familial forms of FTD remain to be identified. Abnormal aggregates of tau <span class="tagged-filter" title="Association Word">protein</span> characterize the brain lesions of <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">FTDP-17</a></span> patients and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> inclusions have been found in FTD with <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">linked</span> to chromosome 9. In this study the frontal cortices of 3 FTD-3 patients from a unique Danish family were examined for characteristic neuropathological features. In these brains tau inclusions were present in neurons and some glial cells in the <span class="tagged-filter" title="Association Word">absence</span> of beta-amyloid deposits. The presence of filamentous tau protein in the frontal cortex of these patients suggests a possible link between tau and the genetic defect present on chromosome 3 and <span class="tagged-filter" title="Association Word">associated</span> with FTD-3, although the limited amount of tau deposits <span class="tagged-filter" title="Association Word">observed</span> makes it difficult to define this as a tauopathy.
motor_neuron_disease	MAPT	False Negative	1.441	12481984	<strong class="title">Tolnay M, Probst A: <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal lobar degeneration</span>--tau as a pied piper? . Neurogenetics. 2002 Oct;4(2):63-75.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0751072">Frontotemporal lobar degeneration</span> (FTLD) is the second most-common form of cortical <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> in the presenium after <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer disease.</span> Clinically three disease entities can be distinguished: <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0338462">semantic dementia,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0282513">primary progressive aphasia.</span> The underlying neuropathology can be classified into disorders with tau pathology (including <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration,</span> <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy,</span> and familial <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> with <span class="tagged-disease" title="UMLS Concept ID: C0242422">parkinsonism</span> <span class="tagged-filter" title="Association Word">linked</span> to chromosome 17 - <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">FTDP-17),</a></span> and into disorders that lack tau abnormalities (including <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinctive histology and <span class="tagged-query" title="Query">motor neuron disease</span> inclusion <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia).</span> The recent discovery of tau <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">FTDP-17</a></span> brought tau to the center stage, but <span class="tagged-filter" title="Association Word">led</span> to the erroneous trend of collectively grouping all forms of FTLD as <span class="tagged-disease" title="UMLS Concept ID: C0949664">tauopathies.</span> However, clinicopathological and genetic studies strongly suggest that the majority of sporadic and familial FTLD cases are not <span class="tagged-filter" title="Association Word">associated</span> with tau pathology and/or tau <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations.</span> Furthermore, recent studies have <span class="tagged-filter" title="Association Word">linked</span> several <span class="tagged-filter" title="Association Word">autosomal</span> dominantly inherited familial <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> cases to a variety of <span class="tagged-filter" title="Association Word">gene</span> loci on different chromosomes. Thus, this review is intended to summarize our current knowledge about the sporadic and familial FTLD disorders that lack tau pathology, and shall further strengthen the view that FTLD is heterogeneous, both in terms of clinicopathological phenotypes as well as genetic backgrounds.
motor_neuron_disease	MAPT	True Positive	1.441	11711205	<strong class="title">Adamec E, Chang HT, Stopa EG, Hedreen JC, Vonsattel JP: Tau protein <span class="tagged-filter" title="Association Word">expression</span> in frontotemporal <span class="tagged-disease" title="UMLS Concept ID: C0497327">dementias.</span> Neurosci Lett. 2001 Nov 23;315(1-2):21-4.</strong> The syndrome of <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> represents a diverse group of diseases presenting with behavioral and cognitive disturbances. The <span class="tagged-filter" title="Association Word">expression</span> of the <span class="tagged-gene" title="SwissProt ID: P10636; Entrez Gene ID: 4137; HGNC ID: 6893; HPRD ID: 01142; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10636">microtubule-associated protein tau</a></span> was studied in postmortem samples of frontal cortex of 19 cases (12 <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick's disease</span> A, B, C; 4 <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinct histology; 3 <span class="tagged-query" title="Query">motor neuron disease</span> type) by Western blotting with a phosphorylation-independent anti-tau <span class="tagged-filter" title="Association Word">antibody.</span> The presence of tau <span class="tagged-filter" title="Association Word">protein</span> was detected in all cases evaluated, including the 11 brains classified as frontotemporal lobe degeneration (diagnostic categories <span class="tagged-disease" title="UMLS Concept ID: C0236642">Pick's disease</span> B, C and <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">lacking</span> distinct histology). These findings indicate that the recently reported decreased expression of tau <span class="tagged-filter" title="Association Word">protein</span> in frontotemporal lobe degeneration represents pathogenic mechanism of <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration</span> detectable only in a special subset of these disorders.
motor_neuron_disease	Semaphorin-3A	True Negative	1.441	16677822	<strong class="title">De Winter F, Vo T, Stam FJ, Wisman LA, Bar PR, Niclou SP, van Muiswinkel FL, Verhaagen J: The <span class="tagged-filter" title="Association Word">expression</span> of the chemorepellent <span class="tagged-gene" title="SwissProt ID: Q14563; Entrez Gene ID: 10371; HGNC ID: 10723; HPRD ID: 04908; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14563">Semaphorin 3A</a></span> is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in <span class="tagged-query" title="Query">motor neuron disease.</span> Mol Cell Neurosci. 2006 May-Jun;32(1-2):102-17. Epub 2006 May 3.</strong> Neuromuscular synapses differ markedly in their plasticity. Motor nerve terminals innervating slow muscle fibers sprout vigorously following synaptic blockage, while those innervating fast-fatigable muscle fibers fail to exhibit any sprouting. Here, we show that the axon repellent <span class="tagged-gene" title="SwissProt ID: Q14563; Entrez Gene ID: 10371; HGNC ID: 10723; HPRD ID: 04908; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14563">Semaphorin 3A</a></span> is differentially <span class="tagged-filter" title="Association Word">expressed</span> in terminal Schwann cells (TSCs) on different populations of muscle fibers: postnatal, regenerative and paralysis induced remodeling of neuromuscular connections is accompanied by increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q14563; Entrez Gene ID: 10371; HGNC ID: 10723; HPRD ID: 04908; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14563">Sema3A</a></span> selectively in TSCs on fast-fatigable muscle fibers. To our knowledge, this is the first demonstration of a molecular difference between TSCs on neuromuscular junctions of different subtypes of muscle fibers. Interestingly, also in a mouse model for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS), <span class="tagged-gene" title="SwissProt ID: Q14563; Entrez Gene ID: 10371; HGNC ID: 10723; HPRD ID: 04908; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14563">Sema3A</a></span> is <span class="tagged-filter" title="Association Word">expressed</span> at NMJs of fast-fatigable muscle fibers. We propose that <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: Q14563; Entrez Gene ID: 10371; HGNC ID: 10723; HPRD ID: 04908; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14563">Sema3A</a></span> by TSCs not only suppresses nerve terminal plasticity at specific neuromuscular synapses, but may also contribute to their early and selective loss in the <span class="tagged-query" title="Query">motor neuron disease</span> ALS.
motor_neuron_disease	Dynactin	True Positive	6.075	17360970	<strong class="title">Haghnia M, Cavalli V, Shah SB, Schimmelpfeng K, Brusch R, Yang G, Herrera C, Pilling A, Goldstein LS: <span class="tagged-gene" title="Protein Family or Complex">Dynactin</span> is required for coordinated bidirectional motility, but not for <span class="tagged-gene" title="Protein Family or Complex">dynein</span> membrane attachment. Mol Biol Cell. 2007 Jun;18(6):2081-9. Epub 2007 Mar 14.</strong> Transport of cellular and neuronal vesicles, organelles, and other particles along microtubules requires the molecular motor <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="Protein Family or Complex">dynein</span> (Mallik and Gross, 2004). Critical to <span class="tagged-gene" title="Protein Family or Complex">dynein</span> function is <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> a multiprotein complex commonly thought to be required for <span class="tagged-gene" title="Protein Family or Complex">dynein</span> attachment to membrane compartments (Karki and Holzbaur, 1999). Recent work also has found that <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> can <span class="tagged-filter" title="Association Word">cause</span> the human <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (Puls et al., 2003). Thus, it is essential to understand the in vivo function of <span class="tagged-gene" title="Protein Family or Complex">dynactin.</span> To test directly and rigorously the hypothesis that <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> is required to attach <span class="tagged-gene" title="Protein Family or Complex">dynein</span> to membranes, we used both a Drosophila mutant and RNA interference to generate organisms and cells <span class="tagged-filter" title="Association Word">lacking</span> the critical <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> subunit, <span class="tagged-gene" title="SwissProt ID: O94805; Entrez Gene ID: 51412; HGNC ID: 160; HPRD ID: 12419; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O94805">actin-related protein</a></span> 1. Contrary to expectation, we found that apparently normal amounts of <span class="tagged-gene" title="Protein Family or Complex">dynein</span> associate with membrane compartments in the <span class="tagged-filter" title="Association Word">absence</span> of a fully assembled <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> complex. In addition, anterograde and retrograde organelle movement in <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> <span class="tagged-filter" title="Association Word">deficient</span> axons was completely disrupted, resulting in substantial changes in vesicle kinematic properties. Although effects on retrograde transport are predicted by the proposed function of <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> as a regulator of <span class="tagged-gene" title="Protein Family or Complex">dynein</span> processivity, the additional effects we <span class="tagged-filter" title="Association Word">observed</span> on anterograde transport also suggest potential <span class="tagged-filter" title="Association Word">roles</span> for <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> in mediating kinesin-driven transport and in coordinating the <span class="tagged-filter" title="Association Word">activity</span> of opposing motors (King and Schroer, 2000).
motor_neuron_disease	Dynactin	True Positive	6.075	16533145	<strong class="title">Bruijn LI, Cudkowicz M: Therapeutic targets for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis:</span> current treatments and prospects for more effective therapies. Expert Rev Neurother. 2006 Mar;6(3):417-28.</strong> Although <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) was described more than 130 years ago, the <span class="tagged-filter" title="Association Word">cause</span> (s) of most cases of this adult <span class="tagged-query" title="Query">motor neuron disease</span> remains a mystery. With the discovery of <span class="tagged-filter" title="Association Word">mutations</span> in one <span class="tagged-filter" title="Association Word">gene</span> (Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase)</a></span> as a primary <span class="tagged-filter" title="Association Word">cause</span> of some forms of ALS, model systems have been developed that have helped us begin to understand mechanisms <span class="tagged-filter" title="Association Word">involved</span> in motor neuron death and enabled testing of potential new therapies. Several other <span class="tagged-filter" title="Association Word">genes</span> have been implicated as risk factors in <span class="tagged-query" title="Query">motor neuron diseases,</span> including neurofilaments, cytoplasmic dynein and <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor,</a></span> and <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin.</a></span> With advances in the basic research of the disease, many hypotheses accounting for motor neuron death are being explored, including loss of trophic support, <span class="tagged-filter" title="Association Word">protein</span> mishandling, mitochondrial dysfunction, excitotoxicity, axonal abnormalities and inflammation. Many of these mechanisms are the focus of research in other <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders,</span> such as Parkinson's, Alzheimer's and <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease.</span>
motor_neuron_disease	Dynactin	True Positive	6.075	16505168	<strong class="title">Levy JR, Sumner CJ, Caviston JP, Tokito MK, Ranganathan S, Ligon LA, Wallace KE, LaMonte BH, Harmison GG, Puls I, Fischbeck KH, Holzbaur EL: A <span class="tagged-query" title="Query">motor neuron disease</span>-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">mutation</span> in p150Glued perturbs <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> function and induces <span class="tagged-filter" title="Association Word">protein</span> aggregation. J Cell Biol. 2006 Feb 27;172(5):733-45.</strong> The microtubule motor cytoplasmic <span class="tagged-gene" title="Protein Family or Complex">dynein</span> and its activator <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> drive vesicular transport and mitotic spindle organization. <span class="tagged-gene" title="Protein Family or Complex">Dynactin</span> is ubiquitously <span class="tagged-filter" title="Association Word">expressed</span> in eukaryotes, but a G59S <span class="tagged-filter" title="Association Word">mutation</span> in the p150Glued subunit of <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> results in the specific degeneration of motor neurons. This <span class="tagged-filter" title="Association Word">mutation</span> in the conserved cytoskeleton-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">protein,</span> <span class="tagged-metabolite" title="HMDB: HMDB00123"><span class="tagged-gene" title="SwissProt ID: Q5XLJ0; Entrez Gene ID: 56899; HGNC ID: 24600; HPRD ID: 07426; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span>-rich <span class="tagged-drug" title="DrugBank: APRD00862"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00862">(CAP</a></span>-Gly) domain lowers the affinity of p150Glued for microtubules and <a href="http://beta.uniprot.org/uniprot/Q5XLJ0">EB1.</a></span> Cell lines from patients are morphologically normal but show delayed recovery after nocodazole treatment, consistent with a subtle disruption of <span class="tagged-gene" title="Protein Family or Complex">dynein</span>/<span class="tagged-gene" title="Protein Family or Complex">dynactin</span> function. The G59S <span class="tagged-filter" title="Association Word">mutation</span> disrupts the folding of the <span class="tagged-drug" title="DrugBank: APRD00862"><span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00862">CAP</a></span>-Gly domain, resulting in aggregation of the p150Glued <span class="tagged-filter" title="Association Word">protein</span> both in vitro and in vivo, which is accompanied by an increase in cell death in a motor neuron cell line. Overexpression of the chaperone <a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> inhibits aggregate formation and prevents cell death. These data support a model in which a point <span class="tagged-filter" title="Association Word">mutation</span> in p150Glued <span class="tagged-filter" title="Association Word">causes</span> both loss of <span class="tagged-gene" title="Protein Family or Complex">dynein</span>/<span class="tagged-gene" title="Protein Family or Complex">dynactin</span> function and gain of toxic function, which together <span class="tagged-filter" title="Association Word">lead</span> to motor neuron cell death.
motor_neuron_disease	Dynactin	True Positive	6.075	15852399	<strong class="title">Puls I, Oh SJ, Sumner CJ, Wallace KE, Floeter MK, Mann EA, Kennedy WR, Wendelschafer-Crabb G, Vortmeyer A, Powers R, Finnegan K, Holzbaur EL, Fischbeck KH, Ludlow CL: Distal spinal and bulbar <span class="tagged-disease" title="UMLS Concept ID: C0026846">muscular atrophy</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> <span class="tagged-filter" title="Association Word">mutation.</span> Ann Neurol. 2005 May;57(5):687-94.</strong> Impaired axonal transport has been postulated to play a <span class="tagged-filter" title="Association Word">role</span> in the pathophysiology of multiple <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders.</span> In this report, we describe the results of clinical and neuropathological studies in a family with an inherited form of <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-filter" title="Association Word">mutation</span> in the p150Glued subunit of <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> a microtubule motor <span class="tagged-filter" title="Association Word">protein</span> essential for retrograde axonal transport. Affected family members had a distinct clinical phenotype characterized by early bilateral vocal fold paralysis affecting the adductor and abductor laryngeal muscles. They later experienced weakness and atrophy in the face, hands, and distal legs. The extremity involvement was greater in the hands than in the legs, and it had a particular predilection for the thenar muscles. No clinical or electrophysiological sensory abnormality existed; however, skin biopsy results showed morphological abnormalities of epidermal nerve fibers. An autopsy study of one patient showed motor neuron degeneration and axonal loss in the ventral horn of the spinal cord and hypoglossal nucleus of the medulla. Immunohistochemistry showed abnormal inclusions of <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> and <span class="tagged-gene" title="Protein Family or Complex">dynein</span> in motor neurons. This <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> a ubiquitously <span class="tagged-filter" title="Association Word">expressed</span> <span class="tagged-filter" title="Association Word">protein,</span> <span class="tagged-filter" title="Association Word">causes</span> a unique pattern of motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> that is <span class="tagged-filter" title="Association Word">associated</span> with the accumulation of <span class="tagged-gene" title="Protein Family or Complex">dynein</span> and <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> in neuronal inclusions.
motor_neuron_disease	Dynactin	True Positive	6.075	15217349	<strong class="title">Bruijn LI, Miller TM, Cleveland DW: Unraveling the mechanisms <span class="tagged-filter" title="Association Word">involved</span> in motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in ALS. Annu Rev Neurosci. 2004;27:723-49.</strong> Although Charcot described <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) more than 130 years ago, the mechanism underlying the characteristic selective degeneration and death of motor neurons in this common adult <span class="tagged-query" title="Query">motor neuron disease</span> has remained a mystery. There is no effective remedy for this progressive, fatal disorder. Modern genetics has now identified <span class="tagged-filter" title="Association Word">mutations</span> in one <span class="tagged-filter" title="Association Word">gene</span> [Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)]</a></span> as a primary <span class="tagged-filter" title="Association Word">cause</span> and implicated others [encoding neurofilaments, cytoplasmic dynein and its processivity factor <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> and <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">(VEGF)]</a></span> as contributors to, or <span class="tagged-filter" title="Association Word">causes</span> of, <span class="tagged-query" title="Query">motor neuron diseases.</span> These insights have enabled development of model systems to test hypotheses of disease mechanism and potential therapies. Along with errors in the handling of synaptic <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> and the potential excitotoxic response this provokes, these model systems highlight the involvement of nonneuronal cells in disease progression and provide new therapeutic strategies.
motor_neuron_disease	Dynactin	True Positive	6.075	12627231	<strong class="title">Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH Jr, Ludlow CL, Fischbeck KH: Mutant <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> in <span class="tagged-query" title="Query">motor neuron disease.</span> Nat Genet. 2003 Apr;33(4):455-6. Epub 2003 Mar 10.</strong> Impaired axonal transport in motor neurons has been proposed as a mechanism for neuronal degeneration in <span class="tagged-query" title="Query">motor neuron disease.</span> Here we show <span class="tagged-filter" title="Association Word">linkage</span> of a <span class="tagged-disease" title="UMLS Concept ID: C0270764">lower motor neuron disease</span> to a region of 4 Mb at chromosome 2p13. <span class="tagged-filter" title="Association Word">Mutation</span> analysis of a <span class="tagged-filter" title="Association Word">gene</span> in this interval that encodes the largest subunit of the axonal transport <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="Protein Family or Complex">dynactin</span> showed a single base-pair change resulting in an amino-acid substitution that is predicted to distort the folding of dynactin's microtubule-binding domain. Binding assays show decreased binding of the mutant <span class="tagged-filter" title="Association Word">protein</span> to microtubules. Our results show that dysfunction of <span class="tagged-gene" title="Protein Family or Complex">dynactin</span>-mediated transport can <span class="tagged-filter" title="Association Word">lead</span> to human <span class="tagged-query" title="Query">motor neuron disease.</span>
motor_neuron_disease	glutaredoxin	True Negative	1.441	17512091	<strong class="title">Diwakar L, Kenchappa RS, Annepu J, Ravindranath V: Downregulation of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> but not <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> loss <span class="tagged-filter" title="Association Word">leads</span> to mitochondrial dysfunction in female mice CNS: Implications in excitotoxicity. Neurochem Int. 2007 Jul;51(1):37-46. Epub 2007 Apr 5.</strong> Oxidative stress, excitotoxicity and mitochondrial dysfunction play synergistic <span class="tagged-filter" title="Association Word">roles</span> in <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration.</span> Maintenance of thiol homeostasis is important for normal mitochondrial function and dysregulation of <span class="tagged-filter" title="Association Word">protein</span> thiol homeostasis by oxidative stress <span class="tagged-filter" title="Association Word">leads</span> to mitochondrial dysfunction and <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration.</span> We examined the critical <span class="tagged-filter" title="Association Word">roles</span> played by the antioxidant, non-<span class="tagged-filter" title="Association Word">protein</span> thiol, <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span> and <span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">enzyme,</span> <a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in maintaining mitochondrial function during excitotoxicity <span class="tagged-filter" title="Association Word">caused</span> by beta-N-oxalyl amino-<span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">l-alanine</a></span> (l-BOAA), the causative factor of neurolathyrism, a <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">involving</span> the pyramidal system. l-BOAA <span class="tagged-filter" title="Association Word">causes</span> loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> and inhibition of mitochondrial <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C1535036">lumbosacral</span> cord of male mice through oxidation of thiol groups, while female mice are resistant. Reducing <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> levels in female mice CNS by pretreatment with diethyl <span class="tagged-metabolite" title="HMDB: HMDB00176"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00176">maleate</a></span> or l-propargyl <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span> did not result in inhibition of <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity,</span> unlike male mice. Further, treatment of female mice depleted of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> with l-BOAA did not induce inhibition of <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> indicating that <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> levels were not critical for maintaining <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> in female mice unlike their male counterpart. <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">Glutaredoxin,</a></span> a thiol disulfide <span class="tagged-gene" title="SwissProt ID: O14756; Entrez Gene ID: 8630; HGNC ID: 23316; HPRD ID: 09431; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14756">oxidoreductase</a></span> helps maintain redox status of <span class="tagged-filter" title="Association Word">proteins</span> and downregulation of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> results in loss of mitochondrial <span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity.</span> Female mice express higher levels of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in certain CNS regions and downregulation of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> using antisense oligonucleotides sensitizes them to l-BOAA toxicity seen as mitochondrial <span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> loss. Ovariectomy downregulates <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> and renders female mice vulnerable to l-BOAA toxicity as evidenced by activation of <span class="tagged-gene" title="SwissProt ID: P05412; Entrez Gene ID: 3725; HGNC ID: 6204; HPRD ID: 01302; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05412">AP1,</a></span> loss of <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: Q16795; Entrez Gene ID: 4704; HGNC ID: 7693; HPRD ID: 04832; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">GSH</a></span> and <a href="http://beta.uniprot.org/uniprot/Q16795">complex I</a></span> <span class="tagged-filter" title="Association Word">activity</span> indicating the important <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in neuroprotection. <span class="tagged-metabolite" title="HMDB: HMDB01926"><span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01926">Estrogen</a></span> protects against mitochondrial dysfunction <span class="tagged-filter" title="Association Word">caused</span> by excitotoxicity by maintaining cellular redox status through higher constitutive <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> in the CNS. Therapeutic interventions designed to upregulate <span class="tagged-gene" title="SwissProt ID: P35754; Entrez Gene ID: 2745; HGNC ID: 4330; HPRD ID: 02707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35754">glutaredoxin</a></span> may offer neuroprotection against excitotoxicity in motor neurons.
motor_neuron_disease	Apolipoprotein	True Negative	1.441	10833320	<strong class="title">Pickering-Brown SM, Owen F, Isaacs A, Snowden J, Varma A, Neary D, Furlong R, Daniel SE, Cairns NJ, Mann DM: <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">Apolipoprotein E</a></span> epsilon4 allele has no effect on age at onset or duration of disease in cases of <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> with pick- or microvacuolar-type histology. Exp Neurol. 2000 Jun;163(2):452-6.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0338451">Frontotemporal dementia</span> (FTD) is the second most common <span class="tagged-filter" title="Association Word">cause</span> of <span class="tagged-disease" title="UMLS Concept ID: C0011265">presenile dementia.</span> Here we have investigated the frequency of the epsilon4 allele of the <span class="tagged-gene" title="SwissProt ID: Q16609; Entrez Gene ID: 80350; HGNC ID: 21210; HPRD ID: 17441; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16609">Apolipoprotein</a></span> <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">(APOE)</a></span> <span class="tagged-filter" title="Association Word">gene</span> in FTD and in other non-Alzheimer forms of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> <span class="tagged-filter" title="Association Word">related</span> to FTD such as <span class="tagged-query" title="Query">Motor Neurone disease</span> <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0338462">semantic dementia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0338457">progressive aphasia,</span> <span class="tagged-disease" title="UMLS Concept ID: C0038868">progressive supranuclear palsy,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0393570">corticobasal degeneration.</span> In none of these diagnostic groups did we find a significant increase in the <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">APOE</a></span> epsilon4 allelic frequency, compared to population values. Neither did we <span class="tagged-filter" title="Association Word">observe</span> any affects of the epsilon4 allele upon age at onset or duration of disease. We conclude therefore that <span class="tagged-filter" title="Association Word">polymorphic</span> variations in the <span class="tagged-gene" title="SwissProt ID: P02649; Entrez Gene ID: 348; HGNC ID: 613; HPRD ID: 00135; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02649">APOE</a></span> <span class="tagged-filter" title="Association Word">gene</span> do not modulate either the occurrence or progression of these non-Alzheimer forms of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span>
motor_neuron_disease	Gemin6	True Positive	1.441	15843395	<strong class="title">Feng W, Gubitz AK, Wan L, Battle DJ, Dostie J, Golembe TJ, Dreyfuss G: Gemins modulate the <span class="tagged-filter" title="Association Word">expression</span> and <span class="tagged-filter" title="Association Word">activity</span> of the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex. Hum Mol Genet. 2005 Jun 15;14(12):1605-11. Epub 2005 Apr 20.</strong> Reduction in the <span class="tagged-filter" title="Association Word">expression</span> of the survival of motor neurons <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">(SMN)</a></span> <span class="tagged-filter" title="Association Word">protein</span> results in <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA),</a></span> a common motor neuron <span class="tagged-disease" title="UMLS Concept ID: C1285162">degenerative disease.</span> <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> is part of a large macromolecular complex (the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex) that includes at least six additional <span class="tagged-filter" title="Association Word">proteins</span> called Gemins <span class="tagged-gene" title="SwissProt ID: O14893; Entrez Gene ID: 8487; HGNC ID: 10884; HPRD ID: 03999; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14893">(Gemin2</a></span>-7). The <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex is <span class="tagged-filter" title="Association Word">expressed</span> in all cells and is present throughout the cytoplasm and in the nucleus where it is concentrated in Gems. The <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex plays an essential <span class="tagged-filter" title="Association Word">role</span> in the <span class="tagged-filter" title="Association Word">production</span> of spliceosomal small nuclear ribonucleoproteins (snRNPs) and likely other RNPs. To study the <span class="tagged-filter" title="Association Word">roles</span> of the individual <span class="tagged-filter" title="Association Word">proteins,</span> we systematically reduced the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> and each of the Gemins (2-6) by RNA interference. We show that the reduction of <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">leads</span> to a decrease in <span class="tagged-gene" title="SwissProt ID: Q9Y333; Entrez Gene ID: 57819; HGNC ID: 13940; HPRD ID: 06282; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y333">snRNP</a></span> assembly, the disappearance of Gems, and to a drastic reduction in the amounts of several Gemins. Moreover, reduction of <span class="tagged-gene" title="SwissProt ID: O14893; Entrez Gene ID: 8487; HGNC ID: 10884; HPRD ID: 03999; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14893">Gemin2</a></span> or <span class="tagged-gene" title="SwissProt ID: Q8WXD5; Entrez Gene ID: 79833; HGNC ID: 20044; HPRD ID: 06110; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WXD5">Gemin6</a></span> strongly decreases the <span class="tagged-filter" title="Association Word">activity</span> of the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex. These findings demonstrate that other components of the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> complex, in addition to <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN,</a></span> are critical for the <span class="tagged-filter" title="Association Word">activity</span> of the complex and suggest that <span class="tagged-gene" title="SwissProt ID: O14893; Entrez Gene ID: 8487; HGNC ID: 10884; HPRD ID: 03999; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O14893">Gemin2</a></span> and <span class="tagged-gene" title="SwissProt ID: Q8WXD5; Entrez Gene ID: 79833; HGNC ID: 20044; HPRD ID: 06110; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WXD5">Gemin6</a></span> are potentially important modifiers of <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> as well as potential disease <span class="tagged-filter" title="Association Word">genes</span> for non-<span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	phosphatidylinositol-3-kinase	True Positive	3.579	11311806	<strong class="title">Wagey R, Lurot S, Perrelet D, Pelech SL, Sagot Y, Krieger C: <span class="tagged-gene" title="Protein Family or Complex">Phosphatidylinositol 3-kinase</span> <span class="tagged-filter" title="Association Word">activity</span> in murine <span class="tagged-query" title="Query">motoneuron disease:</span> the progressive <span class="tagged-disease" title="UMLS Concept ID: C0235025">motor neuropathy</span> mouse. Neuroscience. 2001;103(1):257-66.</strong> A murine model of <span class="tagged-query" title="Query">motoneuron disease,</span> the pmn/pmn mouse, shows a reduction in the retrograde transport of fluorescent probes applied directly onto the cut end of sciatic nerve. <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">Brain-derived neurotrophic factor</a></span> <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">(BDNF),</a></span> when co-applied with fluorescent tracers, increases the number of retrograde labelled motoneurons. We demonstrate here that spinal cord tissue from pmn/pmn mice had significantly reduced <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> <span class="tagged-filter" title="Association Word">activity</span> and <span class="tagged-filter" title="Association Word">expression</span> in the particulate fraction compared to controls, without changes in the activities or <span class="tagged-filter" title="Association Word">expression</span> of the downstream kinases, <span class="tagged-gene" title="SwissProt ID: P31749; Entrez Gene ID: 207; HGNC ID: 391; HPRD ID: 01261; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P31749">protein kinase B</a></span>/Akt or <span class="tagged-gene" title="SwissProt ID: P27361; Entrez Gene ID: 5595; HGNC ID: 6877; HPRD ID: 03479; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27361">Erk1.</a></span> Systemic administration of <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> augmented <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> specific <span class="tagged-filter" title="Association Word">activity</span> in spinal cord tissue from pmn/pmn and control mice, with a greater elevation in the particulate fractions of pmn/pmn mice than in controls. We examined the effect of inhibitors of <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> and <span class="tagged-gene" title="Protein Family or Complex">mitogen-activated protein kinase</span> kinase on the retrograde labelling of motoneurons, 24h following the direct application of inhibitors and Fluorogold to the cut end of sciatic nerve in control and pmn/pmn mice (labelling index). The <span class="tagged-gene" title="Protein Family or Complex">mitogen-activated protein kinase</span> kinase inhibitor PD 98059 had no effect on the labelling index in control or pmn/pmn mice. In the <span class="tagged-filter" title="Association Word">absence</span> of exogenous <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF,</a></span> <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> inhibitors reduced the number of labelled motoneurons in control mice, without changing the labelling index in pmn/pmn. Co-application of <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> inhibitors with <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> to the cut end of sciatic nerve blocked the action of <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> on retrograde labelling in pmn/pmn mice. These results indicate that the retrograde labelling of motoneurons is mediated by <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span>-dependent and -independent pathways. In pmn/pmn mice, <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> <span class="tagged-filter" title="Association Word">activity</span> in spinal neurons is below the level required for optimal retrograde labelling of motoneurons and labelling can be augmented by the administration of growth factors stimulating <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> <span class="tagged-filter" title="Association Word">activity.</span> The data indicate that <span class="tagged-gene" title="Protein Family or Complex">phosphatidylinositol 3-kinase</span> <span class="tagged-filter" title="Association Word">activity</span> is important in the uptake and/or retrograde transport of substances by motoneurons and is <span class="tagged-filter" title="Association Word">altered</span> in this model of motoneuron diseases.
motor_neuron_disease	DYNC1H1	True Negative	1.441	16546759	<strong class="title">Shah PR, Ahmad-Annuar A, Ahmadi KR, Russ C, Sapp PC, Horvitz HR, Brown RH Jr, Goldstein DB, Fisher EM: No <span class="tagged-filter" title="Association Word">association</span> of <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> with sporadic ALS in a case-control study of a northern European derived population: a tagging <span class="tagged-filter" title="Association Word">SNP</span> approach. Amyotroph Lateral Scler. 2006 Mar;7(1):46-56.</strong> The cytoplasmic <span class="tagged-gene" title="Protein Family or Complex">dynein</span>-<span class="tagged-gene" title="Protein Family or Complex">dynactin</span> complex has been implicated in the aetiology of motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in both mouse models and human forms of <span class="tagged-query" title="Query">motor neuron disease.</span> We have previously shown that <span class="tagged-filter" title="Association Word">mutations</span> in the cytoplasmic <span class="tagged-gene" title="Protein Family or Complex">dynein</span> 1 heavy chain 1 <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(Dync1h1)</a></span> are causal in a mouse model of late-onset motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> but have found no <span class="tagged-filter" title="Association Word">association</span> of the homologous sites in human <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> with human <span class="tagged-query" title="Query">motor neuron disease.</span> Here we extend these analyses to investigate the <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> genomic <span class="tagged-filter" title="Association Word">locus</span> to determine if it is <span class="tagged-filter" title="Association Word">associated</span> with sporadic <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) in a northern European-derived population. Among the 16 single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> <span class="tagged-filter" title="Association Word">(SNPs)</span> we examined, just two <span class="tagged-filter" title="Association Word">SNPs</span> (rs2251644 and rs941793) were sufficient to tag the majority of haplotypic variation (r2 > or = 0.85) and these were tested in a case-control <span class="tagged-filter" title="Association Word">association</span> study with 266 North American sporadic ALS patients and 225 matched controls. We found no <span class="tagged-filter" title="Association Word">association</span> between genetic variation at <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> and sporadic ALS (rs2251644; p = 0.538, rs941793; p = 0.204, haplotype; p = 0.956). In addition we investigated patterns of diversity at <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DYNC1H1</a></span> in Japanese and Cameroonian populations to establish the evolutionary history for this <span class="tagged-filter" title="Association Word">gene</span> and <span class="tagged-filter" title="Association Word">observed</span> reduced genetic diversity in the northern Europeans suggestive of selection at this <span class="tagged-filter" title="Association Word">locus.</span>
motor_neuron_disease	DYNC1H1	True Negative	1.441	13129801	<strong class="title">Ahmad-Annuar A, Shah P, Hafezparast M, Hummerich H, Witherden AS, Morrison KE, Shaw PJ, Kirby J, Warner TT, Crosby A, Proukakis C, Wilkinson P, Orrell RW, Bradley L, Martin JE, Fisher EM: No <span class="tagged-filter" title="Association Word">association</span> with common Caucasian genotypes in exons 8, 13 and 14 of the human <span class="tagged-gene" title="SwissProt ID: O00432; Entrez Gene ID: 79659; HGNC ID: 2962; HPRD ID: 10344; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00432">cytoplasmic dynein heavy chain</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(DNCHC1)</a></span> and familial motor neuron disorders. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):150-7.</strong> We have shown in a mouse model of <span class="tagged-query" title="Query">motor neuron disease,</span> the legs-at-odd-angles (Loa) mutant, and that <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: O00432; Entrez Gene ID: 79659; HGNC ID: 2962; HPRD ID: 10344; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00432">cytoplasmic dynein heavy chain</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(Dnchc1)</a></span> <span class="tagged-filter" title="Association Word">cause</span> motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> Mice exhibiting the Loa phenotype suffer progressive loss of locomotor function and homozygous animals have neuronal inclusion bodies that are positive for <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1,</a></span> <span class="tagged-gene" title="SwissProt ID: Q00535; Entrez Gene ID: 1020; HGNC ID: 1774; HPRD ID: 00449; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q00535">CDK5,</a></span> neurofilament and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> <span class="tagged-filter" title="Association Word">proteins.</span> As this phenotype models some aspects of human motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> disorders, we think there is a reasonable likelihood that <span class="tagged-gene" title="Protein Family or Complex">dynein</span> may be a causative <span class="tagged-filter" title="Association Word">gene</span> or susceptibility factor in human <span class="tagged-query" title="Query">motor neuron disease.</span> Therefore we have screened exons of this <span class="tagged-filter" title="Association Word">gene</span> in a set of human patients with familial forms of disparate motor neuron degeneration diseases, affecting both upper and lower motor neurons: <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS), <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA),</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0037773">hereditary spastic paraplegia.</span> As part of this study, we have determined that <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DNCHC1</a></span> is a large <span class="tagged-filter" title="Association Word">gene</span> of 78 exons spanning 86 kb genomic length. We have focused on the exons known to be <span class="tagged-filter" title="Association Word">mutated</span> in Loa, and in a very similar mouse <span class="tagged-filter" title="Association Word">mutation,</span> cramping 1 (Cra1); both <span class="tagged-filter" title="Association Word">mutations</span> result in loss of anterior horn cells. The exons studied are highly conserved in a wide range of eukaryotes. We screened our patient samples by sequencing and although we detect single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms,</span> our results show these occur at the same frequency in our patient group as in control samples of unaffected individuals. Therefore we do not find any <span class="tagged-filter" title="Association Word">association</span> between <span class="tagged-disease" title="UMLS Concept ID: C0270763">familial motor neuron disease</span> and the genotypes presented here in the exons screened.
motor_neuron_disease	cytoplasmic-dynein-heavy-chain	True Negative	1.441	13129801	<strong class="title">Ahmad-Annuar A, Shah P, Hafezparast M, Hummerich H, Witherden AS, Morrison KE, Shaw PJ, Kirby J, Warner TT, Crosby A, Proukakis C, Wilkinson P, Orrell RW, Bradley L, Martin JE, Fisher EM: No <span class="tagged-filter" title="Association Word">association</span> with common Caucasian genotypes in exons 8, 13 and 14 of the human <span class="tagged-gene" title="SwissProt ID: O00432; Entrez Gene ID: 79659; HGNC ID: 2962; HPRD ID: 10344; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00432">cytoplasmic dynein heavy chain</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(DNCHC1)</a></span> and familial motor neuron disorders. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):150-7.</strong> We have shown in a mouse model of <span class="tagged-query" title="Query">motor neuron disease,</span> the legs-at-odd-angles (Loa) mutant, and that <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: O00432; Entrez Gene ID: 79659; HGNC ID: 2962; HPRD ID: 10344; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00432">cytoplasmic dynein heavy chain</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">(Dnchc1)</a></span> <span class="tagged-filter" title="Association Word">cause</span> motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> Mice exhibiting the Loa phenotype suffer progressive loss of locomotor function and homozygous animals have neuronal inclusion bodies that are positive for <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1,</a></span> <span class="tagged-gene" title="SwissProt ID: Q00535; Entrez Gene ID: 1020; HGNC ID: 1774; HPRD ID: 00449; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q00535">CDK5,</a></span> neurofilament and <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span> <span class="tagged-filter" title="Association Word">proteins.</span> As this phenotype models some aspects of human motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> disorders, we think there is a reasonable likelihood that <span class="tagged-gene" title="Protein Family or Complex">dynein</span> may be a causative <span class="tagged-filter" title="Association Word">gene</span> or susceptibility factor in human <span class="tagged-query" title="Query">motor neuron disease.</span> Therefore we have screened exons of this <span class="tagged-filter" title="Association Word">gene</span> in a set of human patients with familial forms of disparate motor neuron degeneration diseases, affecting both upper and lower motor neurons: <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS), <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA),</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0037773">hereditary spastic paraplegia.</span> As part of this study, we have determined that <span class="tagged-gene" title="SwissProt ID: Q14204; Entrez Gene ID: 1778; HGNC ID: 2961; HPRD ID: 02524; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14204">DNCHC1</a></span> is a large <span class="tagged-filter" title="Association Word">gene</span> of 78 exons spanning 86 kb genomic length. We have focused on the exons known to be <span class="tagged-filter" title="Association Word">mutated</span> in Loa, and in a very similar mouse <span class="tagged-filter" title="Association Word">mutation,</span> cramping 1 (Cra1); both <span class="tagged-filter" title="Association Word">mutations</span> result in loss of anterior horn cells. The exons studied are highly conserved in a wide range of eukaryotes. We screened our patient samples by sequencing and although we detect single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms,</span> our results show these occur at the same frequency in our patient group as in control samples of unaffected individuals. Therefore we do not find any <span class="tagged-filter" title="Association Word">association</span> between <span class="tagged-disease" title="UMLS Concept ID: C0270763">familial motor neuron disease</span> and the genotypes presented here in the exons screened.
motor_neuron_disease	nNOS	False Negative	1.441	12200626	<strong class="title">Baxter RG, Martin JE, Pullen AH: Reduced neuronal <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P29475; Entrez Gene ID: 4842; HGNC ID: 7872; HPRD ID: 01226; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <a href="http://beta.uniprot.org/uniprot/P29475">(NOS1)</a></span> <span class="tagged-filter" title="Association Word">antigen</span> in sacral motor neurones in <span class="tagged-query" title="Query">motor neurone disease.</span> Acta Neuropathol. 2002 Oct;104(4):391-7. Epub 2002 Jun 26.</strong> Immunocytochemistry and microdensitometry applied under standardised conditions were used to evaluate neuronal nitric oxide synthase <span class="tagged-gene" title="SwissProt ID: P29475; Entrez Gene ID: 4842; HGNC ID: 7872; HPRD ID: 01226; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29475">(NOS1)</a></span> <span class="tagged-filter" title="Association Word">antigen</span> in segmental motor neurones (MN) of six subjects without <span class="tagged-disease" title="UMLS Concept ID: C0027765">neurological disease,</span> nine subjects with sporadic <span class="tagged-query" title="Query">motor neurone disease</span> (MND) and five with <span class="tagged-disease" title="UMLS Concept ID: C0027765">neurological disease</span> unrelated to MND. No significant segmental differences in levels of <span class="tagged-gene" title="SwissProt ID: P29475; Entrez Gene ID: 4842; HGNC ID: 7872; HPRD ID: 01226; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29475">NOS1</a></span> immunoreactivity occurred between the two control groups, and differences between cervical, thoracic and lumbar MN of the three subject groups were not significant. However, MND patients showed a significantly reduced level of <span class="tagged-gene" title="SwissProt ID: P29475; Entrez Gene ID: 4842; HGNC ID: 7872; HPRD ID: 01226; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29475">NOS1</a></span> immunoreactivity in the Onuf's nucleus (ON); this is discussed in relation to neuroprotection and the relative sparing of ON in MND.
motor_neuron_disease	Bcl-2	True Negative	1.441	12699624	<strong class="title">Ferri A, Sanes JR, Coleman MP, Cunningham JM, Kato AC: Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of <span class="tagged-query" title="Query">motoneuron disease.</span> Curr Biol. 2003 Apr 15;13(8):669-73.</strong> Apoptosis is a hallmark of motoneuron diseases such as <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and <span class="tagged-disease" title="UMLS Concept ID: C0026847">spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> [1]. In a widely used mouse model of <span class="tagged-query" title="Query">motoneuron disease</span> (progressive <span class="tagged-disease" title="UMLS Concept ID: Not Available">motor neuronopathy</span> or pmn) [2-4], transgenic <span class="tagged-filter" title="Association Word">expression</span> of the anti-apoptotic <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">bcl-2</a></span> <span class="tagged-filter" title="Association Word">gene</span> [5] or treatment with <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">glial cell-derived neurotrophic factor</a></span> [6] prevents the apoptosis of the motoneuron soma; however, they were unable to affect the life span of the animals. The goal of the present work was to determine whether the pmn phenotype could be rescued by means of a <span class="tagged-filter" title="Association Word">gene</span> that inhibits axon degeneration. For this reason, the pmn mice were crossed with mice bearing the <span class="tagged-filter" title="Association Word">dominant</span> Wlds ("slow <span class="tagged-disease" title="UMLS Concept ID: C0043020">Wallerian degeneration")</span> <span class="tagged-filter" title="Association Word">mutation,</span> which slows axon degeneration and synapse loss [7-9]. We show here that the Wlds <span class="tagged-filter" title="Association Word">gene</span> product attenuates symptoms, extends life span, prevents axon degeneration, rescues motoneuron number and size, and delays retrograde transport deficits in pmn/pmn mice. These results suggest new pathogenic mechanisms and therapeutic avenues for motoneuron diseases.
motor_neuron_disease	Bcl-2	True Negative	1.441	11438832	<strong class="title">Yamashita S, Mita S, Arima T, Maeda Y, Kimura E, Nishida Y, Murakami T, Okado H, Uchino M: <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> by retrograde transport of adenoviral vectors with Cre-loxP recombination system in motor neurons of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mice. Gene Ther. 2001 Jul;8(13):977-86.</strong> We investigated <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">expression</span> by retrograde axonal transport of replication-defective adenoviruses carrying <span class="tagged-filter" title="Association Word">genes</span> for LacZ (AdLacZ) and <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> in motor neurons of transgenic mice expressing mutant human Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> containing a substitution of <span class="tagged-metabolite" title="HMDB: HMDB00161"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> for <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span> at position 93. We found that intramuscular injection of AdLacZ into the tongue of mutant <a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mice and their wild-type littermates at various ages results in high <span class="tagged-filter" title="Association Word">expression</span> of the transgene and similar time course of <span class="tagged-filter" title="Association Word">expression</span> in hypoglossal cranial nerve nuclei, suggesting no difference in the behavior of the transgene <span class="tagged-filter" title="Association Word">expression</span> between the two groups. Subsequently, we employed a molecular switching cassette for <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> designed to express <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> by Cre-loxP recombination using adenoviral vectors, and examined the COS7 and primary neuronal cells with the mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">gene.</span> The overexpression of <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> in both cells and the neuronal protection against staurosporine-induced apoptosis were <span class="tagged-filter" title="Association Word">observed,</span> after dual infection of adenoviral vectors with cassette for <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> (AxCALNLBcl-2) and Cre recombinase (AxCANCre). After inoculation of AxCALNLBcl-2 followed by AxCANCre into the tongue of both mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> transgenic mice and wild-type littermates, <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> was detected in both the injection site and the hypoglossal nuclei of brainstems, suggesting that this was the result of retrograde transport of AxCALNLBcl-2 and AxCANCre and <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> by Cre recombinase in the hypoglossal nuclei. This strategy for delivery of exogenous <span class="tagged-filter" title="Association Word">genes</span> such as <span class="tagged-gene" title="SwissProt ID: P10415; Entrez Gene ID: 596; HGNC ID: 990; HPRD ID: 01045; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10415">Bcl-2</a></span> will be useful for studying neuronal death/survival and introducing foreign <span class="tagged-filter" title="Association Word">genes</span> into postmitotic motor neurons, and in <span class="tagged-filter" title="Association Word">gene</span> therapy for <span class="tagged-query" title="Query">motor neuron diseases</span> such as ALS.
motor_neuron_disease	Survival-of-Motor-Neuron	True Positive	1.441	16118268	<strong class="title">Olaso R, Joshi V, Fernandez J, Roblot N, Courageot S, Bonnefont JP, Melki J: Activation of RNA metabolism-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes</span> in mouse but not human tissues <span class="tagged-filter" title="Association Word">deficient</span> in <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN.</a></span> Physiol Genomics. 2006 Jan 12;24(2):97-104. Epub 2005 Aug 23.</strong> <span class="tagged-filter" title="Association Word">Mutations</span> of the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6606; HGNC ID: 11117; HPRD ID: 02646; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">survival of motor neuron</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6607; HGNC ID: 11118; HPRD ID: 09036; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">(SMN1)</a></span> are responsible for spinal <span class="tagged-disease" title="UMLS Concept ID: C0026846">muscular atrophies</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA),</a></span> a frequent <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-query" title="Query">motor neuron disease.</span> <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> is <span class="tagged-filter" title="Association Word">involved</span> in various processes including RNA metabolism. However, the molecular pathway linking marked <span class="tagged-filter" title="Association Word">deficiency</span> of <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> to <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> phenotype remains unclear. Homozygous deletion of murine Smn exon 7 directed to neurons or skeletal muscle <span class="tagged-filter" title="Association Word">causes</span> severe motor axonal or myofiber degeneration, respectively. With the use of cDNA microarrays, <span class="tagged-filter" title="Association Word">expression</span> profiles of 8,400 <span class="tagged-filter" title="Association Word">genes</span> were analyzed in skeletal muscle and spinal cord of muscular and neuronal mutants, respectively, and compared with age-matched controls. A high proportion of <span class="tagged-filter" title="Association Word">genes</span> (20 of 429, 5%) was <span class="tagged-filter" title="Association Word">involved</span> in pre-<span class="tagged-filter" title="Association Word">mRNA</span> splicing, ribosomal RNA processing, or RNA decay, and 18 of them were upregulated in mutant tissues. By analyzing other <span class="tagged-disease" title="UMLS Concept ID: C0027868">neuromuscular disorders,</span> we showed that most of them (14 of 18) were specific to the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> defect. Quantitative PCR analysis of these transcripts showed that <span class="tagged-filter" title="Association Word">gene</span> activation was an early adaptive response to the lack but not reduced amount of full-length <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> in mouse mutant tissues. In human <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span> tissues, activation of this program was not <span class="tagged-filter" title="Association Word">observed,</span> which could be ascribed to the reduction but not the <span class="tagged-filter" title="Association Word">absence</span> of full-length <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN.</a></span>
motor_neuron_disease	Survival-of-Motor-Neuron	False Negative	1.441	11135666	<strong class="title">Selenko P, Sprangers R, Stier G, Buhler D, Fischer U, Sattler M: <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> tudor domain structure and its interaction with the Sm <span class="tagged-filter" title="Association Word">proteins.</span> Nat Struct Biol. 2001 Jan;8(1):27-31.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0026847">Spinal muscular atrophy</span> <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">(SMA)</a></span> is a common <span class="tagged-query" title="Query">motor neuron disease</span> that results from <span class="tagged-filter" title="Association Word">mutations</span> in the <span class="tagged-gene" title="SwissProt ID: Q16637; Entrez Gene ID: 6606; HGNC ID: 11117; HPRD ID: 02646; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q16637">Survival of Motor Neuron</a></span> <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">(SMN)</a></span> <span class="tagged-filter" title="Association Word">gene.</span> The <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> <span class="tagged-filter" title="Association Word">protein</span> plays a crucial <span class="tagged-filter" title="Association Word">role</span> in the assembly of spliceosomal <span class="tagged-metabolite" title="HMDB: HMDB00296"><span class="tagged-gene" title="SwissProt ID: Q9Y333; Entrez Gene ID: 57819; HGNC ID: 13940; HPRD ID: 06282; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00296">uridine</a></span>-rich small nuclear ribonucleoprotein (U <a href="http://beta.uniprot.org/uniprot/Q9Y333">snRNP)</a></span> complexes via binding to the spliceosomal Sm core <span class="tagged-filter" title="Association Word">proteins.</span> <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> contains a central Tudor domain that facilitates the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span>-Sm <span class="tagged-filter" title="Association Word">protein</span> interaction. A <span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA</a></span>-<span class="tagged-filter" title="Association Word">causing</span> point <span class="tagged-filter" title="Association Word">mutation</span> (E134K) within the <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN</a></span> Tudor domain prevents Sm binding. Here, we have determined the three-dimensional structure of the Tudor domain of human <span class="tagged-gene" title="SwissProt ID: P16949; Entrez Gene ID: 3925; HGNC ID: 6510; HPRD ID: 01047; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16949">SMN.</a></span> The structure exhibits a conserved negatively charged surface that is shown to interact with the C-terminal <span class="tagged-metabolite" title="HMDB: HMDB00517"><span class="tagged-gene" title="Entrez Gene ID: 6592; HGNC ID: 11096; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00517">Arg</a></span> and Gly-rich tails of Sm <span class="tagged-filter" title="Association Word">proteins.</span> The E134K <span class="tagged-filter" title="Association Word">mutation</span> does not disrupt the Tudor structure but affects the charge distribution within this binding site. An intriguing structural similarity between the Tudor domain and the Sm <span class="tagged-filter" title="Association Word">proteins</span> suggests the presence of an additional binding interface that resembles that in hetero-oligomeric complexes of Sm <span class="tagged-filter" title="Association Word">proteins.</span> Our data provide a structural basis for a molecular defect underlying <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6592">SMA.</a></span>
motor_neuron_disease	92-kDa-gelatinase	True Positive	1.441	15729130	<strong class="title">Dewil M, Schurmans C, Starckx S, Opdenakker G, Van Den Bosch L, Robberecht W: <span class="tagged-filter" title="Association Word">Role</span> of <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">matrix metalloproteinase-9</a></span> in a mouse model for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Neuroreport. 2005 Mar 15;16(4):321-4.</strong> The pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> remains poorly understood, but microglial and astroglial activation are thought to contribute to motor neuron death. Evidence suggests that <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">matrix metalloproteinase-9</a></span> <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">(MMP-9)</a></span> is a mediator of this deleterious effect. In this study, we evaluated the effect of <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">MMP-9</a></span> on the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Although marked microglial and astroglial proliferation was seen in the spinal cord and in-vitro studies proved <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">MMP-9</a></span> to be <span class="tagged-filter" title="Association Word">produced</span> by these cells, deletion of the <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">MMP-9</a></span> <span class="tagged-filter" title="Association Word">gene</span> in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G93A) mice accelerated rather than delayed the <span class="tagged-query" title="Query">motor neuron disease</span> and significantly reduced survival. Our results suggest that the effect of <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">MMP-9</a></span> on mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase-1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)</a></span>-induced <span class="tagged-query" title="Query">motor neuron disease</span> is protective rather than hazardous. Therefore, the effect of pharmacological inhibition of <span class="tagged-gene" title="SwissProt ID: P14780; Entrez Gene ID: 4318; HGNC ID: 7176; HPRD ID: 00387; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14780">MMP-9</a></span> <span class="tagged-filter" title="Association Word">activity</span> is unlikely to be of therapeutical benefit in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span>
motor_neuron_disease	LCCS	True Negative	1.441	17443787	<strong class="title">Pakkasjarvi N, Kerosuo L, Nousiainen H, Gentile M, Saharinen J, Suhonen S, Sariola H, Peltonen L, Kestila M, Wartiovaara K: Neural precursor cells from a fatal human <span class="tagged-query" title="Query">motoneuron disease</span> differentiate despite aberrant gene expression. Dev Neurobiol. 2007 Feb 15;67(3):270-84.</strong> Precursor cells of the human central nervous system can be cultured in vitro to reveal pathogenesis of diseases or developmental disorders. Here, we have studied the biology of neural precursor cells (NPCs) from patients of <span class="tagged-disease" title="UMLS Concept ID: Not Available">lethal congenital contracture syndrome</span> <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">(LCCS),</a></span> a severe <span class="tagged-query" title="Query">motoneuron disease</span> <span class="tagged-filter" title="Association Word">leading</span> to prenatal death before the 32nd gestational week. <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">LCCS</a></span> fetuses are immobile because of a motoneuron defect, seen as degeneration of the anterior horn and descending tracts of the developing spinal cord. The genetic defect for the syndrome is unknown. We show that NPCs isolated postmortem from <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">LCCS</a></span> fetuses grow and are maintained in culture, but display increased cell cycle <span class="tagged-filter" title="Association Word">activity.</span> Global transcript analysis of undifferentiated <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">LCCS</a></span> precursor cells present with changes in <span class="tagged-gene" title="SwissProt ID: P01133; Entrez Gene ID: 1950; HGNC ID: 3229; HPRD ID: 00578; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01133">EGF</a></span>-<span class="tagged-filter" title="Association Word">related</span> signaling when compared with healthy age-matched human controls. Further, we show that <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">LCCS</a></span>-derived NPCs differentiate into cells of neuronal and glial lineage and that the initial differentiation is not accompanied by overt apoptosis. Cells expressing <span class="tagged-filter" title="Association Word">markers</span> <span class="tagged-gene" title="SwissProt ID: P61371; Entrez Gene ID: 3670; HGNC ID: 6132; HPRD ID: 02650; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61371">Islet-1</a></span> and Hb9 are also generated from the <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">LCCS</a></span> NPCs, suggesting that the pathogenic mechanism of <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">LCCS</a></span> does not directly affect the differentiation capacity or survival of the cells, but the <span class="tagged-filter" title="Association Word">absence</span> of motoneurons in <span class="tagged-gene" title="Entrez Gene ID: 8012; HGNC ID: 30995; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8012">LCCS</a></span> may be <span class="tagged-filter" title="Association Word">caused</span> by a noncell autonomous mechanism.
motor_neuron_disease	poliovirus-receptor	True Positive	1.441	15076773	<strong class="title">Saunderson R, Yu B, Trent RJ, Pamphlett R: A <span class="tagged-filter" title="Association Word">polymorphism</span> in the <span class="tagged-gene" title="SwissProt ID: P15151; Entrez Gene ID: 5817; HGNC ID: 9705; HPRD ID: 01434; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15151">poliovirus receptor</a></span> <span class="tagged-filter" title="Association Word">gene</span> differs in <span class="tagged-query" title="Query">motor neuron disease.</span> Neuroreport. 2004 Feb 9;15(2):383-6.</strong> Poliovirus has been implicated in the etiology of sporadic <span class="tagged-query" title="Query">motor neuron disease.</span> DNA <span class="tagged-filter" title="Association Word">polymorphisms</span> in the <span class="tagged-gene" title="SwissProt ID: P15151; Entrez Gene ID: 5817; HGNC ID: 9705; HPRD ID: 01434; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15151">poliovirus receptor</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P15151; Entrez Gene ID: 5817; HGNC ID: 9705; HPRD ID: 01434; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15151">(PVR)</a></span> are <span class="tagged-filter" title="Association Word">associated</span> with persistent poliovirus infection in cell culture. <span class="tagged-gene" title="SwissProt ID: P15151; Entrez Gene ID: 5817; HGNC ID: 9705; HPRD ID: 01434; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15151">PVR</a></span> DNA <span class="tagged-filter" title="Association Word">polymorphisms</span> were therefore studied in 110 cases of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> 30 cases of <span class="tagged-disease" title="UMLS Concept ID: C0917981">progressive muscular atrophy</span> (a disorder of lower motor neurons) and 280 normal controls. In exon 2 of <span class="tagged-gene" title="SwissProt ID: P15151; Entrez Gene ID: 5817; HGNC ID: 9705; HPRD ID: 01434; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15151">PVR</a></span> the heterozygous Ala67Thr change was detected in 20.0% of <span class="tagged-disease" title="UMLS Concept ID: C0917981">progressive muscular atrophy,</span> 11.8% of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> and 6.8% of control subjects. The frequency of the <span class="tagged-filter" title="Association Word">polymorphism</span> was significantly higher in patients with <span class="tagged-disease" title="UMLS Concept ID: C0917981">progressive muscular atrophy</span> than in controls. Differences in the <span class="tagged-gene" title="SwissProt ID: P15151; Entrez Gene ID: 5817; HGNC ID: 9705; HPRD ID: 01434; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15151">poliovirus receptor</a></span> <span class="tagged-filter" title="Association Word">gene</span> may result in slowly progressive <span class="tagged-disease" title="UMLS Concept ID: C0010827">viral cytopathic effects</span> that <span class="tagged-filter" title="Association Word">lead</span> to lower motor neuron forms of <span class="tagged-query" title="Query">motor neuron disease.</span>
motor_neuron_disease	Hsp70	True Negative	1.441	16184763	<strong class="title">Batulan Z, Nalbantoglu J, Durham HD: Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells. Cell Stress Chaperones. 2005 Autumn;10(3):185-96.</strong> Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to amplify the heat shock response in cell lines by increasing the binding of <span class="tagged-gene" title="SwissProt ID: Q00613; Entrez Gene ID: 3297; HGNC ID: 5224; HPRD ID: 00778; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q00613">heat shock transcription factor-1</a></span> to heat shock elements within heat shock <span class="tagged-filter" title="Association Word">gene</span> promoters. Because overexpression of the inducible heat shock <span class="tagged-filter" title="Association Word">protein</span> 70 <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">(Hsp70)</a></span> was neuroprotective in a culture model of <span class="tagged-query" title="Query">motor neuron disease,</span> this study investigated whether NSAIDs induce <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> and confer cytoprotection in motor neurons of dissociated spinal cord cultures exposed to various stresses. Two NSAIDs, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> and niflumic acid, lowered the temperature threshold for induction of <a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in glia but failed to do so in motor neurons. At concentrations that increased <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in heat shocked glial cells, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> failed to delay death of motor neurons exposed to <span class="tagged-disease" title="UMLS Concept ID: C0236832">hyperthermia,</span> paraquat-mediated oxidative stress, and <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> excitotoxicity. Neither <span class="tagged-metabolite" title="HMDB: HMDB00588"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> nor the <a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> inhibitor, niflumic acid, protected motor neurons from the toxicity of <span class="tagged-filter" title="Association Word">mutated</span> Cu/Zn-<span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD-1)</a></span> <span class="tagged-filter" title="Association Word">linked</span> to a familial form of the <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Thus, treatment with 2 types of NSAIDs failed to overcome the high threshold for the activation of heat shock response in motor neurons.
motor_neuron_disease	glutathione-S-transferase	False Positive	6.039	15341277	<strong class="title">Zherebtsova AL, Shadrina MI, Levitskii GN, Levintskaia NI, Alekhin AV, Slominskii PA, Skvortsova VI, Limborskaia SA: [Analysis of the <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> P1 <span class="tagged-filter" title="Association Word">gene</span> Ile105Val <span class="tagged-filter" title="Association Word">polymorphism</span> in the patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> from Russia]. Genetika. 2004 Jun;40(6):850-2.</strong> Ile105Val <span class="tagged-filter" title="Association Word">polymorphism</span> in exon 5 of <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> <span class="tagged-gene" title="SwissProt ID: P09211; Entrez Gene ID: 2950; HGNC ID: 4638; HPRD ID: 00614; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09211">(GSTP1)</a></span> <span class="tagged-filter" title="Association Word">gene</span> was examined in a group of patients with <span class="tagged-query" title="Query">motor neuron disease</span> (MND) and control sample. No statistically significant differences in the allele and genotype frequency distributions between the samples examined were demonstrated. We conclude that Ile105Val <span class="tagged-filter" title="Association Word">polymorphism</span> is not <span class="tagged-filter" title="Association Word">associated</span> with the risk of the disease development in the patients from Russia with sporadic form of MND.
motor_neuron_disease	glutathione-S-transferase	False Positive	6.039	12500684	<strong class="title">Shadrina MI, Kondrat'eva EA, Slominskii PA, Levitskaia NI, Levitskii GN, Skvortsova VA, Limborskaia SA: <span class="tagged-filter" title="Association Word">[Polymorphism</span> of <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> <span class="tagged-filter" title="Association Word">genes</span> M1 and T1 in patients with <span class="tagged-query" title="Query">motor neuron disease</span> from the city of Moscow]. Genetika. 2002 Nov;38(11):1566-8.</strong> Comparison of the frequency distributions of alleles, genotypes, and genotype combinations of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P09488; Entrez Gene ID: 2944; HGNC ID: 4632; HPRD ID: 00707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09488">GSTM1</a></span> and <span class="tagged-gene" title="SwissProt ID: P30711; Entrez Gene ID: 2952; HGNC ID: 4641; HPRD ID: 02700; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30711">GSTT1</a></span> did not show statistically significant differences between patients with <span class="tagged-query" title="Query">motor neuron disease</span> (MND) and a random sample from the Moscow population. Apparently, these <span class="tagged-filter" title="Association Word">genes</span> are not <span class="tagged-filter" title="Association Word">involved</span> in MND pathogenesis in these patients.
motor_neuron_disease	guanine-nucleotide-exchange-factor	True Negative	1.441	17239822	<strong class="title">Suzuki-Utsunomiya K, Hadano S, Otomo A, Kunita R, Mizumura H, Osuga H, Ikeda JE: <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-interactor, modulates <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-mediated endosome dynamics. Biochem Biophys Res Commun. 2007 Mar 9;354(2):491-7. Epub 2007 Jan 11.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> the causative <span class="tagged-filter" title="Association Word">gene</span> product for a number of <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases,</span> is a <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine-nucleotide exchange factor</a></span> for <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5,</a></span> and acts as a modulator for endosome dynamics. Recently, we have identified a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> homolog, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> which is highly homologous to the C-terminal half of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> In this study, we investigate the molecular features of <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> and its functional relationship with <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> A majority of <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is present as a homo-dimeric form, which can interact with the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-oligomer, resulting in the formation of the large <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> heteromeric complex. In cultured cells, overexpressed <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is colocalized with <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> onto membranous compartments. Further, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> dominantly suppresses the endosome enlargement induced by a constitutively active form of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> and results in an extensive perinuclear tubulo-membranous phenotype, which are dependent upon the <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span>-<span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> interaction. Collectively, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-interacting <span class="tagged-filter" title="Association Word">protein</span> and is implicated in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-mediated endosome dynamics.
motor_neuron_disease	interleukin-10	True Negative	1.441	16216944	<strong class="title">Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, Heinemann U, Zerr I: <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">Interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> levels are <span class="tagged-filter" title="Association Word">elevated</span> in the cerebrospinal fluid of patients with <span class="tagged-disease" title="UMLS Concept ID: C0022336">Creutzfeldt-Jakob disease.</span> Arch Neurol. 2005 Oct;62(10):1591-4.</strong> BACKGROUND: In <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases,</span> increasing attention has been focused on inflammatory mediators such as pro-inflammatory and anti-inflammatory cytokines and their potential influence in the process of <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration.</span> In <span class="tagged-disease" title="UMLS Concept ID: C0162534">prion diseases,</span> much data has been gained on the cell culture and animal disease models level, but only limited information is available on humans affected by <span class="tagged-disease" title="UMLS Concept ID: C0022336">Creutzfeldt-Jakob disease</span> <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">(CJD).</a></span> OBJECTIVE: To obtain data on anti-inflammatory cytokines <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> in the cerebrospinal fluid of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD,</a></span> patients with other <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia,</span> and nondemented neurological patients and controls. DESIGN: Cerebrospinal fluid samples were collected from <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> patients and control subjects, and concentrations of the anti-inflammatory cytokines <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> were determined using an <span class="tagged-filter" title="Association Word">enzyme</span>-<span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay. PATIENTS: Cerebrospinal fluid samples from 61 patients were analyzed. The group was composed of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> (n = 20), patients with other forms of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (n = 10), patients with <span class="tagged-query" title="Query">motoneuron disease</span> (n = 6), patients with <span class="tagged-disease" title="UMLS Concept ID: C0020258">normal pressure hydrocephalus</span> (n = 5), and control subjects (n = 20). RESULTS: <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">Interleukin 10</a></span> levels were significantly <span class="tagged-filter" title="Association Word">elevated</span> in the cerebrospinal fluid of <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> patients (median, 9.8 pg/mL). The elevation was significant to other <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (median, 7.9 pg/mL, P <.05), <span class="tagged-query" title="Query">motoneuron disease</span> (median, 7.9 pg/mL, P <.05), <span class="tagged-disease" title="UMLS Concept ID: C0020258">normal pressure hydrocephalus</span> (median, 7.0 pg/mL, P <.05), and controls (median, 1.3 pg/mL, P <.001). Levels of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> were significantly <span class="tagged-filter" title="Association Word">elevated</span> in cerebrospinal fluid of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> (median, 26.4 pg/mL) compared with control subjects (median, 6.2 pg/mL, P <.001) and patients with a <span class="tagged-query" title="Query">motoneuron disease</span> (median, 10.5 pg/mL, P <.001) CONCLUSIONS: <span class="tagged-filter" title="Association Word">Elevated</span> levels of the anti-inflammatory cytokines <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> in cerebrospinal fluid of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> are new findings. The data of the present study provide a clue toward the possible <span class="tagged-filter" title="Association Word">role</span> of cytokines as immunological modifiers in the neurodegenerative process of <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD.</a></span>
motor_neuron_disease	Interleukin-4	True Negative	1.441	16216944	<strong class="title">Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, Heinemann U, Zerr I: <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">Interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> levels are <span class="tagged-filter" title="Association Word">elevated</span> in the cerebrospinal fluid of patients with <span class="tagged-disease" title="UMLS Concept ID: C0022336">Creutzfeldt-Jakob disease.</span> Arch Neurol. 2005 Oct;62(10):1591-4.</strong> BACKGROUND: In <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative diseases,</span> increasing attention has been focused on inflammatory mediators such as pro-inflammatory and anti-inflammatory cytokines and their potential influence in the process of <span class="tagged-disease" title="UMLS Concept ID: C0027746">neurodegeneration.</span> In <span class="tagged-disease" title="UMLS Concept ID: C0162534">prion diseases,</span> much data has been gained on the cell culture and animal disease models level, but only limited information is available on humans affected by <span class="tagged-disease" title="UMLS Concept ID: C0022336">Creutzfeldt-Jakob disease</span> <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">(CJD).</a></span> OBJECTIVE: To obtain data on anti-inflammatory cytokines <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> in the cerebrospinal fluid of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD,</a></span> patients with other <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia,</span> and nondemented neurological patients and controls. DESIGN: Cerebrospinal fluid samples were collected from <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> patients and control subjects, and concentrations of the anti-inflammatory cytokines <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> were determined using an <span class="tagged-filter" title="Association Word">enzyme</span>-<span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay. PATIENTS: Cerebrospinal fluid samples from 61 patients were analyzed. The group was composed of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> (n = 20), patients with other forms of <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (n = 10), patients with <span class="tagged-query" title="Query">motoneuron disease</span> (n = 6), patients with <span class="tagged-disease" title="UMLS Concept ID: C0020258">normal pressure hydrocephalus</span> (n = 5), and control subjects (n = 20). RESULTS: <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">Interleukin 10</a></span> levels were significantly <span class="tagged-filter" title="Association Word">elevated</span> in the cerebrospinal fluid of <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> patients (median, 9.8 pg/mL). The elevation was significant to other <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (median, 7.9 pg/mL, P <.05), <span class="tagged-query" title="Query">motoneuron disease</span> (median, 7.9 pg/mL, P <.05), <span class="tagged-disease" title="UMLS Concept ID: C0020258">normal pressure hydrocephalus</span> (median, 7.0 pg/mL, P <.05), and controls (median, 1.3 pg/mL, P <.001). Levels of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> were significantly <span class="tagged-filter" title="Association Word">elevated</span> in cerebrospinal fluid of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> (median, 26.4 pg/mL) compared with control subjects (median, 6.2 pg/mL, P <.001) and patients with a <span class="tagged-query" title="Query">motoneuron disease</span> (median, 10.5 pg/mL, P <.001) CONCLUSIONS: <span class="tagged-filter" title="Association Word">Elevated</span> levels of the anti-inflammatory cytokines <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin 4</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin 10</a></span> in cerebrospinal fluid of patients with <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD</a></span> are new findings. The data of the present study provide a clue toward the possible <span class="tagged-filter" title="Association Word">role</span> of cytokines as immunological modifiers in the neurodegenerative process of <span class="tagged-gene" title="SwissProt ID: P04156; Entrez Gene ID: 5621; HGNC ID: 9449; HPRD ID: 01453; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04156">CJD.</a></span>
motor_neuron_disease	Mu-1	True Positive	6.039	12500684	<strong class="title">Shadrina MI, Kondrat'eva EA, Slominskii PA, Levitskaia NI, Levitskii GN, Skvortsova VA, Limborskaia SA: <span class="tagged-filter" title="Association Word">[Polymorphism</span> of <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> <span class="tagged-filter" title="Association Word">genes</span> M1 and T1 in patients with <span class="tagged-query" title="Query">motor neuron disease</span> from the city of Moscow]. Genetika. 2002 Nov;38(11):1566-8.</strong> Comparison of the frequency distributions of alleles, genotypes, and genotype combinations of <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P09488; Entrez Gene ID: 2944; HGNC ID: 4632; HPRD ID: 00707; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09488">GSTM1</a></span> and <span class="tagged-gene" title="SwissProt ID: P30711; Entrez Gene ID: 2952; HGNC ID: 4641; HPRD ID: 02700; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30711">GSTT1</a></span> did not show statistically significant differences between patients with <span class="tagged-query" title="Query">motor neuron disease</span> (MND) and a random sample from the Moscow population. Apparently, these <span class="tagged-filter" title="Association Word">genes</span> are not <span class="tagged-filter" title="Association Word">involved</span> in MND pathogenesis in these patients.
motor_neuron_disease	ALS4	True Positive	2.172	16644229	<strong class="title">Chen YZ, Hashemi SH, Anderson SK, Huang Y, Moreira MC, Lynch DR, Glass IA, Chance PF, Bennett CL: <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">Senataxin,</a></span> the yeast Sen1p orthologue: characterization of a unique <span class="tagged-filter" title="Association Word">protein</span> in which <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-filter" title="Association Word">mutations</span> <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">ataxia</span> and <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-filter" title="Association Word">mutations</span> <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-query" title="Query">motor neuron disease.</span> Neurobiol Dis. 2006 Jul;23(1):97-108. Epub 2006 Apr 27.</strong> A severe <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">cerebellar ataxia,</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">Ataxia</span>-<span class="tagged-disease" title="UMLS Concept ID: C0271270">Oculomotor Apraxia</span> 2 <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">(AOA2)</a></span> and a juvenile onset form of <span class="tagged-filter" title="Association Word">dominant</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">(ALS4)</a></span> result from <span class="tagged-filter" title="Association Word">mutations</span> of the <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">Senataxin</a></span> <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">(SETX)</a></span> <span class="tagged-filter" title="Association Word">gene.</span> To begin characterization this disease <span class="tagged-filter" title="Association Word">protein,</span> we developed a specific <span class="tagged-filter" title="Association Word">antibody</span> to the DNA/<span class="tagged-gene" title="SwissProt ID: O94894; Entrez Gene ID: 9879; HGNC ID: 18681; HPRD ID: 10862; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O94894">RNA helicase</a></span> domain of <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX.</a></span> In murine brain, <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX</a></span> concentrates in several regions, including cerebellum, hippocampus and olfactory bulb with a general neuronal <span class="tagged-filter" title="Association Word">expression</span> profile, colocalizing with NeuN. In cultured cells, we found that <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX</a></span> was cytoplasmically diffuse, but in the nucleus, <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX</a></span> was punctate, colocalizing with <span class="tagged-gene" title="SwissProt ID: P22087; Entrez Gene ID: 2091; HGNC ID: 3599; HPRD ID: 00617; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22087">fibrillarin,</a></span> a <span class="tagged-filter" title="Association Word">marker</span> of the nucleolus. In differentiated non-cycling cells, nuclear <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX</a></span> was not restricted to the nucleolus but was diffuse within the nucleoplasm, suggesting cell-cycle-dependent localization. <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX</a></span> missense <span class="tagged-filter" title="Association Word">mutations</span> cluster within the N-terminus and <span class="tagged-gene" title="SwissProt ID: Q92771; Entrez Gene ID: 440081; HGNC ID: 2737; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92771">helicase</a></span> domains. Flag tagging at the N-terminus <span class="tagged-filter" title="Association Word">caused</span> <span class="tagged-filter" title="Association Word">protein</span> mislocation to the nucleoplasm and failure to export to the cytoplasm, suggesting that the N-terminus may be essential for correct <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX</a></span> localization. We report here the first characterization of <span class="tagged-gene" title="SwissProt ID: Q5JUJ0; Entrez Gene ID: 23064; HGNC ID: 445; HPRD ID: 07622; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5JUJ0">SETX</a></span> <span class="tagged-filter" title="Association Word">protein,</span> which may provide future insights into a new mechanism <span class="tagged-filter" title="Association Word">leading</span> to neuron death.
motor_neuron_disease	cyclooxygenase-2	True Negative	1.441	16184763	<strong class="title">Batulan Z, Nalbantoglu J, Durham HD: Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells. Cell Stress Chaperones. 2005 Autumn;10(3):185-96.</strong> Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to amplify the heat shock response in cell lines by increasing the binding of <span class="tagged-gene" title="SwissProt ID: Q00613; Entrez Gene ID: 3297; HGNC ID: 5224; HPRD ID: 00778; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q00613">heat shock transcription factor-1</a></span> to heat shock elements within heat shock <span class="tagged-filter" title="Association Word">gene</span> promoters. Because overexpression of the inducible heat shock <span class="tagged-filter" title="Association Word">protein</span> 70 <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">(Hsp70)</a></span> was neuroprotective in a culture model of <span class="tagged-query" title="Query">motor neuron disease,</span> this study investigated whether NSAIDs induce <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> and confer cytoprotection in motor neurons of dissociated spinal cord cultures exposed to various stresses. Two NSAIDs, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> and niflumic acid, lowered the temperature threshold for induction of <a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in glia but failed to do so in motor neurons. At concentrations that increased <span class="tagged-gene" title="SwissProt ID: P34932; Entrez Gene ID: 3308; HGNC ID: 5237; HPRD ID: 09025; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34932">Hsp70</a></span> in heat shocked glial cells, <span class="tagged-metabolite" title="HMDB: HMDB00588"><span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> failed to delay death of motor neurons exposed to <span class="tagged-disease" title="UMLS Concept ID: C0236832">hyperthermia,</span> paraquat-mediated oxidative stress, and <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> excitotoxicity. Neither <span class="tagged-metabolite" title="HMDB: HMDB00588"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00588">sodium</a></span> <span class="tagged-metabolite" title="HMDB: HMDB01895"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01895">salicylate</a></span> nor the <a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> inhibitor, niflumic acid, protected motor neurons from the toxicity of <span class="tagged-filter" title="Association Word">mutated</span> Cu/Zn-<span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD-1)</a></span> <span class="tagged-filter" title="Association Word">linked</span> to a familial form of the <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Thus, treatment with 2 types of NSAIDs failed to overcome the high threshold for the activation of heat shock response in motor neurons.
motor_neuron_disease	cyclooxygenase-2	True Negative	1.441	14991384	<strong class="title">Yokota O, Terada S, Ishizu H, Ishihara T, Nakashima H, Kugo A, Tsuchiya K, Ikeda K, Hayabara T, Saito Y, Murayama S, Ueda K, Checler F, Kuroda S: Increased <span class="tagged-filter" title="Association Word">expression</span> of neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> in the hippocampus in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> both with and without <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia.</span> Acta Neuropathol. 2004 May;107(5):399-405. Epub 2004 Feb 25.</strong> The pathophysiological basis of cognitive dysfunction, including <span class="tagged-disease" title="UMLS Concept ID: C0338451">frontotemporal dementia</span> (FTD), in patients with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and ALS with <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> (ALSD) remains unclear. On the other hand, increased <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">cyclooxygenase-2</a></span> <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">(COX-2)</a></span> in the spinal cord is thought to play a pivotal <span class="tagged-filter" title="Association Word">role</span> in motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in ALS. In this study, to assess the relationship between the neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in the cerebrum, the formation of tau- and <span class="tagged-gene" title="SwissProt ID: P37840; Entrez Gene ID: 6622; HGNC ID: 11138; HPRD ID: 01227; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P37840">alpha-synuclein</a></span>-negative but <span class="tagged-gene" title="SwissProt ID: P62988; Entrez Gene ID: 7316; HGNC ID: 12468; HPRD ID: 07038; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62988">ubiquitin</a></span>-positive neuronal inclusions (UPIs), and <span class="tagged-disease" title="UMLS Concept ID: C1534449">dementia</span> in <span class="tagged-query" title="Query">motor neuron disease</span> (MND), we examined neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> immunoreactivity in the frontal cortex and hippocampus of patients with non-demented ALS without UPIs ( n=11), ALSD with UPIs ( n=6), and normal controls ( n=24) using a quantitative immunohistochemical technique. Neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in all <span class="tagged-gene" title="SwissProt ID: P00915; Entrez Gene ID: 759; HGNC ID: 1368; HPRD ID: 00265; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00915">CA1</a></span>-4 in the hippocampus was significantly up-regulated in the ALSD group, and, to lesser degree but significantly, in the ALS group. Neuronal <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in the frontal cortex was also significantly up-regulated in the ALSD group but not in the ALS group. These findings suggest that (1) the frontal cortex and hippocampus of MND are <span class="tagged-filter" title="Association Word">involved</span> in the same pathogenic process <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> induction that has been <span class="tagged-filter" title="Association Word">observed</span> in spinal anterior horn cells, (2) <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> induction in the cerebrum is a pathogenic process that can occur even in the <span class="tagged-filter" title="Association Word">absence</span> of UPI formation in MND, and (3) <span class="tagged-gene" title="SwissProt ID: P35354; Entrez Gene ID: 5743; HGNC ID: 9605; HPRD ID: 02599; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35354">COX-2</a></span> <span class="tagged-filter" title="Association Word">expression</span> in the cerebrum may be <span class="tagged-filter" title="Association Word">associated</span> with cognitive dysfunction in MND.
motor_neuron_disease	SCA1	True Negative	1.441	12651867	<strong class="title">Okuda T, Hattori H, Takeuchi S, Shimizu J, Ueda H, Palvimo JJ, Kanazawa I, Kawano H, Nakagawa M, Okazawa H: <span class="tagged-gene" title="SwissProt ID: O60828; Entrez Gene ID: 10084; HGNC ID: 9330; HPRD ID: 02354; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60828">PQBP-1</a></span> transgenic mice show a late-onset <span class="tagged-query" title="Query">motor neuron disease</span>-like phenotype. Hum Mol Genet. 2003 Apr 1;12(7):711-25.</strong> A body of experimental evidence indicates that transcription and/or mRNA processing factors interacting with the <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: O60828; Entrez Gene ID: 10084; HGNC ID: 9330; HPRD ID: 02354; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> disease <span class="tagged-filter" title="Association Word">gene</span> products play crucial <span class="tagged-filter" title="Association Word">roles</span> in the pathology. <a href="http://beta.uniprot.org/uniprot/O60828">PQBP-1</a></span> is one of these factors and it has been shown to interact with the <span class="tagged-disease" title="UMLS Concept ID: C0752120">spinocerebellar ataxia type-1</span> <span class="tagged-gene" title="SwissProt ID: P54253; Entrez Gene ID: 6310; HGNC ID: 10548; HPRD ID: 03333; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54253">(SCA1)</a></span> disease <span class="tagged-filter" title="Association Word">gene</span> product, <span class="tagged-gene" title="SwissProt ID: P54253; Entrez Gene ID: 6310; HGNC ID: 10548; HPRD ID: 03333; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54253">ataxin-1.</a></span> Our previous data suggested that relatively high <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: O60828; Entrez Gene ID: 10084; HGNC ID: 9330; HPRD ID: 02354; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60828">PQBP-1</a></span> in the cerebellum might explain the selective neuronal degeneration of <span class="tagged-gene" title="SwissProt ID: P54253; Entrez Gene ID: 6310; HGNC ID: 10548; HPRD ID: 03333; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54253">SCA1.</a></span> To further test whether <span class="tagged-gene" title="SwissProt ID: O60828; Entrez Gene ID: 10084; HGNC ID: 9330; HPRD ID: 02354; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60828">PQBP-1</a></span> <span class="tagged-filter" title="Association Word">expression</span> level regulates neuronal death, we generated transgenic mice of human <span class="tagged-gene" title="SwissProt ID: O60828; Entrez Gene ID: 10084; HGNC ID: 9330; HPRD ID: 02354; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60828">PQBP-1</a></span> driven by a regulatory element for ubiquitous gene expression. The mice showed a late-onset and gradually progressive <span class="tagged-query" title="Query">motor neuron disease</span>-like phenotype, which might be <span class="tagged-filter" title="Association Word">related</span> to <span class="tagged-disease" title="UMLS Concept ID: C0270948">neurogenic muscular atrophy</span> <span class="tagged-filter" title="Association Word">observed</span> in <span class="tagged-gene" title="SwissProt ID: P54253; Entrez Gene ID: 6310; HGNC ID: 10548; HPRD ID: 03333; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54253">SCA1</a></span> patients. <span class="tagged-disease" title="UMLS Concept ID: Not Available">Ataxia</span> could not be discriminated from predominant progressive weakness. Pathological examinations of the transgenic mice revealed loss of Purkinje and granular cells in the cerebellum as well as that of spinal motor neurons, corresponding to the pathology of human <span class="tagged-gene" title="SwissProt ID: P54253; Entrez Gene ID: 6310; HGNC ID: 10548; HPRD ID: 03333; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54253">SCA1.</a></span> These findings show that excessive action of <span class="tagged-gene" title="SwissProt ID: O60828; Entrez Gene ID: 10084; HGNC ID: 9330; HPRD ID: 02354; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60828">PQBP-1</a></span> <span class="tagged-filter" title="Association Word">causes</span> neuronal dysfunction and support <span class="tagged-gene" title="SwissProt ID: O60828; Entrez Gene ID: 10084; HGNC ID: 9330; HPRD ID: 02354; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60828">PQBP-1</a></span> being <span class="tagged-filter" title="Association Word">involved</span> in the pathology of <span class="tagged-gene" title="SwissProt ID: P54253; Entrez Gene ID: 6310; HGNC ID: 10548; HPRD ID: 03333; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P54253">SCA1.</a></span>
motor_neuron_disease	hexosaminidase	False Positive	3.724	17491335	<strong class="title">Takado Y, Koide T, Yoshikawa K, Amaya N, Yoshida Y, Ishiguro H: [A patient with <span class="tagged-disease" title="UMLS Concept ID: C0268274">GM2 gangliosidosis</span> presenting with <span class="tagged-query" title="Query">motor neuron disease</span> symptom in his forties]. Rinsho Shinkeigaku. 2007 Jan;47(1):37-41.</strong> Here, we report a Japanese man with <span class="tagged-disease" title="UMLS Concept ID: C0751489">adult Sandhoff disease</span> who presented with a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype with slow progression. At the age of 42, he noticed weakness in his legs. At the age of 46, he was admitted to our hospital. Neurological examination revealed muscle weakness and atrophy of the upper and lower extremities, and hyperreflexia of the upper extremities. Magnetic resonance imaging showed very mild cerebellar atrophy. We <span class="tagged-filter" title="Association Word">diagnosed</span> him as having atypical <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Because of the atypical course of <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-gene" title="Protein Family or Complex">hexosaminidase</span> <span class="tagged-filter" title="Association Word">activity</span> in peripheral leukocytes was indicated. Asseys of <span class="tagged-gene" title="SwissProt ID: P06865; Entrez Gene ID: 3073; HGNC ID: 4878; HPRD ID: 06040; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06865">hexosaminidase A</a></span> and <span class="tagged-gene" title="SwissProt ID: P07686; Entrez Gene ID: 3074; HGNC ID: 4879; HPRD ID: 06043; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07686">hexosaminidase B</a></span> showed low activities, and we found a membranous cytoplasmic body in the submucosal nerve, <span class="tagged-filter" title="Association Word">leading</span> to the <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-disease" title="UMLS Concept ID: C0036161">Sandhoff disease.</span> This is the second case of a Japanese adult with <span class="tagged-disease" title="UMLS Concept ID: C0036161">Sandhoff disease</span> presenting with a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype, and to our knowledge, this is the latest age of onset in Japan.
motor_neuron_disease	hexosaminidase	False Positive	3.724	11433765	<strong class="title">Kohno Y, Yoshizawa T, Ohkoshi N, Tamaoka A, Shoji S: <span class="tagged-disease" title="UMLS Concept ID: C0751489">[Adult Sandhoff disease</span> presented as a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype with slow progression]. Rinsho Shinkeigaku. 2001 Jan;41(1):36-9.</strong> A 35-year old Japanese male with <span class="tagged-disease" title="UMLS Concept ID: C0751489">adult Sandhoff disease</span> was described, who was presented as a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype with slow progression. At the age of 15, he first noticed weakness in his thigh. At the age of 28, his upper and lower motor neuron disturbances were disclosed. He was <span class="tagged-filter" title="Association Word">diagnosed</span> as atypical <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> At the age of 34, a slight <span class="tagged-disease" title="UMLS Concept ID: C0152027">sensory disturbance</span> appeared in the lower extremities. When he was admitted to our hospital, he displayed marked atrophy and weakness in his quadriceps femoris muscles, but no signs of <span class="tagged-disease" title="UMLS Concept ID: C0234985">mental deterioration</span> and <span class="tagged-disease" title="UMLS Concept ID: Not Available">cerebellar ataxia.</span> Because of the atypical course of <span class="tagged-query" title="Query">motor neuron disease,</span> <span class="tagged-gene" title="Protein Family or Complex">hexosaminidase</span> <span class="tagged-filter" title="Association Word">activity</span> in peripheral leukocytes was determined. The assay of total <span class="tagged-gene" title="Protein Family or Complex">hexosaminidase,</span> <span class="tagged-gene" title="SwissProt ID: P06865; Entrez Gene ID: 3073; HGNC ID: 4878; HPRD ID: 06040; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06865">hexosaminidase A</a></span> and <span class="tagged-gene" title="SwissProt ID: P07686; Entrez Gene ID: 3074; HGNC ID: 4879; HPRD ID: 06043; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07686">hexosaminidase B</a></span> activities demonstrated low levels of these activities (7-15% of controls), <span class="tagged-filter" title="Association Word">leading</span> the <span class="tagged-filter" title="Association Word">diagnosis</span> of Sandoff disease. He was a member of non-consanguineous family, and the abnormal patterns of hexasaminidase activities were different between his father and mother. These data appear to show that he is a compound heterozygote in the <span class="tagged-filter" title="Association Word">locus</span> of the <span class="tagged-gene" title="SwissProt ID: P07686; Entrez Gene ID: 3074; HGNC ID: 4879; HPRD ID: 06043; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07686">hexosaminidase B</a></span> <span class="tagged-filter" title="Association Word">gene.</span> This is the first Japanese case of adult Sanhoff disease presented as a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype.
motor_neuron_disease	peripherin	True Positive	1.441	15773754	<strong class="title">Julien JP, Millecamps S, Kriz J: Cytoskeletal defects in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> <span class="tagged-query" title="Query">(motor neuron disease).</span> Novartis Found Symp. 2005;264:183-92; discussion 192-6</strong> There is growing evidence for the involvement of cytoskeletal defects in the pathogenesis of <span class="tagged-query" title="Query">motor neuron disease</span> and especially in components of the microtubule-based transport system. Here we will review our recent work aiming to elucidate the role of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) and to address the mechanism of disease <span class="tagged-filter" title="Association Word">caused</span> by deletions in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> that <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-filter" title="Association Word">recessive</span> forms of juvenile ALS and <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis</span> <span class="tagged-gene" title="SwissProt ID: P53634; Entrez Gene ID: 1075; HGNC ID: 2528; HPRD ID: 03841; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P53634">(PLS).</a></span> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin</a></span> is an intermediate filament <span class="tagged-filter" title="Association Word">protein</span> detected in spheroids, a hallmark of ALS, and increased levels of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> have been found in some ALS cases. Our transgenic mouse and cell culture studies support the view of a <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> involvement in ALS. However, a <span class="tagged-filter" title="Association Word">gene</span> knockout approach demonstrated that <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> is not a key contributor of <span class="tagged-query" title="Query">motor neuron disease</span> <span class="tagged-filter" title="Association Word">caused</span> by mutant <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-filter" title="Association Word">linked</span> to familial ALS. A recent breakthrough in the field of ALS came with the discovery of frameshift deletions in the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">gene</span> coding for <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin.</a></span> Our transfection experiments in cultured cells suggest that <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin</a></span> is a cytoskeletal <span class="tagged-filter" title="Association Word">protein</span> with dual endosomal and centrosomal localizations. We have generated a mouse knockout for <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin</a></span> that develops progressive motor dysfunction during ageing. Thus, it is anticipated that this mouse model will be useful to investigate the pathogenic pathways <span class="tagged-filter" title="Association Word">linked</span> to <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Alsin</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations.</span>
motor_neuron_disease	peripherin	True Positive	1.441	15446584	<strong class="title">Leung CL, He CZ, Kaufmann P, Chin SS, Naini A, Liem RK, Mitsumoto H, Hays AP: A pathogenic <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutation</span> in a patient with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis.</span> Biochimie. 2002 Nov;84(11):1151-60.</strong> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin</a></span> is a neuronal intermediate filament <span class="tagged-filter" title="Association Word">protein</span> that is <span class="tagged-filter" title="Association Word">expressed</span> chiefly in motor neurons and other nerve cells that project into the peripheral nervous system. Transgenic mice that over-express <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> develop motor neuron degeneration, suggesting that <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> could contribute to the development of <span class="tagged-query" title="Query">motor neuron disease.</span> In this paper, we report the identification of a homozygous <span class="tagged-filter" title="Association Word">mutation</span> in the <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">(PRPH)</a></span> in a patient with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). The <span class="tagged-filter" title="Association Word">mutation</span> resulted in a substitution of <span class="tagged-metabolite" title="HMDB: HMDB00191"><span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00191">aspartate</a></span> with <span class="tagged-metabolite" title="HMDB: HMDB00158"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00158">tyrosine</a></span> at amino acid position 141, which is located within the first linker region of the rod domain. Immunocytochemical analysis of the spinal cord of the patient upon autopsy revealed distinctive large aggregates within the cell bodies of residual spinal motor neurons that contained <a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> and was also immunoreactive with <span class="tagged-filter" title="Association Word">antibodies</span> to the neurofilament <span class="tagged-filter" title="Association Word">proteins.</span> In order to study the effect of the <span class="tagged-filter" title="Association Word">mutation</span> on <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> assembly, we performed transient transfections. Unlike wild-type <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin,</a></span> which self-assembles to form a filamentous network, the mutant <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> was prone to form aggregates in transfected cells, indicating that the <span class="tagged-filter" title="Association Word">mutation</span> adversely affects <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> assembly. Moreover, the neurofilament light <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">(NF-L)</a></span> <span class="tagged-filter" title="Association Word">protein</span> was not able to rescue the mutant <span class="tagged-filter" title="Association Word">protein</span> from forming aggregates. These data imply that <span class="tagged-filter" title="Association Word">mutation</span> of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">PRPH</a></span> is a contributing factor for ALS.
motor_neuron_disease	peripherin	True Positive	1.441	15132161	<strong class="title">Beaulieu JM, Nguyen MD, Julien JP: Late onset of motor neurons in mice overexpressing wild-type <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin.</a></span> . J Neurosci. 2000 Jul 15;20(14):5321-8.</strong> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin,</a></span> a type III intermediate filament (IF) <span class="tagged-filter" title="Association Word">protein,</span> upregulated by injury and inflammatory cytokines, is a component of IF inclusion bodies <span class="tagged-filter" title="Association Word">associated</span> with degenerating motor neurons in sporadic <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). We report here that sustained overexpression of wild-type <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> in mice provokes massive and selective degeneration of motor axons during aging. Remarkably, the onset of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span>-mediated disease was precipitated by a <span class="tagged-filter" title="Association Word">deficiency</span> of neurofilament light <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">(NF-L)</a></span> <span class="tagged-gene" title="SwissProt ID: P07602; Entrez Gene ID: 5660; HGNC ID: 9498; HPRD ID: 01460; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07602">protein, a</a></span> phenomenon <span class="tagged-filter" title="Association Word">associated</span> with sporadic ALS. In <span class="tagged-gene" title="SwissProt ID: P07196; Entrez Gene ID: 4747; HGNC ID: 7739; HPRD ID: 01206; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P07196">NF-L</a></span> null mice, the overexpression of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">led</span> to early- onset formation of IF inclusions and to the selective death of spinal motor neurons at 6 mo of age. We also report the formation of similar <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> inclusions in presymptomatic transgenic mice expressing a mutant form of <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-filter" title="Association Word">linked</span> to ALS. Taken together, these results suggest that IF inclusions containing <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> may play a contributory <span class="tagged-filter" title="Association Word">role</span> in <span class="tagged-query" title="Query">motor neuron disease.</span>
motor_neuron_disease	peripherin	True Positive	1.441	12828939	<strong class="title">Lariviere RC, Beaulieu JM, Nguyen MD, Julien JP: <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin</a></span> is not a contributing factor to <span class="tagged-query" title="Query">motor neuron disease</span> in a mouse model of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> <span class="tagged-filter" title="Association Word">caused</span> by mutant <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase.</a></span>  227-30.</strong> <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">Peripherin</a></span> is a type III intermediate filament <span class="tagged-filter" title="Association Word">protein</span> detected in axonal spheroids <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). The overexpression of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> induces degeneration of spinal motor neurons during aging in transgenic mice and in cultured neuronal cells derived from <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> transgenic embryos. Here, we investigated whether <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> is a contributor of pathogenesis in mice overexpressing a mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1</a></span> (G37R)) <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">linked</span> to familial ALS. This was done by the generation and analysis of <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G37R) mice that either overexpress a <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> transgene (G37R;TgPer mice) or lack the endogenous <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">gene</span> (G37R;Per-/- mice). Surprisingly, upregulation or suppression of <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> <span class="tagged-filter" title="Association Word">expression</span> had no effects on disease onset, mortality, and loss of motor neurons in <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> (G37R) mice. These results provide compelling evidence that <span class="tagged-gene" title="SwissProt ID: P23942; Entrez Gene ID: 5961; HGNC ID: 9942; HPRD ID: 01553; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23942">peripherin</a></span> is not a key contributor of motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> <span class="tagged-filter" title="Association Word">associated</span> with toxicity of mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1.</a></span>
motor_neuron_disease	Rab5	True Negative	1.441	17239822	<strong class="title">Suzuki-Utsunomiya K, Hadano S, Otomo A, Kunita R, Mizumura H, Osuga H, Ikeda JE: <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-interactor, modulates <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-mediated endosome dynamics. Biochem Biophys Res Commun. 2007 Mar 9;354(2):491-7. Epub 2007 Jan 11.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> the causative <span class="tagged-filter" title="Association Word">gene</span> product for a number of <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases,</span> is a <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine-nucleotide exchange factor</a></span> for <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5,</a></span> and acts as a modulator for endosome dynamics. Recently, we have identified a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> homolog, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL,</a></span> which is highly homologous to the C-terminal half of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> In this study, we investigate the molecular features of <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> and its functional relationship with <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span> A majority of <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is present as a homo-dimeric form, which can interact with the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-oligomer, resulting in the formation of the large <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>/<span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> heteromeric complex. In cultured cells, overexpressed <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is colocalized with <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> onto membranous compartments. Further, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> dominantly suppresses the endosome enlargement induced by a constitutively active form of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> and results in an extensive perinuclear tubulo-membranous phenotype, which are dependent upon the <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span>-<span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> interaction. Collectively, <span class="tagged-gene" title="SwissProt ID: Q60I27; Entrez Gene ID: 259173; HGNC ID: 20605; HPRD ID: 10643; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q60I27">ALS2CL</a></span> is a novel <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-interacting <span class="tagged-filter" title="Association Word">protein</span> and is implicated in <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span>-mediated endosome dynamics.
motor_neuron_disease	Rab5	True Negative	1.441	16769894	<strong class="title">Devon RS, Orban PC, Gerrow K, Barbieri MA, Schwab C, Cao LP, Helm JR, Bissada N, Cruz-Aguado R, Davidson TL, Witmer J, Metzler M, Lam CK, Tetzlaff W, Simpson EM, McCaffery JM, El-Husseini AE, Leavitt BR, Hayden MR: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> mice exhibit disturbances in endosome trafficking <span class="tagged-filter" title="Association Word">associated</span> with motor behavioral abnormalities. Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9595-600. Epub 2006 Jun 12.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> is an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">recessive</span> form of spastic paraparesis <span class="tagged-query" title="Query">(motor neuron disease)</span> with juvenile onset and slow progression <span class="tagged-filter" title="Association Word">caused</span> by loss of function of alsin, an activator of <span class="tagged-gene" title="SwissProt ID: P63000; Entrez Gene ID: 5879; HGNC ID: 9801; HPRD ID: 03627; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P63000">Rac1</a></span> and <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> small GTPases. To establish an animal model of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> and derive insights into the pathogenesis of this illness, we have generated alsin-null mice. Cytosol from brains of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice shows marked diminution of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span>-dependent endosome fusion <span class="tagged-filter" title="Association Word">activity.</span> Furthermore, primary neurons from <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice show a disturbance in endosomal transport of <span class="tagged-gene" title="SwissProt ID: P01308; Entrez Gene ID: 3630; HGNC ID: 6081; HPRD ID: 01455; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01308">insulin</a></span>-like growth factor 1 <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">(IGF1)</a></span> and <span class="tagged-gene" title="SwissProt ID: P23560; Entrez Gene ID: 627; HGNC ID: 1033; HPRD ID: 00214; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23560">BDNF</a></span> receptors, whereas neuronal viability and endocytosis of <span class="tagged-gene" title="SwissProt ID: P02787; Entrez Gene ID: 7018; HGNC ID: 11740; HPRD ID: 01811; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02787">transferrin</a></span> and dextran seem unaltered. There is a significant decrease in the size of cortical motor neurons, and <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice are mildly hypoactive. <span class="tagged-filter" title="Association Word">Altered</span> trophic receptor trafficking in neurons of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">Als2</a></span> (-/-) mice may underlie the histopathological and behavioral changes <span class="tagged-filter" title="Association Word">observed</span> and the pathogenesis of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2.</a></span>
motor_neuron_disease	Rab5	True Negative	1.441	12837691	<strong class="title">Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, Showguchi-Miyata J, Yanagisawa Y, Kohiki E, Suga E, Yasuda M, Osuga H, Nishimoto T, Narumiya S, Ikeda JE: <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2,</a></span> a novel <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> for the small GTPase <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5,</a></span> is implicated in endosomal dynamics. Hum Mol Genet. 2003 Jul 15;12(14):1671-87.</strong> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> account for a number of <span class="tagged-filter" title="Association Word">recessive</span> <span class="tagged-query" title="Query">motor neuron diseases</span> including forms of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0154682">primary lateral sclerosis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0037773">hereditary spastic paraplegia.</span> Although computational predictions suggest that <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> encodes a <span class="tagged-filter" title="Association Word">protein</span> containing multiple <span class="tagged-gene" title="SwissProt ID: Q13972; Entrez Gene ID: 5923; HGNC ID: 9875; HPRD ID: 07362; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13972">guanine nucleotide exchange factor</a></span> <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">(GEF)</a></span> domains <span class="tagged-gene" title="SwissProt ID: Q9P258; Entrez Gene ID: 55920; HGNC ID: 30297; HPRD ID: 18171; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9P258">[RCC1-like</a></span> domain (RLD), the Dbl homology and <span class="tagged-gene" title="SwissProt ID: P08567; Entrez Gene ID: 5341; HGNC ID: 9070; HPRD ID: 15935; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08567">pleckstrin</a></span> homology (DH/PH), and the vacuolar <span class="tagged-filter" title="Association Word">protein</span> sorting 9 (VPS9)], the functions of the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> have not been revealed as yet. Here we show that the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> specifically binds to small GTPase <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> and functions as a <span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">GEF</a></span> for <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5.</a></span> Ectopically <span class="tagged-filter" title="Association Word">expressed</span> <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> localizes with <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> and <span class="tagged-gene" title="SwissProt ID: Q15075; Entrez Gene ID: 8411; HGNC ID: 3185; HPRD ID: 05460; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15075">early endosome antigen-1</a></span> <span class="tagged-gene" title="SwissProt ID: Q15075; Entrez Gene ID: 8411; HGNC ID: 3185; HPRD ID: 05460; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15075">(EEA1)</a></span> onto early endosomal compartments and stimulates the enlargement of endosomes in cultured cortical neurons. The carboxy-terminus of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> carrying a <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain</a></span> mediates not only the activation of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> via a <span class="tagged-metabolite" title="HMDB: HMDB00132"><span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00132">guanine</a></span>-nucleotide exchanging reaction but also the endosomal localization of the <a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein,</span> while the amino-terminal half containing RLD acts suppressive in its membranous localization. Further, the DH/PH domain in the middle portion of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> enhances the <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain</a></span>-mediated endosome fusions. Taken together, the <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">protein</span> as a novel <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span>-<span class="tagged-gene" title="SwissProt ID: Q92974; Entrez Gene ID: 9181; HGNC ID: 682; HPRD ID: 10458; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92974">GEF,</a></span> ALS2rab5GEF seems to be implicated in the endosomal dynamics in vivo. Notably, a feature common to eight reported <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> among <span class="tagged-query" title="Query">motor neuron diseases</span> is the loss of <span class="tagged-gene" title="Entrez Gene ID: 84079; HGNC ID: 25310; HPRD ID: 10650; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84079">VPS9 domain,</a></span> resulting in the failure of <span class="tagged-gene" title="SwissProt ID: P20339; Entrez Gene ID: 5868; HGNC ID: 9783; HPRD ID: 01542; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20339">Rab5</a></span> activation. Thus, a perturbation of endosomal dynamics <span class="tagged-filter" title="Association Word">caused</span> by loss of <span class="tagged-gene" title="SwissProt ID: Q96Q42; Entrez Gene ID: 57679; HGNC ID: 443; HPRD ID: 05893; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q96Q42">ALS2</a></span> rab5GEF <span class="tagged-filter" title="Association Word">activity</span> might underlie neuronal dysfunction and degeneration in a number of <span class="tagged-query" title="Query">motor neuron diseases.</span>
motor_neuron_disease	MT-II	True Positive	1.441	16179515	<strong class="title">Ignacio S, Moore DH, Smith AP, Lee NM: Effect of neuroprotective drugs on gene expression in G93A/<span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice. Ann N Y Acad Sci. 2005 Aug;1053:121-36.</strong> Gene expression analysis is a powerful tool that has been used to define the <span class="tagged-disease" title="UMLS Concept ID: C0030660">pathological processes</span> underlying many diseases. Several laboratories, including our own, have used this approach to identify molecular abnormalities in the G93A/<span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mouse, an animal model of <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). Here, we report the results of analysis of an expanded panel of <span class="tagged-filter" title="Association Word">genes</span> throughout the entire lifetime in the spinal cord of these animals. In addition to upregulation of microglia/neuroinflammatory <span class="tagged-filter" title="Association Word">genes</span> identified previously, we <span class="tagged-filter" title="Association Word">observed</span> upregulation of <span class="tagged-gene" title="Protein Family or Complex">metallothionein</span>-I and -II (MT-I, <span class="tagged-gene" title="SwissProt ID: P02795; Entrez Gene ID: 4502; HGNC ID: 7406; HPRD ID: 08863; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02795">MT-II).</a></span> MT-I and <span class="tagged-gene" title="SwissProt ID: P02795; Entrez Gene ID: 4502; HGNC ID: 7406; HPRD ID: 08863; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02795">MT-II</a></span> play an important <span class="tagged-filter" title="Association Word">role</span> in disposition of <span class="tagged-metabolite" title="HMDB: HMDB01303"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01303">zinc ion,</a></span> and other studies have also indicated their levels are <span class="tagged-filter" title="Association Word">altered</span> in development of <span class="tagged-query" title="Query">motor neuron disease</span> in these animals. We also analyzed the effect on these <span class="tagged-filter" title="Association Word">expression</span> profiles of several candidate drugs that have been shown to have neuroprotective effects in vivo or in vitro. That is, we asked whether administration to the G93A/<a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice of any of these drugs could reverse the alterations in gene expression patterns that occur as the animals develop. The mice were given daily doses of these drugs when they were 9-11 weeks old, at a stage early in development of <span class="tagged-query" title="Query">motor neuron disease,</span> continuing for 5 weeks, at which time they were sacrificed. Treatment of the mice with <span class="tagged-metabolite" title="HMDB: HMDB00033"><span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00033">l-carnosine,</a></span> a dipeptide that scavenges free radicals and chelates zinc, did not affect <span class="tagged-filter" title="Association Word">expression</span> of any of the <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-filter" title="Association Word">altered</span> in these animals. However, it did upregulate 3 <span class="tagged-filter" title="Association Word">genes</span> unaffected by the presence of the G93A/<a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> <span class="tagged-filter" title="Association Word">mutation:</span> <span class="tagged-gene" title="SwissProt ID: P14136; Entrez Gene ID: 2670; HGNC ID: 4235; HPRD ID: 00675; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14136">glial fibrillary acidic protein</a></span> <span class="tagged-gene" title="SwissProt ID: P14136; Entrez Gene ID: 2670; HGNC ID: 4235; HPRD ID: 00675; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14136">(GFAP),</a></span> stroma-derived factor-1 <span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P48061">(SDF-1),</a></span> and <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">excitatory amino acid transporter-2</a></span> <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">(EAAT2).</a></span> In contrast, <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">metallothionein-III</a></span> <span class="tagged-gene" title="SwissProt ID: P25713; Entrez Gene ID: 4504; HGNC ID: 7408; HPRD ID: 00752; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P25713">(MT-III)</a></span> was downregulated. Treatment of the animals with baicalein, an herbal extract with anti-inflammatory and numerous other effects, downregulated the microglia <span class="tagged-filter" title="Association Word">markers</span> <span class="tagged-gene" title="SwissProt ID: P34810; Entrez Gene ID: 968; HGNC ID: 1693; HPRD ID: 01093; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P34810">CD68,</a></span> <span class="tagged-gene" title="SwissProt ID: P33681; Entrez Gene ID: 941; HGNC ID: 1700; HPRD ID: 00202; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P33681">CD80,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42081; Entrez Gene ID: 942; HGNC ID: 1705; HPRD ID: 03011; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42081">CD86,</a></span> all of which were upregulated in untreated mutant animals. Baicalein treatment also downregulated <span class="tagged-gene" title="Protein Family or Complex">tumor necrosis factor receptor</span> (TNFRp55) and upregulated noninducible <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P29475; Entrez Gene ID: 4842; HGNC ID: 7872; HPRD ID: 01226; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> synthase <a href="http://beta.uniprot.org/uniprot/P29475">(nNOS)</a></span> and <span class="tagged-gene" title="SwissProt ID: P15104; Entrez Gene ID: 2752; HGNC ID: 4341; HPRD ID: 00701; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15104">glutamine synthase</a></span> (GS). These 3 <span class="tagged-filter" title="Association Word">genes</span> were unaffected by the presence of the G93A <span class="tagged-filter" title="Association Word">mutation.</span> We discuss the implication of these results for testing the effects of these and other candidate drugs in mutant <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice.
motor_neuron_disease	glutamate-receptor	False Positive	1.049	16523673	<strong class="title">Zherebtsova AL, Shadrina MI, Semenova EV, Levitskii GN, Alekhin AV, Slominskii PA, Skvortsova VI, Limborskaia SA: [Analysis of the possible involvement of the <span class="tagged-metabolite" title="HMDB: HMDB03339"><span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> transporter <span class="tagged-filter" title="Association Word">gene</span> <a href="http://beta.uniprot.org/uniprot/P43004">EAAT2</a></span> and the <span class="tagged-gene" title="SwissProt ID: Q6EER8; Entrez Gene ID: 145781; HPRD ID: 08091; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q6EER8">glutamate receptor</a></span> <span class="tagged-filter" title="Association Word">genes</span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> in pathogenesis of <span class="tagged-query" title="Query">motor neuron disease</span> in the Russian population]. Genetika. 2006 Jan;42(1):104-9.</strong> <span class="tagged-filter" title="Association Word">Polymorphisms</span> of the <span class="tagged-filter" title="Association Word">genes</span> of the glutamatergic system <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> have been analyzed in patients with sporadic <span class="tagged-query" title="Query">motor neuron disease</span> (MND) from Russia. The disease is not <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-filter" title="Association Word">polymorphic</span> alleles of the <span class="tagged-filter" title="Association Word">genes</span> studied, which indicates that <span class="tagged-gene" title="SwissProt ID: P43004; Entrez Gene ID: 6506; HGNC ID: 10940; HPRD ID: 02625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43004">EAAT2,</a></span> <span class="tagged-gene" title="SwissProt ID: P42261; Entrez Gene ID: 2890; HGNC ID: 4571; HPRD ID: 00695; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42261">GRIA1,</a></span> and <span class="tagged-gene" title="SwissProt ID: P42262; Entrez Gene ID: 2891; HGNC ID: 4572; HPRD ID: 04726; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42262">GRIA2</a></span> play an insignificant <span class="tagged-filter" title="Association Word">role</span> in the pathogenesis of sporadic MND.
motor_neuron_disease	GDNFR-alpha	True Positive	1.441	10447463	<strong class="title">Yamamoto M, Mitsuma N, Inukai A, Ito Y, Li M, Mitsuma T, Sobue G: <span class="tagged-filter" title="Association Word">Expression</span> of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> <span class="tagged-filter" title="Association Word">mRNAs</span> in muscles of patients with <span class="tagged-query" title="Query">motor neuron diseases.</span> Neurochem Res. 1999 Jun;24(6):785-90.</strong> The <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> levels of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF,</a></span> <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> and <span class="tagged-gene" title="SwissProt ID: O43519; Entrez Gene ID: 5979; HGNC ID: 9967; HPRD ID: 01266; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43519">RET</a></span> were examined in the muscles of amyotrophic lateral screlosis (ALS) and X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA).</a></span> <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> levels were significantly <span class="tagged-filter" title="Association Word">elevated</span> to variable extent in the diseased muscles compared to control muscles, although they were not specific to the type of the diseases. The diseased muscles also have a different <span class="tagged-filter" title="Association Word">expression</span> pattern of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> isoforms from controls. <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression,</span> however, tended to reduce in advanced muscle pathology. On the other hand, <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> levels were not changed significantly on <span class="tagged-filter" title="Association Word">expression</span> levels in the diseased muscles. In situ hybridization study revealed that <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> and <span class="tagged-gene" title="SwissProt ID: P56159; Entrez Gene ID: 2674; HGNC ID: 4243; HPRD ID: 03291; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P56159">GDNFR-alpha</a></span> <span class="tagged-filter" title="Association Word">mRNAs</span> were localized in subsarcolemmal space of muscle cells. <span class="tagged-gene" title="SwissProt ID: O43519; Entrez Gene ID: 5979; HGNC ID: 9967; HPRD ID: 01266; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43519">RET</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> was not detected in control nor diseased muscles. These results suggest that the <span class="tagged-filter" title="Association Word">elevated</span> muscle <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> acts as a trophic signal for motor neurons of <span class="tagged-query" title="Query">motor neuron diseases,</span> implying a possible therapeutic implication of <span class="tagged-gene" title="SwissProt ID: P39905; Entrez Gene ID: 2668; HGNC ID: 4232; HPRD ID: 02906; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P39905">GDNF</a></span> to this type of diseases.
motor_neuron_disease	VEGF	True Positive	4.729	17130418	<strong class="title">Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JH, Hardiman O: <span class="tagged-filter" title="Association Word">Elevated</span> serum <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> levels in ALS. Neurology. 2006 Nov 28;67(10):1833-6.</strong> BACKGROUND: The role of <span class="tagged-disease" title="UMLS Concept ID: C0242184">hypoxia</span> responsive <span class="tagged-filter" title="Association Word">genes</span> in the pathogenesis of ALS was first suggested when deletions of the <span class="tagged-disease" title="UMLS Concept ID: C0242184">hypoxia</span>-responsive element of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">(VEGF)</a></span> promoter <span class="tagged-filter" title="Association Word">caused</span> a <span class="tagged-query" title="Query">motor neuron disease</span> phenotype in mice. The discovery of ALS-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">mutations</span> in <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">ANG,</a></span> a <span class="tagged-disease" title="UMLS Concept ID: C0242184">hypoxia</span> responsive <span class="tagged-filter" title="Association Word">gene</span> coding for the <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin,</a></span> has further supported this pathogenic mechanism in human ALS. In endothelium, <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> can regulate <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF.</a></span> To date, the patterns of serum <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> <span class="tagged-filter" title="Association Word">expression</span> among patients with ALS have not been assessed. METHODS: Serum <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> and <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> levels were quantified at <span class="tagged-filter" title="Association Word">diagnosis</span> in 79 patients with definite or probable ALS and 72 healthy controls, using a quantitative sandwich <span class="tagged-filter" title="Association Word">enzyme</span>-<span class="tagged-filter" title="Association Word">linked</span> immunoassay. RESULTS: Patients with ALS exhibited higher serum <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> (p = 0.006) but not <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> (p = 0.55) levels than matched control subjects. Subgroup analysis showed a greater elevation in <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> levels for spinal- (p < 0.001) than bulbar- (p = 0.11) onset ALS vs controls. At 12 months, <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> levels remained <span class="tagged-filter" title="Association Word">elevated.</span> No correlation was noted between <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> and <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> levels (r = -0.08, p = 0.49) in ALS patient serum. CONCLUSION: These data suggest a modest elevation in serum <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> in ALS at <span class="tagged-filter" title="Association Word">diagnosis.</span> Further investigation will be required to assess the utility of serum <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin</a></span> as a <span class="tagged-filter" title="Association Word">biomarker</span> for ALS and as a predictor of disease progression.
motor_neuron_disease	VEGF	True Positive	4.729	16533145	<strong class="title">Bruijn LI, Cudkowicz M: Therapeutic targets for <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis:</span> current treatments and prospects for more effective therapies. Expert Rev Neurother. 2006 Mar;6(3):417-28.</strong> Although <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) was described more than 130 years ago, the <span class="tagged-filter" title="Association Word">cause</span> (s) of most cases of this adult <span class="tagged-query" title="Query">motor neuron disease</span> remains a mystery. With the discovery of <span class="tagged-filter" title="Association Word">mutations</span> in one <span class="tagged-filter" title="Association Word">gene</span> (Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase)</a></span> as a primary <span class="tagged-filter" title="Association Word">cause</span> of some forms of ALS, model systems have been developed that have helped us begin to understand mechanisms <span class="tagged-filter" title="Association Word">involved</span> in motor neuron death and enabled testing of potential new therapies. Several other <span class="tagged-filter" title="Association Word">genes</span> have been implicated as risk factors in <span class="tagged-query" title="Query">motor neuron diseases,</span> including neurofilaments, cytoplasmic dynein and <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor,</a></span> and <span class="tagged-gene" title="SwissProt ID: P03950; Entrez Gene ID: 283; HGNC ID: 483; HPRD ID: 00105; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P03950">angiogenin.</a></span> With advances in the basic research of the disease, many hypotheses accounting for motor neuron death are being explored, including loss of trophic support, <span class="tagged-filter" title="Association Word">protein</span> mishandling, mitochondrial dysfunction, excitotoxicity, axonal abnormalities and inflammation. Many of these mechanisms are the focus of research in other <span class="tagged-disease" title="UMLS Concept ID: C0524851">neurodegenerative disorders,</span> such as Parkinson's, Alzheimer's and <span class="tagged-disease" title="UMLS Concept ID: C0020179">Huntington's disease.</span>
motor_neuron_disease	VEGF	True Positive	4.729	16355213	<strong class="title">Greenberg DA, Jin K: From angiogenesis to neuropathology. Nature. 2005 Dec 15;438(7070):954-9.</strong> Angiogenesis--the growth of new blood vessels--is a crucial force for shaping the nervous system and protecting it from disease. Recent advances have improved our understanding of how the brain and other tissues grow new blood vessels under normal and pathological conditions. Angiogenesis factors, especially <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor,</a></span> are now known to have <span class="tagged-filter" title="Association Word">roles</span> in the birth of new neurons (neurogenesis), the prevention or mitigation of neuronal injury (neuroprotection), and the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0038454">stroke,</span> <span class="tagged-disease" title="UMLS Concept ID: C0002395">Alzheimer's disease</span> and <span class="tagged-query" title="Query">motor neuron disease.</span> As our understanding of pathophysiology grows, these developments may point the way towards new molecular and cell-based therapies.
motor_neuron_disease	VEGF	True Positive	4.729	15350962	<strong class="title">Van Den Bosch L, Storkebaum E, Vleminckx V, Moons L, Vanopdenbosch L, Scheveneels W, Carmeliet P, Robberecht W: Effects of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">(VEGF)</a></span> on motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> Neurobiol Dis. 2004 Oct;17(1):21-8.</strong> Both in mice and humans, low <span class="tagged-filter" title="Association Word">expression</span> levels of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">(VEGF)</a></span> are <span class="tagged-filter" title="Association Word">linked</span> to adult-onset <span class="tagged-query" title="Query">motor neuron disease</span> or <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS). The mechanism through which reduced <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> levels result in this phenotype is unknown. We therefore examined the direct effects of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> on motor neurons and found <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> to have a direct neurotrophic effect on motor neurons in vitro. Survival and vulnerability to excitotoxicity of motor neurons from <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> (delta/delta) mice was however similar to that of motor neurons from non-transgenic littermates. The <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> concentration in the spinal cord of mutant (G93A) <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice was not different from that found in wild-type <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> overexpressing mice. Upregulation of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> in the spinal cord, by housing mutant (G93A) <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">SOD1</a></span> mice in hypoxic conditions, did not affect their life span. Our results show that <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> is a <span class="tagged-gene" title="SwissProt ID: P20783; Entrez Gene ID: 4908; HGNC ID: 8023; HPRD ID: 01219; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20783">neurotrophic factor</a></span> for motor neurons in vitro, and shortage of this <span class="tagged-gene" title="SwissProt ID: P20783; Entrez Gene ID: 4908; HGNC ID: 8023; HPRD ID: 01219; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20783">neurotrophic factor</a></span> may contribute to the motor neuron death <span class="tagged-filter" title="Association Word">observed</span> in humans and animals with low <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> <span class="tagged-filter" title="Association Word">expression</span> levels.
motor_neuron_disease	VEGF	True Positive	4.729	15217349	<strong class="title">Bruijn LI, Miller TM, Cleveland DW: Unraveling the mechanisms <span class="tagged-filter" title="Association Word">involved</span> in motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration</span> in ALS. Annu Rev Neurosci. 2004;27:723-49.</strong> Although Charcot described <span class="tagged-disease" title="UMLS Concept ID: C0002736">amyotrophic lateral sclerosis</span> (ALS) more than 130 years ago, the mechanism underlying the characteristic selective degeneration and death of motor neurons in this common adult <span class="tagged-query" title="Query">motor neuron disease</span> has remained a mystery. There is no effective remedy for this progressive, fatal disorder. Modern genetics has now identified <span class="tagged-filter" title="Association Word">mutations</span> in one <span class="tagged-filter" title="Association Word">gene</span> [Cu/Zn <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">(SOD1)]</a></span> as a primary <span class="tagged-filter" title="Association Word">cause</span> and implicated others [encoding neurofilaments, cytoplasmic dynein and its processivity factor <span class="tagged-gene" title="Protein Family or Complex">dynactin,</span> and <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">(VEGF)]</a></span> as contributors to, or <span class="tagged-filter" title="Association Word">causes</span> of, <span class="tagged-query" title="Query">motor neuron diseases.</span> These insights have enabled development of model systems to test hypotheses of disease mechanism and potential therapies. Along with errors in the handling of synaptic <span class="tagged-metabolite" title="HMDB: HMDB03339"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03339">glutamate</a></span> and the potential excitotoxic response this provokes, these model systems highlight the involvement of nonneuronal cells in disease progression and provide new therapeutic strategies.
motor_neuron_disease	VEGF	True Positive	4.729	15003169	<strong class="title">Sopher BL, Thomas PS Jr, LaFevre-Bernt MA, Holm IE, Wilke SA, Ware CB, Jin LW, Libby RT, Ellerby LM, La Spada AR: <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">Androgen receptor</a></span> YAC transgenic mice recapitulate <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">motor neuronopathy</span> and implicate VEGF164 in the motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> Neuron. 2004 Mar 4;41(5):687-99.</strong> X-linked <span class="tagged-disease" title="UMLS Concept ID: Not Available">spinal and bulbar muscular atrophy</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">(SBMA)</a></span> is an inherited <span class="tagged-disease" title="UMLS Concept ID: C0027868">neuromuscular disorder</span> characterized by lower motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration.</span> <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> is <span class="tagged-filter" title="Association Word">caused</span> by <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> repeat expansions in the <a href="http://beta.uniprot.org/uniprot/P10275">androgen receptor</a></span> (AR). To determine the basis of AR <span class="tagged-metabolite" title="HMDB: HMDB00641"><span class="tagged-gene" title="SwissProt ID: O60424; Entrez Gene ID: 1387; HGNC ID: 2348; HPRD ID: 02534; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span> neurotoxicity, we introduced human AR yeast artificial chromosomes carrying either 20 or 100 CAGs into mouse embryonic stem cells. The AR100 transgenic mice developed a late-onset, gradually progressive neuromuscular phenotype accompanied by motor <span class="tagged-disease" title="UMLS Concept ID: C0027746">neuron degeneration,</span> indicating striking recapitulation of the human disease. We then tested the hypothesis that <span class="tagged-metabolite" title="HMDB: HMDB00641"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00641">polyglutamine</a></span>-expanded AR interferes with <a href="http://beta.uniprot.org/uniprot/O60424">CREB binding protein</a></span> <span class="tagged-gene" title="SwissProt ID: P06730; Entrez Gene ID: 1977; HGNC ID: 3287; HPRD ID: 00591; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06730">(CBP)</a></span>-mediated transcription of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">vascular endothelial growth factor</a></span> <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">(VEGF)</a></span> and <span class="tagged-filter" title="Association Word">observed</span> <span class="tagged-filter" title="Association Word">altered</span> <span class="tagged-gene" title="SwissProt ID: P06730; Entrez Gene ID: 1977; HGNC ID: 3287; HPRD ID: 00591; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P06730">CBP</a></span>-AR binding and <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> reduction in AR100 mice. We found that mutant AR-induced death of motor neuron-like cells could be rescued by <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF.</a></span> Our results suggest that <span class="tagged-gene" title="SwissProt ID: P10275; Entrez Gene ID: 367; HGNC ID: 644; HPRD ID: 02437; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10275">SBMA</a></span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">motor neuronopathy</span> involves <span class="tagged-filter" title="Association Word">altered</span> <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF,</a></span> consistent with a <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: P15692; Entrez Gene ID: 7422; HGNC ID: 12680; HPRD ID: 01889; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P15692">VEGF</a></span> as a neurotrophic/survival factor in <span class="tagged-query" title="Query">motor neuron disease.</span>
omphalocele	CD34	True Negative	1.537	11435469	<strong class="title">Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM: <span class="tagged-disease" title="UMLS Concept ID: C0003460">Anuria,</span> <span class="tagged-query" title="Query">omphalocele,</span> and perinatal lethality in mice <span class="tagged-filter" title="Association Word">lacking</span> the <span class="tagged-gene" title="SwissProt ID: P28906; Entrez Gene ID: 947; HGNC ID: 1662; HPRD ID: 00790; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28906">CD34</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">protein</span> podocalyxin. J Exp Med. 2001 Jul 2;194(1):13-27.</strong> Podocalyxin is a <span class="tagged-gene" title="SwissProt ID: P28906; Entrez Gene ID: 947; HGNC ID: 1662; HPRD ID: 00790; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28906">CD34</a></span>-<span class="tagged-filter" title="Association Word">related</span> sialomucin that is <span class="tagged-filter" title="Association Word">expressed</span> at high levels by podocytes, and also by mesothelial cells, vascular endothelia, platelets, and hematopoietic stem cells. To elucidate the function of podocalyxin, we generated podocalyxin-<span class="tagged-filter" title="Association Word">deficient</span> (podxl (-/)-) mice by homologous recombination. Null mice exhibit profound defects in kidney development and die within 24 hours of birth with anuric <span class="tagged-disease" title="UMLS Concept ID: C1579030">renal failure.</span> Although podocytes are present in the glomeruli of the podxl (-/)- mice, they fail to form foot processes and slit diaphragms and instead exhibit cell--cell junctional complexes (tight and adherens junctions). The corresponding reduction in permeable, glomerular filtration surface area presumably <span class="tagged-filter" title="Association Word">leads</span> to the <span class="tagged-filter" title="Association Word">observed</span> block in urine <span class="tagged-filter" title="Association Word">production.</span> In addition, podxl (-/)- mice frequently display <span class="tagged-disease" title="UMLS Concept ID: C0019270">herniation</span> of the gut <span class="tagged-query" title="Query">(omphalocele),</span> suggesting that podocalyxin may be required for retraction of the gut from the umbilical cord during development. Hematopoietic and vascular endothelial cells develop normally in the podocalyxin-<span class="tagged-filter" title="Association Word">deficient</span> mice, possibly through functional compensation by other sialomucins (such as <span class="tagged-gene" title="SwissProt ID: P28906; Entrez Gene ID: 947; HGNC ID: 1662; HPRD ID: 00790; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28906">CD34).</a></span> Our results provide the first example of an essential <span class="tagged-filter" title="Association Word">role</span> for a sialomucin in development and suggest that defects in podocalyxin could play a <span class="tagged-filter" title="Association Word">role</span> in podocyte dysfunction in <span class="tagged-disease" title="UMLS Concept ID: C1579030">renal failure</span> and <span class="tagged-query" title="Query">omphalocele</span> in humans.
omphalocele	acetylcholinesterase	True Negative	1.537	7130957	<strong class="title">Guibaud S, Simplot A, Bonnet M, Thoulon JM, Guibaud P, Robert JM: <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">[Acetylcholinesterase</a></span> of amniotic fluid: application to prenatal <span class="tagged-filter" title="Association Word">diagnosis</span> of neural tube closing defects. J Genet Hum. 1982 Mar;30(1):51-9.</strong> I. Quantitative tests]. <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">Acetylcholinesterase</a></span> <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">(AChE)</a></span> in amniotic fluid from 165 normal pregnancies and 38 abnormal pregnancies was measured, using a direct assay of <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">AChE</a></span> <span class="tagged-filter" title="Association Word">activity</span> after inhibition of ChnS with ethopropozine <span class="tagged-drug" title="DrugBank: APRD00729"><span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00729">("Lysivane").</a></span> Samples from normal pregnancies of 16-24 weeks gestation have a mean <a href="http://beta.uniprot.org/uniprot/P22303">AChE</a></span> <span class="tagged-filter" title="Association Word">activity</span> of 2,7 U/1 and those obtained at 26-40 weeks have a mean level of 0,6 U/l. Contamination of amniotic fluid with fetal or maternal blood was <span class="tagged-filter" title="Association Word">observed</span> to <span class="tagged-filter" title="Association Word">elevate</span> <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">AChE</a></span> <span class="tagged-filter" title="Association Word">activity</span> <span class="tagged-filter" title="Association Word">leading</span> to uninterpretable results. Assays in artificial mixtures of amniotic fluid with maternal or fetal blood confirm the risk <span class="tagged-filter" title="Association Word">related</span> to added erythrocyte number. Higher mean <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">AChE</a></span> <span class="tagged-filter" title="Association Word">activity,</span> 8 U/l, was <span class="tagged-filter" title="Association Word">observed</span> in <span class="tagged-filter" title="Association Word">association</span> with open NTD, but in 7 cases the level was as in normal pregnancy. <span class="tagged-filter" title="Association Word">Elevated</span> levels of <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">AChE</a></span> were found in <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-disease" title="UMLS Concept ID: C0041408">Turner's syndrome</span> (1) and intra uterine death (2); no increase was <span class="tagged-filter" title="Association Word">observed</span> in 7 cases of <span class="tagged-query" title="Query">omphalocele</span> or laparoschisis, in 6 cases of atresia and 2 cases of <span class="tagged-disease" title="UMLS Concept ID: C0020255">hydrocephaly.</span> In practice frequent occurence of bloody samples, specially from abnormal pregnancies, limits application of the test for antenatal open NTD <span class="tagged-filter" title="Association Word">diagnosis.</span> This test appears as and useful preliminary stage providing informations for realization and interpretation of gel electrophoresis of cholinesterases.
omphalocele	acetylcholinesterase	True Negative	1.537	6171116	<strong class="title">Grob PJ: <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">[Alpha-1-fetoprotein</a></span> screening--development and problems] . Soz Praventivmed. 1981 Sep;26(4):217-20.</strong> Principle and logistic of <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-1-fetoprotein</a></span> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">(AFP</a></span>-) screening is explained. It is estimated that approximately 2% of women pregnant for 16 to 18 weeks have <span class="tagged-filter" title="Association Word">elevated</span> circulating <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP.</a></span> By again measuring serum-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> and by ultrasound examination such abnormal values can be explained by multiple pregnancies, wrongly estimated duration of pregnancy, abortus, etc, in approximately half of the cases. In 0.8 to 1% of all pregnant women the high-serum-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> remains unexplained and an amniocentesis is indicated. An <span class="tagged-filter" title="Association Word">elevated</span> amniotic <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> (0.1 to 0.2% of all pregnant women) strongly points to a fetus with an open <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect.</span> By also measuring amniotic <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">acetylcholinesterase,</a></span> this <span class="tagged-filter" title="Association Word">diagnosis</span> can be distinguished from other fetal abnormalities <span class="tagged-filter" title="Association Word">associated</span> with high amniotic <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP,</a></span> such as <span class="tagged-query" title="Query">omphalocele.</span>
omphalocele	transcobalamin-II	True Positive	8.881	15937947	<strong class="title">Mills JL, Druschel CM, Pangilinan F, Pass K, Cox C, Seltzer RR, Conley MR, Brody LC: <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">Folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes</span> and <span class="tagged-query" title="Query">omphalocele.</span> Am J Med Genet A. 2005 Jul 1;136(1):8-11.</strong> Women who take <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> in the periconceptional period greatly reduce their chances of having a child with a <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect</span> (NTD). Using multivitamins may also reduce the risk of having a child with an <span class="tagged-query" title="Query">omphalocele.</span> In this study, we tested single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">genes</span> for <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> <span class="tagged-filter" title="Association Word">Polymorphisms</span> in <a href="http://beta.uniprot.org/uniprot/P42898">methylenetetrahydrofolate reductase</a></span> <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">(MTHFR),</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">methylenetetrahydrofolate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">(MTHFD1),</a></span> the reduced <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span> carrier <a href="http://beta.uniprot.org/uniprot/P41440">(SLC19A1),</a></span> and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">transcobalamin II</a></span> <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">(TCN2)</a></span> were examined in 25 children with euploid <span class="tagged-query" title="Query">omphalocele</span> and 59 matched controls. <span class="tagged-query" title="Query">Omphalocele</span> cases were significantly more likely to carry the T allele of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR</a></span> 677C--> T, a known risk factor for NTDs (odds ratio 3.50, 95% confidence interval 1.07-11.47, P=0.035). The <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">MTHFD1</a></span> R653Q, <span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41440">SLC19A1</a></span> R27H, and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">TCN2</a></span> P259R <span class="tagged-filter" title="Association Word">polymorphisms</span> showed no significant <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> In this small study, the thermolabile variant of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR,</a></span> 677C--> T, was <span class="tagged-filter" title="Association Word">associated</span> with an increased risk for <span class="tagged-query" title="Query">omphalocele.</span> This variant <span class="tagged-filter" title="Association Word">causes</span> reduced <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity,</span> thus suggesting a mechanism by which multivitamins with <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> might prevent <span class="tagged-query" title="Query">omphalocele.</span> Additional investigation is required.
omphalocele	IGF2	False Negative	1.537	11846487	<strong class="title">Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A: Overgrowth of a mouse model of the <span class="tagged-disease" title="UMLS Concept ID: Not Available">Simpson-Golabi-Behmel syndrome</span> is independent of IGF signaling. Dev Biol. 2002 Mar 1;243(1):185-206.</strong> The type 1 Simpson-Golabi-Behmel overgrowth syndrome <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">(SGBS1)</a></span> is <span class="tagged-filter" title="Association Word">caused</span> by loss-of-function <span class="tagged-filter" title="Association Word">mutations</span> of the X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> <span class="tagged-filter" title="Association Word">gene</span> encoding <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">glypican-3,</a></span> a cell-surface <span class="tagged-gene" title="SwissProt ID: P16070; Entrez Gene ID: 960; HGNC ID: 1681; HPRD ID: 00115; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16070">heparan sulfate proteoglycan</a></span> that apparently plays a negative <span class="tagged-filter" title="Association Word">role</span> in growth control by an unknown mechanism. Mice carrying a <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">Gpc3</a></span> <span class="tagged-filter" title="Association Word">gene</span> knockout exhibited several phenotypic features that resemble clinical hallmarks of <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">SGBS1,</a></span> including somatic overgrowth, renal <span class="tagged-disease" title="UMLS Concept ID: C0334044">dysplasia,</span> accessory spleens, <span class="tagged-disease" title="UMLS Concept ID: Not Available">polydactyly,</span> and placentomegaly. In <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">Gpc3</a></span>/DeltaH19 double mutants <span class="tagged-filter" title="Association Word">(lacking</span> <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> and also carrying a deletion around the <span class="tagged-gene" title="Entrez Gene ID: 283120; HGNC ID: 4713; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=283120">H19</a></span> <span class="tagged-filter" title="Association Word">gene</span> region that <span class="tagged-filter" title="Association Word">causes</span> bialellic <span class="tagged-filter" title="Association Word">expression</span> of the closely <span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">Igf2</a></span> <span class="tagged-filter" title="Association Word">gene</span> by imprint relaxation), the <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">Gpc3</a></span>-null phenotype was exacerbated, while additional <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">SGBS1</a></span> features <span class="tagged-query" title="Query">(omphalocele</span> and skeletal defects) were manifested. However, results from a detailed comparative analysis of growth patterns in double mutants <span class="tagged-filter" title="Association Word">lacking</span> <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> and also <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF2,</a></span> <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> or the type 1 IGF receptor <span class="tagged-gene" title="SwissProt ID: O43467; Entrez Gene ID: 3480; HGNC ID: 5465; HPRD ID: 00932; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43467">(IGF1R)</a></span> provided conclusive genetic evidence inconsistent with the hypothesis that <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> acts as a growth suppressor by sequestering or downregulating an IGF ligand. Nevertheless, our data are compatible with a model positing that there is downstream convergence of the independent signaling pathways in which either IGFs or (indirectly) <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> participate.
omphalocele	IGF2	True Positive	1.537	9389646	<strong class="title">Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A: Mouse mutant embryos overexpressing <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF-II</a></span> exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev. 1997 Dec 1;11(23):3128-42.</strong> In mice, the imprinted <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">Igf2</a></span> <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">(expressed</span> from the paternal allele), which encodes a growth-promoting factor <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">(IGF-II),</a></span> is <span class="tagged-filter" title="Association Word">linked</span> closely to the reciprocally imprinted <span class="tagged-gene" title="Entrez Gene ID: 283120; HGNC ID: 4713; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=283120">H19</a></span> <span class="tagged-filter" title="Association Word">locus</span> on chromosome 7. Also imprinted <span class="tagged-filter" title="Association Word">(expressed</span> from the maternal allele) is the Igf2r <span class="tagged-filter" title="Association Word">gene</span> on chromsome 17 encoding the type 2 IGF receptor that is <span class="tagged-filter" title="Association Word">involved</span> in degradation of excess <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF-II.</a></span> Double mutant embryos carrying a deletion around the <span class="tagged-gene" title="Entrez Gene ID: 283120; HGNC ID: 4713; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=283120">H19</a></span> region and also a targeted Igf2r allele, both inherited maternally, have extremely high levels of <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF-II</a></span> (7- and 11-fold higher than normal in tissues and serum, respectively) as a result of biallelic <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">Igf2</a></span> <span class="tagged-filter" title="Association Word">expression</span> (imprint relaxation by deletion of <span class="tagged-gene" title="Entrez Gene ID: 283120; HGNC ID: 4713; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=283120">H19</a></span>-<span class="tagged-filter" title="Association Word">associated</span> sequence) in combination with lack of the <span class="tagged-gene" title="SwissProt ID: P11717; Entrez Gene ID: 3482; HGNC ID: 5467; HPRD ID: 00928; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11717">IGF2R</a></span>-mediated <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF-II</a></span> turnover. This excess of <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF-II</a></span> <span class="tagged-filter" title="Association Word">causes</span> somatic overgrowth, <span class="tagged-disease" title="UMLS Concept ID: C0042782">visceromegaly,</span> placentomegaly, <span class="tagged-query" title="Query">omphalocele,</span> and cardiac and <span class="tagged-metabolite" title="HMDB: HMDB00068"><span class="tagged-gene" title="Entrez Gene ID: 283120; HGNC ID: 4713; Linking to Entrez Gene"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00068">adrenal</a></span> defects, which are also features of the <span class="tagged-disease" title="UMLS Concept ID: C0004903">Beckwith-Wiedemann syndrome</span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=283120">(BWS),</a></span> a genetically complex human disorder <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0008625">chromosomal abnormalities</span> in the 11p15.5 region where the <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF2</a></span> <span class="tagged-filter" title="Association Word">gene</span> resides. In addition, the double mutant mouse embryos exhibit skeletal defects and <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate,</span> which are manifestations <span class="tagged-filter" title="Association Word">observed</span> frequently in the <span class="tagged-disease" title="UMLS Concept ID: Not Available">Simpson-Golabi-Behmel syndrome,</span> another overgrowth disorder overlapping phenotypically, but not genetically, with <span class="tagged-gene" title="Entrez Gene ID: 283120; HGNC ID: 4713; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=283120">BWS.</a></span>
omphalocele	SGBS1	True Negative	1.537	11846487	<strong class="title">Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A: Overgrowth of a mouse model of the <span class="tagged-disease" title="UMLS Concept ID: Not Available">Simpson-Golabi-Behmel syndrome</span> is independent of IGF signaling. Dev Biol. 2002 Mar 1;243(1):185-206.</strong> The type 1 Simpson-Golabi-Behmel overgrowth syndrome <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">(SGBS1)</a></span> is <span class="tagged-filter" title="Association Word">caused</span> by loss-of-function <span class="tagged-filter" title="Association Word">mutations</span> of the X-<span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> <span class="tagged-filter" title="Association Word">gene</span> encoding <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">glypican-3,</a></span> a cell-surface <span class="tagged-gene" title="SwissProt ID: P16070; Entrez Gene ID: 960; HGNC ID: 1681; HPRD ID: 00115; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16070">heparan sulfate proteoglycan</a></span> that apparently plays a negative <span class="tagged-filter" title="Association Word">role</span> in growth control by an unknown mechanism. Mice carrying a <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">Gpc3</a></span> <span class="tagged-filter" title="Association Word">gene</span> knockout exhibited several phenotypic features that resemble clinical hallmarks of <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">SGBS1,</a></span> including somatic overgrowth, renal <span class="tagged-disease" title="UMLS Concept ID: C0334044">dysplasia,</span> accessory spleens, <span class="tagged-disease" title="UMLS Concept ID: Not Available">polydactyly,</span> and placentomegaly. In <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">Gpc3</a></span>/DeltaH19 double mutants <span class="tagged-filter" title="Association Word">(lacking</span> <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> and also carrying a deletion around the <span class="tagged-gene" title="Entrez Gene ID: 283120; HGNC ID: 4713; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=283120">H19</a></span> <span class="tagged-filter" title="Association Word">gene</span> region that <span class="tagged-filter" title="Association Word">causes</span> bialellic <span class="tagged-filter" title="Association Word">expression</span> of the closely <span class="tagged-filter" title="Association Word">linked</span> <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">Igf2</a></span> <span class="tagged-filter" title="Association Word">gene</span> by imprint relaxation), the <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">Gpc3</a></span>-null phenotype was exacerbated, while additional <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">SGBS1</a></span> features <span class="tagged-query" title="Query">(omphalocele</span> and skeletal defects) were manifested. However, results from a detailed comparative analysis of growth patterns in double mutants <span class="tagged-filter" title="Association Word">lacking</span> <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> and also <span class="tagged-gene" title="SwissProt ID: P01344; Entrez Gene ID: 3481; HGNC ID: 5466; HPRD ID: 00939; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01344">IGF2,</a></span> <span class="tagged-gene" title="SwissProt ID: P01343; Entrez Gene ID: 3479; HGNC ID: 5464; HPRD ID: 00936; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01343">IGF1,</a></span> or the type 1 IGF receptor <span class="tagged-gene" title="SwissProt ID: O43467; Entrez Gene ID: 3480; HGNC ID: 5465; HPRD ID: 00932; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O43467">(IGF1R)</a></span> provided conclusive genetic evidence inconsistent with the hypothesis that <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> acts as a growth suppressor by sequestering or downregulating an IGF ligand. Nevertheless, our data are compatible with a model positing that there is downstream convergence of the independent signaling pathways in which either IGFs or (indirectly) <span class="tagged-gene" title="SwissProt ID: P51654; Entrez Gene ID: 2719; HGNC ID: 4451; HPRD ID: 02074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51654">GPC3</a></span> participate.
omphalocele	SLC19A1	True Positive	1.537	15937947	<strong class="title">Mills JL, Druschel CM, Pangilinan F, Pass K, Cox C, Seltzer RR, Conley MR, Brody LC: <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">Folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes</span> and <span class="tagged-query" title="Query">omphalocele.</span> Am J Med Genet A. 2005 Jul 1;136(1):8-11.</strong> Women who take <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> in the periconceptional period greatly reduce their chances of having a child with a <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect</span> (NTD). Using multivitamins may also reduce the risk of having a child with an <span class="tagged-query" title="Query">omphalocele.</span> In this study, we tested single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">genes</span> for <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> <span class="tagged-filter" title="Association Word">Polymorphisms</span> in <a href="http://beta.uniprot.org/uniprot/P42898">methylenetetrahydrofolate reductase</a></span> <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">(MTHFR),</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">methylenetetrahydrofolate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">(MTHFD1),</a></span> the reduced <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span> carrier <a href="http://beta.uniprot.org/uniprot/P41440">(SLC19A1),</a></span> and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">transcobalamin II</a></span> <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">(TCN2)</a></span> were examined in 25 children with euploid <span class="tagged-query" title="Query">omphalocele</span> and 59 matched controls. <span class="tagged-query" title="Query">Omphalocele</span> cases were significantly more likely to carry the T allele of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR</a></span> 677C--> T, a known risk factor for NTDs (odds ratio 3.50, 95% confidence interval 1.07-11.47, P=0.035). The <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">MTHFD1</a></span> R653Q, <span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41440">SLC19A1</a></span> R27H, and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">TCN2</a></span> P259R <span class="tagged-filter" title="Association Word">polymorphisms</span> showed no significant <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> In this small study, the thermolabile variant of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR,</a></span> 677C--> T, was <span class="tagged-filter" title="Association Word">associated</span> with an increased risk for <span class="tagged-query" title="Query">omphalocele.</span> This variant <span class="tagged-filter" title="Association Word">causes</span> reduced <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity,</span> thus suggesting a mechanism by which multivitamins with <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> might prevent <span class="tagged-query" title="Query">omphalocele.</span> Additional investigation is required.
omphalocele	methylenetetrahydrofolate-dehydrogenase	True Positive	1.537	15937947	<strong class="title">Mills JL, Druschel CM, Pangilinan F, Pass K, Cox C, Seltzer RR, Conley MR, Brody LC: <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">Folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes</span> and <span class="tagged-query" title="Query">omphalocele.</span> Am J Med Genet A. 2005 Jul 1;136(1):8-11.</strong> Women who take <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> in the periconceptional period greatly reduce their chances of having a child with a <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect</span> (NTD). Using multivitamins may also reduce the risk of having a child with an <span class="tagged-query" title="Query">omphalocele.</span> In this study, we tested single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">genes</span> for <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> <span class="tagged-filter" title="Association Word">Polymorphisms</span> in <a href="http://beta.uniprot.org/uniprot/P42898">methylenetetrahydrofolate reductase</a></span> <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">(MTHFR),</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">methylenetetrahydrofolate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">(MTHFD1),</a></span> the reduced <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span> carrier <a href="http://beta.uniprot.org/uniprot/P41440">(SLC19A1),</a></span> and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">transcobalamin II</a></span> <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">(TCN2)</a></span> were examined in 25 children with euploid <span class="tagged-query" title="Query">omphalocele</span> and 59 matched controls. <span class="tagged-query" title="Query">Omphalocele</span> cases were significantly more likely to carry the T allele of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR</a></span> 677C--> T, a known risk factor for NTDs (odds ratio 3.50, 95% confidence interval 1.07-11.47, P=0.035). The <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">MTHFD1</a></span> R653Q, <span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41440">SLC19A1</a></span> R27H, and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">TCN2</a></span> P259R <span class="tagged-filter" title="Association Word">polymorphisms</span> showed no significant <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> In this small study, the thermolabile variant of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR,</a></span> 677C--> T, was <span class="tagged-filter" title="Association Word">associated</span> with an increased risk for <span class="tagged-query" title="Query">omphalocele.</span> This variant <span class="tagged-filter" title="Association Word">causes</span> reduced <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity,</span> thus suggesting a mechanism by which multivitamins with <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> might prevent <span class="tagged-query" title="Query">omphalocele.</span> Additional investigation is required.
omphalocele	alpha-fetoprotein	True Positive	1.996	10420042	<strong class="title">Forrester MB, Merz RD: Impact of demographic factors on prenatal <span class="tagged-filter" title="Association Word">diagnosis</span> and elective pregnancy termination because of abdominal wall defects, Hawaii, 1986-1997. Fetal Diagn Ther. 1999 Jul-Aug;14(4):206-11.</strong> OBJECTIVE: The intent of this study was to investigate the impact of various demographic factors on the antenatal <span class="tagged-filter" title="Association Word">diagnosis</span> and elective termination of <span class="tagged-disease" title="UMLS Concept ID: C0265706">abdominal wall defect</span> pregnancies. METHOD: Data were obtained from a birth defects registry in Hawaii between 1986 and 1997. RESULTS: The antenatal <span class="tagged-filter" title="Association Word">diagnosis</span> rate was higher for <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> than for <span class="tagged-query" title="Query">omphalocele</span> (76 vs. 60%). However, <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> pregnancies were substantially less frequently electively terminated than <span class="tagged-query" title="Query">omphalocele</span> pregnancies (8 vs. 29%). Factors such as year of <span class="tagged-filter" title="Association Word">diagnosis</span> and delivery, maternal age, race/ethnicity, residence, and maternal serum <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> screening affected the prenatal <span class="tagged-filter" title="Association Word">diagnosis</span> and/or elective termination of both <span class="tagged-query" title="Query">omphalocele</span> and <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> pregnancies, but frequently in different ways. CONCLUSION: This investigation determined that antenatal <span class="tagged-filter" title="Association Word">diagnosis</span> and elective termination varied with the type of <span class="tagged-disease" title="UMLS Concept ID: C0265706">abdominal wall defect</span> and selected demographic factors.
omphalocele	alpha-fetoprotein	True Positive	1.996	7524003	<strong class="title">Saller DN Jr, Canick JA, Palomaki GE, Knight GJ, Haddow JE: Second-trimester maternal serum <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein,</a></span> unconjugated <span class="tagged-metabolite" title="HMDB: HMDB00153"><span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00153">estriol,</a></span> and hCG levels in pregnancies with ventral wall defects. Obstet Gynecol. 1994 Nov;84(5):852-5.</strong> OBJECTIVE: To determine if second-trimester maternal serum concentrations of unconjugated <span class="tagged-metabolite" title="HMDB: HMDB00153"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00153">estriol</a></span> (E3) and hCG are <span class="tagged-filter" title="Association Word">altered</span> in pregnancies <span class="tagged-filter" title="Association Word">associated</span> with fetal <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> or <span class="tagged-query" title="Query">omphalocele.</span> METHODS: Concentrations of <a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">(AFP),</a></span> unconjugated E3, and hCG were measured in a case-control study <span class="tagged-filter" title="Association Word">involving</span> 23 cases of <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis,</span> 17 cases of <span class="tagged-query" title="Query">omphalocele,</span> and 200 matched unaffected pregnancies. RESULTS: As reported previously, median <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> levels were significantly higher in pregnancies with <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> and <span class="tagged-query" title="Query">omphalocele</span> compared to unaffected pregnancies (9.42 and 4.18 multiples of the unaffected population median [MoM], respectively). The median hCG values were not significantly different for the two defects (1.10 and 1.13 MoM, respectively). Six of the cases of <span class="tagged-query" title="Query">omphalocele</span> were <span class="tagged-filter" title="Association Word">associated</span> with other anomalies, but exclusion of these cases from the analysis did not <span class="tagged-filter" title="Association Word">alter</span> the conclusions. CONCLUSIONS: Unconjugated E3 and hCG measurements are not useful in screening for, or distinguishing between, open ventral wall defects. <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">Alpha-fetoprotein</a></span> measurements alone will detect nearly all cases of <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> and most cases of <span class="tagged-query" title="Query">omphalocele.</span>
omphalocele	alpha-fetoprotein	True Positive	1.996	6191039	<strong class="title">Schaffer RM, Barone C, Friedman AP: The ultrasonographic spectrum of fetal <span class="tagged-query" title="Query">omphalocele.</span> J Ultrasound Med. 1983 May;2(5):219-22.</strong> Four cases of fetal <span class="tagged-query" title="Query">omphalocele</span> <span class="tagged-filter" title="Association Word">diagnosed</span> in utero by ultrasonography represent variations in the sonographic appearance of this rare anomaly. A possible pathogenesis of <span class="tagged-query" title="Query">omphalocele</span> is presented, with a discussion of the <span class="tagged-filter" title="Association Word">associated</span> complications and the effect of diagnosing <span class="tagged-query" title="Query">omphalocele</span> prenatally on the management of the pregnancy itself. The <span class="tagged-filter" title="Association Word">association</span> between fetal <span class="tagged-query" title="Query">omphalocele</span> and <span class="tagged-filter" title="Association Word">elevated</span> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> is significant, and may <span class="tagged-metabolite" title="HMDB: HMDB01859"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01859">prompt</a></span> a search for a small <span class="tagged-query" title="Query">omphalocele</span> that would otherwise be missed on a routine obstetric sonogram. The differentiation of <span class="tagged-query" title="Query">omphalocele</span> from <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> is difficult, yet the two anomalies can be reliably differentiated sonographically.
omphalocele	alpha-fetoprotein	True Positive	1.996	6171116	<strong class="title">Grob PJ: <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">[Alpha-1-fetoprotein</a></span> screening--development and problems] . Soz Praventivmed. 1981 Sep;26(4):217-20.</strong> Principle and logistic of <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-1-fetoprotein</a></span> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">(AFP</a></span>-) screening is explained. It is estimated that approximately 2% of women pregnant for 16 to 18 weeks have <span class="tagged-filter" title="Association Word">elevated</span> circulating <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP.</a></span> By again measuring serum-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> and by ultrasound examination such abnormal values can be explained by multiple pregnancies, wrongly estimated duration of pregnancy, abortus, etc, in approximately half of the cases. In 0.8 to 1% of all pregnant women the high-serum-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> remains unexplained and an amniocentesis is indicated. An <span class="tagged-filter" title="Association Word">elevated</span> amniotic <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> (0.1 to 0.2% of all pregnant women) strongly points to a fetus with an open <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect.</span> By also measuring amniotic <span class="tagged-gene" title="SwissProt ID: P22303; Entrez Gene ID: 43; HGNC ID: 108; HPRD ID: 00010; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22303">acetylcholinesterase,</a></span> this <span class="tagged-filter" title="Association Word">diagnosis</span> can be distinguished from other fetal abnormalities <span class="tagged-filter" title="Association Word">associated</span> with high amniotic <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP,</a></span> such as <span class="tagged-query" title="Query">omphalocele.</span>
omphalocele	alpha-fetoprotein	True Positive	1.996	6170192	<strong class="title">Weise W, Hemke G: <span class="tagged-filter" title="Association Word">[Cause</span> for increased <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> values in amniotic fluid in prenatal <span class="tagged-filter" title="Association Word">diagnosis</span> of genetic defects (author's transl)]. Zentralbl Gynakol. 1981;103(13):740-50.</strong> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">Alpha-fetoprotein</a></span> measurement was undertaken in 1,582 instances, with 957 tests being applied to 776 patients for prenatal <span class="tagged-filter" title="Association Word">diagnosis</span> of genetic defects, against the background of various indications - increased <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> levels were recorded from the amniotic fluid of 24 patients (3.1 per cent). Values were defined as being increased, when they had exceeded threefold standard deviation from normal mean values. The <span class="tagged-filter" title="Association Word">causes</span> underlying increased <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> levels included six cases of anencephalia, one case of <span class="tagged-disease" title="UMLS Concept ID: C0041408">Turner's syndrome,</span> one <span class="tagged-query" title="Query">omphalocele,</span> one intra-uterine foetal death, and one puncturing injury to a foetus. No foetal malformation or other foetal disorder, known to be accompanied by increased <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> values, was recordable from 14 patients. Displacement of the pathological limit value to data five times the standard deviation reduced the number of erroneously positive findings to 0.8 per cent. Possibilities are discussed for differential of increased <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> values. The proposal is made to respond to increased <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> levels by another intensive ultrasonic B-scan test, control puncture, and, in certain cases, amniofetography.
omphalocele	alpha-fetoprotein	True Positive	1.996	6169278	<strong class="title">Fisher NL, Luthy DA, Peterson A, Karp LE, Williamson R, Cheng E: Prenatal <span class="tagged-filter" title="Association Word">diagnosis</span> of neural tube defects: predictive value of AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> in a low-risk population. Am J Med Genet. 1981;9(3):201-9.</strong> Amniotic fluid <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> (AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP)</a></span> determinations were performed on 1,215 women who were at low risk for fetal neural tube defects and who were undergoing mid-trimester amniocentesis for cytogenetic indications, primarily age-related aneuploidy. Maternal sera obtained before amniocentesis and amniotic fluids were assayed in duplicate for <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> by radioimmunoassay. Of the 1,215 low-risk women, eight (0.7%) had significant elevations of AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> (greater than or equal to +5 SD). In none of the cases was the elevation <span class="tagged-filter" title="Association Word">associated</span> with a fetal <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect.</span> Two cases with <span class="tagged-filter" title="Association Word">elevated</span> AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> were <span class="tagged-filter" title="Association Word">associated</span> with chromosome aberrations; one with impending fetal demise; one with fetal blood contamination; and one case was due to a laboratory error. In one case, no source for the <span class="tagged-filter" title="Association Word">elevated</span> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> was found, and a normal infant was delivered at term. In the final two cases, the <span class="tagged-filter" title="Association Word">cause</span> of the <span class="tagged-filter" title="Association Word">elevated</span> AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> was a fetal <span class="tagged-disease" title="UMLS Concept ID: C0265706">abdominal wall defect</span> (one <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> and one <span class="tagged-query" title="Query">omphalocele).</span> The predictive value of an <span class="tagged-filter" title="Association Word">elevated</span> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> varies with the population screened, and is reduced by routine ultrasonography before amniocentesis, which at least identifies <span class="tagged-disease" title="UMLS Concept ID: Not Available">anencephaly.</span> In a low-risk population, an <span class="tagged-filter" title="Association Word">elevated</span> AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> is most often not <span class="tagged-filter" title="Association Word">associated</span> with a fetal <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect.</span> Because of the low predictive value and the nonspecificity of AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP,</a></span> genetic counselors should reconsider the recommendation of routine AF-<span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> in low-risk maternal populations.
omphalocele	alpha-fetoprotein	True Positive	1.996	2453005	<strong class="title">Palomaki GE, Hill LE, Knight GJ, Haddow JE, Carpenter M: Second-trimester maternal serum <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> levels in pregnancies <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> and <span class="tagged-query" title="Query">omphalocele.</span> Obstet Gynecol. 1988 Jun;71(6 Pt 1):906-9.</strong> This population-based study analyzes maternal serum <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> (MSAFP) distributions for 20 cases of <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> and 13 cases of <span class="tagged-query" title="Query">omphalocele</span> occurring in singleton pregnancies from among 72,782 second-trimester pregnancies in Maine and Rhode Island screened consecutively between January 1, 1979 and February 28, 1987. Median values (and ranges) for the two lesions were 4.1 multiples of the median (0.5-29.8) for <span class="tagged-query" title="Query">omphalocele</span> and 7.0 multiples of the median (3.6-13.5) for <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis.</span> The MSAFP distributions for the two conditions were both log-Gaussian, and the log standard deviation was smaller for <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> than for <span class="tagged-query" title="Query">omphalocele.</span> The MSAFP screening sensitivity was greater for <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> than for <span class="tagged-query" title="Query">omphalocele</span> at any given cutoff, and the overall sensitivity of this screening process for detecting open ventral wall defects will differ, therefore, depending upon the relative proportion of <span class="tagged-disease" title="UMLS Concept ID: C0265706">gastroschisis</span> and <span class="tagged-query" title="Query">omphalocele</span> cases that occur in the screened population.
omphalocele	alpha-fetoprotein	True Positive	1.996	74953	<strong class="title">King CR, Prescott GH: Amniotic fluid <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> elevation with fetal <span class="tagged-query" title="Query">omphalocele</span> and a possible mechanism for its occurrence. Am J Obstet Gynecol. 1978 Feb 1;130(3):279-83.</strong> Prenatal <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-disease" title="UMLS Concept ID: C0019247">genetic disease</span> and congenital malformations has become a major area of study in obstetrics. The assessment of amniotic fluid <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">alpha-fetoprotein</a></span> <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">(AFP)</a></span> is useful for the <span class="tagged-filter" title="Association Word">diagnosis</span> of neural tube defects. As more patients have been evaluated abnormal increases have been found in other defects, such as <span class="tagged-query" title="Query">omphalocele,</span> <span class="tagged-disease" title="UMLS Concept ID: Not Available">duodenal atresia,</span> and congenital <span class="tagged-disease" title="UMLS Concept ID: C0027720">nephrosis.</span> Two patients with <span class="tagged-query" title="Query">omphalocele</span> are reported with <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> measurement. A tenfold elevation of <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> was found in the first patient. In the second case a small <span class="tagged-query" title="Query">omphalocele</span> <span class="tagged-filter" title="Association Word">associated</span> with exstrophy of the cloaca was not accompanied by an abnormal <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> increase. The mechanism of <span class="tagged-gene" title="SwissProt ID: P02771; Entrez Gene ID: 174; HGNC ID: 317; HPRD ID: 00074; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02771">AFP</a></span> elevation is discussed.
omphalocele	Alk3	True Positive	1.537	17588538	<strong class="title">Sun J, Liu YH, Chen H, Nguyen MP, Mishina Y, Upperman JS, Ford HR, Shi W: <span class="tagged-filter" title="Association Word">Deficient</span> <span class="tagged-gene" title="SwissProt ID: P36894; Entrez Gene ID: 657; HGNC ID: 1076; HPRD ID: 03192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P36894">Alk3</a></span>-mediated BMP signaling <span class="tagged-filter" title="Association Word">causes</span> prenatal <span class="tagged-query" title="Query">omphalocele</span>-like defect. Biochem Biophys Res Commun. 2007 Aug 17;360(1):238-43. Epub 2007 Jun 15.</strong> BMP signaling plays important <span class="tagged-filter" title="Association Word">roles</span> in many embryonic developmental processes. <span class="tagged-gene" title="SwissProt ID: P36894; Entrez Gene ID: 657; HGNC ID: 1076; HPRD ID: 03192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P36894">Alk3</a></span> is one of two BMP type I receptors that transduces BMP signal from the cell surface into cell. Conventional knockout of <span class="tagged-gene" title="SwissProt ID: P36894; Entrez Gene ID: 657; HGNC ID: 1076; HPRD ID: 03192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P36894">Alk3</a></span> resulted in early embryonic lethality around E7.5-E9.5. In this study, we have generated embryonic mesoderm-specific <span class="tagged-gene" title="SwissProt ID: P36894; Entrez Gene ID: 657; HGNC ID: 1076; HPRD ID: 03192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P36894">Alk3</a></span> conditional knockout by crossing <span class="tagged-gene" title="SwissProt ID: Q8WVJ9; Entrez Gene ID: 117581; HGNC ID: 20670; HPRD ID: 09616; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8WVJ9">Dermo1</a></span>-Cre and floxed <span class="tagged-gene" title="SwissProt ID: P36894; Entrez Gene ID: 657; HGNC ID: 1076; HPRD ID: 03192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P36894">Alk3</a></span> mice. Abrogation of <span class="tagged-gene" title="SwissProt ID: P36894; Entrez Gene ID: 657; HGNC ID: 1076; HPRD ID: 03192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P36894">Alk3</a></span>-mediated BMP signaling in this mouse resulted in severe defect of secondary ventral body wall formation, replicating the <span class="tagged-query" title="Query">omphalocele</span> phenotype in human. Our finding suggests that <span class="tagged-gene" title="SwissProt ID: P36894; Entrez Gene ID: 657; HGNC ID: 1076; HPRD ID: 03192; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P36894">Alk3</a></span> plays an essential <span class="tagged-filter" title="Association Word">role</span> in the formation of embryonic ventral abdominal wall, and abrogation of BMP signaling <span class="tagged-filter" title="Association Word">activity</span> due to <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">mutations</span> in its signaling components could be one of the underlying <span class="tagged-filter" title="Association Word">causes</span> of <span class="tagged-query" title="Query">omphalocele</span> at birth.
omphalocele	methylenetetrahydrofolate-reductase	True Positive	6.127	15937947	<strong class="title">Mills JL, Druschel CM, Pangilinan F, Pass K, Cox C, Seltzer RR, Conley MR, Brody LC: <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">Folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">genes</span> and <span class="tagged-query" title="Query">omphalocele.</span> Am J Med Genet A. 2005 Jul 1;136(1):8-11.</strong> Women who take <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> in the periconceptional period greatly reduce their chances of having a child with a <span class="tagged-disease" title="UMLS Concept ID: Not Available">neural tube defect</span> (NTD). Using multivitamins may also reduce the risk of having a child with an <span class="tagged-query" title="Query">omphalocele.</span> In this study, we tested single nucleotide <span class="tagged-filter" title="Association Word">polymorphisms</span> in <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">genes</span> for <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> <span class="tagged-filter" title="Association Word">Polymorphisms</span> in <a href="http://beta.uniprot.org/uniprot/P42898">methylenetetrahydrofolate reductase</a></span> <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">(MTHFR),</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">methylenetetrahydrofolate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">(MTHFD1),</a></span> the reduced <span class="tagged-metabolite" title="HMDB: HMDB00121"><span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folate</a></span> carrier <a href="http://beta.uniprot.org/uniprot/P41440">(SLC19A1),</a></span> and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">transcobalamin II</a></span> <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">(TCN2)</a></span> were examined in 25 children with euploid <span class="tagged-query" title="Query">omphalocele</span> and 59 matched controls. <span class="tagged-query" title="Query">Omphalocele</span> cases were significantly more likely to carry the T allele of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR</a></span> 677C--> T, a known risk factor for NTDs (odds ratio 3.50, 95% confidence interval 1.07-11.47, P=0.035). The <span class="tagged-gene" title="SwissProt ID: P11586; Entrez Gene ID: 4522; HGNC ID: 7432; HPRD ID: 01403; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11586">MTHFD1</a></span> R653Q, <span class="tagged-gene" title="SwissProt ID: P41440; Entrez Gene ID: 6573; HGNC ID: 10937; HPRD ID: 02691; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P41440">SLC19A1</a></span> R27H, and <span class="tagged-gene" title="SwissProt ID: P20062; Entrez Gene ID: 6948; HGNC ID: 11653; HPRD ID: 02037; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P20062">TCN2</a></span> P259R <span class="tagged-filter" title="Association Word">polymorphisms</span> showed no significant <span class="tagged-filter" title="Association Word">association</span> with <span class="tagged-query" title="Query">omphalocele.</span> In this small study, the thermolabile variant of <span class="tagged-gene" title="SwissProt ID: P42898; Entrez Gene ID: 4524; HGNC ID: 7436; HPRD ID: 06158; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P42898">MTHFR,</a></span> 677C--> T, was <span class="tagged-filter" title="Association Word">associated</span> with an increased risk for <span class="tagged-query" title="Query">omphalocele.</span> This variant <span class="tagged-filter" title="Association Word">causes</span> reduced <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">activity,</span> thus suggesting a mechanism by which multivitamins with <span class="tagged-metabolite" title="HMDB: HMDB00121"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00121">folic acid</a></span> might prevent <span class="tagged-query" title="Query">omphalocele.</span> Additional investigation is required.
omphalocele	vesicular-inhibitory-amino-acid-transporter	True Positive	1.537	16701208	<strong class="title">Wojcik SM, Katsurabayashi S, Guillemin I, Friauf E, Rosenmund C, Brose N, Rhee JS: A shared vesicular carrier allows synaptic corelease of <span class="tagged-metabolite" title="HMDB: HMDB00112"><span class="tagged-gene" title="SwissProt ID: Q9H598; Entrez Gene ID: 140679; HGNC ID: 11018; HPRD ID: 18058; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00112">GABA</a></span> and <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine.</a></span> . Neuron. 2006 May 18;50(4):575-87.</strong> The type of vesicular transporter <span class="tagged-filter" title="Association Word">expressed</span> by a neuron is thought to determine its neurotransmitter phenotype. We show that inactivation of the <a href="http://beta.uniprot.org/uniprot/Q9H598">vesicular inhibitory amino acid transporter</a></span> (Viaat, <span class="tagged-gene" title="SwissProt ID: Q9H598; Entrez Gene ID: 140679; HGNC ID: 11018; HPRD ID: 18058; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9H598">VGAT)</a></span> <span class="tagged-filter" title="Association Word">leads</span> to embryonic lethality, an abdominal defect known as <span class="tagged-query" title="Query">omphalocele,</span> and a <span class="tagged-disease" title="UMLS Concept ID: C0008925">cleft palate.</span> Loss of Viaat <span class="tagged-filter" title="Association Word">causes</span> a drastic reduction of neurotransmitter release in both GABAergic and glycinergic neurons, indicating that glycinergic neurons do not express a separate vesicular <span class="tagged-metabolite" title="HMDB: HMDB00123"><span class="tagged-gene" title="SwissProt ID: Q9H2X9; Entrez Gene ID: 57468; HGNC ID: 13818; HPRD ID: 09469; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span> transporter. This loss of GABAergic and glycinergic synaptic transmission does not impair the development of inhibitory synapses or the <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/Q9H2X9">KCC2,</a></span> the K+ -Cl- cotransporter known to be essential for the establishment of inhibitory neurotransmission. In the <span class="tagged-filter" title="Association Word">absence</span> of Viaat, <span class="tagged-metabolite" title="HMDB: HMDB00112"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00112">GABA</a></span>-synthesizing enzymes are partially lost from presynaptic terminals. Since <span class="tagged-metabolite" title="HMDB: HMDB00112"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00112">GABA</a></span> and <span class="tagged-metabolite" title="HMDB: HMDB00123"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00123">glycine</a></span> compete for vesicular uptake, these data point to a close <span class="tagged-filter" title="Association Word">association</span> of Viaat with <span class="tagged-metabolite" title="HMDB: HMDB00112"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00112">GABA</a></span>-synthesizing enzymes as a key factor in specifying GABAergic neuronal phenotypes.
omphalocele	FLNA	True Positive	1.537	15378534	<strong class="title">Katz LA, Schultz RE, Semina EV, Torfs CP, Krahn KN, Murray JC: <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> may contribute to cases of <span class="tagged-query" title="Query">omphalocele</span> and VATER-like syndromes. Am J Med Genet A. 2004 Oct 15;130(3):277-83.</strong> <span class="tagged-query" title="Query">Omphalocele</span> is a congenital anomaly with substantial morbidity. <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome,</span> an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> disorder, is characterized by craniofacial abnormalities and abdominal wall defects. <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> are etiologic in > 40% of cases of <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome.</span> We demonstrate that the birth prevalence of <span class="tagged-query" title="Query">omphalocele</span> is significantly higher in <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome</span> than in the general population, with omphaloceles found in 0.03% in the Iowa newborn population and 4.3% of patients with <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome.</span> Our objective was to screen coding and conserved non-coding regions of <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> for <span class="tagged-filter" title="Association Word">mutations</span> in 209 patients with <span class="tagged-query" title="Query">omphalocele.</span> We identified remarkable evolutionarily conserved regions by comparing the 3'UTR of <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">Pitx2</a></span> in 13 vertebrate and 3 invertebrate species. No <span class="tagged-filter" title="Association Word">mutations</span> changing the amino acid sequence were found within the <span class="tagged-query" title="Query">omphalocele</span> population. In one case of <span class="tagged-query" title="Query">omphalocele</span> with VATER-like additional anomalies, a three nucleotide deletion was found in the 3'UTR. This deletion was not seen in 1,186 controls. Also in the 3'UTR, we identified a single nucleotide <span class="tagged-filter" title="Association Word">polymorphism</span> at a highly conserved residue. Our findings suggest additional studies of <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> conserved regions will be valuable. We also screened the <span class="tagged-query" title="Query">omphalocele</span> cases for <span class="tagged-filter" title="Association Word">mutations</span> in exon 5 of the <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA.</a></span> <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA</a></span> have been shown to <span class="tagged-filter" title="Association Word">cause</span> a broad range of congenital malformations, including <span class="tagged-disease" title="UMLS Concept ID: C0265251">otopalatodigital syndrome</span> type 2 in which a missense <span class="tagged-filter" title="Association Word">mutation</span> occurring in exon 5 of <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA</a></span> results in <span class="tagged-query" title="Query">omphalocele</span> as part of the phenotype. We did not find any <span class="tagged-filter" title="Association Word">mutations</span> in exon 5 of <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA</a></span> in 179 <span class="tagged-query" title="Query">omphalocele</span> cases studied.
omphalocele	Calreticulin	True Positive	1.537	10085286	<strong class="title">Mesaeli N, Nakamura K, Zvaritch E, Dickie P, Dziak E, Krause KH, Opas M, MacLennan DH, Michalak M: <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">Calreticulin</a></span> is essential for cardiac development. J Cell Biol. 1999 Mar 8;144(5):857-68.</strong> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">Calreticulin</a></span> is a ubiquitous Ca2+ binding <span class="tagged-filter" title="Association Word">protein,</span> located in the endoplasmic reticulum lumen, which has been implicated in many diverse functions including: <span class="tagged-filter" title="Association Word">regulation</span> of intracellular Ca2+ homeostasis, chaperone <span class="tagged-filter" title="Association Word">activity,</span> steroid-mediated <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-filter" title="Association Word">regulation,</span> and cell adhesion. To understand the physiological function of <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> we used <span class="tagged-filter" title="Association Word">gene</span> targeting to create a knockout mouse for <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin.</a></span> Mice homozygous for the <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> <span class="tagged-filter" title="Association Word">gene</span> disruption developed <span class="tagged-query" title="Query">omphalocele</span> (failure of absorption of the umbilical <span class="tagged-disease" title="UMLS Concept ID: C0019270">hernia)</span> and showed a marked decrease in ventricular wall thickness and deep intertrabecular recesses in the ventricular walls. Transgenic mice expressing a green fluorescent <span class="tagged-filter" title="Association Word">protein</span> reporter <span class="tagged-filter" title="Association Word">gene</span> under the control of the <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> promoter were used to show that the <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> <span class="tagged-filter" title="Association Word">gene</span> is highly activated in the cardiovascular system during the early stages of cardiac development. <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">Calreticulin</a></span> <span class="tagged-filter" title="Association Word">protein</span> is also highly expressed in the developing heart, but it is only a minor component of the mature heart. <span class="tagged-gene" title="SwissProt ID: P01042; Entrez Gene ID: 3827; HGNC ID: 6383; HPRD ID: 01970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01042">Bradykinin</a></span>-induced Ca2+ release by the InsP3-dependent pathway was inhibited in crt-/- cells, suggesting that <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> plays a <span class="tagged-filter" title="Association Word">role</span> in Ca2+ homeostasis. <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">Calreticulin</a></span>-<span class="tagged-filter" title="Association Word">deficient</span> cells also exhibited impaired nuclear import of nuclear factor of activated T cell <span class="tagged-gene" title="SwissProt ID: Q14934; Entrez Gene ID: 4776; HGNC ID: 7778; HPRD ID: 09096; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14934">(NF-AT3)</a></span> transcription factor indicating that <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> plays a <span class="tagged-filter" title="Association Word">role</span> in cardiac development as a component of the Ca2+/<span class="tagged-gene" title="Protein Family or Complex">calcineurin</span>/NF-AT/<span class="tagged-gene" title="SwissProt ID: P43694; Entrez Gene ID: 2626; HGNC ID: 4173; HPRD ID: 08994; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P43694">GATA-4</a></span> transcription pathway.
omphalocele	PITX2	True Positive	1.537	15378534	<strong class="title">Katz LA, Schultz RE, Semina EV, Torfs CP, Krahn KN, Murray JC: <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> may contribute to cases of <span class="tagged-query" title="Query">omphalocele</span> and VATER-like syndromes. Am J Med Genet A. 2004 Oct 15;130(3):277-83.</strong> <span class="tagged-query" title="Query">Omphalocele</span> is a congenital anomaly with substantial morbidity. <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome,</span> an <span class="tagged-filter" title="Association Word">autosomal</span> <span class="tagged-filter" title="Association Word">dominant</span> disorder, is characterized by craniofacial abnormalities and abdominal wall defects. <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> <span class="tagged-filter" title="Association Word">mutations</span> are etiologic in > 40% of cases of <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome.</span> We demonstrate that the birth prevalence of <span class="tagged-query" title="Query">omphalocele</span> is significantly higher in <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome</span> than in the general population, with omphaloceles found in 0.03% in the Iowa newborn population and 4.3% of patients with <span class="tagged-disease" title="UMLS Concept ID: C0265341">Rieger syndrome.</span> Our objective was to screen coding and conserved non-coding regions of <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> for <span class="tagged-filter" title="Association Word">mutations</span> in 209 patients with <span class="tagged-query" title="Query">omphalocele.</span> We identified remarkable evolutionarily conserved regions by comparing the 3'UTR of <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">Pitx2</a></span> in 13 vertebrate and 3 invertebrate species. No <span class="tagged-filter" title="Association Word">mutations</span> changing the amino acid sequence were found within the <span class="tagged-query" title="Query">omphalocele</span> population. In one case of <span class="tagged-query" title="Query">omphalocele</span> with VATER-like additional anomalies, a three nucleotide deletion was found in the 3'UTR. This deletion was not seen in 1,186 controls. Also in the 3'UTR, we identified a single nucleotide <span class="tagged-filter" title="Association Word">polymorphism</span> at a highly conserved residue. Our findings suggest additional studies of <span class="tagged-gene" title="SwissProt ID: Q99697; Entrez Gene ID: 5308; HGNC ID: 9005; HPRD ID: 03328; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q99697">PITX2</a></span> conserved regions will be valuable. We also screened the <span class="tagged-query" title="Query">omphalocele</span> cases for <span class="tagged-filter" title="Association Word">mutations</span> in exon 5 of the <span class="tagged-filter" title="Association Word">gene</span> <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA.</a></span> <span class="tagged-filter" title="Association Word">Mutations</span> in <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA</a></span> have been shown to <span class="tagged-filter" title="Association Word">cause</span> a broad range of congenital malformations, including <span class="tagged-disease" title="UMLS Concept ID: C0265251">otopalatodigital syndrome</span> type 2 in which a missense <span class="tagged-filter" title="Association Word">mutation</span> occurring in exon 5 of <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA</a></span> results in <span class="tagged-query" title="Query">omphalocele</span> as part of the phenotype. We did not find any <span class="tagged-filter" title="Association Word">mutations</span> in exon 5 of <span class="tagged-gene" title="SwissProt ID: P21333; Entrez Gene ID: 2316; HGNC ID: 3754; HPRD ID: 02060; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21333">FLNA</a></span> in 179 <span class="tagged-query" title="Query">omphalocele</span> cases studied.
onchocerciasis	cutaneous-T-cell-attracting-chemokine	False Negative	1.122	16232219	<strong class="title">Fendt J, Hamm DM, Banla M, Schulz-Key H, Wolf H, Helling-Giese G, Heuschkel C, Soboslay PT: Chemokines in <span class="tagged-query" title="Query">onchocerciasis</span> patients after a single dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin.</a></span> . Clin Exp Immunol. 2005 Nov;142(2):318-26.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> treatment will effectively diminish microfilariae (Mf) of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in the skin of patients, but therapy is <span class="tagged-filter" title="Association Word">associated</span> with adverse host inflammatory responses. To investigate the <span class="tagged-filter" title="Association Word">association</span> of proinflammatory chemokines with the intensity of infection and clinical adverse reactions, <a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> serum levels were measured in patients following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment (100 microg/kg, 150 microg/kg or 200 microg/kg) or placebo. The density of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> Mf per mg skin decreased by 85%, 97%, 97% and 90% at day 3, at month 3, month 6 and at 1 year post-<span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin.</a></span> The <a href="http://beta.uniprot.org/uniprot/Q9Y4X3">cutaneous T cell-attracting chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">(CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27)</a></span> was found highly <span class="tagged-filter" title="Association Word">elevated</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients compared to infection-free European controls (P = 0.0004) and it did not change following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> or placebo to 1 year post-therapy. The <a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span>/<span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">CCL5</a></span> (regulated on activated and normally T cell-<span class="tagged-filter" title="Association Word">expressed)</span> was similarly high in <span class="tagged-query" title="Query">onchocerciasis</span> patients and infection-free European controls; the <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span>/<span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">CCL5</a></span> levels did not change following treatment until 6 months post-therapy but were slightly <span class="tagged-filter" title="Association Word">elevated</span> at 1 year post-therapy (P < 0.02). In contrast, the Th2-type chemoattractants, <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">thymus and activation regulated chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">(TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17)</a></span> and <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">macrophage-derived chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">(MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22),</a></span> were activated at 3 days post-<span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (P < 0.0001) to return to pretreatment or lower levels thereafter. The Th1-type chemoattractants, macrophage inflammatory <span class="tagged-filter" title="Association Word">protein</span> <a href="http://beta.uniprot.org/uniprot/Q92973">(MIP)</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4</a></span> were low before <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment, but following clearance of microfilariae of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> their levels increased from 6 months post-therapy onwards (for both at 12 months post-therapy, P < 0.0001). The adverse reaction scores (RS) in treated patients increased significantly on day 3 (P < 0.02) while it remained unchanged in those who received placebo (P = 0.22); RS interacted with the microfilarial density (P = 0.01), but not with the dose of <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> or with the serum levels of <a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17,</a></span> <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27.</a></span> Our observations suggest that following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin,</a></span> macrophages as well as memory Th2-type lymphocytes and B cells, attracted and activated by <a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27,</a></span> may contribute to dermal immune responses and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> Mf killing and clearance. The transient changes of <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17</a></span> and <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22</a></span> were not <span class="tagged-filter" title="Association Word">associated</span> with clinical adverse responses, and the later rise of <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4</a></span> showed a reactivation of Type 1 immune responses <span class="tagged-filter" title="Association Word">associated</span> with persistent low levels of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae and an expiring O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection.
onchocerciasis	eosinophil-derived-neurotoxin	True Positive	1.122	10206116	<strong class="title">Tischendorf FW, Brattig NW, Burchard GD, Kubica T, Kreuzpaintner G, Lintzel M: Eosinophils, <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">eosinophil cationic protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">eosinophil-derived neurotoxin</a></span> in serum and urine of patients with <span class="tagged-query" title="Query">onchocerciasis</span> coinfected with intestinal nematodes and in <span class="tagged-disease" title="UMLS Concept ID: C0276926">urinary schistosomiasis.</span> Acta Trop. 1999 Mar 15;72(2):157-73.</strong> Eosinophils, <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">eosinophil cationic protein</a></span> <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">(ECP),</a></span> <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">eosinophil-derived neurotoxin</a></span> <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">(EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX),</a></span> <span class="tagged-gene" title="SwissProt ID: P05164; Entrez Gene ID: 4353; HGNC ID: 7218; HPRD ID: 06102; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05164">myeloperoxidase</a></span> <span class="tagged-gene" title="SwissProt ID: P05164; Entrez Gene ID: 4353; HGNC ID: 7218; HPRD ID: 06102; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05164">(MPO)</a></span> and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> were measured in blood, serum and/or urine in <span class="tagged-disease" title="UMLS Concept ID: C0276926">Schistosoma haematobium</span>- and Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected Guineans and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>- and S. haematobium-negative Guineans coinfected or infected with intestinal nematodes. The number of eosinophils and levels of eosinophil granule <span class="tagged-filter" title="Association Word">proteins</span> but not of <span class="tagged-gene" title="SwissProt ID: P05164; Entrez Gene ID: 4353; HGNC ID: 7218; HPRD ID: 06102; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05164">MPO</a></span> were found to be strongly <span class="tagged-filter" title="Association Word">elevated</span> in all Africans as compared to European controls. The highest serum <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> and serum and urinary <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> levels were <span class="tagged-filter" title="Association Word">observed</span> in the hyperreactive form of <span class="tagged-query" title="Query">onchocerciasis</span> (sowda). <span class="tagged-query" title="Query">Onchocerciasis</span> patients and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-negative Africans coinfected or infected with intestinal nematodes (hookworm and/or Ascaris lumbricoides) revealed higher serum granule <span class="tagged-filter" title="Association Word">protein</span> concentrations and/or absolute eosinophil counts and urinary <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> than those without <span class="tagged-disease" title="UMLS Concept ID: C0027583">nematode infections.</span> Statistical differences between both sections were found for the absolute eosinophil counts and for serum <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> in generalized <span class="tagged-query" title="Query">onchocerciasis,</span> and for urinary <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> in sowda, indicating stimulation of the eosinophil potential of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-positive patients by coexistent <span class="tagged-disease" title="UMLS Concept ID: C0019911">hookworm infection.</span> This worm species, in contrast to A. lumbricoides, <span class="tagged-filter" title="Association Word">causes</span> especially high eosinophil counts and <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> levels. From these results it is concluded that in nematode diseases, <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> and <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> levels reflect the degree of antigenic stimulation, eosinophil activation and eosinophil turnover rates. Serum <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> and serum and urinary <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> may, therefore, serve as parameters to monitor <span class="tagged-disease" title="UMLS Concept ID: C0018889">helminth infection.</span> Urinary <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> may be a <span class="tagged-filter" title="Association Word">marker</span> of eosinophiluria secondary to urogenital manifestation of S. haematobium. It is <span class="tagged-filter" title="Association Word">elevated</span> in hyperreactive <span class="tagged-query" title="Query">onchocerciasis</span> activated by intestinal nematodes.
onchocerciasis	cytokine	True Positive	3.411	17302900	<strong class="title">Mai CS, Hamm DM, Banla M, Agossou A, Schulz-Key H, Heuschkel C, Soboslay PT: Onchocerca volvulus-specific <span class="tagged-filter" title="Association Word">antibody</span> and <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses in <span class="tagged-query" title="Query">onchocerciasis</span> patients after 16 years of repeated <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy. Clin Exp Immunol. 2007 Mar;147(3):504-12.</strong> The recommended control option against <span class="tagged-query" title="Query">onchocerciasis</span> is repeated <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment, which will need to be implemented for decades, and it remains unknown how repeated <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy might affect immunity against Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in the long term. O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific <span class="tagged-filter" title="Association Word">antibody</span> reactivity and cellular <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> were investigated in <span class="tagged-query" title="Query">onchocerciasis</span> patients receiving <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (150 microg/kg) annually for 16 years. In treated patients, the T helper type 2 (Th2) <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL)-5</a></span> and T regulatory <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in response to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> (OvAg) and bacteria-derived Streptolysin O (SL-O) diminished to levels found in infection-free endemic controls; also, cellular release of Th1-type <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon (IFN)-gamma</a></span> at 16 years post initial <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment (p.i.t.) approached control levels. In <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-treated <span class="tagged-query" title="Query">onchocerciasis</span> patients, <a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production</span> in responses to the mitogen phytohaemagglutinin <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">(PHA)</a></span> decreased, but <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in response <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">PHA</a></span> increased, and neither attained the <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> levels of endemic controls. At 16 years p.i.t., O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific IgG1 and IgG4 subclass reactivity still persisted at higher levels in <span class="tagged-query" title="Query">onchocerciasis</span> patients than in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> exposed but microfilariae-free endemic controls. In addition, <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses remained depressed in <span class="tagged-query" title="Query">onchocerciasis</span> patients infected concurrently with Mansonella perstans and Necator americanus or Entamoeba histolytica/dispar. Thus, long-term <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy of <span class="tagged-query" title="Query">onchocerciasis</span> may not suffice to re-establish fully a balanced Th1 and Th2 immune responsiveness in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae-negative individuals. Such <span class="tagged-filter" title="Association Word">deficient</span> reconstitution of immune competence may be due to an as yet continuing and uncontrolled reinfection with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> but parasite co-infections can also bias and may prevent the development of such immunity.
onchocerciasis	cytokine	True Positive	3.411	12010965	<strong class="title">MacDonald AJ, Turaga PS, Harmon-Brown C, Tierney TJ, Bennett KE, McCarthy MC, Simonek SC, Enyong PA, Moukatte DW, Lustigman S: Differential <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> and <span class="tagged-filter" title="Association Word">antibody</span> responses to adult and larval stages of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> consistent with the development of concomitant immunity. Infect Immun. 2002 Jun;70(6):2796-804.</strong> The possibility of concomitant immunity and its potential mechanisms in <span class="tagged-query" title="Query">Onchocerca volvulus infection</span> were examined by analyzing <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> and <span class="tagged-filter" title="Association Word">antibody</span> responses to infective larval (third-stage larvae [L3] and molting L3 [mL3]), adult female worm (F-OvAg), and skin microfilaria (Smf) <span class="tagged-filter" title="Association Word">antigens</span> in infected individuals in a region of hyperendemicity in Cameroon as a function of age. Peripheral blood mononuclear cell <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin 5</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL-5)</a></span> responses to F-OvAg and Smf <span class="tagged-filter" title="Association Word">declined</span> significantly with age (equivalent to years of exposure to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus).</span> In contrast, <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> secretion in response to L3 and mL3 remained <span class="tagged-filter" title="Association Word">elevated</span> with increasing age. <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">Gamma interferon</a></span> responses to L3, mL3, and F-OvAg were low or suppressed and unrelated to age, except for responses to Smf in older subjects. <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> levels were uniformly <span class="tagged-filter" title="Association Word">elevated,</span> regardless of age, in response to L3, mL3, and F-OvAg but not to Smf, for which levels <span class="tagged-filter" title="Association Word">declined</span> with age. A total of 49 to 60% of subjects had <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> responses to all O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> unrelated to age. Analysis of levels of stage-specific <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> G3 (IgG3) and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> revealed a striking, age-dependent dissociation between <span class="tagged-filter" title="Association Word">antibody</span> responses to larval <span class="tagged-filter" title="Association Word">antigens</span> (L3 and a recombinant L3-specific <span class="tagged-filter" title="Association Word">protein,</span> O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">ALT-1)</a></span> which were significantly increased or maintained with age and <span class="tagged-filter" title="Association Word">antibody</span> responses to F-OvAg, which decreased. Levels of IgG1 to L3 and F-OvAg were <span class="tagged-filter" title="Association Word">elevated</span> regardless of age, and levels of IgG4 increased significantly with age, although not to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: P24298; Entrez Gene ID: 2875; HGNC ID: 4552; HPRD ID: 00689; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P24298">ALT-1,</a></span> which may have unique L3-specific epitopes. Immunofluorescence staining of whole larvae showed that total anti-L3 <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> levels also increased with the age of the serum donor. The separate and distinct <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> and <span class="tagged-filter" title="Association Word">antibody</span> responses to adult and infective larval stages of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> which are age <span class="tagged-filter" title="Association Word">related</span> are consistent with the acquisition of concomitant immunity in infected individuals.
onchocerciasis	cytokine	True Positive	3.411	10403926	<strong class="title">Soboslay PT, Geiger SM, Drabner B, Banla M, Batchassi E, Kowu LA, Stadler A, Schulz-Key H: Prenatal immune priming in <span class="tagged-query" title="Query">onchocerciasis</span>-onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific cellular responsiveness and <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> in newborns from infected mothers. Clin Exp Immunol. 1999 Jul;117(1):130-7.</strong> This study investigated the effect of maternal <span class="tagged-query" title="Query">Onchocerca volvulus infection</span> on humoral and cellular responsiveness in newborn children and their mothers. Onchocerca volvulus-specific IgG isotypes and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> were significantly <span class="tagged-filter" title="Association Word">elevated</span> in infected mothers and their infants. One year post partum, O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific IgG4 was strongly reduced in children of infected mothers, while IgG1 responses weakened only slightly. Umbilical cord mononuclear blood cells (UCBC) and peripheral blood cells (PBMC) from mothers proliferated in response to phytohaemagglutinin <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">(PHA),</a></span> concanavalin A (Con A), and the bacterial <span class="tagged-filter" title="Association Word">antigens</span> streptolysin-O (SL-O) or purified <span class="tagged-filter" title="Association Word">protein</span> derivative <span class="tagged-gene" title="SwissProt ID: P32754; Entrez Gene ID: 3242; HGNC ID: 5147; HPRD ID: 02041; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32754">(PPD).</a></span> UCBC from neonates born to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected mothers responded lower (P < 0.01) to Con A (at 5 micrograms/ml), <span class="tagged-gene" title="SwissProt ID: P32754; Entrez Gene ID: 3242; HGNC ID: 5147; HPRD ID: 02041; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P32754">PPD</a></span> (at 10 and 50 micrograms/ml) and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-derived <span class="tagged-filter" title="Association Word">antigens</span> (OvAg) (at 35 micrograms/ml), and in parallel, a diminished cellular reactivity (P < 0.01) by PBMC was <span class="tagged-filter" title="Association Word">observed</span> to OvAg in mothers positive for O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Several Th1-type <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">(IL-2,</a></span> <span class="tagged-gene" title="Protein Family or Complex">IL-12,</span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour necrosis</span> factor-alpha <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF-alpha))</a></span> and Th2-type <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">(IL-4,</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5,</a></span> <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10,</a></span> <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13)</a></span> cytokines were secreted by UCBC and PBMC in response to OvAg, bacterial SL-O and <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">PHA.</a></span> OvAg did not stimulate <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and none of the mitogens or <span class="tagged-filter" title="Association Word">antigens</span> induced <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> in neonates. In response to OvAg, substantially <span class="tagged-filter" title="Association Word">elevated</span> (P < 0.01) amounts of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> were <span class="tagged-filter" title="Association Word">produced</span> by UCBC from newborns of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected mothers. UCBC secreted low levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13,</a></span> while higher amounts of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> were found (P < 0. 01) in newborns from <span class="tagged-query" title="Query">onchocerciasis</span>-free mothers. In conclusion, maternal O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infection will sensitize in utero parasite-specific cellular immune responsiveness in neonates and activate OvAg-specific <span class="tagged-filter" title="Association Word">production</span> of several Th1- and Th2-type cytokines.
onchocerciasis	cytokine	True Positive	3.411	9291349	<strong class="title">Brattig N, Nietz C, Hounkpatin S, Lucius R, Seeber F, Pichlmeier U, Pogonka T: Differences in <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> extract and recombinant Ov33 and OvL3-1 <span class="tagged-filter" title="Association Word">proteins</span> in exposed subjects with various parasitologic and clinical states. J Infect Dis. 1997 Sep;176(3):838-42.</strong> Subjects with generalized <span class="tagged-query" title="Query">onchocerciasis</span> (GEN), with the sowdah form, and with exposure but without <span class="tagged-query" title="Query">onchocerciasis</span> (endemic normal/putatively immune; EN/PI) were studied for <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> extract (OvAg) and recombinant Ov33 and OvL3-1 <span class="tagged-filter" title="Association Word">proteins.</span> Higher levels of cytokines were <span class="tagged-filter" title="Association Word">produced</span> in response to OvAgs in sowdah and EN/PI than in GEN subjects. Peripheral blood mononuclear cells did not <span class="tagged-filter" title="Association Word">produce</span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> in response to <span class="tagged-filter" title="Association Word">antigens.</span> OvAg induced <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL)-5,</a></span> <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2,</a></span> <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">(GM-CSF),</a></span> and soluble <span class="tagged-gene" title="SwissProt ID: P14784; Entrez Gene ID: 3560; HGNC ID: 6009; HPRD ID: 00896; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14784">IL-2 receptor.</a></span> EN/PI and sowdah persons <span class="tagged-filter" title="Association Word">produced</span> significantly more <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> than GEN subjects, and EN/PI subjects had significantly higher <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> levels than GEN persons. The low <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> levels in GEN subjects were increased by addition of exogenous <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2.</a></span> Ov33 and OvL3-1 stimulated <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and less <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2.</a></span> The study groups did not show a strict Th2-like <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> response.
onchocerciasis	cytokine	True Positive	3.411	8187332	<strong class="title">Soboslay PT, Luder CG, Hoffmann WH, Michaelis I, Helling G, Heuschkel C, Dreweck CM, Blanke CH, Pritze S, Banla M, et al.: <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span>-facilitated immunity in <span class="tagged-query" title="Query">onchocerciasis;</span> activation of parasite-specific Th1-type responses with subclinical <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Clin Exp Immunol. 1994 May;96(2):238-44.</strong> The present study examined the quantitative and qualitative changes registered in the parasite-specific <span class="tagged-filter" title="Association Word">antibody</span> response, cellular reactivity and <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> profile in <span class="tagged-query" title="Query">onchocerciasis</span> patients repeatedly treated with <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P32754; Entrez Gene ID: 3242; HGNC ID: 5147; HPRD ID: 02041; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> over a period of 8 years. The densities of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae (mf) in treated patients remained significantly reduced, whereas the number of permanently amicrofilaridermic patients <span class="tagged-disease" title="UMLS Concept ID: C0275522">(subclinical infection)</span> increased with repeated treatments. In vitro cellular responses to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> (OvAg) were highest (P < 0.01) in untreated control individuals exposed to infection, but negative for mf of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> (endemic normals). Cellular reactivity in repeatedly treated patients was higher at 84 than at 36 months post initial treatment (p.i.t); furthermore, the proliferative responses to OvAg, mycobacterial purified <span class="tagged-filter" title="Association Word">protein</span> derivative <a href="http://beta.uniprot.org/uniprot/P32754">(PPD)</a></span> and streptococcal SL-O were greater (P < 0.05) at 84 months p.i.t. in amicrofilaridermic than in microfilaria-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients. In amicrofilaridermic patients such reactivity approached the magnitude <span class="tagged-filter" title="Association Word">observed</span> in endemic normals. Peripheral blood mononuclear cells (PBMC) from patients and endemic normals <span class="tagged-filter" title="Association Word">produced</span> equivalent amounts of <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2,</a></span> <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> in response to mitogenic stimulation with phytohaemagglutinin <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">(PHA);</a></span> in response to OvAg, however, significantly more <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> were <span class="tagged-filter" title="Association Word">produced</span> by PBMC from subclinical amicrofilaridermic patients or endemic normals than by mf-positive patients. OvAg-specific <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> by PBMC from treated patients was lower at 84 than at 36 months p.i.t. At three months p.i.t. the titres of circulating OvAg-specific IgG1-3 had increased (P < 0.05), but they then continuously <span class="tagged-filter" title="Association Word">declined</span> with repeated treatments. Only IgG1 and IgG4 bound to OvAg of mol. wt 2-12 kD at 1 month p.i.t., while recognition of OvAg of mol. wt 10-200 kD by IgG1, IgG2 and IgG4 reached a maximum intensity at 3-6 months p.i.t., with the overall intensity of binding to OvAg gradually weakening thereafter. These results suggest that <span class="tagged-query" title="Query">onchocerciasis</span>-<span class="tagged-filter" title="Association Word">associated</span> immunosuppression is reversible following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-induced permanent clearance of microfilariae from the skin; and that a vigorous parasite-specific cellular reactivity and a sustained <span class="tagged-filter" title="Association Word">production</span> of <a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> in amicrofilaridermic individuals may contribute to controlling O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection.
onchocerciasis	cytokine	True Positive	3.411	7930742	<strong class="title">Steel C, Lujan-Trangay A, Gonzalez-Peralta C, Zea-Flores G, Nutman TB: Transient changes in <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> profiles following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis.</span> J Infect Dis. 1994 Oct;170(4):962-70.</strong> <a href="http://beta.uniprot.org/uniprot/Q06643">Cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> by peripheral blood mononuclear cells after <span class="tagged-filter" title="Association Word">antigen</span> or mitogen stimulation was assessed before and after semiannual <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of 27 patients with <span class="tagged-query" title="Query">onchocerciasis.</span> Before treatment, Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> (OvA) elicited <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <a href="http://beta.uniprot.org/uniprot/P05113">(IL)-5</a></span> <span class="tagged-filter" title="Association Word">production</span> but inhibited <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10,</a></span> <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">(GM-CSF),</a></span> and <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">tumor necrosis factor-alpha.</a></span> Six months after the first dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin,</a></span> there were increases in the <a href="http://beta.uniprot.org/uniprot/P60568">IL-2,</a></span> <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4,</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5,</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> responses to mitogen and in the <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> responses to OvA. By 24 months (after four <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> doses), OvA-induced <a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> <span class="tagged-filter" title="Association Word">production</span> and mitogen-induced <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> <span class="tagged-filter" title="Association Word">production</span> remained <span class="tagged-filter" title="Association Word">elevated</span> above pretreatment levels, whereas that of other cytokines returned to or below pretreatment levels. These transient changes in <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> response profiles of patients with <span class="tagged-query" title="Query">onchocerciasis</span> following <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment likely reflect changes in <span class="tagged-filter" title="Association Word">antigen</span> load.
onchocerciasis	cytokine	True Positive	3.411	1918387	<strong class="title">Limaye AP, Abrams JS, Silver JE, Awadzi K, Francis HF, Ottesen EA, Nutman TB: <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">Interleukin-5</a></span> and the posttreatment <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> in patients with <span class="tagged-query" title="Query">onchocerciasis.</span> J Clin Invest. 1991 Oct;88(4):1418-21.</strong> To understand the <span class="tagged-filter" title="Association Word">role</span> of the eosinophilopoietic <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in humans, the posttreatment eosinophilic response in a group of microfilaria (mf)-positive patients with <span class="tagged-query" title="Query">onchocerciasis</span> (n = 10) was examined before and after treatment with <span class="tagged-drug" title="DrugBank: APRD00918"><span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">diethylcarbamazine</a></span> (6 mg/kg for 7 d). Sequential blood samples were assessed at 24 and 1 h before treatment (baseline values), then at frequent intervals over the next 14 d. Symptom scores, skin microfilariae (mf), and peripheral blood eosinophil counts were recorded as a function of time after treatment, and serum levels of <a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> were quantitated by a highly sensitive (sensitivity greater than or equal to 20 pg/ml) monoclonal-based ELISA. Pretreatment eosinophil counts ranged from 240 to 1,186 eosinophils/microliter (geometric mean, 675), and the mf counts from 10 to 218 per mg skin (geometric mean, 79). After an initial <span class="tagged-filter" title="Association Word">decline</span> in the peripheral eosinophil count to 28 +/- 8% of pretreatment levels at 8 h after beginning treatment, the eosinophil counts steadily increased over the next 2 wk, reaching a maximum at 14 d (257 +/- 38% of pretreatment levels). Serum levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> rose sharply from pretreatment levels to a peak of 70.5 +/- 11 pg/ml by 24 h after treatment. Serum <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> remained <span class="tagged-filter" title="Association Word">elevated</span> over the next 2-3 d and <span class="tagged-filter" title="Association Word">declined</span> toward baseline by approximately 6 d after treatment, at which time the eosinophil levels were steadily increasing. <span class="tagged-gene" title="SwissProt ID: P08700; Entrez Gene ID: 3562; HGNC ID: 6011; HPRD ID: 00987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08700">IL-3</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte macrophage colony-stimulating factor,</a></span> two other cytokines implicated in eosinophilopoeisis, were not detectable in the serum at any time before or after treatment. The rise in serum <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> before the posttreatment <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> seen in this group of patients with <span class="tagged-query" title="Query">onchocerciasis</span> demonstrates a temporal relationship between <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and the subsequent development of <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> and implicates <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> as an important mediator of <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> in humans.
onchocerciasis	ALT-2	True Negative	1.122	15611611	<strong class="title">Ramachandran S, Kumar MP, Rami RM, Chinnaiah HB, Nutman T, Kaliraj P, McCarthy J: The larval specific lymphatic filarial <span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8N9E2">ALT-2:</a></span> induction of protection using <span class="tagged-filter" title="Association Word">protein</span> or DNA vaccination. Microbiol Immunol. 2004;48(12):945-55.</strong> <span class="tagged-filter" title="Association Word">Genes</span> from the infective stage of lymphatic filarial parasites <span class="tagged-filter" title="Association Word">expressed</span> at the time of host invasion have been identified as potential vaccine candidates. By screening an L3 cDNA library with sera from uninfected longstanding residents of an area endemic for <span class="tagged-query" title="Query">onchocerciasis,</span> so-called "endemic normals" (EN), we have cloned and characterized one such <span class="tagged-filter" title="Association Word">gene</span> termed the abundant larval transcript two <span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8N9E2">(ALT-2).</a></span> The stage specificity of <span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8N9E2">ALT-2</a></span> <span class="tagged-filter" title="Association Word">gene</span> transcription and protein synthesis was confirmed by PCR using genespecific primers, and by western blot analysis of <span class="tagged-filter" title="Association Word">protein</span> extracts from various stages of the parasite life cycle using specific antisera. Significant differences in <span class="tagged-filter" title="Association Word">antibody</span> response to the recombinant <span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8N9E2">ALT-2</a></span> were <span class="tagged-filter" title="Association Word">observed</span> in endemic populations with differing clinical manifestations of <span class="tagged-disease" title="UMLS Concept ID: C0013884">lymphatic filariasis</span> with an <span class="tagged-filter" title="Association Word">antibody</span> response present in sera from 18 of 25 (72%) EN subjects compared to 9 of 25 (36%) with subclinical microfilaracmia (MF) and 14 of 25 (52%) of those with chronic lymphatic obstruction (CP) (P=0.01 for comparison of EN to CP or to MF). This differential responsiveness suggests that the protective immunity postulated to account for their uninfected status might be <span class="tagged-filter" title="Association Word">associated</span> with a response to this <span class="tagged-filter" title="Association Word">protein.</span> When the utility of <span class="tagged-gene" title="SwissProt ID: Q8N9E2; Entrez Gene ID: 84706; HGNC ID: 18062; HPRD ID: 06307; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q8N9E2">ALT-2</a></span> as a vaccine candidate was tested in a murine model using either recombinant <span class="tagged-filter" title="Association Word">protein</span> or a DNA vaccine construct, statistically significant protection was <span class="tagged-filter" title="Association Word">observed</span> when compared to a control filarial <span class="tagged-filter" title="Association Word">gene</span> product <span class="tagged-filter" title="Association Word">expressed</span> across all stages of the parasite lifecycle (SXP-1; P=0.02 for <span class="tagged-filter" title="Association Word">protein</span> and P=0.01 for the DNA vaccine) or compared to adjuvant alone. This level of protection indicates that this vaccine is a promising candidate for further development.
onchocerciasis	OV-1	True Negative	1.122	7690712	<strong class="title">Chandrashekar R, Ogunrinade AF, Henry RW, Lustigman S, Weil GJ: Onchocerca volvulus: monoclonal <span class="tagged-filter" title="Association Word">antibodies</span> to immune complex-<span class="tagged-filter" title="Association Word">associated</span> parasite <span class="tagged-filter" title="Association Word">antigens.</span> Exp Parasitol. 1993 Sep;77(2):224-34.</strong> Improved methods for <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">onchocerciasis</span> are needed. We have recently identified immune complex-<span class="tagged-filter" title="Association Word">associated</span> parasite <span class="tagged-filter" title="Association Word">antigens</span> in sera from <span class="tagged-query" title="Query">onchocerciasis</span> patients. The goal of this study was to <span class="tagged-filter" title="Association Word">produce</span> monoclonal <span class="tagged-filter" title="Association Word">antibodies</span> to these <span class="tagged-filter" title="Association Word">antigens</span> that might be used in <span class="tagged-filter" title="Association Word">antigen</span> detection assays. Two monoclonal <span class="tagged-filter" title="Association Word">antibodies</span> <span class="tagged-gene" title="SwissProt ID: Q12974; Entrez Gene ID: 8073; HGNC ID: 9635; HPRD ID: 03348; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12974">(OV-1</a></span> and OV-5) that bind to parasite <span class="tagged-filter" title="Association Word">antigens</span> in immunoblots of <span class="tagged-gene" title="SwissProt ID: P09466; Entrez Gene ID: 5047; HGNC ID: 8573; HPRD ID: 01411; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09466">PEG</a></span>-precipitated immune complexes from human <span class="tagged-query" title="Query">onchocerciasis</span> sera and to corresponding <span class="tagged-filter" title="Association Word">antigens</span> in adult worm extracts and excretory-secretory products were <span class="tagged-filter" title="Association Word">produced.</span> The target epitopes of the monoclonals are heat stable, resistant to trypsin, and destroyed by Pronase. The two monoclonals <span class="tagged-filter" title="Association Word">produce</span> similar but not identical patterns of binding to immunoblots of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> adult worm <span class="tagged-filter" title="Association Word">antigen</span> with major bands at 43-47, 58-63, and 70 kDa. <span class="tagged-gene" title="SwissProt ID: Q12974; Entrez Gene ID: 8073; HGNC ID: 9635; HPRD ID: 03348; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12974">OV-1</a></span> and OV-5 appear to bind to two distinct but closely <span class="tagged-filter" title="Association Word">related</span> epitopes, neither of which is <span class="tagged-metabolite" title="HMDB: HMDB01565"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB01565">phosphorylcholine.</a></span> Immunoelectron microscopy showed that the epitopes recognized by these monoclonals are widely distributed in adult female worms, but concentrated in the uterus and intestine. <span class="tagged-filter" title="Association Word">Antigen</span> assays based on these <span class="tagged-filter" title="Association Word">antibodies</span> detected parasite <span class="tagged-filter" title="Association Word">antigen</span> in 9 of 14 sera from <span class="tagged-query" title="Query">onchocerciasis</span> patients, but significant background signal was detected in some nonendemic human sera. Thus, although this study has provided new information on parasite <span class="tagged-filter" title="Association Word">antigens</span> in sera from <span class="tagged-query" title="Query">onchocerciasis</span> patients, additional work will be needed to achieve the goal of producing a sensitive and specific <span class="tagged-filter" title="Association Word">antigen</span> diagnostic test for <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	IFN-gamma	True Positive	3.411	10722581	<strong class="title">Turaga PS, Tierney TJ, Bennett KE, McCarthy MC, Simonek SC, Enyong PA, Moukatte DW, Lustigman S: Immunity to <span class="tagged-query" title="Query">onchocerciasis:</span> cells from putatively immune individuals <span class="tagged-filter" title="Association Word">produce</span> enhanced levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5,</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">gamma interferon,</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> in response to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> larval and male worm <span class="tagged-filter" title="Association Word">antigens.</span> Infect Immun. 2000 Apr;68(4):1905-11.</strong> <span class="tagged-filter" title="Association Word">Antigen</span>-specific <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL-5),</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">gamma interferon</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma),</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">(GM-CSF)</a></span> responses in individuals living in an area of hyperendemicity for <span class="tagged-query" title="Query">onchocerciasis</span> in Cameroon were examined. The responses against <span class="tagged-filter" title="Association Word">antigens</span> prepared from Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> third-stage larvae (L3), molting L3 (mL3), and crude extract from adult males (M-OvAg) were compared to the responses against <span class="tagged-filter" title="Association Word">antigens</span> from adult female worms and skin microfilariae. <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">Cytokine</a></span> responses for the putatively immune individuals (PI) and the infected individuals <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">(INF)</a></span> were compared. A differential <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> profile of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> (Th2 phenotype) and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> (Th1 phenotype) was found in these individuals in response to the <span class="tagged-filter" title="Association Word">antigens.</span> In both the PI and the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> Th2 responses against all the <span class="tagged-filter" title="Association Word">antigens</span> tested were <span class="tagged-filter" title="Association Word">dominant.</span> However, in the PI group as a whole, there was an enhanced Th2 response against the larval <span class="tagged-filter" title="Association Word">antigens</span> and the adult male and adult female <span class="tagged-filter" title="Association Word">antigens,</span> and a Th1 response in a subgroup of the PI (27 to 54.5%) against L3, mL3, and M-OvAg <span class="tagged-filter" title="Association Word">antigens</span> was present. While the PI <span class="tagged-filter" title="Association Word">produced</span> significantly higher levels of <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> against L3, mL3, and M-OvAg <span class="tagged-filter" title="Association Word">antigens</span> than the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> there was no difference in the <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> responses of the groups against the other <span class="tagged-filter" title="Association Word">antigens.</span> The present study indicated that, in comparison to the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> the PI have distinct larva-specific and adult male-specific <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses, thus supporting the premise that immunological studies of the PI would <span class="tagged-filter" title="Association Word">lead</span> to the identification of immune mechanisms and the target <span class="tagged-filter" title="Association Word">genes</span> that play a <span class="tagged-filter" title="Association Word">role</span> in protective immunity.
onchocerciasis	IFN-gamma	True Positive	3.411	9717193	<strong class="title">Johnson EH, Schynder-Candrian S, Rajan TV, Nelson FK, Lustigman S, Abraham D: Immune responses to third stage larvae of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> and <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin-4</a></span> knockout mice. Parasite Immunol. 1998 Jul;20(7):319-24.</strong> To shed clarity on the dichotomy of reported results relative to the significance of T helper-1 vs T helper-2 immune responses in <span class="tagged-query" title="Query">onchocerciasis,</span> we compared the survivability of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> third-stage larvae (L3) in immunized mice that had either a targeted disruption of the <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">Interleukin-4</a></span> or <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">Interferon-gamma</a></span> <span class="tagged-filter" title="Association Word">gene.</span> Treatment groups consisted of control mice and mice immunized with irradiated O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> L3. All mice were challenged with diffusion chambers containing viable L3. Vaccinated <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span>-/- were unable to kill this larval target. In contrast, vaccinated <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF</a></span>-gamma-/- and C57BL/6 mice, exhibited high levels of killing, had <span class="tagged-filter" title="Association Word">elevated</span> levels of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> and significantly greater numbers of eosinophils in their diffusion chambers than the <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span>-/-. Whereas, levels of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> in all three groups of immunized mice were equivalent to those of control mice, levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> were <span class="tagged-filter" title="Association Word">elevated,</span> even in the <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span>-/-, indicating that cytokines other than <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> were <span class="tagged-filter" title="Association Word">involved</span> in its <span class="tagged-filter" title="Association Word">production.</span> The protective immune response to third-stage larvae of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in mice vaccinated with irradiated larvae has an absolute <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> requirement.
onchocerciasis	IFN-gamma	True Positive	3.411	9176114	<strong class="title">Soboslay PT, Geiger SM, Weiss N, Banla M, Luder CG, Dreweck CM, Batchassi E, Boatin BA, Stadler A, Schulz-Key H: The diverse <span class="tagged-filter" title="Association Word">expression</span> of immunity in humans at distinct states of <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Immunology. 1997 Apr;90(4):592-9.</strong> This study examined the development and persistence of immunity in humans presenting defined states of <span class="tagged-query" title="Query">Onchocerca volvulus infection,</span> i.e. in exposed endemic control individuals without microfilaridermia and clinical disease, in patients with patent or post-patent <span class="tagged-query" title="Query">onchocerciasis,</span> and in patients concurrently infected with Mansonella perstans. Onchocerca volvulus <span class="tagged-filter" title="Association Word">antigen</span> (OvAg)-specific cellular reactivity was significantly diminished in microfilariae (mf)-positive patients, while the highest reactivity was measured in exposed but mf-negative endemic controls, those being free of any clinical signs of onchocercal disease. In patients who became post-patent, responses to OvAg were significantly augmented, but did not approach entirely the magnitude <span class="tagged-filter" title="Association Word">observed</span> in endemic controls. In <span class="tagged-query" title="Query">onchocerciasis</span> patients with concurrent <span class="tagged-disease" title="UMLS Concept ID: C0024759">mansonelliasis,</span> cellular unresponsiveness to OvAg persisted, even when mf of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> were eliminated permanently by repeated <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy. Cells from mf-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients <span class="tagged-filter" title="Association Word">produced</span> significantly less <a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> (P < 0.01) and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL-5)</a></span> (P < 0.05) in response to OvAg than those taken from endemic controls or post-patent individuals in whom <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production</span> was similarly high. In contrast, both OvAg-driven as well as spontaneous <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> secretion was higher in mf-positive patients than in endemic controls or post-patent cases. In all individuals examined, serological recognition of OvAg by <span class="tagged-gene" title="Protein Family or Complex">immunoglobulins</span> was dominated by IgG4; in mf-positive patients OvAg of 205,000-12,000 molecular weight (MW) were strongly bound. In post-patent individuals, and similarly in endemic controls. OvAg recognition by IgG4 varied from intense (with numerous <span class="tagged-filter" title="Association Word">antigens</span> being recognized) to weak or absent <span class="tagged-filter" title="Association Word">antigen</span> binding. Significantly <span class="tagged-filter" title="Association Word">elevated</span> OvAg-specific IgG isotypes were measured in mf-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients in comparison with endemic controls or post-patent individuals (with the exception of IgG3). IgG1, IgG2 and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> were higher, but IgG4 was lower in endemic controls compared with post-patent <span class="tagged-query" title="Query">onchocerciasis</span> patients. The ratios of IgG4/IgG1 differed (P < 0.001) between endemic controls and mf-positive or post-patent <span class="tagged-query" title="Query">onchocerciasis</span> patients, with IgG4/IgG1 ratios of R < 3.0 being characteristic for endemic controls and post-patent O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection. In conclusion, this cross-sectional immunoepidemiological investigation showed that distinct states of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection correlate with a particular cellular and humoral immune response. The mf-free condition appeared to be <span class="tagged-filter" title="Association Word">associated</span> with a vigorous parasite-specific cellular reactivity and a particular <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> profile, while concurrent M. perstans infection depressed OvAg-specific cellular responsiveness. <span class="tagged-filter" title="Association Word">Antibody</span> responses, in all likelihood, reflected the intensity and state of infection, and not the degree of acquired immunity protective against parasite aggregation.
onchocerciasis	IFN-gamma	True Positive	3.411	8706329	<strong class="title">Luder CG, Schulz-Key H, Banla M, Pritze S, Soboslay PT: Immunoregulation in <span class="tagged-query" title="Query">onchocerciasis:</span> predominance of Th1-type responsiveness to low molecular weight <span class="tagged-filter" title="Association Word">antigens</span> of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in exposed individuals without microfilaridermia and clinical disease. Clin Exp Immunol. 1996 Aug;105(2):245-53.</strong> Chronic and generalized <span class="tagged-query" title="Query">onchocerciasis</span> is <span class="tagged-filter" title="Association Word">associated</span> with suppression of the parasite-specific cellular responsiveness, while exposed individuals without parasitological and clinical evidence of infection (endemic normals) display prominent cellular reactivity to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> (OvAg). In order to identify those parasite <span class="tagged-filter" title="Association Word">antigens</span> which may account for this differential cellular responsiveness, total adult worm-derived OvAg were fractionated by means of preparative <span class="tagged-metabolite" title="HMDB: HMDB05004"><span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB05004">SDS</a></span>-PAGE and blot-elution into 22 <span class="tagged-filter" title="Association Word">antigen</span> fractions of continuously decreasing molecular weight. Peripheral blood mononuclear cells (PBMC) from microfilariae (mf)-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients (n = 18) proliferated weakly in response to all OvAg fractions. In contrast, in vitro reactivity of PBMC from endemic normals (n = 9) was depressed in response to OvAg of mol. wt 200-30 kD only, while <span class="tagged-filter" title="Association Word">antigens</span> of mol. wt < 30 kD induced vigorous proliferation in these individuals compared with the microfilaridermic patients (P < 0.05). Highest proliferative reactivity of cells from endemic normals was <span class="tagged-filter" title="Association Word">observed</span> in response to OvAg of mol. wt 15-11 kD. Furthermore, these low mol. wt <span class="tagged-filter" title="Association Word">antigen</span> fractions induced substantial <span class="tagged-filter" title="Association Word">production</span> of <a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> in PBMC from endemic normals, but not in those from <span class="tagged-query" title="Query">onchocerciasis</span> patients. Cells from individuals of both groups secreted similar amounts of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in response to all OvAg fractions, with highest <span class="tagged-filter" title="Association Word">production</span> again being induced by low mol. wt OvAg. In contrast, PBMC from <span class="tagged-query" title="Query">onchocerciasis</span> patients clearly <span class="tagged-filter" title="Association Word">produced</span> more <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> than did cells from endemic normals. This augmented <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> <span class="tagged-filter" title="Association Word">production</span> by PBMC from mf-positive individuals was not only <span class="tagged-filter" title="Association Word">observed</span> after stimulation with OvAg fractions, but was measured in unstimulated control cultures as well. <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span>-specific <span class="tagged-filter" title="Association Word">mRNA</span> in <span class="tagged-filter" title="Association Word">antigen</span>-stimulated PBMC from endemic normals appeared to be more prominent than in cells from <span class="tagged-query" title="Query">onchocerciasis</span> patients. However, <span class="tagged-filter" title="Association Word">mRNA</span> transcripts of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> were clearly present in patients, but were absent or inconsistently <span class="tagged-filter" title="Association Word">observed</span> in endemic normals. Our results suggest that vigorous Th1-type cellular responsiveness encountered in endemic normals is restricted to low mol. wt <span class="tagged-filter" title="Association Word">antigens</span> of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> while such reactivity will not be present in mf-positive individuals. Furthermore, spontaneous <span class="tagged-filter" title="Association Word">production</span> of high levels of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients is likely to suppress Th1-type immunity, and thus may favour manifestation of chronic <span class="tagged-query" title="Query">onchocerciasis.</span> These traits of cellular immunity may contribute to the differential outcome of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection, the manifestation of clinical disease, and may also regulate the build up of acquired immunity in humans.
onchocerciasis	IFN-gamma	True Positive	3.411	8187332	<strong class="title">Soboslay PT, Luder CG, Hoffmann WH, Michaelis I, Helling G, Heuschkel C, Dreweck CM, Blanke CH, Pritze S, Banla M, et al.: <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span>-facilitated immunity in <span class="tagged-query" title="Query">onchocerciasis;</span> activation of parasite-specific Th1-type responses with subclinical <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Clin Exp Immunol. 1994 May;96(2):238-44.</strong> The present study examined the quantitative and qualitative changes registered in the parasite-specific <span class="tagged-filter" title="Association Word">antibody</span> response, cellular reactivity and <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> profile in <span class="tagged-query" title="Query">onchocerciasis</span> patients repeatedly treated with <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P32754; Entrez Gene ID: 3242; HGNC ID: 5147; HPRD ID: 02041; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> over a period of 8 years. The densities of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae (mf) in treated patients remained significantly reduced, whereas the number of permanently amicrofilaridermic patients <span class="tagged-disease" title="UMLS Concept ID: C0275522">(subclinical infection)</span> increased with repeated treatments. In vitro cellular responses to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> (OvAg) were highest (P < 0.01) in untreated control individuals exposed to infection, but negative for mf of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> (endemic normals). Cellular reactivity in repeatedly treated patients was higher at 84 than at 36 months post initial treatment (p.i.t); furthermore, the proliferative responses to OvAg, mycobacterial purified <span class="tagged-filter" title="Association Word">protein</span> derivative <a href="http://beta.uniprot.org/uniprot/P32754">(PPD)</a></span> and streptococcal SL-O were greater (P < 0.05) at 84 months p.i.t. in amicrofilaridermic than in microfilaria-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients. In amicrofilaridermic patients such reactivity approached the magnitude <span class="tagged-filter" title="Association Word">observed</span> in endemic normals. Peripheral blood mononuclear cells (PBMC) from patients and endemic normals <span class="tagged-filter" title="Association Word">produced</span> equivalent amounts of <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2,</a></span> <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> in response to mitogenic stimulation with phytohaemagglutinin <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">(PHA);</a></span> in response to OvAg, however, significantly more <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> were <span class="tagged-filter" title="Association Word">produced</span> by PBMC from subclinical amicrofilaridermic patients or endemic normals than by mf-positive patients. OvAg-specific <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> by PBMC from treated patients was lower at 84 than at 36 months p.i.t. At three months p.i.t. the titres of circulating OvAg-specific IgG1-3 had increased (P < 0.05), but they then continuously <span class="tagged-filter" title="Association Word">declined</span> with repeated treatments. Only IgG1 and IgG4 bound to OvAg of mol. wt 2-12 kD at 1 month p.i.t., while recognition of OvAg of mol. wt 10-200 kD by IgG1, IgG2 and IgG4 reached a maximum intensity at 3-6 months p.i.t., with the overall intensity of binding to OvAg gradually weakening thereafter. These results suggest that <span class="tagged-query" title="Query">onchocerciasis</span>-<span class="tagged-filter" title="Association Word">associated</span> immunosuppression is reversible following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-induced permanent clearance of microfilariae from the skin; and that a vigorous parasite-specific cellular reactivity and a sustained <span class="tagged-filter" title="Association Word">production</span> of <a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> in amicrofilaridermic individuals may contribute to controlling O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection.
onchocerciasis	protein-C	True Negative	1.122	8077726	<strong class="title">Njoo FL, Hack CE, Oosting J, Luyendijk L, Stilma JS, Kijlstra A: <span class="tagged-gene" title="SwissProt ID: P02741; Entrez Gene ID: 1401; HGNC ID: 2367; HPRD ID: 00422; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02741">C-reactive protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> are <span class="tagged-filter" title="Association Word">elevated</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P07602; Entrez Gene ID: 5660; HGNC ID: 9498; HPRD ID: 01460; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. J Infect Dis. 1994 Sep;170(3):663-8.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis</span> can induce adverse reactions. Mechanisms underlying these reactions are poorly understood but may include activation of neutrophils. This study investigated the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients during 2 days after <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. The acute-phase <a href="http://beta.uniprot.org/uniprot/P07602">protein C</a></span>-reactive <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">(CRP)</a></span> and cytokines that mediate the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(tumor necrosis factor-alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">[TNF alpha]</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">[IL-6])</a></span> were measured in 144 skin snip-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients and 12 skin snip-negative controls who received one dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (150 micrograms/kg). No <span class="tagged-filter" title="Association Word">elevated</span> <a href="http://beta.uniprot.org/uniprot/P01375">TNF alpha</a></span> levels were found, but <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> and <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP</a></span> were <span class="tagged-filter" title="Association Word">elevated</span> in 25.7% and 50.7% of the patients, respectively, after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. Most patients (89.2%) with raised <a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> also had raised <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP.</a></span> Such increases were not <span class="tagged-filter" title="Association Word">observed</span> in controls and in patients were correlated with adverse reactions and microfilarial densities. These findings suggest a possible <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in microfilarial destruction following <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment.
onchocerciasis	TLR2	True Negative	1.122	15210803	<strong class="title">Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A: The major surface <span class="tagged-filter" title="Association Word">protein</span> of Wolbachia endosymbionts in filarial nematodes elicits immune responses through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span> J Immunol. 2004 Jul 1;173(1):437-45.</strong> More than 150 million humans in tropical countries are infected by filarial nematodes which harbor intracellular bacterial endosymbionts of the genus Wolbachia (Rickettsiales). These bacteria have been implicated in adverse effects of drug treatment in <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> The present study provides evidence that purified major Wolbachia surface <span class="tagged-filter" title="Association Word">protein</span> (rWSP) acts as an inducer of the innate immune system through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4:</a></span> 1) recombinant, stringently purified rWSP elicited the release of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha,</a></span> <span class="tagged-gene" title="Protein Family or Complex">IL-12,</span> and <span class="tagged-gene" title="SwissProt ID: P10145; Entrez Gene ID: 3576; HGNC ID: 6025; HPRD ID: 00909; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10145">IL-8</a></span> from cultured blood cells of both Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected and uninfected people; 2) the inflammatory response to rWSP challenge was <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span>- and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4</a></span>-dependent as demonstrated with TLR-transfected fibroblastoid cells, as well as macrophages and dendritic cells from functional TLR-<span class="tagged-filter" title="Association Word">deficient</span> mice; 3) blood cells of <span class="tagged-query" title="Query">onchocerciasis</span> patients exposed to rWSP also generated down-regulating mediators <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and PGE (2) after 6 days of culture; 4) furthermore, rWSP-reactive IgG1 Abs were present in sera of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected people but not in those of uninfected Europeans. The lack of rWSP-reactive <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and IgG4 in serum indicated a bias toward a Th1-type adaptive immune response. Abs against rWSP stained endobacteria in living and degenerating adult O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> filariae, tissue microfilariae and host tissue macrophages that apparently had engulfed microfilariae. Thus, filarial helminths, through products of their endobacteria such as WSP, acquire characteristics of a typical microbial pathogen inducing immune responses via <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span>
onchocerciasis	IL-12	False Positive	4.493	15210803	<strong class="title">Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A: The major surface <span class="tagged-filter" title="Association Word">protein</span> of Wolbachia endosymbionts in filarial nematodes elicits immune responses through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span> J Immunol. 2004 Jul 1;173(1):437-45.</strong> More than 150 million humans in tropical countries are infected by filarial nematodes which harbor intracellular bacterial endosymbionts of the genus Wolbachia (Rickettsiales). These bacteria have been implicated in adverse effects of drug treatment in <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> The present study provides evidence that purified major Wolbachia surface <span class="tagged-filter" title="Association Word">protein</span> (rWSP) acts as an inducer of the innate immune system through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4:</a></span> 1) recombinant, stringently purified rWSP elicited the release of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha,</a></span> <span class="tagged-gene" title="Protein Family or Complex">IL-12,</span> and <span class="tagged-gene" title="SwissProt ID: P10145; Entrez Gene ID: 3576; HGNC ID: 6025; HPRD ID: 00909; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10145">IL-8</a></span> from cultured blood cells of both Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected and uninfected people; 2) the inflammatory response to rWSP challenge was <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span>- and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4</a></span>-dependent as demonstrated with TLR-transfected fibroblastoid cells, as well as macrophages and dendritic cells from functional TLR-<span class="tagged-filter" title="Association Word">deficient</span> mice; 3) blood cells of <span class="tagged-query" title="Query">onchocerciasis</span> patients exposed to rWSP also generated down-regulating mediators <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and PGE (2) after 6 days of culture; 4) furthermore, rWSP-reactive IgG1 Abs were present in sera of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected people but not in those of uninfected Europeans. The lack of rWSP-reactive <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and IgG4 in serum indicated a bias toward a Th1-type adaptive immune response. Abs against rWSP stained endobacteria in living and degenerating adult O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> filariae, tissue microfilariae and host tissue macrophages that apparently had engulfed microfilariae. Thus, filarial helminths, through products of their endobacteria such as WSP, acquire characteristics of a typical microbial pathogen inducing immune responses via <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span>
onchocerciasis	IL-5	True Positive	13.689	17302900	<strong class="title">Mai CS, Hamm DM, Banla M, Agossou A, Schulz-Key H, Heuschkel C, Soboslay PT: Onchocerca volvulus-specific <span class="tagged-filter" title="Association Word">antibody</span> and <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses in <span class="tagged-query" title="Query">onchocerciasis</span> patients after 16 years of repeated <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy. Clin Exp Immunol. 2007 Mar;147(3):504-12.</strong> The recommended control option against <span class="tagged-query" title="Query">onchocerciasis</span> is repeated <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment, which will need to be implemented for decades, and it remains unknown how repeated <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy might affect immunity against Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in the long term. O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific <span class="tagged-filter" title="Association Word">antibody</span> reactivity and cellular <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> were investigated in <span class="tagged-query" title="Query">onchocerciasis</span> patients receiving <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (150 microg/kg) annually for 16 years. In treated patients, the T helper type 2 (Th2) <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL)-5</a></span> and T regulatory <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in response to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> (OvAg) and bacteria-derived Streptolysin O (SL-O) diminished to levels found in infection-free endemic controls; also, cellular release of Th1-type <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon (IFN)-gamma</a></span> at 16 years post initial <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment (p.i.t.) approached control levels. In <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-treated <span class="tagged-query" title="Query">onchocerciasis</span> patients, <a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production</span> in responses to the mitogen phytohaemagglutinin <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">(PHA)</a></span> decreased, but <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in response <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">PHA</a></span> increased, and neither attained the <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> levels of endemic controls. At 16 years p.i.t., O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific IgG1 and IgG4 subclass reactivity still persisted at higher levels in <span class="tagged-query" title="Query">onchocerciasis</span> patients than in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> exposed but microfilariae-free endemic controls. In addition, <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses remained depressed in <span class="tagged-query" title="Query">onchocerciasis</span> patients infected concurrently with Mansonella perstans and Necator americanus or Entamoeba histolytica/dispar. Thus, long-term <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy of <span class="tagged-query" title="Query">onchocerciasis</span> may not suffice to re-establish fully a balanced Th1 and Th2 immune responsiveness in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae-negative individuals. Such <span class="tagged-filter" title="Association Word">deficient</span> reconstitution of immune competence may be due to an as yet continuing and uncontrolled reinfection with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> but parasite co-infections can also bias and may prevent the development of such immunity.
onchocerciasis	IL-5	True Positive	13.689	10722581	<strong class="title">Turaga PS, Tierney TJ, Bennett KE, McCarthy MC, Simonek SC, Enyong PA, Moukatte DW, Lustigman S: Immunity to <span class="tagged-query" title="Query">onchocerciasis:</span> cells from putatively immune individuals <span class="tagged-filter" title="Association Word">produce</span> enhanced levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5,</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">gamma interferon,</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> in response to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> larval and male worm <span class="tagged-filter" title="Association Word">antigens.</span> Infect Immun. 2000 Apr;68(4):1905-11.</strong> <span class="tagged-filter" title="Association Word">Antigen</span>-specific <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL-5),</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">gamma interferon</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma),</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">(GM-CSF)</a></span> responses in individuals living in an area of hyperendemicity for <span class="tagged-query" title="Query">onchocerciasis</span> in Cameroon were examined. The responses against <span class="tagged-filter" title="Association Word">antigens</span> prepared from Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> third-stage larvae (L3), molting L3 (mL3), and crude extract from adult males (M-OvAg) were compared to the responses against <span class="tagged-filter" title="Association Word">antigens</span> from adult female worms and skin microfilariae. <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">Cytokine</a></span> responses for the putatively immune individuals (PI) and the infected individuals <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">(INF)</a></span> were compared. A differential <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> profile of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> (Th2 phenotype) and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> (Th1 phenotype) was found in these individuals in response to the <span class="tagged-filter" title="Association Word">antigens.</span> In both the PI and the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> Th2 responses against all the <span class="tagged-filter" title="Association Word">antigens</span> tested were <span class="tagged-filter" title="Association Word">dominant.</span> However, in the PI group as a whole, there was an enhanced Th2 response against the larval <span class="tagged-filter" title="Association Word">antigens</span> and the adult male and adult female <span class="tagged-filter" title="Association Word">antigens,</span> and a Th1 response in a subgroup of the PI (27 to 54.5%) against L3, mL3, and M-OvAg <span class="tagged-filter" title="Association Word">antigens</span> was present. While the PI <span class="tagged-filter" title="Association Word">produced</span> significantly higher levels of <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> against L3, mL3, and M-OvAg <span class="tagged-filter" title="Association Word">antigens</span> than the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> there was no difference in the <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> responses of the groups against the other <span class="tagged-filter" title="Association Word">antigens.</span> The present study indicated that, in comparison to the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> the PI have distinct larva-specific and adult male-specific <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses, thus supporting the premise that immunological studies of the PI would <span class="tagged-filter" title="Association Word">lead</span> to the identification of immune mechanisms and the target <span class="tagged-filter" title="Association Word">genes</span> that play a <span class="tagged-filter" title="Association Word">role</span> in protective immunity.
onchocerciasis	IL-5	True Positive	13.689	9294549	<strong class="title">Brattig NW, Henkle-Duhrsen KH, Hounkpatin S, Liebau E, Kruppa TF, Zipfel PF: Characterization of human immune responses to the cytosolic <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> and <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> from Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Trop Med Int Health. 1997 Aug;2(8):788-98.</strong> In <span class="tagged-query" title="Query">onchocerciasis</span> patients and in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-exposed individuals without signs of onchocericiasis, T- and B-cell responses to two recombinantly <span class="tagged-filter" title="Association Word">expressed</span> O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> enzymes were analysed and compared to responses to total <span class="tagged-filter" title="Association Word">protein</span> extract of adult parasites. The cytosolic enzymes Cu/Zn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> (OvSOD1) and <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase 2</a></span> (OvGST2) represent 2 detoxifying molecules which may play an important <span class="tagged-filter" title="Association Word">role</span> in parasite defense against host-induced oxidative stress. The T-cell response to the two recombinant <span class="tagged-filter" title="Association Word">proteins</span> was analysed by investigating the <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses of peripheral blood mononuclear cells. Induction of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> at the <span class="tagged-filter" title="Association Word">mRNA</span> level and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> at the <span class="tagged-filter" title="Association Word">protein</span> level was demonstrated in patients with the generalized form of <span class="tagged-query" title="Query">onchocerciasis</span> and endemic normals without clinical manifestations. <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> was not found to be induced by either <span class="tagged-filter" title="Association Word">antigen.</span> This pattern of <span class="tagged-gene" title="SwissProt ID: P22749; Entrez Gene ID: 10578; HGNC ID: 4414; HPRD ID: 01788; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22749">lymphokine</a></span> <span class="tagged-filter" title="Association Word">expression</span> is indicative of a Th2-type response. Compared to patients with the generalized form, a higher level of <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> induction was <span class="tagged-filter" title="Association Word">observed</span> in the group of endemic normals. Low but significant IgG levels were <span class="tagged-filter" title="Association Word">observed</span> against OvSOD1 in patients with <span class="tagged-query" title="Query">onchocerciasis;</span> higher <span class="tagged-filter" title="Association Word">antibody</span> levels were found against OvGST2 in patients and endemic normals. The highest IgG levels were detected against the crude O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> extract. These results indicate that the two recombinant O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">proteins</span> induce moderate T and B cell responses.
onchocerciasis	IL-5	True Positive	13.689	9176114	<strong class="title">Soboslay PT, Geiger SM, Weiss N, Banla M, Luder CG, Dreweck CM, Batchassi E, Boatin BA, Stadler A, Schulz-Key H: The diverse <span class="tagged-filter" title="Association Word">expression</span> of immunity in humans at distinct states of <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Immunology. 1997 Apr;90(4):592-9.</strong> This study examined the development and persistence of immunity in humans presenting defined states of <span class="tagged-query" title="Query">Onchocerca volvulus infection,</span> i.e. in exposed endemic control individuals without microfilaridermia and clinical disease, in patients with patent or post-patent <span class="tagged-query" title="Query">onchocerciasis,</span> and in patients concurrently infected with Mansonella perstans. Onchocerca volvulus <span class="tagged-filter" title="Association Word">antigen</span> (OvAg)-specific cellular reactivity was significantly diminished in microfilariae (mf)-positive patients, while the highest reactivity was measured in exposed but mf-negative endemic controls, those being free of any clinical signs of onchocercal disease. In patients who became post-patent, responses to OvAg were significantly augmented, but did not approach entirely the magnitude <span class="tagged-filter" title="Association Word">observed</span> in endemic controls. In <span class="tagged-query" title="Query">onchocerciasis</span> patients with concurrent <span class="tagged-disease" title="UMLS Concept ID: C0024759">mansonelliasis,</span> cellular unresponsiveness to OvAg persisted, even when mf of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> were eliminated permanently by repeated <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy. Cells from mf-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients <span class="tagged-filter" title="Association Word">produced</span> significantly less <a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> (P < 0.01) and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL-5)</a></span> (P < 0.05) in response to OvAg than those taken from endemic controls or post-patent individuals in whom <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production</span> was similarly high. In contrast, both OvAg-driven as well as spontaneous <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> secretion was higher in mf-positive patients than in endemic controls or post-patent cases. In all individuals examined, serological recognition of OvAg by <span class="tagged-gene" title="Protein Family or Complex">immunoglobulins</span> was dominated by IgG4; in mf-positive patients OvAg of 205,000-12,000 molecular weight (MW) were strongly bound. In post-patent individuals, and similarly in endemic controls. OvAg recognition by IgG4 varied from intense (with numerous <span class="tagged-filter" title="Association Word">antigens</span> being recognized) to weak or absent <span class="tagged-filter" title="Association Word">antigen</span> binding. Significantly <span class="tagged-filter" title="Association Word">elevated</span> OvAg-specific IgG isotypes were measured in mf-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients in comparison with endemic controls or post-patent individuals (with the exception of IgG3). IgG1, IgG2 and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> were higher, but IgG4 was lower in endemic controls compared with post-patent <span class="tagged-query" title="Query">onchocerciasis</span> patients. The ratios of IgG4/IgG1 differed (P < 0.001) between endemic controls and mf-positive or post-patent <span class="tagged-query" title="Query">onchocerciasis</span> patients, with IgG4/IgG1 ratios of R < 3.0 being characteristic for endemic controls and post-patent O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection. In conclusion, this cross-sectional immunoepidemiological investigation showed that distinct states of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection correlate with a particular cellular and humoral immune response. The mf-free condition appeared to be <span class="tagged-filter" title="Association Word">associated</span> with a vigorous parasite-specific cellular reactivity and a particular <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> profile, while concurrent M. perstans infection depressed OvAg-specific cellular responsiveness. <span class="tagged-filter" title="Association Word">Antibody</span> responses, in all likelihood, reflected the intensity and state of infection, and not the degree of acquired immunity protective against parasite aggregation.
onchocerciasis	IL-5	True Positive	13.689	8099937	<strong class="title">Steel C, Nutman TB: <span class="tagged-filter" title="Association Word">Regulation</span> of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in <span class="tagged-query" title="Query">onchocerciasis.</span> J Immunol. 1993 Jun 15;150(12):5511-8.</strong> A critical <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2.</a></span> . The <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> profiles of PBMC obtained from individuals "immune" to <span class="tagged-query" title="Query">Onchocerca volvulus infection</span> were compared to those from infected individuals. The immune individuals had significantly higher levels of both <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in response to parasite Ag than did those individuals with active infection (mean <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> = 1.3 and 0.138 U/ml, respectively; mean <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> = 973 and 147.4 pg/ml, respectively), and there was a direct correlation between the <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5.</a></span> To examine the mechanism underlying the possible <span class="tagged-filter" title="Association Word">association</span> between these two cytokines in patients infected with <span class="tagged-query" title="Query">onchocerciasis,</span> reverse transcription followed by polymerase chain reaction was used to measure <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA.</span> In response to rIL-2, <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> appeared as early as early as 3 h after stimulation of patient PBMC, reaching a peak at 24 h; further, this response was inhibited with neutralizing <span class="tagged-filter" title="Association Word">antibodies</span> to <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2.</a></span> <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> was unable to induce <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> for <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4,</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma,</a></span> <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10,</a></span> or granulocyte-macrophage-CSF. To assess whether <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> was specifically responsible for the up-<span class="tagged-filter" title="Association Word">regulation</span> of Ag-induced <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production</span> in patients with <span class="tagged-query" title="Query">onchocerciasis,</span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> was measured in PBMC stimulated with parasite Ag. Up-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> was seen in all patients (peaking at 72 h) in response to Ag stimulation and was found to be independent of proliferation to Ag; in addition, this up-<span class="tagged-filter" title="Association Word">regulation</span> was specifically inhibited by neutralizing anti-<span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">antibodies.</span> Further, the primary source of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> was determined to be <span class="tagged-gene" title="SwissProt ID: P01730; Entrez Gene ID: 920; HGNC ID: 1678; HPRD ID: 01740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01730">CD4+</a></span> T cells. These findings suggest that <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">production</span> is required to induce <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and further implicates <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> as a possible mediator of protection in <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	IL-5	True Positive	13.689	1918387	<strong class="title">Limaye AP, Abrams JS, Silver JE, Awadzi K, Francis HF, Ottesen EA, Nutman TB: <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">Interleukin-5</a></span> and the posttreatment <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> in patients with <span class="tagged-query" title="Query">onchocerciasis.</span> J Clin Invest. 1991 Oct;88(4):1418-21.</strong> To understand the <span class="tagged-filter" title="Association Word">role</span> of the eosinophilopoietic <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in humans, the posttreatment eosinophilic response in a group of microfilaria (mf)-positive patients with <span class="tagged-query" title="Query">onchocerciasis</span> (n = 10) was examined before and after treatment with <span class="tagged-drug" title="DrugBank: APRD00918"><span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">diethylcarbamazine</a></span> (6 mg/kg for 7 d). Sequential blood samples were assessed at 24 and 1 h before treatment (baseline values), then at frequent intervals over the next 14 d. Symptom scores, skin microfilariae (mf), and peripheral blood eosinophil counts were recorded as a function of time after treatment, and serum levels of <a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> were quantitated by a highly sensitive (sensitivity greater than or equal to 20 pg/ml) monoclonal-based ELISA. Pretreatment eosinophil counts ranged from 240 to 1,186 eosinophils/microliter (geometric mean, 675), and the mf counts from 10 to 218 per mg skin (geometric mean, 79). After an initial <span class="tagged-filter" title="Association Word">decline</span> in the peripheral eosinophil count to 28 +/- 8% of pretreatment levels at 8 h after beginning treatment, the eosinophil counts steadily increased over the next 2 wk, reaching a maximum at 14 d (257 +/- 38% of pretreatment levels). Serum levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> rose sharply from pretreatment levels to a peak of 70.5 +/- 11 pg/ml by 24 h after treatment. Serum <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> remained <span class="tagged-filter" title="Association Word">elevated</span> over the next 2-3 d and <span class="tagged-filter" title="Association Word">declined</span> toward baseline by approximately 6 d after treatment, at which time the eosinophil levels were steadily increasing. <span class="tagged-gene" title="SwissProt ID: P08700; Entrez Gene ID: 3562; HGNC ID: 6011; HPRD ID: 00987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08700">IL-3</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte macrophage colony-stimulating factor,</a></span> two other cytokines implicated in eosinophilopoeisis, were not detectable in the serum at any time before or after treatment. The rise in serum <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> before the posttreatment <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> seen in this group of patients with <span class="tagged-query" title="Query">onchocerciasis</span> demonstrates a temporal relationship between <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and the subsequent development of <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> and implicates <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> as an important mediator of <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia</span> in humans.
onchocerciasis	IRBP	False Negative	1.122	2378211	<strong class="title">Van der Lelij A, Rothova A, Stilma JS, Vetter JC, Hoekzema R, Kijlstra A: Humoral and cell-mediated immune response against human retinal <span class="tagged-filter" title="Association Word">antigens</span> in relation to <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> Acta Leiden. 1990;59(1-2):271-83.</strong> Autoimmune mechanisms are thought to be <span class="tagged-filter" title="Association Word">involved</span> in the pathogenesis of the chorioretinal changes in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> The humoral <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response</span> was determined by measuring serum levels of autoantibodies, directed against human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: P10745; Entrez Gene ID: 5949; HGNC ID: 9921; HPRD ID: 01581; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10745">interphotoreceptor retinoid binding protein</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">(IRBP)</a></span> using an <span class="tagged-filter" title="Association Word">enzyme</span> immunoassay. The cell-mediated immune response to these <span class="tagged-filter" title="Association Word">antigens</span> and a crude retinal extract was investigated by means of a two-step migration inhibition factor assay. Patients with <span class="tagged-query" title="Query">onchocerciasis</span> (n = 50) were subdivided into three groups: 1. without ocular involvement (n = 10), 2. with <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis</span> limited to the anterior segment (n = 19), 3. with onchocercal <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy</span> (n = 21). A group of endemic controls from Sierra Leone, West Africa were also studied. The cellular immune response to Concanavalin A was measured to assess the general capacity of lymphocytes to respond to a mitogen. High levels of anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were detected in patients with <span class="tagged-query" title="Query">onchocerciasis</span> and endemic controls. The levels of both anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were significantly higher in <span class="tagged-query" title="Query">onchocerciasis</span> patients compared to endemic controls (Mann-Whitney ranksum test; p less than 0.001 respectively 0.002). No relationship could be demonstrated between the anti-retinal <span class="tagged-filter" title="Association Word">antibody</span> level and the occurrence of <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> The occurrence of the anti-retinal <span class="tagged-filter" title="Association Word">antibodies</span> as a result of crossreactivity of anti-retinal <span class="tagged-filter" title="Association Word">antibodies</span> with parasitic <span class="tagged-filter" title="Association Word">antigens</span> or of induction of polyclonal B-cell activation due to <span class="tagged-disease" title="UMLS Concept ID: C0747256">parasitic infection</span> is discussed, since high <span class="tagged-filter" title="Association Word">antibody</span> levels were also found in patients with <span class="tagged-disease" title="UMLS Concept ID: C0392663">Bancroftian filariasis</span> from Papua New Guinea and Surinam. The migration inhibition factor assay, in which the cell-mediated immune response to human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen,</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> and retinal extract was tested, showed that four out of 50 (8%) patients with <span class="tagged-query" title="Query">onchocerciasis</span> and four out of 25 (16%) endemic controls reacted with at least one retinal <span class="tagged-filter" title="Association Word">antigen.</span> From the patients with onchocercal <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy</span> two out of 21 (10%) showed a positive cellular response. The general mitogen response tested with Con A was positive in all these individuals. In conclusion, circulating <span class="tagged-filter" title="Association Word">antibodies</span> against human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> or human <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> are thus nor specific for <span class="tagged-query" title="Query">onchocerciasis</span> and in themselves not sufficient to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy</span> in <span class="tagged-query" title="Query">onchocerciasis,</span> although their pathogenic <span class="tagged-filter" title="Association Word">role</span> in an ongoing <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> cannot be excluded. Furthermore a <span class="tagged-filter" title="Association Word">role</span> for a cell-mediated anti-retinal autoimmune mechanism in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> in <span class="tagged-query" title="Query">onchocerciasis</span> as studied with human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen,</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> or crude retinal extract could not be demonstrated.
onchocerciasis	IRBP	True Positive	1.122	2365568	<strong class="title">Van der Lelij A, Doekes G, Hwan BS, Vetter JC, Rietveld E, Stilma JS, Kijlstra A: Humoral <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response</span> against <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1374-80.</strong> Autoimmune mechanisms are thought to play a <span class="tagged-filter" title="Association Word">role</span> in the pathogenesis of the chorioretinal changes in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> In this study, the involvement of autoimmunity against retinal <span class="tagged-filter" title="Association Word">antigens</span> in developing <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> was investigated. Serum levels of autoantibodies, directed against human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: P10745; Entrez Gene ID: 5949; HGNC ID: 9921; HPRD ID: 01581; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10745">interphotoreceptor retinoid-binding protein</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">(IRBP),</a></span> were determined in patients with <span class="tagged-query" title="Query">onchocerciasis</span> (n = 46) and endemic controls (n = 38) from Sierra Leone with the use of an <span class="tagged-filter" title="Association Word">enzyme</span> immunoassay. In both groups high levels of anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were detected. No relationship could be demonstrated between the antiretinal <span class="tagged-filter" title="Association Word">antibody</span> level and the occurrence of <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> in <span class="tagged-query" title="Query">onchocerciasis.</span> The levels of both anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were significantly higher in patients with <span class="tagged-query" title="Query">onchocerciasis</span> compared with endemic controls (P less than 0.001). Cross-reactivity of antiretinal <span class="tagged-filter" title="Association Word">antibodies</span> with parasitic <span class="tagged-filter" title="Association Word">antigens</span> could not be demonstrated as a possible explanation for the higher levels in patients with <span class="tagged-query" title="Query">onchocerciasis.</span> No correlation was found between the levels of <span class="tagged-filter" title="Association Word">antibodies</span> of different classes against the crude Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> the egg <span class="tagged-filter" title="Association Word">antigen,</span> or the microfilariae and the antiretinal <span class="tagged-filter" title="Association Word">antibody</span> levels. Furthermore, in a panel of 13 different monoclonal <span class="tagged-filter" title="Association Word">antibodies</span> directed against O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> only one showed a slight anti-human <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> reactivity and none reacted with <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen.</a></span> The immune response against the two retinal <span class="tagged-filter" title="Association Word">antigens</span> investigated was not specific for <span class="tagged-query" title="Query">onchocerciasis</span> because high <span class="tagged-filter" title="Association Word">antibody</span> levels were also found in patients with <span class="tagged-disease" title="UMLS Concept ID: C0392663">Bancroftian filariasis</span> from Papua, New Guinea, and Surinam.(ABSTRACT TRUNCATED AT 250 WORDS)
onchocerciasis	immunoglobulin	True Positive	2.870	15642982	<strong class="title">Gomez-Priego A, Mendoza R, de-la-Rosa JL: Prevalence of <span class="tagged-filter" title="Association Word">antibodies</span> to onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in residents of Oaxaca, Mexico, treated for 10 years with <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin.</a></span> Clin Diagn Lab Immunol. 2005 Jan;12(1):40-3.</strong> Studies to determine the prevalence of <span class="tagged-filter" title="Association Word">antibodies</span> to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> prior to and after actions carried out to interrupt transmission, are scarce in Mexico. Here we report the prevalence of <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> G (IgG) and IgG4 <span class="tagged-filter" title="Association Word">antibodies</span> in an <span class="tagged-filter" title="Association Word">enzyme</span>-<span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay (ELISA) against a crude extract of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> adult worm in serum samples from persons under noninterrupted biannual treatment with <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> in areas of <span class="tagged-query" title="Query">onchocercosis</span> endemicity in Mexico. To perform the prevalence studies, the ELISA procedures were first evaluated. Serological studies were performed with serum samples from skin microfilaria carriers from Guatemala and from people microfilariodermic negative living in the same area as the Guatemalan patients. Sensitivity values for IgG or IgG4 detection were 71 and 86%, while specificities were 92 and 100%, respectively. No anti-O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antibodies</span> were found in samples from nonendemic controls from Mexico, but 3 of 71 samples from residents in the <span class="tagged-query" title="Query">onchocercosis</span> area of Oaxaca, Mexico, and who have been under <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment during the last 10 years were only positive to IgG. Notwithstanding that the IgG4 isotype was not detected and a low (4.2%) anti-O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> IgG <span class="tagged-filter" title="Association Word">antibody</span> prevalence was found, a seroepidemiological follow-up must be performed in order to confirm interruption of <span class="tagged-query" title="Query">onchocercosis</span> transmission in the area of Oaxaca, Mexico, in which <span class="tagged-query" title="Query">onchocercosis</span> is endemic.
onchocerciasis	immunoglobulin	True Positive	2.870	9196778	<strong class="title">Wanni NO, Strote G, Rubaale T, Brattig NW: Demonstration of <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> G <span class="tagged-filter" title="Association Word">antibodies</span> against Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> excretory-secretory <span class="tagged-filter" title="Association Word">antigens</span> in different forms and stages of <span class="tagged-query" title="Query">onchocerciasis.</span> Trans R Soc Trop Med Hyg. 1997 Mar-Apr;91(2):226-30.</strong> The excretory-secretory (E-S) products of helminths are considered to comprise immunogenic molecules of high diagnostic value. In the present study, the serodiagnostic potential of the E-S products released in vitro by cultured female Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> was investigated by <span class="tagged-filter" title="Association Word">enzyme</span>-<span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay (ELISA) and Western blotting using 190 serum samples from persons infected with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> and unexposed persons. The sensitivity of detection of anti-O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> E-S <span class="tagged-filter" title="Association Word">antibodies</span> was 94% for sera from patients with the generalized form of <span class="tagged-query" title="Query">onchocerciasis</span> and 100% for sera from patients with the chronic hyperreactive form (sowda). 95% of the sera from amicrofilaridermic persons, who subsequently became microfilaridermic within 2 years, reacted with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> E-S <span class="tagged-filter" title="Association Word">antigens</span> and the donors were therefore regarded as having had a prepatent infection when first examined. These sera gave higher (P < 0.05) ELISA optical densities than sera from the same persons obtained when they had become patent, indicating a loss of <span class="tagged-filter" title="Association Word">antibody</span> reactivity after emergence of microfilariae. The specificity of the E-S ELISA was 100% when sera of subjects infected with Wuchereria bancrofti were used, and at least 88% for Mansonella perstans sera. In Western blot analysis, the sera of persons with generalized <span class="tagged-query" title="Query">onchocerciasis</span> recognized 7 <span class="tagged-filter" title="Association Word">protein</span> bands. Many E-S <span class="tagged-filter" title="Association Word">proteins</span> were stained less intensely by the sera of subjects with generalized <span class="tagged-query" title="Query">onchocerciasis</span> than by the sera of sowda patients. Similar <span class="tagged-filter" title="Association Word">antigen</span> bands were demonstrated using sera from the persons with prepatent infections.
onchocerciasis	immunoglobulin	True Positive	2.870	8770512	<strong class="title">Gbakima AA, Nutman TB, Bradley JE, McReynolds LA, Winget MD, Hong Y, Scott AL: <span class="tagged-gene" title="Protein Family or Complex">Immunoglobulin</span> G subclass responses of children during infection with Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Clin Diagn Lab Immunol. 1996 Jan;3(1):98-104.</strong> To characterize the patterns of <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> G (IgG) subclass and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> reactivity during the early stages of <span class="tagged-query" title="Query">onchocerciasis,</span> sera were collected from 224 children (age groups, 2 to 5, 6 to 10, and 11 to 15 years) residing in a region of Sierra Leone where Onchocerca volvulus is endemic, and these samples were tested by <span class="tagged-filter" title="Association Word">enzyme</span>-<span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay for their reactivity to adult <span class="tagged-filter" title="Association Word">antigens</span> (OvAg) and against four recombinant <span class="tagged-filter" title="Association Word">proteins</span> (OV11, OV27, OV29, and OV16). Over 88% of the samples contained detectable levels of anti-OvAg IgG. In samples from microfilaria (MF)-positive children, IgG4 responses were significantly <span class="tagged-filter" title="Association Word">elevated</span> and constituted on average 39, 35 and 28% of the total IgG responses for the age groups of 2 to 5, 6 to 10, and 11 to 15 years, respectively. For MF-negative individuals, the mean contributions of IgG4 to the total IgG response were 11% (2 to 5 years), 27% (6 to 10 years), and 56% (11 to 15 years). OvAg-specific <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> was detectable in the sera from both MF-negative and MF-positive individuals. To increase the specificity of the response, recombinant <span class="tagged-filter" title="Association Word">antigens</span> OV11, OV27, and OV29 were tested individually or as a <span class="tagged-drug" title="DrugBank: APRD00080"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00080">cocktail.</a></span> Nearly 50% of the MF-negative children and 85% of the MF-positive children had detectable levels of IgG against at least one of the recombinant <span class="tagged-filter" title="Association Word">antigens.</span> Only a small portion of the IgG against the recombinant peptides was IgG4. The prevalence of IgG against OV16 in samples from MF-negative children was 51%, and that for MF-positive children was 75%. The general profile of the humoral immune responses mounted by both MF-positive and a large percentage of the MF-negative children during the initial phases of infection with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> is similar to the profile reported for adults harboring chronic O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infections. These results suggest that very quickly after infection, the interactions between parasite and host result in an immunological environment that may contribute to the maintenance of a long-term, <span class="tagged-disease" title="UMLS Concept ID: C0151317">chronic infection.</span>
onchocerciasis	immunoglobulin	True Positive	2.870	8349749	<strong class="title">Ogunrinade AF, Chandrashekar R, Eberhard ML, Weil GJ: Preliminary evaluation of recombinant Onchocerca volvulus <span class="tagged-filter" title="Association Word">antigens</span> for serodiagnosis of <span class="tagged-query" title="Query">onchocerciasis.</span> J Clin Microbiol. 1993 Jul;31(7):1741-5.</strong> Serodiagnostic assays for <span class="tagged-query" title="Query">onchocerciasis</span> based on native <span class="tagged-filter" title="Association Word">antigens</span> are hampered by the scarcity of <span class="tagged-filter" title="Association Word">antigen,</span> and they suffer from poor specificity. The present study was designed to evaluate the diagnostic utility of recently described recombinant Onchocerca volvulus <span class="tagged-filter" title="Association Word">antigens</span> OC 3.6 and OC 9.3 in <span class="tagged-filter" title="Association Word">enzyme</span> immunoassays. The recombinant <span class="tagged-filter" title="Association Word">proteins</span> were <span class="tagged-filter" title="Association Word">expressed</span> as <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> fusions and were tested in several <span class="tagged-filter" title="Association Word">enzyme</span> immunoassay formats to measure <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> G (IgG) and IgG4 <span class="tagged-filter" title="Association Word">antibodies</span> with sera from patients with <span class="tagged-query" title="Query">onchocerciasis</span> in Nigeria and with various types of control sera. The best results were obtained by measuring IgG4 <span class="tagged-filter" title="Association Word">antibodies</span> to the fusion <span class="tagged-filter" title="Association Word">proteins.</span> Forty of 42 (95%) serum specimens from patients with <span class="tagged-query" title="Query">onchocerciasis</span> were reactive with OC 3.6; the reactivity with OC 9.3 was 81%. Results obtained with sera from experimentally infected chimpanzees suggest that OC 3.6 might be especially useful for detecting prepatent infections in humans, while OC 9.3 mainly detects mature, patent infections. Sera from individuals in Nigeria and the United States residing in areas nonendemic for <span class="tagged-query" title="Query">onchocerciasis</span> were uniformly nonreactive with these <span class="tagged-filter" title="Association Word">antigens</span> in IgG and IgG4 assays, as were sera from patients with <span class="tagged-disease" title="UMLS Concept ID: C0392663">bancroftian filariasis,</span> brugian <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0003950">ascariasis,</span> schistomiasis, and <span class="tagged-disease" title="UMLS Concept ID: C0013100">dracunculiasis.</span> These results suggest that <span class="tagged-filter" title="Association Word">enzyme</span> immunoassays based on the recombinant <span class="tagged-filter" title="Association Word">antigens</span> OC 3.6 and OC 9.3 are useful for the <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	immunoglobulin	True Positive	2.870	3324466	<strong class="title">Parkhouse RM, Almond NM, Cabrera Z, Harnett W: Nematode <span class="tagged-filter" title="Association Word">antigens</span> in protection, <span class="tagged-filter" title="Association Word">diagnosis</span> and pathology. Vet Immunol Immunopathol. 1987 Dec;17(1-4):313-24.</strong> A thorough study of parasite <span class="tagged-filter" title="Association Word">antigens</span> is a prerequisite for control programmes based on protection by vaccination, accurate serodiagnosis and perhaps immune modulation to diminish pathological sequelae. Stage specific surface secreted and somatic <span class="tagged-filter" title="Association Word">antigens</span> may be of particular value in proceeding towards these goals. The design of vaccines is most appropriately focused on surface <span class="tagged-filter" title="Association Word">antigens.</span> With respect to pathology, certain <span class="tagged-filter" title="Association Word">antigens</span> must stimulate humoral and, or cellular immune responses which are responsible for the undesirable immunopathologic consequences of the disease. The ultimate objective, therefore, is identification of those particular <span class="tagged-filter" title="Association Word">antigens</span> followed by appropriate down <span class="tagged-filter" title="Association Word">regulation</span> of the immune system in order to delete such potentially harmful immunological reactions. The relevant illustration presented in this context is an interesting correlation between one particular clinical condition of <span class="tagged-query" title="Query">onchocerciasis</span> ("sowda") and the serological response, defined both in terms of the parasite <span class="tagged-filter" title="Association Word">antigen</span> and an <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> class restricted <span class="tagged-filter" title="Association Word">antibody</span> response. Current parasitological methods of <span class="tagged-filter" title="Association Word">diagnosis</span> consistently underestimate parasite prevalence. Failure to detect low level patent infections incurs the risk of having a reservoir capable of perpetuating infections. There is, then, an urgent requirement for accurate serodiagnosis, to be used in <span class="tagged-filter" title="Association Word">association</span> with, and for the evaluation of, drug treatment and vector elimination in parasite control programmes. Given the high sensitivity of current immunoassay technology, the only bar to establishing the necessary immunological tests is the choice of suitably specific antibody-<span class="tagged-filter" title="Association Word">antigen</span> systems. Once these are identified, a combination of recombinant nucleic acid biochemistry and hybridoma technology should provide the necessary reagents for inexpensive, robust and specific diagnostic tests. In addition, it may not be many years before the ubiquitous RIA and ELISA technology gives way to the newly developing biosensor systems. Finally, given the sensitivity and specificity of today's nucleic acid hybridization techniques, we may soon expect to see specific identification of infective larvae in their vectors of this, a cloned DNA probe specific for Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> and with potential for the detection of infective larvae in blackflies is described.
onchocerciasis	immunoglobulin	True Positive	2.870	3224441	<strong class="title">Cabrera Z, Buttner DW, Parkhouse RM: Unique recognition of a low molecular weight Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> by IgG3 <span class="tagged-filter" title="Association Word">antibodies</span> in chronic hyper-reactive oncho-<span class="tagged-disease" title="UMLS Concept ID: C0011603">dermatitis</span> <span class="tagged-disease" title="UMLS Concept ID: C0344024">(Sowda).</span> Clin Exp Immunol. 1988 Nov;74(2):223-9.</strong> Individual human Ig class responses to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> have been evaluated by Western blotting using sera from cases of generalized <span class="tagged-query" title="Query">onchocerciasis</span> and chronic hyper-reactive <span class="tagged-query" title="Query">onchocerciasis</span> <span class="tagged-disease" title="UMLS Concept ID: C0344024">(Sowda).</span> in all cases except IgG3 the patterns of recognition by human <span class="tagged-filter" title="Association Word">antibody</span> classes were similar in <span class="tagged-disease" title="UMLS Concept ID: C0344024">Sowda</span> and generalized <span class="tagged-query" title="Query">onchocerciasis.</span> Weak or undetectable responses were seen with IgG1, IgG2 and IgM. The total profiles of <span class="tagged-filter" title="Association Word">antigens</span> recognized by the other Ig classes were different, although in some cases certain bands were commonly identified. The result with IgG3, however, was striking. Here, two major <span class="tagged-filter" title="Association Word">antigens</span> (9 kD and 72kD) were recognized by IgG3 <span class="tagged-filter" title="Association Word">antibodies</span> in <span class="tagged-disease" title="UMLS Concept ID: C0344024">Sowda</span> sera but not generalized <span class="tagged-query" title="Query">onchocerciasis</span> sera. Furthermore, these two <span class="tagged-filter" title="Association Word">antigens</span> were not recognised by any other Ig class, either in generalized or <span class="tagged-disease" title="UMLS Concept ID: C0344024">Sowda</span> <span class="tagged-query" title="Query">onchocerciasis,</span> nor were they detected by <span class="tagged-filter" title="Association Word">antibodies</span> of any class present in a collection of sera representative of other <span class="tagged-disease" title="UMLS Concept ID: C0027583">nematode infections.</span> This difference in the IgG3 response was so pronounced that <span class="tagged-disease" title="UMLS Concept ID: C0344024">Sowda</span> sera could be distinguished from generalized <span class="tagged-query" title="Query">onchocerciasis</span> sera by an IgG3-specific ELISA assay with a <span class="tagged-gene" title="SwissProt ID: P30536; Entrez Gene ID: 706; HGNC ID: 1158; HPRD ID: 15913; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P30536">PBS</a></span> parasite extract as the <span class="tagged-filter" title="Association Word">antigen.</span> Thus, a correlation has been established between one particular clinical condition of <span class="tagged-query" title="Query">onchocerciasis</span> <span class="tagged-disease" title="UMLS Concept ID: C0344024">(Sowda)</span> and a serological response, defined in terms of both the parasite <span class="tagged-filter" title="Association Word">antigens</span> and an <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> class restricted <span class="tagged-filter" title="Association Word">antibody</span> response.
onchocerciasis	immunoglobulin	True Positive	2.870	2682485	<strong class="title">Parkhouse RM, Harrison LJ: <span class="tagged-filter" title="Association Word">Antigens</span> of parasitic helminths in <span class="tagged-filter" title="Association Word">diagnosis,</span> protection and pathology. Parasitology. 1989;99 Suppl:S5-19.</strong> A thorough study of parasitic helminth <span class="tagged-filter" title="Association Word">antigens</span> is a pre-requisite for control programmes based on accurate immunochemical <span class="tagged-filter" title="Association Word">diagnosis,</span> protection by vaccination and perhaps immune modulation to diminish pathological sequelae. Studies should be directed at the identification of those stage- or age-specific surface, secreted and somatic <span class="tagged-filter" title="Association Word">antigens</span> which are <span class="tagged-filter" title="Association Word">involved</span> in the host-parasite interactions responsible for immunity and/or pathology. Current methods of <span class="tagged-filter" title="Association Word">diagnosis</span> of parasitic infections often fail to detect low-level patent infections, which incurs the risk of having a reservoir capable of perpetuating infections. There is, then, an urgent requirement for accurate immunochemical <span class="tagged-filter" title="Association Word">diagnosis,</span> to be used in <span class="tagged-filter" title="Association Word">association</span> with, and for the evaluation of, drug treatment and vector elimination, in parasite control programmes. Given the high sensitivity of current immunoassay technology, the only bar to establishing the necessary immunological tests is the choice of suitably specific <span class="tagged-filter" title="Association Word">antigen</span>/<span class="tagged-filter" title="Association Word">antibody</span> systems. Assays designed to detect parasite products or <span class="tagged-filter" title="Association Word">antigens</span> are a major priority, as they indicate current infection, whereas those which detect <span class="tagged-filter" title="Association Word">antibody</span> only indicate exposure to infection, which may or may not be current. Surface and secreted <span class="tagged-filter" title="Association Word">antigens</span> are the most likely targets for protective immune responses and thus form a logical focus for vaccine design. The cestodes, which present such strong evidence for immunity following natural infection, are likely to yield effective vaccines by modern procedures. Certain <span class="tagged-filter" title="Association Word">antigens</span> must, however, stimulate the humoral and/or cellular responses which are responsible for the undesirable immunopathological consequences of many helminthic diseases. The nematodes and trematodes furnish some extreme examples of such pathology. The ultimate objective in identifying these particular <span class="tagged-filter" title="Association Word">antigens</span> is to utilize them in the appropriate down-<span class="tagged-filter" title="Association Word">regulation</span> of the immune response responsible for such pathology. As an illustration, we have presented an interesting correlation between one particular clinical condition of <span class="tagged-query" title="Query">onchocerciasis</span> <span class="tagged-disease" title="UMLS Concept ID: C0344024">(Sowda)</span> and the serological response, defined both in terms of the parasite <span class="tagged-filter" title="Association Word">antigens</span> and an <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> class-restricted <span class="tagged-filter" title="Association Word">antibody</span> response. Finally, the complexity of these parasite systems and the host response to the parasite should not be underestimated. Modern analytical techniques allow their detailed analysis in terms of the humoral <span class="tagged-filter" title="Association Word">antibody</span> responses and afford the possibility of the future development of control and disease management procedures tailored to each individual host-parasite system. However, novel systems are required to complete the analysis of the cellular components of the immune response to parasite <span class="tagged-filter" title="Association Word">antigens,</span> and functional studies are needed to determine the role that these parasite <span class="tagged-filter" title="Association Word">antigens</span> play in the complex interaction between parasite and host.
onchocerciasis	MCP-3	True Negative	1.122	10794432	<strong class="title">Cooper PJ, Beck LA, Espinel I, Deyampert NM, Hartnell A, Jose PJ, Paredes W, Guderian RH, Nutman TB: <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">Eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> <span class="tagged-filter" title="Association Word">expression</span> by the dermal endothelium is <span class="tagged-filter" title="Association Word">associated</span> with eosinophil infiltration after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis.</span> Clin Immunol. 2000 Apr;95(1 Pt 1):51-61.</strong> The <span class="tagged-filter" title="Association Word">roles</span> of <a href="http://beta.uniprot.org/uniprot/P51671">eotaxin,</a></span> <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES,</a></span> and <span class="tagged-gene" title="SwissProt ID: P80098; Entrez Gene ID: 6354; HGNC ID: 10634; HPRD ID: 01150; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P80098">MCP-3</a></span> <span class="tagged-filter" title="Association Word">expression</span> in eosinophil recruitment to the site of parasite killing that occurs following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis</span> were assessed in the skin of 13 Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected subjects and two noninfected controls before and after <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. Adverse reactions in infected subjects were <span class="tagged-filter" title="Association Word">associated</span> with the appearance of eosinophils in the dermis as part of a perivascular inflammatory infiltrate. Although no <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> and <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> was seen in dermal vascular endothelial cells in biopsies taken before treatment (nor at any time in the skin of uninfected controls), endothelial <span class="tagged-filter" title="Association Word">expression</span> of both <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> was noted by 24 h following treatment. While <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> <span class="tagged-filter" title="Association Word">expression</span> was transient, <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> <span class="tagged-filter" title="Association Word">expression</span> increased in parallel with increasing eosinophil recruitment up to 60 h posttreatment. These observations indicate that endothelial <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> may have an important <span class="tagged-filter" title="Association Word">role</span> in eosinophil recruitment into the skin during helminth-killing reactions.
onchocerciasis	myosin	True Negative	1.122	8719949	<strong class="title">Zhang D, Miller DJ: Characterization of a novel non-muscle <span class="tagged-gene" title="SwissProt ID: Q14786; Entrez Gene ID: 389031; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14786">myosin</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">protein</span> from Onchocerca gibsoni. Int J Parasitol. 1995 Dec;25(12):1385-91.</strong> A cDNA library was constructed in lambda gt11 using poly (A)+ <span class="tagged-filter" title="Association Word">mRNA</span> from early larvae of Onchocerca gibsoni. Screening of the library using serum from a single <span class="tagged-query" title="Query">onchocerciasis</span> patient yielded several strongly immunoreactive clones, one of which (OGK2) was found to encode a novel <span class="tagged-gene" title="SwissProt ID: Q14786; Entrez Gene ID: 389031; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14786">myosin</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">protein.</span> cDNA clone OGK2 contained an insert of 2017 bp, consisting of continuous open reading frame in frame with the vector, hence this clone encodes 671 amino acid residues of a larger <span class="tagged-filter" title="Association Word">protein.</span> A fragment (619 nt) of the OGK2 cDNA was subcloned into the <span class="tagged-filter" title="Association Word">expression</span> vector pGEX-1N to generate a <span class="tagged-gene" title="SwissProt ID: Q15424; Entrez Gene ID: 6294; HGNC ID: 10520; HPRD ID: 04205; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q15424">glutathione S-transferase fusion protein.</a></span> Polyclonal antiserum raised to this fusion <span class="tagged-filter" title="Association Word">protein</span> strongly recognised an O. gibsoni <span class="tagged-filter" title="Association Word">protein</span> of approximately 220 kDa. Immunolocalization studies indicated that this <span class="tagged-filter" title="Association Word">protein</span> was <span class="tagged-filter" title="Association Word">associated</span> predominantly with the hypodermis and a number of other specific membrane layers in the adult parasite. <span class="tagged-gene" title="SwissProt ID: Q14786; Entrez Gene ID: 389031; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14786">Myosin</a></span>-<span class="tagged-filter" title="Association Word">related</span> <span class="tagged-filter" title="Association Word">proteins</span> are frequently immunodominant parasite <span class="tagged-filter" title="Association Word">antigens</span> and in a number of studies have been shown to confer a degree of protective immunity against the corresponding parasite. Evaluation of the protective potential of the OGK2 <span class="tagged-filter" title="Association Word">protein,</span> therefore, appears to be warranted.
onchocerciasis	TNF-alpha	True Positive	1.122	15210803	<strong class="title">Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A: The major surface <span class="tagged-filter" title="Association Word">protein</span> of Wolbachia endosymbionts in filarial nematodes elicits immune responses through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span> J Immunol. 2004 Jul 1;173(1):437-45.</strong> More than 150 million humans in tropical countries are infected by filarial nematodes which harbor intracellular bacterial endosymbionts of the genus Wolbachia (Rickettsiales). These bacteria have been implicated in adverse effects of drug treatment in <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> The present study provides evidence that purified major Wolbachia surface <span class="tagged-filter" title="Association Word">protein</span> (rWSP) acts as an inducer of the innate immune system through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4:</a></span> 1) recombinant, stringently purified rWSP elicited the release of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha,</a></span> <span class="tagged-gene" title="Protein Family or Complex">IL-12,</span> and <span class="tagged-gene" title="SwissProt ID: P10145; Entrez Gene ID: 3576; HGNC ID: 6025; HPRD ID: 00909; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10145">IL-8</a></span> from cultured blood cells of both Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected and uninfected people; 2) the inflammatory response to rWSP challenge was <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span>- and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4</a></span>-dependent as demonstrated with TLR-transfected fibroblastoid cells, as well as macrophages and dendritic cells from functional TLR-<span class="tagged-filter" title="Association Word">deficient</span> mice; 3) blood cells of <span class="tagged-query" title="Query">onchocerciasis</span> patients exposed to rWSP also generated down-regulating mediators <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and PGE (2) after 6 days of culture; 4) furthermore, rWSP-reactive IgG1 Abs were present in sera of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected people but not in those of uninfected Europeans. The lack of rWSP-reactive <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and IgG4 in serum indicated a bias toward a Th1-type adaptive immune response. Abs against rWSP stained endobacteria in living and degenerating adult O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> filariae, tissue microfilariae and host tissue macrophages that apparently had engulfed microfilariae. Thus, filarial helminths, through products of their endobacteria such as WSP, acquire characteristics of a typical microbial pathogen inducing immune responses via <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span>
onchocerciasis	TNF-alpha	True Positive	1.122	9226684	<strong class="title">Winkler S, Paiha S, Winkler H, Graninger W, Marberger M, Steiner GE: Microfilarial clearance in <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis</span> involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations. Parasite Immunol. 1996 Sep;18(9):479-82.</strong> <span class="tagged-drug" title="DrugBank: APRD00918"><span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">Diethylcarbamazine</a></span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">(DEC)</a></span> induced clearance of microfilaraemia in <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis</span> is <span class="tagged-filter" title="Association Word">associated</span> with severe posttreatment reactions. To define the switch from hypo- to hyper-responsiveness <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC</a></span> treatment, phenotypic alterations of T-lymphocytes, characterized by flow cytometry, and cytokines, determined by <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay, were monitored in a microfilaraemic patient. In contrast to reports on <span class="tagged-query" title="Query">onchocerciasis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0013884">lymphatic filariases,</span> no elevation of <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">(IL)-6</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour necrosis</span> factor <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)-alpha</a></span> was <span class="tagged-filter" title="Association Word">observed.</span> The most severe side effects coincided with an elevation of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon (IFN)-gamma</a></span> on day 3, followed by <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10,</a></span> transforming growth factor <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">(TGF)-beta 2</a></span> and <span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">macrophage inflammatory protein-1 alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">(MIP-1 alpha)</a></span> peaking on day 5. Phenotypically, T-cell activation <span class="tagged-filter" title="Association Word">markers</span> <span class="tagged-gene" title="SwissProt ID: P28907; Entrez Gene ID: 952; HGNC ID: 1667; HPRD ID: 00116; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28907">CD38,</a></span> <span class="tagged-gene" title="SwissProt ID: P05362; Entrez Gene ID: 3383; HGNC ID: 5344; HPRD ID: 00996; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05362">CD54</a></span> and <span class="tagged-gene" title="SwissProt ID: Q59F22; Entrez Gene ID: 3669; HGNC ID: 6130; HPRD ID: 05169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q59F22">CD25</a></span> were significantly <span class="tagged-filter" title="Association Word">expressed</span> before treatment, with high <span class="tagged-gene" title="SwissProt ID: P28907; Entrez Gene ID: 952; HGNC ID: 1667; HPRD ID: 00116; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28907">CD38</a></span> <span class="tagged-filter" title="Association Word">expression</span> still existing one year after clearance of microfilaraemia. Treatment-related increases were <span class="tagged-filter" title="Association Word">observed</span> with anti-<span class="tagged-gene" title="SwissProt ID: P14784; Entrez Gene ID: 3560; HGNC ID: 6009; HPRD ID: 00896; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14784">CD122,</a></span> anti-<span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-DR</a></span> and anti-<span class="tagged-gene" title="SwissProt ID: Q07108; Entrez Gene ID: 969; HGNC ID: 1694; HPRD ID: 00119; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07108">CD69.</a></span> <span class="tagged-gene" title="HGNC ID: 19376; Linking to HGNC"><a href="http://www.gene.ucl.ac.uk/nomenclature/data/get_data.php?hgnc_id=19376">CD28</a></span> was <span class="tagged-filter" title="Association Word">expressed</span> before treatment on almost 100% of <span class="tagged-gene" title="SwissProt ID: P01730; Entrez Gene ID: 920; HGNC ID: 1678; HPRD ID: 01740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01730">CD4+</a></span> and <span class="tagged-gene" title="SwissProt ID: P01732; Entrez Gene ID: 925; HGNC ID: 1706; HPRD ID: 01737; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01732">CD8+</a></span> T cells and dropped to 20% by day 5, reaching again baseline levels on day 21. Furthermore, there emerged 20% <span class="tagged-gene" title="SwissProt ID: P01848; Entrez Gene ID: 6955; HGNC ID: 12027; HPRD ID: 01736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01848">TCR alpha</a></span> beta+/CD3+ T cells and 10% anti-beta V5 (c)+ T cells, altogether indicating a specific pattern of T-helper (Th) 1 and Th2 cytokines as well as expansion of certain pauciclonal T-cell populations in response to microfilarial clearance.
onchocerciasis	TNF-alpha	False Negative	1.122	8077726	<strong class="title">Njoo FL, Hack CE, Oosting J, Luyendijk L, Stilma JS, Kijlstra A: <span class="tagged-gene" title="SwissProt ID: P02741; Entrez Gene ID: 1401; HGNC ID: 2367; HPRD ID: 00422; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02741">C-reactive protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> are <span class="tagged-filter" title="Association Word">elevated</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P07602; Entrez Gene ID: 5660; HGNC ID: 9498; HPRD ID: 01460; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. J Infect Dis. 1994 Sep;170(3):663-8.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis</span> can induce adverse reactions. Mechanisms underlying these reactions are poorly understood but may include activation of neutrophils. This study investigated the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients during 2 days after <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. The acute-phase <a href="http://beta.uniprot.org/uniprot/P07602">protein C</a></span>-reactive <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">(CRP)</a></span> and cytokines that mediate the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(tumor necrosis factor-alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">[TNF alpha]</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">[IL-6])</a></span> were measured in 144 skin snip-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients and 12 skin snip-negative controls who received one dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (150 micrograms/kg). No <span class="tagged-filter" title="Association Word">elevated</span> <a href="http://beta.uniprot.org/uniprot/P01375">TNF alpha</a></span> levels were found, but <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> and <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP</a></span> were <span class="tagged-filter" title="Association Word">elevated</span> in 25.7% and 50.7% of the patients, respectively, after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. Most patients (89.2%) with raised <a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> also had raised <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP.</a></span> Such increases were not <span class="tagged-filter" title="Association Word">observed</span> in controls and in patients were correlated with adverse reactions and microfilarial densities. These findings suggest a possible <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in microfilarial destruction following <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment.
onchocerciasis	RANTES	True Positive	2.657	16232219	<strong class="title">Fendt J, Hamm DM, Banla M, Schulz-Key H, Wolf H, Helling-Giese G, Heuschkel C, Soboslay PT: Chemokines in <span class="tagged-query" title="Query">onchocerciasis</span> patients after a single dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin.</a></span> . Clin Exp Immunol. 2005 Nov;142(2):318-26.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> treatment will effectively diminish microfilariae (Mf) of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in the skin of patients, but therapy is <span class="tagged-filter" title="Association Word">associated</span> with adverse host inflammatory responses. To investigate the <span class="tagged-filter" title="Association Word">association</span> of proinflammatory chemokines with the intensity of infection and clinical adverse reactions, <a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> serum levels were measured in patients following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment (100 microg/kg, 150 microg/kg or 200 microg/kg) or placebo. The density of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> Mf per mg skin decreased by 85%, 97%, 97% and 90% at day 3, at month 3, month 6 and at 1 year post-<span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin.</a></span> The <a href="http://beta.uniprot.org/uniprot/Q9Y4X3">cutaneous T cell-attracting chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">(CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27)</a></span> was found highly <span class="tagged-filter" title="Association Word">elevated</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients compared to infection-free European controls (P = 0.0004) and it did not change following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> or placebo to 1 year post-therapy. The <a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span>/<span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">CCL5</a></span> (regulated on activated and normally T cell-<span class="tagged-filter" title="Association Word">expressed)</span> was similarly high in <span class="tagged-query" title="Query">onchocerciasis</span> patients and infection-free European controls; the <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span>/<span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">CCL5</a></span> levels did not change following treatment until 6 months post-therapy but were slightly <span class="tagged-filter" title="Association Word">elevated</span> at 1 year post-therapy (P < 0.02). In contrast, the Th2-type chemoattractants, <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">thymus and activation regulated chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">(TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17)</a></span> and <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">macrophage-derived chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">(MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22),</a></span> were activated at 3 days post-<span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (P < 0.0001) to return to pretreatment or lower levels thereafter. The Th1-type chemoattractants, macrophage inflammatory <span class="tagged-filter" title="Association Word">protein</span> <a href="http://beta.uniprot.org/uniprot/Q92973">(MIP)</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4</a></span> were low before <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment, but following clearance of microfilariae of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> their levels increased from 6 months post-therapy onwards (for both at 12 months post-therapy, P < 0.0001). The adverse reaction scores (RS) in treated patients increased significantly on day 3 (P < 0.02) while it remained unchanged in those who received placebo (P = 0.22); RS interacted with the microfilarial density (P = 0.01), but not with the dose of <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> or with the serum levels of <a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17,</a></span> <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27.</a></span> Our observations suggest that following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin,</a></span> macrophages as well as memory Th2-type lymphocytes and B cells, attracted and activated by <a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27,</a></span> may contribute to dermal immune responses and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> Mf killing and clearance. The transient changes of <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17</a></span> and <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22</a></span> were not <span class="tagged-filter" title="Association Word">associated</span> with clinical adverse responses, and the later rise of <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4</a></span> showed a reactivation of Type 1 immune responses <span class="tagged-filter" title="Association Word">associated</span> with persistent low levels of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae and an expiring O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection.
onchocerciasis	RANTES	True Positive	2.657	10794432	<strong class="title">Cooper PJ, Beck LA, Espinel I, Deyampert NM, Hartnell A, Jose PJ, Paredes W, Guderian RH, Nutman TB: <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">Eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> <span class="tagged-filter" title="Association Word">expression</span> by the dermal endothelium is <span class="tagged-filter" title="Association Word">associated</span> with eosinophil infiltration after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis.</span> Clin Immunol. 2000 Apr;95(1 Pt 1):51-61.</strong> The <span class="tagged-filter" title="Association Word">roles</span> of <a href="http://beta.uniprot.org/uniprot/P51671">eotaxin,</a></span> <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES,</a></span> and <span class="tagged-gene" title="SwissProt ID: P80098; Entrez Gene ID: 6354; HGNC ID: 10634; HPRD ID: 01150; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P80098">MCP-3</a></span> <span class="tagged-filter" title="Association Word">expression</span> in eosinophil recruitment to the site of parasite killing that occurs following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis</span> were assessed in the skin of 13 Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected subjects and two noninfected controls before and after <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. Adverse reactions in infected subjects were <span class="tagged-filter" title="Association Word">associated</span> with the appearance of eosinophils in the dermis as part of a perivascular inflammatory infiltrate. Although no <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> and <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> was seen in dermal vascular endothelial cells in biopsies taken before treatment (nor at any time in the skin of uninfected controls), endothelial <span class="tagged-filter" title="Association Word">expression</span> of both <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> was noted by 24 h following treatment. While <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> <span class="tagged-filter" title="Association Word">expression</span> was transient, <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> <span class="tagged-filter" title="Association Word">expression</span> increased in parallel with increasing eosinophil recruitment up to 60 h posttreatment. These observations indicate that endothelial <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> may have an important <span class="tagged-filter" title="Association Word">role</span> in eosinophil recruitment into the skin during helminth-killing reactions.
onchocerciasis	PDGFRA	True Negative	1.122	16931288	<strong class="title">Schwartz LB: Diagnostic value of tryptase in <span class="tagged-disease" title="UMLS Concept ID: C0002792">anaphylaxis</span> and <span class="tagged-disease" title="UMLS Concept ID: C1521812">mastocytosis.</span> Immunol Allergy Clin North Am. 2006 Aug;26(3):451-63.</strong> Serum (or plasma) levels of total and mature tryptase measurements are recommended in the diagnostic evaluation of <span class="tagged-disease" title="UMLS Concept ID: C0002792">systemic anaphylaxis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0221013">systemic mastocytosis,</span> but their interpretation must be considered in the context of a complete workup of each patient. Total tryptase levels generally reflect the increased burden of mast cells in patients with all forms of <span class="tagged-disease" title="UMLS Concept ID: C0221013">systemic mastocytosis</span> <span class="tagged-disease" title="UMLS Concept ID: C0272203">(indolent systemic mastocytosis,</span> smoldering <span class="tagged-disease" title="UMLS Concept ID: C0221013">systemic mastocytosis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0221013">systemic mastocytosis</span> <span class="tagged-filter" title="Association Word">associated</span> with a hematologic clonal non-<span class="tagged-disease" title="UMLS Concept ID: C0024899">mast cell disorder,</span> <span class="tagged-disease" title="UMLS Concept ID: C1112486">aggressive systemic mastocytosis,</span> and <span class="tagged-disease" title="UMLS Concept ID: C0023461">mast cell leukemia)</span> and the decreased burden of mast cells <span class="tagged-filter" title="Association Word">associated</span> with cytoreductive therapies in these disorders. <span class="tagged-filter" title="Association Word">Causes</span> of an <span class="tagged-filter" title="Association Word">elevated</span> total tryptase level other than <span class="tagged-disease" title="UMLS Concept ID: C0221013">systemic mastocytosis</span> must be considered, however, and include <span class="tagged-disease" title="UMLS Concept ID: C0002792">systemic anaphylaxis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0023467">acute myelocytic leukemia,</span> various <span class="tagged-disease" title="UMLS Concept ID: C0026986">myelodysplastic syndromes,</span> <span class="tagged-disease" title="UMLS Concept ID: C1540912">hypereosinophilic syndrome</span> <span class="tagged-filter" title="Association Word">associated</span> with the FLP1L1-<span class="tagged-gene" title="SwissProt ID: P16234; Entrez Gene ID: 5156; HGNC ID: 8803; HPRD ID: 01429; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P16234">PDGFRA</a></span> <span class="tagged-filter" title="Association Word">mutation,</span> <span class="tagged-disease" title="UMLS Concept ID: C1261469">end-stage renal failure,</span> and treatment of <span class="tagged-query" title="Query">onchocerciasis.</span> Mature (beta) tryptase levels generally reflect the magnitude of mast cell activation and are <span class="tagged-filter" title="Association Word">elevated</span> during most cases of <span class="tagged-disease" title="UMLS Concept ID: C0002792">systemic anaphylaxis,</span> particularly with <span class="tagged-drug" title="DrugBank: APRD00688"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00688">parenteral</a></span> exposure to the inciting agent.
onchocerciasis	NADH-dehydrogenase-subunit-4	False Negative	1.122	16892627	<strong class="title">Rodriguez-Perez MA, Nunez-Gonzalez CA, Lizarazo-Ortega C, Sanchez-Varela A, Wooten MC, Unnasch TR: Analysis of genetic variation in ribosomal DNA internal transcribed spacer and the <span class="tagged-gene" title="Entrez Gene ID: 4538; HGNC ID: 7459; HPRD ID: 08954; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4538">NADH dehydrogenase subunit 4</a></span> mitochondrial <span class="tagged-filter" title="Association Word">genes</span> of the <span class="tagged-query" title="Query">onchocerciasis</span> vector Simulium ochraceum. J Med Entomol. 2006 Jul;43(4):701-6.</strong> <span class="tagged-query" title="Query">Onchocerciasis</span> is a serious disease vectored by black flies in the genus Simulium that are infected with the filarial parasite Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> In the Americas, black flies of the Simulium ochraceum s.l. species complex are important vectors of this parasite. Cytological studies have suggested that this species complex consists of at least three cytotypes that inhabit distinct habitats. In this study, the <span class="tagged-gene" title="SwissProt ID: O95298; Entrez Gene ID: 4718; HGNC ID: 7706; HPRD ID: 11960; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O95298">NADH dehydrogenase</a></span> subunit four <span class="tagged-gene" title="Entrez Gene ID: 4538; HGNC ID: 7459; HPRD ID: 08954; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4538">(ND4)</a></span> and internal transcribed spacer <span class="tagged-gene" title="Entrez Gene ID: 282551; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=282551">(ITS)</a></span> of the ribosomal RNA <span class="tagged-filter" title="Association Word">gene</span> cluster were used to explore the degree of genetic diversity among S. ochraceum s.l. populations found in the three O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> foci in Mexico. Both sequence regions were found to exhibit intra- and interpopulation variation. Four different <span class="tagged-gene" title="Entrez Gene ID: 4538; HGNC ID: 7459; HPRD ID: 08954; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4538">ND4</a></span> alleles were found among the populations examined. Similarly, variation was noted in the <span class="tagged-gene" title="Entrez Gene ID: 282551; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=282551">ITS</a></span> domain sequences within and among populations. Variation within the <span class="tagged-gene" title="Entrez Gene ID: 282551; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=282551">ITS</a></span> sequence was primarily confined to a complex microsatellite <span class="tagged-filter" title="Association Word">locus.</span> Four <span class="tagged-gene" title="Entrez Gene ID: 282551; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=282551">ITS</a></span> length variants were <span class="tagged-filter" title="Association Word">observed,</span> two of which were only seen in flies collected from the <span class="tagged-query" title="Query">onchocerciasis</span> focus in northern Chiapas. These data suggest that the <span class="tagged-gene" title="Entrez Gene ID: 4538; HGNC ID: 7459; HPRD ID: 08954; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4538">ND4</a></span> and <span class="tagged-gene" title="Entrez Gene ID: 282551; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=282551">ITS</a></span> sequences may prove to be useful <span class="tagged-filter" title="Association Word">markers</span> for exploring interactions within and among the S. ochraceum s.l. populations in Mexico.
onchocerciasis	lactoferrin	True Negative	1.122	8222324	<strong class="title">Njoo FL, Hack CE, Oosting J, Stilma JS, Kijlstra A: Neutrophil activation in <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P02788; Entrez Gene ID: 4057; HGNC ID: 6720; HPRD ID: 01028; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-treated <span class="tagged-query" title="Query">onchocerciasis</span> patients. Clin Exp Immunol. 1993 Nov;94(2):330-3.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> is a safe and effective drug for <span class="tagged-query" title="Query">onchocerciasis</span> treatment. In certain individuals, however, therapy is accompanied by adverse reactions. The mechanisms underlying these reactions are not yet known. The aim of the present study was to investigate whether neutrophils are <span class="tagged-filter" title="Association Word">involved</span> in the development of these adverse reactions. Elastase and <a href="http://beta.uniprot.org/uniprot/P02788">lactoferrin,</a></span> two <span class="tagged-filter" title="Association Word">markers</span> for the release of neutrophil azurophilic and specific granule contents respectively, were measured by radioimmunoassays in plasma of <span class="tagged-query" title="Query">onchocerciasis</span> patients with varying degrees of side effects, as well as in control subjects before and 1 and 2 days after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P02788; Entrez Gene ID: 4057; HGNC ID: 6720; HPRD ID: 01028; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. A considerable increase of elastase levels after treatment was <span class="tagged-filter" title="Association Word">observed,</span> whereas <a href="http://beta.uniprot.org/uniprot/P02788">lactoferrin</a></span> levels did not change. The percentage of patients with <span class="tagged-filter" title="Association Word">elevated</span> elastase levels was significantly correlated with the degree of side effects. These findings suggest that neutrophil activation may be <span class="tagged-filter" title="Association Word">involved</span> in the development of adverse reactions in these patients.
onchocerciasis	eosinophil-cationic-protein	True Positive	1.247	10206116	<strong class="title">Tischendorf FW, Brattig NW, Burchard GD, Kubica T, Kreuzpaintner G, Lintzel M: Eosinophils, <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">eosinophil cationic protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">eosinophil-derived neurotoxin</a></span> in serum and urine of patients with <span class="tagged-query" title="Query">onchocerciasis</span> coinfected with intestinal nematodes and in <span class="tagged-disease" title="UMLS Concept ID: C0276926">urinary schistosomiasis.</span> Acta Trop. 1999 Mar 15;72(2):157-73.</strong> Eosinophils, <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">eosinophil cationic protein</a></span> <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">(ECP),</a></span> <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">eosinophil-derived neurotoxin</a></span> <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">(EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX),</a></span> <span class="tagged-gene" title="SwissProt ID: P05164; Entrez Gene ID: 4353; HGNC ID: 7218; HPRD ID: 06102; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05164">myeloperoxidase</a></span> <span class="tagged-gene" title="SwissProt ID: P05164; Entrez Gene ID: 4353; HGNC ID: 7218; HPRD ID: 06102; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05164">(MPO)</a></span> and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> were measured in blood, serum and/or urine in <span class="tagged-disease" title="UMLS Concept ID: C0276926">Schistosoma haematobium</span>- and Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected Guineans and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>- and S. haematobium-negative Guineans coinfected or infected with intestinal nematodes. The number of eosinophils and levels of eosinophil granule <span class="tagged-filter" title="Association Word">proteins</span> but not of <span class="tagged-gene" title="SwissProt ID: P05164; Entrez Gene ID: 4353; HGNC ID: 7218; HPRD ID: 06102; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05164">MPO</a></span> were found to be strongly <span class="tagged-filter" title="Association Word">elevated</span> in all Africans as compared to European controls. The highest serum <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> and serum and urinary <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> levels were <span class="tagged-filter" title="Association Word">observed</span> in the hyperreactive form of <span class="tagged-query" title="Query">onchocerciasis</span> (sowda). <span class="tagged-query" title="Query">Onchocerciasis</span> patients and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-negative Africans coinfected or infected with intestinal nematodes (hookworm and/or Ascaris lumbricoides) revealed higher serum granule <span class="tagged-filter" title="Association Word">protein</span> concentrations and/or absolute eosinophil counts and urinary <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> than those without <span class="tagged-disease" title="UMLS Concept ID: C0027583">nematode infections.</span> Statistical differences between both sections were found for the absolute eosinophil counts and for serum <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> in generalized <span class="tagged-query" title="Query">onchocerciasis,</span> and for urinary <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> in sowda, indicating stimulation of the eosinophil potential of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-positive patients by coexistent <span class="tagged-disease" title="UMLS Concept ID: C0019911">hookworm infection.</span> This worm species, in contrast to A. lumbricoides, <span class="tagged-filter" title="Association Word">causes</span> especially high eosinophil counts and <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> and <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> levels. From these results it is concluded that in nematode diseases, <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> and <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> levels reflect the degree of antigenic stimulation, eosinophil activation and eosinophil turnover rates. Serum <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> and serum and urinary <span class="tagged-gene" title="SwissProt ID: P10153; Entrez Gene ID: 6036; HGNC ID: 10045; HPRD ID: 00577; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10153">EDN</a></span>/<span class="tagged-gene" title="SwissProt ID: P11678; Entrez Gene ID: 8288; HGNC ID: 3423; HPRD ID: 00576; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P11678">EPX</a></span> may, therefore, serve as parameters to monitor <span class="tagged-disease" title="UMLS Concept ID: C0018889">helminth infection.</span> Urinary <span class="tagged-gene" title="SwissProt ID: P12724; Entrez Gene ID: 6037; HGNC ID: 10046; HPRD ID: 00575; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P12724">ECP</a></span> may be a <span class="tagged-filter" title="Association Word">marker</span> of eosinophiluria secondary to urogenital manifestation of S. haematobium. It is <span class="tagged-filter" title="Association Word">elevated</span> in hyperreactive <span class="tagged-query" title="Query">onchocerciasis</span> activated by intestinal nematodes.
onchocerciasis	glyceraldehyde-3-phosphate-dehydrogenase	True Negative	1.122	15955451	<strong class="title">Erttmann KD, Kleensang A, Schneider E, Hammerschmidt S, Buttner DW, Gallin M: Cloning, characterization and DNA immunization of an Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">glyceraldehyde-3-phosphate dehydrogenase</a></span> (Ov-<span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">GAPDH).</a></span> Biochim Biophys Acta. 2005 Jun 30;1741(1-2):85-94. Epub 2005 Jan 5.</strong> In the search for Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> possibly <span class="tagged-filter" title="Association Word">involved</span> in protection against human <span class="tagged-query" title="Query">onchocerciasis,</span> partial amino acid sequence analysis of one of the O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> of the serologically identified <span class="tagged-filter" title="Association Word">proteins</span> showed a close relationship to the <span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">glyceraldehyde-3-phosphate dehydrogenase</a></span> <span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">(GAPDH)</a></span> <span class="tagged-filter" title="Association Word">protein</span> family. Subsequent adult worm cDNA library screening and cloning <span class="tagged-filter" title="Association Word">produced</span> a clone of 1650 bp. An open reading frame spans over 1020 bp encoding for a <span class="tagged-filter" title="Association Word">protein</span> of 340 amino acids with an apparent molecular weight of 38000. Comparison of the complete amino acid sequence identified this <span class="tagged-filter" title="Association Word">protein</span> as a member of the <span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">GAPDH</a></span> <span class="tagged-filter" title="Association Word">protein</span> family. The recombinantly <span class="tagged-filter" title="Association Word">expressed</span> <span class="tagged-filter" title="Association Word">protein</span> shows <span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">GAPDH</a></span> enzymatic <span class="tagged-filter" title="Association Word">activity</span> as well as <span class="tagged-gene" title="SwissProt ID: P00747; Entrez Gene ID: 5340; HGNC ID: 9071; HPRD ID: 01417; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00747">plasminogen</a></span>-binding capacity. DNA sequence analysis of the corresponding <span class="tagged-filter" title="Association Word">gene</span> revealed the presence of two introns. Using immunohistology Ov-<span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">GAPDH</a></span> was <span class="tagged-filter" title="Association Word">observed</span> in microfilariae, infective larvae, and adult male and female worms. Most striking was the labelling of the musculature of the body wall. Labelling was also <span class="tagged-filter" title="Association Word">observed</span> in the pseudocoeloma cavity and in a subset of cell nuclei, suggesting additional, non-glycolytic functions of the Ov-<span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">GAPDH.</a></span> <span class="tagged-filter" title="Association Word">Gene</span> gun immunization with the DNA-construct in cattle <span class="tagged-filter" title="Association Word">led</span> to specific humoral immune responses. Thus, the protective potential of the DNA-construct of Ov-<span class="tagged-gene" title="SwissProt ID: P04406; Entrez Gene ID: 2597; HGNC ID: 4141; HPRD ID: 00713; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04406">GAPDH</a></span> can be evaluated in vaccination trials using animal models such as the cattle/Onchocerca ochengi model.
onchocerciasis	calreticulin	True Positive	8.821	10320638	<strong class="title">Eggleton P, Llewellyn DH: Pathophysiological <span class="tagged-filter" title="Association Word">roles</span> of <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune disease.</span> Scand J Immunol. 1999 May;49(5):466-73.</strong> Autoantibodies against the endoplasmic reticulum (ER) <span class="tagged-drug" title="DrugBank: APRD00184"><span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00184">luminal</a></span> <span class="tagged-filter" title="Association Word">protein,</span> <a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> are often present in sera from patients with <span class="tagged-disease" title="UMLS Concept ID: C0024141">systemic lupus erythematosus,</span> <span class="tagged-disease" title="UMLS Concept ID: C0035435">rheumatic disease</span> and various <span class="tagged-disease" title="UMLS Concept ID: C0030499">parasitic diseases</span> including <span class="tagged-query" title="Query">onchocerciasis.</span> New information has revealed that <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> is implicated in a number of autoimmune processes, including molecular <span class="tagged-disease" title="UMLS Concept ID: C0233577">mimicry,</span> epitope spreading, complement inactivation and stimulation of inflammatory mediators, such as <span class="tagged-metabolite" title="HMDB: HMDB03378"><span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB03378">nitric oxide</a></span> <span class="tagged-filter" title="Association Word">production.</span> <a href="http://beta.uniprot.org/uniprot/P27797">Calreticulin</a></span> also binds to the Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">antigen</span> complex, which is composed of at least three immunologically distinct <span class="tagged-filter" title="Association Word">proteins</span> bound to a group of small cytoplasmic RNAs that together form a common target for <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune responses.</span> Up-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> at the <span class="tagged-filter" title="Association Word">protein</span> and RNA levels can be triggered by cell stresses, including heat shock, exposure to heavy metals and perturbation of normal ER function, which may in some cases <span class="tagged-filter" title="Association Word">lead</span> to its secretion from cells. <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">Calreticulin</a></span> is targeted by autoantibodies following its release into the extracellular environment, possibly as a result of cell death, or its presence at the cell surface in response to insults such as <span class="tagged-disease" title="UMLS Concept ID: C0042769">viral infection</span> or ultraviolet irradiation. These findings suggest that <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> is not just an autoantigen, but plays an active <span class="tagged-filter" title="Association Word">role</span> in the pathology of various <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune disease</span> through determinant spreading.
onchocerciasis	calreticulin	True Positive	8.821	7901281	<strong class="title">Meilof JF, Van der Lelij A, Rokeach LA, Hoch SO, Smeenk RJ: Autoimmunity and <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> J Immunol. 1993 Nov 15;151(10):5800-9.</strong> Autoantibodies against cytoplasmic cellular <span class="tagged-filter" title="Association Word">proteins</span> in sera of patients with <span class="tagged-query" title="Query">onchocerciasis.</span> <span class="tagged-query" title="Query">Onchocerciasis</span> or <span class="tagged-disease" title="UMLS Concept ID: C0029002">"river blindness"</span> is a vector-borne <span class="tagged-disease" title="UMLS Concept ID: C1336827">tropical disease</span> resulting from infection with the filarial nematode Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Disease manifestations include <span class="tagged-disease" title="UMLS Concept ID: C0011603">dermatitis,</span> rheumatic complaints, and blindness. Recent findings have suggested an autoimmune etiology for the occurrence of <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy,</span> a disease of the eye which together with sclerosing <span class="tagged-disease" title="UMLS Concept ID: C0022573">keratoconjunctivitis</span> is responsible for approximately 400,000 <span class="tagged-query" title="Query">onchocerciasis</span>-<span class="tagged-filter" title="Association Word">related</span> cases of blindness. The identification of <span class="tagged-query" title="Query">onchocerciasis</span> as an important <span class="tagged-filter" title="Association Word">cause</span> of tropical <span class="tagged-disease" title="UMLS Concept ID: C0035435">rheumatism</span> prompted us to evaluate serologically the presence of systemic <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune disease</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients and local controls from a hyperendemic area in Sierra Leone. In both groups there was a marked <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response</span> against cytoplasmic non-RNA-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-filter" title="Association Word">proteins</span> consisting of autoantibodies against five major Ag with respective m.w. of 35, 51, 64, 83, and 110 kDa. These five <span class="tagged-filter" title="Association Word">proteins</span> are novel autoantigens that could be distinguished from <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin,</a></span> the human homologue of the onchocercal Ag <span class="tagged-drug" title="DrugBank: APRD00400"><span class="tagged-gene" title="SwissProt ID: P05455; Entrez Gene ID: 6741; HGNC ID: 11316; HPRD ID: 00168; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00400">RAL</a></span>-1, and known autoantigens such as the 50-kDa La/<a href="http://beta.uniprot.org/uniprot/P05455">SS-B</a></span> or 52- and 60-kDa Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">proteins</span> by immunoblotting and ELISA assays. Furthermore, autoantibody reactivity against <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> was significantly higher in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected individuals than in endemic controls. Autoantibody reactivity against the five major autoantigens, anti-<span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> reactivity, and <span class="tagged-filter" title="Association Word">antibody</span> reactivity against the 65-kDa <span class="tagged-disease" title="UMLS Concept ID: C1559996">arthritis</span>-<span class="tagged-filter" title="Association Word">associated</span> mycobacterial heat shock <span class="tagged-filter" title="Association Word">protein</span> were intercorrelated as parts of an <span class="tagged-query" title="Query">onchocerciasis</span>-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response.</span> The implication of autoimmunity in the disease pathogenesis of <span class="tagged-query" title="Query">onchocerciasis</span> could have important consequences for future research on therapeutical regimens, pathogenetic mechanisms, and serological <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	calreticulin	True Positive	8.821	7836063	<strong class="title">Max H, Halder T, Kalbus M, Gnau V, Jung G, Kalbacher H: A 16mer peptide of the human autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> is a most prominent <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span>-DR4Dw4-<span class="tagged-filter" title="Association Word">associated</span> self-peptide. Hum Immunol. 1994 Sep;41(1):39-45.</strong> The human Ca (2+)-binding (storage) <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin,</a></span> located in the lumen of the endoplasmic reticulum, is proposed to play a <span class="tagged-filter" title="Association Word">role</span> as autoantigen: anticalreticulin autoantibodies occur in the sera of patients with SLE and patients with <span class="tagged-query" title="Query">onchocerciasis</span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin</a></span> shows a high sequence homology to the Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> <span class="tagged-drug" title="DrugBank: APRD00400"><span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00400">RAL</a></span>-1). Here we present sequencing data of a <a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span>-DR4Dw4-<span class="tagged-filter" title="Association Word">associated</span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> peptide fragment, Cal (295-310), purified from a DR4Dw4 self-peptide pool. Cal (295-310) proved to be one of three commonest self-peptides <span class="tagged-filter" title="Association Word">associated</span> with DR4Dw4 molecules that were isolated from the EBV-transformed B-cell line BSM (DR4Dw4, DRw53). We tested the binding of Cal (295-309) and the analogous <span class="tagged-drug" title="DrugBank: APRD00400"><span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00400">RAL</a></span>-1 peptide to <a href="http://beta.uniprot.org/uniprot/O00157">HLA-DR</a></span> molecules: Cal (295-309) exhibited specific binding characteristics for DR4Dw4. Binding assays using self-peptide analogues with replaced amino acids <span class="tagged-filter" title="Association Word">led</span> us to a DR4Dw4-binding motif with anchor residues at relative positions 1 and 6. The sequencing data suggest that <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> is a frequently processed intracellular <span class="tagged-filter" title="Association Word">protein.</span> The abundance of <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> makes the presentation of different <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> peptides <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-D</a></span> molecules likely to occur, supporting the immunologic relevance of this molecule.
onchocerciasis	calreticulin	True Positive	8.821	7680295	<strong class="title">Routsias JG, Tzioufas AG, Sakarellos-Daitsiotis M, Sakarellos C, Moutsopoulos HM: <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">Calreticulin</a></span> synthetic peptide analogues: anti-peptide <span class="tagged-filter" title="Association Word">antibodies</span> in autoimmune <span class="tagged-disease" title="UMLS Concept ID: C0035435">rheumatic diseases.</span> Clin Exp Immunol. 1993 Mar;91(3):437-41.</strong> Autoantibodies in sera from patients with <span class="tagged-disease" title="UMLS Concept ID: C0024141">systemic lupus erythematosus</span> (SLE) and <span class="tagged-query" title="Query">onchocerciasis</span> recognize <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> <span class="tagged-gene" title="SwissProt ID: Q04762; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q04762">(CaR),</a></span> a <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: Q04762; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span>-binding <span class="tagged-filter" title="Association Word">protein,</span> as <span class="tagged-filter" title="Association Word">antigen.</span> In this study we present the immunological properties of two synthetic peptides prepared to correspond to the 1-24 and 7-24 amino acid sequence of <a href="http://beta.uniprot.org/uniprot/Q04762">CaR.</a></span> In contrast to information previously reported for the recombinant <span class="tagged-filter" title="Association Word">protein,</span> the <span class="tagged-gene" title="SwissProt ID: Q04762; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q04762">CaR</a></span>-peptide analogues appeared immunoreactive to anti-Ro/<span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">SSA</a></span> autoimmune sera. Human sera from patients with SLE, <span class="tagged-disease" title="UMLS Concept ID: C1527336">Sjogren's syndrome</span> (SS), <span class="tagged-disease" title="UMLS Concept ID: C0003873">rheumatoid arthritis</span> (RA), as well as <span class="tagged-disease" title="UMLS Concept ID: C0026272">mixed connective tissue disease</span> <span class="tagged-disease" title="UMLS Concept ID: C0026272">(MCTD),</span> demonstrated a positive <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response</span> (binding of <span class="tagged-filter" title="Association Word">antibodies),</span> to the <span class="tagged-gene" title="SwissProt ID: Q04762; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q04762">CaR</a></span>-peptide analogues. These findings suggest that anti-<span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> autoantibodies are not restricted to any disease specificity.
onchocerciasis	calreticulin	True Positive	8.821	7520419	<strong class="title">Rokeach LA, Zimmerman PA, Unnasch TR: Epitopes of the Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> RAL1 <span class="tagged-filter" title="Association Word">antigen,</span> a member of the <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> family of <span class="tagged-filter" title="Association Word">proteins,</span> recognized by sera from patients with <span class="tagged-query" title="Query">onchocerciasis.</span> Infect Immun. 1994 Sep;62(9):3696-704.</strong> RAL1 is an <span class="tagged-filter" title="Association Word">antigen</span> (Ag) encoded by the filarial nematode Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> the parasite <span class="tagged-filter" title="Association Word">causing</span> <span class="tagged-query" title="Query">onchocerciasis</span> <span class="tagged-disease" title="UMLS Concept ID: C0029002">(river blindness).</span> RAL1 shares 64.4% identity with the autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin.</a></span> The striking similarity of the parasite Ag and the human autoantigen has <span class="tagged-filter" title="Association Word">led</span> to the hypothesis that RAL1 may induce a cross-reactive immune response to <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin,</a></span> which in turn may be <span class="tagged-filter" title="Association Word">involved</span> in the pathogenesis of <span class="tagged-query" title="Query">onchocerciasis.</span> To test this hypothesis, we explored the immune response to RAL1 recombinant Ag (RAL1 rAg) and human <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin</a></span> in patients with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection. A total of 86% of the O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected individuals <span class="tagged-filter" title="Association Word">produced</span> <span class="tagged-filter" title="Association Word">antibodies</span> recognizing RAL1 rAg. <span class="tagged-filter" title="Association Word">Antibody</span> reactivity to RAL1 rAg in patient sera was confined primarily to the central and carboxyl-terminal parts of the molecule. No significant correlations were found to associate recognition of RAL1 rAg, or any particular portion thereof, with a particular disease state. <span class="tagged-filter" title="Association Word">Antibodies</span> against RAL1 thus appear to be <span class="tagged-filter" title="Association Word">produced</span> as a general immune reaction to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection and do not necessarily <span class="tagged-filter" title="Association Word">lead</span> to a cross-reacting response with the host <span class="tagged-filter" title="Association Word">protein.</span> In contrast, 33% of the patient sera tested bound recombinant human <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">calreticulin.</a></span> All of these sera also recognized a polypeptide encompassing the carboxyl-terminal portion of the RAL1 rAg. These results suggest that recognition of an epitope encoded in the carboxyl-terminal portion of RAL1 is at least in part responsible for inducing a cross-reacting immune response to the host <span class="tagged-filter" title="Association Word">protein.</span>
onchocerciasis	calreticulin	True Positive	8.821	1602002	<strong class="title">Lux FA, McCauliffe DP, Buttner DW, Lucius R, Capra JD, Sontheimer RD, Lieu TS: Serological cross-reactivity between a human Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> and the lambda Ral-1 <span class="tagged-filter" title="Association Word">antigen</span> of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> J Clin Invest. 1992 Jun;89(6):1945-51.</strong> We have cloned and sequenced a 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-filter" title="Association Word">gene</span> that is the human homologue of the <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span>-binding <span class="tagged-filter" title="Association Word">protein,</span> <a href="http://beta.uniprot.org/uniprot/P27797">calreticulin.</a></span> The sequence of this 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> has significant homology to lambda Ral-1, a recombinant cDNA clone corresponding to a major <span class="tagged-filter" title="Association Word">antigen</span> of the nematode, Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> the infectious agent of <span class="tagged-query" title="Query">onchocerciasis.</span> We therefore sought to determine whether <span class="tagged-filter" title="Association Word">antibodies</span> <span class="tagged-filter" title="Association Word">produced</span> by <span class="tagged-query" title="Query">onchocerciasis</span> patients might crossreact with the human 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin).</a></span> 20 of 22 sera from Liberian <span class="tagged-query" title="Query">onchocerciasis</span> patients who had no known evidence of <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune disease</span> were found to contain <span class="tagged-filter" title="Association Word">antibodies</span> that reacted with the 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> by immunoblot analysis. Characteristic of sera reactive with Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">antigens,</span> some <span class="tagged-query" title="Query">onchocerciasis</span> sera also immunoprecipitated the Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span>-<span class="tagged-filter" title="Association Word">associated</span> hY RNAs. In addition, a monoclonal <span class="tagged-filter" title="Association Word">antibody</span> raised against O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> organisms reacted to purified human WiL-2 cell 46 kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">antigen</span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> by ELISA. These results strongly suggest that <span class="tagged-query" title="Query">onchocerciasis</span> patients <span class="tagged-filter" title="Association Word">produce</span> <span class="tagged-filter" title="Association Word">antibodies</span> that crossreact with the 46-kD human Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> and raise the possibility that infectious organisms such as O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> might play a triggering or exacerbating <span class="tagged-filter" title="Association Word">role</span> in the human Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response.</span>
onchocerciasis	IL-8	True Negative	1.122	15210803	<strong class="title">Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A: The major surface <span class="tagged-filter" title="Association Word">protein</span> of Wolbachia endosymbionts in filarial nematodes elicits immune responses through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span> J Immunol. 2004 Jul 1;173(1):437-45.</strong> More than 150 million humans in tropical countries are infected by filarial nematodes which harbor intracellular bacterial endosymbionts of the genus Wolbachia (Rickettsiales). These bacteria have been implicated in adverse effects of drug treatment in <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> The present study provides evidence that purified major Wolbachia surface <span class="tagged-filter" title="Association Word">protein</span> (rWSP) acts as an inducer of the innate immune system through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4:</a></span> 1) recombinant, stringently purified rWSP elicited the release of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha,</a></span> <span class="tagged-gene" title="Protein Family or Complex">IL-12,</span> and <span class="tagged-gene" title="SwissProt ID: P10145; Entrez Gene ID: 3576; HGNC ID: 6025; HPRD ID: 00909; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10145">IL-8</a></span> from cultured blood cells of both Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected and uninfected people; 2) the inflammatory response to rWSP challenge was <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span>- and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4</a></span>-dependent as demonstrated with TLR-transfected fibroblastoid cells, as well as macrophages and dendritic cells from functional TLR-<span class="tagged-filter" title="Association Word">deficient</span> mice; 3) blood cells of <span class="tagged-query" title="Query">onchocerciasis</span> patients exposed to rWSP also generated down-regulating mediators <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and PGE (2) after 6 days of culture; 4) furthermore, rWSP-reactive IgG1 Abs were present in sera of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected people but not in those of uninfected Europeans. The lack of rWSP-reactive <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and IgG4 in serum indicated a bias toward a Th1-type adaptive immune response. Abs against rWSP stained endobacteria in living and degenerating adult O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> filariae, tissue microfilariae and host tissue macrophages that apparently had engulfed microfilariae. Thus, filarial helminths, through products of their endobacteria such as WSP, acquire characteristics of a typical microbial pathogen inducing immune responses via <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span>
onchocerciasis	IL-2	True Positive	1.122	8706329	<strong class="title">Luder CG, Schulz-Key H, Banla M, Pritze S, Soboslay PT: Immunoregulation in <span class="tagged-query" title="Query">onchocerciasis:</span> predominance of Th1-type responsiveness to low molecular weight <span class="tagged-filter" title="Association Word">antigens</span> of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in exposed individuals without microfilaridermia and clinical disease. Clin Exp Immunol. 1996 Aug;105(2):245-53.</strong> Chronic and generalized <span class="tagged-query" title="Query">onchocerciasis</span> is <span class="tagged-filter" title="Association Word">associated</span> with suppression of the parasite-specific cellular responsiveness, while exposed individuals without parasitological and clinical evidence of infection (endemic normals) display prominent cellular reactivity to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> (OvAg). In order to identify those parasite <span class="tagged-filter" title="Association Word">antigens</span> which may account for this differential cellular responsiveness, total adult worm-derived OvAg were fractionated by means of preparative <span class="tagged-metabolite" title="HMDB: HMDB05004"><span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB05004">SDS</a></span>-PAGE and blot-elution into 22 <span class="tagged-filter" title="Association Word">antigen</span> fractions of continuously decreasing molecular weight. Peripheral blood mononuclear cells (PBMC) from microfilariae (mf)-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients (n = 18) proliferated weakly in response to all OvAg fractions. In contrast, in vitro reactivity of PBMC from endemic normals (n = 9) was depressed in response to OvAg of mol. wt 200-30 kD only, while <span class="tagged-filter" title="Association Word">antigens</span> of mol. wt < 30 kD induced vigorous proliferation in these individuals compared with the microfilaridermic patients (P < 0.05). Highest proliferative reactivity of cells from endemic normals was <span class="tagged-filter" title="Association Word">observed</span> in response to OvAg of mol. wt 15-11 kD. Furthermore, these low mol. wt <span class="tagged-filter" title="Association Word">antigen</span> fractions induced substantial <span class="tagged-filter" title="Association Word">production</span> of <a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> in PBMC from endemic normals, but not in those from <span class="tagged-query" title="Query">onchocerciasis</span> patients. Cells from individuals of both groups secreted similar amounts of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in response to all OvAg fractions, with highest <span class="tagged-filter" title="Association Word">production</span> again being induced by low mol. wt OvAg. In contrast, PBMC from <span class="tagged-query" title="Query">onchocerciasis</span> patients clearly <span class="tagged-filter" title="Association Word">produced</span> more <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> than did cells from endemic normals. This augmented <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> <span class="tagged-filter" title="Association Word">production</span> by PBMC from mf-positive individuals was not only <span class="tagged-filter" title="Association Word">observed</span> after stimulation with OvAg fractions, but was measured in unstimulated control cultures as well. <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span>-specific <span class="tagged-filter" title="Association Word">mRNA</span> in <span class="tagged-filter" title="Association Word">antigen</span>-stimulated PBMC from endemic normals appeared to be more prominent than in cells from <span class="tagged-query" title="Query">onchocerciasis</span> patients. However, <span class="tagged-filter" title="Association Word">mRNA</span> transcripts of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> were clearly present in patients, but were absent or inconsistently <span class="tagged-filter" title="Association Word">observed</span> in endemic normals. Our results suggest that vigorous Th1-type cellular responsiveness encountered in endemic normals is restricted to low mol. wt <span class="tagged-filter" title="Association Word">antigens</span> of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> while such reactivity will not be present in mf-positive individuals. Furthermore, spontaneous <span class="tagged-filter" title="Association Word">production</span> of high levels of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients is likely to suppress Th1-type immunity, and thus may favour manifestation of chronic <span class="tagged-query" title="Query">onchocerciasis.</span> These traits of cellular immunity may contribute to the differential outcome of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection, the manifestation of clinical disease, and may also regulate the build up of acquired immunity in humans.
onchocerciasis	IL-2	True Positive	1.122	8187332	<strong class="title">Soboslay PT, Luder CG, Hoffmann WH, Michaelis I, Helling G, Heuschkel C, Dreweck CM, Blanke CH, Pritze S, Banla M, et al.: <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span>-facilitated immunity in <span class="tagged-query" title="Query">onchocerciasis;</span> activation of parasite-specific Th1-type responses with subclinical <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Clin Exp Immunol. 1994 May;96(2):238-44.</strong> The present study examined the quantitative and qualitative changes registered in the parasite-specific <span class="tagged-filter" title="Association Word">antibody</span> response, cellular reactivity and <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> profile in <span class="tagged-query" title="Query">onchocerciasis</span> patients repeatedly treated with <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P32754; Entrez Gene ID: 3242; HGNC ID: 5147; HPRD ID: 02041; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> over a period of 8 years. The densities of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae (mf) in treated patients remained significantly reduced, whereas the number of permanently amicrofilaridermic patients <span class="tagged-disease" title="UMLS Concept ID: C0275522">(subclinical infection)</span> increased with repeated treatments. In vitro cellular responses to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> (OvAg) were highest (P < 0.01) in untreated control individuals exposed to infection, but negative for mf of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> (endemic normals). Cellular reactivity in repeatedly treated patients was higher at 84 than at 36 months post initial treatment (p.i.t); furthermore, the proliferative responses to OvAg, mycobacterial purified <span class="tagged-filter" title="Association Word">protein</span> derivative <a href="http://beta.uniprot.org/uniprot/P32754">(PPD)</a></span> and streptococcal SL-O were greater (P < 0.05) at 84 months p.i.t. in amicrofilaridermic than in microfilaria-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients. In amicrofilaridermic patients such reactivity approached the magnitude <span class="tagged-filter" title="Association Word">observed</span> in endemic normals. Peripheral blood mononuclear cells (PBMC) from patients and endemic normals <span class="tagged-filter" title="Association Word">produced</span> equivalent amounts of <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2,</a></span> <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> in response to mitogenic stimulation with phytohaemagglutinin <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">(PHA);</a></span> in response to OvAg, however, significantly more <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> were <span class="tagged-filter" title="Association Word">produced</span> by PBMC from subclinical amicrofilaridermic patients or endemic normals than by mf-positive patients. OvAg-specific <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> by PBMC from treated patients was lower at 84 than at 36 months p.i.t. At three months p.i.t. the titres of circulating OvAg-specific IgG1-3 had increased (P < 0.05), but they then continuously <span class="tagged-filter" title="Association Word">declined</span> with repeated treatments. Only IgG1 and IgG4 bound to OvAg of mol. wt 2-12 kD at 1 month p.i.t., while recognition of OvAg of mol. wt 10-200 kD by IgG1, IgG2 and IgG4 reached a maximum intensity at 3-6 months p.i.t., with the overall intensity of binding to OvAg gradually weakening thereafter. These results suggest that <span class="tagged-query" title="Query">onchocerciasis</span>-<span class="tagged-filter" title="Association Word">associated</span> immunosuppression is reversible following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-induced permanent clearance of microfilariae from the skin; and that a vigorous parasite-specific cellular reactivity and a sustained <span class="tagged-filter" title="Association Word">production</span> of <a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> in amicrofilaridermic individuals may contribute to controlling O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection.
onchocerciasis	IL-2	True Positive	1.122	8099937	<strong class="title">Steel C, Nutman TB: <span class="tagged-filter" title="Association Word">Regulation</span> of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in <span class="tagged-query" title="Query">onchocerciasis.</span> J Immunol. 1993 Jun 15;150(12):5511-8.</strong> A critical <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2.</a></span> . The <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> profiles of PBMC obtained from individuals "immune" to <span class="tagged-query" title="Query">Onchocerca volvulus infection</span> were compared to those from infected individuals. The immune individuals had significantly higher levels of both <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in response to parasite Ag than did those individuals with active infection (mean <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> = 1.3 and 0.138 U/ml, respectively; mean <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> = 973 and 147.4 pg/ml, respectively), and there was a direct correlation between the <span class="tagged-filter" title="Association Word">production</span> of <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5.</a></span> To examine the mechanism underlying the possible <span class="tagged-filter" title="Association Word">association</span> between these two cytokines in patients infected with <span class="tagged-query" title="Query">onchocerciasis,</span> reverse transcription followed by polymerase chain reaction was used to measure <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA.</span> In response to rIL-2, <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> appeared as early as early as 3 h after stimulation of patient PBMC, reaching a peak at 24 h; further, this response was inhibited with neutralizing <span class="tagged-filter" title="Association Word">antibodies</span> to <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2.</a></span> <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> was unable to induce <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> for <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4,</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma,</a></span> <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10,</a></span> or granulocyte-macrophage-CSF. To assess whether <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> was specifically responsible for the up-<span class="tagged-filter" title="Association Word">regulation</span> of Ag-induced <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production</span> in patients with <span class="tagged-query" title="Query">onchocerciasis,</span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> <span class="tagged-filter" title="Association Word">expression</span> was measured in PBMC stimulated with parasite Ag. Up-<span class="tagged-filter" title="Association Word">regulation</span> of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> was seen in all patients (peaking at 72 h) in response to Ag stimulation and was found to be independent of proliferation to Ag; in addition, this up-<span class="tagged-filter" title="Association Word">regulation</span> was specifically inhibited by neutralizing anti-<span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">antibodies.</span> Further, the primary source of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">mRNA</span> was determined to be <span class="tagged-gene" title="SwissProt ID: P01730; Entrez Gene ID: 920; HGNC ID: 1678; HPRD ID: 01740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01730">CD4+</a></span> T cells. These findings suggest that <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">production</span> is required to induce <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and further implicates <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> as a possible mediator of protection in <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	IL-2	True Positive	1.122	2892372	<strong class="title">Pedersen BK, Bygbjerg IC, Svenson M: Increase in natural killer cell <span class="tagged-filter" title="Association Word">activity</span> during <span class="tagged-drug" title="DrugBank: APRD00918"><span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">diethylcarbamazine</a></span> treatment of patients with <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> Acta Trop. 1987 Sep;44(3):353-5.</strong> Two patients, one with <span class="tagged-disease" title="UMLS Concept ID: C0392663">Bancroftian filariasis</span> and the other with <span class="tagged-query" title="Query">onchocerciasis,</span> and two healthy controls were treated with <span class="tagged-drug" title="DrugBank: APRD00918"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">diethylcarbamazine</a></span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">(DEC).</a></span> The natural killer (NK) cell <span class="tagged-filter" title="Association Word">activity</span> of the two patients increased during <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC</a></span> treatment to 2.5 and 2.8 times, respectively, while that of the controls remained unchanged. We conclude that the augmentation of baseline NK cell <span class="tagged-filter" title="Association Word">activity,</span> as well as <span class="tagged-gene" title="Protein Family or Complex">interferon</span>- and <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">interleukin-2</a></span>-enhanced NK cell <span class="tagged-filter" title="Association Word">activity</span> seen in the patients, is not a direct effect of <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC,</a></span> but is <span class="tagged-filter" title="Association Word">related</span> to the reaction to <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0013884">lymphatic filariasis</span> and <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	IL-2	True Positive	1.122	2051025	<strong class="title">Soboslay PT, Dreweck CM, Taylor HR, Brotman B, Wenk P, Greene BM: Experimental <span class="tagged-query" title="Query">onchocerciasis</span> in chimpanzees. J Immunol. 1991 Jul 1;147(1):346-53.</strong> Cell-mediated immune responses, and <span class="tagged-filter" title="Association Word">production</span> and effects of <span class="tagged-gene" title="SwissProt ID: P01584; Entrez Gene ID: 3553; HGNC ID: 5992; HPRD ID: 00985; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01584">IL-1</a></span> and <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> with <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Nine of eighteen chimpanzees inoculated with infective third-stage larvae of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> developed patent infection with microfilariae in skin biopsies. In all infected chimpanzees the in vitro cellular reactivity to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> adult worm-derived Ag (OvAg) increased significantly after exposure to third-stage larvae. However, during prepatency the in vitro cellular responses to OvAg decreased gradually in subsequently mf positive (patent) animals, and returned with patency to values not different to those before infection. In non-patent chimpanzees cellular responses remained significantly higher than before infection. Stimulation of PBMC in vitro with bacterial Ag and mitogen did not show any differences between the experimental groups through 20 months p.i. The addition of exogenous <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> did not restore the impaired responses of PBMC to OvAg in patent animals. Exogenous <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> elicited an additive increase of the cellular response to OvAg in nonpatent, and a mitogenic effect to OvAg in patent animals. Selective depletion of adherent, suppressor/cytotoxic <span class="tagged-gene" title="SwissProt ID: P01732; Entrez Gene ID: 925; HGNC ID: 1706; HPRD ID: 01737; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01732">(CD8+),</a></span> NK cells <span class="tagged-gene" title="SwissProt ID: O75015; Entrez Gene ID: 2215; HGNC ID: 3620; HPRD ID: 09951; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O75015">(CD16+)</a></span> and the use of autologous serum had no effect on antigenic and mitogenic cellular responsiveness. OvAg-induced <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">production</span> decreased after patency, whereas, <span class="tagged-gene" title="SwissProt ID: P01584; Entrez Gene ID: 3553; HGNC ID: 5992; HPRD ID: 00985; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01584">IL-1</a></span> <span class="tagged-filter" title="Association Word">production</span> was significantly greater in both patent and nonpatent than in control chimpanzees. In summary, these data demonstrate that experimental O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection in chimpanzees stimulated a substantial cell-mediated immune response. In patent chimpanzees an OvAg-specific cellular hyporesponsiveness occurred before onset of patency, possibly due to decreased <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">production</span> and responsiveness.
onchocerciasis	DP-alpha	True Positive	1.122	8854084	<strong class="title">Meyer CG, Schnittger L, May J: Met-11 of <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> class II <span class="tagged-gene" title="SwissProt ID: P08240; Entrez Gene ID: 6734; HGNC ID: 11307; HPRD ID: 01645; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08240">DP alpha</a></span> 1 first domain <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-query" title="Query">onchocerciasis.</span> Exp Clin Immunogenet. 1996;13(1):12-9.</strong> Human infection with the pathogenic tissue nematode Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> may result in a spectrum of clinical manifestations or in a putatively immune condition. A <span class="tagged-metabolite" title="HMDB: HMDB00696"><span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00696">methionine</a></span> at amino acid position 11 of the <a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> class II <span class="tagged-gene" title="SwissProt ID: P08240; Entrez Gene ID: 6734; HGNC ID: 11307; HPRD ID: 01645; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P08240">DP alpha</a></span> 1 chain correlates with the occurring disease after infection (relative risk 3.3). The alternative <span class="tagged-metabolite" title="HMDB: HMDB00161"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00161">alanine</a></span> at position 11 is, conversely, <span class="tagged-filter" title="Association Word">associated</span> with protection from disease ("relative protection' 3.5). DPA1*0301 is <span class="tagged-filter" title="Association Word">associated</span> with the localized form of disease after O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection.
onchocerciasis	IL-1	True Positive	1.122	2051025	<strong class="title">Soboslay PT, Dreweck CM, Taylor HR, Brotman B, Wenk P, Greene BM: Experimental <span class="tagged-query" title="Query">onchocerciasis</span> in chimpanzees. J Immunol. 1991 Jul 1;147(1):346-53.</strong> Cell-mediated immune responses, and <span class="tagged-filter" title="Association Word">production</span> and effects of <span class="tagged-gene" title="SwissProt ID: P01584; Entrez Gene ID: 3553; HGNC ID: 5992; HPRD ID: 00985; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01584">IL-1</a></span> and <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> with <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Nine of eighteen chimpanzees inoculated with infective third-stage larvae of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> developed patent infection with microfilariae in skin biopsies. In all infected chimpanzees the in vitro cellular reactivity to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> adult worm-derived Ag (OvAg) increased significantly after exposure to third-stage larvae. However, during prepatency the in vitro cellular responses to OvAg decreased gradually in subsequently mf positive (patent) animals, and returned with patency to values not different to those before infection. In non-patent chimpanzees cellular responses remained significantly higher than before infection. Stimulation of PBMC in vitro with bacterial Ag and mitogen did not show any differences between the experimental groups through 20 months p.i. The addition of exogenous <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> did not restore the impaired responses of PBMC to OvAg in patent animals. Exogenous <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> elicited an additive increase of the cellular response to OvAg in nonpatent, and a mitogenic effect to OvAg in patent animals. Selective depletion of adherent, suppressor/cytotoxic <span class="tagged-gene" title="SwissProt ID: P01732; Entrez Gene ID: 925; HGNC ID: 1706; HPRD ID: 01737; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01732">(CD8+),</a></span> NK cells <span class="tagged-gene" title="SwissProt ID: O75015; Entrez Gene ID: 2215; HGNC ID: 3620; HPRD ID: 09951; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O75015">(CD16+)</a></span> and the use of autologous serum had no effect on antigenic and mitogenic cellular responsiveness. OvAg-induced <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">production</span> decreased after patency, whereas, <span class="tagged-gene" title="SwissProt ID: P01584; Entrez Gene ID: 3553; HGNC ID: 5992; HPRD ID: 00985; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01584">IL-1</a></span> <span class="tagged-filter" title="Association Word">production</span> was significantly greater in both patent and nonpatent than in control chimpanzees. In summary, these data demonstrate that experimental O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection in chimpanzees stimulated a substantial cell-mediated immune response. In patent chimpanzees an OvAg-specific cellular hyporesponsiveness occurred before onset of patency, possibly due to decreased <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> <span class="tagged-filter" title="Association Word">production</span> and responsiveness.
onchocerciasis	glutathione-S-transferase	False Negative	1.122	9270737	<strong class="title">Liebau E, Spillner E, Henkle-Duhrsen K: pOVEX vector: prokaryotic <span class="tagged-filter" title="Association Word">expression</span> and purification of <span class="tagged-query" title="Query">onchocerciasis</span> vaccine candidate <span class="tagged-filter" title="Association Word">antigens</span> as fusion <span class="tagged-filter" title="Association Word">proteins</span> with the 24 kD Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase.</a></span> Trop Med Int Health. 1997 Jul;2(7):691-4.</strong> An <span class="tagged-filter" title="Association Word">expression</span> vector, pOVEX, has been designed and constructed, combining the advantages of the <span class="tagged-filter" title="Association Word">expression</span> vectors pGEX-3X and pJC2o. The pOVEX vector <span class="tagged-filter" title="Association Word">produces</span> a fusion <span class="tagged-filter" title="Association Word">protein</span> with the 24 kD Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> (OvGST2) which is easy to purify in one step from bacterial extracts under non-denaturing conditions using <span class="tagged-metabolite" title="HMDB: HMDB00125"><span class="tagged-gene" title="SwissProt ID: P00742; Entrez Gene ID: 2159; HGNC ID: 3528; HPRD ID: 01966; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00125">glutathione</a></span>-sepharose chromatography. High yields of fusion <span class="tagged-filter" title="Association Word">protein</span> were <span class="tagged-filter" title="Association Word">produced</span> from this T7 RNA polymerase-dependent <span class="tagged-filter" title="Association Word">expression</span> vector, which were then cleaved by digestion with the <a href="http://beta.uniprot.org/uniprot/P00742">factor Xa</a></span> protease to separate the OVGST2 polypeptide from the <span class="tagged-filter" title="Association Word">expressed</span> <span class="tagged-filter" title="Association Word">protein</span> of interest. This vector will be particularly useful to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> investigators for the <span class="tagged-filter" title="Association Word">production</span> of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> for the analyses of host humoral and cellular responses to these <span class="tagged-filter" title="Association Word">proteins</span> and for immunization studies.
onchocerciasis	glutathione-S-transferase	True Positive	1.122	8349749	<strong class="title">Ogunrinade AF, Chandrashekar R, Eberhard ML, Weil GJ: Preliminary evaluation of recombinant Onchocerca volvulus <span class="tagged-filter" title="Association Word">antigens</span> for serodiagnosis of <span class="tagged-query" title="Query">onchocerciasis.</span> J Clin Microbiol. 1993 Jul;31(7):1741-5.</strong> Serodiagnostic assays for <span class="tagged-query" title="Query">onchocerciasis</span> based on native <span class="tagged-filter" title="Association Word">antigens</span> are hampered by the scarcity of <span class="tagged-filter" title="Association Word">antigen,</span> and they suffer from poor specificity. The present study was designed to evaluate the diagnostic utility of recently described recombinant Onchocerca volvulus <span class="tagged-filter" title="Association Word">antigens</span> OC 3.6 and OC 9.3 in <span class="tagged-filter" title="Association Word">enzyme</span> immunoassays. The recombinant <span class="tagged-filter" title="Association Word">proteins</span> were <span class="tagged-filter" title="Association Word">expressed</span> as <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> fusions and were tested in several <span class="tagged-filter" title="Association Word">enzyme</span> immunoassay formats to measure <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> G (IgG) and IgG4 <span class="tagged-filter" title="Association Word">antibodies</span> with sera from patients with <span class="tagged-query" title="Query">onchocerciasis</span> in Nigeria and with various types of control sera. The best results were obtained by measuring IgG4 <span class="tagged-filter" title="Association Word">antibodies</span> to the fusion <span class="tagged-filter" title="Association Word">proteins.</span> Forty of 42 (95%) serum specimens from patients with <span class="tagged-query" title="Query">onchocerciasis</span> were reactive with OC 3.6; the reactivity with OC 9.3 was 81%. Results obtained with sera from experimentally infected chimpanzees suggest that OC 3.6 might be especially useful for detecting prepatent infections in humans, while OC 9.3 mainly detects mature, patent infections. Sera from individuals in Nigeria and the United States residing in areas nonendemic for <span class="tagged-query" title="Query">onchocerciasis</span> were uniformly nonreactive with these <span class="tagged-filter" title="Association Word">antigens</span> in IgG and IgG4 assays, as were sera from patients with <span class="tagged-disease" title="UMLS Concept ID: C0392663">bancroftian filariasis,</span> brugian <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0003950">ascariasis,</span> schistomiasis, and <span class="tagged-disease" title="UMLS Concept ID: C0013100">dracunculiasis.</span> These results suggest that <span class="tagged-filter" title="Association Word">enzyme</span> immunoassays based on the recombinant <span class="tagged-filter" title="Association Word">antigens</span> OC 3.6 and OC 9.3 are useful for the <span class="tagged-filter" title="Association Word">diagnosis</span> of <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	TLR4	True Negative	1.122	15210803	<strong class="title">Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A: The major surface <span class="tagged-filter" title="Association Word">protein</span> of Wolbachia endosymbionts in filarial nematodes elicits immune responses through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span> J Immunol. 2004 Jul 1;173(1):437-45.</strong> More than 150 million humans in tropical countries are infected by filarial nematodes which harbor intracellular bacterial endosymbionts of the genus Wolbachia (Rickettsiales). These bacteria have been implicated in adverse effects of drug treatment in <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> The present study provides evidence that purified major Wolbachia surface <span class="tagged-filter" title="Association Word">protein</span> (rWSP) acts as an inducer of the innate immune system through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4:</a></span> 1) recombinant, stringently purified rWSP elicited the release of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha,</a></span> <span class="tagged-gene" title="Protein Family or Complex">IL-12,</span> and <span class="tagged-gene" title="SwissProt ID: P10145; Entrez Gene ID: 3576; HGNC ID: 6025; HPRD ID: 00909; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10145">IL-8</a></span> from cultured blood cells of both Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected and uninfected people; 2) the inflammatory response to rWSP challenge was <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span>- and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4</a></span>-dependent as demonstrated with TLR-transfected fibroblastoid cells, as well as macrophages and dendritic cells from functional TLR-<span class="tagged-filter" title="Association Word">deficient</span> mice; 3) blood cells of <span class="tagged-query" title="Query">onchocerciasis</span> patients exposed to rWSP also generated down-regulating mediators <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and PGE (2) after 6 days of culture; 4) furthermore, rWSP-reactive IgG1 Abs were present in sera of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected people but not in those of uninfected Europeans. The lack of rWSP-reactive <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and IgG4 in serum indicated a bias toward a Th1-type adaptive immune response. Abs against rWSP stained endobacteria in living and degenerating adult O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> filariae, tissue microfilariae and host tissue macrophages that apparently had engulfed microfilariae. Thus, filarial helminths, through products of their endobacteria such as WSP, acquire characteristics of a typical microbial pathogen inducing immune responses via <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span>
onchocerciasis	S-antigen	False Negative	1.122	2378211	<strong class="title">Van der Lelij A, Rothova A, Stilma JS, Vetter JC, Hoekzema R, Kijlstra A: Humoral and cell-mediated immune response against human retinal <span class="tagged-filter" title="Association Word">antigens</span> in relation to <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> Acta Leiden. 1990;59(1-2):271-83.</strong> Autoimmune mechanisms are thought to be <span class="tagged-filter" title="Association Word">involved</span> in the pathogenesis of the chorioretinal changes in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> The humoral <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response</span> was determined by measuring serum levels of autoantibodies, directed against human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: P10745; Entrez Gene ID: 5949; HGNC ID: 9921; HPRD ID: 01581; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10745">interphotoreceptor retinoid binding protein</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">(IRBP)</a></span> using an <span class="tagged-filter" title="Association Word">enzyme</span> immunoassay. The cell-mediated immune response to these <span class="tagged-filter" title="Association Word">antigens</span> and a crude retinal extract was investigated by means of a two-step migration inhibition factor assay. Patients with <span class="tagged-query" title="Query">onchocerciasis</span> (n = 50) were subdivided into three groups: 1. without ocular involvement (n = 10), 2. with <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis</span> limited to the anterior segment (n = 19), 3. with onchocercal <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy</span> (n = 21). A group of endemic controls from Sierra Leone, West Africa were also studied. The cellular immune response to Concanavalin A was measured to assess the general capacity of lymphocytes to respond to a mitogen. High levels of anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were detected in patients with <span class="tagged-query" title="Query">onchocerciasis</span> and endemic controls. The levels of both anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were significantly higher in <span class="tagged-query" title="Query">onchocerciasis</span> patients compared to endemic controls (Mann-Whitney ranksum test; p less than 0.001 respectively 0.002). No relationship could be demonstrated between the anti-retinal <span class="tagged-filter" title="Association Word">antibody</span> level and the occurrence of <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> The occurrence of the anti-retinal <span class="tagged-filter" title="Association Word">antibodies</span> as a result of crossreactivity of anti-retinal <span class="tagged-filter" title="Association Word">antibodies</span> with parasitic <span class="tagged-filter" title="Association Word">antigens</span> or of induction of polyclonal B-cell activation due to <span class="tagged-disease" title="UMLS Concept ID: C0747256">parasitic infection</span> is discussed, since high <span class="tagged-filter" title="Association Word">antibody</span> levels were also found in patients with <span class="tagged-disease" title="UMLS Concept ID: C0392663">Bancroftian filariasis</span> from Papua New Guinea and Surinam. The migration inhibition factor assay, in which the cell-mediated immune response to human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen,</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> and retinal extract was tested, showed that four out of 50 (8%) patients with <span class="tagged-query" title="Query">onchocerciasis</span> and four out of 25 (16%) endemic controls reacted with at least one retinal <span class="tagged-filter" title="Association Word">antigen.</span> From the patients with onchocercal <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy</span> two out of 21 (10%) showed a positive cellular response. The general mitogen response tested with Con A was positive in all these individuals. In conclusion, circulating <span class="tagged-filter" title="Association Word">antibodies</span> against human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> or human <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> are thus nor specific for <span class="tagged-query" title="Query">onchocerciasis</span> and in themselves not sufficient to <span class="tagged-filter" title="Association Word">cause</span> <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy</span> in <span class="tagged-query" title="Query">onchocerciasis,</span> although their pathogenic <span class="tagged-filter" title="Association Word">role</span> in an ongoing <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> cannot be excluded. Furthermore a <span class="tagged-filter" title="Association Word">role</span> for a cell-mediated anti-retinal autoimmune mechanism in the pathogenesis of <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> in <span class="tagged-query" title="Query">onchocerciasis</span> as studied with human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen,</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> or crude retinal extract could not be demonstrated.
onchocerciasis	S-antigen	True Positive	1.122	2365568	<strong class="title">Van der Lelij A, Doekes G, Hwan BS, Vetter JC, Rietveld E, Stilma JS, Kijlstra A: Humoral <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response</span> against <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1374-80.</strong> Autoimmune mechanisms are thought to play a <span class="tagged-filter" title="Association Word">role</span> in the pathogenesis of the chorioretinal changes in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> In this study, the involvement of autoimmunity against retinal <span class="tagged-filter" title="Association Word">antigens</span> in developing <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> was investigated. Serum levels of autoantibodies, directed against human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: P10745; Entrez Gene ID: 5949; HGNC ID: 9921; HPRD ID: 01581; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10745">interphotoreceptor retinoid-binding protein</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">(IRBP),</a></span> were determined in patients with <span class="tagged-query" title="Query">onchocerciasis</span> (n = 46) and endemic controls (n = 38) from Sierra Leone with the use of an <span class="tagged-filter" title="Association Word">enzyme</span> immunoassay. In both groups high levels of anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were detected. No relationship could be demonstrated between the antiretinal <span class="tagged-filter" title="Association Word">antibody</span> level and the occurrence of <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> in <span class="tagged-query" title="Query">onchocerciasis.</span> The levels of both anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were significantly higher in patients with <span class="tagged-query" title="Query">onchocerciasis</span> compared with endemic controls (P less than 0.001). Cross-reactivity of antiretinal <span class="tagged-filter" title="Association Word">antibodies</span> with parasitic <span class="tagged-filter" title="Association Word">antigens</span> could not be demonstrated as a possible explanation for the higher levels in patients with <span class="tagged-query" title="Query">onchocerciasis.</span> No correlation was found between the levels of <span class="tagged-filter" title="Association Word">antibodies</span> of different classes against the crude Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> the egg <span class="tagged-filter" title="Association Word">antigen,</span> or the microfilariae and the antiretinal <span class="tagged-filter" title="Association Word">antibody</span> levels. Furthermore, in a panel of 13 different monoclonal <span class="tagged-filter" title="Association Word">antibodies</span> directed against O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> only one showed a slight anti-human <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> reactivity and none reacted with <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen.</a></span> The immune response against the two retinal <span class="tagged-filter" title="Association Word">antigens</span> investigated was not specific for <span class="tagged-query" title="Query">onchocerciasis</span> because high <span class="tagged-filter" title="Association Word">antibody</span> levels were also found in patients with <span class="tagged-disease" title="UMLS Concept ID: C0392663">Bancroftian filariasis</span> from Papua, New Guinea, and Surinam.(ABSTRACT TRUNCATED AT 250 WORDS)
onchocerciasis	IL-13	True Positive	4.956	11825773	<strong class="title">Hoerauf A, Kruse S, Brattig NW, Heinzmann A, Mueller-Myhsok B, Deichmann KA: The variant Arg110Gln of human <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> is <span class="tagged-filter" title="Association Word">associated</span> with an immunologically hyper-reactive form of <span class="tagged-query" title="Query">onchocerciasis</span> (sowda). Microbes Infect. 2002 Jan;4(1):37-42.</strong> <span class="tagged-query" title="Query">Onchocerca volvulus infection</span> usually results in a predominantly immunopermissive reaction called generalized <span class="tagged-query" title="Query">onchocerciasis</span> and characterized by high microfilarial burden and immunological tolerance to the worms. Rarely, however, infection <span class="tagged-filter" title="Association Word">leads</span> to the sowda form of the disease displaying low microfilarial numbers, i.e. microfilarial control, and a T helper 2 (Th2)-type immune response including high <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> (Ig) E levels, and <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">(IL)-13</a></span> being one of the key cytokines. The aim of this study was to investigate a possible <span class="tagged-filter" title="Association Word">association</span> of a variant of the <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> <span class="tagged-filter" title="Association Word">gene,</span> which confers an <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span>-independent risk for <span class="tagged-disease" title="UMLS Concept ID: C1537190">asthma</span> and atopy, with the immunologically hyper-reactive sowda form of <span class="tagged-query" title="Query">onchocerciasis.</span> Genotyping for the <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> variant Arg110Gln revealed a highly significant <span class="tagged-filter" title="Association Word">association</span> of Arg110Gln with the sowda form (relative risk of 2.98, n = 19 patients), whereas the frequency of the variant was significantly lower in patients with generalized <span class="tagged-query" title="Query">onchocerciasis</span> (n = 92 individuals). <span class="tagged-disease" title="UMLS Concept ID: C0344024">Sowda</span> patients had higher <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> levels than those with generalized <span class="tagged-query" title="Query">onchocerciasis.</span> Logistic regression analysis revealed that <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> are independent variables, each increasing the relative risk for sowda. Arg110Gln has been suggested to <span class="tagged-filter" title="Association Word">lead</span> to enhanced <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> signaling and thus may be <span class="tagged-filter" title="Association Word">involved</span> in shifting the immune reaction towards the hyper-reactivity characteristic for the sowda form, thereby promoting defense mechanisms.
onchocerciasis	chemokine	True Positive	2.329	16232219	<strong class="title">Fendt J, Hamm DM, Banla M, Schulz-Key H, Wolf H, Helling-Giese G, Heuschkel C, Soboslay PT: Chemokines in <span class="tagged-query" title="Query">onchocerciasis</span> patients after a single dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin.</a></span> . Clin Exp Immunol. 2005 Nov;142(2):318-26.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> treatment will effectively diminish microfilariae (Mf) of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in the skin of patients, but therapy is <span class="tagged-filter" title="Association Word">associated</span> with adverse host inflammatory responses. To investigate the <span class="tagged-filter" title="Association Word">association</span> of proinflammatory chemokines with the intensity of infection and clinical adverse reactions, <a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> serum levels were measured in patients following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment (100 microg/kg, 150 microg/kg or 200 microg/kg) or placebo. The density of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> Mf per mg skin decreased by 85%, 97%, 97% and 90% at day 3, at month 3, month 6 and at 1 year post-<span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin.</a></span> The <a href="http://beta.uniprot.org/uniprot/Q9Y4X3">cutaneous T cell-attracting chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">(CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27)</a></span> was found highly <span class="tagged-filter" title="Association Word">elevated</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients compared to infection-free European controls (P = 0.0004) and it did not change following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P48061; Entrez Gene ID: 6387; HGNC ID: 10672; HPRD ID: 02904; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> or placebo to 1 year post-therapy. The <a href="http://beta.uniprot.org/uniprot/P48061">chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span>/<span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">CCL5</a></span> (regulated on activated and normally T cell-<span class="tagged-filter" title="Association Word">expressed)</span> was similarly high in <span class="tagged-query" title="Query">onchocerciasis</span> patients and infection-free European controls; the <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span>/<span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">CCL5</a></span> levels did not change following treatment until 6 months post-therapy but were slightly <span class="tagged-filter" title="Association Word">elevated</span> at 1 year post-therapy (P < 0.02). In contrast, the Th2-type chemoattractants, <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">thymus and activation regulated chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">(TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17)</a></span> and <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">macrophage-derived chemokine</a></span> <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">(MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22),</a></span> were activated at 3 days post-<span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (P < 0.0001) to return to pretreatment or lower levels thereafter. The Th1-type chemoattractants, macrophage inflammatory <span class="tagged-filter" title="Association Word">protein</span> <a href="http://beta.uniprot.org/uniprot/Q92973">(MIP)</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4</a></span> were low before <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment, but following clearance of microfilariae of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> their levels increased from 6 months post-therapy onwards (for both at 12 months post-therapy, P < 0.0001). The adverse reaction scores (RS) in treated patients increased significantly on day 3 (P < 0.02) while it remained unchanged in those who received placebo (P = 0.22); RS interacted with the microfilarial density (P = 0.01), but not with the dose of <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> or with the serum levels of <a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17,</a></span> <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27.</a></span> Our observations suggest that following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin,</a></span> macrophages as well as memory Th2-type lymphocytes and B cells, attracted and activated by <a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22,</a></span> <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17</a></span> and <span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CTACK</a></span>/<span class="tagged-gene" title="SwissProt ID: Q9Y4X3; Entrez Gene ID: 10850; HGNC ID: 10626; HPRD ID: 05321; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q9Y4X3">CCL27,</a></span> may contribute to dermal immune responses and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> Mf killing and clearance. The transient changes of <span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">TARC</a></span>/<span class="tagged-gene" title="SwissProt ID: Q92583; Entrez Gene ID: 6361; HGNC ID: 10615; HPRD ID: 03309; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92583">CCL17</a></span> and <span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">MDC</a></span>/<span class="tagged-gene" title="SwissProt ID: O00626; Entrez Gene ID: 6367; HGNC ID: 10621; HPRD ID: 04263; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00626">CCL22</a></span> were not <span class="tagged-filter" title="Association Word">associated</span> with clinical adverse responses, and the later rise of <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1alpha/<span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">CCL3</a></span> and <span class="tagged-gene" title="SwissProt ID: Q92973; Entrez Gene ID: 3842; HGNC ID: 6401; HPRD ID: 04210; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q92973">MIP</a></span>-1beta/<span class="tagged-gene" title="SwissProt ID: P13236; Entrez Gene ID: 6351; HGNC ID: 10630; HPRD ID: 01657; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13236">CCL4</a></span> showed a reactivation of Type 1 immune responses <span class="tagged-filter" title="Association Word">associated</span> with persistent low levels of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae and an expiring O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection.
onchocerciasis	mast-cell-tryptase	True Positive	1.122	9698269	<strong class="title">Korten S, Wildenburg G, Darge K, Buttner DW: Mast cells in onchocercomas from patients with hyperreactive <span class="tagged-query" title="Query">onchocerciasis</span> (sowda). Acta Trop. 1998 Jun 30;70(2):217-31.</strong> In <span class="tagged-query" title="Query">onchocerciasis,</span> variations of the host's immune responsiveness <span class="tagged-filter" title="Association Word">produce</span> a spectrum of clinical manifestations ranging from the common generalized to the rare hyperreactive form (sowda). For further characterization of the immune response, the localization and frequency of mast cells in onchocercomas from untreated and <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q6NTB8; Entrez Gene ID: 23430; HGNC ID: 14118; HPRD ID: 08345; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-treated patients with hyperreactive <span class="tagged-query" title="Query">onchocerciasis</span> from Liberia and the Yemen were analysed and compared to the generalized form by immunohistochemistry with <span class="tagged-filter" title="Association Word">antibodies</span> specific for human <a href="http://beta.uniprot.org/uniprot/Q6NTB8">mast cell tryptase</a></span> and <span class="tagged-gene" title="SwissProt ID: P23946; Entrez Gene ID: 1215; HGNC ID: 2097; HPRD ID: 00346; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23946">chymase,</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00870"><span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00870">histamine</a></span> and <a href="http://beta.uniprot.org/uniprot/P01854">IgE.</a></span> The nodules were selected with special regard to only one pair of live, microfilariae-producing Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Throughout the <span class="tagged-drug" title="DrugBank: APRD00734"><span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00734">nodular</a></span> tissue of the hyperreactive form, mast cells accumulated in the strong inflammatory infiltrates, especially near eosinophils and around cellular attacks on microfilariae as well as perivascularly. Their number was significantly higher in the whole <span class="tagged-drug" title="DrugBank: APRD00734"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00734">nodular</a></span> tissue compared to the generalized form. The highest numbers occurred in the nodule centre. Mast cells carried <a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and appeared activated. No mast cells were <span class="tagged-filter" title="Association Word">observed</span> in the cystic parts or attached to adult worms or microfilariae. In onchocercomas, 1 and 3 days after treatment with <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin,</a></span> microgranuloma formation by eosinophils and macrophages around damaged microfilariae was enhanced and accompanied by numerous mast cells. Attacks of neutrophils were also pronounced, but attacks by mast cells were not <span class="tagged-filter" title="Association Word">observed.</span> In conclusion, hyperreactivity against microfilariae in onchocercomas clearly correlates with a strong <span class="tagged-disease" title="UMLS Concept ID: C1521812">mastocytosis</span> and <a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> <span class="tagged-filter" title="Association Word">production</span> parallel to tissue <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia.</span>
onchocerciasis	IL-10	True Positive	13.689	17302900	<strong class="title">Mai CS, Hamm DM, Banla M, Agossou A, Schulz-Key H, Heuschkel C, Soboslay PT: Onchocerca volvulus-specific <span class="tagged-filter" title="Association Word">antibody</span> and <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses in <span class="tagged-query" title="Query">onchocerciasis</span> patients after 16 years of repeated <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy. Clin Exp Immunol. 2007 Mar;147(3):504-12.</strong> The recommended control option against <span class="tagged-query" title="Query">onchocerciasis</span> is repeated <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment, which will need to be implemented for decades, and it remains unknown how repeated <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy might affect immunity against Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in the long term. O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific <span class="tagged-filter" title="Association Word">antibody</span> reactivity and cellular <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> were investigated in <span class="tagged-query" title="Query">onchocerciasis</span> patients receiving <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (150 microg/kg) annually for 16 years. In treated patients, the T helper type 2 (Th2) <a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL)-5</a></span> and T regulatory <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in response to O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigen</span> (OvAg) and bacteria-derived Streptolysin O (SL-O) diminished to levels found in infection-free endemic controls; also, cellular release of Th1-type <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon (IFN)-gamma</a></span> at 16 years post initial <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment (p.i.t.) approached control levels. In <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-treated <span class="tagged-query" title="Query">onchocerciasis</span> patients, <a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production</span> in responses to the mitogen phytohaemagglutinin <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">(PHA)</a></span> decreased, but <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in response <span class="tagged-gene" title="SwissProt ID: Q14739; Entrez Gene ID: 3930; HGNC ID: 6518; HPRD ID: 02488; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q14739">PHA</a></span> increased, and neither attained the <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> <span class="tagged-filter" title="Association Word">production</span> levels of endemic controls. At 16 years p.i.t., O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-specific IgG1 and IgG4 subclass reactivity still persisted at higher levels in <span class="tagged-query" title="Query">onchocerciasis</span> patients than in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> exposed but microfilariae-free endemic controls. In addition, <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses remained depressed in <span class="tagged-query" title="Query">onchocerciasis</span> patients infected concurrently with Mansonella perstans and Necator americanus or Entamoeba histolytica/dispar. Thus, long-term <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> therapy of <span class="tagged-query" title="Query">onchocerciasis</span> may not suffice to re-establish fully a balanced Th1 and Th2 immune responsiveness in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> microfilariae-negative individuals. Such <span class="tagged-filter" title="Association Word">deficient</span> reconstitution of immune competence may be due to an as yet continuing and uncontrolled reinfection with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> but parasite co-infections can also bias and may prevent the development of such immunity.
onchocerciasis	IL-10	True Positive	13.689	15210803	<strong class="title">Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A: The major surface <span class="tagged-filter" title="Association Word">protein</span> of Wolbachia endosymbionts in filarial nematodes elicits immune responses through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span> J Immunol. 2004 Jul 1;173(1):437-45.</strong> More than 150 million humans in tropical countries are infected by filarial nematodes which harbor intracellular bacterial endosymbionts of the genus Wolbachia (Rickettsiales). These bacteria have been implicated in adverse effects of drug treatment in <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> The present study provides evidence that purified major Wolbachia surface <span class="tagged-filter" title="Association Word">protein</span> (rWSP) acts as an inducer of the innate immune system through <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4:</a></span> 1) recombinant, stringently purified rWSP elicited the release of <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">TNF-alpha,</a></span> <span class="tagged-gene" title="Protein Family or Complex">IL-12,</span> and <span class="tagged-gene" title="SwissProt ID: P10145; Entrez Gene ID: 3576; HGNC ID: 6025; HPRD ID: 00909; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10145">IL-8</a></span> from cultured blood cells of both Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected and uninfected people; 2) the inflammatory response to rWSP challenge was <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span>- and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4</a></span>-dependent as demonstrated with TLR-transfected fibroblastoid cells, as well as macrophages and dendritic cells from functional TLR-<span class="tagged-filter" title="Association Word">deficient</span> mice; 3) blood cells of <span class="tagged-query" title="Query">onchocerciasis</span> patients exposed to rWSP also generated down-regulating mediators <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and PGE (2) after 6 days of culture; 4) furthermore, rWSP-reactive IgG1 Abs were present in sera of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected people but not in those of uninfected Europeans. The lack of rWSP-reactive <span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and IgG4 in serum indicated a bias toward a Th1-type adaptive immune response. Abs against rWSP stained endobacteria in living and degenerating adult O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> filariae, tissue microfilariae and host tissue macrophages that apparently had engulfed microfilariae. Thus, filarial helminths, through products of their endobacteria such as WSP, acquire characteristics of a typical microbial pathogen inducing immune responses via <span class="tagged-gene" title="SwissProt ID: O60603; Entrez Gene ID: 7097; HGNC ID: 11848; HPRD ID: 04323; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O60603">TLR2</a></span> and <span class="tagged-gene" title="SwissProt ID: O00206; Entrez Gene ID: 7099; HGNC ID: 11850; HPRD ID: 04325; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00206">TLR4.</a></span>
onchocerciasis	IL-10	True Positive	13.689	9806045	<strong class="title">Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB: Impaired <span class="tagged-disease" title="UMLS Concept ID: C0039614">tetanus</span>-specific cellular and humoral responses following <span class="tagged-disease" title="UMLS Concept ID: C0039614">tetanus</span> vaccination in human <span class="tagged-query" title="Query">onchocerciasis:</span> a possible <span class="tagged-filter" title="Association Word">role</span> for <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin-10.</a></span> J Infect Dis. 1998 Oct;178(4):1133-8.</strong> <span class="tagged-query" title="Query">Onchocerca volvulus infection</span> has been <span class="tagged-filter" title="Association Word">associated</span> with impaired cellular responses to parasite <span class="tagged-filter" title="Association Word">antigens,</span> an impairment that may also extend to nonparasite <span class="tagged-filter" title="Association Word">antigens.</span> To investigate the mechanism of this impaired immune response, the effect of concurrent O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection on the immune response to <span class="tagged-disease" title="UMLS Concept ID: C0039614">tetanus</span> toxoid (TT) following <span class="tagged-disease" title="UMLS Concept ID: C0039614">tetanus</span> vaccination was studied. The proliferative, <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine,</a></span> and <span class="tagged-filter" title="Association Word">antibody</span> response to TT of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected subjects (n = 19) and comparable noninfected controls (n = 20) were studied before and 6 months after vaccination with TT. Following vaccination, <span class="tagged-filter" title="Association Word">antibody</span> levels, proliferative responses, and levels of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> were significantly greater in noninfected subjects (P < .05, .001, and .05, respectively); however, infected subjects <span class="tagged-filter" title="Association Word">produced</span> <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin-10,</a></span> but noninfected controls did not (P < .001). These studies indicate that concurrent infection with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> can diminish the immune response to an unrelated <span class="tagged-filter" title="Association Word">antigen</span> (TT) by a mechanism that is likely to <span class="tagged-filter" title="Association Word">involve</span> <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">interleukin-10.</a></span>
onchocerciasis	IL-10	True Positive	13.689	9294549	<strong class="title">Brattig NW, Henkle-Duhrsen KH, Hounkpatin S, Liebau E, Kruppa TF, Zipfel PF: Characterization of human immune responses to the cytosolic <span class="tagged-gene" title="SwissProt ID: P04179; Entrez Gene ID: 6648; HGNC ID: 11180; HPRD ID: 00938; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04179">superoxide dismutase</a></span> and <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase</a></span> from Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Trop Med Int Health. 1997 Aug;2(8):788-98.</strong> In <span class="tagged-query" title="Query">onchocerciasis</span> patients and in O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-exposed individuals without signs of onchocericiasis, T- and B-cell responses to two recombinantly <span class="tagged-filter" title="Association Word">expressed</span> O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> enzymes were analysed and compared to responses to total <span class="tagged-filter" title="Association Word">protein</span> extract of adult parasites. The cytosolic enzymes Cu/Zn <span class="tagged-gene" title="SwissProt ID: P00441; Entrez Gene ID: 6647; HGNC ID: 11179; HPRD ID: 00937; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P00441">superoxide dismutase 1</a></span> (OvSOD1) and <span class="tagged-gene" title="SwissProt ID: P09210; Entrez Gene ID: 2939; HGNC ID: 4627; HPRD ID: 00709; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P09210">glutathione S-transferase 2</a></span> (OvGST2) represent 2 detoxifying molecules which may play an important <span class="tagged-filter" title="Association Word">role</span> in parasite defense against host-induced oxidative stress. The T-cell response to the two recombinant <span class="tagged-filter" title="Association Word">proteins</span> was analysed by investigating the <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses of peripheral blood mononuclear cells. Induction of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> at the <span class="tagged-filter" title="Association Word">mRNA</span> level and <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> and <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> at the <span class="tagged-filter" title="Association Word">protein</span> level was demonstrated in patients with the generalized form of <span class="tagged-query" title="Query">onchocerciasis</span> and endemic normals without clinical manifestations. <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> was not found to be induced by either <span class="tagged-filter" title="Association Word">antigen.</span> This pattern of <span class="tagged-gene" title="SwissProt ID: P22749; Entrez Gene ID: 10578; HGNC ID: 4414; HPRD ID: 01788; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22749">lymphokine</a></span> <span class="tagged-filter" title="Association Word">expression</span> is indicative of a Th2-type response. Compared to patients with the generalized form, a higher level of <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> induction was <span class="tagged-filter" title="Association Word">observed</span> in the group of endemic normals. Low but significant IgG levels were <span class="tagged-filter" title="Association Word">observed</span> against OvSOD1 in patients with <span class="tagged-query" title="Query">onchocerciasis;</span> higher <span class="tagged-filter" title="Association Word">antibody</span> levels were found against OvGST2 in patients and endemic normals. The highest IgG levels were detected against the crude O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> extract. These results indicate that the two recombinant O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">proteins</span> induce moderate T and B cell responses.
onchocerciasis	IL-10	True Positive	13.689	8706329	<strong class="title">Luder CG, Schulz-Key H, Banla M, Pritze S, Soboslay PT: Immunoregulation in <span class="tagged-query" title="Query">onchocerciasis:</span> predominance of Th1-type responsiveness to low molecular weight <span class="tagged-filter" title="Association Word">antigens</span> of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in exposed individuals without microfilaridermia and clinical disease. Clin Exp Immunol. 1996 Aug;105(2):245-53.</strong> Chronic and generalized <span class="tagged-query" title="Query">onchocerciasis</span> is <span class="tagged-filter" title="Association Word">associated</span> with suppression of the parasite-specific cellular responsiveness, while exposed individuals without parasitological and clinical evidence of infection (endemic normals) display prominent cellular reactivity to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> (OvAg). In order to identify those parasite <span class="tagged-filter" title="Association Word">antigens</span> which may account for this differential cellular responsiveness, total adult worm-derived OvAg were fractionated by means of preparative <span class="tagged-metabolite" title="HMDB: HMDB05004"><span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB05004">SDS</a></span>-PAGE and blot-elution into 22 <span class="tagged-filter" title="Association Word">antigen</span> fractions of continuously decreasing molecular weight. Peripheral blood mononuclear cells (PBMC) from microfilariae (mf)-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients (n = 18) proliferated weakly in response to all OvAg fractions. In contrast, in vitro reactivity of PBMC from endemic normals (n = 9) was depressed in response to OvAg of mol. wt 200-30 kD only, while <span class="tagged-filter" title="Association Word">antigens</span> of mol. wt < 30 kD induced vigorous proliferation in these individuals compared with the microfilaridermic patients (P < 0.05). Highest proliferative reactivity of cells from endemic normals was <span class="tagged-filter" title="Association Word">observed</span> in response to OvAg of mol. wt 15-11 kD. Furthermore, these low mol. wt <span class="tagged-filter" title="Association Word">antigen</span> fractions induced substantial <span class="tagged-filter" title="Association Word">production</span> of <a href="http://beta.uniprot.org/uniprot/P60568">IL-2</a></span> and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> in PBMC from endemic normals, but not in those from <span class="tagged-query" title="Query">onchocerciasis</span> patients. Cells from individuals of both groups secreted similar amounts of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> in response to all OvAg fractions, with highest <span class="tagged-filter" title="Association Word">production</span> again being induced by low mol. wt OvAg. In contrast, PBMC from <span class="tagged-query" title="Query">onchocerciasis</span> patients clearly <span class="tagged-filter" title="Association Word">produced</span> more <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> than did cells from endemic normals. This augmented <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> <span class="tagged-filter" title="Association Word">production</span> by PBMC from mf-positive individuals was not only <span class="tagged-filter" title="Association Word">observed</span> after stimulation with OvAg fractions, but was measured in unstimulated control cultures as well. <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span>-specific <span class="tagged-filter" title="Association Word">mRNA</span> in <span class="tagged-filter" title="Association Word">antigen</span>-stimulated PBMC from endemic normals appeared to be more prominent than in cells from <span class="tagged-query" title="Query">onchocerciasis</span> patients. However, <span class="tagged-filter" title="Association Word">mRNA</span> transcripts of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> and <span class="tagged-gene" title="SwissProt ID: P35225; Entrez Gene ID: 3596; HGNC ID: 5973; HPRD ID: 00981; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P35225">IL-13</a></span> were clearly present in patients, but were absent or inconsistently <span class="tagged-filter" title="Association Word">observed</span> in endemic normals. Our results suggest that vigorous Th1-type cellular responsiveness encountered in endemic normals is restricted to low mol. wt <span class="tagged-filter" title="Association Word">antigens</span> of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> while such reactivity will not be present in mf-positive individuals. Furthermore, spontaneous <span class="tagged-filter" title="Association Word">production</span> of high levels of <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10</a></span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients is likely to suppress Th1-type immunity, and thus may favour manifestation of chronic <span class="tagged-query" title="Query">onchocerciasis.</span> These traits of cellular immunity may contribute to the differential outcome of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection, the manifestation of clinical disease, and may also regulate the build up of acquired immunity in humans.
onchocerciasis	interleukin	True Negative	1.122	9226684	<strong class="title">Winkler S, Paiha S, Winkler H, Graninger W, Marberger M, Steiner GE: Microfilarial clearance in <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis</span> involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations. Parasite Immunol. 1996 Sep;18(9):479-82.</strong> <span class="tagged-drug" title="DrugBank: APRD00918"><span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">Diethylcarbamazine</a></span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">(DEC)</a></span> induced clearance of microfilaraemia in <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis</span> is <span class="tagged-filter" title="Association Word">associated</span> with severe posttreatment reactions. To define the switch from hypo- to hyper-responsiveness <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC</a></span> treatment, phenotypic alterations of T-lymphocytes, characterized by flow cytometry, and cytokines, determined by <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay, were monitored in a microfilaraemic patient. In contrast to reports on <span class="tagged-query" title="Query">onchocerciasis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0013884">lymphatic filariases,</span> no elevation of <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">(IL)-6</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour necrosis</span> factor <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)-alpha</a></span> was <span class="tagged-filter" title="Association Word">observed.</span> The most severe side effects coincided with an elevation of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon (IFN)-gamma</a></span> on day 3, followed by <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10,</a></span> transforming growth factor <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">(TGF)-beta 2</a></span> and <span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">macrophage inflammatory protein-1 alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">(MIP-1 alpha)</a></span> peaking on day 5. Phenotypically, T-cell activation <span class="tagged-filter" title="Association Word">markers</span> <span class="tagged-gene" title="SwissProt ID: P28907; Entrez Gene ID: 952; HGNC ID: 1667; HPRD ID: 00116; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28907">CD38,</a></span> <span class="tagged-gene" title="SwissProt ID: P05362; Entrez Gene ID: 3383; HGNC ID: 5344; HPRD ID: 00996; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05362">CD54</a></span> and <span class="tagged-gene" title="SwissProt ID: Q59F22; Entrez Gene ID: 3669; HGNC ID: 6130; HPRD ID: 05169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q59F22">CD25</a></span> were significantly <span class="tagged-filter" title="Association Word">expressed</span> before treatment, with high <span class="tagged-gene" title="SwissProt ID: P28907; Entrez Gene ID: 952; HGNC ID: 1667; HPRD ID: 00116; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28907">CD38</a></span> <span class="tagged-filter" title="Association Word">expression</span> still existing one year after clearance of microfilaraemia. Treatment-related increases were <span class="tagged-filter" title="Association Word">observed</span> with anti-<span class="tagged-gene" title="SwissProt ID: P14784; Entrez Gene ID: 3560; HGNC ID: 6009; HPRD ID: 00896; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14784">CD122,</a></span> anti-<span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-DR</a></span> and anti-<span class="tagged-gene" title="SwissProt ID: Q07108; Entrez Gene ID: 969; HGNC ID: 1694; HPRD ID: 00119; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07108">CD69.</a></span> <span class="tagged-gene" title="HGNC ID: 19376; Linking to HGNC"><a href="http://www.gene.ucl.ac.uk/nomenclature/data/get_data.php?hgnc_id=19376">CD28</a></span> was <span class="tagged-filter" title="Association Word">expressed</span> before treatment on almost 100% of <span class="tagged-gene" title="SwissProt ID: P01730; Entrez Gene ID: 920; HGNC ID: 1678; HPRD ID: 01740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01730">CD4+</a></span> and <span class="tagged-gene" title="SwissProt ID: P01732; Entrez Gene ID: 925; HGNC ID: 1706; HPRD ID: 01737; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01732">CD8+</a></span> T cells and dropped to 20% by day 5, reaching again baseline levels on day 21. Furthermore, there emerged 20% <span class="tagged-gene" title="SwissProt ID: P01848; Entrez Gene ID: 6955; HGNC ID: 12027; HPRD ID: 01736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01848">TCR alpha</a></span> beta+/CD3+ T cells and 10% anti-beta V5 (c)+ T cells, altogether indicating a specific pattern of T-helper (Th) 1 and Th2 cytokines as well as expansion of certain pauciclonal T-cell populations in response to microfilarial clearance.
onchocerciasis	IL-4	True Positive	3.952	10583601	<strong class="title">Hogarth PJ, Bianco AE: <span class="tagged-gene" title="SwissProt ID: P29460; Entrez Gene ID: 3593; HGNC ID: 5970; HPRD ID: 01194; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P29460">Interleukin-12</a></span> modulates T-cell responses to microfilariae but fails to abrogate <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5</a></span>-dependent immunity in a mouse model of <span class="tagged-query" title="Query">onchocerciasis.</span> Immunology. 1999 Nov;98(3):406-12.</strong> Infection of mice with microfilariae of Onchocerca lienalis induces high levels of protective immunity to reinfection, which is dependent on <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL)-5</a></span> but not <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4.</a></span> Here, we have investigated the effect of exogenous <span class="tagged-gene" title="Protein Family or Complex">IL-12</span> administration during either the priming or effector phases of the immune response. When administered during priming, <span class="tagged-gene" title="Protein Family or Complex">IL-12</span> induced down-<span class="tagged-filter" title="Association Word">regulation</span> of parasite-specific serum <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> (Ig) E and up-<span class="tagged-filter" title="Association Word">regulation</span> of IgG2a. <span class="tagged-filter" title="Association Word">Antigen</span>-specific <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> responses were strongly suppressed, whilst blood eosinophil levels were partially reduced. When administered during a challenge infection, <span class="tagged-gene" title="Protein Family or Complex">IL-12</span> did not significantly influence the balance of <span class="tagged-filter" title="Association Word">antibody</span> isotypes, but partially reduced eosinophil <span class="tagged-filter" title="Association Word">production.</span> <span class="tagged-filter" title="Association Word">Antigen</span>-specific <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> responses were again completely ablated. Unusually, <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma)</a></span> responses were not significantly affected following <span class="tagged-gene" title="Protein Family or Complex">IL-12</span> administration, either during priming or after challenge infections. Moreover, despite a fall in <span class="tagged-filter" title="Association Word">antigen</span>-specific <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> <span class="tagged-filter" title="Association Word">production,</span> the <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span>-dependent immunity, as determined by reduction in worm recoveries, was fully maintained. These data demonstrate that parasite-induced <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> can be abrogated without affecting protective immunity to Onchocerca microfilariae in mice. In view of the established <span class="tagged-filter" title="Association Word">role</span> of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> in pathogenesis, this may have important implications for the development of immunoprophylaxis aimed at microfilariae and the alleviation of pathology in <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	IL-4	True Positive	3.952	9717193	<strong class="title">Johnson EH, Schynder-Candrian S, Rajan TV, Nelson FK, Lustigman S, Abraham D: Immune responses to third stage larvae of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon-gamma</a></span> and <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">interleukin-4</a></span> knockout mice. Parasite Immunol. 1998 Jul;20(7):319-24.</strong> To shed clarity on the dichotomy of reported results relative to the significance of T helper-1 vs T helper-2 immune responses in <span class="tagged-query" title="Query">onchocerciasis,</span> we compared the survivability of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> third-stage larvae (L3) in immunized mice that had either a targeted disruption of the <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">Interleukin-4</a></span> or <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">Interferon-gamma</a></span> <span class="tagged-filter" title="Association Word">gene.</span> Treatment groups consisted of control mice and mice immunized with irradiated O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> L3. All mice were challenged with diffusion chambers containing viable L3. Vaccinated <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span>-/- were unable to kill this larval target. In contrast, vaccinated <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF</a></span>-gamma-/- and C57BL/6 mice, exhibited high levels of killing, had <span class="tagged-filter" title="Association Word">elevated</span> levels of <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> and significantly greater numbers of eosinophils in their diffusion chambers than the <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span>-/-. Whereas, levels of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> in all three groups of immunized mice were equivalent to those of control mice, levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> were <span class="tagged-filter" title="Association Word">elevated,</span> even in the <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span>-/-, indicating that cytokines other than <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> were <span class="tagged-filter" title="Association Word">involved</span> in its <span class="tagged-filter" title="Association Word">production.</span> The protective immune response to third-stage larvae of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> in mice vaccinated with irradiated larvae has an absolute <span class="tagged-gene" title="SwissProt ID: P05112; Entrez Gene ID: 3565; HGNC ID: 6014; HPRD ID: 00989; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05112">IL-4</a></span> requirement.
onchocerciasis	SS-A	True Positive	1.122	1602002	<strong class="title">Lux FA, McCauliffe DP, Buttner DW, Lucius R, Capra JD, Sontheimer RD, Lieu TS: Serological cross-reactivity between a human Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> and the lambda Ral-1 <span class="tagged-filter" title="Association Word">antigen</span> of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> J Clin Invest. 1992 Jun;89(6):1945-51.</strong> We have cloned and sequenced a 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-filter" title="Association Word">gene</span> that is the human homologue of the <span class="tagged-metabolite" title="HMDB: HMDB00464"><span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00464">calcium</a></span>-binding <span class="tagged-filter" title="Association Word">protein,</span> <a href="http://beta.uniprot.org/uniprot/P27797">calreticulin.</a></span> The sequence of this 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> has significant homology to lambda Ral-1, a recombinant cDNA clone corresponding to a major <span class="tagged-filter" title="Association Word">antigen</span> of the nematode, Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> the infectious agent of <span class="tagged-query" title="Query">onchocerciasis.</span> We therefore sought to determine whether <span class="tagged-filter" title="Association Word">antibodies</span> <span class="tagged-filter" title="Association Word">produced</span> by <span class="tagged-query" title="Query">onchocerciasis</span> patients might crossreact with the human 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin).</a></span> 20 of 22 sera from Liberian <span class="tagged-query" title="Query">onchocerciasis</span> patients who had no known evidence of <span class="tagged-disease" title="UMLS Concept ID: C0004364">autoimmune disease</span> were found to contain <span class="tagged-filter" title="Association Word">antibodies</span> that reacted with the 46-kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> by immunoblot analysis. Characteristic of sera reactive with Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">antigens,</span> some <span class="tagged-query" title="Query">onchocerciasis</span> sera also immunoprecipitated the Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span>-<span class="tagged-filter" title="Association Word">associated</span> hY RNAs. In addition, a monoclonal <span class="tagged-filter" title="Association Word">antibody</span> raised against O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> organisms reacted to purified human WiL-2 cell 46 kD Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-filter" title="Association Word">antigen</span> <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> by ELISA. These results strongly suggest that <span class="tagged-query" title="Query">onchocerciasis</span> patients <span class="tagged-filter" title="Association Word">produce</span> <span class="tagged-filter" title="Association Word">antibodies</span> that crossreact with the 46-kD human Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> autoantigen <span class="tagged-gene" title="SwissProt ID: P27797; Entrez Gene ID: 811; HGNC ID: 1455; HPRD ID: 00169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27797">(calreticulin)</a></span> and raise the possibility that infectious organisms such as O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> might play a triggering or exacerbating <span class="tagged-filter" title="Association Word">role</span> in the human Ro/<span class="tagged-gene" title="SwissProt ID: P10155; Entrez Gene ID: 6738; HGNC ID: 11313; HPRD ID: 15964; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10155">SS-A</a></span> <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response.</span>
onchocerciasis	collagen	True Negative	1.122	8644904	<strong class="title">Garate T, Conraths FJ, Harnett W, Buttner DW, Parkhouse RM: Identification of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: Q5TAT6; Entrez Gene ID: 1305; HGNC ID: 2190; HPRD ID: 00383; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5TAT6">collagen</a></span> as an <span class="tagged-filter" title="Association Word">antigen</span> mainly recognized by <span class="tagged-filter" title="Association Word">antibodies</span> in chronic hyper-reactive <span class="tagged-disease" title="UMLS Concept ID: C0344020">onchodermatitis</span> (sowda). Am J Trop Med Hyg. 1996 May;54(5):490-7.</strong> An Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">expression</span> library was differentially screened to identify a molecular <span class="tagged-filter" title="Association Word">marker</span> distinguishing sowda (lichenified <span class="tagged-disease" title="UMLS Concept ID: C0344020">onchodermatitis)</span> from other <span class="tagged-query" title="Query">onchocerciasis</span> forms. One clone, PG3, was recognized by pooled sera from patients with sowda, but not by pooled sera from patients with generalized <span class="tagged-query" title="Query">onchocerciasis;</span> it was not recognized by sera from patients with <span class="tagged-disease" title="UMLS Concept ID: C0013884">lymphatic filariasis</span> or other helminth infections. The DNA of PG3 hybridized strongly with O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> Eco RI-digested DNA, but not with DNA from Brugia spp., Trichinella spp., and humans. A weak reaction was <span class="tagged-filter" title="Association Word">observed</span> with DNA from O. gibsoni and Acanthocheilonema viteae. The PG3 DNA sequence showed a high homology with both human and nematode collagens. Confirmation of the <span class="tagged-gene" title="SwissProt ID: Q5TAT6; Entrez Gene ID: 1305; HGNC ID: 2190; HPRD ID: 00383; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5TAT6">collagen</a></span>-like nature of the sowda-specific PG3 product was obtained by amino terminal sequencing of the PG3 <span class="tagged-filter" title="Association Word">expression</span> product, as well as by demonstrating its susceptibility to collagenase digestion. The characteristic recognition of the O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: Q5TAT6; Entrez Gene ID: 1305; HGNC ID: 2190; HPRD ID: 00383; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5TAT6">collagen</a></span> specified by clone PG3 was confirmed by measuring <span class="tagged-filter" title="Association Word">antibody</span> levels to the <span class="tagged-filter" title="Association Word">expressed</span> product in individual sowda and generalized <span class="tagged-query" title="Query">onchocerciasis</span> sera, respectively. Identification of a nematode <span class="tagged-gene" title="SwissProt ID: Q5TAT6; Entrez Gene ID: 1305; HGNC ID: 2190; HPRD ID: 00383; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5TAT6">collagen</a></span> <span class="tagged-filter" title="Association Word">antigen</span> mainly recognized in sowda patients raises the possibility that this extreme form of <span class="tagged-disease" title="UMLS Concept ID: C0011603">dermatitis</span> might arise through cross-reactivity between anti-O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-gene" title="SwissProt ID: Q5TAT6; Entrez Gene ID: 1305; HGNC ID: 2190; HPRD ID: 00383; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5TAT6">collagen</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> and human <span class="tagged-gene" title="SwissProt ID: Q5TAT6; Entrez Gene ID: 1305; HGNC ID: 2190; HPRD ID: 00383; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q5TAT6">collagen.</a></span> However, a relationship between the PG3 recognition by <span class="tagged-filter" title="Association Word">antibodies</span> and the sowda pathogenesis could not be demonstrated.
onchocerciasis	HLA-DQ	True Positive	3.411	9328789	<strong class="title">Murdoch ME, Payton A, Abiose A, Thomson W, Panicker VK, Dyer PA, Jones BR, Maizels RM, Ollier WE: <span class="tagged-gene" title="SwissProt ID: P01909; Entrez Gene ID: 3117; HGNC ID: 4942; HPRD ID: 06765; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01909">HLA-DQ</a></span> alleles associate with cutaneous features of <span class="tagged-query" title="Query">onchocerciasis.</span> Hum Immunol. 1997 Jun;55(1):46-52.</strong> The Kaduna-London-Manchester Collaboration for Research on <span class="tagged-query" title="Query">Onchocerciasis.</span> <span class="tagged-query" title="Query">Onchocerciasis</span> is <span class="tagged-filter" title="Association Word">associated</span> with a spectrum of cutaneous changes, ranging from clinically normal skin to acute and chronic pathology. An important aspect of disease <span class="tagged-filter" title="Association Word">expression</span> may be the level of immune response to parasite <span class="tagged-filter" title="Association Word">antigens,</span> which is likely to be regulated by <span class="tagged-gene" title="SwissProt ID: P13747; Entrez Gene ID: 3133; HGNC ID: 4962; HPRD ID: 00877; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13747">MHC</a></span>-encoded molecules. We therefore investigated <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> class I and class II phenotypes in Nigerian residents of an area endemic for <span class="tagged-query" title="Query">onchocerciasis.</span> All study subjects were carefully characterized for parasite load and skin pathology. Individuals with <span class="tagged-disease" title="UMLS Concept ID: C0162835">depigmentation</span> had increased frequencies of DQA1*0501 and DQB1*0301 compared with persons with normal skin and high microfilarial load (NSHMF) (Odds Ratios 3.6 (95% CI 1.0 to 13.2) and 3.8 (1.0 to 15.2), respectively). Conversely, individuals with <span class="tagged-disease" title="UMLS Concept ID: C0162835">depigmentation</span> had a decreased frequency of DQA1*0101 and Cw6 compared with NSHMF (Odds Ratios 0.2 (0.1 to 0.9) and 0.1 (0.02 to 0.8), respectively). When NSHMF subjects were examined by age, a further decrease in DQA1*0501 frequency and increase in DQA1*0101 frequency were <span class="tagged-filter" title="Association Word">observed</span> in older NSHMF individuals. These results strongly suggest that there is an immunogenetic basis for the spectrum of cutaneous presentations in <span class="tagged-query" title="Query">onchocerciasis</span> and that <span class="tagged-gene" title="SwissProt ID: P01909; Entrez Gene ID: 3117; HGNC ID: 4942; HPRD ID: 06765; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01909">HLA-DQ</a></span> molecules are <span class="tagged-filter" title="Association Word">associated</span> with the level of immune response to parasite <span class="tagged-filter" title="Association Word">antigens.</span>
onchocerciasis	IL-6	True Positive	1.122	9226684	<strong class="title">Winkler S, Paiha S, Winkler H, Graninger W, Marberger M, Steiner GE: Microfilarial clearance in <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis</span> involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations. Parasite Immunol. 1996 Sep;18(9):479-82.</strong> <span class="tagged-drug" title="DrugBank: APRD00918"><span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">Diethylcarbamazine</a></span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">(DEC)</a></span> induced clearance of microfilaraemia in <span class="tagged-disease" title="UMLS Concept ID: C0023968">loiasis</span> is <span class="tagged-filter" title="Association Word">associated</span> with severe posttreatment reactions. To define the switch from hypo- to hyper-responsiveness <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC</a></span> treatment, phenotypic alterations of T-lymphocytes, characterized by flow cytometry, and cytokines, determined by <span class="tagged-filter" title="Association Word">enzyme</span> <span class="tagged-filter" title="Association Word">linked</span> immunosorbent assay, were monitored in a microfilaraemic patient. In contrast to reports on <span class="tagged-query" title="Query">onchocerciasis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0013884">lymphatic filariases,</span> no elevation of <span class="tagged-gene" title="Protein Family or Complex">interleukin</span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">(IL)-6</a></span> and <span class="tagged-disease" title="UMLS Concept ID: C0333516">tumour necrosis</span> factor <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(TNF)-alpha</a></span> was <span class="tagged-filter" title="Association Word">observed.</span> The most severe side effects coincided with an elevation of <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">interferon (IFN)-gamma</a></span> on day 3, followed by <span class="tagged-gene" title="SwissProt ID: P22301; Entrez Gene ID: 3586; HGNC ID: 5962; HPRD ID: 00495; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P22301">IL-10,</a></span> transforming growth factor <span class="tagged-gene" title="SwissProt ID: P61812; Entrez Gene ID: 7042; HGNC ID: 11768; HPRD ID: 01828; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P61812">(TGF)-beta 2</a></span> and <span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">macrophage inflammatory protein-1 alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P10147; Entrez Gene ID: 6348; HGNC ID: 10627; HPRD ID: 01656; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10147">(MIP-1 alpha)</a></span> peaking on day 5. Phenotypically, T-cell activation <span class="tagged-filter" title="Association Word">markers</span> <span class="tagged-gene" title="SwissProt ID: P28907; Entrez Gene ID: 952; HGNC ID: 1667; HPRD ID: 00116; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28907">CD38,</a></span> <span class="tagged-gene" title="SwissProt ID: P05362; Entrez Gene ID: 3383; HGNC ID: 5344; HPRD ID: 00996; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05362">CD54</a></span> and <span class="tagged-gene" title="SwissProt ID: Q59F22; Entrez Gene ID: 3669; HGNC ID: 6130; HPRD ID: 05169; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q59F22">CD25</a></span> were significantly <span class="tagged-filter" title="Association Word">expressed</span> before treatment, with high <span class="tagged-gene" title="SwissProt ID: P28907; Entrez Gene ID: 952; HGNC ID: 1667; HPRD ID: 00116; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P28907">CD38</a></span> <span class="tagged-filter" title="Association Word">expression</span> still existing one year after clearance of microfilaraemia. Treatment-related increases were <span class="tagged-filter" title="Association Word">observed</span> with anti-<span class="tagged-gene" title="SwissProt ID: P14784; Entrez Gene ID: 3560; HGNC ID: 6009; HPRD ID: 00896; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P14784">CD122,</a></span> anti-<span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-DR</a></span> and anti-<span class="tagged-gene" title="SwissProt ID: Q07108; Entrez Gene ID: 969; HGNC ID: 1694; HPRD ID: 00119; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q07108">CD69.</a></span> <span class="tagged-gene" title="HGNC ID: 19376; Linking to HGNC"><a href="http://www.gene.ucl.ac.uk/nomenclature/data/get_data.php?hgnc_id=19376">CD28</a></span> was <span class="tagged-filter" title="Association Word">expressed</span> before treatment on almost 100% of <span class="tagged-gene" title="SwissProt ID: P01730; Entrez Gene ID: 920; HGNC ID: 1678; HPRD ID: 01740; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01730">CD4+</a></span> and <span class="tagged-gene" title="SwissProt ID: P01732; Entrez Gene ID: 925; HGNC ID: 1706; HPRD ID: 01737; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01732">CD8+</a></span> T cells and dropped to 20% by day 5, reaching again baseline levels on day 21. Furthermore, there emerged 20% <span class="tagged-gene" title="SwissProt ID: P01848; Entrez Gene ID: 6955; HGNC ID: 12027; HPRD ID: 01736; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01848">TCR alpha</a></span> beta+/CD3+ T cells and 10% anti-beta V5 (c)+ T cells, altogether indicating a specific pattern of T-helper (Th) 1 and Th2 cytokines as well as expansion of certain pauciclonal T-cell populations in response to microfilarial clearance.
onchocerciasis	IL-6	True Positive	1.122	8077726	<strong class="title">Njoo FL, Hack CE, Oosting J, Luyendijk L, Stilma JS, Kijlstra A: <span class="tagged-gene" title="SwissProt ID: P02741; Entrez Gene ID: 1401; HGNC ID: 2367; HPRD ID: 00422; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02741">C-reactive protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> are <span class="tagged-filter" title="Association Word">elevated</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P07602; Entrez Gene ID: 5660; HGNC ID: 9498; HPRD ID: 01460; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. J Infect Dis. 1994 Sep;170(3):663-8.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis</span> can induce adverse reactions. Mechanisms underlying these reactions are poorly understood but may include activation of neutrophils. This study investigated the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients during 2 days after <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. The acute-phase <a href="http://beta.uniprot.org/uniprot/P07602">protein C</a></span>-reactive <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">(CRP)</a></span> and cytokines that mediate the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(tumor necrosis factor-alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">[TNF alpha]</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">[IL-6])</a></span> were measured in 144 skin snip-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients and 12 skin snip-negative controls who received one dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (150 micrograms/kg). No <span class="tagged-filter" title="Association Word">elevated</span> <a href="http://beta.uniprot.org/uniprot/P01375">TNF alpha</a></span> levels were found, but <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> and <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP</a></span> were <span class="tagged-filter" title="Association Word">elevated</span> in 25.7% and 50.7% of the patients, respectively, after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. Most patients (89.2%) with raised <a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> also had raised <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP.</a></span> Such increases were not <span class="tagged-filter" title="Association Word">observed</span> in controls and in patients were correlated with adverse reactions and microfilarial densities. These findings suggest a possible <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in microfilarial destruction following <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment.
onchocerciasis	IL-6	True Positive	1.122	2036808	<strong class="title">Van der Lelij A, Rothova A, De Vries JP, Vetter JC, Van Haren MA, Stilma JS, Kijlstra A: Analysis of aqueous humour in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> Curr Eye Res. 1991 Feb;10(2):169-76.</strong> The development of an onchocercal <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy</span> from the first detectable signs to a full blown oncho fundus is not fully understood. We investigated the intraocular humoral immune response against Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen,</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> and crude retinal extract (using an ELISA) by examining paired aqueous humour and serum samples obtained from <span class="tagged-query" title="Query">onchocerciasis</span> patients (without [n = 10] and with ocular symptoms [n = 8]) and endemic controls [n = 14] from Sierra Leone (West Africa). A local intraocular anti-retinal IgG <span class="tagged-filter" title="Association Word">antibody</span> <span class="tagged-filter" title="Association Word">production</span> could not be demonstrated in <span class="tagged-query" title="Query">onchocerciasis</span> patients, whether they had ocular symptoms or not. A significantly higher level of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antibodies</span> and IgG was measured in the aqueous of <span class="tagged-query" title="Query">onchocerciasis</span> patients with ocular involvement, as compared to patients without ocular symptoms (Mann-Whitney ranksum test; p less than 0.001 and p less than 0.02 respectively). Since <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">(IL-6)</a></span> plays an essential <span class="tagged-filter" title="Association Word">role</span> in the differentiation of B cells into <span class="tagged-gene" title="Protein Family or Complex">immunoglobulin</span> producing plasma cells, we therefore measured this <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> in paired aqueous and serum samples. <span class="tagged-filter" title="Association Word">Elevated</span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> levels were found in the aqueous of two out of eight <span class="tagged-query" title="Query">onchocerciasis</span> patients tested. In view of these findings it seems improbable that retinal autoimmunity is a major factor in the pathogenesis of onchocercal <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy.</span> The high intraocular levels of <span class="tagged-filter" title="Association Word">antibodies</span> against the parasite suggest a direct involvement of the parasite in the pathogenesis of onchocercal <span class="tagged-disease" title="UMLS Concept ID: C0339383">chorioretinopathy.</span>
onchocerciasis	heat-shock-protein-60	True Negative	1.122	10779593	<strong class="title">Wu Y, Egerton G, Ball A, Tanguay RM, Bianco AE: Characterization of the <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">heat-shock protein 60</a></span> <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">chaperonin</a></span> from Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Mol Biochem Parasitol. 2000 Apr 15;107(2):155-68.</strong> <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">Chaperonin</a></span> 60 (cpn60) belongs to the group of ubiquitous molecular chaperones that comprise the heat shock <span class="tagged-filter" title="Association Word">proteins,</span> nucleoplasmins and <span class="tagged-gene" title="Protein Family or Complex">chaperonins.</span> <span class="tagged-filter" title="Association Word">Antibodies</span> to recombinant <span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">CPN60</a></span> from humans was used to screen a cDNA library of Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> and <span class="tagged-filter" title="Association Word">antigen</span>-positive clones were selected. Sequencing of the DNA inserts confirmed their identity as cpn60 transcripts. These are distinct from a cpn60 sequence recorded previously from O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> (GenBank accession number Y09416) that appears to be of endobacterial origin, rather than derived from the parasite itself. The full-length sequence of the cDNA (designated Ov-cpn60) codes for a <span class="tagged-filter" title="Association Word">protein</span> of 64.3kDa (598 amino acid residues) and shares significant identity with homologous <span class="tagged-filter" title="Association Word">gene</span> products from Caenorhabditis elegans (72%), humans (69%), yeast (53%) and Escherichia coli (50%). The endobacterial and parasite sequences are 41% conserved. Ov-<span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">CPN60</a></span> migrates with an apparent molecular mass of 65kDa on <span class="tagged-metabolite" title="HMDB: HMDB05004"><span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB05004">SDS</a></span>-PAGE and is present in all life-cycle stages, as determined by immunoblotting with rabbit <span class="tagged-filter" title="Association Word">antibodies</span> raised against the recombinant <span class="tagged-filter" title="Association Word">protein.</span> Immunogold electron microscopy identified the <span class="tagged-filter" title="Association Word">protein</span> within mitochondria, as expected, but also in extra-mitochondrial sites, including inclusion bodies of the glandular oesophagus (in infective larvae), the uterine wall, cytosol of developing spermatids, and the hypodermis and cuticle. Endobacteria were also labelled, indicating cross-reactivity between <a href="http://beta.uniprot.org/uniprot/P10809">CPN60</a></span> from the parasite and its intracellular symbiont. In human infections, serum <span class="tagged-filter" title="Association Word">antibodies</span> to Ov-<span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">CPN60</a></span> were present in only 11% of cases from Ecuador, but in 81-89% of subjects in three separate foci from West Africa. There was no relationship between <span class="tagged-filter" title="Association Word">antibody</span> levels and age, sex, or infection intensity, and no consistent <span class="tagged-filter" title="Association Word">association</span> between the serological response and immune status. An evaluation of <span class="tagged-filter" title="Association Word">antibody</span> specificities in individual sera revealed a mixture of parasite-specific and host crossreactive anti-<span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">CPN60</a></span> <span class="tagged-filter" title="Association Word">antibodies,</span> the ratio of which varied amongst geographic areas. It is concluded that <span class="tagged-filter" title="Association Word">antibody</span> responses to Ov-<span class="tagged-gene" title="SwissProt ID: P10809; Entrez Gene ID: 3329; HGNC ID: 5261; HPRD ID: 00318; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10809">CPN60</a></span> are unlikely to contribute either to host protection or pathology in <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	interphotoreceptor-retinoid-binding-protein	True Positive	1.122	2365568	<strong class="title">Van der Lelij A, Doekes G, Hwan BS, Vetter JC, Rietveld E, Stilma JS, Kijlstra A: Humoral <span class="tagged-disease" title="UMLS Concept ID: C0004366">autoimmune response</span> against <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1374-80.</strong> Autoimmune mechanisms are thought to play a <span class="tagged-filter" title="Association Word">role</span> in the pathogenesis of the chorioretinal changes in <span class="tagged-disease" title="UMLS Concept ID: C0029002">ocular onchocerciasis.</span> In this study, the involvement of autoimmunity against retinal <span class="tagged-filter" title="Association Word">antigens</span> in developing <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> was investigated. Serum levels of autoantibodies, directed against human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: P10745; Entrez Gene ID: 5949; HGNC ID: 9921; HPRD ID: 01581; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10745">interphotoreceptor retinoid-binding protein</a></span> <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">(IRBP),</a></span> were determined in patients with <span class="tagged-query" title="Query">onchocerciasis</span> (n = 46) and endemic controls (n = 38) from Sierra Leone with the use of an <span class="tagged-filter" title="Association Word">enzyme</span> immunoassay. In both groups high levels of anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were detected. No relationship could be demonstrated between the antiretinal <span class="tagged-filter" title="Association Word">antibody</span> level and the occurrence of <span class="tagged-disease" title="UMLS Concept ID: C0008513">chorioretinitis</span> in <span class="tagged-query" title="Query">onchocerciasis.</span> The levels of both anti-human <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen</a></span> and <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> were significantly higher in patients with <span class="tagged-query" title="Query">onchocerciasis</span> compared with endemic controls (P less than 0.001). Cross-reactivity of antiretinal <span class="tagged-filter" title="Association Word">antibodies</span> with parasitic <span class="tagged-filter" title="Association Word">antigens</span> could not be demonstrated as a possible explanation for the higher levels in patients with <span class="tagged-query" title="Query">onchocerciasis.</span> No correlation was found between the levels of <span class="tagged-filter" title="Association Word">antibodies</span> of different classes against the crude Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> the egg <span class="tagged-filter" title="Association Word">antigen,</span> or the microfilariae and the antiretinal <span class="tagged-filter" title="Association Word">antibody</span> levels. Furthermore, in a panel of 13 different monoclonal <span class="tagged-filter" title="Association Word">antibodies</span> directed against O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus,</span> only one showed a slight anti-human <span class="tagged-gene" title="SwissProt ID: Q13322; Entrez Gene ID: 2887; HGNC ID: 4564; HPRD ID: 03312; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q13322">IRBP</a></span> reactivity and none reacted with <span class="tagged-gene" title="SwissProt ID: P10523; Entrez Gene ID: 6295; HGNC ID: 10521; HPRD ID: 01625; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P10523">S-antigen.</a></span> The immune response against the two retinal <span class="tagged-filter" title="Association Word">antigens</span> investigated was not specific for <span class="tagged-query" title="Query">onchocerciasis</span> because high <span class="tagged-filter" title="Association Word">antibody</span> levels were also found in patients with <span class="tagged-disease" title="UMLS Concept ID: C0392663">Bancroftian filariasis</span> from Papua, New Guinea, and Surinam.(ABSTRACT TRUNCATED AT 250 WORDS)
onchocerciasis	chymase	True Negative	1.122	9698269	<strong class="title">Korten S, Wildenburg G, Darge K, Buttner DW: Mast cells in onchocercomas from patients with hyperreactive <span class="tagged-query" title="Query">onchocerciasis</span> (sowda). Acta Trop. 1998 Jun 30;70(2):217-31.</strong> In <span class="tagged-query" title="Query">onchocerciasis,</span> variations of the host's immune responsiveness <span class="tagged-filter" title="Association Word">produce</span> a spectrum of clinical manifestations ranging from the common generalized to the rare hyperreactive form (sowda). For further characterization of the immune response, the localization and frequency of mast cells in onchocercomas from untreated and <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: Q6NTB8; Entrez Gene ID: 23430; HGNC ID: 14118; HPRD ID: 08345; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span>-treated patients with hyperreactive <span class="tagged-query" title="Query">onchocerciasis</span> from Liberia and the Yemen were analysed and compared to the generalized form by immunohistochemistry with <span class="tagged-filter" title="Association Word">antibodies</span> specific for human <a href="http://beta.uniprot.org/uniprot/Q6NTB8">mast cell tryptase</a></span> and <span class="tagged-gene" title="SwissProt ID: P23946; Entrez Gene ID: 1215; HGNC ID: 2097; HPRD ID: 00346; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P23946">chymase,</a></span> <span class="tagged-metabolite" title="HMDB: HMDB00870"><span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://hmdb.ca/scripts/show_card.cgi?METABOCARD=HMDB00870">histamine</a></span> and <a href="http://beta.uniprot.org/uniprot/P01854">IgE.</a></span> The nodules were selected with special regard to only one pair of live, microfilariae-producing Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus.</span> Throughout the <span class="tagged-drug" title="DrugBank: APRD00734"><span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00734">nodular</a></span> tissue of the hyperreactive form, mast cells accumulated in the strong inflammatory infiltrates, especially near eosinophils and around cellular attacks on microfilariae as well as perivascularly. Their number was significantly higher in the whole <span class="tagged-drug" title="DrugBank: APRD00734"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00734">nodular</a></span> tissue compared to the generalized form. The highest numbers occurred in the nodule centre. Mast cells carried <a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> and appeared activated. No mast cells were <span class="tagged-filter" title="Association Word">observed</span> in the cystic parts or attached to adult worms or microfilariae. In onchocercomas, 1 and 3 days after treatment with <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01854; Entrez Gene ID: 3497; HGNC ID: 5522; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin,</a></span> microgranuloma formation by eosinophils and macrophages around damaged microfilariae was enhanced and accompanied by numerous mast cells. Attacks of neutrophils were also pronounced, but attacks by mast cells were not <span class="tagged-filter" title="Association Word">observed.</span> In conclusion, hyperreactivity against microfilariae in onchocercomas clearly correlates with a strong <span class="tagged-disease" title="UMLS Concept ID: C1521812">mastocytosis</span> and <a href="http://beta.uniprot.org/uniprot/P01854">IgE</a></span> <span class="tagged-filter" title="Association Word">production</span> parallel to tissue <span class="tagged-disease" title="UMLS Concept ID: C0014457">eosinophilia.</span>
onchocerciasis	Eotaxin	False Negative	1.122	10794432	<strong class="title">Cooper PJ, Beck LA, Espinel I, Deyampert NM, Hartnell A, Jose PJ, Paredes W, Guderian RH, Nutman TB: <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">Eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> <span class="tagged-filter" title="Association Word">expression</span> by the dermal endothelium is <span class="tagged-filter" title="Association Word">associated</span> with eosinophil infiltration after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis.</span> Clin Immunol. 2000 Apr;95(1 Pt 1):51-61.</strong> The <span class="tagged-filter" title="Association Word">roles</span> of <a href="http://beta.uniprot.org/uniprot/P51671">eotaxin,</a></span> <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES,</a></span> and <span class="tagged-gene" title="SwissProt ID: P80098; Entrez Gene ID: 6354; HGNC ID: 10634; HPRD ID: 01150; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P80098">MCP-3</a></span> <span class="tagged-filter" title="Association Word">expression</span> in eosinophil recruitment to the site of parasite killing that occurs following <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis</span> were assessed in the skin of 13 Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span>-infected subjects and two noninfected controls before and after <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. Adverse reactions in infected subjects were <span class="tagged-filter" title="Association Word">associated</span> with the appearance of eosinophils in the dermis as part of a perivascular inflammatory infiltrate. Although no <span class="tagged-filter" title="Association Word">expression</span> of <a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> and <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> was seen in dermal vascular endothelial cells in biopsies taken before treatment (nor at any time in the skin of uninfected controls), endothelial <span class="tagged-filter" title="Association Word">expression</span> of both <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> was noted by 24 h following treatment. While <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> <span class="tagged-filter" title="Association Word">expression</span> was transient, <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> <span class="tagged-filter" title="Association Word">expression</span> increased in parallel with increasing eosinophil recruitment up to 60 h posttreatment. These observations indicate that endothelial <span class="tagged-filter" title="Association Word">expression</span> of <span class="tagged-gene" title="SwissProt ID: P51671; Entrez Gene ID: 6356; HGNC ID: 10610; HPRD ID: 03098; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P51671">eotaxin</a></span> and <span class="tagged-gene" title="SwissProt ID: P13501; Entrez Gene ID: 6352; HGNC ID: 10632; HPRD ID: 01751; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P13501">RANTES</a></span> may have an important <span class="tagged-filter" title="Association Word">role</span> in eosinophil recruitment into the skin during helminth-killing reactions.
onchocerciasis	HLA-DR	True Positive	2.870	15275211	<strong class="title">Meyer CG, Kremsner PG: <span class="tagged-disease" title="UMLS Concept ID: C1576436">Malaria</span> and <span class="tagged-query" title="Query">onchocerciasis:</span> On <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> and <span class="tagged-filter" title="Association Word">related</span> matters. Parasitol Today. 1996 May;12(5):179-86.</strong> In recent years, associations of particular factors of the human <span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">leukocyte antigen</a></span> <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">(HLA)</a></span> system with two major infectious diseases of tropical countries have been recognized: common West African <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> <span class="tagged-filter" title="Association Word">antigens</span> are <span class="tagged-filter" title="Association Word">associated</span> with protection from severe <span class="tagged-disease" title="UMLS Concept ID: C0024535">Plasmodium falciparum malaria,</span> and <span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-D</a></span> alleles are <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0849867">generalized disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0277565">localized disease</span> and putative immunity in <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Here, Christian Meyer and Peter Kremsner summarize current information on the involvement of <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> factors in P. <span class="tagged-disease" title="UMLS Concept ID: C0024535">falciparum malaria</span> and O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection, and briefly report on <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span>-<span class="tagged-filter" title="Association Word">related</span> immunological characteristics of various conditions in these infectious diseases.
onchocerciasis	HLA-DR	True Positive	2.870	8052611	<strong class="title">Meyer CG, Gallin M, Erttmann KD, Brattig N, Schnittger L, Gelhaus A, Tannich E, Begovich AB, Erlich HA, Horstmann RD: <span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-D</a></span> alleles <span class="tagged-filter" title="Association Word">associated</span> with <span class="tagged-disease" title="UMLS Concept ID: C0849867">generalized disease,</span> <span class="tagged-disease" title="UMLS Concept ID: C0277565">localized disease,</span> and putative immunity in <span class="tagged-query" title="Query">Onchocerca volvulus infection.</span> Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7515-9.</strong> Human infections with the tissue nematode Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> result in a variety of clinical conditions that possibly include protective immunity. In a West African area hyperendemic for human <span class="tagged-query" title="Query">onchocerciasis,</span> 120 residents were classified according to clinical and laboratory findings as presenting with generalized <span class="tagged-query" title="Query">onchocerciasis,</span> localized <span class="tagged-query" title="Query">onchocerciasis,</span> or as being putatively immune. The three groups differed in the distribution of <span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-D</a></span> variants as determined by DNA typing. The most pronounced differences were found among alleles of the DQ loci. The haplotype DQA1*0501-DQB1*0301 was significantly more frequent among putatively immune individuals than among patients with generalized or <span class="tagged-disease" title="UMLS Concept ID: C0277565">localized disease.</span> Conversely, DQA1*0101-<span class="tagged-gene" title="SwissProt ID: P01919; Entrez Gene ID: 3119; HGNC ID: 4944; HPRD ID: 05054; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01919">DQB1*0501</a></span> and, independently, the allele DQB1*0201 were more frequent in <span class="tagged-disease" title="UMLS Concept ID: C0849867">generalized disease</span> than in <span class="tagged-disease" title="UMLS Concept ID: C0277565">localized disease</span> or putative immunity. In these correlations, the frequencies of allelic variants were in <span class="tagged-disease" title="UMLS Concept ID: C0277565">localized disease</span> intermediate to those of the two other groups. The only distinct <span class="tagged-filter" title="Association Word">association</span> found with <span class="tagged-disease" title="UMLS Concept ID: C0277565">localized disease</span> was that of the DP allele DPB1*0402. The findings indicate that <span class="tagged-gene" title="SwissProt ID: O00157; Entrez Gene ID: 3127; HGNC ID: 4953; HPRD ID: 09209; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00157">HLA-D</a></span> variants influence the course of O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> infection and help to define a state that may reflect protective immunity.
onchocerciasis	desmoglein-1	False Negative	1.122	15610512	<strong class="title">Diaz LA, Arteaga LA, Hilario-Vargas J, Valenzuela JG, Li N, Warren S, Aoki V, Hans-Filho G, Eaton D, dos Santos V, Nutman TB, de Mayolo AA, Qaqish BF, Sampaio SA, Rivitti EA: Anti-<span class="tagged-gene" title="SwissProt ID: Q02413; Entrez Gene ID: 1828; HGNC ID: 3048; HPRD ID: 00515; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02413">desmoglein-1</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> in <span class="tagged-query" title="Query">onchocerciasis,</span> <span class="tagged-disease" title="UMLS Concept ID: C0023281">leishmaniasis</span> and <span class="tagged-disease" title="UMLS Concept ID: C0041234">Chagas disease</span> suggest a possible etiological link to <span class="tagged-disease" title="UMLS Concept ID: C0263314">Fogo selvagem.</span> J Invest Dermatol. 2004 Dec;123(6):1045-51.</strong> <span class="tagged-disease" title="UMLS Concept ID: C0263313">Pemphigus foliaceus</span> (PF) and the endemic form <span class="tagged-disease" title="UMLS Concept ID: C0263314">Fogo Selvagem</span> (FS) are mediated by pathogenic <span class="tagged-filter" title="Association Word">antibodies</span> to the <span class="tagged-gene" title="Entrez Gene ID: 4819; HGNC ID: 7832; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4819">EC1</a></span>-2 domains of <span class="tagged-gene" title="SwissProt ID: Q02413; Entrez Gene ID: 1828; HGNC ID: 3048; HPRD ID: 00515; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02413">desmoglein-1.</a></span> There is a preclinical phase with <span class="tagged-filter" title="Association Word">antibodies</span> to only EC5. Based on geographic clustering of cases, FS is thought to have an, as yet unidentified, environmental trigger. In this study we have searched for anti-<span class="tagged-gene" title="SwissProt ID: Q02413; Entrez Gene ID: 1828; HGNC ID: 3048; HPRD ID: 00515; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02413">desmoglein-1</a></span> <span class="tagged-filter" title="Association Word">antibodies</span> in sera from parasitic <span class="tagged-disease" title="UMLS Concept ID: C0023281">(leishmaniasis,</span> Chagas, and <span class="tagged-query" title="Query">onchocerciasis),</span> and infectious diseases <span class="tagged-disease" title="UMLS Concept ID: C0023343">(leprosy</span> and South American (SA) <span class="tagged-disease" title="UMLS Concept ID: C0005717">blastomycosis),</span> which are prevalent in the same geographic regions of Brazil as FS. A specific and sensitive <span class="tagged-gene" title="SwissProt ID: Q02413; Entrez Gene ID: 1828; HGNC ID: 3048; HPRD ID: 00515; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q02413">desmoglein-1</a></span> ELISA detected <span class="tagged-filter" title="Association Word">antibodies</span> in 34 of 41 <span class="tagged-query" title="Query">onchocerciasis</span> (83%), 38 of 88 <span class="tagged-disease" title="UMLS Concept ID: C0023281">leishmaniasis</span> (43%), 18 of 31 <span class="tagged-disease" title="UMLS Concept ID: C0041234">Chagas disease</span> (58%), 7 of 28 SA <span class="tagged-disease" title="UMLS Concept ID: C0005717">blastomycosis</span> (25%), and 14 of 83 <span class="tagged-disease" title="UMLS Concept ID: C0023343">leprosy</span> sera (17%). These sera recognized epitopes restricted to the EC5 domain. These findings identify several etiological factors for FS. It is hypothesized that a component of insect vector saliva, rather than the parasite itself may trigger an <span class="tagged-filter" title="Association Word">antibody</span> response to EC-5. In persons with the known <span class="tagged-gene" title="SwissProt ID: O00664; Entrez Gene ID: 3126; HGNC ID: 4952; HPRD ID: 09986; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/O00664">HLA</a></span> susceptibility alleles and living in endemic areas, a response to the <span class="tagged-gene" title="Entrez Gene ID: 4819; HGNC ID: 7832; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4819">EC1</a></span>-2 domains may subsequently develop by epitope spreading with <span class="tagged-filter" title="Association Word">associated</span> clinical signs of FS.
onchocerciasis	Cam1	True Negative	1.122	1598508	<strong class="title">Engelbrecht F, Eisenhardt G, Turner J, Sundaralingam J, Owen D, Braun G, Connor V, Taylor DW: Analysis of <span class="tagged-filter" title="Association Word">antibody</span> responses directed against two Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> <span class="tagged-filter" title="Association Word">antigens</span> defined by monoclonal <span class="tagged-filter" title="Association Word">antibodies.</span> Trop Med Parasitol. 1992 Mar;43(1):47-53.</strong> Monoclonal <span class="tagged-filter" title="Association Word">antibodies,</span> reactive with <span class="tagged-filter" title="Association Word">antigens</span> solubilised from the body wall of intact female Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> using 2% 2-beta-mercaptoethanol, have been characterised. Two IgG1 <span class="tagged-filter" title="Association Word">antibodies,</span> <span class="tagged-gene" title="SwissProt ID: P62158; Entrez Gene ID: 808; HGNC ID: 1449; HPRD ID: 00243; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62158">Cam1</a></span> and Cam28, recognised <span class="tagged-filter" title="Association Word">antigens</span> of apparent molecular weights of 18,000 and 28,000; and 120,000, respectively. The target <span class="tagged-filter" title="Association Word">antigens</span> of <span class="tagged-gene" title="SwissProt ID: P62158; Entrez Gene ID: 808; HGNC ID: 1449; HPRD ID: 00243; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62158">Cam1</a></span> and Cam28 could be localised in the cuticle. Inhibition ELISAs showed that target epitopes of both monoclonal <span class="tagged-filter" title="Association Word">antibodies</span> induce an <span class="tagged-filter" title="Association Word">antibody</span> response in <span class="tagged-query" title="Query">onchocerciasis</span> patients. 153 sera from Sierra Leonean patients were tested for their individual <span class="tagged-filter" title="Association Word">antibody</span> levels against <span class="tagged-filter" title="Association Word">antigen</span> epitopes recognised by <span class="tagged-gene" title="SwissProt ID: P62158; Entrez Gene ID: 808; HGNC ID: 1449; HPRD ID: 00243; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62158">Cam1</a></span> and Cam28. Patients within the age of 5-8 years had the highest levels of <span class="tagged-filter" title="Association Word">antibodies</span> against the Cam28-epitope, whereas patients above 60 years had almost none. Amicrofilaremic patients had higher anti-Cam28 <span class="tagged-filter" title="Association Word">antibody</span> levels than microfilaremic patients and there was a significant difference between groups with no <span class="tagged-disease" title="UMLS Concept ID: C1290009">chronic skin disease</span> and those with mild or severe signs. A high percentage of patients (80.4%) recognised the <span class="tagged-gene" title="SwissProt ID: P62158; Entrez Gene ID: 808; HGNC ID: 1449; HPRD ID: 00243; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62158">Cam1</a></span>-epitope, highest <span class="tagged-filter" title="Association Word">antibody</span> levels being found in patients within the age group of 15 to 45 years and in microfilaremic patients. However, levels of <span class="tagged-filter" title="Association Word">antibodies</span> inhibiting monoclonal <span class="tagged-filter" title="Association Word">antibody</span> <span class="tagged-gene" title="SwissProt ID: P62158; Entrez Gene ID: 808; HGNC ID: 1449; HPRD ID: 00243; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P62158">Cam1</a></span> could not be correlated with presence or <span class="tagged-filter" title="Association Word">absence</span> of <span class="tagged-disease" title="UMLS Concept ID: C0037274">skin disease.</span>
onchocerciasis	interferon	True Negative	1.122	2892372	<strong class="title">Pedersen BK, Bygbjerg IC, Svenson M: Increase in natural killer cell <span class="tagged-filter" title="Association Word">activity</span> during <span class="tagged-drug" title="DrugBank: APRD00918"><span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">diethylcarbamazine</a></span> treatment of patients with <span class="tagged-disease" title="UMLS Concept ID: C0016085">filariasis.</span> Acta Trop. 1987 Sep;44(3):353-5.</strong> Two patients, one with <span class="tagged-disease" title="UMLS Concept ID: C0392663">Bancroftian filariasis</span> and the other with <span class="tagged-query" title="Query">onchocerciasis,</span> and two healthy controls were treated with <span class="tagged-drug" title="DrugBank: APRD00918"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00918">diethylcarbamazine</a></span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">(DEC).</a></span> The natural killer (NK) cell <span class="tagged-filter" title="Association Word">activity</span> of the two patients increased during <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC</a></span> treatment to 2.5 and 2.8 times, respectively, while that of the controls remained unchanged. We conclude that the augmentation of baseline NK cell <span class="tagged-filter" title="Association Word">activity,</span> as well as <span class="tagged-gene" title="Protein Family or Complex">interferon</span>- and <span class="tagged-gene" title="SwissProt ID: P60568; Entrez Gene ID: 3558; HGNC ID: 6001; HPRD ID: 00979; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P60568">interleukin-2</a></span>-enhanced NK cell <span class="tagged-filter" title="Association Word">activity</span> seen in the patients, is not a direct effect of <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC,</a></span> but is <span class="tagged-filter" title="Association Word">related</span> to the reaction to <span class="tagged-gene" title="Entrez Gene ID: 8037; Linking to Entrez Gene"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8037">DEC</a></span> in <span class="tagged-disease" title="UMLS Concept ID: C0013884">lymphatic filariasis</span> and <span class="tagged-query" title="Query">onchocerciasis.</span>
onchocerciasis	keratin	True Positive	1.122	7539474	<strong class="title">Chandrashekar R, Curtis KC, Weil GJ: Molecular characterization of a parasite <span class="tagged-filter" title="Association Word">antigen</span> in sera from <span class="tagged-query" title="Query">onchocerciasis</span> patients that is immunologically cross-reactive with human <span class="tagged-gene" title="Protein Family or Complex">keratin.</span> J Infect Dis. 1995 Jun;171(6):1586-92.</strong> Onchocerca volvulus is a nematode that <span class="tagged-filter" title="Association Word">causes</span> severe <span class="tagged-disease" title="UMLS Concept ID: C0011603">dermatitis</span> and blindness in humans. Prior studies have shown that immune complexes in sera from <span class="tagged-query" title="Query">onchocerciasis</span> patients contain parasite <span class="tagged-filter" title="Association Word">antigens</span> with M (r) of 23,000 and 65,000-70,000. Monoclonal antibody <span class="tagged-gene" title="SwissProt ID: Q12974; Entrez Gene ID: 8073; HGNC ID: 9635; HPRD ID: 03348; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12974">OV-1</a></span> binds to these <span class="tagged-filter" title="Association Word">antigens</span> and to corresponding <span class="tagged-filter" title="Association Word">antigens</span> in adult worm extracts and in vitro culture supernatants. <span class="tagged-gene" title="SwissProt ID: Q12974; Entrez Gene ID: 8073; HGNC ID: 9635; HPRD ID: 03348; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q12974">OV-1</a></span> was used to immunoscreen an O. <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> adult worm cDNA library. Clone OV1CF contains a 1632-bp open-reading frame that codes for a <span class="tagged-filter" title="Association Word">protein</span> with a predicted M (r) of 63,000. The deduced <span class="tagged-filter" title="Association Word">protein</span> sequence of OV1CF has 78% identity with Ascaris lumbricoides intermediate filament A and 40%-50% identity with several mammalian intermediate filaments. <span class="tagged-filter" title="Association Word">Antibodies</span> raised to OV1CF bind to human <span class="tagged-gene" title="Protein Family or Complex">keratin,</span> and some sera from <span class="tagged-query" title="Query">onchocerciasis</span> patients contain <span class="tagged-filter" title="Association Word">antibodies</span> to OV1CF and to <span class="tagged-gene" title="Protein Family or Complex">keratin.</span> Thus, immune complexes from <span class="tagged-query" title="Query">onchocerciasis</span> patients contain a parasite <span class="tagged-filter" title="Association Word">antigen</span> that is immunologically cross-reactive with human intermediate filament <span class="tagged-filter" title="Association Word">proteins.</span>
onchocerciasis	C-reactive-protein	True Positive	1.122	8077726	<strong class="title">Njoo FL, Hack CE, Oosting J, Luyendijk L, Stilma JS, Kijlstra A: <span class="tagged-gene" title="SwissProt ID: P02741; Entrez Gene ID: 1401; HGNC ID: 2367; HPRD ID: 00422; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P02741">C-reactive protein</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> are <span class="tagged-filter" title="Association Word">elevated</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P07602; Entrez Gene ID: 5660; HGNC ID: 9498; HPRD ID: 01460; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. J Infect Dis. 1994 Sep;170(3):663-8.</strong> <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">Ivermectin</a></span> treatment of <span class="tagged-query" title="Query">onchocerciasis</span> can induce adverse reactions. Mechanisms underlying these reactions are poorly understood but may include activation of neutrophils. This study investigated the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in <span class="tagged-query" title="Query">onchocerciasis</span> patients during 2 days after <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. The acute-phase <a href="http://beta.uniprot.org/uniprot/P07602">protein C</a></span>-reactive <span class="tagged-filter" title="Association Word">protein</span> <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">(CRP)</a></span> and cytokines that mediate the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">(tumor necrosis factor-alpha</a></span> <span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01375">[TNF alpha]</a></span> and <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">interleukin-6</a></span> <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">[IL-6])</a></span> were measured in 144 skin snip-positive <span class="tagged-query" title="Query">onchocerciasis</span> patients and 12 skin snip-negative controls who received one dose of <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P01375; Entrez Gene ID: 7124; HGNC ID: 11892; HPRD ID: 01855; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> (150 micrograms/kg). No <span class="tagged-filter" title="Association Word">elevated</span> <a href="http://beta.uniprot.org/uniprot/P01375">TNF alpha</a></span> levels were found, but <span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> and <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP</a></span> were <span class="tagged-filter" title="Association Word">elevated</span> in 25.7% and 50.7% of the patients, respectively, after <span class="tagged-drug" title="DrugBank: APRD01058"><span class="tagged-gene" title="SwissProt ID: P05231; Entrez Gene ID: 3569; HGNC ID: 6018; HPRD ID: 00970; Linking to SwissProt"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment. Most patients (89.2%) with raised <a href="http://beta.uniprot.org/uniprot/P05231">IL-6</a></span> also had raised <span class="tagged-gene" title="SwissProt ID: P21291; Entrez Gene ID: 1465; HGNC ID: 2469; HPRD ID: 00470; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P21291">CRP.</a></span> Such increases were not <span class="tagged-filter" title="Association Word">observed</span> in controls and in patients were correlated with adverse reactions and microfilarial densities. These findings suggest a possible <span class="tagged-filter" title="Association Word">role</span> of the <span class="tagged-disease" title="UMLS Concept ID: C0001349">acute-phase response</span> in microfilarial destruction following <span class="tagged-drug" title="DrugBank: APRD01058"><a href="http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD01058">ivermectin</a></span> treatment.
onchocerciasis	granulocyte-macrophage-colony-stimulating-factor	True Positive	1.122	10722581	<strong class="title">Turaga PS, Tierney TJ, Bennett KE, McCarthy MC, Simonek SC, Enyong PA, Moukatte DW, Lustigman S: Immunity to <span class="tagged-query" title="Query">onchocerciasis:</span> cells from putatively immune individuals <span class="tagged-filter" title="Association Word">produce</span> enhanced levels of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5,</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">gamma interferon,</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> in response to Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> larval and male worm <span class="tagged-filter" title="Association Word">antigens.</span> Infect Immun. 2000 Apr;68(4):1905-11.</strong> <span class="tagged-filter" title="Association Word">Antigen</span>-specific <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">interleukin-5</a></span> <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">(IL-5),</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">gamma interferon</a></span> <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">(IFN-gamma),</a></span> and <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">granulocyte-macrophage colony-stimulating factor</a></span> <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">(GM-CSF)</a></span> responses in individuals living in an area of hyperendemicity for <span class="tagged-query" title="Query">onchocerciasis</span> in Cameroon were examined. The responses against <span class="tagged-filter" title="Association Word">antigens</span> prepared from Onchocerca <span class="tagged-disease" title="UMLS Concept ID: C0042961">volvulus</span> third-stage larvae (L3), molting L3 (mL3), and crude extract from adult males (M-OvAg) were compared to the responses against <span class="tagged-filter" title="Association Word">antigens</span> from adult female worms and skin microfilariae. <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">Cytokine</a></span> responses for the putatively immune individuals (PI) and the infected individuals <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">(INF)</a></span> were compared. A differential <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> profile of <span class="tagged-gene" title="SwissProt ID: P05113; Entrez Gene ID: 3567; HGNC ID: 6016; HPRD ID: 00997; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P05113">IL-5</a></span> (Th2 phenotype) and <span class="tagged-gene" title="SwissProt ID: P01579; Entrez Gene ID: 3458; HGNC ID: 5438; HPRD ID: 00957; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P01579">IFN-gamma</a></span> (Th1 phenotype) was found in these individuals in response to the <span class="tagged-filter" title="Association Word">antigens.</span> In both the PI and the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> Th2 responses against all the <span class="tagged-filter" title="Association Word">antigens</span> tested were <span class="tagged-filter" title="Association Word">dominant.</span> However, in the PI group as a whole, there was an enhanced Th2 response against the larval <span class="tagged-filter" title="Association Word">antigens</span> and the adult male and adult female <span class="tagged-filter" title="Association Word">antigens,</span> and a Th1 response in a subgroup of the PI (27 to 54.5%) against L3, mL3, and M-OvAg <span class="tagged-filter" title="Association Word">antigens</span> was present. While the PI <span class="tagged-filter" title="Association Word">produced</span> significantly higher levels of <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> against L3, mL3, and M-OvAg <span class="tagged-filter" title="Association Word">antigens</span> than the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> there was no difference in the <span class="tagged-gene" title="SwissProt ID: P04141; Entrez Gene ID: 1437; HGNC ID: 2434; HPRD ID: 00734; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P04141">GM-CSF</a></span> responses of the groups against the other <span class="tagged-filter" title="Association Word">antigens.</span> The present study indicated that, in comparison to the <span class="tagged-gene" title="SwissProt ID: P27352; Entrez Gene ID: 2694; HGNC ID: 4268; HPRD ID: 02024; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/P27352">INF,</a></span> the PI have distinct larva-specific and adult male-specific <span class="tagged-gene" title="SwissProt ID: Q06643; Entrez Gene ID: 4050; HGNC ID: 6711; HPRD ID: 02987; Linking to SwissProt"><a href="http://beta.uniprot.org/uniprot/Q06643">cytokine</a></span> responses, thus supporting the premise that immunological studies of the PI would <span class="tagged-filter" title="Association Word">lead</span> to the identification of immune mechanisms and the target <span class="tagged-filter" title="Association Word">genes</span> that play a <span class="tagged-filter" title="Association Word">role</span> in protective immunity.
